Site,PatientID,Sex,IBD_Type,med_class_base,med_class_v1,med_class_v2,med_class_v3,med_class_v4,NC_Value,NC_Seroconversion,RBD_Value,RBD_Seroconversion,Age_Group,DX_sero_days,Vaccine_Status,Serology_Date,Group,pv1,v1type,pv2,v2type,pv3,v3type,pv4,v4type,pv5,v5type,agecollection,decade,crohn,baseantitnf,basevedo,baseuste,basejak,basesteroid,baseasa,baseimmuno,v1antitnf,v1vedo,v1uste,v1jak,v1steroidyn,v1asayn,v1immyn,v2antitnf,v2vedo,v2uste,v2jak,v2steroidyn,v2asayn,v2immyn,v3antitnf,v3vedo,v3uste,v3jak,v3steroidyn,v3asayn,v3immyn,v4antitnf,v4vedo,v4uste,v4jak,v4steroidyn,v4asayn,v4immyn,BAU,TestNumber,TestMonth,TestYear,Days_since_pv1,Days_since_pv2,Days_since_pv3,Days_since_pv4,TestStatus,rbdrange,coviddays2,dbv1v2,sched12,dbv2v3,sched23,dbv3v4,db1c,db2c,db3c,db4c,db5c
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.64,Negative,96,Positive,Adult,-164,Post-1st,01-Jun-21,baseline,09-Apr-21,Moderna,18-Jun-21,Moderna,14-Oct-21,Moderna,24-Jun-22,Moderna,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,14,1,June,2021,53,,,,Completed,50-249,N/A,70,Delayed,118,Scheduled,253,53,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.7,Positive,5465,Positive,Adult,0,Post-3rd (1-8 Weeks),12-Nov-21,baseline,09-Apr-21,Moderna,18-Jun-21,Moderna,14-Oct-21,Moderna,24-Jun-22,Moderna,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,776,2,November,2021,,,29,,Completed,,N/A,70,Delayed,118,Scheduled,253,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.52,Negative,433,Positive,Adult,105,Post-3rd (8+ Weeks),25-Feb-22,baseline,09-Apr-21,Moderna,18-Jun-21,Moderna,14-Oct-21,Moderna,24-Jun-22,Moderna,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,3,February,2022,,,134,,Completed,250-999,N/A,70,Delayed,118,Scheduled,253,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,64,Positive,Adult,,Post-1st,13-May-21,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,9,1,May,2021,45,,,,Completed,50-249,N/A,64,Delayed,114,Scheduled,209,45,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,3374,Positive,Adult,,Post-2nd (1-8 Weeks),24-Jun-21,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,479,2,June,2021,,23,,,Completed,1000-4999,N/A,64,Delayed,114,Scheduled,209,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,2332,Positive,Adult,,Post-3rd (1-8 Weeks),27-Oct-21,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,331,3,October,2021,,,34,,Completed,1000-4999,N/A,64,Delayed,114,Scheduled,209,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,521,Positive,Adult,,Post-3rd (8+ Weeks),15-Jan-22,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,74,4,January,2022,,,114,,Completed,250-999,N/A,64,Delayed,114,Scheduled,209,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,2230,Positive,Adult,,Post-4th,19-May-22,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,317,5,May,2022,,,,29,Completed,1000-4999,N/A,64,Delayed,114,Scheduled,209,,,,29,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2021,Positive,Adult,-299,Post-1st,30-Apr-21,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,287,1,April,2021,25,,,,Completed,1000-4999,N/A,47,Scheduled,132,Delayed,,25,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,16932,Positive,Adult,-233,Post-2nd (1-8 Weeks),05-Jul-21,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2404,2,July,2021,,44,,,Completed,10000+,N/A,47,Scheduled,132,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.66,Negative,5131,Positive,Adult,-146,Post-2nd (8+ Weeks),30-Sep-21,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,729,3,September,2021,,131,,,Completed,,N/A,47,Scheduled,132,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.37,Negative,80000,Positive,Adult,-120,Post-3rd (1-8 Weeks),26-Oct-21,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11360,4,October,2021,,,25,,Completed,10000+,N/A,47,Scheduled,132,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.21,Negative,15190,Positive,Adult,-27,Post-3rd (8+ Weeks),27-Jan-22,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,40,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2157,5,January,2022,,,118,,Completed,10000+,N/A,47,Scheduled,132,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.04,Negative,713,Positive,Elderly,-341,Post-2nd (1-8 Weeks),20-May-21,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,84,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101,1,May,2021,,29,,,Completed,250-999,N/A,39,Scheduled,180,Delayed,177,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.04,Negative,162,Positive,Elderly,-194,Post-2nd (8+ Weeks),14-Oct-21,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,84,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,2,October,2021,,176,,,Completed,50-249,N/A,39,Scheduled,180,Delayed,177,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,1873,Positive,Elderly,-138,Post-3rd (1-8 Weeks),09-Dec-21,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,85,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,266,3,December,2021,,,52,,Completed,1000-4999,N/A,39,Scheduled,180,Delayed,177,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.06,Negative,780,Positive,Elderly,-61,Post-3rd (8+ Weeks),24-Feb-22,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,85,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111,4,February,2022,,,129,,Completed,250-999,N/A,39,Scheduled,180,Delayed,177,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,5.44,Positive,80000,Positive,Elderly,30,Post-4th,26-May-22,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,85,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,5,May,2022,,,,43,Completed,10000+,N/A,39,Scheduled,180,Delayed,177,,,,43,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.18,Negative,1689,Positive,Adult,-390,Post-1st,19-May-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,57,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,240,1,May,2021,40,,,,Completed,1000-4999,N/A,63,Delayed,185,Delayed,,40,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.07,Negative,14975,Positive,Adult,-320,Post-2nd (1-8 Weeks),28-Jul-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,57,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2126,2,July,2021,,47,,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,3751,Positive,Adult,-216,Post-2nd (8+ Weeks),09-Nov-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,58,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,533,3,November,2021,,151,,,Completed,1000-4999,N/A,63,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.11,Negative,56221,Positive,Adult,-140,Post-3rd (1-8 Weeks),24-Jan-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,58,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7983,4,January,2022,,,42,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.14,Negative,26446,Positive,Adult,-68,Post-3rd (8+ Weeks),06-Apr-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,58,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3755,5,April,2022,,,114,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,963,Positive,Elderly,205,Post-1st,30-Apr-21,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,65,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,137,1,April,2021,31,,,,Completed,250-999,N/A,71,Delayed,184,Delayed,,31,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,2403,Positive,Elderly,268,Post-2nd (1-8 Weeks),02-Jul-21,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,65,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,341,2,July,2021,,23,,,Completed,1000-4999,N/A,71,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,12605,Positive,Elderly,457,Post-3rd (1-8 Weeks),07-Jan-22,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,65,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1790,3,January,2022,,,28,,Completed,10000+,N/A,71,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,4.27,Positive,40000,Positive,Elderly,586,Post-3rd (8+ Weeks),16-May-22,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,66,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5680,4,May,2022,,,157,,Completed,10000+,N/A,71,Delayed,184,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.05,Negative,431,Positive,Adult,,Post-1st,28-May-21,baseline,05-Apr-21,Pfizer,30-May-21,Pfizer,,,,,,,19,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,1,May,2021,53,,,,Completed,250-999,N/A,55,Scheduled,,Delayed,,53,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,83,Positive,Adult,,Post-1st,06-May-21,baseline,02-Apr-21,Pfizer,13-May-21,Pfizer,06-Oct-21,Pfizer,26-Jul-22,Moderna,,,51,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,12,1,May,2021,34,,,,Completed,50-249,N/A,41,Scheduled,146,Delayed,293,34,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,1723,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,02-Apr-21,Pfizer,13-May-21,Pfizer,06-Oct-21,Pfizer,26-Jul-22,Moderna,,,51,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,245,2,July,2021,,53,,,Completed,1000-4999,N/A,41,Scheduled,146,Delayed,293,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,274,Positive,Adult,,Post-2nd (8+ Weeks),01-Oct-21,baseline,02-Apr-21,Pfizer,13-May-21,Pfizer,06-Oct-21,Pfizer,26-Jul-22,Moderna,,,52,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,39,3,October,2021,,141,,,Completed,250-999,N/A,41,Scheduled,146,Delayed,293,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,5799,Positive,Adult,,Post-3rd (1-8 Weeks),05-Nov-21,baseline,02-Apr-21,Pfizer,13-May-21,Pfizer,06-Oct-21,Pfizer,26-Jul-22,Moderna,,,52,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,824,4,November,2021,,,30,,Completed,,N/A,41,Scheduled,146,Delayed,293,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,105,Positive,Adult,,Post-1st,26-May-21,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,15,1,May,2021,50,,,,Completed,50-249,N/A,78,Delayed,153,Delayed,,50,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,422,Positive,Adult,,Post-2nd (1-8 Weeks),11-Aug-21,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,60,2,August,2021,,49,,,Completed,250-999,N/A,78,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,307,Positive,Adult,,Post-2nd (8+ Weeks),03-Nov-21,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,44,3,November,2021,,133,,,Completed,250-999,N/A,78,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,5055,Positive,Adult,,Post-3rd (1-8 Weeks),15-Dec-21,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,718,4,December,2021,,,22,,Completed,,N/A,78,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,784,Positive,Adult,,Post-3rd (8+ Weeks),13-Apr-22,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,45,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,111,5,April,2022,,,141,,Completed,250-999,N/A,78,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.51,Negative,1163,Positive,Adult,,Post-2nd (8+ Weeks),24-Apr-21,baseline,14-Jan-21,Pfizer,22-Feb-21,Pfizer,08-Oct-21,Moderna,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,165,1,April,2021,,61,,,Completed,1000-4999,N/A,39,Scheduled,228,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,347,Positive,Adult,-240,Post-1st,10-May-21,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,1,May,2021,54,,,,Completed,250-999,N/A,80,Delayed,97,Scheduled,,54,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,2448,Positive,Adult,-187,Post-2nd (1-8 Weeks),02-Jul-21,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,348,2,July,2021,,27,,,Completed,1000-4999,N/A,80,Delayed,97,Scheduled,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,16850,Positive,Adult,-96,Post-3rd (1-8 Weeks),01-Oct-21,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2393,3,October,2021,,,21,,Completed,10000+,N/A,80,Delayed,97,Scheduled,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,3.17,Positive,21633,Positive,Adult,9,Post-3rd (8+ Weeks),14-Jan-22,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3072,4,January,2022,,,126,,Completed,10000+,N/A,80,Delayed,97,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,336,Positive,Adult,-90,Post-2nd (1-8 Weeks),31-May-21,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,48,1,May,2021,,34,,,Completed,250-999,N/A,26,Scheduled,148,Delayed,205,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,39,Negative,Adult,-5,Post-2nd (8+ Weeks),24-Aug-21,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,5,2,August,2021,,119,,,Completed,0-49,N/A,26,Scheduled,148,Delayed,205,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.48,Negative,39669,Positive,Adult,38,Post-3rd (1-8 Weeks),06-Oct-21,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,5633,3,October,2021,,,14,,Completed,10000+,N/A,26,Scheduled,148,Delayed,205,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.6,Negative,8744,Positive,Adult,169,Post-3rd (8+ Weeks),14-Feb-22,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1242,4,February,2022,,,145,,Completed,,N/A,26,Scheduled,148,Delayed,205,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,2.74,Positive,18507,Positive,Adult,291,Post-4th,16-Jun-22,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2628,5,June,2022,,,,62,Completed,10000+,N/A,26,Scheduled,148,Delayed,205,,,,62,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,1004,Positive,Adult,,Post-1st,05-May-21,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,143,1,May,2021,30,,,,Completed,1000-4999,N/A,59,Delayed,203,Delayed,218,30,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,11254,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jun-21,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1598,2,June,2021,,11,,,Completed,10000+,N/A,59,Delayed,203,Delayed,218,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.06,Negative,2568,Positive,Adult,,Post-2nd (8+ Weeks),18-Oct-21,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,365,3,October,2021,,137,,,Completed,1000-4999,N/A,59,Delayed,203,Delayed,218,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.06,Negative,8725,Positive,Adult,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1239,4,February,2022,,,42,,Completed,,N/A,59,Delayed,203,Delayed,218,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.12,Negative,6692,Positive,Adult,,Post-3rd (8+ Weeks),26-Apr-22,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,39,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,950,5,April,2022,,,124,,Completed,,N/A,59,Delayed,203,Delayed,218,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.06,Negative,57,Positive,Elderly,,Post-1st,29-Apr-21,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,8,1,April,2021,48,,,,Completed,50-249,N/A,83,Delayed,161,Delayed,153,48,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,,,,Elderly,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,,2,July,2021,,46,,,Processed,,N/A,83,Delayed,161,Delayed,153,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.69,Negative,4141,Positive,Elderly,,Post-3rd (1-8 Weeks),23-Nov-21,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,73,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,588,3,November,2021,,,12,,Completed,1000-4999,N/A,83,Delayed,161,Delayed,153,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.08,Negative,251,Positive,Elderly,,Post-3rd (8+ Weeks),01-Apr-22,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,73,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,36,4,April,2022,,,141,,Completed,250-999,N/A,83,Delayed,161,Delayed,153,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,2.67,Positive,24113,Positive,Elderly,,Post-4th,16-May-22,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,73,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,3424,5,May,2022,,,,33,Completed,10000+,N/A,83,Delayed,161,Delayed,153,,,,33,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.01,Negative,2803,Positive,Adult,,Post-1st,11-May-21,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,61,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,398,1,May,2021,19,,,,Completed,1000-4999,N/A,28,Scheduled,204,Delayed,186,19,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.03,Negative,51805,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jun-21,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,61,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,7356,2,June,2021,,20,,,Completed,10000+,N/A,28,Scheduled,204,Delayed,186,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.01,Negative,3123,Positive,Adult,,Post-2nd (8+ Weeks),22-Sep-21,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,62,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,443,3,September,2021,,125,,,Completed,1000-4999,N/A,28,Scheduled,204,Delayed,186,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.03,Negative,21242,Positive,Adult,,Post-3rd (1-8 Weeks),02-Feb-22,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,62,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,3016,4,February,2022,,,54,,Completed,10000+,N/A,28,Scheduled,204,Delayed,186,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.04,Negative,12092,Positive,Adult,,Post-3rd (8+ Weeks),19-Apr-22,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,62,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1717,5,April,2022,,,130,,Completed,10000+,N/A,28,Scheduled,204,Delayed,186,,,,,
University of Calgary,,Female,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.03,Negative,330,Positive,Adult,,Post-1st,21-May-21,baseline,17-Apr-21,Pfizer,05-Jun-21,Pfizer,,,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,1,May,2021,34,,,,Completed,250-999,N/A,49,Scheduled,,Delayed,,34,,,,
University of Calgary,,Female,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.04,Negative,5380,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,17-Apr-21,Pfizer,05-Jun-21,Pfizer,,,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,764,2,July,2021,,55,,,Completed,,N/A,49,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,458,Positive,Adult,-262,Post-1st,17-May-21,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,38,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,65,1,May,2021,31,,,,Completed,250-999,N/A,58,Delayed,198,Delayed,,31,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.07,Negative,17788,Positive,Adult,-218,Post-2nd (1-8 Weeks),30-Jun-21,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2526,2,June,2021,,17,,,Completed,10000+,N/A,58,Delayed,198,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,1224,Positive,Adult,-77,Post-2nd (8+ Weeks),18-Nov-21,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,174,3,November,2021,,158,,,Completed,1000-4999,N/A,58,Delayed,198,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,24677,Positive,Adult,-23,Post-3rd (1-8 Weeks),11-Jan-22,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3504,4,January,2022,,,14,,Completed,10000+,N/A,58,Delayed,198,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.61,Negative,27712,Positive,Adult,85,Post-3rd (8+ Weeks),29-Apr-22,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3935,5,April,2022,,,122,,Completed,10000+,N/A,58,Delayed,198,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,1553,Positive,Adult,-401,Post-1st,19-May-21,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,30,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,221,1,May,2021,28,,,,Completed,1000-4999,N/A,56,Scheduled,213,Delayed,,28,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,31026,Positive,Adult,-350,Post-2nd (1-8 Weeks),09-Jul-21,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,30,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,4406,2,July,2021,,23,,,Completed,10000+,N/A,56,Scheduled,213,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.16,Negative,9806,Positive,Adult,-210,Post-2nd (8+ Weeks),26-Nov-21,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,30,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1392,3,November,2021,,163,,,Completed,,N/A,56,Scheduled,213,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,16056,Positive,Adult,-39,Post-3rd (8+ Weeks),16-May-22,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,31,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2280,4,May,2022,,,121,,Completed,10000+,N/A,56,Scheduled,213,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.37,Negative,1582,Positive,Adult,,Post-1st,30-May-21,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,225,1,May,2021,43,,,,Completed,1000-4999,N/A,56,Scheduled,217,Delayed,,43,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.2,Negative,19787,Positive,Adult,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2810,2,July,2021,,26,,,Completed,10000+,N/A,56,Scheduled,217,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.9,Positive,650,Positive,Adult,,Post-2nd (8+ Weeks),03-Jan-22,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,92,3,January,2022,,205,,,Completed,250-999,N/A,56,Scheduled,217,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,4.31,Positive,54975,Positive,Adult,,Post-3rd (1-8 Weeks),04-Feb-22,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7806,4,February,2022,,,20,,Completed,10000+,N/A,56,Scheduled,217,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.92,Positive,21373,Positive,Adult,,Post-3rd (8+ Weeks),22-May-22,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3035,5,May,2022,,,127,,Completed,10000+,N/A,56,Scheduled,217,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,31,Negative,Adult,,Post-1st,06-May-21,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,4,1,May,2021,33,,,,Completed,0-49,N/A,83,Delayed,98,Scheduled,,33,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,,,,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,2,July,2021,,26,,,Processed,,N/A,83,Delayed,98,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.09,Negative,19640,Positive,Adult,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2789,3,October,2021,,,13,,Completed,10000+,N/A,83,Delayed,98,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.14,Negative,1565,Positive,Adult,,Post-3rd (8+ Weeks),23-Feb-22,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,222,4,February,2022,,,145,,Completed,1000-4999,N/A,83,Delayed,98,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.1,Negative,63,Positive,Adult,,Post-1st,11-May-21,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,9,1,May,2021,28,,,,Completed,50-249,N/A,44,Scheduled,203,Delayed,,28,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,1447,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,206,2,July,2021,,43,,,Completed,1000-4999,N/A,44,Scheduled,203,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.17,Negative,293,Positive,Adult,,Post-2nd (8+ Weeks),03-Oct-21,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,42,3,October,2021,,129,,,Completed,250-999,N/A,44,Scheduled,203,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.11,Negative,16718,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2374,4,January,2022,,,21,,Completed,10000+,N/A,44,Scheduled,203,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.62,Negative,74193,Positive,Adult,,Post-3rd (8+ Weeks),27-Apr-22,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,10535,5,April,2022,,,132,,Completed,10000+,N/A,44,Scheduled,203,Delayed,,,,,,
University of Calgary,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.04,Negative,6,Negative,Elderly,,Post-1st,31-May-21,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,72,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,1,May,2021,55,,,,Completed,0-49,N/A,83,Delayed,127,Delayed,153,55,,,,
University of Calgary,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.05,Negative,16,Negative,Elderly,,Post-2nd (8+ Weeks),25-Aug-21,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,72,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,2,2,August,2021,,58,,,Completed,0-49,N/A,83,Delayed,127,Delayed,153,,,,,
University of Calgary,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.03,Negative,183,Positive,Elderly,,Post-3rd (1-8 Weeks),02-Dec-21,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,73,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,26,3,December,2021,,,30,,Completed,50-249,N/A,83,Delayed,127,Delayed,153,,,,,
University of Calgary,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.05,Negative,10,Negative,Elderly,,Post-3rd (8+ Weeks),02-Mar-22,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,73,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,4,March,2022,,,120,,Completed,0-49,N/A,83,Delayed,127,Delayed,153,,,,,
University of Calgary,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.02,Negative,36,Negative,Elderly,,Post-4th,06-Jun-22,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,73,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,5,5,June,2022,,,,63,Completed,0-49,N/A,83,Delayed,127,Delayed,153,,,,63,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,28,Negative,Elderly,-112,Post-1st,27-Apr-21,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4,1,April,2021,40,,,,Completed,0-49,N/A,73,Delayed,201,Delayed,208,40,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,592,Positive,Elderly,-26,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,84,2,July,2021,,53,,,Completed,250-999,N/A,73,Delayed,201,Delayed,208,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,200,Positive,Elderly,48,Post-2nd (8+ Weeks),04-Oct-21,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,28,3,October,2021,,127,,,Completed,50-249,N/A,73,Delayed,201,Delayed,208,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,5240,Positive,Elderly,162,Post-3rd (1-8 Weeks),26-Jan-22,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,70,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,744,4,January,2022,,,40,,Completed,,N/A,73,Delayed,201,Delayed,208,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,757,Positive,Elderly,245,Post-3rd (8+ Weeks),19-Apr-22,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,70,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,107,5,April,2022,,,123,,Completed,250-999,N/A,73,Delayed,201,Delayed,208,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,394,Positive,Adult,-275,Post-1st,10-May-21,baseline,03-Apr-21,Pfizer,07-May-21,Pfizer,03-Sep-21,Pfizer,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,56,1,May,2021,37,,,,Completed,250-999,N/A,34,Scheduled,119,Scheduled,,37,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.07,Negative,9370,Positive,Elderly,,Post-2nd (1-8 Weeks),17-May-21,baseline,07-Apr-21,Pfizer,30-Apr-21,Pfizer,21-Oct-21,Pfizer,07-Apr-22,Pfizer,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1331,1,May,2021,,17,,,Completed,,N/A,23,Scheduled,174,Delayed,168,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.07,Negative,1885,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,07-Apr-21,Pfizer,30-Apr-21,Pfizer,21-Oct-21,Pfizer,07-Apr-22,Pfizer,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,268,2,September,2021,,132,,,Completed,1000-4999,N/A,23,Scheduled,174,Delayed,168,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.08,Negative,3808,Positive,Elderly,,Post-3rd (8+ Weeks),08-Mar-22,baseline,07-Apr-21,Pfizer,30-Apr-21,Pfizer,21-Oct-21,Pfizer,07-Apr-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,541,3,March,2022,,,138,,Completed,1000-4999,N/A,23,Scheduled,174,Delayed,168,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.11,Negative,28166,Positive,Elderly,,Post-4th,05-May-22,baseline,07-Apr-21,Pfizer,30-Apr-21,Pfizer,21-Oct-21,Pfizer,07-Apr-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,4000,4,May,2022,,,,28,Completed,10000+,N/A,23,Scheduled,174,Delayed,168,,,,28,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.01,Negative,613,Positive,Elderly,,Post-1st,18-May-21,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,70,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,87,1,May,2021,53,,,,Completed,250-999,N/A,80,Delayed,183,Delayed,155,53,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,3709,Positive,Elderly,,Post-2nd (1-8 Weeks),02-Jul-21,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,70,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,527,2,July,2021,,18,,,Completed,1000-4999,N/A,80,Delayed,183,Delayed,155,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,1342,Positive,Elderly,,Post-2nd (8+ Weeks),17-Nov-21,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,70,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,191,3,November,2021,,156,,,Completed,1000-4999,N/A,80,Delayed,183,Delayed,155,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.04,Negative,14311,Positive,Elderly,,Post-3rd (1-8 Weeks),18-Jan-22,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,71,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2032,4,January,2022,,,35,,Completed,10000+,N/A,80,Delayed,183,Delayed,155,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.07,Negative,5220,Positive,Elderly,,Post-3rd (8+ Weeks),04-May-22,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,71,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,741,5,May,2022,,,141,,Completed,,N/A,80,Delayed,183,Delayed,155,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,19571,Positive,Elderly,,Post-4th,22-Jun-22,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,71,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2779,6,June,2022,,,,35,Completed,10000+,N/A,80,Delayed,183,Delayed,155,,,,35,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,Adult,-265,Post-1st,12-May-21,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,1,May,2021,34,,,,Processed,,N/A,64,Delayed,98,Scheduled,241,34,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,5757,Positive,Adult,-209,Post-2nd (1-8 Weeks),07-Jul-21,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,818,2,July,2021,,26,,,Completed,,N/A,64,Delayed,98,Scheduled,241,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,21080,Positive,Adult,-125,Post-3rd (1-8 Weeks),29-Sep-21,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2993,3,September,2021,,,12,,Completed,10000+,N/A,64,Delayed,98,Scheduled,241,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,953,Positive,Adult,-13,Post-3rd (8+ Weeks),19-Jan-22,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,135,4,January,2022,,,124,,Completed,250-999,N/A,64,Delayed,98,Scheduled,241,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.08,Negative,18891,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,26,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2683,1,July,2021,,25,,,Completed,10000+,N/A,47,Scheduled,104,Scheduled,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.07,Negative,16622,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,26,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2360,2,October,2021,,,36,,Completed,10000+,N/A,47,Scheduled,104,Scheduled,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.07,Negative,1228,Positive,Adult,,Post-3rd (8+ Weeks),18-Feb-22,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,174,3,February,2022,,,149,,Completed,1000-4999,N/A,47,Scheduled,104,Scheduled,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.1,Negative,4900,Positive,Adult,,Post-4th,14-Apr-22,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,696,4,April,2022,,,,50,Completed,1000-4999,N/A,47,Scheduled,104,Scheduled,154,,,,50,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.06,Negative,252,Positive,Adult,,Post-1st,21-May-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,1,May,2021,39,,,,Completed,250-999,N/A,99,Delayed,,Delayed,,39,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,158,Positive,Adult,,Post-1st,14-Jul-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,2,July,2021,93,,,,Completed,50-249,N/A,99,Delayed,,Delayed,,93,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,,,61,Positive,Adult,,Post-1st,14-Jul-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,3,July,2021,93,,,,Completed,50-249,N/A,99,Delayed,,Delayed,,93,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,6512,Positive,Adult,,Post-2nd (1-8 Weeks),13-Aug-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,925,4,August,2021,,24,,,Completed,,N/A,99,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1044,Positive,Adult,,Post-1st,07-May-21,baseline,11-Apr-21,Pfizer,24-May-21,Pfizer,09-Oct-21,Pfizer,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,148,1,May,2021,26,,,,Completed,1000-4999,N/A,43,Scheduled,138,Delayed,,26,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.47,Negative,3761,Positive,Adult,,Post-2nd (8+ Weeks),27-Aug-21,baseline,11-Apr-21,Pfizer,24-May-21,Pfizer,09-Oct-21,Pfizer,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,534,2,August,2021,,95,,,Completed,1000-4999,N/A,43,Scheduled,138,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.38,Negative,19063,Positive,Adult,,Post-3rd (1-8 Weeks),22-Oct-21,baseline,11-Apr-21,Pfizer,24-May-21,Pfizer,09-Oct-21,Pfizer,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2707,3,October,2021,,,13,,Completed,10000+,N/A,43,Scheduled,138,Delayed,,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Vedolizumab Only,0.02,Negative,18,Negative,Adult,,Post-1st,04-May-21,baseline,10-Apr-21,Pfizer,26-Jun-21,Pfizer,23-Sep-21,Pfizer,14-Apr-22,Pfizer,,,54,50-59,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,3,1,May,2021,24,,,,Completed,0-49,N/A,77,Delayed,89,Scheduled,203,24,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Vedolizumab Only,0.03,Negative,20140,Positive,Adult,,Post-2nd (1-8 Weeks),09-Aug-21,baseline,10-Apr-21,Pfizer,26-Jun-21,Pfizer,23-Sep-21,Pfizer,14-Apr-22,Pfizer,,,54,50-59,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,2860,2,August,2021,,44,,,Completed,10000+,N/A,77,Delayed,89,Scheduled,203,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Vedolizumab Only,0.01,Negative,8460,Positive,Adult,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,10-Apr-21,Pfizer,26-Jun-21,Pfizer,23-Sep-21,Pfizer,14-Apr-22,Pfizer,,,54,50-59,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,1201,3,October,2021,,,21,,Completed,,N/A,77,Delayed,89,Scheduled,203,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Vedolizumab Only,0.04,Negative,1171,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,10-Apr-21,Pfizer,26-Jun-21,Pfizer,23-Sep-21,Pfizer,14-Apr-22,Pfizer,,,55,50-59,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,166,4,February,2022,,,145,,Completed,1000-4999,N/A,77,Delayed,89,Scheduled,203,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.18,Negative,1579,Positive,Adult,,Post-1st,25-May-21,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,52,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,224,1,May,2021,32,,,,Completed,1000-4999,N/A,63,Delayed,193,Delayed,133,32,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.04,Negative,29201,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,52,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4147,2,July,2021,,21,,,Completed,10000+,N/A,63,Delayed,193,Delayed,133,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.22,Negative,72714,Positive,Adult,,Post-3rd (1-8 Weeks),28-Jan-22,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,52,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10325,3,January,2022,,,24,,Completed,10000+,N/A,63,Delayed,193,Delayed,133,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.23,Negative,79882,Positive,Adult,,Post-4th,13-Jun-22,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11343,4,June,2022,,,,27,Completed,10000+,N/A,63,Delayed,193,Delayed,133,,,,27,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,445,Positive,Adult,,Post-1st,06-May-21,baseline,11-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,17-Dec-21,Pfizer,,,,,64,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,1,May,2021,56,,,,Completed,250-999,N/A,97,Delayed,184,Delayed,,56,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,4130,Positive,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,11-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,17-Dec-21,Pfizer,,,,,64,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,586,2,July,2021,,40,,,Completed,1000-4999,N/A,97,Delayed,184,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,463,Positive,Elderly,,Post-2nd (8+ Weeks),10-Nov-21,baseline,11-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,17-Dec-21,Pfizer,,,,,64,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,66,3,November,2021,,147,,,Completed,250-999,N/A,97,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.35,Negative,404,Positive,Adult,-390,Post-1st,24-Apr-21,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,57,1,April,2021,25,,,,Completed,250-999,N/A,51,Scheduled,113,Scheduled,,25,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.26,Negative,4866,Positive,Adult,-300,Post-2nd (8+ Weeks),23-Jul-21,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,691,2,July,2021,,64,,,Completed,1000-4999,N/A,51,Scheduled,113,Scheduled,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.43,Negative,19643,Positive,Adult,-185,Post-3rd (8+ Weeks),15-Nov-21,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2789,3,November,2021,,,66,,Completed,10000+,N/A,51,Scheduled,113,Scheduled,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.15,Negative,2668,Positive,Adult,-73,Post-3rd (8+ Weeks),07-Mar-22,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,379,4,March,2022,,,178,,Completed,1000-4999,N/A,51,Scheduled,113,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,74,Positive,Elderly,,Post-1st,29-Apr-21,baseline,14-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Dec-21,Pfizer,,,,,74,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,1,April,2021,46,,,,Completed,50-249,N/A,88,Delayed,197,Delayed,,46,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.12,Negative,4997,Positive,Elderly,,Post-2nd (8+ Weeks),12-Nov-21,baseline,14-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Dec-21,Pfizer,,,,,74,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,710,2,November,2021,,155,,,Completed,1000-4999,N/A,88,Delayed,197,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.23,Negative,62495,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,14-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Dec-21,Pfizer,,,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8874,3,February,2022,,,41,,Completed,10000+,N/A,88,Delayed,197,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,1296,Positive,Adult,-237,Post-1st,07-May-21,Post Vaccine covid,09-Apr-21,Pfizer,02-Jun-21,Pfizer,13-Oct-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,184,1,May,2021,28,,,,Completed,1000-4999,N/A,54,Scheduled,133,Delayed,,28,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,2520,Positive,Adult,-162,Post-2nd (1-8 Weeks),21-Jul-21,Post Vaccine covid,09-Apr-21,Pfizer,02-Jun-21,Pfizer,13-Oct-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,358,2,July,2021,,49,,,Completed,1000-4999,N/A,54,Scheduled,133,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,6967,Positive,Adult,-50,Post-3rd (1-8 Weeks),10-Nov-21,Post Vaccine covid,09-Apr-21,Pfizer,02-Jun-21,Pfizer,13-Oct-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,989,3,November,2021,,,28,,Completed,,N/A,54,Scheduled,133,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.79,Positive,11065,Positive,Adult,56,Post-3rd (8+ Weeks),24-Feb-22,Post Vaccine covid,09-Apr-21,Pfizer,02-Jun-21,Pfizer,13-Oct-21,Pfizer,,,,,38,30-39,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1571,4,February,2022,,,134,,Completed,10000+,N/A,54,Scheduled,133,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,13,Negative,Elderly,,Post-1st,08-Jun-21,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,73,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2,1,June,2021,62,,,,Completed,0-49,N/A,82,Delayed,205,Delayed,,62,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,,,,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,73,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,2,July,2021,,28,,,Processed,,N/A,82,Delayed,205,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,82,Positive,Elderly,,Post-2nd (8+ Weeks),08-Dec-21,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,73,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,12,3,December,2021,,163,,,Completed,50-249,N/A,82,Delayed,205,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,3205,Positive,Elderly,,Post-3rd (8+ Weeks),07-Jun-22,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,74,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,455,4,June,2022,,,139,,Completed,1000-4999,N/A,82,Delayed,205,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,17,Negative,Adult,-225,Post-1st,16-Jun-21,Post Vaccine covid,03-Apr-21,Pfizer,18-Jun-21,Pfizer,,,,,,,56,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,June,2021,74,,,,Completed,0-49,N/A,76,Delayed,,Delayed,,74,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,2172,Positive,Adult,-169,Post-2nd (1-8 Weeks),11-Aug-21,Post Vaccine covid,03-Apr-21,Pfizer,18-Jun-21,Pfizer,,,,,,,56,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,308,2,August,2021,,54,,,Completed,1000-4999,N/A,76,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,495,Positive,Adult,-8,Post-2nd (8+ Weeks),19-Jan-22,Post Vaccine covid,03-Apr-21,Pfizer,18-Jun-21,Pfizer,,,,,,,57,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70,3,January,2022,,215,,,Completed,250-999,N/A,76,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,282,Positive,Adult,-345,Post-1st,29-Apr-21,baseline,05-Apr-21,Pfizer,26-May-21,Pfizer,23-Sep-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,40,1,April,2021,24,,,,Completed,250-999,N/A,51,Scheduled,120,Scheduled,,24,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.11,Negative,7424,Positive,Adult,-302,Post-2nd (1-8 Weeks),11-Jun-21,baseline,05-Apr-21,Pfizer,26-May-21,Pfizer,23-Sep-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1054,2,June,2021,,16,,,Completed,,N/A,51,Scheduled,120,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.17,Negative,12395,Positive,Adult,-187,Post-3rd (1-8 Weeks),04-Oct-21,baseline,05-Apr-21,Pfizer,26-May-21,Pfizer,23-Sep-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1760,3,October,2021,,,11,,Completed,10000+,N/A,51,Scheduled,120,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.24,Negative,1380,Positive,Adult,-36,Post-3rd (8+ Weeks),04-Mar-22,baseline,05-Apr-21,Pfizer,26-May-21,Pfizer,23-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,196,4,March,2022,,,162,,Completed,1000-4999,N/A,51,Scheduled,120,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,126,Positive,Adult,,Post-1st,11-May-21,baseline,26-Apr-21,Pfizer,23-Jun-21,Pfizer,09-Jan-22,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,1,May,2021,15,,,,Completed,50-249,N/A,58,Delayed,200,Delayed,,15,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,4263,Positive,Adult,,Post-3rd (8+ Weeks),02-May-22,baseline,26-Apr-21,Pfizer,23-Jun-21,Pfizer,09-Jan-22,Pfizer,,,,,49,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,605,2,May,2022,,,113,,Completed,1000-4999,N/A,58,Delayed,200,Delayed,,,,,,
University of Calgary,,Male,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,,,,Adult,,Post-1st,28-Apr-21,baseline,17-Mar-21,AstraZeneca,02-Jun-21,Moderna,25-Oct-21,Moderna,,,,,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,1,April,2021,42,,,,Processed,,N/A,77,Delayed,145,Delayed,,42,,,,
University of Calgary,,Male,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,4554,Positive,Adult,,Post-2nd (8+ Weeks),10-Aug-21,baseline,17-Mar-21,AstraZeneca,02-Jun-21,Moderna,25-Oct-21,Moderna,,,,,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,647,2,August,2021,,69,,,Completed,1000-4999,N/A,77,Delayed,145,Delayed,,,,,,
University of Calgary,,Male,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,3.89,Positive,80000,Positive,Adult,,Post-3rd (8+ Weeks),18-Feb-22,baseline,17-Mar-21,AstraZeneca,02-Jun-21,Moderna,25-Oct-21,Moderna,,,,,64,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,3,February,2022,,,116,,Completed,10000+,N/A,77,Delayed,145,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3185,Positive,Elderly,,Post-2nd (1-8 Weeks),10-May-21,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,452,1,May,2021,,28,,,Completed,1000-4999,N/A,41,Scheduled,227,Delayed,145,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,1081,Positive,Elderly,,Post-2nd (8+ Weeks),01-Sep-21,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,154,2,September,2021,,142,,,Completed,1000-4999,N/A,41,Scheduled,227,Delayed,145,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.36,Negative,4266,Positive,Elderly,,Post-3rd (1-8 Weeks),18-Jan-22,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,606,3,January,2022,,,54,,Completed,1000-4999,N/A,41,Scheduled,227,Delayed,145,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,581,Positive,Elderly,,Post-3rd (8+ Weeks),16-Mar-22,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,83,4,March,2022,,,111,,Completed,250-999,N/A,41,Scheduled,227,Delayed,145,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.52,Negative,23929,Positive,Elderly,,Post-4th,03-May-22,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3398,5,May,2022,,,,14,Completed,10000+,N/A,41,Scheduled,227,Delayed,145,,,,14,
University of Calgary,,Male,UC,Corticosteroids,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,,6.63,Positive,4771,Positive,Elderly,23,Post-1st,10-May-21,Post Vaccine covid,25-Mar-21,Pfizer,05-May-21,Pfizer,02-Dec-21,Pfizer,,,,,66,60-69,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,678,1,May,2021,46,,,,Completed,1000-4999,N/A,41,Scheduled,211,Delayed,,46,,,,
University of Calgary,,Male,UC,Corticosteroids,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,,1.26,Positive,3676,Positive,Elderly,108,Post-2nd (8+ Weeks),03-Aug-21,Post Vaccine covid,25-Mar-21,Pfizer,05-May-21,Pfizer,02-Dec-21,Pfizer,,,,,67,60-69,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,522,2,August,2021,,90,,,Completed,1000-4999,N/A,41,Scheduled,211,Delayed,,,,,,
University of Calgary,,Male,UC,Corticosteroids,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,,1.57,Positive,52521,Positive,Elderly,243,Post-3rd (1-8 Weeks),16-Dec-21,Post Vaccine covid,25-Mar-21,Pfizer,05-May-21,Pfizer,02-Dec-21,Pfizer,,,,,67,60-69,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7458,3,December,2021,,,14,,Completed,10000+,N/A,41,Scheduled,211,Delayed,,,,,,
University of Calgary,,Male,UC,Corticosteroids,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,,1.55,Positive,10603,Positive,Elderly,355,Post-3rd (8+ Weeks),07-Apr-22,Post Vaccine covid,25-Mar-21,Pfizer,05-May-21,Pfizer,02-Dec-21,Pfizer,,,,,67,60-69,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1506,4,April,2022,,,126,,Completed,10000+,N/A,41,Scheduled,211,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,516,Positive,Elderly,-232,Post-1st,06-May-21,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,73,1,May,2021,22,,,,Completed,250-999,N/A,56,Scheduled,107,Scheduled,,22,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,482,Positive,Elderly,-137,Post-2nd (8+ Weeks),09-Aug-21,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,68,2,August,2021,,61,,,Completed,250-999,N/A,56,Scheduled,107,Scheduled,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,942,Positive,Elderly,-64,Post-3rd (1-8 Weeks),21-Oct-21,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,134,3,October,2021,,,27,,Completed,250-999,N/A,56,Scheduled,107,Scheduled,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.41,Positive,38242,Positive,Elderly,25,Post-3rd (8+ Weeks),18-Jan-22,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5430,4,January,2022,,,116,,Completed,10000+,N/A,56,Scheduled,107,Scheduled,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.62,Negative,11021,Positive,Elderly,117,Post-3rd (8+ Weeks),20-Apr-22,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,73,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1565,5,April,2022,,,208,,Completed,10000+,N/A,56,Scheduled,107,Scheduled,,,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,114,Positive,Adult,,Post-1st,29-Apr-21,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,53,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,16,1,April,2021,26,,,,Completed,50-249,N/A,61,Delayed,119,Scheduled,182,26,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,316,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jun-21,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,45,2,June,2021,,19,,,Completed,250-999,N/A,61,Delayed,119,Scheduled,182,,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,805,Positive,Adult,,Post-3rd (1-8 Weeks),29-Oct-21,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,114,3,October,2021,,,29,,Completed,250-999,N/A,61,Delayed,119,Scheduled,182,,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,575,Positive,Adult,,Post-3rd (8+ Weeks),28-Jan-22,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,82,4,January,2022,,,120,,Completed,250-999,N/A,61,Delayed,119,Scheduled,182,,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,3641,Positive,Adult,,Post-4th,28-Apr-22,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,517,5,April,2022,,,,28,Completed,1000-4999,N/A,61,Delayed,119,Scheduled,182,,,,28,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,7418,Positive,Adult,,Post-2nd (1-8 Weeks),07-Jul-21,baseline,19-Apr-21,Pfizer,16-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1053,1,July,2021,,21,,,Completed,,N/A,58,Delayed,204,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,164,Positive,Adult,,Post-1st,01-Jun-21,baseline,04-Apr-21,Pfizer,09-Jun-21,Pfizer,06-Dec-21,Pfizer,27-May-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,23,1,June,2021,58,,,,Completed,50-249,N/A,66,Delayed,180,Delayed,172,58,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,4202,Positive,Adult,,Post-3rd (8+ Weeks),11-Mar-22,baseline,04-Apr-21,Pfizer,09-Jun-21,Pfizer,06-Dec-21,Pfizer,27-May-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,597,2,March,2022,,,95,,Completed,1000-4999,N/A,66,Delayed,180,Delayed,172,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.01,Negative,477,Positive,Elderly,,Post-1st,23-Apr-21,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,68,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,68,1,April,2021,28,,,,Completed,250-999,N/A,85,Delayed,183,Delayed,213,28,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,5664,Positive,Elderly,,Post-2nd (1-8 Weeks),12-Jul-21,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,68,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,804,2,July,2021,,23,,,Completed,,N/A,85,Delayed,183,Delayed,213,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.15,Negative,2667,Positive,Elderly,,Post-2nd (8+ Weeks),05-Nov-21,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,379,3,November,2021,,139,,,Completed,1000-4999,N/A,85,Delayed,183,Delayed,213,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.2,Negative,14549,Positive,Elderly,,Post-3rd (1-8 Weeks),04-Jan-22,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2066,4,January,2022,,,16,,Completed,10000+,N/A,85,Delayed,183,Delayed,213,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.28,Negative,5926,Positive,Elderly,,Post-3rd (8+ Weeks),21-Apr-22,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,841,5,April,2022,,,123,,Completed,,N/A,85,Delayed,183,Delayed,213,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,9120,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,05-Apr-21,Pfizer,20-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1295,1,July,2021,,32,,,Completed,,N/A,76,Delayed,94,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,10411,Positive,Adult,,Post-3rd (1-8 Weeks),12-Nov-21,baseline,05-Apr-21,Pfizer,20-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1478,2,November,2021,,,51,,Completed,10000+,N/A,76,Delayed,94,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.06,Negative,1512,Positive,Adult,,Post-3rd (8+ Weeks),13-Jan-22,baseline,05-Apr-21,Pfizer,20-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,215,3,January,2022,,,113,,Completed,1000-4999,N/A,76,Delayed,94,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.07,Negative,34,Negative,Adult,-359,Post-1st,04-May-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,5,1,May,2021,34,,,,Completed,0-49,N/A,35,Scheduled,120,Scheduled,153,34,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.07,Negative,136,Positive,Adult,-304,Post-2nd (1-8 Weeks),28-Jun-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,19,2,June,2021,,54,,,Completed,50-249,N/A,35,Scheduled,120,Scheduled,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.07,Negative,87,Positive,Adult,-239,Post-2nd (8+ Weeks),01-Sep-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,12,3,September,2021,,119,,,Completed,50-249,N/A,35,Scheduled,120,Scheduled,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.15,Negative,4893,Positive,Adult,-220,Post-3rd (1-8 Weeks),20-Sep-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,695,4,September,2021,,,18,,Completed,1000-4999,N/A,35,Scheduled,120,Scheduled,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.07,Negative,1241,Positive,Adult,-112,Post-3rd (8+ Weeks),06-Jan-22,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,176,5,January,2022,,,126,,Completed,1000-4999,N/A,35,Scheduled,120,Scheduled,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.89,Positive,27116,Positive,Adult,-50,Post-4th,09-Mar-22,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,3850,6,March,2022,,,,35,Completed,10000+,N/A,35,Scheduled,120,Scheduled,153,,,,35,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,1.75,Positive,48659,Positive,Adult,40,Post-4th,07-Jun-22,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,6910,7,June,2022,,,,125,Completed,10000+,N/A,35,Scheduled,120,Scheduled,153,,,,125,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,592,Positive,Adult,,Post-1st,07-Jun-21,baseline,04-May-21,Moderna,20-Jun-21,Moderna,30-Sep-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,84,1,June,2021,34,,,,Completed,250-999,N/A,47,Scheduled,102,Scheduled,,34,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,15571,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,04-May-21,Moderna,20-Jun-21,Moderna,30-Sep-21,Moderna,,,,,40,40-49,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,2211,2,November,2021,,,34,,Completed,10000+,N/A,47,Scheduled,102,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,3.96,Positive,80000,Positive,Adult,,Post-3rd (8+ Weeks),26-Jan-22,baseline,04-May-21,Moderna,20-Jun-21,Moderna,30-Sep-21,Moderna,,,,,40,40-49,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,11360,3,January,2022,,,118,,Completed,10000+,N/A,47,Scheduled,102,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,308,Positive,Adult,,Post-1st,15-May-21,baseline,09-Apr-21,Pfizer,12-Jun-21,Pfizer,06-Sep-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,44,1,May,2021,36,,,,Completed,250-999,N/A,64,Delayed,86,Scheduled,,36,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,4990,Positive,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,09-Apr-21,Pfizer,12-Jun-21,Pfizer,06-Sep-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,709,2,July,2021,,24,,,Completed,1000-4999,N/A,64,Delayed,86,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,1761,Positive,Adult,,Post-3rd (8+ Weeks),23-Dec-21,baseline,09-Apr-21,Pfizer,12-Jun-21,Pfizer,06-Sep-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,250,3,December,2021,,,108,,Completed,1000-4999,N/A,64,Delayed,86,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,No Immunosuppressives,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,18225,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,25-Apr-21,Pfizer,30-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2588,1,July,2021,,16,,,Completed,10000+,N/A,66,Delayed,196,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,No Immunosuppressives,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,30908,Positive,Adult,,Post-3rd (1-8 Weeks),10-Feb-22,baseline,25-Apr-21,Pfizer,30-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4389,2,February,2022,,,29,,Completed,10000+,N/A,66,Delayed,196,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,No Immunosuppressives,Ustekinumab Only,Ustekinumab Only,,0.13,Negative,3732,Positive,Adult,,Post-3rd (8+ Weeks),30-May-22,baseline,25-Apr-21,Pfizer,30-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,530,3,May,2022,,,138,,Completed,1000-4999,N/A,66,Delayed,196,Delayed,,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.01,Negative,273,Positive,Adult,,Post-1st,15-Jun-21,baseline,13-Apr-21,Pfizer,29-Jun-21,Pfizer,26-Nov-21,Pfizer,,,,,45,40-49,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,39,1,June,2021,63,,,,Completed,250-999,N/A,77,Delayed,150,Delayed,,63,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,,,,,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,13-Apr-21,Pfizer,29-Jun-21,Pfizer,26-Nov-21,Pfizer,,,,,45,40-49,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,,2,July,2021,,24,,,Processed,,N/A,77,Delayed,150,Delayed,,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.19,Negative,61393,Positive,Adult,,Post-3rd (1-8 Weeks),31-Dec-21,baseline,13-Apr-21,Pfizer,29-Jun-21,Pfizer,26-Nov-21,Pfizer,,,,,46,40-49,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,8718,3,December,2021,,,35,,Completed,10000+,N/A,77,Delayed,150,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.02,Negative,432,Positive,Adult,-217,Post-1st,25-May-21,Post Vaccine covid,14-Apr-21,Pfizer,20-Jun-21,Pfizer,,,,,,,36,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,1,May,2021,41,,,,Completed,250-999,N/A,67,Delayed,,Delayed,,41,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,1.69,Positive,17117,Positive,Adult,57,Post-2nd (8+ Weeks),23-Feb-22,Post Vaccine covid,14-Apr-21,Pfizer,20-Jun-21,Pfizer,,,,,,,37,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2431,2,February,2022,,248,,,Completed,10000+,N/A,67,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2703,Positive,Elderly,,Post-1st,08-Jun-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,66,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,384,1,June,2021,74,,,,Completed,1000-4999,N/A,71,Delayed,110,Scheduled,155,74,,,,
University of Calgary,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,10676,Positive,Elderly,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1516,2,October,2021,,,35,,Completed,10000+,N/A,71,Delayed,110,Scheduled,155,,,,,
University of Calgary,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,1343,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,191,3,February,2022,,,133,,Completed,1000-4999,N/A,71,Delayed,110,Scheduled,155,,,,,
University of Calgary,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,4040,Positive,Elderly,,Post-4th,26-May-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,574,4,May,2022,,,,90,Completed,1000-4999,N/A,71,Delayed,110,Scheduled,155,,,,90,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,7692,Positive,Adult,-354,Post-2nd (1-8 Weeks),17-Jun-21,baseline,12-Apr-21,Moderna,25-May-21,Moderna,26-Sep-21,Moderna,,,,,20,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1092,1,June,2021,,23,,,Completed,,N/A,43,Scheduled,124,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,13359,Positive,Adult,-230,Post-3rd (1-8 Weeks),19-Oct-21,baseline,12-Apr-21,Moderna,25-May-21,Moderna,26-Sep-21,Moderna,,,,,21,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1897,2,October,2021,,,23,,Completed,10000+,N/A,43,Scheduled,124,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,3644,Positive,Adult,-94,Post-3rd (8+ Weeks),04-Mar-22,baseline,12-Apr-21,Moderna,25-May-21,Moderna,26-Sep-21,Moderna,,,,,21,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,517,3,March,2022,,,159,,Completed,1000-4999,N/A,43,Scheduled,124,Delayed,,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.03,Negative,85,Positive,Adult,,Post-1st,18-Jun-21,baseline,13-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Sep-21,Pfizer,22-Jun-22,Pfizer,,,44,40-49,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,12,1,June,2021,66,,,,Completed,50-249,N/A,66,Delayed,84,Scheduled,285,66,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.02,Negative,1051,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,13-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Sep-21,Pfizer,22-Jun-22,Pfizer,,,44,40-49,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,149,2,July,2021,,28,,,Completed,1000-4999,N/A,66,Delayed,84,Scheduled,285,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.11,Negative,1465,Positive,Adult,,Post-3rd (8+ Weeks),07-Feb-22,baseline,13-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Sep-21,Pfizer,22-Jun-22,Pfizer,,,45,40-49,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,208,3,February,2022,,,150,,Completed,1000-4999,N/A,66,Delayed,84,Scheduled,285,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.02,Negative,169,Positive,Adult,,Post-1st,12-May-21,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,52,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,24,1,May,2021,29,,,,Completed,50-249,N/A,60,Delayed,212,Delayed,,29,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.03,Negative,994,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,52,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,141,2,August,2021,,55,,,Completed,250-999,N/A,60,Delayed,212,Delayed,,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.02,Negative,488,Positive,Adult,,Post-2nd (8+ Weeks),24-Nov-21,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,52,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,69,3,November,2021,,165,,,Completed,250-999,N/A,60,Delayed,212,Delayed,,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.83,Positive,16141,Positive,Adult,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,53,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2292,4,February,2022,,,24,,Completed,10000+,N/A,60,Delayed,212,Delayed,,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,1.5,Positive,25291,Positive,Adult,,Post-3rd (8+ Weeks),25-May-22,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,53,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3591,5,May,2022,,,135,,Completed,10000+,N/A,60,Delayed,212,Delayed,,,,,,
University of Calgary,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.19,Negative,3698,Positive,Adult,-304,Post-2nd (1-8 Weeks),07-Jul-21,baseline,03-May-21,Pfizer,12-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,39,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,525,1,July,2021,,25,,,Completed,1000-4999,N/A,40,Scheduled,104,Scheduled,,,,,,
University of Calgary,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,7312,Positive,Adult,-135,Post-3rd (8+ Weeks),23-Dec-21,baseline,03-May-21,Pfizer,12-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1038,2,December,2021,,,90,,Completed,,N/A,40,Scheduled,104,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,4069,Positive,Elderly,-181,Post-2nd (1-8 Weeks),24-Jun-21,Post Vaccine covid,28-Mar-21,Pfizer,04-Jun-21,Pfizer,09-Nov-21,Pfizer,17-May-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,578,1,June,2021,,20,,,Completed,1000-4999,N/A,68,Delayed,158,Delayed,189,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.08,Positive,43671,Positive,Elderly,0,Post-3rd (1-8 Weeks),22-Dec-21,Post Vaccine covid,28-Mar-21,Pfizer,04-Jun-21,Pfizer,09-Nov-21,Pfizer,17-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,6201,2,December,2021,,,43,,Completed,10000+,N/A,68,Delayed,158,Delayed,189,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.4,Negative,24448,Positive,Elderly,91,Post-3rd (8+ Weeks),23-Mar-22,Post Vaccine covid,28-Mar-21,Pfizer,04-Jun-21,Pfizer,09-Nov-21,Pfizer,17-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3472,3,March,2022,,,134,,Completed,10000+,N/A,68,Delayed,158,Delayed,189,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,Combination Therapy,0.03,Negative,6583,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,10-Apr-21,Pfizer,17-Jun-21,Pfizer,05-Oct-21,Pfizer,07-Apr-22,Pfizer,,,34,30-39,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,935,1,July,2021,,22,,,Completed,,N/A,68,Delayed,110,Scheduled,184,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,Combination Therapy,0.04,Negative,9821,Positive,Adult,,Post-3rd (1-8 Weeks),05-Nov-21,baseline,10-Apr-21,Pfizer,17-Jun-21,Pfizer,05-Oct-21,Pfizer,07-Apr-22,Pfizer,,,34,30-39,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1395,2,November,2021,,,31,,Completed,,N/A,68,Delayed,110,Scheduled,184,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,Combination Therapy,0.05,Negative,22632,Positive,Adult,,Post-4th,06-May-22,baseline,10-Apr-21,Pfizer,17-Jun-21,Pfizer,05-Oct-21,Pfizer,07-Apr-22,Pfizer,,,35,30-39,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,3214,3,May,2022,,,,29,Completed,10000+,N/A,68,Delayed,110,Scheduled,184,,,,29,
University of Calgary,,Female,UC,Corticosteroids,Anti-TNF Only,Corticosteroids,Anti-TNF Only,,0.02,Negative,350,Positive,Adult,-189,Post-2nd (8+ Weeks),22-Jun-21,Post Vaccine covid,24-Feb-21,Pfizer,06-Apr-21,Pfizer,10-Nov-21,Pfizer,,,,,52,50-59,0,1,0,0,0,1,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,50,1,June,2021,,77,,,Completed,250-999,N/A,41,Scheduled,218,Delayed,,,,,,
University of Calgary,,Female,UC,Corticosteroids,Anti-TNF Only,Corticosteroids,Anti-TNF Only,,0.02,Negative,254,Positive,Adult,-132,Post-2nd (8+ Weeks),18-Aug-21,Post Vaccine covid,24-Feb-21,Pfizer,06-Apr-21,Pfizer,10-Nov-21,Pfizer,,,,,52,50-59,0,1,0,0,0,1,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,36,2,August,2021,,134,,,Completed,250-999,N/A,41,Scheduled,218,Delayed,,,,,,
University of Calgary,,Female,UC,Corticosteroids,Anti-TNF Only,Corticosteroids,Anti-TNF Only,,0.68,Negative,67933,Positive,Adult,98,Post-3rd (8+ Weeks),05-Apr-22,Post Vaccine covid,24-Feb-21,Pfizer,06-Apr-21,Pfizer,10-Nov-21,Pfizer,,,,,53,50-59,0,1,0,0,0,1,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9646,3,April,2022,,,146,,Completed,10000+,N/A,41,Scheduled,218,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,626,Positive,Adult,,Post-1st,19-May-21,baseline,08-Apr-21,Moderna,26-Jun-21,Moderna,18-Jan-22,Moderna,21-Jun-22,Moderna,,,60,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89,1,May,2021,41,,,,Completed,250-999,N/A,79,Delayed,206,Delayed,154,41,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.04,Negative,9869,Positive,Adult,,Post-2nd (1-8 Weeks),07-Aug-21,baseline,08-Apr-21,Moderna,26-Jun-21,Moderna,18-Jan-22,Moderna,21-Jun-22,Moderna,,,60,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1401,2,August,2021,,42,,,Completed,,N/A,79,Delayed,206,Delayed,154,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.1,Negative,56212,Positive,Adult,,Post-3rd (8+ Weeks),17-Mar-22,baseline,08-Apr-21,Moderna,26-Jun-21,Moderna,18-Jan-22,Moderna,21-Jun-22,Moderna,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7982,3,March,2022,,,58,,Completed,10000+,N/A,79,Delayed,206,Delayed,154,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,25819,Positive,Adult,,Post-3rd (8+ Weeks),31-May-22,baseline,08-Apr-21,Moderna,26-Jun-21,Moderna,18-Jan-22,Moderna,21-Jun-22,Moderna,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3666,4,May,2022,,,133,,Completed,10000+,N/A,79,Delayed,206,Delayed,154,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,506,Positive,Adult,,Post-1st,18-May-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,72,1,May,2021,40,,,,Completed,250-999,N/A,69,Delayed,91,Scheduled,,40,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,5458,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,775,2,August,2021,,49,,,Completed,,N/A,69,Delayed,91,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,20289,Positive,Adult,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2881,3,September,2021,,,14,,Completed,10000+,N/A,69,Delayed,91,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.1,Negative,2696,Positive,Adult,,Post-3rd (8+ Weeks),29-Jan-22,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,383,4,January,2022,,,136,,Completed,1000-4999,N/A,69,Delayed,91,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,47,Negative,Elderly,-231,Post-1st,17-Jun-21,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,7,1,June,2021,71,,,,Completed,0-49,N/A,89,Delayed,122,Delayed,171,71,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,31280,Positive,Elderly,-199,Post-2nd (1-8 Weeks),19-Jul-21,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4442,2,July,2021,,14,,,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,12014,Positive,Elderly,-63,Post-3rd (1-8 Weeks),02-Dec-21,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1706,3,December,2021,,,28,,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,4.19,Positive,36757,Positive,Elderly,49,Post-3rd (8+ Weeks),24-Mar-22,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5220,4,March,2022,,,140,,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.71,Positive,40000,Positive,Elderly,105,Post-4th,19-May-22,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5680,5,May,2022,,,,25,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,25,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.14,Negative,0,Negative,Adult,,Post-1st,03-May-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,May,2021,30,,,,Completed,0-49,N/A,33,Scheduled,124,Delayed,153,30,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.14,Negative,131,Positive,Adult,,Post-2nd (1-8 Weeks),21-May-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,19,2,May,2021,,15,,,Completed,50-249,N/A,33,Scheduled,124,Delayed,153,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.33,Negative,5598,Positive,Adult,,Post-3rd (1-8 Weeks),20-Sep-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,795,3,September,2021,,,13,,Completed,,N/A,33,Scheduled,124,Delayed,153,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.32,Negative,7184,Positive,Adult,,Post-3rd (8+ Weeks),11-Jan-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1020,4,January,2022,,,126,,Completed,,N/A,33,Scheduled,124,Delayed,153,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.52,Negative,30848,Positive,Adult,,Post-4th,24-Feb-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,4380,5,February,2022,,,,17,Completed,10000+,N/A,33,Scheduled,124,Delayed,153,,,,17,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.58,Negative,48955,Positive,Adult,,Post-4th,23-Jun-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,56,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,6952,6,June,2022,,,,136,Completed,10000+,N/A,33,Scheduled,124,Delayed,153,,,,136,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,20,Negative,Elderly,,Post-1st,20-May-21,baseline,06-Apr-21,Pfizer,26-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,69,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,May,2021,44,,,,Completed,0-49,N/A,81,Delayed,94,Scheduled,,44,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,2338,Positive,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,06-Apr-21,Pfizer,26-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,69,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,332,2,July,2021,,30,,,Completed,1000-4999,N/A,81,Delayed,94,Scheduled,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1269,Positive,Elderly,,Post-3rd (1-8 Weeks),08-Nov-21,baseline,06-Apr-21,Pfizer,26-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,69,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,180,3,November,2021,,,41,,Completed,1000-4999,N/A,81,Delayed,94,Scheduled,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.92,Positive,70,Positive,Elderly,,Post-1st,12-Jun-21,baseline,26-Apr-21,Moderna,24-Jun-21,Moderna,,,,,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,1,June,2021,47,,,,Completed,50-249,N/A,59,Delayed,,Delayed,,47,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,1.16,Positive,727,Positive,Elderly,,Post-2nd (8+ Weeks),09-Feb-22,baseline,26-Apr-21,Moderna,24-Jun-21,Moderna,,,,,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,103,2,February,2022,,230,,,Completed,250-999,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.07,Negative,31557,Positive,Adult,,Post-2nd (8+ Weeks),14-Aug-21,baseline,14-Apr-21,Moderna,19-Jun-21,Moderna,05-Dec-21,Moderna,,,,,25,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4481,1,August,2021,,56,,,Completed,10000+,N/A,66,Delayed,169,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,80000,Positive,Adult,,Post-3rd (8+ Weeks),12-Apr-22,baseline,14-Apr-21,Moderna,19-Jun-21,Moderna,05-Dec-21,Moderna,,,,,26,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,2,April,2022,,,128,,Completed,10000+,N/A,66,Delayed,169,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,,,,,Adult,,Post-1st,25-May-21,baseline,03-Apr-21,Pfizer,14-Jun-21,Pfizer,11-Jan-22,Pfizer,,,,,22,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,May,2021,52,,,,Processed,,N/A,72,Delayed,211,Delayed,,52,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.2,Negative,2012,Positive,Adult,,Post-2nd (8+ Weeks),30-Aug-21,baseline,03-Apr-21,Pfizer,14-Jun-21,Pfizer,11-Jan-22,Pfizer,,,,,22,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,286,2,August,2021,,77,,,Completed,1000-4999,N/A,72,Delayed,211,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,41,Negative,Adult,-205,Post-1st,10-Jun-21,baseline,26-Apr-21,Pfizer,02-Jul-21,Moderna,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,June,2021,45,,,,Completed,0-49,N/A,67,Delayed,,Delayed,,45,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,6055,Positive,Adult,-157,Post-2nd (1-8 Weeks),28-Jul-21,baseline,26-Apr-21,Pfizer,02-Jul-21,Moderna,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,860,2,July,2021,,26,,,Completed,,N/A,67,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.01,Negative,198,Positive,Adult,-26,Post-2nd (8+ Weeks),06-Dec-21,baseline,26-Apr-21,Pfizer,02-Jul-21,Moderna,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,3,December,2021,,157,,,Completed,50-249,N/A,67,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.05,Negative,140,Positive,Elderly,,Post-1st,25-May-21,baseline,05-May-21,Pfizer,22-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,20,1,May,2021,20,,,,Completed,50-249,N/A,48,Scheduled,168,Delayed,,20,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.07,Negative,4168,Positive,Elderly,,Post-3rd (8+ Weeks),11-Mar-22,baseline,05-May-21,Pfizer,22-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,592,2,March,2022,,,94,,Completed,1000-4999,N/A,48,Scheduled,168,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,1949,Positive,Adult,,Post-2nd (1-8 Weeks),26-May-21,baseline,29-Mar-21,Pfizer,01-May-21,Pfizer,03-Sep-21,Pfizer,02-Feb-22,Moderna,,,42,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,277,1,May,2021,,25,,,Completed,1000-4999,N/A,33,Scheduled,125,Delayed,152,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,5158,Positive,Adult,,Post-4th,08-Jun-22,baseline,29-Mar-21,Pfizer,01-May-21,Pfizer,03-Sep-21,Pfizer,02-Feb-22,Moderna,,,43,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,732,2,June,2022,,,,126,Completed,,N/A,33,Scheduled,125,Delayed,152,,,,126,
University of Calgary,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Ustekinumab Only,,0.04,Negative,85,Positive,Adult,,Post-1st,20-May-21,baseline,14-Apr-21,Pfizer,14-Jun-21,Pfizer,27-Feb-22,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,1,May,2021,36,,,,Completed,50-249,N/A,61,Delayed,258,Delayed,,36,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Ustekinumab Only,,0.5,Negative,7320,Positive,Adult,,Post-2nd (8+ Weeks),09-Aug-21,baseline,14-Apr-21,Pfizer,14-Jun-21,Pfizer,27-Feb-22,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1039,2,August,2021,,56,,,Completed,,N/A,61,Delayed,258,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,8076,Positive,Adult,-268,Post-2nd (1-8 Weeks),27-May-21,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1147,1,May,2021,,17,,,Completed,,N/A,29,Scheduled,140,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,317,Positive,Adult,-157,Post-2nd (8+ Weeks),15-Sep-21,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,45,2,September,2021,,128,,,Completed,250-999,N/A,29,Scheduled,140,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,15623,Positive,Adult,-124,Post-3rd (1-8 Weeks),18-Oct-21,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2218,3,October,2021,,,21,,Completed,10000+,N/A,29,Scheduled,140,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,1682,Positive,Adult,-18,Post-3rd (8+ Weeks),01-Feb-22,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,239,4,February,2022,,,127,,Completed,1000-4999,N/A,29,Scheduled,140,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,520,Positive,Adult,,Post-1st,08-Jun-21,baseline,23-Apr-21,Pfizer,11-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,50,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,74,1,June,2021,46,,,,Completed,250-999,N/A,49,Scheduled,204,Delayed,,46,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,7700,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,23-Apr-21,Pfizer,11-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,50,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1093,2,July,2021,,38,,,Completed,,N/A,49,Scheduled,204,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.57,Positive,12499,Positive,Adult,,Post-3rd (8+ Weeks),16-May-22,baseline,23-Apr-21,Pfizer,11-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,51,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1775,3,May,2022,,,135,,Completed,10000+,N/A,49,Scheduled,204,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,190,Positive,Adult,,Post-1st,17-Jun-21,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,56,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,1,June,2021,35,,,,Completed,50-249,N/A,51,Scheduled,187,Delayed,,35,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,16325,Positive,Adult,,Post-2nd (1-8 Weeks),17-Jul-21,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,56,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2318,2,July,2021,,14,,,Completed,10000+,N/A,51,Scheduled,187,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,827,Positive,Adult,,Post-2nd (8+ Weeks),30-Nov-21,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,57,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,117,3,November,2021,,150,,,Completed,250-999,N/A,51,Scheduled,187,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.42,Negative,15533,Positive,Adult,,Post-3rd (1-8 Weeks),01-Feb-22,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,57,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2206,4,February,2022,,,26,,Completed,10000+,N/A,51,Scheduled,187,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.09,Negative,6433,Positive,Adult,,Post-3rd (8+ Weeks),13-May-22,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,57,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,914,5,May,2022,,,127,,Completed,,N/A,51,Scheduled,187,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,246,Positive,Adult,,Post-1st,26-May-21,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,35,1,May,2021,43,,,,Completed,50-249,N/A,48,Scheduled,115,Scheduled,147,43,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,540,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,77,2,September,2021,,101,,,Completed,250-999,N/A,48,Scheduled,115,Scheduled,147,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,1644,Positive,Adult,,Post-3rd (8+ Weeks),15-Dec-21,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,233,3,December,2021,,,83,,Completed,1000-4999,N/A,48,Scheduled,115,Scheduled,147,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.15,Negative,1153,Positive,Adult,,Post-3rd (8+ Weeks),14-Jan-22,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,164,4,January,2022,,,113,,Completed,1000-4999,N/A,48,Scheduled,115,Scheduled,147,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,14690,Positive,Adult,,Post-4th,28-Feb-22,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2086,5,February,2022,,,,11,Completed,10000+,N/A,48,Scheduled,115,Scheduled,147,,,,11,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.16,Negative,1914,Positive,Adult,,Post-4th,20-Jun-22,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,272,6,June,2022,,,,123,Completed,1000-4999,N/A,48,Scheduled,115,Scheduled,147,,,,123,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,,0.02,Negative,167,Positive,Adult,,Post-1st,10-Jun-21,baseline,08-May-21,Pfizer,11-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,36,30-39,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,24,1,June,2021,33,,,,Completed,50-249,N/A,34,Scheduled,165,Delayed,,33,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,,0.03,Negative,1993,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,08-May-21,Pfizer,11-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,36,30-39,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,283,2,July,2021,,28,,,Completed,1000-4999,N/A,34,Scheduled,165,Delayed,,,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,,0.03,Negative,15843,Positive,Adult,,Post-3rd (8+ Weeks),22-Jan-22,baseline,08-May-21,Pfizer,11-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,36,30-39,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,2250,3,January,2022,,,60,,Completed,10000+,N/A,34,Scheduled,165,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,116,Positive,Adult,,Post-1st,08-Jun-21,baseline,09-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Dec-21,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,16,1,June,2021,60,,,,Completed,50-249,N/A,63,Delayed,201,Delayed,,60,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,6050,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,09-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Dec-21,Pfizer,,,,,46,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,859,2,August,2021,,55,,,Completed,,N/A,63,Delayed,201,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,1061,Positive,Adult,,Post-1st,15-Jun-21,baseline,03-May-21,Pfizer,02-Jul-21,Pfizer,06-Mar-22,Pfizer,,,,,23,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,151,1,June,2021,43,,,,Completed,1000-4999,N/A,60,Delayed,247,Delayed,,43,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.04,Negative,23599,Positive,Adult,,Post-2nd (1-8 Weeks),18-May-21,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3351,1,May,2021,,24,,,Completed,10000+,N/A,21,Scheduled,147,Delayed,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.03,Negative,4545,Positive,Elderly,,Post-2nd (8+ Weeks),16-Aug-21,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,645,2,August,2021,,114,,,Completed,1000-4999,N/A,21,Scheduled,147,Delayed,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.03,Negative,80000,Positive,Elderly,,Post-3rd (1-8 Weeks),01-Oct-21,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,October,2021,,,13,,Completed,10000+,N/A,21,Scheduled,147,Delayed,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,1.18,Positive,13009,Positive,Elderly,,Post-3rd (8+ Weeks),18-Jan-22,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1847,4,January,2022,,,122,,Completed,10000+,N/A,21,Scheduled,147,Delayed,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.55,Negative,42264,Positive,Elderly,,Post-4th,08-Mar-22,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6002,5,March,2022,,,,14,Completed,10000+,N/A,21,Scheduled,147,Delayed,157,,,,14,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.26,Negative,7844,Positive,Elderly,,Post-4th,22-Jun-22,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1114,6,June,2022,,,,120,Completed,,N/A,21,Scheduled,147,Delayed,157,,,,120,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,965,Positive,Adult,-325,Post-1st,02-Jun-21,baseline,23-Apr-21,Moderna,18-Jun-21,Moderna,11-Feb-22,Moderna,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,137,1,June,2021,40,,,,Completed,250-999,N/A,56,Scheduled,238,Delayed,,40,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.09,Negative,7097,Positive,Adult,-285,Post-2nd (1-8 Weeks),12-Jul-21,baseline,23-Apr-21,Moderna,18-Jun-21,Moderna,11-Feb-22,Moderna,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1008,2,July,2021,,24,,,Completed,,N/A,56,Scheduled,238,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,848,Positive,Adult,-130,Post-2nd (8+ Weeks),14-Dec-21,baseline,23-Apr-21,Moderna,18-Jun-21,Moderna,11-Feb-22,Moderna,,,,,44,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,120,3,December,2021,,179,,,Completed,250-999,N/A,56,Scheduled,238,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1648,Positive,Elderly,,Post-2nd (1-8 Weeks),22-Jun-21,baseline,03-Mar-21,Pfizer,04-May-21,Pfizer,04-Dec-21,Pfizer,,,,,78,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,234,1,June,2021,,49,,,Completed,1000-4999,N/A,62,Delayed,214,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,4.97,Positive,12789,Positive,Adult,39,Pre-1st,26-May-21,covid,01-Jun-21,Moderna,20-Jul-21,Moderna,,,,,,,35,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1816,1,May,2021,,,,,Completed,10000+,N/A,49,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,2323,Positive,Adult,-310,Post-1st,09-Jun-21,baseline,27-Apr-21,Pfizer,16-Jun-21,Pfizer,23-Oct-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,330,1,June,2021,43,,,,Completed,1000-4999,N/A,50,Scheduled,129,Delayed,,43,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,6,Negative,Adult,-308,Post-1st,21-May-21,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,May,2021,35,,,,Completed,0-49,N/A,70,Delayed,193,Delayed,,35,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,1961,Positive,Adult,-249,Post-2nd (1-8 Weeks),19-Jul-21,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,278,2,July,2021,,24,,,Completed,1000-4999,N/A,70,Delayed,193,Delayed,,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,12074,Positive,Adult,-57,Post-3rd (1-8 Weeks),27-Jan-22,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1715,3,January,2022,,,23,,Completed,10000+,N/A,70,Delayed,193,Delayed,,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.19,Negative,45607,Positive,Adult,63,Post-3rd (8+ Weeks),27-May-22,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,55,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6476,4,May,2022,,,143,,Completed,10000+,N/A,70,Delayed,193,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,970,Positive,Adult,-208,Post-1st,31-May-21,Post Vaccine covid,25-Apr-21,Moderna,14-Jun-21,Moderna,22-Apr-22,Pfizer,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,138,1,May,2021,36,,,,Completed,250-999,N/A,50,Scheduled,312,Delayed,,36,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,10164,Positive,Adult,-156,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,25-Apr-21,Moderna,14-Jun-21,Moderna,22-Apr-22,Pfizer,,,,,36,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1443,2,July,2021,,38,,,Completed,10000+,N/A,50,Scheduled,312,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,2345,Positive,Adult,-2,Post-2nd (8+ Weeks),23-Dec-21,Post Vaccine covid,25-Apr-21,Moderna,14-Jun-21,Moderna,22-Apr-22,Pfizer,,,,,36,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,333,3,December,2021,,192,,,Completed,1000-4999,N/A,50,Scheduled,312,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.17,Positive,40000,Positive,Adult,156,Post-3rd (1-8 Weeks),30-May-22,Post Vaccine covid,25-Apr-21,Moderna,14-Jun-21,Moderna,22-Apr-22,Pfizer,,,,,36,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5680,4,May,2022,,,38,,Completed,10000+,N/A,50,Scheduled,312,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,14,Negative,Adult,,Post-1st,29-May-21,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2,1,May,2021,42,,,,Completed,0-49,N/A,55,Scheduled,85,Scheduled,149,42,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,7763,Positive,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1102,2,June,2021,,14,,,Completed,,N/A,55,Scheduled,85,Scheduled,149,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,1541,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,219,3,October,2021,,,54,,Completed,1000-4999,N/A,55,Scheduled,85,Scheduled,149,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,762,Positive,Adult,,Post-4th,04-Jul-22,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,108,4,July,2022,,,,154,Completed,250-999,N/A,55,Scheduled,85,Scheduled,149,,,,154,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,1671,Positive,Adult,,Post-2nd (8+ Weeks),10-Aug-21,New biologic/Tofacitinib start,20-Apr-21,Pfizer,10-Jun-21,Pfizer,18-Nov-21,Pfizer,14-Jun-22,Pfizer,,,33,30-39,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,237,1,August,2021,,61,,,Completed,1000-4999,N/A,51,Scheduled,161,Delayed,208,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3138,Positive,Adult,,Post-3rd (8+ Weeks),03-Mar-22,New biologic/Tofacitinib start,20-Apr-21,Pfizer,10-Jun-21,Pfizer,18-Nov-21,Pfizer,14-Jun-22,Pfizer,,,34,30-39,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,446,2,March,2022,,,105,,Completed,1000-4999,N/A,51,Scheduled,161,Delayed,208,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,978,Positive,Adult,,Post-1st,25-May-21,baseline,15-Apr-21,Pfizer,24-Jun-21,Pfizer,23-Dec-21,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,139,1,May,2021,40,,,,Completed,250-999,N/A,70,Delayed,182,Delayed,,40,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,11028,Positive,Adult,,Post-2nd (1-8 Weeks),07-Aug-21,baseline,15-Apr-21,Pfizer,24-Jun-21,Pfizer,23-Dec-21,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1566,2,August,2021,,44,,,Completed,10000+,N/A,70,Delayed,182,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,2359,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,15-Apr-21,Pfizer,24-Jun-21,Pfizer,23-Dec-21,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,335,3,December,2021,,181,,,Completed,1000-4999,N/A,70,Delayed,182,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,4070,Positive,Adult,-202,Post-2nd (1-8 Weeks),14-Jun-21,Post Vaccine covid,20-Mar-21,Pfizer,24-Apr-21,Pfizer,,,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,578,1,June,2021,,51,,,Completed,1000-4999,N/A,35,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,558,Positive,Adult,-130,Post-2nd (8+ Weeks),25-Aug-21,Post Vaccine covid,20-Mar-21,Pfizer,24-Apr-21,Pfizer,,,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79,2,August,2021,,123,,,Completed,250-999,N/A,35,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,6.75,Positive,80000,Positive,Adult,24,Post-2nd (8+ Weeks),26-Jan-22,Post Vaccine covid,20-Mar-21,Pfizer,24-Apr-21,Pfizer,,,,,,,31,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,January,2022,,277,,,Completed,10000+,N/A,35,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,126,Positive,Adult,,Post-1st,02-Jun-21,baseline,22-Apr-21,Pfizer,02-Jul-21,Pfizer,03-Jan-22,Moderna,,,,,34,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,18,1,June,2021,41,,,,Completed,50-249,N/A,71,Delayed,185,Delayed,,41,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,2689,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jul-21,baseline,22-Apr-21,Pfizer,02-Jul-21,Pfizer,03-Jan-22,Moderna,,,,,34,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,382,2,July,2021,,26,,,Completed,1000-4999,N/A,71,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.29,Negative,21080,Positive,Adult,,Post-3rd (8+ Weeks),11-Mar-22,baseline,22-Apr-21,Pfizer,02-Jul-21,Pfizer,03-Jan-22,Moderna,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2993,3,March,2022,,,67,,Completed,10000+,N/A,71,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,120,Positive,Adult,,Post-1st,16-Jun-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,1,June,2021,38,,,,Completed,50-249,N/A,59,Delayed,179,Delayed,,38,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,3889,Positive,Adult,,Post-2nd (8+ Weeks),22-Sep-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,61,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,552,2,September,2021,,77,,,Completed,1000-4999,N/A,59,Delayed,179,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,35432,Positive,Adult,,Post-3rd (1-8 Weeks),21-Jan-22,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,61,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5031,3,January,2022,,,19,,Completed,10000+,N/A,59,Delayed,179,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,8267,Positive,Adult,,Post-3rd (8+ Weeks),29-Jun-22,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,62,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1174,4,June,2022,,,178,,Completed,,N/A,59,Delayed,179,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,,0.05,Negative,2186,Positive,Adult,,Post-2nd (8+ Weeks),31-Aug-21,baseline,15-Apr-21,Pfizer,17-Jun-21,Pfizer,02-Jan-22,Moderna,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,310,1,August,2021,,75,,,Completed,1000-4999,N/A,63,Delayed,199,Delayed,,,,,,
University of Calgary,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.03,Negative,82,Positive,Adult,,Post-1st,02-Jun-21,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,58,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,12,1,June,2021,35,,,,Completed,50-249,N/A,43,Scheduled,189,Delayed,,35,,,,
University of Calgary,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.04,Negative,1856,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,58,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,263,2,July,2021,,25,,,Completed,1000-4999,N/A,43,Scheduled,189,Delayed,,,,,,
University of Calgary,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.03,Negative,979,Positive,Adult,,Post-2nd (8+ Weeks),09-Aug-21,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,58,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,139,3,August,2021,,60,,,Completed,250-999,N/A,43,Scheduled,189,Delayed,,,,,,
University of Calgary,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.06,Negative,53528,Positive,Adult,,Post-3rd (1-8 Weeks),17-Jan-22,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,59,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,7601,4,January,2022,,,32,,Completed,10000+,N/A,43,Scheduled,189,Delayed,,,,,,
University of Calgary,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.04,Negative,10547,Positive,Adult,,Post-3rd (8+ Weeks),09-May-22,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,59,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,1498,5,May,2022,,,144,,Completed,10000+,N/A,43,Scheduled,189,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,2586,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jun-21,baseline,01-May-21,Moderna,29-May-21,Moderna,10-Sep-21,Moderna,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,367,1,June,2021,,11,,,Completed,1000-4999,N/A,28,Scheduled,104,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2836,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,01-May-21,Moderna,29-May-21,Moderna,10-Sep-21,Moderna,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,403,2,September,2021,,96,,,Completed,1000-4999,N/A,28,Scheduled,104,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,8790,Positive,Adult,,Post-3rd (8+ Weeks),24-Nov-21,baseline,01-May-21,Moderna,29-May-21,Moderna,10-Sep-21,Moderna,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1248,3,November,2021,,,75,,Completed,,N/A,28,Scheduled,104,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,3946,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,01-May-21,Moderna,29-May-21,Moderna,10-Sep-21,Moderna,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,560,4,February,2022,,,151,,Completed,1000-4999,N/A,28,Scheduled,104,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,86,Positive,Adult,,Post-1st,31-May-21,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,12,1,May,2021,45,,,,Completed,50-249,N/A,65,Delayed,116,Scheduled,155,45,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,642,Positive,Elderly,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,91,2,July,2021,,39,,,Completed,250-999,N/A,65,Delayed,116,Scheduled,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2125,Positive,Elderly,,Post-3rd (1-8 Weeks),12-Nov-21,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,302,3,November,2021,,,29,,Completed,1000-4999,N/A,65,Delayed,116,Scheduled,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,763,Positive,Elderly,,Post-3rd (8+ Weeks),07-Feb-22,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,108,4,February,2022,,,116,,Completed,250-999,N/A,65,Delayed,116,Scheduled,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,4252,Positive,Elderly,,Post-4th,04-Apr-22,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,604,5,April,2022,,,,17,Completed,1000-4999,N/A,65,Delayed,116,Scheduled,155,,,,17,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,7.63,Positive,6488,Positive,Adult,28,Pre-1st,27-May-21,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,921,1,May,2021,,,,,Completed,,N/A,41,Scheduled,183,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,6.85,Positive,25891,Positive,Adult,69,Post-1st,07-Jul-21,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3676,2,July,2021,40,,,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,40,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,5.22,Positive,51122,Positive,Adult,84,Post-2nd (1-8 Weeks),22-Jul-21,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7259,3,July,2021,,14,,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.39,Positive,14685,Positive,Adult,252,Post-2nd (8+ Weeks),06-Jan-22,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2085,4,January,2022,,182,,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.11,Positive,23994,Positive,Adult,272,Post-3rd (1-8 Weeks),26-Jan-22,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3407,5,January,2022,,,19,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.7,Positive,16462,Positive,Adult,383,Post-3rd (8+ Weeks),17-May-22,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,59,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2338,6,May,2022,,,130,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,478,Positive,Adult,,Post-1st,03-Jun-21,baseline,28-Apr-21,Pfizer,25-Jul-21,Pfizer,,,,,,,20,18-29,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68,1,June,2021,36,,,,Completed,250-999,N/A,88,Delayed,,Delayed,,36,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,7548,Positive,Adult,-74,Post-2nd (1-8 Weeks),17-Jun-21,Post Vaccine covid,01-Apr-21,Pfizer,13-May-21,Pfizer,23-Dec-21,Pfizer,,,,,45,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1072,1,June,2021,,35,,,Completed,,N/A,42,Scheduled,224,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.54,Positive,76775,Positive,Adult,25,Post-2nd (8+ Weeks),24-Sep-21,Post Vaccine covid,01-Apr-21,Pfizer,13-May-21,Pfizer,23-Dec-21,Pfizer,,,,,45,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10902,2,September,2021,,134,,,Completed,10000+,N/A,42,Scheduled,224,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.27,Negative,31029,Positive,Adult,176,Post-3rd (8+ Weeks),22-Feb-22,Post Vaccine covid,01-Apr-21,Pfizer,13-May-21,Pfizer,23-Dec-21,Pfizer,,,,,46,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4406,3,February,2022,,,61,,Completed,10000+,N/A,42,Scheduled,224,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,3901,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,33,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,554,1,July,2021,,30,,,Completed,1000-4999,N/A,56,Scheduled,202,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.11,Negative,734,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,104,2,December,2021,,196,,,Completed,250-999,N/A,56,Scheduled,202,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,2.11,Positive,24703,Positive,Adult,,Post-3rd (1-8 Weeks),18-Feb-22,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3508,3,February,2022,,,52,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.73,Positive,35511,Positive,Adult,,Post-3rd (8+ Weeks),10-Jun-22,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5043,4,June,2022,,,164,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,345,Positive,Adult,,Post-1st,08-Jun-21,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,49,1,June,2021,19,,,,Completed,250-999,N/A,21,Scheduled,239,Delayed,,19,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,4403,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,625,2,June,2021,,18,,,Completed,1000-4999,N/A,21,Scheduled,239,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.19,Negative,20077,Positive,Adult,,Post-3rd (1-8 Weeks),23-Mar-22,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2851,3,March,2022,,,47,,Completed,10000+,N/A,21,Scheduled,239,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.16,Negative,7213,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1024,4,June,2022,,,131,,Completed,,N/A,21,Scheduled,239,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.06,Negative,25,Negative,Adult,,Post-1st,15-Jun-21,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,4,1,June,2021,45,,,,Completed,0-49,N/A,55,Scheduled,127,Delayed,196,45,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.05,Negative,5556,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,789,2,July,2021,,34,,,Completed,,N/A,55,Scheduled,127,Delayed,196,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.11,Negative,9128,Positive,Adult,,Post-3rd (1-8 Weeks),17-Nov-21,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,1296,3,November,2021,,,18,,Completed,,N/A,55,Scheduled,127,Delayed,196,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.21,Negative,986,Positive,Adult,,Post-3rd (8+ Weeks),09-Mar-22,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,140,4,March,2022,,,130,,Completed,250-999,N/A,55,Scheduled,127,Delayed,196,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,0.02,Negative,2648,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,11-Apr-21,Pfizer,22-May-21,Pfizer,17-Sep-21,Pfizer,04-Jul-22,Moderna,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,376,1,June,2021,,37,,,Completed,1000-4999,N/A,41,Scheduled,118,Scheduled,290,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,0.02,Negative,442,Positive,Adult,,Post-3rd (8+ Weeks),18-Nov-21,baseline,11-Apr-21,Pfizer,22-May-21,Pfizer,17-Sep-21,Pfizer,04-Jul-22,Moderna,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,63,2,November,2021,,,62,,Completed,250-999,N/A,41,Scheduled,118,Scheduled,290,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,4.84,Positive,31010,Positive,Adult,36,Post-1st,10-Jun-21,Post Vaccine covid,08-Apr-21,Pfizer,10-Jun-21,Pfizer,26-Sep-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,4403,1,June,2021,63,,,,Completed,10000+,N/A,63,Delayed,108,Scheduled,,63,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,,,,Adult,90,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,08-Apr-21,Pfizer,10-Jun-21,Pfizer,26-Sep-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,,2,August,2021,,54,,,Processed,,N/A,63,Delayed,108,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.34,Positive,59991,Positive,Adult,184,Post-3rd (1-8 Weeks),05-Nov-21,Post Vaccine covid,08-Apr-21,Pfizer,10-Jun-21,Pfizer,26-Sep-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,8519,3,November,2021,,,40,,Completed,10000+,N/A,63,Delayed,108,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.62,Positive,18702,Positive,Adult,302,Post-3rd (8+ Weeks),03-Mar-22,Post Vaccine covid,08-Apr-21,Pfizer,10-Jun-21,Pfizer,26-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,2656,4,March,2022,,,158,,Completed,10000+,N/A,63,Delayed,108,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,437,Positive,Adult,,Post-1st,03-Jun-21,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,1,June,2021,42,,,,Completed,250-999,N/A,44,Scheduled,123,Delayed,156,42,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,13168,Positive,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1870,2,June,2021,,20,,,Completed,10000+,N/A,44,Scheduled,123,Delayed,156,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.15,Negative,25019,Positive,Adult,,Post-3rd (1-8 Weeks),29-Oct-21,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3553,3,October,2021,,,23,,Completed,10000+,N/A,44,Scheduled,123,Delayed,156,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.24,Negative,1180,Positive,Adult,,Post-3rd (8+ Weeks),17-Feb-22,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,168,4,February,2022,,,134,,Completed,1000-4999,N/A,44,Scheduled,123,Delayed,156,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.27,Negative,2997,Positive,Adult,,Post-4th,31-Mar-22,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,426,5,March,2022,,,,20,Completed,1000-4999,N/A,44,Scheduled,123,Delayed,156,,,,20,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,614,Positive,Adult,-238,Post-1st,15-Jun-21,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,42,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,87,1,June,2021,39,,,,Completed,250-999,N/A,63,Delayed,67,Scheduled,,39,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,13848,Positive,Adult,-193,Post-2nd (1-8 Weeks),30-Jul-21,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,42,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1966,2,July,2021,,21,,,Completed,10000+,N/A,63,Delayed,67,Scheduled,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.11,Negative,7730,Positive,Adult,-102,Post-3rd (1-8 Weeks),29-Oct-21,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,42,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1098,3,October,2021,,,45,,Completed,,N/A,63,Delayed,67,Scheduled,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.1,Negative,2374,Positive,Adult,-4,Post-3rd (8+ Weeks),04-Feb-22,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,43,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,337,4,February,2022,,,143,,Completed,1000-4999,N/A,63,Delayed,67,Scheduled,,,,,,
University of Calgary,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,10395,Positive,Adult,,Post-2nd (1-8 Weeks),02-Jun-21,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,54,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1476,1,June,2021,,13,,,Completed,10000+,N/A,37,Scheduled,184,Delayed,164,,,,,
University of Calgary,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,917,Positive,Adult,,Post-2nd (8+ Weeks),29-Sep-21,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,54,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,130,2,September,2021,,132,,,Completed,250-999,N/A,37,Scheduled,184,Delayed,164,,,,,
University of Calgary,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,23705,Positive,Adult,,Post-3rd (1-8 Weeks),03-Dec-21,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,55,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3366,3,December,2021,,,13,,Completed,10000+,N/A,37,Scheduled,184,Delayed,164,,,,,
University of Calgary,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,3399,Positive,Adult,,Post-3rd (8+ Weeks),17-Mar-22,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,55,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,483,4,March,2022,,,117,,Completed,1000-4999,N/A,37,Scheduled,184,Delayed,164,,,,,
University of Calgary,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,20410,Positive,Adult,,Post-4th,14-Jun-22,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,55,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2898,5,June,2022,,,,42,Completed,10000+,N/A,37,Scheduled,184,Delayed,164,,,,42,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.33,Negative,4902,Positive,Adult,31,Post-1st,08-Jun-21,covid,22-May-21,Pfizer,25-Aug-21,Pfizer,08-Jun-22,Pfizer,,,,,18,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,696,1,June,2021,17,,,,Completed,1000-4999,N/A,95,Delayed,287,Delayed,,17,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,549,Positive,Adult,,Post-1st,07-Jul-21,baseline,20-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78,1,July,2021,48,,,,Completed,250-999,N/A,49,Scheduled,,Delayed,,48,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.05,Negative,6627,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,20-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,941,2,September,2021,,56,,,Completed,,N/A,49,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,272,Positive,Adult,,Post-2nd (8+ Weeks),23-Dec-21,baseline,20-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,44,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,3,December,2021,,168,,,Completed,250-999,N/A,49,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,120,Positive,Adult,,Post-1st,31-May-21,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,17,1,May,2021,38,,,,Completed,50-249,N/A,52,Scheduled,85,Scheduled,206,38,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,10851,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1541,2,July,2021,,39,,,Completed,10000+,N/A,52,Scheduled,85,Scheduled,206,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,12952,Positive,Adult,,Post-3rd (1-8 Weeks),30-Sep-21,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1839,3,September,2021,,,23,,Completed,10000+,N/A,52,Scheduled,85,Scheduled,206,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,4322,Positive,Adult,,Post-3rd (8+ Weeks),07-Jan-22,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,614,4,January,2022,,,122,,Completed,1000-4999,N/A,52,Scheduled,85,Scheduled,206,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,12841,Positive,Adult,,Post-4th,29-Apr-22,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1823,5,April,2022,,,,28,Completed,10000+,N/A,52,Scheduled,85,Scheduled,206,,,,28,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,522,Positive,Adult,,Post-2nd (1-8 Weeks),20-May-21,baseline,31-Mar-21,Pfizer,26-Apr-21,Pfizer,16-Nov-21,Pfizer,,,,,64,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,74,1,May,2021,,24,,,Completed,250-999,N/A,26,Scheduled,204,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,46,Negative,Elderly,,Post-2nd (8+ Weeks),07-Sep-21,baseline,31-Mar-21,Pfizer,26-Apr-21,Pfizer,16-Nov-21,Pfizer,,,,,64,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,2,September,2021,,134,,,Completed,0-49,N/A,26,Scheduled,204,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.4,Negative,6932,Positive,Elderly,,Post-3rd (1-8 Weeks),01-Dec-21,baseline,31-Mar-21,Pfizer,26-Apr-21,Pfizer,16-Nov-21,Pfizer,,,,,64,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,984,3,December,2021,,,15,,Completed,,N/A,26,Scheduled,204,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.64,Negative,981,Positive,Elderly,,Post-3rd (8+ Weeks),06-Apr-22,baseline,31-Mar-21,Pfizer,26-Apr-21,Pfizer,16-Nov-21,Pfizer,,,,,65,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,139,4,April,2022,,,141,,Completed,250-999,N/A,26,Scheduled,204,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,42,Negative,Adult,,Post-1st,28-Jun-21,baseline,13-May-21,Moderna,23-Jun-21,Moderna,02-Jan-22,Moderna,,,,,47,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,June,2021,46,,,,Completed,0-49,N/A,41,Scheduled,193,Delayed,,46,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,16989,Positive,Elderly,,Post-2nd (1-8 Weeks),16-Jun-21,baseline,29-Mar-21,Pfizer,03-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,68,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2412,1,June,2021,,13,,,Completed,10000+,N/A,66,Delayed,186,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,76847,Positive,Elderly,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,29-Mar-21,Pfizer,03-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10912,2,January,2022,,,31,,Completed,10000+,N/A,66,Delayed,186,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,30,Negative,Adult,,Post-1st,17-May-21,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4,1,May,2021,24,,,,Completed,0-49,N/A,59,Delayed,75,Scheduled,153,24,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.08,Negative,2598,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,369,2,July,2021,,31,,,Completed,1000-4999,N/A,59,Delayed,75,Scheduled,153,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,3111,Positive,Adult,,Post-3rd (8+ Weeks),30-Dec-21,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,442,3,December,2021,,,117,,Completed,1000-4999,N/A,59,Delayed,75,Scheduled,153,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,3.9,Positive,80000,Positive,Adult,,Post-4th,20-Jun-22,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,4,June,2022,,,,136,Completed,10000+,N/A,59,Delayed,75,Scheduled,153,,,,136,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,14678,Positive,Elderly,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,10-Dec-21,Pfizer,25-May-22,Pfizer,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2084,1,July,2021,,49,,,Completed,10000+,N/A,77,Delayed,183,Delayed,166,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,7607,Positive,Elderly,,Post-3rd (8+ Weeks),23-Feb-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,10-Dec-21,Pfizer,25-May-22,Pfizer,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1080,2,February,2022,,,75,,Completed,,N/A,77,Delayed,183,Delayed,166,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,39645,Positive,Elderly,,Post-4th,13-Jun-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,10-Dec-21,Pfizer,25-May-22,Pfizer,,,73,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5630,3,June,2022,,,,19,Completed,10000+,N/A,77,Delayed,183,Delayed,166,,,,19,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.39,Negative,11447,Positive,Adult,66,Post-2nd (1-8 Weeks),21-Jul-21,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1625,1,July,2021,,47,,,Completed,10000+,N/A,55,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.09,Negative,530,Positive,Adult,243,Post-2nd (8+ Weeks),14-Jan-22,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,75,2,January,2022,,224,,,Completed,250-999,N/A,55,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.47,Negative,39004,Positive,Adult,267,Post-3rd (1-8 Weeks),07-Feb-22,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,5539,3,February,2022,,,17,,Completed,10000+,N/A,55,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.46,Negative,6005,Positive,Adult,386,Post-3rd (8+ Weeks),06-Jun-22,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,853,4,June,2022,,,136,,Completed,,N/A,55,Scheduled,231,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,430,Positive,Adult,,Post-2nd (1-8 Weeks),25-May-21,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,61,1,May,2021,,49,,,Completed,250-999,N/A,21,Scheduled,150,Delayed,227,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,112,Positive,Adult,,Post-2nd (8+ Weeks),16-Jul-21,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,16,2,July,2021,,101,,,Completed,50-249,N/A,21,Scheduled,150,Delayed,227,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,5952,Positive,Adult,,Post-3rd (1-8 Weeks),20-Sep-21,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,845,3,September,2021,,,17,,Completed,,N/A,21,Scheduled,150,Delayed,227,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,5966,Positive,Adult,,Post-3rd (8+ Weeks),14-Jan-22,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,847,4,January,2022,,,133,,Completed,,N/A,21,Scheduled,150,Delayed,227,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,1356,Positive,Adult,-191,Post-1st,13-Jul-21,Post Vaccine covid,03-Jun-21,Pfizer,16-Aug-21,Pfizer,,,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,193,1,July,2021,40,,,,Completed,1000-4999,N/A,74,Delayed,,Delayed,,40,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,5335,Positive,Adult,-86,Post-2nd (8+ Weeks),26-Oct-21,Post Vaccine covid,03-Jun-21,Pfizer,16-Aug-21,Pfizer,,,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,758,2,October,2021,,71,,,Completed,,N/A,74,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.47,Negative,23620,Positive,Adult,8,Post-2nd (8+ Weeks),28-Jan-22,Post Vaccine covid,03-Jun-21,Pfizer,16-Aug-21,Pfizer,,,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3354,3,January,2022,,165,,,Completed,10000+,N/A,74,Delayed,,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,546,Positive,Adult,,Post-1st,17-Jun-21,baseline,23-Apr-21,Moderna,22-Jun-21,Moderna,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78,1,June,2021,55,,,,Completed,250-999,N/A,60,Delayed,,Delayed,,55,,,,
University of Calgary,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.32,Negative,3558,Positive,Adult,,Post-2nd (8+ Weeks),26-Aug-21,baseline,23-Apr-21,Moderna,22-Jun-21,Moderna,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,505,2,August,2021,,65,,,Completed,1000-4999,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.4,Negative,895,Positive,Adult,,Post-2nd (8+ Weeks),19-Nov-21,baseline,23-Apr-21,Moderna,22-Jun-21,Moderna,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,127,3,November,2021,,150,,,Completed,250-999,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,108,Positive,Elderly,,Post-2nd (8+ Weeks),07-Jun-21,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,80,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,15,1,June,2021,,59,,,Completed,50-249,N/A,39,Scheduled,139,Delayed,164,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,3119,Positive,Elderly,,Post-3rd (1-8 Weeks),28-Sep-21,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,80,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,443,2,September,2021,,,33,,Completed,1000-4999,N/A,39,Scheduled,139,Delayed,164,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.48,Negative,366,Positive,Elderly,,Post-3rd (8+ Weeks),18-Jan-22,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,80,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,52,3,January,2022,,,145,,Completed,250-999,N/A,39,Scheduled,139,Delayed,164,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,7480,Positive,Elderly,,Post-4th,14-Mar-22,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,80,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1062,4,March,2022,,,,36,Completed,,N/A,39,Scheduled,139,Delayed,164,,,,36,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.31,Negative,983,Positive,Elderly,,Post-4th,04-Jul-22,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,81,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,140,5,July,2022,,,,148,Completed,250-999,N/A,39,Scheduled,139,Delayed,164,,,,148,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,191,Positive,Adult,,Post-2nd (8+ Weeks),11-Sep-21,baseline,16-May-21,Pfizer,02-Jul-21,Pfizer,07-Jun-22,Pfizer,,,,,46,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,27,1,September,2021,,71,,,Completed,50-249,N/A,47,Scheduled,340,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.03,Negative,75,Positive,Adult,,Post-1st,17-Jun-21,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,62,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,11,1,June,2021,89,,,,Completed,50-249,N/A,88,Delayed,145,Delayed,31,89,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.06,Negative,255,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,62,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,36,2,August,2021,,50,,,Completed,250-999,N/A,88,Delayed,145,Delayed,31,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.05,Negative,34251,Positive,Adult,,Post-4th,29-Dec-21,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,4864,3,December,2021,,,,20,Completed,10000+,N/A,88,Delayed,145,Delayed,31,,,,20,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.05,Negative,37283,Positive,Adult,,Post-5th,02-May-22,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,5294,4,May,2022,,,,,Completed,10000+,N/A,88,Delayed,145,Delayed,31,,,,,9
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.06,Negative,4224,Positive,Adult,,Post-2nd (1-8 Weeks),11-Aug-21,baseline,25-May-21,Pfizer,24-Jul-21,Pfizer,,,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,600,1,August,2021,,18,,,Completed,1000-4999,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.92,Positive,2371,Positive,Adult,52,Post-2nd (1-8 Weeks),17-Jun-21,Post Vaccine covid,07-Apr-21,Pfizer,07-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,337,1,June,2021,,10,,,Completed,1000-4999,52 Days Before Collection Days After Collection,61,Delayed,192,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,246,Positive,Adult,217,Post-2nd (8+ Weeks),29-Nov-21,Post Vaccine covid,07-Apr-21,Pfizer,07-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,35,2,November,2021,,175,,,Completed,50-249,217 Days Before Collection Days After Collection,61,Delayed,192,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,7.31,Positive,3754,Positive,Adult,393,Post-3rd (8+ Weeks),24-May-22,Post Vaccine covid,07-Apr-21,Pfizer,07-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,41,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,533,3,May,2022,,,159,,Completed,1000-4999,393 Days Before Collection Days Before Collection,61,Delayed,192,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.87,Positive,78,Positive,Adult,38,Pre-1st,15-Jun-21,covid,16-Jun-21,Pfizer,03-Sep-21,Pfizer,,,,,,,21,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,1,June,2021,,,,,Completed,50-249,N/A,79,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.43,Negative,6723,Positive,Adult,117,Post-1st,02-Sep-21,covid,16-Jun-21,Pfizer,03-Sep-21,Pfizer,,,,,,,21,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,955,2,September,2021,78,,,,Completed,,N/A,79,Delayed,,Delayed,,78,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,5.54,Positive,3907,Positive,Adult,265,Post-2nd (8+ Weeks),28-Jan-22,covid,16-Jun-21,Pfizer,03-Sep-21,Pfizer,,,,,,,22,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,555,3,January,2022,,147,,,Completed,1000-4999,N/A,79,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,441,Positive,Adult,,Post-1st,15-Jun-21,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,41,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,63,1,June,2021,53,,,,Completed,250-999,N/A,61,Delayed,162,Delayed,,53,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,80000,Positive,Adult,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,41,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,2,July,2021,,15,,,Completed,10000+,N/A,61,Delayed,162,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,3552,Positive,Adult,,Post-2nd (8+ Weeks),01-Nov-21,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,504,3,November,2021,,131,,,Completed,1000-4999,N/A,61,Delayed,162,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.1,Negative,29244,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4153,4,January,2022,,,35,,Completed,10000+,N/A,61,Delayed,162,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.18,Negative,8252,Positive,Adult,,Post-3rd (8+ Weeks),28-Apr-22,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1172,5,April,2022,,,147,,Completed,,N/A,61,Delayed,162,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,242,Positive,Adult,,Post-1st,30-Jun-21,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,1,June,2021,32,,,,Completed,50-249,N/A,39,Scheduled,168,Delayed,,32,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,10835,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1539,2,August,2021,,29,,,Completed,10000+,N/A,39,Scheduled,168,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,1191,Positive,Adult,,Post-2nd (8+ Weeks),17-Nov-21,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,169,3,November,2021,,133,,,Completed,1000-4999,N/A,39,Scheduled,168,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.08,Negative,17220,Positive,Adult,,Post-3rd (1-8 Weeks),10-Feb-22,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,54,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2445,4,February,2022,,,50,,Completed,10000+,N/A,39,Scheduled,168,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.11,Negative,8937,Positive,Adult,,Post-3rd (8+ Weeks),06-May-22,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,54,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1269,5,May,2022,,,135,,Completed,,N/A,39,Scheduled,168,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,7789,Positive,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,11-Apr-21,Pfizer,19-Jun-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,27,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1106,1,July,2021,,17,,,Completed,,N/A,69,Delayed,96,Scheduled,201,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,6595,Positive,Adult,-294,Post-2nd (1-8 Weeks),16-Jun-21,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,936,1,June,2021,,19,,,Completed,,N/A,37,Scheduled,148,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,167,Positive,Adult,-197,Post-2nd (8+ Weeks),21-Sep-21,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,2,September,2021,,116,,,Completed,50-249,N/A,37,Scheduled,148,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,1924,Positive,Adult,-111,Post-3rd (1-8 Weeks),16-Dec-21,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,273,3,December,2021,,,54,,Completed,1000-4999,N/A,37,Scheduled,148,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,327,Positive,Adult,-34,Post-3rd (8+ Weeks),03-Mar-22,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,46,4,March,2022,,,131,,Completed,250-999,N/A,37,Scheduled,148,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.11,Negative,11629,Positive,Adult,,Post-2nd (1-8 Weeks),24-Jun-21,baseline,10-Apr-21,Pfizer,07-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,56,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1651,1,June,2021,,17,,,Completed,10000+,N/A,58,Delayed,189,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.18,Negative,3849,Positive,Adult,,Post-3rd (8+ Weeks),07-Apr-22,baseline,10-Apr-21,Pfizer,07-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,57,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,547,2,April,2022,,,115,,Completed,1000-4999,N/A,58,Delayed,189,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,,0.24,Negative,218,Positive,Adult,,Post-2nd (8+ Weeks),10-Aug-21,baseline,30-Mar-21,Pfizer,03-Jun-21,Pfizer,20-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,0,0,0,0,0,0,0,31,1,August,2021,,68,,,Completed,50-249,N/A,65,Delayed,231,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,,0.16,Negative,869,Positive,Adult,,Post-3rd (8+ Weeks),03-Jun-22,baseline,30-Mar-21,Pfizer,03-Jun-21,Pfizer,20-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,0,0,0,0,0,0,0,123,2,June,2022,,,134,,Completed,250-999,N/A,65,Delayed,231,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,7572,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,03-Sep-21,Pfizer,07-Feb-22,Moderna,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1075,1,June,2021,,19,,,Completed,,N/A,65,Delayed,84,Scheduled,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,58071,Positive,Adult,,Post-3rd (1-8 Weeks),24-Sep-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,03-Sep-21,Pfizer,07-Feb-22,Moderna,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,8246,2,September,2021,,,21,,Completed,10000+,N/A,65,Delayed,84,Scheduled,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.46,Positive,45728,Positive,Adult,,Post-4th,03-Mar-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,03-Sep-21,Pfizer,07-Feb-22,Moderna,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,6493,3,March,2022,,,,24,Completed,10000+,N/A,65,Delayed,84,Scheduled,157,,,,24,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.95,Positive,8609,Positive,Adult,,Post-4th,16-Jun-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,03-Sep-21,Pfizer,07-Feb-22,Moderna,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1222,4,June,2022,,,,129,Completed,,N/A,65,Delayed,84,Scheduled,157,,,,129,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,2701,Positive,Adult,,Post-2nd (8+ Weeks),16-Aug-21,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,384,1,August,2021,,60,,,Completed,1000-4999,N/A,57,Delayed,218,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,807,Positive,Adult,-199,Post-2nd (8+ Weeks),23-Jul-21,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,115,1,July,2021,,70,,,Completed,250-999,N/A,42,Scheduled,126,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,358,Positive,Adult,-157,Post-2nd (8+ Weeks),03-Sep-21,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,51,2,September,2021,,112,,,Completed,250-999,N/A,42,Scheduled,126,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,7236,Positive,Adult,-69,Post-3rd (8+ Weeks),30-Nov-21,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1028,3,November,2021,,,74,,Completed,,N/A,42,Scheduled,126,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,1226,Positive,Adult,11,Post-3rd (8+ Weeks),18-Feb-22,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,174,4,February,2022,,,154,,Completed,1000-4999,N/A,42,Scheduled,126,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.05,Negative,33873,Positive,Elderly,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,02-May-21,Moderna,30-Jun-21,Moderna,07-Jan-22,Moderna,,,,,64,60-69,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4810,1,July,2021,,20,,,Completed,10000+,N/A,59,Delayed,191,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.08,Negative,31413,Positive,Elderly,,Post-3rd (8+ Weeks),11-May-22,baseline,02-May-21,Moderna,30-Jun-21,Moderna,07-Jan-22,Moderna,,,,,65,60-69,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4461,2,May,2022,,,124,,Completed,10000+,N/A,59,Delayed,191,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,8443,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,21-Apr-21,Pfizer,27-May-21,Pfizer,16-Nov-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1199,1,July,2021,,43,,,Completed,,N/A,36,Scheduled,173,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,15164,Positive,Adult,,Post-2nd (1-8 Weeks),04-Jun-21,baseline,29-Mar-21,Pfizer,20-May-21,Pfizer,02-Sep-21,Pfizer,,,,,45,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2153,1,June,2021,,15,,,Completed,10000+,N/A,52,Scheduled,105,Scheduled,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,12333,Positive,Adult,,Post-3rd (8+ Weeks),25-Nov-21,baseline,29-Mar-21,Pfizer,20-May-21,Pfizer,02-Sep-21,Pfizer,,,,,46,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1751,2,November,2021,,,84,,Completed,10000+,N/A,52,Scheduled,105,Scheduled,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,8771,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,29-Mar-21,Pfizer,20-May-21,Pfizer,02-Sep-21,Pfizer,,,,,46,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1246,3,January,2022,,,140,,Completed,,N/A,52,Scheduled,105,Scheduled,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,3914,Positive,Adult,-226,Post-2nd (1-8 Weeks),18-Jun-21,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,556,1,June,2021,,20,,,Completed,1000-4999,N/A,40,Scheduled,186,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.01,Negative,597,Positive,Adult,-82,Post-2nd (8+ Weeks),09-Nov-21,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,85,2,November,2021,,164,,,Completed,250-999,N/A,40,Scheduled,186,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,18547,Positive,Adult,-41,Post-3rd (1-8 Weeks),20-Dec-21,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2634,3,December,2021,,,19,,Completed,10000+,N/A,40,Scheduled,186,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.79,Positive,80000,Positive,Adult,79,Post-3rd (8+ Weeks),19-Apr-22,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,41,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,4,April,2022,,,139,,Completed,10000+,N/A,40,Scheduled,186,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,742,Positive,Elderly,,Post-2nd (8+ Weeks),20-Jul-21,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105,1,July,2021,,76,,,Completed,250-999,N/A,36,Scheduled,184,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,361,Positive,Elderly,,Post-2nd (8+ Weeks),30-Sep-21,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,2,September,2021,,148,,,Completed,250-999,N/A,36,Scheduled,184,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,6816,Positive,Elderly,,Post-3rd (1-8 Weeks),13-Dec-21,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,968,3,December,2021,,,38,,Completed,,N/A,36,Scheduled,184,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,2762,Positive,Elderly,,Post-3rd (8+ Weeks),04-Apr-22,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,392,4,April,2022,,,150,,Completed,1000-4999,N/A,36,Scheduled,184,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,22184,Positive,Adult,,Post-2nd (1-8 Weeks),03-Jul-21,baseline,12-Apr-21,Moderna,05-Jun-21,Moderna,28-Dec-21,Pfizer,22-Jul-22,Pfizer,,,56,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,3150,1,July,2021,,28,,,Completed,10000+,N/A,54,Scheduled,206,Delayed,206,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.06,Negative,54888,Positive,Adult,,Post-3rd (1-8 Weeks),22-Jan-22,baseline,12-Apr-21,Moderna,05-Jun-21,Moderna,28-Dec-21,Pfizer,22-Jul-22,Pfizer,,,57,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,7794,2,January,2022,,,25,,Completed,10000+,N/A,54,Scheduled,206,Delayed,206,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.25,Negative,21016,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,20-Apr-21,Moderna,21-Jun-21,Moderna,12-Feb-22,Moderna,,,,,61,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2984,1,July,2021,,23,,,Completed,10000+,N/A,62,Delayed,236,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.68,Negative,2990,Positive,Adult,,Post-2nd (8+ Weeks),23-Dec-21,baseline,20-Apr-21,Moderna,21-Jun-21,Moderna,12-Feb-22,Moderna,,,,,62,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,425,2,December,2021,,185,,,Completed,1000-4999,N/A,62,Delayed,236,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.66,Negative,80000,Positive,Adult,,Post-3rd (1-8 Weeks),28-Feb-22,baseline,20-Apr-21,Moderna,21-Jun-21,Moderna,12-Feb-22,Moderna,,,,,62,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,February,2022,,,16,,Completed,10000+,N/A,62,Delayed,236,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.52,Negative,32041,Positive,Adult,,Post-3rd (8+ Weeks),07-Jul-22,baseline,20-Apr-21,Moderna,21-Jun-21,Moderna,12-Feb-22,Moderna,,,,,62,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4550,4,July,2022,,,145,,Completed,10000+,N/A,62,Delayed,236,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,0,Negative,Elderly,,Post-2nd (1-8 Weeks),22-Jun-21,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,73,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,June,2021,,52,,,Completed,0-49,N/A,29,Scheduled,124,Delayed,193,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,,,Elderly,,Post-3rd (1-8 Weeks),17-Sep-21,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,73,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,2,September,2021,,,15,,Processed,,N/A,29,Scheduled,124,Delayed,193,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,0,Negative,Elderly,,Post-3rd (8+ Weeks),23-Feb-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,February,2022,,,174,,Completed,0-49,N/A,29,Scheduled,124,Delayed,193,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,0,Negative,Elderly,,Post-4th,31-May-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,May,2022,,,,78,Completed,0-49,N/A,29,Scheduled,124,Delayed,193,,,,78,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,0,Negative,Elderly,,Post-4th,11-Jul-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,July,2022,,,,119,Completed,0-49,N/A,29,Scheduled,124,Delayed,193,,,,119,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,691,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,98,1,July,2021,,38,,,Completed,250-999,N/A,75,Delayed,180,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,85,Positive,Adult,,Post-2nd (8+ Weeks),02-Dec-21,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,2,December,2021,,172,,,Completed,50-249,N/A,75,Delayed,180,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,2371,Positive,Adult,,Post-3rd (8+ Weeks),24-Feb-22,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,337,3,February,2022,,,76,,Completed,1000-4999,N/A,75,Delayed,180,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1862,Positive,Adult,,Post-3rd (8+ Weeks),16-May-22,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,264,4,May,2022,,,157,,Completed,1000-4999,N/A,75,Delayed,180,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,7636,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jun-21,baseline,22-Mar-21,AstraZeneca,10-Jun-21,Pfizer,15-Dec-21,Pfizer,,,,,61,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1084,1,June,2021,,19,,,Completed,,N/A,80,Delayed,188,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,1246,Positive,Adult,,Post-2nd (8+ Weeks),07-Dec-21,baseline,22-Mar-21,AstraZeneca,10-Jun-21,Pfizer,15-Dec-21,Pfizer,,,,,62,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,177,2,December,2021,,180,,,Completed,1000-4999,N/A,80,Delayed,188,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,0.02,Negative,2,Negative,Elderly,,Post-1st,15-Jun-21,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,71,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,June,2021,31,,,,Completed,0-49,N/A,60,Delayed,,Delayed,,31,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,,,,,Elderly,,Post-2nd (1-8 Weeks),10-Aug-21,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,71,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,August,2021,,27,,,Processed,,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,0.06,Negative,37,Negative,Elderly,,Post-2nd (8+ Weeks),30-Nov-21,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,71,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,3,November,2021,,139,,,Completed,0-49,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,0.15,Negative,0,Negative,Elderly,,Post-2nd (8+ Weeks),14-Jul-22,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,72,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,July,2022,,365,,,Completed,0-49,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,5580,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Feb-22,Pfizer,,,,,52,50-59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,792,1,July,2021,,19,,,Completed,,N/A,65,Delayed,238,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.05,Negative,4686,Positive,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,20-Apr-21,Moderna,03-Jun-21,Moderna,20-Oct-21,Moderna,,,,,36,30-39,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,665,1,June,2021,,22,,,Completed,1000-4999,N/A,44,Scheduled,139,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.05,Negative,25349,Positive,Adult,,Post-3rd (8+ Weeks),25-Mar-22,baseline,20-Apr-21,Moderna,03-Jun-21,Moderna,20-Oct-21,Moderna,,,,,37,30-39,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,3600,2,March,2022,,,156,,Completed,10000+,N/A,44,Scheduled,139,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,108,Positive,Adult,,Post-2nd (8+ Weeks),30-Jun-21,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,15,1,June,2021,,60,,,Completed,50-249,N/A,29,Scheduled,124,Delayed,160,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,1273,Positive,Adult,,Post-3rd (1-8 Weeks),22-Sep-21,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,181,2,September,2021,,,20,,Completed,1000-4999,N/A,29,Scheduled,124,Delayed,160,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,228,Positive,Adult,,Post-3rd (8+ Weeks),24-Jan-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,32,3,January,2022,,,144,,Completed,50-249,N/A,29,Scheduled,124,Delayed,160,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,395,Positive,Adult,,Post-4th,19-Mar-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,56,4,March,2022,,,,38,Completed,250-999,N/A,29,Scheduled,124,Delayed,160,,,,38,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,27432,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,02-May-21,Pfizer,12-Jul-21,Moderna,,,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3895,1,July,2021,,14,,,Completed,10000+,N/A,71,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,2136,Positive,Adult,,Post-2nd (8+ Weeks),10-Jan-22,baseline,02-May-21,Pfizer,12-Jul-21,Moderna,,,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,303,2,January,2022,,182,,,Completed,1000-4999,N/A,71,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2258,Positive,Adult,,Post-2nd (8+ Weeks),15-Jul-21,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,321,1,July,2021,,60,,,Completed,1000-4999,N/A,39,Scheduled,108,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,12198,Positive,Adult,,Post-3rd (1-8 Weeks),15-Sep-21,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1732,2,September,2021,,,14,,Completed,10000+,N/A,39,Scheduled,108,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2073,Positive,Adult,,Post-3rd (8+ Weeks),12-Jan-22,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,294,3,January,2022,,,133,,Completed,1000-4999,N/A,39,Scheduled,108,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1897,Positive,Adult,,Post-3rd (8+ Weeks),14-Jan-22,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,269,4,January,2022,,,135,,Completed,1000-4999,N/A,39,Scheduled,108,Scheduled,,,,,,
University of Calgary,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.31,Negative,6800,Positive,Adult,,Post-1st,23-Jul-21,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,966,1,July,2021,92,,,,Completed,,N/A,101,Delayed,65,Scheduled,162,92,,,,
University of Calgary,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.21,Negative,7774,Positive,Adult,,Post-2nd (1-8 Weeks),09-Sep-21,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1104,2,September,2021,,39,,,Completed,,N/A,101,Delayed,65,Scheduled,162,,,,,
University of Calgary,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.18,Negative,12209,Positive,Adult,,Post-3rd (1-8 Weeks),05-Nov-21,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1734,3,November,2021,,,31,,Completed,10000+,N/A,101,Delayed,65,Scheduled,162,,,,,
University of Calgary,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.07,Negative,3235,Positive,Adult,,Post-3rd (8+ Weeks),23-Feb-22,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,459,4,February,2022,,,141,,Completed,1000-4999,N/A,101,Delayed,65,Scheduled,162,,,,,
University of Calgary,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,7.62,Positive,14366,Positive,Adult,,Post-4th,15-Jun-22,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,2040,5,June,2022,,,,91,Completed,10000+,N/A,101,Delayed,65,Scheduled,162,,,,91,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.01,Negative,2426,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,19-Apr-21,Moderna,14-Jun-21,Moderna,28-Sep-21,Moderna,,,,,40,40-49,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,344,1,July,2021,,38,,,Completed,1000-4999,N/A,56,Scheduled,106,Scheduled,,,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.01,Negative,9724,Positive,Adult,,Post-3rd (1-8 Weeks),29-Oct-21,baseline,19-Apr-21,Moderna,14-Jun-21,Moderna,28-Sep-21,Moderna,,,,,41,40-49,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1381,2,October,2021,,,31,,Completed,,N/A,56,Scheduled,106,Scheduled,,,,,,
University of Calgary,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,1536,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,19-Apr-21,Moderna,14-Jun-21,Moderna,28-Sep-21,Moderna,,,,,41,40-49,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,218,3,February,2022,,,133,,Completed,1000-4999,N/A,56,Scheduled,106,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,,,,,0.02,Negative,,,Adult,-98,,24-Sep-21,Baseline to COVID,,,,,,,,,,,41,40-49,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,September,2021,,,,,Processed,,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,1064,Positive,Adult,,Post-1st,19-Aug-21,baseline,27-Jul-21,Pfizer,24-Aug-21,Pfizer,,,,,,,62,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,151,1,August,2021,23,,,,Completed,1000-4999,N/A,28,Scheduled,,Delayed,,23,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,48561,Positive,Adult,,Post-2nd (1-8 Weeks),16-Sep-21,baseline,27-Jul-21,Pfizer,24-Aug-21,Pfizer,,,,,,,62,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6896,2,September,2021,,23,,,Completed,10000+,N/A,28,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,4242,Positive,Adult,,Post-2nd (8+ Weeks),27-Jan-22,baseline,27-Jul-21,Pfizer,24-Aug-21,Pfizer,,,,,,,63,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,602,3,January,2022,,156,,,Completed,1000-4999,N/A,28,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,883,Positive,Adult,-135,Post-2nd (8+ Weeks),14-Sep-21,Post Vaccine covid,17-Mar-21,AstraZeneca,08-Jun-21,Pfizer,16-Oct-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,125,1,September,2021,,98,,,Completed,250-999,N/A,83,Delayed,130,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.48,Negative,6233,Positive,Adult,-84,Post-3rd (1-8 Weeks),04-Nov-21,Post Vaccine covid,17-Mar-21,AstraZeneca,08-Jun-21,Pfizer,16-Oct-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,885,2,November,2021,,,19,,Completed,,N/A,83,Delayed,130,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,3.92,Positive,80000,Positive,Adult,40,Post-3rd (8+ Weeks),08-Mar-22,Post Vaccine covid,17-Mar-21,AstraZeneca,08-Jun-21,Pfizer,16-Oct-21,Pfizer,,,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,March,2022,,,143,,Completed,10000+,N/A,83,Delayed,130,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,2366,Positive,Adult,,Post-2nd (8+ Weeks),03-Sep-21,baseline,06-May-21,Pfizer,27-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,336,1,September,2021,,68,,,Completed,1000-4999,N/A,52,Scheduled,188,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,21200,Positive,Adult,,Post-3rd (8+ Weeks),28-Feb-22,baseline,06-May-21,Pfizer,27-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3010,2,February,2022,,,58,,Completed,10000+,N/A,52,Scheduled,188,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.02,Negative,4450,Positive,Adult,,Post-2nd (8+ Weeks),28-Sep-21,baseline,12-May-21,Pfizer,24-Jul-21,Pfizer,19-Oct-21,Pfizer,19-Apr-22,Pfizer,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,632,1,September,2021,,66,,,Completed,1000-4999,N/A,73,Delayed,87,Scheduled,182,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.06,Negative,6295,Positive,Adult,,Post-3rd (1-8 Weeks),12-Nov-21,baseline,12-May-21,Pfizer,24-Jul-21,Pfizer,19-Oct-21,Pfizer,19-Apr-22,Pfizer,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,894,2,November,2021,,,24,,Completed,,N/A,73,Delayed,87,Scheduled,182,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.11,Negative,748,Positive,Adult,,Post-3rd (8+ Weeks),07-Apr-22,baseline,12-May-21,Pfizer,24-Jul-21,Pfizer,19-Oct-21,Pfizer,19-Apr-22,Pfizer,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,106,3,April,2022,,,170,,Completed,250-999,N/A,73,Delayed,87,Scheduled,182,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.11,Negative,5921,Positive,Adult,,Post-4th,12-May-22,baseline,12-May-21,Pfizer,24-Jul-21,Pfizer,19-Oct-21,Pfizer,19-Apr-22,Pfizer,,,31,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,841,4,May,2022,,,,23,Completed,,N/A,73,Delayed,87,Scheduled,182,,,,23,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,7049,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,22-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Sep-21,Pfizer,04-Apr-22,Pfizer,,,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1001,1,September,2021,,83,,,Completed,,N/A,50,Scheduled,110,Scheduled,187,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,56345,Positive,Adult,,Post-3rd (1-8 Weeks),19-Oct-21,baseline,22-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Sep-21,Pfizer,04-Apr-22,Pfizer,,,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,8001,2,October,2021,,,20,,Completed,10000+,N/A,50,Scheduled,110,Scheduled,187,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,40145,Positive,Adult,,Post-4th,27-Apr-22,baseline,22-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Sep-21,Pfizer,04-Apr-22,Pfizer,,,57,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5701,3,April,2022,,,,23,Completed,10000+,N/A,50,Scheduled,110,Scheduled,187,,,,23,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,4.59,Positive,36168,Positive,Adult,21,Post-2nd (8+ Weeks),21-Sep-21,Post Vaccine covid,28-Apr-21,Pfizer,06-Jun-21,Pfizer,30-Sep-21,Pfizer,,,,,23,18-29,1,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5136,1,September,2021,,107,,,Completed,10000+,N/A,39,Scheduled,116,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,4.61,Positive,40116,Positive,Adult,62,Post-3rd (1-8 Weeks),01-Nov-21,Post Vaccine covid,28-Apr-21,Pfizer,06-Jun-21,Pfizer,30-Sep-21,Pfizer,,,,,23,18-29,1,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5696,2,November,2021,,,32,,Completed,10000+,N/A,39,Scheduled,116,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,3.19,Positive,38833,Positive,Adult,181,Post-3rd (8+ Weeks),28-Feb-22,Post Vaccine covid,28-Apr-21,Pfizer,06-Jun-21,Pfizer,30-Sep-21,Pfizer,,,,,23,18-29,1,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5514,3,February,2022,,,151,,Completed,10000+,N/A,39,Scheduled,116,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.1,Negative,1864,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,26-Apr-21,Moderna,14-Jul-21,Moderna,14-Jan-22,,,,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,265,1,September,2021,,63,,,Completed,1000-4999,N/A,79,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,2.16,Positive,80000,Positive,Adult,36,Post-2nd (8+ Weeks),16-Nov-21,Post Vaccine covid,09-Apr-21,Pfizer,12-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,11360,1,November,2021,,157,,,Completed,10000+,N/A,64,Delayed,214,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,2.03,Positive,40848,Positive,Adult,,Post-3rd (8+ Weeks),27-Jan-22,baseline,01-May-21,Pfizer,22-Jul-21,Pfizer,29-Oct-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5800,1,January,2022,,,90,,Completed,10000+,N/A,82,Delayed,99,Scheduled,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,368,Positive,Elderly,,Post-1st,11-May-21,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,68,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,52,1,May,2021,38,,,,Completed,250-999,N/A,52,Scheduled,111,Scheduled,195,38,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,23927,Positive,Elderly,,Post-2nd (1-8 Weeks),11-Jun-21,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,68,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,3398,2,June,2021,,17,,,Completed,10000+,N/A,52,Scheduled,111,Scheduled,195,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.58,Negative,37642,Positive,Elderly,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,68,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5345,3,September,2021,,,16,,Completed,10000+,N/A,52,Scheduled,111,Scheduled,195,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.66,Negative,4205,Positive,Elderly,,Post-3rd (8+ Weeks),13-Jan-22,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,69,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,597,4,January,2022,,,122,,Completed,1000-4999,N/A,52,Scheduled,111,Scheduled,195,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,118,Positive,Adult,-357,Post-1st,04-May-21,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,48,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,17,1,May,2021,29,,,,Completed,50-249,N/A,59,Delayed,93,Scheduled,153,29,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,652,Positive,Adult,-306,Post-2nd (1-8 Weeks),24-Jun-21,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,48,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,93,2,June,2021,,21,,,Completed,250-999,N/A,59,Delayed,93,Scheduled,153,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.54,Negative,60,Positive,Adult,-94,Post-3rd (8+ Weeks),22-Jan-22,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,49,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,9,3,January,2022,,,140,,Completed,50-249,N/A,59,Delayed,93,Scheduled,153,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.91,Positive,4732,Positive,Adult,-56,Post-4th,01-Mar-22,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,49,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,672,4,March,2022,,,,25,Completed,1000-4999,N/A,59,Delayed,93,Scheduled,153,,,,25,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.46,Positive,4028,Positive,Adult,55,Post-4th,20-Jun-22,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,49,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,572,5,June,2022,,,,136,Completed,1000-4999,N/A,59,Delayed,93,Scheduled,153,,,,136,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,2.65,Positive,640,Positive,Adult,30,Pre-1st,06-Apr-21,Baseline to COVID,22-Apr-21,Pfizer,27-May-21,Pfizer,27-Sep-21,Pfizer,06-Jun-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,91,1,April,2021,,,,,Completed,250-999,N/A,35,Scheduled,123,Delayed,252,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,2.91,Positive,24248,Positive,Adult,395,Post-3rd (8+ Weeks),06-Apr-22,Baseline to COVID,22-Apr-21,Pfizer,27-May-21,Pfizer,27-Sep-21,Pfizer,06-Jun-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3443,2,April,2022,,,191,,Completed,10000+,N/A,35,Scheduled,123,Delayed,252,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,971,Positive,Adult,,Post-1st,10-Sep-21,baseline,17-Jun-21,Moderna,29-Sep-21,Moderna,,,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,138,1,September,2021,85,,,,Completed,250-999,N/A,104,Delayed,,Delayed,,85,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,30146,Positive,Adult,,Post-2nd (1-8 Weeks),08-Oct-21,baseline,17-Jun-21,Moderna,29-Sep-21,Moderna,,,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4281,2,October,2021,,9,,,Completed,10000+,N/A,104,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.02,Negative,11649,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,,,,,,,31,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1654,1,July,2021,,30,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,681,Positive,Adult,-259,Post-1st,07-May-21,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,97,1,May,2021,34,,,,Completed,250-999,N/A,35,Scheduled,134,Delayed,268,34,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,4255,Positive,Adult,-212,Post-2nd (1-8 Weeks),23-Jun-21,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,604,2,June,2021,,46,,,Completed,1000-4999,N/A,35,Scheduled,134,Delayed,268,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,3525,Positive,Adult,-135,Post-2nd (8+ Weeks),08-Sep-21,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,500,3,September,2021,,123,,,Completed,1000-4999,N/A,35,Scheduled,134,Delayed,268,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,7109,Positive,Adult,-4,Post-3rd (8+ Weeks),17-Jan-22,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1010,4,January,2022,,,120,,Completed,,N/A,35,Scheduled,134,Delayed,268,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,3.03,Positive,39003,Positive,Adult,18,Post-3rd (8+ Weeks),08-Feb-22,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,42,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5538,5,February,2022,,,142,,Completed,10000+,N/A,35,Scheduled,134,Delayed,268,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,0,Negative,Adult,-271,Pre-1st,09-Apr-21,Post Vaccine covid,22-Apr-21,Pfizer,17-Jun-21,Pfizer,15-Sep-21,Pfizer,01-Jun-22,Pfizer,,,29,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,56,Scheduled,90,Scheduled,259,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,597,Positive,Adult,,Post-1st,07-Jun-21,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,85,1,June,2021,55,,,,Completed,250-999,N/A,68,Delayed,166,Delayed,,55,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,21136,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3001,2,August,2021,,61,,,Completed,10000+,N/A,68,Delayed,166,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,4646,Positive,Adult,,Post-2nd (8+ Weeks),01-Dec-21,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,660,3,December,2021,,164,,,Completed,1000-4999,N/A,68,Delayed,166,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,9861,Positive,Adult,,Post-3rd (8+ Weeks),15-Mar-22,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1400,4,March,2022,,,102,,Completed,,N/A,68,Delayed,166,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,11117,Positive,Adult,,Post-3rd (8+ Weeks),08-Jun-22,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1579,5,June,2022,,,187,,Completed,10000+,N/A,68,Delayed,166,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,,0.08,Negative,6062,Positive,Adult,,Post-2nd (1-8 Weeks),07-Jul-21,baseline,19-Apr-21,Pfizer,15-Jun-21,Pfizer,09-Feb-22,Pfizer,,,,,53,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,861,1,July,2021,,22,,,Completed,,N/A,57,Delayed,239,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,,0.08,Negative,453,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,19-Apr-21,Pfizer,15-Jun-21,Pfizer,09-Feb-22,Pfizer,,,,,53,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,64,2,December,2021,,190,,,Completed,250-999,N/A,57,Delayed,239,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,621,Positive,Adult,,Post-1st,30-Mar-21,baseline,23-Feb-21,Pfizer,05-Apr-21,Pfizer,07-Dec-21,Pfizer,,,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,88,1,March,2021,35,,,,Completed,250-999,N/A,41,Scheduled,246,Delayed,,35,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,4274,Positive,Adult,,Post-2nd (1-8 Weeks),26-May-21,baseline,23-Feb-21,Pfizer,05-Apr-21,Pfizer,07-Dec-21,Pfizer,,,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,607,2,May,2021,,51,,,Completed,1000-4999,N/A,41,Scheduled,246,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,747,Positive,Adult,,Post-2nd (8+ Weeks),15-Sep-21,baseline,23-Feb-21,Pfizer,05-Apr-21,Pfizer,07-Dec-21,Pfizer,,,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,106,3,September,2021,,163,,,Completed,250-999,N/A,41,Scheduled,246,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.08,Negative,1976,Positive,Adult,,Post-3rd (8+ Weeks),14-Mar-22,baseline,23-Feb-21,Pfizer,05-Apr-21,Pfizer,07-Dec-21,Pfizer,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,281,4,March,2022,,,97,,Completed,1000-4999,N/A,41,Scheduled,246,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,348,Positive,Adult,,Post-2nd (1-8 Weeks),04-Sep-21,baseline,18-Jun-21,Pfizer,20-Jul-21,Pfizer,29-Oct-21,Pfizer,31-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,49,1,September,2021,,46,,,Completed,250-999,N/A,32,Scheduled,101,Scheduled,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,622,Positive,Adult,,Post-3rd (8+ Weeks),15-Jan-22,baseline,18-Jun-21,Pfizer,20-Jul-21,Pfizer,29-Oct-21,Pfizer,31-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,88,2,January,2022,,,78,,Completed,250-999,N/A,32,Scheduled,101,Scheduled,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,4553,Positive,Adult,,Post-4th,09-Apr-22,baseline,18-Jun-21,Pfizer,20-Jul-21,Pfizer,29-Oct-21,Pfizer,31-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,647,3,April,2022,,,,9,Completed,1000-4999,N/A,32,Scheduled,101,Scheduled,153,,,,9,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,1056,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,22-Apr-21,Pfizer,17-Jun-21,Pfizer,12-Oct-21,Pfizer,05-May-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,150,1,July,2021,,18,,,Completed,1000-4999,N/A,56,Scheduled,117,Scheduled,205,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,4282,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,22-Apr-21,Pfizer,17-Jun-21,Pfizer,12-Oct-21,Pfizer,05-May-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,608,2,November,2021,,,22,,Completed,1000-4999,N/A,56,Scheduled,117,Scheduled,205,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,435,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,22-Apr-21,Pfizer,17-Jun-21,Pfizer,12-Oct-21,Pfizer,05-May-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,3,February,2022,,,125,,Completed,250-999,N/A,56,Scheduled,117,Scheduled,205,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.1,Negative,691,Positive,Adult,,Post-2nd (8+ Weeks),29-Nov-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,09-Dec-21,Pfizer,09-Dec-21,Pfizer ,,,34,30-39,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,98,1,November,2021,,244,,,Completed,250-999,N/A,38,Scheduled,254,Delayed,0,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.37,Negative,12658,Positive,Adult,,Post-4th,10-Mar-22,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,09-Dec-21,Pfizer,09-Dec-21,Pfizer ,,,35,30-39,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1797,2,March,2022,,,,91,Completed,10000+,N/A,38,Scheduled,254,Delayed,0,,,,91,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,702,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jun-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,100,1,June,2021,,41,,,Completed,250-999,N/A,33,Scheduled,133,Delayed,197,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,504,Positive,Adult,,Post-2nd (8+ Weeks),17-Aug-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,72,2,August,2021,,97,,,Completed,250-999,N/A,33,Scheduled,133,Delayed,197,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.52,Negative,3880,Positive,Adult,,Post-3rd (8+ Weeks),07-Dec-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,551,3,December,2021,,,76,,Completed,1000-4999,N/A,33,Scheduled,133,Delayed,197,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.34,Negative,6476,Positive,Adult,,Post-4th,24-May-22,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,920,4,May,2022,,,,47,Completed,,N/A,33,Scheduled,133,Delayed,197,,,,47,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,211,Positive,Elderly,-344,Post-1st,03-May-21,baseline,27-Mar-21,Pfizer,14-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,30,1,May,2021,37,,,,Completed,50-249,N/A,79,Delayed,206,Delayed,,37,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,9143,Positive,Elderly,-288,Post-2nd (1-8 Weeks),28-Jun-21,baseline,27-Mar-21,Pfizer,14-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1298,2,June,2021,,14,,,Completed,,N/A,79,Delayed,206,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.09,Negative,1078,Positive,Elderly,-111,Post-2nd (8+ Weeks),22-Dec-21,baseline,27-Mar-21,Pfizer,14-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,153,3,December,2021,,191,,,Completed,1000-4999,N/A,79,Delayed,206,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.21,Negative,28529,Positive,Elderly,-83,Post-3rd (1-8 Weeks),19-Jan-22,baseline,27-Mar-21,Pfizer,14-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4051,4,January,2022,,,13,,Completed,10000+,N/A,79,Delayed,206,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,5508,Positive,Adult,-55,Post-2nd (1-8 Weeks),30-Jun-21,Post Vaccine covid,08-Apr-21,Pfizer,15-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,782,1,June,2021,,15,,,Completed,,N/A,68,Delayed,148,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,9147,Positive,Adult,-249,Post-2nd (1-8 Weeks),12-May-21,Post Vaccine covid,07-Apr-21,Pfizer,01-May-21,Pfizer,30-Sep-21,Pfizer,06-May-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1299,1,May,2021,,11,,,Completed,,N/A,24,Scheduled,152,Delayed,218,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,2313,Positive,Adult,-163,Post-2nd (8+ Weeks),06-Aug-21,Post Vaccine covid,07-Apr-21,Pfizer,01-May-21,Pfizer,30-Sep-21,Pfizer,06-May-22,Pfizer,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,328,2,August,2021,,97,,,Completed,1000-4999,N/A,24,Scheduled,152,Delayed,218,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.3,Positive,41323,Positive,Adult,40,Post-3rd (8+ Weeks),25-Feb-22,Post Vaccine covid,07-Apr-21,Pfizer,01-May-21,Pfizer,30-Sep-21,Pfizer,06-May-22,Pfizer,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5868,3,February,2022,,,148,,Completed,10000+,N/A,24,Scheduled,152,Delayed,218,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,626,Positive,Adult,,Post-1st,18-May-21,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,89,1,May,2021,27,,,,Completed,250-999,N/A,57,Delayed,228,Delayed,,27,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,28498,Positive,Adult,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4047,2,July,2021,,33,,,Completed,10000+,N/A,57,Delayed,228,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.16,Negative,1705,Positive,Adult,,Post-2nd (8+ Weeks),04-Jan-22,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,242,3,January,2022,,201,,,Completed,1000-4999,N/A,57,Delayed,228,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,19817,Positive,Adult,,Post-3rd (8+ Weeks),02-Jun-22,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2814,4,June,2022,,,122,,Completed,10000+,N/A,57,Delayed,228,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,17240,Positive,Adult,-220,Post-2nd (1-8 Weeks),21-Jun-21,Post Vaccine covid,14-Apr-21,Moderna,28-May-21,Moderna,21-Oct-21,Moderna,,,,,42,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2448,1,June,2021,,24,,,Completed,10000+,N/A,44,Scheduled,146,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,50221,Positive,Adult,-71,Post-3rd (1-8 Weeks),17-Nov-21,Post Vaccine covid,14-Apr-21,Moderna,28-May-21,Moderna,21-Oct-21,Moderna,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7131,2,November,2021,,,27,,Completed,10000+,N/A,44,Scheduled,146,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.82,Positive,29326,Positive,Adult,41,Post-3rd (8+ Weeks),09-Mar-22,Post Vaccine covid,14-Apr-21,Moderna,28-May-21,Moderna,21-Oct-21,Moderna,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4164,3,March,2022,,,139,,Completed,10000+,N/A,44,Scheduled,146,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2455,Positive,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,New biologic/Tofacitinib start,13-Apr-21,Pfizer,26-Jun-21,Pfizer,26-Oct-21,Pfizer,28-Mar-22,Pfizer ,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,349,1,July,2021,,30,,,Completed,1000-4999,N/A,74,Delayed,122,Delayed,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,1358,Positive,Elderly,,Post-3rd (8+ Weeks),10-Jan-22,New biologic/Tofacitinib start,13-Apr-21,Pfizer,26-Jun-21,Pfizer,26-Oct-21,Pfizer,28-Mar-22,Pfizer ,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,193,2,January,2022,,,76,,Completed,1000-4999,N/A,74,Delayed,122,Delayed,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,5675,Positive,Elderly,,Post-4th,20-May-22,New biologic/Tofacitinib start,13-Apr-21,Pfizer,26-Jun-21,Pfizer,26-Oct-21,Pfizer,28-Mar-22,Pfizer ,,,70,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,806,3,May,2022,,,,53,Completed,,N/A,74,Delayed,122,Delayed,153,,,,53,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,4.11,Positive,74,Positive,Adult,18,Pre-1st,25-May-21,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,1,May,2021,,,,,Completed,50-249,N/A,40,Scheduled,216,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,3.57,Positive,10406,Positive,Adult,59,Post-1st,05-Jul-21,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1478,2,July,2021,40,,,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,40,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,3.04,Positive,16757,Positive,Adult,82,Post-2nd (1-8 Weeks),28-Jul-21,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2380,3,July,2021,,23,,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.02,Positive,15844,Positive,Adult,294,Post-3rd (1-8 Weeks),25-Feb-22,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2250,4,February,2022,,,19,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,4.47,Positive,11438,Positive,Adult,405,Post-3rd (8+ Weeks),16-Jun-22,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1624,5,June,2022,,,130,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,125,Positive,Adult,,Post-1st,20-May-21,baseline,09-Apr-21,Pfizer,20-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,May,2021,41,,,,Completed,50-249,N/A,72,Delayed,96,Scheduled,,41,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,09-Apr-21,Pfizer,20-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,July,2021,,24,,,Processed,,N/A,72,Delayed,96,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.49,Negative,295,Positive,Adult,,Post-3rd (8+ Weeks),24-Feb-22,baseline,09-Apr-21,Pfizer,20-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,42,3,February,2022,,,153,,Completed,250-999,N/A,72,Delayed,96,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,,6.82,Positive,3430,Positive,Elderly,40,Pre-1st,18-Feb-21,Baseline to COVID,16-Sep-21,Pfizer,06-Nov-21,Pfizer,,,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,487,1,February,2021,,,,,Completed,1000-4999,40 Days Before Collection Days Before Collection,51,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,,0.14,Negative,80000,Positive,Elderly,265,Post-1st,01-Oct-21,Baseline to COVID,16-Sep-21,Pfizer,06-Nov-21,Pfizer,,,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,2,October,2021,15,,,,Completed,10000+,265 Days Before Collection Days Before Collection,51,Scheduled,,Delayed,,15,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,,0.1,Negative,27335,Positive,Elderly,331,Post-2nd (1-8 Weeks),06-Dec-21,Baseline to COVID,16-Sep-21,Pfizer,06-Nov-21,Pfizer,,,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3882,3,December,2021,,30,,,Completed,10000+,331 Days Before Collection Days Before Collection,51,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.11,Negative,10178,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,23-Apr-21,Pfizer,04-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,26,18-29,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1445,1,July,2021,,48,,,Completed,10000+,N/A,42,Scheduled,197,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.45,Negative,42358,Positive,Adult,,Post-3rd (1-8 Weeks),11-Jan-22,baseline,23-Apr-21,Pfizer,04-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,27,18-29,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6015,2,January,2022,,,24,,Completed,10000+,N/A,42,Scheduled,197,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,1.07,Positive,9357,Positive,Adult,,Post-3rd (8+ Weeks),07-May-22,baseline,23-Apr-21,Pfizer,04-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,27,18-29,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1329,3,May,2022,,,140,,Completed,,N/A,42,Scheduled,197,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,6831,Positive,Adult,-218,Post-2nd (8+ Weeks),01-Sep-21,baseline,08-Apr-21,Moderna,05-Jun-21,Moderna,09-Oct-21,Pfizer,,,,,37,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,970,1,September,2021,,88,,,Completed,,N/A,58,Delayed,126,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,12399,Positive,Adult,-135,Post-3rd (1-8 Weeks),23-Nov-21,baseline,08-Apr-21,Moderna,05-Jun-21,Moderna,09-Oct-21,Pfizer,,,,,37,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1761,2,November,2021,,,45,,Completed,10000+,N/A,58,Delayed,126,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,13866,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,21-Apr-21,Pfizer,11-Jun-21,Pfizer,07-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1969,1,June,2021,,19,,,Completed,10000+,N/A,51,Scheduled,88,Scheduled,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,8761,Positive,Adult,-290,Post-2nd (1-8 Weeks),07-Jul-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,20-Sep-21,Pfizer,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1244,1,July,2021,,21,,,Completed,,N/A,69,Delayed,96,Scheduled,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,14754,Positive,Adult,-177,Post-3rd (1-8 Weeks),28-Oct-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,20-Sep-21,Pfizer,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2095,2,October,2021,,,38,,Completed,10000+,N/A,69,Delayed,96,Scheduled,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,4404,Positive,Adult,-92,Post-3rd (8+ Weeks),21-Jan-22,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,20-Sep-21,Pfizer,,,,,44,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,625,3,January,2022,,,123,,Completed,1000-4999,N/A,69,Delayed,96,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.54,Negative,2919,Positive,Adult,,Post-2nd (1-8 Weeks),07-Aug-21,baseline,08-May-21,Pfizer,04-Jul-21,Pfizer,24-Sep-21,Pfizer,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,414,1,August,2021,,34,,,Completed,1000-4999,N/A,57,Delayed,82,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,4548,Positive,Adult,,Post-3rd (8+ Weeks),03-Dec-21,baseline,08-May-21,Pfizer,04-Jul-21,Pfizer,24-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,646,2,December,2021,,,70,,Completed,1000-4999,N/A,57,Delayed,82,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.02,Negative,3203,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,17-Jan-22,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,455,1,August,2021,,49,,,Completed,1000-4999,N/A,68,Delayed,215,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,21561,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,55,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,3062,1,July,2021,,15,,,Completed,10000+,N/A,28,Scheduled,99,Scheduled,138,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,21697,Positive,Adult,,Post-3rd (1-8 Weeks),27-Oct-21,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,56,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,3081,2,October,2021,,,26,,Completed,10000+,N/A,28,Scheduled,99,Scheduled,138,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,830,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,56,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,118,3,February,2022,,,125,,Completed,250-999,N/A,28,Scheduled,99,Scheduled,138,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.17,Negative,80000,Positive,Adult,,Post-4th,03-Mar-22,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,56,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,11360,4,March,2022,,,,15,Completed,10000+,N/A,28,Scheduled,99,Scheduled,138,,,,15,
University of Calgary,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,29137,Positive,Adult,,Post-4th,24-Jun-22,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,56,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,4137,5,June,2022,,,,128,Completed,10000+,N/A,28,Scheduled,99,Scheduled,138,,,,128,
University of Calgary,,Female,CD,Vedolizumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,22215,Positive,Adult,,Post-2nd (8+ Weeks),10-Aug-21,baseline,29-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,38,30-39,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3155,1,August,2021,,56,,,Completed,10000+,N/A,47,Scheduled,105,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.24,Negative,13806,Positive,Adult,,Post-3rd (8+ Weeks),09-Dec-21,baseline,29-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,38,30-39,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1960,2,December,2021,,,72,,Completed,10000+,N/A,47,Scheduled,105,Scheduled,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,,0.2,Negative,566,Positive,Adult,203,Pre-1st,15-Mar-21,covid,15-Apr-21,Moderna,13-Jun-21,Moderna,31-Dec-21,Moderna,,,,,28,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,80,1,March,2021,,,,,Completed,250-999,N/A,59,Delayed,201,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,,0.05,Negative,9647,Positive,Adult,522,Post-3rd (1-8 Weeks),28-Jan-22,covid,15-Apr-21,Moderna,13-Jun-21,Moderna,31-Dec-21,Moderna,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1370,2,January,2022,,,28,,Completed,,N/A,59,Delayed,201,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2,Negative,Adult,123,Pre-1st,10-Feb-21,Post Vaccine covid,31-Mar-21,Pfizer,11-Jun-21,Pfizer,02-Sep-21,Pfizer,31-Mar-22,Pfizer,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,February,2021,,,,,Completed,0-49,123 Days Before Collection Days After Collection,72,Delayed,83,Scheduled,210,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.4,Negative,34,Negative,Adult,142,Pre-1st,25-Feb-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,February,2021,,,,,Completed,0-49,N/A,51,Scheduled,208,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.22,Negative,3486,Positive,Adult,225,Post-1st,19-May-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,495,2,May,2021,33,,,,Completed,1000-4999,N/A,51,Scheduled,208,Delayed,,33,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,,Adult,282,Post-2nd (1-8 Weeks),15-Jul-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,3,July,2021,,39,,,Processed,,N/A,51,Scheduled,208,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.12,Negative,213,Positive,Adult,444,Post-2nd (8+ Weeks),24-Dec-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,30,4,December,2021,,201,,,Completed,50-249,N/A,51,Scheduled,208,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.11,Negative,2168,Positive,Adult,470,Post-3rd (1-8 Weeks),19-Jan-22,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,308,5,January,2022,,,19,,Completed,1000-4999,N/A,51,Scheduled,208,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.31,Positive,3666,Positive,Adult,582,Post-3rd (8+ Weeks),11-May-22,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,521,6,May,2022,,,131,,Completed,1000-4999,N/A,51,Scheduled,208,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,3.13,Positive,67844,Positive,Adult,,Post-3rd (8+ Weeks),06-Jul-22,baseline,27-Apr-21,Moderna,11-Jun-21,Moderna,21-Dec-21,Moderna,,,,,40,40-49,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9634,1,July,2022,,,197,,Completed,10000+,N/A,45,Scheduled,193,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,12249,Positive,Adult,-259,Post-2nd (1-8 Weeks),24-Jul-21,baseline,30-Apr-21,Pfizer,27-Jun-21,Moderna,03-Jan-22,Moderna,,,,,54,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1739,1,July,2021,,27,,,Completed,10000+,N/A,58,Delayed,190,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,3.9,Positive,39359,Positive,Adult,18,Post-3rd (8+ Weeks),27-Apr-22,baseline,30-Apr-21,Pfizer,27-Jun-21,Moderna,03-Jan-22,Moderna,,,,,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5589,2,April,2022,,,114,,Completed,10000+,N/A,58,Delayed,190,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,124,Positive,Adult,-301,Post-1st,13-Apr-21,baseline,30-Mar-21,Pfizer,06-May-21,Pfizer,19-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,April,2021,14,,,,Completed,50-249,N/A,37,Scheduled,136,Delayed,,14,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,6698,Positive,Adult,-124,Post-3rd (1-8 Weeks),07-Oct-21,baseline,30-Mar-21,Pfizer,06-May-21,Pfizer,19-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,951,2,October,2021,,,18,,Completed,,N/A,37,Scheduled,136,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,5778,Positive,Adult,-224,Post-2nd (1-8 Weeks),24-Jun-21,Post Vaccine covid,03-Apr-21,Pfizer,17-May-21,Pfizer,03-Sep-21,Pfizer,17-Feb-22,Pfizer,,,25,18-29,1,1,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,820,1,June,2021,,38,,,Completed,,N/A,44,Scheduled,109,Scheduled,167,,,,,
University of Calgary,,Female,CD,Combination Therapy,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,4.13,Positive,80000,Positive,Adult,43,Post-4th,18-Mar-22,Post Vaccine covid,03-Apr-21,Pfizer,17-May-21,Pfizer,03-Sep-21,Pfizer,17-Feb-22,Pfizer,,,26,18-29,1,1,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,2,March,2022,,,,29,Completed,10000+,N/A,44,Scheduled,109,Scheduled,167,,,,29,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,1873,Positive,Adult,-294,Post-1st,12-Feb-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,266,1,February,2021,40,,,,Completed,1000-4999,N/A,40,Scheduled,294,Delayed,147,40,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,31538,Positive,Adult,-287,Post-2nd (1-8 Weeks),19-Feb-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4478,2,February,2021,,7,,,Completed,10000+,N/A,40,Scheduled,294,Delayed,147,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,1.11,Positive,1655,Positive,Adult,0,Post-2nd (8+ Weeks),03-Dec-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,235,3,December,2021,,294,,,Completed,1000-4999,N/A,40,Scheduled,294,Delayed,147,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.69,Negative,14403,Positive,Adult,5,Post-2nd (8+ Weeks),08-Dec-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,2045,4,December,2021,,299,,,Completed,10000+,N/A,40,Scheduled,294,Delayed,147,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,7.35,Positive,754,Positive,Adult,25,Pre-1st,09-Dec-20,covid,06-Jul-21,Moderna,28-Sep-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107,1,December,2020,,,,,Completed,250-999,N/A,84,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.25,Negative,2448,Positive,Adult,304,Post-1st,14-Sep-21,covid,06-Jul-21,Moderna,28-Sep-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,348,2,September,2021,70,,,,Completed,1000-4999,N/A,84,Delayed,,Delayed,,70,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2,Negative,Adult,238,Pre-1st,18-Jan-21,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,January,2021,,,,,Completed,0-49,N/A,62,Delayed,183,Delayed,151,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,929,Positive,Adult,408,Post-2nd (1-8 Weeks),07-Jul-21,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,132,2,July,2021,,28,,,Completed,250-999,N/A,62,Delayed,183,Delayed,151,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.16,Negative,6691,Positive,Adult,590,Post-3rd (1-8 Weeks),05-Jan-22,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,950,3,January,2022,,,27,,Completed,,N/A,62,Delayed,183,Delayed,151,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,2010,Positive,Adult,696,Post-3rd (8+ Weeks),21-Apr-22,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,285,4,April,2022,,,133,,Completed,1000-4999,N/A,62,Delayed,183,Delayed,151,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.14,Negative,5866,Positive,Adult,738,Post-4th,02-Jun-22,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,833,5,June,2022,,,,24,Completed,,N/A,62,Delayed,183,Delayed,151,,,,24,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,2.02,Positive,243,Positive,Adult,101,Pre-1st,26-Feb-21,covid,22-Apr-21,Pfizer,20-Jun-21,Pfizer,,,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,1,February,2021,,,,,Completed,50-249,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.28,Negative,12233,Positive,Adult,273,Post-2nd (8+ Weeks),17-Aug-21,covid,22-Apr-21,Pfizer,20-Jun-21,Pfizer,,,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1737,2,August,2021,,58,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.83,Positive,983,Positive,Adult,119,Pre-1st,24-Mar-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,46,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,140,1,March,2021,,,,,Completed,250-999,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.57,Negative,25010,Positive,Adult,199,Post-1st,12-Jun-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,46,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3551,2,June,2021,20,,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,20,,,,
University of Calgary,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.54,Negative,78173,Positive,Adult,238,Post-2nd (1-8 Weeks),21-Jul-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,46,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11101,3,July,2021,,18,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.46,Negative,12262,Positive,Adult,378,Post-2nd (8+ Weeks),08-Dec-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,47,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1741,4,December,2021,,158,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,164,Positive,Adult,-359,Post-1st,12-May-21,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,23,1,May,2021,32,,,,Completed,50-249,N/A,49,Scheduled,206,Delayed,,32,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,1153,Positive,Adult,-319,Post-2nd (1-8 Weeks),21-Jun-21,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,164,2,June,2021,,23,,,Completed,1000-4999,N/A,49,Scheduled,206,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,170,Positive,Adult,-239,Post-2nd (8+ Weeks),09-Sep-21,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,3,September,2021,,103,,,Completed,50-249,N/A,49,Scheduled,206,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,4787,Positive,Adult,-105,Post-3rd (1-8 Weeks),21-Jan-22,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,680,4,January,2022,,,31,,Completed,1000-4999,N/A,49,Scheduled,206,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,1980,Positive,Adult,-236,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,281,1,July,2021,,40,,,Completed,1000-4999,N/A,57,Delayed,210,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,143,Positive,Adult,-98,Post-2nd (8+ Weeks),07-Dec-21,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,20,2,December,2021,,178,,,Completed,50-249,N/A,57,Delayed,210,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,6599,Positive,Adult,-32,Post-3rd (1-8 Weeks),11-Feb-22,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,937,3,February,2022,,,34,,Completed,,N/A,57,Delayed,210,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.18,Negative,9581,Positive,Adult,73,Post-3rd (8+ Weeks),27-May-22,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1361,4,May,2022,,,139,,Completed,,N/A,57,Delayed,210,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3,Negative,Adult,,Pre-1st,01-Mar-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,125,Delayed,244,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,163,Positive,Adult,,Post-1st,03-May-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,23,2,May,2021,51,,,,Completed,50-249,N/A,71,Delayed,125,Delayed,244,51,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,1897,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,269,3,July,2021,,43,,,Completed,1000-4999,N/A,71,Delayed,125,Delayed,244,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,795,Positive,Adult,,Post-2nd (8+ Weeks),03-Sep-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,113,4,September,2021,,103,,,Completed,250-999,N/A,71,Delayed,125,Delayed,244,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,54482,Positive,Adult,,Post-3rd (1-8 Weeks),12-Oct-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,7736,5,October,2021,,,17,,Completed,10000+,N/A,71,Delayed,125,Delayed,244,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,2089,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,297,6,February,2022,,,143,,Completed,1000-4999,N/A,71,Delayed,125,Delayed,244,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,31314,Positive,Elderly,,Post-4th,10-Jun-22,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4447,7,June,2022,,,,14,Completed,10000+,N/A,71,Delayed,125,Delayed,244,,,,14,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.02,Negative,2755,Positive,Adult,-198,Post-2nd (1-8 Weeks),04-Aug-21,Post Vaccine covid,20-Apr-21,Moderna,30-Jun-21,Moderna,26-Mar-22,Moderna,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,391,1,August,2021,,35,,,Completed,1000-4999,N/A,71,Delayed,269,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.68,Negative,11154,Positive,Adult,21,Post-2nd (8+ Weeks),11-Mar-22,Post Vaccine covid,20-Apr-21,Moderna,30-Jun-21,Moderna,26-Mar-22,Moderna,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1584,2,March,2022,,254,,,Completed,10000+,N/A,71,Delayed,269,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,240,Positive,Adult,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,34,1,July,2021,,22,,,Completed,50-249,N/A,65,Delayed,104,Scheduled,161,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,1911,Positive,Adult,,Post-3rd (1-8 Weeks),08-Nov-21,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,271,2,November,2021,,,41,,Completed,1000-4999,N/A,65,Delayed,104,Scheduled,161,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,138,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,20,3,February,2022,,,128,,Completed,50-249,N/A,65,Delayed,104,Scheduled,161,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,2150,Positive,Adult,,Post-4th,04-Apr-22,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,305,4,April,2022,,,,27,Completed,1000-4999,N/A,65,Delayed,104,Scheduled,161,,,,27,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,373,Positive,Adult,,Post-4th,20-Jul-22,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,53,5,July,2022,,,,134,Completed,250-999,N/A,65,Delayed,104,Scheduled,161,,,,134,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,2.88,Positive,7,Negative,Adult,-220,Pre-1st,14-Dec-20,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,December,2020,,,,,Completed,0-49,N/A,60,Delayed,105,Scheduled,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,2.51,Positive,,,Adult,-71,Post-1st,12-May-21,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,May,2021,26,,,,Processed,,N/A,60,Delayed,105,Scheduled,,26,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.75,Positive,1832,Positive,Adult,0,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,260,3,July,2021,,37,,,Completed,1000-4999,N/A,60,Delayed,105,Scheduled,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,2.38,Positive,6868,Positive,Adult,93,Post-3rd (1-8 Weeks),23-Oct-21,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,975,4,October,2021,,,25,,Completed,,N/A,60,Delayed,105,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,2.93,Positive,195,Positive,Adult,37,Pre-1st,06-Jan-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,28,1,January,2021,,,,,Completed,50-249,N/A,33,Scheduled,132,Delayed,210,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.37,Positive,117,Positive,Adult,71,Pre-1st,09-Feb-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,17,2,February,2021,,,,,Completed,50-249,N/A,33,Scheduled,132,Delayed,210,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,2464,Positive,Adult,183,Post-2nd (1-8 Weeks),01-Jun-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,350,3,June,2021,,11,,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.18,Negative,2094,Positive,Adult,233,Post-2nd (8+ Weeks),21-Jul-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,297,4,July,2021,,61,,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.17,Negative,1293,Positive,Adult,291,Post-2nd (8+ Weeks),17-Sep-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,184,5,September,2021,,119,,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.14,Negative,1216,Positive,Adult,395,Post-3rd (8+ Weeks),30-Dec-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,173,6,December,2021,,,91,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,3274,Positive,Adult,540,Post-4th,24-May-22,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,465,7,May,2022,,,,26,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,26,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,1613,Positive,Elderly,-321,Post-2nd (1-8 Weeks),07-Jul-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,07-Sep-21,Pfizer,21-Apr-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,229,1,July,2021,,27,,,Completed,1000-4999,N/A,75,Delayed,89,Scheduled,226,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.09,Negative,365,Positive,Elderly,-197,Post-3rd (8+ Weeks),08-Nov-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,07-Sep-21,Pfizer,21-Apr-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,52,2,November,2021,,,62,,Completed,250-999,N/A,75,Delayed,89,Scheduled,226,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.17,Negative,1,Negative,Adult,-210,Pre-1st,14-Jul-21,baseline,16-Sep-21,Moderna,14-Oct-21,Moderna,,,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,July,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,2914,Positive,Adult,,Post-2nd (1-8 Weeks),12-Jul-21,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,414,1,July,2021,,26,,,Completed,1000-4999,N/A,68,Delayed,86,Scheduled,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,4543,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,645,2,November,2021,,,54,,Completed,1000-4999,N/A,68,Delayed,86,Scheduled,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,2112,Positive,Adult,,Post-3rd (8+ Weeks),18-Jan-22,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,300,3,January,2022,,,130,,Completed,1000-4999,N/A,68,Delayed,86,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,135,Positive,Elderly,-280,Post-1st,24-Apr-21,Post Vaccine covid,25-Mar-21,Pfizer,19-Jun-21,Pfizer,,,,,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,1,April,2021,30,,,,Completed,50-249,N/A,86,Delayed,,Delayed,,30,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.41,Negative,3685,Positive,Elderly,-203,Post-2nd (1-8 Weeks),10-Jul-21,Post Vaccine covid,25-Mar-21,Pfizer,19-Jun-21,Pfizer,,,,,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,523,2,July,2021,,21,,,Completed,1000-4999,N/A,86,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,544,Positive,Elderly,-75,Post-2nd (8+ Weeks),15-Nov-21,Post Vaccine covid,25-Mar-21,Pfizer,19-Jun-21,Pfizer,,,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77,3,November,2021,,149,,,Completed,250-999,N/A,86,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,1.33,Positive,27496,Positive,Elderly,158,Post-2nd (8+ Weeks),06-Jul-22,Post Vaccine covid,25-Mar-21,Pfizer,19-Jun-21,Pfizer,,,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3904,4,July,2022,,382,,,Completed,10000+,N/A,86,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.09,Negative,1014,Positive,Adult,,Post-2nd (1-8 Weeks),09-Aug-21,baseline,09-Apr-21,Pfizer,18-Jun-21,Pfizer,07-Dec-21,Pfizer,09-May-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,144,1,August,2021,,52,,,Completed,1000-4999,N/A,70,Delayed,172,Delayed,153,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.24,Positive,16365,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,09-Apr-21,Pfizer,18-Jun-21,Pfizer,07-Dec-21,Pfizer,09-May-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2324,2,February,2022,,,63,,Completed,10000+,N/A,70,Delayed,172,Delayed,153,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,137,Positive,Adult,-185,Post-2nd (1-8 Weeks),29-Jul-21,Post Vaccine covid,23-Mar-21,AstraZeneca,07-Jun-21,Pfizer,04-Sep-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,19,1,July,2021,,52,,,Completed,50-249,N/A,76,Delayed,89,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.37,Negative,623,Positive,Adult,-93,Post-3rd (1-8 Weeks),29-Oct-21,Post Vaccine covid,23-Mar-21,AstraZeneca,07-Jun-21,Pfizer,04-Sep-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,88,2,October,2021,,,55,,Completed,250-999,N/A,76,Delayed,89,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.32,Negative,115,Positive,Adult,-10,Post-3rd (8+ Weeks),20-Jan-22,Post Vaccine covid,23-Mar-21,AstraZeneca,07-Jun-21,Pfizer,04-Sep-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,16,3,January,2022,,,138,,Completed,50-249,N/A,76,Delayed,89,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,3,Negative,Adult,,Pre-1st,16-Mar-21,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,57,Delayed,100,Scheduled,157,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,6178,Positive,Adult,,Post-3rd (1-8 Weeks),27-Oct-21,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,877,2,October,2021,,,30,,Completed,,N/A,57,Delayed,100,Scheduled,157,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,777,Positive,Adult,,Post-3rd (8+ Weeks),22-Feb-22,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,110,3,February,2022,,,148,,Completed,250-999,N/A,57,Delayed,100,Scheduled,157,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,5726,Positive,Adult,,Post-4th,19-Apr-22,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,813,4,April,2022,,,,47,Completed,,N/A,57,Delayed,100,Scheduled,157,,,,47,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2051,Positive,Adult,,Post-4th,21-Jul-22,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,291,5,July,2022,,,,140,Completed,1000-4999,N/A,57,Delayed,100,Scheduled,157,,,,140,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,357,Positive,Adult,-243,Post-2nd (8+ Weeks),03-Aug-21,baseline,30-Mar-21,Pfizer,06-May-21,Pfizer,25-Sep-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,51,1,August,2021,,89,,,Completed,250-999,N/A,37,Scheduled,142,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,4679,Positive,Adult,-137,Post-3rd (1-8 Weeks),17-Nov-21,baseline,30-Mar-21,Pfizer,06-May-21,Pfizer,25-Sep-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,664,2,November,2021,,,53,,Completed,1000-4999,N/A,37,Scheduled,142,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.58,Negative,23,Negative,Adult,159,Pre-1st,13-May-21,covid,04-Jun-21,Pfizer,03-Jul-21,Pfizer,23-Dec-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,May,2021,,,,,Completed,0-49,N/A,29,Scheduled,173,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,5836,Positive,Adult,256,Post-2nd (1-8 Weeks),18-Aug-21,covid,04-Jun-21,Pfizer,03-Jul-21,Pfizer,23-Dec-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,829,2,August,2021,,46,,,Completed,,N/A,29,Scheduled,173,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,4903,Positive,Adult,414,Post-3rd (1-8 Weeks),23-Jan-22,covid,04-Jun-21,Pfizer,03-Jul-21,Pfizer,23-Dec-21,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,696,3,January,2022,,,31,,Completed,1000-4999,N/A,29,Scheduled,173,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,,,Adult,,Post-2nd (1-8 Weeks),17-Jul-21,baseline,30-Apr-21,Pfizer,28-Jun-21,Pfizer,,,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,July,2021,,19,,,Processed,,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,6888,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Sep-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,978,1,July,2021,,32,,,Completed,,N/A,60,Delayed,96,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.15,Negative,2329,Positive,Adult,,Post-3rd (1-8 Weeks),11-Nov-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Sep-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,331,2,November,2021,,,47,,Completed,1000-4999,N/A,60,Delayed,96,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.2,Positive,15402,Positive,Adult,,Post-3rd (8+ Weeks),09-Feb-22,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Sep-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2187,3,February,2022,,,137,,Completed,10000+,N/A,60,Delayed,96,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,3822,Positive,Adult,-211,Post-2nd (1-8 Weeks),18-Jun-21,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,543,1,June,2021,,47,,,Completed,1000-4999,N/A,48,Scheduled,126,Delayed,234,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,3273,Positive,Adult,-133,Post-2nd (8+ Weeks),04-Sep-21,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,465,2,September,2021,,125,,,Completed,1000-4999,N/A,48,Scheduled,126,Delayed,234,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,5102,Positive,Adult,-69,Post-3rd (8+ Weeks),07-Nov-21,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,725,3,November,2021,,,63,,Completed,,N/A,48,Scheduled,126,Delayed,234,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2497,Positive,Adult,-9,Post-3rd (8+ Weeks),06-Jan-22,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,355,4,January,2022,,,123,,Completed,1000-4999,N/A,48,Scheduled,126,Delayed,234,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.23,Negative,860,Positive,Adult,-292,Post-1st,19-Jun-21,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,122,1,June,2021,44,,,,Completed,250-999,N/A,63,Delayed,123,Delayed,,44,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.45,Negative,18776,Positive,Adult,-251,Post-2nd (1-8 Weeks),30-Jul-21,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2666,2,July,2021,,22,,,Completed,10000+,N/A,63,Delayed,123,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.46,Negative,55364,Positive,Adult,-133,Post-3rd (1-8 Weeks),25-Nov-21,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7862,3,November,2021,,,17,,Completed,10000+,N/A,63,Delayed,123,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.27,Negative,10208,Positive,Adult,-17,Post-3rd (8+ Weeks),21-Mar-22,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1449,4,March,2022,,,133,,Completed,10000+,N/A,63,Delayed,123,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,0,Negative,Adult,83,Pre-1st,18-Dec-20,covid,02-May-21,Pfizer,28-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,36,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,December,2020,,,,,Completed,0-49,N/A,57,Delayed,207,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,20683,Positive,Adult,293,Post-2nd (1-8 Weeks),16-Jul-21,covid,02-May-21,Pfizer,28-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,37,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2937,2,July,2021,,18,,,Completed,10000+,N/A,57,Delayed,207,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.31,Negative,47180,Positive,Adult,607,Post-3rd (8+ Weeks),26-May-22,covid,02-May-21,Pfizer,28-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,37,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6700,3,May,2022,,,125,,Completed,10000+,N/A,57,Delayed,207,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.22,Negative,148,Positive,Adult,57,Pre-1st,26-Jan-21,covid,21-Apr-21,Pfizer,11-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,21,1,January,2021,,,,,Completed,50-249,N/A,51,Scheduled,89,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,791,Positive,Adult,226,Post-2nd (1-8 Weeks),14-Jul-21,covid,21-Apr-21,Pfizer,11-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,112,2,July,2021,,33,,,Completed,250-999,N/A,51,Scheduled,89,Scheduled,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.51,Positive,450,Positive,Adult,73,Pre-1st,04-Feb-21,covid,26-Apr-21,Moderna,26-Jun-21,Moderna,14-Dec-21,Pfizer,,,,,49,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,64,1,February,2021,,,,,Completed,250-999,N/A,61,Delayed,171,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,7074,Positive,Adult,217,Post-1st,28-Jun-21,covid,26-Apr-21,Moderna,26-Jun-21,Moderna,14-Dec-21,Pfizer,,,,,50,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1005,2,June,2021,63,,,,Completed,,N/A,61,Delayed,171,Delayed,,63,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,5111,Positive,Adult,240,Post-2nd (1-8 Weeks),21-Jul-21,covid,26-Apr-21,Moderna,26-Jun-21,Moderna,14-Dec-21,Pfizer,,,,,50,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,726,3,July,2021,,25,,,Completed,,N/A,61,Delayed,171,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,1150,Positive,Adult,336,Post-2nd (8+ Weeks),25-Oct-21,covid,26-Apr-21,Moderna,26-Jun-21,Moderna,14-Dec-21,Pfizer,,,,,50,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,163,4,October,2021,,121,,,Completed,1000-4999,N/A,61,Delayed,171,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,4.65,Positive,1672,Positive,Adult,78,Pre-1st,01-Feb-21,covid,16-Apr-21,Pfizer,08-May-21,Pfizer,07-Oct-21,Pfizer,,,,,53,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,237,1,February,2021,,,,,Completed,1000-4999,N/A,22,Scheduled,152,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.16,Negative,6765,Positive,Adult,257,Post-2nd (8+ Weeks),30-Jul-21,covid,16-Apr-21,Pfizer,08-May-21,Pfizer,07-Oct-21,Pfizer,,,,,53,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,961,2,July,2021,,83,,,Completed,,N/A,22,Scheduled,152,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.44,Negative,19615,Positive,Adult,347,Post-3rd (1-8 Weeks),28-Oct-21,covid,16-Apr-21,Pfizer,08-May-21,Pfizer,07-Oct-21,Pfizer,,,,,53,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2785,3,October,2021,,,21,,Completed,10000+,N/A,22,Scheduled,152,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.17,Positive,3391,Positive,Adult,491,Post-3rd (8+ Weeks),21-Mar-22,covid,16-Apr-21,Pfizer,08-May-21,Pfizer,07-Oct-21,Pfizer,,,,,54,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,481,4,March,2022,,,165,,Completed,1000-4999,N/A,22,Scheduled,152,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,199,Positive,Adult,,Post-2nd (8+ Weeks),14-Oct-21,baseline,14-Jan-21,Pfizer,24-Feb-21,Pfizer,20-Jan-22,Moderna,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,1,October,2021,,232,,,Completed,50-249,N/A,41,Scheduled,330,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,7,Negative,Adult,,Pre-1st,30-Dec-20,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,54,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,1,1,December,2020,,,,,Completed,0-49,N/A,64,Delayed,185,Delayed,153,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,3665,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,55,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,520,2,July,2021,,31,,,Completed,1000-4999,N/A,64,Delayed,185,Delayed,153,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,49964,Positive,Adult,,Post-3rd (1-8 Weeks),19-Jan-22,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,55,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,7095,3,January,2022,,,35,,Completed,10000+,N/A,64,Delayed,185,Delayed,153,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,2.91,Positive,40000,Positive,Adult,,Post-3rd (8+ Weeks),19-May-22,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,55,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,5680,4,May,2022,,,155,,Completed,10000+,N/A,64,Delayed,185,Delayed,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,736,Positive,Adult,-64,Post-3rd (8+ Weeks),19-Jan-22,baseline,12-Apr-21,Moderna,12-May-21,Moderna,22-Sep-21,Moderna,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,104,1,January,2022,,,119,,Completed,250-999,N/A,30,Scheduled,133,Delayed,,,,,,
University of Calgary,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,3706,Positive,Adult,-176,Post-2nd (1-8 Weeks),30-Jul-21,Post Vaccine covid,19-Apr-21,Moderna,15-Jun-21,Moderna,05-Jan-22,Moderna,,,,,41,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,526,1,July,2021,,45,,,Completed,1000-4999,N/A,57,Delayed,204,Delayed,,,,,,
University of Calgary,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.81,Positive,10049,Positive,Adult,10,Post-3rd (1-8 Weeks),01-Feb-22,Post Vaccine covid,19-Apr-21,Moderna,15-Jun-21,Moderna,05-Jan-22,Moderna,,,,,42,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1427,2,February,2022,,,27,,Completed,10000+,N/A,57,Delayed,204,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,25,Negative,Elderly,,Post-1st,28-Apr-21,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3,1,April,2021,34,,,,Completed,0-49,N/A,81,Delayed,108,Scheduled,174,34,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,1291,Positive,Elderly,,Post-2nd (1-8 Weeks),28-Jul-21,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,183,2,July,2021,,44,,,Completed,1000-4999,N/A,81,Delayed,108,Scheduled,174,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,7864,Positive,Elderly,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1117,3,October,2021,,,28,,Completed,,N/A,81,Delayed,108,Scheduled,174,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,1173,Positive,Elderly,,Post-3rd (8+ Weeks),24-Feb-22,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,167,4,February,2022,,,147,,Completed,1000-4999,N/A,81,Delayed,108,Scheduled,174,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,10517,Positive,Elderly,,Post-4th,20-Apr-22,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1493,5,April,2022,,,,28,Completed,10000+,N/A,81,Delayed,108,Scheduled,174,,,,28,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,85,Positive,Adult,,Post-1st,18-Jun-21,baseline,24-Apr-21,Moderna,16-Jun-21,Moderna,15-Oct-21,Moderna,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,1,June,2021,55,,,,Completed,50-249,N/A,53,Scheduled,121,Delayed,,55,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,1023,Positive,Adult,,Post-2nd (8+ Weeks),08-Oct-21,baseline,24-Apr-21,Moderna,16-Jun-21,Moderna,15-Oct-21,Moderna,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,145,2,October,2021,,114,,,Completed,1000-4999,N/A,53,Scheduled,121,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,1114,Positive,Adult,-368,Post-2nd (1-8 Weeks),14-Jul-21,baseline,14-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,158,1,July,2021,,29,,,Completed,1000-4999,N/A,62,Delayed,106,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,3093,Positive,Adult,-262,Post-3rd (1-8 Weeks),28-Oct-21,baseline,14-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,439,2,October,2021,,,29,,Completed,1000-4999,N/A,62,Delayed,106,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,659,Positive,Adult,-165,Post-3rd (8+ Weeks),02-Feb-22,baseline,14-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,94,3,February,2022,,,126,,Completed,250-999,N/A,62,Delayed,106,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,159,Positive,Adult,-259,Post-1st,14-Jun-21,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,23,1,June,2021,46,,,,Completed,50-249,N/A,53,Scheduled,157,Delayed,181,46,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,5015,Positive,Adult,-238,Post-2nd (1-8 Weeks),05-Jul-21,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,712,2,July,2021,,14,,,Completed,,N/A,53,Scheduled,157,Delayed,181,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,625,Positive,Adult,-101,Post-2nd (8+ Weeks),19-Nov-21,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,89,3,November,2021,,151,,,Completed,250-999,N/A,53,Scheduled,157,Delayed,181,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,4015,Positive,Adult,-68,Post-3rd (1-8 Weeks),22-Dec-21,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,570,4,December,2021,,,27,,Completed,1000-4999,N/A,53,Scheduled,157,Delayed,181,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.47,Negative,31079,Positive,Adult,63,Post-3rd (8+ Weeks),02-May-22,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4413,5,May,2022,,,158,,Completed,10000+,N/A,53,Scheduled,157,Delayed,181,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.17,Negative,3210,Positive,Adult,-173,Post-2nd (8+ Weeks),11-Aug-21,baseline,10-Apr-21,Pfizer,11-Jun-21,Pfizer,28-Sep-21,Pfizer,27-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,456,1,August,2021,,61,,,Completed,1000-4999,N/A,62,Delayed,109,Scheduled,241,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.27,Negative,16613,Positive,Adult,-89,Post-3rd (1-8 Weeks),03-Nov-21,baseline,10-Apr-21,Pfizer,11-Jun-21,Pfizer,28-Sep-21,Pfizer,27-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2359,2,November,2021,,,36,,Completed,10000+,N/A,62,Delayed,109,Scheduled,241,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,3.33,Positive,29255,Positive,Adult,14,Post-3rd (8+ Weeks),14-Feb-22,baseline,10-Apr-21,Pfizer,11-Jun-21,Pfizer,28-Sep-21,Pfizer,27-May-22,Moderna,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4154,3,February,2022,,,139,,Completed,10000+,N/A,62,Delayed,109,Scheduled,241,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Vedolizumab Only,,0.05,Negative,1,Negative,Adult,,Pre-1st,23-Mar-21,baseline,17-Apr-21,Pfizer,27-Aug-21,Pfizer,03-Nov-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,132,Delayed,68,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Vedolizumab Only,,0.05,Negative,73,Positive,Adult,,Post-1st,17-May-21,baseline,17-Apr-21,Pfizer,27-Aug-21,Pfizer,03-Nov-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,2,May,2021,30,,,,Completed,50-249,N/A,132,Delayed,68,Scheduled,,30,,,,
University of Calgary,,Female,UC,Anti-TNF Only,No Immunosuppressives,No Immunosuppressives,,,0.32,Negative,1633,Positive,Adult,,Post-2nd (8+ Weeks),12-Jul-22,New biologic/Tofacitinib start,20-Apr-21,Pfizer,11-Jun-21,Pfizer,,,,,,,56,50-59,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,232,1,July,2022,,396,,,Completed,1000-4999,N/A,52,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,774,Positive,Elderly,,Post-1st,26-Apr-21,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,110,1,April,2021,33,,,,Completed,250-999,N/A,50,Scheduled,186,Delayed,150,33,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,2690,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,382,2,June,2021,,39,,,Completed,1000-4999,N/A,50,Scheduled,186,Delayed,150,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.4,Negative,1286,Positive,Elderly,,Post-2nd (8+ Weeks),13-Oct-21,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,183,3,October,2021,,153,,,Completed,1000-4999,N/A,50,Scheduled,186,Delayed,150,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.32,Negative,33233,Positive,Elderly,,Post-3rd (1-8 Weeks),13-Dec-21,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4719,4,December,2021,,,28,,Completed,10000+,N/A,50,Scheduled,186,Delayed,150,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,3.03,Positive,40000,Positive,Elderly,,Post-4th,30-May-22,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5680,5,May,2022,,,,46,Completed,10000+,N/A,50,Scheduled,186,Delayed,150,,,,46,
University of Calgary,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.04,Negative,197,Positive,Elderly,,Post-1st,05-May-21,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,68,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,28,1,May,2021,28,,,,Completed,50-249,N/A,70,Delayed,229,Delayed,,28,,,,
University of Calgary,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.07,Negative,7874,Positive,Elderly,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,68,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1118,2,July,2021,,23,,,Completed,,N/A,70,Delayed,229,Delayed,,,,,,
University of Calgary,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,1.78,Positive,80000,Positive,Elderly,,Post-3rd (1-8 Weeks),16-Feb-22,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,69,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,3,February,2022,,,16,,Completed,10000+,N/A,70,Delayed,229,Delayed,,,,,,
University of Calgary,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,2.09,Positive,14475,Positive,Elderly,,Post-3rd (8+ Weeks),29-Jun-22,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,69,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2055,4,June,2022,,,149,,Completed,10000+,N/A,70,Delayed,229,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.77,Positive,653,Positive,Adult,0,Post-2nd (1-8 Weeks),20-Jul-21,baseline,17-Apr-21,Pfizer,25-Jun-21,Pfizer,14-Dec-21,Pfizer,31-May-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,93,1,July,2021,,25,,,Completed,250-999,N/A,69,Delayed,172,Delayed,168,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.59,Negative,461,Positive,Adult,252,Post-3rd (8+ Weeks),29-Mar-22,baseline,17-Apr-21,Pfizer,25-Jun-21,Pfizer,14-Dec-21,Pfizer,31-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,65,2,March,2022,,,105,,Completed,250-999,N/A,69,Delayed,172,Delayed,168,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.83,Positive,10002,Positive,Adult,67,Post-1st,16-Feb-21,Post Vaccine covid,17-Jan-21,Moderna,27-Feb-21,Moderna,12-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1420,1,February,2021,30,,,,Completed,10000+,N/A,41,Scheduled,319,Delayed,,30,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.69,Negative,953,Positive,Adult,213,Post-2nd (8+ Weeks),12-Jul-21,Post Vaccine covid,17-Jan-21,Moderna,27-Feb-21,Moderna,12-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,135,2,July,2021,,135,,,Completed,250-999,N/A,41,Scheduled,319,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,7.01,Positive,6379,Positive,Adult,473,Post-3rd (8+ Weeks),29-Mar-22,Post Vaccine covid,17-Jan-21,Moderna,27-Feb-21,Moderna,12-Jan-22,Moderna,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,906,3,March,2022,,,76,,Completed,,N/A,41,Scheduled,319,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,1,Negative,Adult,-273,Pre-1st,07-Apr-21,Post Vaccine covid,16-May-21,Pfizer,30-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,56,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,45,Scheduled,190,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,2.92,Positive,40000,Positive,Adult,119,Post-3rd (8+ Weeks),04-May-22,Post Vaccine covid,16-May-21,Pfizer,30-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,57,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5680,2,May,2022,,,118,,Completed,10000+,N/A,45,Scheduled,190,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,2,Negative,Adult,-281,Pre-1st,15-Apr-21,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,10012,Positive,Adult,-197,Post-2nd (1-8 Weeks),08-Jul-21,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1422,2,July,2021,,13,,,Completed,10000+,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.05,Negative,135,Positive,Adult,-30,Post-2nd (8+ Weeks),22-Dec-21,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,3,December,2021,,180,,,Completed,50-249,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.08,Negative,14106,Positive,Adult,7,Post-2nd (8+ Weeks),28-Jan-22,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2003,4,January,2022,,217,,,Completed,10000+,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.15,Negative,3421,Positive,Adult,,Post-2nd (8+ Weeks),14-Aug-21,baseline,12-Apr-21,Pfizer,19-Jun-21,Pfizer,03-Jan-22,Pfizer,17-Jun-22,Pfizer,,,34,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,486,1,August,2021,,56,,,Completed,1000-4999,N/A,68,Delayed,198,Delayed,165,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.14,Negative,39976,Positive,Adult,,Post-3rd (1-8 Weeks),29-Jan-22,baseline,12-Apr-21,Pfizer,19-Jun-21,Pfizer,03-Jan-22,Pfizer,17-Jun-22,Pfizer,,,34,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,5677,2,January,2022,,,26,,Completed,10000+,N/A,68,Delayed,198,Delayed,165,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,,,,,6.66,Positive,1468,Positive,Adult,31,,16-Dec-20,covid,,,,,,,,,,,36,30-39,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,208,1,December,2020,,,,,Completed,1000-4999,31 Days Before Collection Days After Collection,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,2801,Positive,Adult,-173,Post-2nd (1-8 Weeks),28-Jul-21,Post Vaccine covid,24-Apr-21,Pfizer,04-Jun-21,Pfizer,,,,,,,24,18-29,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,398,1,July,2021,,54,,,Completed,1000-4999,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,465,Positive,Adult,-6,Post-2nd (8+ Weeks),11-Jan-22,Post Vaccine covid,24-Apr-21,Pfizer,04-Jun-21,Pfizer,,,,,,,25,18-29,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,66,2,January,2022,,221,,,Completed,250-999,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,2879,Positive,Elderly,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,12-Apr-21,Pfizer,01-Jul-21,Pfizer,05-Jan-22,Pfizer,12-Jul-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,409,1,July,2021,,7,,,Completed,1000-4999,N/A,80,Delayed,188,Delayed,188,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.52,Negative,485,Positive,Adult,37,Pre-1st,29-Dec-20,covid,18-Oct-21,Pfizer,17-Nov-21,Pfizer,16-May-22,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,69,1,December,2020,,,,,Completed,250-999,N/A,30,Scheduled,180,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,185,Positive,Adult,268,Pre-1st,17-Aug-21,covid,18-Oct-21,Pfizer,17-Nov-21,Pfizer,16-May-22,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,2,August,2021,,,,,Completed,50-249,N/A,30,Scheduled,180,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,4.84,Positive,17139,Positive,Adult,13,Post-2nd (8+ Weeks),18-Jan-22,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Feb-22,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2434,1,January,2022,,219,,,Completed,10000+,N/A,60,Delayed,240,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.2,Negative,6023,Positive,Adult,145,Post-3rd (8+ Weeks),30-May-22,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Feb-22,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,855,2,May,2022,,,111,,Completed,,N/A,60,Delayed,240,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,,,,,0.03,Negative,,,Adult,,,07-Oct-21,baseline,,,,,,,,,,,55,50-59,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,October,2021,,,,,Processed,,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,,,,,0.28,Negative,5,Negative,Adult,,,05-Apr-21,baseline,,,,,,,,,,,45,40-49,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,2493,Positive,Adult,-221,Post-2nd (1-8 Weeks),15-Jun-21,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,27,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,354,1,June,2021,,25,,,Completed,1000-4999,N/A,29,Scheduled,240,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,358,Positive,Adult,-127,Post-2nd (8+ Weeks),17-Sep-21,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,51,2,September,2021,,119,,,Completed,250-999,N/A,29,Scheduled,240,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.3,Positive,10160,Positive,Adult,32,Post-3rd (1-8 Weeks),23-Feb-22,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1443,3,February,2022,,,38,,Completed,10000+,N/A,29,Scheduled,240,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.15,Negative,10169,Positive,Adult,151,Post-3rd (8+ Weeks),22-Jun-22,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1444,4,June,2022,,,157,,Completed,10000+,N/A,29,Scheduled,240,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,232,Positive,Elderly,,Post-1st,17-May-21,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,33,1,May,2021,58,,,,Completed,50-249,N/A,83,Delayed,185,Delayed,224,58,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,11516,Positive,Elderly,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1635,2,July,2021,,46,,,Completed,10000+,N/A,83,Delayed,185,Delayed,224,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,28755,Positive,Elderly,,Post-3rd (1-8 Weeks),26-Jan-22,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4083,3,January,2022,,,44,,Completed,10000+,N/A,83,Delayed,185,Delayed,224,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,7827,Positive,Elderly,,Post-3rd (8+ Weeks),20-Apr-22,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1111,4,April,2022,,,128,,Completed,,N/A,83,Delayed,185,Delayed,224,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.92,Positive,980,Positive,Adult,60,Pre-1st,08-Apr-21,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,139,1,April,2021,,,,,Completed,250-999,N/A,64,Delayed,221,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,1.6,Positive,14007,Positive,Adult,93,Post-1st,11-May-21,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1989,2,May,2021,37,,,,Completed,10000+,N/A,64,Delayed,221,Delayed,,37,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.56,Negative,21748,Positive,Adult,166,Post-2nd (1-8 Weeks),23-Jul-21,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3088,3,July,2021,,46,,,Completed,10000+,N/A,64,Delayed,221,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.29,Negative,2992,Positive,Adult,331,Post-2nd (8+ Weeks),04-Jan-22,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,425,4,January,2022,,211,,,Completed,1000-4999,N/A,64,Delayed,221,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.27,Negative,38382,Positive,Adult,370,Post-3rd (1-8 Weeks),12-Feb-22,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5450,5,February,2022,,,29,,Completed,10000+,N/A,64,Delayed,221,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.19,Negative,22139,Positive,Adult,484,Post-3rd (8+ Weeks),06-Jun-22,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3144,6,June,2022,,,143,,Completed,10000+,N/A,64,Delayed,221,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,4,Negative,Adult,,Pre-1st,23-Jul-21,baseline,28-Aug-21,Pfizer,20-Sep-21,Pfizer,,,,,,,48,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,July,2021,,,,,Completed,0-49,N/A,23,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,,,Adult,224,Post-2nd (1-8 Weeks),21-Jul-21,Post Vaccine covid,26-Apr-21,Moderna,13-Jun-21,Moderna,,,,,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,July,2021,,38,,,Processed,,224 Days Before Collection Days After Collection,48,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,4569,Positive,Adult,400,Post-2nd (8+ Weeks),13-Jan-22,Post Vaccine covid,26-Apr-21,Moderna,13-Jun-21,Moderna,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,649,2,January,2022,,214,,,Completed,1000-4999,400 Days Before Collection Days Before Collection,48,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,1124,Positive,Adult,567,Post-2nd (8+ Weeks),29-Jun-22,Post Vaccine covid,26-Apr-21,Moderna,13-Jun-21,Moderna,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160,3,June,2022,,381,,,Completed,1000-4999,567 Days Before Collection Days Before Collection,48,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,186,Positive,Elderly,,Post-1st,14-Apr-21,baseline,09-Mar-21,Pfizer,16-Apr-21,Pfizer,16-Oct-21,Pfizer,,,,,78,70+,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,26,1,April,2021,36,,,,Completed,50-249,N/A,38,Scheduled,183,Delayed,,36,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,5019,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,09-Mar-21,Pfizer,16-Apr-21,Pfizer,16-Oct-21,Pfizer,,,,,78,70+,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,713,2,May,2021,,40,,,Completed,,N/A,38,Scheduled,183,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,593,Positive,Elderly,,Post-2nd (8+ Weeks),01-Sep-21,baseline,09-Mar-21,Pfizer,16-Apr-21,Pfizer,16-Oct-21,Pfizer,,,,,78,70+,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,84,3,September,2021,,138,,,Completed,250-999,N/A,38,Scheduled,183,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,8375,Positive,Elderly,,Post-3rd (8+ Weeks),07-Jan-22,baseline,09-Mar-21,Pfizer,16-Apr-21,Pfizer,16-Oct-21,Pfizer,,,,,79,70+,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1189,4,January,2022,,,83,,Completed,,N/A,38,Scheduled,183,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.11,Negative,597,Positive,Elderly,,Post-1st,05-Apr-21,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,85,1,April,2021,39,,,,Completed,250-999,N/A,41,Scheduled,195,Delayed,204,39,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,11702,Positive,Elderly,,Post-2nd (1-8 Weeks),27-May-21,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1662,2,May,2021,,50,,,Completed,10000+,N/A,41,Scheduled,195,Delayed,204,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,1961,Positive,Elderly,,Post-2nd (8+ Weeks),30-Aug-21,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,76,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,279,3,August,2021,,145,,,Completed,1000-4999,N/A,41,Scheduled,195,Delayed,204,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.37,Negative,20865,Positive,Elderly,,Post-3rd (8+ Weeks),04-Jan-22,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,76,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2963,4,January,2022,,,77,,Completed,10000+,N/A,41,Scheduled,195,Delayed,204,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,456,Positive,Adult,-335,Post-2nd (1-8 Weeks),10-Jun-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,19-Oct-21,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,65,1,June,2021,,20,,,Completed,250-999,N/A,29,Scheduled,151,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,84,Positive,Adult,-251,Post-2nd (8+ Weeks),02-Sep-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,19-Oct-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,12,2,September,2021,,104,,,Completed,50-249,N/A,29,Scheduled,151,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,2164,Positive,Adult,-190,Post-3rd (1-8 Weeks),02-Nov-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,19-Oct-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,307,3,November,2021,,,14,,Completed,1000-4999,N/A,29,Scheduled,151,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,189,Positive,Adult,-41,Post-3rd (8+ Weeks),31-Mar-22,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,19-Oct-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,27,4,March,2022,,,163,,Completed,50-249,N/A,29,Scheduled,151,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.39,Negative,1330,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,14-Mar-21,Pfizer,24-Apr-21,Pfizer,15-Oct-21,Pfizer,16-May-22,Pfizer,,,79,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,189,1,May,2021,,32,,,Completed,1000-4999,N/A,41,Scheduled,174,Delayed,213,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.24,Negative,206,Positive,Elderly,,Post-2nd (8+ Weeks),24-Aug-21,baseline,14-Mar-21,Pfizer,24-Apr-21,Pfizer,15-Oct-21,Pfizer,16-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,29,2,August,2021,,122,,,Completed,50-249,N/A,41,Scheduled,174,Delayed,213,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,1400,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,14-Mar-21,Pfizer,24-Apr-21,Pfizer,15-Oct-21,Pfizer,16-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,199,3,February,2022,,,111,,Completed,1000-4999,N/A,41,Scheduled,174,Delayed,213,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,17,Negative,Elderly,,Post-1st,29-Apr-21,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,1,April,2021,34,,,,Completed,0-49,N/A,74,Delayed,182,Delayed,,34,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,330,Positive,Elderly,,Post-2nd (1-8 Weeks),15-Jul-21,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,47,2,July,2021,,37,,,Completed,250-999,N/A,74,Delayed,182,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,4774,Positive,Elderly,,Post-3rd (8+ Weeks),03-Mar-22,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,678,3,March,2022,,,86,,Completed,1000-4999,N/A,74,Delayed,182,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,2646,Positive,Elderly,,Post-3rd (8+ Weeks),12-May-22,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,376,4,May,2022,,,156,,Completed,1000-4999,N/A,74,Delayed,182,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,129,Positive,Adult,,Post-1st,12-Jul-21,baseline,27-May-21,Pfizer,12-Jul-21,Pfizer,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,July,2021,46,,,,Completed,50-249,N/A,46,Scheduled,,Delayed,,46,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,574,Positive,Adult,,Post-2nd (8+ Weeks),24-Dec-21,baseline,27-May-21,Pfizer,12-Jul-21,Pfizer,,,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81,2,December,2021,,165,,,Completed,250-999,N/A,46,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,8229,Positive,Elderly,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1169,1,July,2021,,38,,,Completed,,N/A,61,Delayed,107,Scheduled,173,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.12,Negative,28042,Positive,Elderly,,Post-3rd (1-8 Weeks),27-Oct-21,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3982,2,October,2021,,,30,,Completed,10000+,N/A,61,Delayed,107,Scheduled,173,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.16,Negative,11064,Positive,Elderly,,Post-3rd (8+ Weeks),29-Jan-22,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1571,3,January,2022,,,124,,Completed,10000+,N/A,61,Delayed,107,Scheduled,173,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.29,Negative,58542,Positive,Elderly,,Post-4th,06-Apr-22,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,8313,4,April,2022,,,,18,Completed,10000+,N/A,61,Delayed,107,Scheduled,173,,,,18,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.12,Negative,9848,Positive,Elderly,,Post-4th,20-Jul-22,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1398,5,July,2022,,,,123,Completed,,N/A,61,Delayed,107,Scheduled,173,,,,123,
University of Calgary,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,0.05,Negative,276,Positive,Adult,,Post-2nd (8+ Weeks),23-Aug-21,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,51,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,39,1,August,2021,,87,,,Completed,250-999,N/A,52,Scheduled,97,Scheduled,196,,,,,
University of Calgary,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,0.05,Negative,5113,Positive,Adult,,Post-3rd (1-8 Weeks),22-Sep-21,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,51,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,726,2,September,2021,,,20,,Completed,,N/A,52,Scheduled,97,Scheduled,196,,,,,
University of Calgary,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,0.04,Negative,183,Positive,Adult,,Post-3rd (8+ Weeks),21-Jan-22,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,51,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,3,January,2022,,,141,,Completed,50-249,N/A,52,Scheduled,97,Scheduled,196,,,,,
University of Calgary,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,0.03,Negative,601,Positive,Adult,,Post-4th,26-Jun-22,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,52,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,85,4,June,2022,,,,101,Completed,250-999,N/A,52,Scheduled,97,Scheduled,196,,,,101,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1145,Positive,Adult,-215,Post-2nd (8+ Weeks),11-Aug-21,baseline,11-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,163,1,August,2021,,66,,,Completed,1000-4999,N/A,56,Scheduled,147,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,78052,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11083,1,July,2021,,26,,,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.11,Negative,29608,Positive,Adult,,Post-3rd (8+ Weeks),11-Jan-22,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4204,2,January,2022,,,130,,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.16,Negative,37945,Positive,Adult,,Post-4th,25-Mar-22,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5388,3,March,2022,,,,49,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,49,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,18113,Positive,Adult,,Post-4th,22-Jun-22,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2572,4,June,2022,,,,138,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,138,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,47,Negative,Adult,-190,Post-2nd (8+ Weeks),20-Jul-21,Post Vaccine covid,17-Dec-20,Pfizer,07-Jan-21,Pfizer,22-Sep-21,Pfizer,,,,,43,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,1,July,2021,,194,,,Completed,0-49,N/A,21,Scheduled,258,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,7.25,Positive,39388,Positive,Adult,13,Post-3rd (8+ Weeks),08-Feb-22,Post Vaccine covid,17-Dec-20,Pfizer,07-Jan-21,Pfizer,22-Sep-21,Pfizer,,,,,43,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5593,2,February,2022,,,139,,Completed,10000+,N/A,21,Scheduled,258,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,4,Negative,Adult,-427,Pre-1st,19-Mar-21,baseline,11-Apr-21,Pfizer,27-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,77,Delayed,93,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,121,Positive,Adult,-371,Post-1st,14-May-21,baseline,11-Apr-21,Pfizer,27-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,2,May,2021,33,,,,Completed,50-249,N/A,77,Delayed,93,Scheduled,,33,,,,
University of Calgary,,Male,UC,Anti-TNF Only,,,,,0.05,Negative,2,Negative,Adult,,,12-Jul-21,baseline,,,,,,,,,,,36,30-39,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,July,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.29,Negative,5,Negative,Elderly,,Post-2nd (1-8 Weeks),29-Apr-21,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,84,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,April,2021,,12,,,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,,,,Elderly,,Post-2nd (1-8 Weeks),27-May-21,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,84,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,,2,May,2021,,40,,,Processed,,N/A,37,Scheduled,147,Delayed,177,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.16,Negative,2,Negative,Elderly,,Post-2nd (8+ Weeks),20-Aug-21,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,84,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,3,August,2021,,125,,,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.35,Negative,1,Negative,Elderly,,Post-4th,24-Mar-22,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,85,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,4,March,2022,,,,17,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,17,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.19,Negative,0,Negative,Elderly,,Post-4th,15-Jul-22,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,85,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,5,July,2022,,,,130,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,130,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.28,Negative,415,Positive,Elderly,,Post-1st,16-Apr-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,59,1,April,2021,29,,,,Completed,250-999,N/A,42,Scheduled,209,Delayed,,29,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.42,Negative,5937,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,843,2,May,2021,,27,,,Completed,,N/A,42,Scheduled,209,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,770,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,109,3,September,2021,,139,,,Completed,250-999,N/A,42,Scheduled,209,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.11,Negative,36709,Positive,Elderly,,Post-3rd (1-8 Weeks),21-Dec-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,69,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5213,4,December,2021,,,27,,Completed,10000+,N/A,42,Scheduled,209,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,86,Positive,Adult,-272,Post-2nd (8+ Weeks),26-Aug-21,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,12,1,August,2021,,189,,,Completed,50-249,N/A,39,Scheduled,209,Delayed,153,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,10986,Positive,Adult,-216,Post-3rd (1-8 Weeks),21-Oct-21,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1560,2,October,2021,,,36,,Completed,10000+,N/A,39,Scheduled,209,Delayed,153,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,3560,Positive,Adult,-104,Post-3rd (8+ Weeks),10-Feb-22,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,506,3,February,2022,,,148,,Completed,1000-4999,N/A,39,Scheduled,209,Delayed,153,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,5783,Positive,Adult,-48,Post-4th,07-Apr-22,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,821,4,April,2022,,,,51,Completed,,N/A,39,Scheduled,209,Delayed,153,,,,51,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,690,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,23-Apr-21,Pfizer,03-Jun-21,Pfizer,12-Jan-22,Moderna,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,98,1,September,2021,,98,,,Completed,250-999,N/A,41,Scheduled,223,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,10254,Positive,Adult,,Post-3rd (1-8 Weeks),14-Feb-22,baseline,23-Apr-21,Pfizer,03-Jun-21,Pfizer,12-Jan-22,Moderna,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1456,2,February,2022,,,33,,Completed,10000+,N/A,41,Scheduled,223,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,2004,Positive,Adult,,Post-2nd (1-8 Weeks),18-Jun-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,285,1,June,2021,,8,,,Completed,1000-4999,N/A,61,Delayed,109,Scheduled,249,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,541,Positive,Adult,,Post-2nd (8+ Weeks),13-Aug-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,77,2,August,2021,,64,,,Completed,250-999,N/A,61,Delayed,109,Scheduled,249,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,6328,Positive,Adult,,Post-3rd (1-8 Weeks),15-Nov-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,899,3,November,2021,,,49,,Completed,,N/A,61,Delayed,109,Scheduled,249,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,1570,Positive,Adult,,Post-3rd (8+ Weeks),28-Jan-22,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,223,4,January,2022,,,123,,Completed,1000-4999,N/A,61,Delayed,109,Scheduled,249,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,5,Negative,Adult,,Pre-1st,09-Mar-21,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,33,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,1,March,2021,,,,,Completed,0-49,N/A,28,Scheduled,121,Delayed,158,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,108,Positive,Adult,,Post-1st,03-May-21,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,33,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,15,2,May,2021,25,,,,Completed,50-249,N/A,28,Scheduled,121,Delayed,158,25,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,1909,Positive,Adult,,Post-2nd (1-8 Weeks),01-Jun-21,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,33,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,271,3,June,2021,,26,,,Completed,1000-4999,N/A,28,Scheduled,121,Delayed,158,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,2633,Positive,Adult,,Post-3rd (8+ Weeks),19-Jan-22,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,374,4,January,2022,,,137,,Completed,1000-4999,N/A,28,Scheduled,121,Delayed,158,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.05,Negative,113,Positive,Adult,-236,Post-2nd (8+ Weeks),24-Aug-21,baseline,15-Apr-21,Pfizer,09-May-21,Pfizer,23-Sep-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,16,1,August,2021,,107,,,Completed,50-249,N/A,24,Scheduled,137,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.05,Negative,5467,Positive,Adult,-166,Post-3rd (1-8 Weeks),02-Nov-21,baseline,15-Apr-21,Pfizer,09-May-21,Pfizer,23-Sep-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,776,2,November,2021,,,40,,Completed,,N/A,24,Scheduled,137,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,7,Negative,Adult,,Pre-1st,15-Apr-21,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,64,Delayed,99,Scheduled,221,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2310,Positive,Adult,,Post-1st,26-May-21,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,328,2,May,2021,35,,,,Completed,1000-4999,N/A,64,Delayed,99,Scheduled,221,35,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,,,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,3,July,2021,,27,,,Processed,,N/A,64,Delayed,99,Scheduled,221,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,69216,Positive,Adult,,Post-3rd (1-8 Weeks),22-Oct-21,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,9829,4,October,2021,,,21,,Completed,10000+,N/A,64,Delayed,99,Scheduled,221,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.17,Negative,11212,Positive,Adult,,Post-3rd (8+ Weeks),16-Feb-22,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1592,5,February,2022,,,138,,Completed,10000+,N/A,64,Delayed,99,Scheduled,221,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.76,Positive,1,Negative,Adult,-280,Pre-1st,12-Mar-21,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,47,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,1,March,2021,,,,,Completed,0-49,N/A,62,Delayed,161,Delayed,202,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.58,Negative,797,Positive,Adult,-141,Post-2nd (1-8 Weeks),29-Jul-21,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,47,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,113,2,July,2021,,48,,,Completed,250-999,N/A,62,Delayed,161,Delayed,202,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.81,Positive,1618,Positive,Adult,0,Post-3rd (1-8 Weeks),17-Dec-21,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,48,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,230,3,December,2021,,,28,,Completed,1000-4999,N/A,62,Delayed,161,Delayed,202,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.02,Positive,16667,Positive,Adult,56,Post-3rd (8+ Weeks),11-Feb-22,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,48,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,2367,4,February,2022,,,84,,Completed,10000+,N/A,62,Delayed,161,Delayed,202,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.04,Positive,19260,Positive,Adult,194,Post-4th,29-Jun-22,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,48,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,2735,5,June,2022,,,,20,Completed,10000+,N/A,62,Delayed,161,Delayed,202,,,,20,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,4169,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,11-Apr-21,Moderna,11-Jun-21,Moderna,06-Oct-21,Moderna,,,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,592,1,July,2021,,35,,,Completed,1000-4999,N/A,61,Delayed,117,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,15266,Positive,Adult,,Post-3rd (1-8 Weeks),19-Nov-21,baseline,11-Apr-21,Moderna,11-Jun-21,Moderna,06-Oct-21,Moderna,,,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,2168,2,November,2021,,,44,,Completed,10000+,N/A,61,Delayed,117,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.09,Negative,1850,Positive,Adult,,Post-3rd (8+ Weeks),22-Feb-22,baseline,11-Apr-21,Moderna,11-Jun-21,Moderna,06-Oct-21,Moderna,,,,,48,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,263,3,February,2022,,,139,,Completed,1000-4999,N/A,61,Delayed,117,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,2,Negative,Elderly,,Pre-1st,08-Mar-21,baseline,29-Mar-21,Pfizer,10-Jun-21,Pfizer,13-Sep-21,Pfizer,21-Mar-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,73,Delayed,95,Scheduled,189,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,290,Positive,Elderly,,Post-3rd (8+ Weeks),11-Nov-21,baseline,29-Mar-21,Pfizer,10-Jun-21,Pfizer,13-Sep-21,Pfizer,21-Mar-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,41,2,November,2021,,,59,,Completed,250-999,N/A,73,Delayed,95,Scheduled,189,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,53,Positive,Elderly,,Post-3rd (8+ Weeks),24-Jan-22,baseline,29-Mar-21,Pfizer,10-Jun-21,Pfizer,13-Sep-21,Pfizer,21-Mar-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,8,3,January,2022,,,133,,Completed,50-249,N/A,73,Delayed,95,Scheduled,189,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.02,Negative,4181,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,06-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,594,1,July,2021,,38,,,Completed,1000-4999,N/A,66,Delayed,98,Scheduled,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,2.66,Positive,24237,Positive,Adult,,Post-3rd (8+ Weeks),19-Jan-22,baseline,06-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3442,2,January,2022,,,124,,Completed,10000+,N/A,66,Delayed,98,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,743,Positive,Elderly,-380,Post-1st,17-May-21,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,105,1,May,2021,56,,,,Completed,250-999,N/A,77,Delayed,192,Delayed,,56,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,3671,Positive,Elderly,-337,Post-2nd (1-8 Weeks),29-Jun-21,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,521,2,June,2021,,22,,,Completed,1000-4999,N/A,77,Delayed,192,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,20059,Positive,Elderly,-135,Post-3rd (1-8 Weeks),17-Jan-22,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2848,3,January,2022,,,32,,Completed,10000+,N/A,77,Delayed,192,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,2321,Positive,Elderly,-36,Post-3rd (8+ Weeks),26-Apr-22,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,330,4,April,2022,,,131,,Completed,1000-4999,N/A,77,Delayed,192,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,3,Negative,Adult,,Pre-1st,04-Mar-21,baseline,15-May-21,Pfizer,08-Jul-21,Pfizer,18-Dec-21,Pfizer,,,,,56,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,54,Scheduled,163,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,10,Negative,Adult,,Post-2nd (8+ Weeks),09-Nov-21,baseline,15-May-21,Pfizer,08-Jul-21,Pfizer,18-Dec-21,Pfizer,,,,,57,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,November,2021,,124,,,Completed,0-49,N/A,54,Scheduled,163,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,5520,Positive,Adult,,Post-3rd (1-8 Weeks),18-Jan-22,baseline,15-May-21,Pfizer,08-Jul-21,Pfizer,18-Dec-21,Pfizer,,,,,57,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,784,3,January,2022,,,31,,Completed,,N/A,54,Scheduled,163,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,5,Negative,Adult,,Post-1st,08-Jun-21,baseline,14-Apr-21,Pfizer,10-Jun-21,Pfizer,19-Nov-21,Pfizer,02-May-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,June,2021,55,,,,Completed,0-49,N/A,57,Delayed,162,Delayed,164,55,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,918,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,14-Apr-21,Pfizer,10-Jun-21,Pfizer,19-Nov-21,Pfizer,02-May-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,130,2,June,2021,,20,,,Completed,250-999,N/A,57,Delayed,162,Delayed,164,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,5425,Positive,Adult,,Post-3rd (8+ Weeks),15-Jan-22,baseline,14-Apr-21,Pfizer,10-Jun-21,Pfizer,19-Nov-21,Pfizer,02-May-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,770,3,January,2022,,,57,,Completed,,N/A,57,Delayed,162,Delayed,164,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.18,Negative,3060,Positive,Adult,,Post-3rd (8+ Weeks),02-May-22,baseline,14-Apr-21,Pfizer,10-Jun-21,Pfizer,19-Nov-21,Pfizer,02-May-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,434,4,May,2022,,,164,,Completed,1000-4999,N/A,57,Delayed,162,Delayed,164,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.12,Negative,17,Negative,Adult,-226,Post-2nd (8+ Weeks),03-Sep-21,baseline,07-Apr-21,Pfizer,03-May-21,Pfizer,03-Sep-21,Pfizer,15-Apr-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2,1,September,2021,,123,,,Completed,0-49,N/A,26,Scheduled,123,Delayed,224,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,2168,Positive,Adult,-212,Post-3rd (1-8 Weeks),17-Sep-21,baseline,07-Apr-21,Pfizer,03-May-21,Pfizer,03-Sep-21,Pfizer,15-Apr-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,308,2,September,2021,,,14,,Completed,1000-4999,N/A,26,Scheduled,123,Delayed,224,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,131,Positive,Adult,-100,Post-3rd (8+ Weeks),07-Jan-22,baseline,07-Apr-21,Pfizer,03-May-21,Pfizer,03-Sep-21,Pfizer,15-Apr-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,19,3,January,2022,,,126,,Completed,50-249,N/A,26,Scheduled,123,Delayed,224,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5,Negative,Elderly,,Pre-1st,05-Mar-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,49,Scheduled,132,Delayed,151,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,87,Positive,Elderly,,Post-1st,29-Apr-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,12,2,April,2021,41,,,,Completed,50-249,N/A,49,Scheduled,132,Delayed,151,41,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,1561,Positive,Elderly,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,222,3,June,2021,,47,,,Completed,1000-4999,N/A,49,Scheduled,132,Delayed,151,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,754,Positive,Elderly,,Post-2nd (8+ Weeks),14-Sep-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,107,4,September,2021,,130,,,Completed,250-999,N/A,49,Scheduled,132,Delayed,151,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,24881,Positive,Elderly,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3533,5,October,2021,,,28,,Completed,10000+,N/A,49,Scheduled,132,Delayed,151,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,3461,Positive,Elderly,,Post-3rd (8+ Weeks),13-Jan-22,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,492,6,January,2022,,,119,,Completed,1000-4999,N/A,49,Scheduled,132,Delayed,151,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.95,Positive,80000,Positive,Elderly,,Post-4th,05-Apr-22,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,73,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,7,April,2022,,,,50,Completed,10000+,N/A,49,Scheduled,132,Delayed,151,,,,50,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.28,Negative,80000,Positive,Elderly,,Post-4th,05-Jul-22,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,73,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,8,July,2022,,,,141,Completed,10000+,N/A,49,Scheduled,132,Delayed,151,,,,141,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Anti-TNF Only,0.03,Negative,2,Negative,Adult,-223,Pre-1st,03-Mar-21,baseline,15-Apr-21,Pfizer,19-Jun-21,Pfizer,30-Sep-21,Pfizer,24-Jan-22,Pfizer,,,24,18-29,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,0,0,1,March,2021,,,,,Completed,0-49,N/A,65,Delayed,103,Scheduled,116,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Anti-TNF Only,0.03,Negative,2936,Positive,Adult,-89,Post-2nd (1-8 Weeks),15-Jul-21,baseline,15-Apr-21,Pfizer,19-Jun-21,Pfizer,30-Sep-21,Pfizer,24-Jan-22,Pfizer,,,24,18-29,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,0,417,2,July,2021,,26,,,Completed,1000-4999,N/A,65,Delayed,103,Scheduled,116,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Anti-TNF Only,0.79,Positive,80000,Positive,Adult,0,Post-3rd (1-8 Weeks),12-Oct-21,baseline,15-Apr-21,Pfizer,19-Jun-21,Pfizer,30-Sep-21,Pfizer,24-Jan-22,Pfizer,,,25,18-29,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,0,11360,3,October,2021,,,12,,Completed,10000+,N/A,65,Delayed,103,Scheduled,116,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Anti-TNF Only,0.1,Negative,16237,Positive,Adult,112,Post-4th,01-Feb-22,baseline,15-Apr-21,Pfizer,19-Jun-21,Pfizer,30-Sep-21,Pfizer,24-Jan-22,Pfizer,,,25,18-29,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,0,2306,4,February,2022,,,,8,Completed,10000+,N/A,65,Delayed,103,Scheduled,116,,,,8,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.07,Negative,5,Negative,Adult,,Post-1st,04-May-21,baseline,08-Apr-21,Pfizer,15-May-21,Pfizer,29-Sep-21,Pfizer,,,,,51,50-59,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,1,1,May,2021,26,,,,Completed,0-49,N/A,37,Scheduled,137,Delayed,,26,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.07,Negative,808,Positive,Adult,,Post-2nd (1-8 Weeks),31-May-21,baseline,08-Apr-21,Pfizer,15-May-21,Pfizer,29-Sep-21,Pfizer,,,,,51,50-59,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,115,2,May,2021,,16,,,Completed,250-999,N/A,37,Scheduled,137,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.12,Negative,1102,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,08-Apr-21,Pfizer,15-May-21,Pfizer,29-Sep-21,Pfizer,,,,,51,50-59,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,156,3,October,2021,,,29,,Completed,1000-4999,N/A,37,Scheduled,137,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.1,Negative,181,Positive,Adult,,Post-3rd (8+ Weeks),27-Jan-22,baseline,08-Apr-21,Pfizer,15-May-21,Pfizer,29-Sep-21,Pfizer,,,,,52,50-59,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,26,4,January,2022,,,120,,Completed,50-249,N/A,37,Scheduled,137,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,,,,,Adult,-224,Post-2nd (1-8 Weeks),18-Jun-21,Post Vaccine covid,12-Apr-21,Pfizer,09-May-21,Pfizer,02-Sep-21,Pfizer,30-Apr-22,Pfizer,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,1,June,2021,,40,,,Processed,,N/A,27,Scheduled,116,Scheduled,240,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.03,Negative,6596,Positive,Adult,-113,Post-3rd (1-8 Weeks),07-Oct-21,Post Vaccine covid,12-Apr-21,Pfizer,09-May-21,Pfizer,02-Sep-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,937,2,October,2021,,,35,,Completed,,N/A,27,Scheduled,116,Scheduled,240,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,1.31,Positive,25446,Positive,Adult,20,Post-3rd (8+ Weeks),17-Feb-22,Post Vaccine covid,12-Apr-21,Pfizer,09-May-21,Pfizer,02-Sep-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3613,3,February,2022,,,168,,Completed,10000+,N/A,27,Scheduled,116,Scheduled,240,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,10291,Positive,Adult,-216,Post-2nd (1-8 Weeks),13-Jul-21,Post Vaccine covid,15-Apr-21,Pfizer,16-Jun-21,Pfizer,12-Oct-21,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1461,1,July,2021,,27,,,Completed,10000+,N/A,62,Delayed,118,Scheduled,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,4330,Positive,Adult,-104,Post-3rd (1-8 Weeks),02-Nov-21,Post Vaccine covid,15-Apr-21,Pfizer,16-Jun-21,Pfizer,12-Oct-21,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,615,2,November,2021,,,21,,Completed,1000-4999,N/A,62,Delayed,118,Scheduled,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.84,Positive,9844,Positive,Adult,25,Post-3rd (8+ Weeks),11-Mar-22,Post Vaccine covid,15-Apr-21,Pfizer,16-Jun-21,Pfizer,12-Oct-21,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1398,3,March,2022,,,150,,Completed,,N/A,62,Delayed,118,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Corticosteroids,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,38,Negative,Elderly,,Post-2nd (8+ Weeks),28-Jul-21,baseline,21-Apr-21,Moderna,19-May-21,Moderna,22-Oct-21,Moderna,,,,,71,70+,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,July,2021,,70,,,Completed,0-49,N/A,28,Scheduled,156,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Corticosteroids,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,13,Negative,Elderly,,Post-2nd (8+ Weeks),22-Sep-21,baseline,21-Apr-21,Moderna,19-May-21,Moderna,22-Oct-21,Moderna,,,,,71,70+,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,September,2021,,126,,,Completed,0-49,N/A,28,Scheduled,156,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Corticosteroids,Anti-TNF Only,Anti-TNF Only,,0.5,Negative,529,Positive,Elderly,,Post-3rd (8+ Weeks),12-Jan-22,baseline,21-Apr-21,Moderna,19-May-21,Moderna,22-Oct-21,Moderna,,,,,71,70+,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,75,3,January,2022,,,82,,Completed,250-999,N/A,28,Scheduled,156,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,1012,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jul-21,baseline,14-Apr-21,Pfizer,15-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,144,1,July,2021,,43,,,Completed,1000-4999,N/A,62,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,3,Negative,Adult,,Pre-1st,09-Mar-21,baseline,13-Apr-21,Moderna,27-May-21,Moderna,12-Nov-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,44,Scheduled,169,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,3698,Positive,Adult,,Post-1st,18-May-21,baseline,13-Apr-21,Moderna,27-May-21,Moderna,12-Nov-21,Pfizer,,,,,32,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,525,2,May,2021,35,,,,Completed,1000-4999,N/A,44,Scheduled,169,Delayed,,35,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,52548,Positive,Adult,,Post-3rd (8+ Weeks),31-May-22,baseline,13-Apr-21,Moderna,27-May-21,Moderna,12-Nov-21,Pfizer,,,,,33,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7462,3,May,2022,,,200,,Completed,10000+,N/A,44,Scheduled,169,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,8636,Positive,Adult,,Post-2nd (1-8 Weeks),15-Jun-21,baseline,26-Apr-21,Pfizer,27-May-21,Pfizer,25-Jun-21,Pfizer,01-Sep-21,Pfizer,21-Jul-22,Pfizer,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1226,1,June,2021,,19,,,Completed,,N/A,31,Scheduled,29,Scheduled,68,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,28017,Positive,Adult,,Post-3rd (1-8 Weeks),13-Jul-21,baseline,26-Apr-21,Pfizer,27-May-21,Pfizer,25-Jun-21,Pfizer,01-Sep-21,Pfizer,21-Jul-22,Pfizer,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3978,2,July,2021,,,18,,Completed,10000+,N/A,31,Scheduled,29,Scheduled,68,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,17054,Positive,Adult,,Post-4th,06-Oct-21,baseline,26-Apr-21,Pfizer,27-May-21,Pfizer,25-Jun-21,Pfizer,01-Sep-21,Pfizer,21-Jul-22,Pfizer,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2422,3,October,2021,,,,35,Completed,10000+,N/A,31,Scheduled,29,Scheduled,68,,,,35,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2348,Positive,Adult,,Post-4th,26-Jan-22,baseline,26-Apr-21,Pfizer,27-May-21,Pfizer,25-Jun-21,Pfizer,01-Sep-21,Pfizer,21-Jul-22,Pfizer,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,333,4,January,2022,,,,147,Completed,1000-4999,N/A,31,Scheduled,29,Scheduled,68,,,,147,
University of Calgary,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,,0.31,Negative,101,Positive,Adult,,Post-1st,20-Apr-21,baseline,16-Mar-21,AstraZeneca,17-Jun-21,Pfizer,17-Feb-22,Pfizer,,,,,62,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,14,1,April,2021,35,,,,Completed,50-249,N/A,93,Delayed,245,Delayed,,35,,,,
University of Calgary,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,,0.1,Negative,2449,Positive,Adult,,Post-2nd (1-8 Weeks),15-Jul-21,baseline,16-Mar-21,AstraZeneca,17-Jun-21,Pfizer,17-Feb-22,Pfizer,,,,,63,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,348,2,July,2021,,28,,,Completed,1000-4999,N/A,93,Delayed,245,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,,6.39,Positive,10717,Positive,Adult,,Post-3rd (8+ Weeks),16-May-22,baseline,16-Mar-21,AstraZeneca,17-Jun-21,Pfizer,17-Feb-22,Pfizer,,,,,63,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1522,3,May,2022,,,88,,Completed,10000+,N/A,93,Delayed,245,Delayed,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.04,Negative,1,Negative,Adult,,Pre-1st,01-Mar-21,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,52,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,43,Scheduled,143,Delayed,150,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.03,Negative,3066,Positive,Adult,,Post-2nd (8+ Weeks),27-Jul-21,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,53,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,435,2,July,2021,,73,,,Completed,1000-4999,N/A,43,Scheduled,143,Delayed,150,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.56,Negative,14665,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,53,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,2082,3,November,2021,,,29,,Completed,10000+,N/A,43,Scheduled,143,Delayed,150,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.81,Positive,2992,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,53,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,425,4,February,2022,,,133,,Completed,1000-4999,N/A,43,Scheduled,143,Delayed,150,,,,,
University of Calgary,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,1.24,Positive,27789,Positive,Adult,,Post-4th,01-Apr-22,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,53,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,3946,5,April,2022,,,,28,Completed,10000+,N/A,43,Scheduled,143,Delayed,150,,,,28,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,797,Positive,Elderly,,Post-2nd (8+ Weeks),12-Jul-21,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,113,1,July,2021,,101,,,Completed,250-999,N/A,23,Scheduled,152,Delayed,156,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,20142,Positive,Elderly,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2860,2,September,2021,,,28,,Completed,10000+,N/A,23,Scheduled,152,Delayed,156,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,6760,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,960,3,February,2022,,,155,,Completed,,N/A,23,Scheduled,152,Delayed,156,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,12841,Positive,Elderly,,Post-4th,23-Apr-22,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1823,4,April,2022,,,,78,Completed,10000+,N/A,23,Scheduled,152,Delayed,156,,,,78,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,8956,Positive,Elderly,,Post-4th,21-Jun-22,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1272,5,June,2022,,,,137,Completed,,N/A,23,Scheduled,152,Delayed,156,,,,137,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,26,Negative,Adult,,Post-1st,20-May-21,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,4,1,May,2021,28,,,,Completed,0-49,N/A,40,Scheduled,115,Scheduled,,28,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,540,Positive,Adult,,Post-2nd (1-8 Weeks),18-Jun-21,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,77,2,June,2021,,17,,,Completed,250-999,N/A,40,Scheduled,115,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,2518,Positive,Adult,,Post-3rd (1-8 Weeks),01-Nov-21,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,358,3,November,2021,,,38,,Completed,1000-4999,N/A,40,Scheduled,115,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,842,Positive,Adult,,Post-3rd (8+ Weeks),10-Jan-22,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,120,4,January,2022,,,108,,Completed,250-999,N/A,40,Scheduled,115,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,473,Positive,Adult,,Post-3rd (8+ Weeks),22-Feb-22,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,67,5,February,2022,,,151,,Completed,250-999,N/A,40,Scheduled,115,Scheduled,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.23,Negative,47,Negative,Adult,263,Pre-1st,08-Jan-21,Post Vaccine covid,10-Jun-21,Pfizer,15-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,1,January,2021,,,,,Completed,0-49,N/A,35,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.12,Negative,21450,Positive,Adult,490,Post-2nd (1-8 Weeks),23-Aug-21,Post Vaccine covid,10-Jun-21,Pfizer,15-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3046,2,August,2021,,39,,,Completed,10000+,N/A,35,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.08,Negative,6561,Positive,Adult,634,Post-2nd (8+ Weeks),14-Jan-22,Post Vaccine covid,10-Jun-21,Pfizer,15-Jul-21,Pfizer,,,,,,,51,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,932,3,January,2022,,183,,,Completed,,N/A,35,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,2,Negative,Adult,,Pre-1st,02-Mar-21,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,201,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,8620,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1224,2,July,2021,,42,,,Completed,,N/A,71,Delayed,201,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.26,Negative,26085,Positive,Adult,,Post-3rd (1-8 Weeks),11-Feb-22,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3704,3,February,2022,,,46,,Completed,10000+,N/A,71,Delayed,201,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,1.1,Positive,42404,Positive,Adult,,Post-3rd (8+ Weeks),13-Jul-22,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6021,4,July,2022,,,198,,Completed,10000+,N/A,71,Delayed,201,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,745,Positive,Adult,,Post-3rd (1-8 Weeks),08-Oct-21,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,01-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,106,1,October,2021,,,37,,Completed,250-999,N/A,28,Scheduled,105,Scheduled,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,69,Positive,Adult,,Post-3rd (8+ Weeks),09-Feb-22,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,01-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,2,February,2022,,,161,,Completed,50-249,N/A,28,Scheduled,105,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1648,Positive,Adult,-307,Post-1st,21-May-21,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,234,1,May,2021,37,,,,Completed,1000-4999,N/A,48,Scheduled,211,Delayed,,37,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,19233,Positive,Adult,-280,Post-2nd (1-8 Weeks),17-Jun-21,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2731,2,June,2021,,16,,,Completed,10000+,N/A,48,Scheduled,211,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,1770,Positive,Adult,-98,Post-2nd (8+ Weeks),16-Dec-21,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,251,3,December,2021,,198,,,Completed,1000-4999,N/A,48,Scheduled,211,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.14,Negative,76704,Positive,Adult,-55,Post-3rd (1-8 Weeks),28-Jan-22,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10892,4,January,2022,,,30,,Completed,10000+,N/A,48,Scheduled,211,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,3.87,Positive,40000,Positive,Adult,46,Post-3rd (8+ Weeks),09-May-22,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5680,5,May,2022,,,131,,Completed,10000+,N/A,48,Scheduled,211,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,2,Negative,Adult,,Pre-1st,01-Mar-21,baseline,03-Feb-22,Moderna,07-Apr-22,Moderna,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,63,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,3,Negative,Adult,,Pre-1st,08-Apr-21,baseline,03-Feb-22,Moderna,07-Apr-22,Moderna,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,April,2021,,,,,Completed,0-49,N/A,63,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.93,Positive,2,Negative,Adult,,Pre-1st,28-Jan-22,baseline,03-Feb-22,Moderna,07-Apr-22,Moderna,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,January,2022,,,,,Completed,0-49,N/A,63,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,3752,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,533,1,July,2021,,39,,,Completed,1000-4999,N/A,57,Delayed,102,Scheduled,154,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5870,Positive,Adult,,Post-3rd (1-8 Weeks),19-Oct-21,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,834,2,October,2021,,,27,,Completed,,N/A,57,Delayed,102,Scheduled,154,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2039,Positive,Adult,,Post-3rd (8+ Weeks),24-Jan-22,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,290,3,January,2022,,,124,,Completed,1000-4999,N/A,57,Delayed,102,Scheduled,154,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5408,Positive,Adult,,Post-4th,17-Mar-22,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,768,4,March,2022,,,,22,Completed,,N/A,57,Delayed,102,Scheduled,154,,,,22,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.17,Negative,2964,Positive,Adult,,Post-2nd (1-8 Weeks),31-Jul-21,baseline,30-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Oct-21,Pfizer,20-Mar-22,Pfizer ,,,61,60-69,1,1,1,0,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,1,421,1,July,2021,,51,,,Completed,1000-4999,N/A,72,Delayed,136,Delayed,147,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.14,Negative,961,Positive,Adult,,Post-3rd (8+ Weeks),22-Jan-22,baseline,30-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Oct-21,Pfizer,20-Mar-22,Pfizer ,,,62,60-69,1,1,1,0,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,1,136,2,January,2022,,,90,,Completed,250-999,N/A,72,Delayed,136,Delayed,147,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.55,Negative,838,Positive,Adult,,Post-4th,30-May-22,baseline,30-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Oct-21,Pfizer,20-Mar-22,Pfizer ,,,62,60-69,1,1,1,0,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,1,119,3,May,2022,,,,71,Completed,250-999,N/A,72,Delayed,136,Delayed,147,,,,71,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,2,Negative,Adult,,Pre-1st,01-Mar-21,baseline,03-May-21,Pfizer,30-May-21,Pfizer,02-Oct-21,Pfizer,06-Jun-22,Pfizer,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,27,Scheduled,125,Delayed,247,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,2923,Positive,Adult,,Post-2nd (8+ Weeks),23-Sep-21,baseline,03-May-21,Pfizer,30-May-21,Pfizer,02-Oct-21,Pfizer,06-Jun-22,Pfizer,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,415,2,September,2021,,116,,,Completed,1000-4999,N/A,27,Scheduled,125,Delayed,247,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,18419,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,03-May-21,Pfizer,30-May-21,Pfizer,02-Oct-21,Pfizer,06-Jun-22,Pfizer,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2616,3,October,2021,,,26,,Completed,10000+,N/A,27,Scheduled,125,Delayed,247,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,5293,Positive,Adult,,Post-3rd (8+ Weeks),07-Feb-22,baseline,03-May-21,Pfizer,30-May-21,Pfizer,02-Oct-21,Pfizer,06-Jun-22,Pfizer,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,752,4,February,2022,,,128,,Completed,,N/A,27,Scheduled,125,Delayed,247,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.03,Negative,4,Negative,Adult,,Post-2nd (1-8 Weeks),17-Aug-21,baseline,17-May-21,Pfizer,16-Jul-21,Moderna,05-Oct-21,Pfizer,,,,,63,60-69,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,August,2021,,32,,,Completed,0-49,N/A,60,Delayed,81,Scheduled,,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.06,Negative,8,Negative,Adult,,Post-3rd (1-8 Weeks),16-Nov-21,baseline,17-May-21,Pfizer,16-Jul-21,Moderna,05-Oct-21,Pfizer,,,,,63,60-69,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,November,2021,,,42,,Completed,0-49,N/A,60,Delayed,81,Scheduled,,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.04,Negative,0,Negative,Adult,,Post-3rd (8+ Weeks),08-Mar-22,baseline,17-May-21,Pfizer,16-Jul-21,Moderna,05-Oct-21,Pfizer,,,,,63,60-69,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,March,2022,,,154,,Completed,0-49,N/A,60,Delayed,81,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,26073,Positive,Adult,-393,Post-2nd (1-8 Weeks),25-Jun-21,baseline,22-Apr-21,Moderna,12-Jun-21,Moderna,12-Nov-21,Pfizer,15-Apr-22,Moderna ,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3702,1,June,2021,,13,,,Completed,10000+,N/A,51,Scheduled,153,Delayed,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,13847,Positive,Adult,-190,Post-3rd (8+ Weeks),14-Jan-22,baseline,22-Apr-21,Moderna,12-Jun-21,Moderna,12-Nov-21,Pfizer,15-Apr-22,Moderna ,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1966,2,January,2022,,,63,,Completed,10000+,N/A,51,Scheduled,153,Delayed,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.14,Negative,18888,Positive,Adult,-64,Post-4th,20-May-22,baseline,22-Apr-21,Moderna,12-Jun-21,Moderna,12-Nov-21,Pfizer,15-Apr-22,Moderna ,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2682,3,May,2022,,,,35,Completed,10000+,N/A,51,Scheduled,153,Delayed,154,,,,35,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,4.09,Positive,406,Positive,Adult,23,Pre-1st,15-Apr-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,58,1,April,2021,,,,,Completed,250-999,N/A,44,Scheduled,98,Scheduled,161,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.18,Positive,5941,Positive,Adult,58,Post-1st,20-May-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,844,2,May,2021,32,,,,Completed,,N/A,44,Scheduled,98,Scheduled,161,32,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.27,Positive,10390,Positive,Adult,90,Post-2nd (1-8 Weeks),21-Jun-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1475,3,June,2021,,20,,,Completed,10000+,N/A,44,Scheduled,98,Scheduled,161,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.43,Negative,17803,Positive,Adult,189,Post-3rd (1-8 Weeks),28-Sep-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2528,4,September,2021,,,21,,Completed,10000+,N/A,44,Scheduled,98,Scheduled,161,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.14,Negative,2512,Positive,Adult,300,Post-3rd (8+ Weeks),17-Jan-22,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,357,5,January,2022,,,132,,Completed,1000-4999,N/A,44,Scheduled,98,Scheduled,161,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.11,Negative,18083,Positive,Adult,350,Post-4th,08-Mar-22,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2568,6,March,2022,,,,21,Completed,10000+,N/A,44,Scheduled,98,Scheduled,161,,,,21,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.11,Negative,7207,Positive,Adult,450,Post-4th,16-Jun-22,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1023,7,June,2022,,,,121,Completed,,N/A,44,Scheduled,98,Scheduled,161,,,,121,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.02,Negative,1,Negative,Adult,,Pre-1st,16-Mar-21,baseline,09-Apr-21,Pfizer,02-May-21,Pfizer,22-Sep-21,Pfizer,02-Mar-22,Pfizer,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,23,Scheduled,143,Delayed,161,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.03,Negative,5891,Positive,Adult,,Post-2nd (1-8 Weeks),11-May-21,baseline,09-Apr-21,Pfizer,02-May-21,Pfizer,22-Sep-21,Pfizer,02-Mar-22,Pfizer,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,836,2,May,2021,,9,,,Completed,,N/A,23,Scheduled,143,Delayed,161,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.06,Negative,2463,Positive,Adult,,Post-3rd (8+ Weeks),22-Dec-21,baseline,09-Apr-21,Pfizer,02-May-21,Pfizer,22-Sep-21,Pfizer,02-Mar-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,350,3,December,2021,,,91,,Completed,1000-4999,N/A,23,Scheduled,143,Delayed,161,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,6,Negative,Adult,,Pre-1st,30-Mar-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,64,Delayed,98,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,18,Negative,Adult,,Post-1st,11-May-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,2,May,2021,33,,,,Completed,0-49,N/A,64,Delayed,98,Scheduled,,33,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,139,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jul-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,20,3,July,2021,,47,,,Completed,50-249,N/A,64,Delayed,98,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,108,Positive,Adult,,Post-2nd (8+ Weeks),18-Aug-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,4,August,2021,,68,,,Completed,50-249,N/A,64,Delayed,98,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1379,Positive,Adult,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,196,5,September,2021,,,12,,Completed,1000-4999,N/A,64,Delayed,98,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,31,Negative,Adult,,Post-3rd (8+ Weeks),22-Feb-22,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,6,February,2022,,,158,,Completed,0-49,N/A,64,Delayed,98,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,3.86,Positive,316,Positive,Adult,,Post-3rd (8+ Weeks),17-May-22,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,45,7,May,2022,,,242,,Completed,250-999,N/A,64,Delayed,98,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1233,Positive,Adult,,Post-2nd (1-8 Weeks),17-Jul-21,baseline,16-Mar-21,AstraZeneca,13-Jun-21,AstraZeneca,21-Sep-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,175,1,July,2021,,34,,,Completed,1000-4999,N/A,89,Delayed,100,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,27250,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,16-Mar-21,AstraZeneca,13-Jun-21,AstraZeneca,21-Sep-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3870,2,October,2021,,,37,,Completed,10000+,N/A,89,Delayed,100,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,2368,Positive,Adult,,Post-3rd (8+ Weeks),23-Feb-22,baseline,16-Mar-21,AstraZeneca,13-Jun-21,AstraZeneca,21-Sep-21,Pfizer,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,336,3,February,2022,,,155,,Completed,1000-4999,N/A,89,Delayed,100,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,2,Negative,Adult,-353,Pre-1st,05-Mar-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,22,Scheduled,144,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,9853,Positive,Adult,-272,Post-2nd (1-8 Weeks),25-May-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1399,2,May,2021,,11,,,Completed,,N/A,22,Scheduled,144,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,322,Positive,Adult,-150,Post-2nd (8+ Weeks),24-Sep-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,46,3,September,2021,,133,,,Completed,250-999,N/A,22,Scheduled,144,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.19,Negative,10914,Positive,Adult,-108,Post-3rd (1-8 Weeks),05-Nov-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1550,4,November,2021,,,31,,Completed,10000+,N/A,22,Scheduled,144,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.37,Negative,17930,Positive,Adult,14,Post-3rd (8+ Weeks),07-Mar-22,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2546,5,March,2022,,,153,,Completed,10000+,N/A,22,Scheduled,144,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,62,Positive,Adult,,Post-1st,28-Apr-21,baseline,22-Mar-21,AstraZeneca,27-May-21,Pfizer,14-Sep-21,Pfizer,20-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,9,1,April,2021,37,,,,Completed,50-249,N/A,66,Delayed,110,Scheduled,159,37,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2545,Positive,Adult,,Post-3rd (1-8 Weeks),13-Oct-21,baseline,22-Mar-21,AstraZeneca,27-May-21,Pfizer,14-Sep-21,Pfizer,20-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,361,2,October,2021,,,29,,Completed,1000-4999,N/A,66,Delayed,110,Scheduled,159,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,515,Positive,Adult,,Post-4th,11-May-22,baseline,22-Mar-21,AstraZeneca,27-May-21,Pfizer,14-Sep-21,Pfizer,20-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,73,3,May,2022,,,,80,Completed,250-999,N/A,66,Delayed,110,Scheduled,159,,,,80,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,,,0.06,Negative,1,Negative,Adult,,Pre-1st,16-Aug-21,baseline,12-Oct-21,Pfizer,15-Nov-21,Pfizer,,,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,August,2021,,,,,Completed,0-49,N/A,34,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.51,Positive,1163,Positive,Adult,85,Pre-1st,15-Jan-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,165,1,January,2021,,,,,Completed,1000-4999,N/A,55,Scheduled,117,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.23,Positive,900,Positive,Adult,134,Pre-1st,05-Mar-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,128,2,March,2021,,,,,Completed,250-999,N/A,55,Scheduled,117,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.52,Negative,12636,Positive,Adult,211,Post-1st,21-May-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1794,3,May,2021,32,,,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,32,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.51,Negative,61528,Positive,Adult,246,Post-2nd (1-8 Weeks),25-Jun-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,8737,4,June,2021,,12,,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.27,Negative,16271,Positive,Adult,326,Post-2nd (8+ Weeks),13-Sep-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2310,5,September,2021,,92,,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.29,Negative,59800,Positive,Adult,368,Post-3rd (1-8 Weeks),25-Oct-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,8492,6,October,2021,,,17,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.18,Negative,14853,Positive,Adult,494,Post-3rd (8+ Weeks),28-Feb-22,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2109,7,February,2022,,,143,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.18,Negative,42067,Positive,Adult,527,Post-4th,02-Apr-22,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,5974,8,April,2022,,,,22,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,22,
University of Calgary,,Female,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,9329,Positive,Adult,-167,Post-2nd (1-8 Weeks),06-Aug-21,Post Vaccine covid,08-Apr-21,Pfizer,14-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,45,40-49,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1325,1,August,2021,,53,,,Completed,,N/A,67,Delayed,204,Delayed,,,,,,
University of Calgary,,Female,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.55,Negative,14741,Positive,Adult,12,Post-3rd (1-8 Weeks),01-Feb-22,Post Vaccine covid,08-Apr-21,Pfizer,14-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,45,40-49,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,2093,2,February,2022,,,28,,Completed,10000+,N/A,67,Delayed,204,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,1.56,Positive,1,Negative,Adult,,Pre-1st,09-Jan-21,baseline,01-Sep-21,Pfizer,29-Sep-21,Pfizer,,,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,January,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,1.48,Positive,0,Negative,Adult,,Pre-1st,09-Jul-21,baseline,01-Sep-21,Pfizer,29-Sep-21,Pfizer,,,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,July,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,15,Negative,Adult,-250,Post-1st,12-Jun-21,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,1,June,2021,38,,,,Completed,0-49,N/A,43,Scheduled,97,Scheduled,,38,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,4194,Positive,Adult,-196,Post-2nd (1-8 Weeks),05-Aug-21,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,596,2,August,2021,,49,,,Completed,1000-4999,N/A,43,Scheduled,97,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2196,Positive,Adult,-112,Post-3rd (1-8 Weeks),28-Oct-21,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,312,3,October,2021,,,36,,Completed,1000-4999,N/A,43,Scheduled,97,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,1719,Positive,Adult,-29,Post-3rd (8+ Weeks),19-Jan-22,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,244,4,January,2022,,,119,,Completed,1000-4999,N/A,43,Scheduled,97,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,957,Positive,Adult,,Post-2nd (8+ Weeks),28-Jul-21,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,18-Dec-21,Pfizer,25-May-22,Moderna,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,136,1,July,2021,,70,,,Completed,250-999,N/A,28,Scheduled,213,Delayed,158,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,425,Positive,Adult,,Post-2nd (8+ Weeks),08-Sep-21,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,18-Dec-21,Pfizer,25-May-22,Moderna,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,60,2,September,2021,,112,,,Completed,250-999,N/A,28,Scheduled,213,Delayed,158,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.24,Negative,35285,Positive,Adult,,Post-3rd (1-8 Weeks),15-Jan-22,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,18-Dec-21,Pfizer,25-May-22,Moderna,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,5010,3,January,2022,,,28,,Completed,10000+,N/A,28,Scheduled,213,Delayed,158,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,2,Negative,Adult,-389,Pre-1st,16-Mar-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,40,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,55,Scheduled,85,Scheduled,173,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,1,Negative,Adult,-301,Post-1st,12-Jun-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,2,June,2021,51,,,,Completed,0-49,N/A,55,Scheduled,85,Scheduled,173,51,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,377,Positive,Adult,-274,Post-2nd (1-8 Weeks),09-Jul-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,54,3,July,2021,,23,,,Completed,250-999,N/A,55,Scheduled,85,Scheduled,173,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,3990,Positive,Adult,-192,Post-3rd (1-8 Weeks),29-Sep-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,567,4,September,2021,,,20,,Completed,1000-4999,N/A,55,Scheduled,85,Scheduled,173,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,561,Positive,Adult,-79,Post-3rd (8+ Weeks),20-Jan-22,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,80,5,January,2022,,,133,,Completed,250-999,N/A,55,Scheduled,85,Scheduled,173,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,13263,Positive,Adult,-23,Post-4th,17-Mar-22,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1883,6,March,2022,,,,16,Completed,10000+,N/A,55,Scheduled,85,Scheduled,173,,,,16,
University of Calgary,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,12,Negative,Elderly,,Post-1st,23-Apr-21,baseline,19-Mar-21,Pfizer,30-Apr-21,Pfizer,23-Oct-21,Pfizer,,,,,70,70+,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,1,April,2021,35,,,,Completed,0-49,N/A,42,Scheduled,176,Delayed,,35,,,,
University of Calgary,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,2094,Positive,Elderly,,Post-3rd (8+ Weeks),07-Feb-22,baseline,19-Mar-21,Pfizer,30-Apr-21,Pfizer,23-Oct-21,Pfizer,,,,,71,70+,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,297,2,February,2022,,,107,,Completed,1000-4999,N/A,42,Scheduled,176,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,14,Negative,Adult,-479,Post-1st,11-Feb-21,baseline,07-Jan-21,Pfizer,15-Feb-21,Pfizer,15-Nov-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2,1,February,2021,35,,,,Completed,0-49,N/A,39,Scheduled,273,Delayed,,35,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,235,Positive,Adult,-447,Post-2nd (1-8 Weeks),15-Mar-21,baseline,07-Jan-21,Pfizer,15-Feb-21,Pfizer,15-Nov-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,33,2,March,2021,,28,,,Completed,50-249,N/A,39,Scheduled,273,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,8423,Positive,Adult,-174,Post-3rd (1-8 Weeks),13-Dec-21,baseline,07-Jan-21,Pfizer,15-Feb-21,Pfizer,15-Nov-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1196,3,December,2021,,,28,,Completed,,N/A,39,Scheduled,273,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,2882,Positive,Adult,-72,Post-3rd (8+ Weeks),25-Mar-22,baseline,07-Jan-21,Pfizer,15-Feb-21,Pfizer,15-Nov-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,409,4,March,2022,,,130,,Completed,1000-4999,N/A,39,Scheduled,273,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,3,Negative,Adult,,Pre-1st,01-Apr-21,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,22,Scheduled,197,Delayed,224,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,846,Positive,Adult,,Post-2nd (8+ Weeks),17-Aug-21,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,120,2,August,2021,,92,,,Completed,250-999,N/A,22,Scheduled,197,Delayed,224,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,31547,Positive,Adult,,Post-3rd (1-8 Weeks),14-Jan-22,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4480,3,January,2022,,,45,,Completed,10000+,N/A,22,Scheduled,197,Delayed,224,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,4.67,Positive,42095,Positive,Adult,,Post-3rd (8+ Weeks),27-May-22,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5977,4,May,2022,,,178,,Completed,10000+,N/A,22,Scheduled,197,Delayed,224,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.77,Positive,4,Negative,Adult,-188,Pre-1st,23-Mar-21,baseline,09-Apr-21,Moderna,10-May-21,Moderna,03-Sep-21,Moderna,12-Mar-22,Moderna,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,31,Scheduled,116,Scheduled,190,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.76,Positive,25663,Positive,Adult,0,Post-3rd (1-8 Weeks),27-Sep-21,baseline,09-Apr-21,Moderna,10-May-21,Moderna,03-Sep-21,Moderna,12-Mar-22,Moderna,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3644,2,September,2021,,,24,,Completed,10000+,N/A,31,Scheduled,116,Scheduled,190,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.31,Positive,9914,Positive,Adult,57,Post-3rd (8+ Weeks),23-Nov-21,baseline,09-Apr-21,Moderna,10-May-21,Moderna,03-Sep-21,Moderna,12-Mar-22,Moderna,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1408,3,November,2021,,,81,,Completed,,N/A,31,Scheduled,116,Scheduled,190,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.76,Positive,107,Positive,Elderly,0,Post-1st,06-May-21,baseline,24-Mar-21,Pfizer,01-Jun-21,Pfizer,03-Dec-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,1,May,2021,43,,,,Completed,50-249,N/A,69,Delayed,185,Delayed,,43,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.37,Negative,1423,Positive,Elderly,82,Post-2nd (8+ Weeks),27-Jul-21,baseline,24-Mar-21,Pfizer,01-Jun-21,Pfizer,03-Dec-21,Pfizer,,,,,69,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,202,2,July,2021,,56,,,Completed,1000-4999,N/A,69,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.01,Positive,18323,Positive,Elderly,348,Post-3rd (8+ Weeks),19-Apr-22,baseline,24-Mar-21,Pfizer,01-Jun-21,Pfizer,03-Dec-21,Pfizer,,,,,69,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2602,3,April,2022,,,137,,Completed,10000+,N/A,69,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,1,Negative,Elderly,,Pre-1st,12-Mar-21,baseline,28-Mar-21,Pfizer,24-Apr-21,Pfizer,09-Nov-21,Pfizer,13-Apr-22,Pfizer,,,74,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,27,Scheduled,199,Delayed,155,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.04,Negative,549,Positive,Elderly,,Post-3rd (8+ Weeks),10-Feb-22,baseline,28-Mar-21,Pfizer,24-Apr-21,Pfizer,09-Nov-21,Pfizer,13-Apr-22,Pfizer,,,75,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,78,2,February,2022,,,93,,Completed,250-999,N/A,27,Scheduled,199,Delayed,155,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.05,Negative,376,Positive,Elderly,,Post-3rd (8+ Weeks),19-Apr-22,baseline,28-Mar-21,Pfizer,24-Apr-21,Pfizer,09-Nov-21,Pfizer,13-Apr-22,Pfizer,,,75,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,53,3,April,2022,,,161,,Completed,250-999,N/A,27,Scheduled,199,Delayed,155,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.06,Negative,11975,Positive,Elderly,,Post-4th,04-May-22,baseline,28-Mar-21,Pfizer,24-Apr-21,Pfizer,09-Nov-21,Pfizer,13-Apr-22,Pfizer,,,75,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1700,4,May,2022,,,,21,Completed,10000+,N/A,27,Scheduled,199,Delayed,155,,,,21,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,1408,Positive,Adult,,Post-1st,14-May-21,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,200,1,May,2021,29,,,,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,29,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.08,Negative,2881,Positive,Adult,,Post-2nd (8+ Weeks),24-Aug-21,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,409,2,August,2021,,67,,,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.11,Negative,4703,Positive,Adult,,Post-3rd (8+ Weeks),03-Nov-21,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,668,3,November,2021,,,62,,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.12,Negative,1258,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,179,4,January,2022,,,140,,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.19,Negative,2816,Positive,Adult,,Post-4th,20-Jun-22,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,400,5,June,2022,,,,124,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,,,,124,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,111,Positive,Adult,,Post-1st,11-May-21,baseline,03-Apr-21,Pfizer,19-May-21,Pfizer,04-Oct-21,Pfizer,12-May-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,16,1,May,2021,38,,,,Completed,50-249,N/A,46,Scheduled,138,Delayed,220,38,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,1163,Positive,Adult,,Post-2nd (8+ Weeks),26-Jul-21,baseline,03-Apr-21,Pfizer,19-May-21,Pfizer,04-Oct-21,Pfizer,12-May-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,165,2,July,2021,,68,,,Completed,1000-4999,N/A,46,Scheduled,138,Delayed,220,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,53414,Positive,Adult,,Post-3rd (1-8 Weeks),26-Oct-21,baseline,03-Apr-21,Pfizer,19-May-21,Pfizer,04-Oct-21,Pfizer,12-May-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,7585,3,October,2021,,,22,,Completed,10000+,N/A,46,Scheduled,138,Delayed,220,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,6766,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,03-Apr-21,Pfizer,19-May-21,Pfizer,04-Oct-21,Pfizer,12-May-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,961,4,February,2022,,,133,,Completed,,N/A,46,Scheduled,138,Delayed,220,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,452,Positive,Adult,,Post-2nd (8+ Weeks),23-Jul-21,baseline,12-Apr-21,Pfizer,10-May-21,Pfizer,06-Aug-21,Pfizer,30-Oct-21,Pfizer,10-Mar-22,Moderna ,50,50-59,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,64,1,July,2021,,74,,,Completed,250-999,N/A,28,Scheduled,88,Scheduled,85,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.19,Negative,20473,Positive,Adult,393,Post-2nd (8+ Weeks),13-Apr-21,covid,04-Jan-21,Pfizer,11-Feb-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2907,1,April,2021,,61,,,Completed,10000+,N/A,38,Scheduled,293,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,459,Positive,Elderly,,Post-1st,13-Apr-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,65,1,April,2021,28,,,,Completed,250-999,N/A,24,Scheduled,194,Delayed,160,28,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,2133,Positive,Elderly,,Post-2nd (1-8 Weeks),04-May-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,303,2,May,2021,,25,,,Completed,1000-4999,N/A,24,Scheduled,194,Delayed,160,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,1122,Positive,Elderly,,Post-2nd (8+ Weeks),20-Jul-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,159,3,July,2021,,102,,,Completed,1000-4999,N/A,24,Scheduled,194,Delayed,160,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,24982,Positive,Elderly,,Post-3rd (1-8 Weeks),16-Nov-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3547,4,November,2021,,,27,,Completed,10000+,N/A,24,Scheduled,194,Delayed,160,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,8708,Positive,Elderly,,Post-3rd (8+ Weeks),02-Mar-22,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1236,5,March,2022,,,133,,Completed,,N/A,24,Scheduled,194,Delayed,160,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,80000,Positive,Elderly,,Post-4th,21-Apr-22,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,6,April,2022,,,,23,Completed,10000+,N/A,24,Scheduled,194,Delayed,160,,,,23,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,949,Positive,Adult,,Post-2nd (8+ Weeks),22-Jul-21,baseline,28-Apr-21,Pfizer,19-May-21,Pfizer,29-Dec-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,135,1,July,2021,,64,,,Completed,250-999,N/A,21,Scheduled,224,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,653,Positive,Adult,,Post-2nd (8+ Weeks),17-Sep-21,baseline,28-Apr-21,Pfizer,19-May-21,Pfizer,29-Dec-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,93,2,September,2021,,121,,,Completed,250-999,N/A,21,Scheduled,224,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,802,Positive,Adult,,Post-3rd (1-8 Weeks),07-Jan-22,baseline,28-Apr-21,Pfizer,19-May-21,Pfizer,29-Dec-21,Pfizer,,,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,114,3,January,2022,,,9,,Completed,250-999,N/A,21,Scheduled,224,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,2518,Positive,Adult,,Post-3rd (8+ Weeks),02-May-22,baseline,28-Apr-21,Pfizer,19-May-21,Pfizer,29-Dec-21,Pfizer,,,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,358,4,May,2022,,,124,,Completed,1000-4999,N/A,21,Scheduled,224,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,1,Negative,Adult,,Pre-1st,17-Apr-21,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,59,Delayed,192,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,5,Negative,Adult,,Post-1st,10-Jun-21,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,June,2021,35,,,,Completed,0-49,N/A,59,Delayed,192,Delayed,,35,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,491,Positive,Adult,,Post-2nd (1-8 Weeks),21-Aug-21,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,70,3,August,2021,,48,,,Completed,250-999,N/A,59,Delayed,192,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.14,Negative,682,Positive,Adult,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,97,4,February,2022,,,22,,Completed,250-999,N/A,59,Delayed,192,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,121,Positive,Adult,,Post-3rd (8+ Weeks),10-Jun-22,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,17,5,June,2022,,,149,,Completed,50-249,N/A,59,Delayed,192,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,3147,Positive,Adult,,Post-1st,04-May-21,baseline,13-Apr-21,Moderna,15-Jul-21,Moderna,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,447,1,May,2021,21,,,,Completed,1000-4999,N/A,93,Delayed,,Delayed,,21,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.06,Negative,19905,Positive,Adult,,Post-2nd (1-8 Weeks),19-Aug-21,baseline,13-Apr-21,Moderna,15-Jul-21,Moderna,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2826,2,August,2021,,35,,,Completed,10000+,N/A,93,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,3881,Positive,Adult,,Post-2nd (8+ Weeks),17-Feb-22,baseline,13-Apr-21,Moderna,15-Jul-21,Moderna,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,551,3,February,2022,,217,,,Completed,1000-4999,N/A,93,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.61,Negative,12,Negative,Adult,43,Pre-1st,05-Feb-21,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2,1,February,2021,,,,,Completed,0-49,N/A,47,Scheduled,103,Scheduled,158,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,250,Positive,Adult,159,Post-1st,01-Jun-21,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,35,2,June,2021,32,,,,Completed,50-249,N/A,47,Scheduled,103,Scheduled,158,32,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,886,Positive,Adult,197,Post-2nd (1-8 Weeks),09-Jul-21,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,126,3,July,2021,,23,,,Completed,250-999,N/A,47,Scheduled,103,Scheduled,158,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,2458,Positive,Adult,302,Post-3rd (1-8 Weeks),22-Oct-21,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,349,4,October,2021,,,25,,Completed,1000-4999,N/A,47,Scheduled,103,Scheduled,158,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,5.88,Positive,7953,Positive,Adult,411,Post-3rd (8+ Weeks),08-Feb-22,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,45,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1129,5,February,2022,,,134,,Completed,,N/A,47,Scheduled,103,Scheduled,158,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.96,Positive,21234,Positive,Adult,464,Post-4th,02-Apr-22,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,45,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,3015,6,April,2022,,,,29,Completed,10000+,N/A,47,Scheduled,103,Scheduled,158,,,,29,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.25,Negative,6189,Positive,Adult,566,Post-4th,13-Jul-22,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,45,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,879,7,July,2022,,,,131,Completed,,N/A,47,Scheduled,103,Scheduled,158,,,,131,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,3771,Positive,Adult,,Post-2nd (8+ Weeks),27-Aug-21,baseline,09-Apr-21,Pfizer,14-Jun-21,Pfizer,08-Dec-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,535,1,August,2021,,74,,,Completed,1000-4999,N/A,66,Delayed,177,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,4246,Positive,Adult,,Post-3rd (1-8 Weeks),20-Jan-22,baseline,09-Apr-21,Pfizer,14-Jun-21,Pfizer,08-Dec-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,603,2,January,2022,,,43,,Completed,1000-4999,N/A,66,Delayed,177,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.23,Negative,9962,Positive,Adult,,Post-3rd (8+ Weeks),28-Apr-22,baseline,09-Apr-21,Pfizer,14-Jun-21,Pfizer,08-Dec-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1415,3,April,2022,,,141,,Completed,,N/A,66,Delayed,177,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,3,Negative,Adult,,Pre-1st,01-Apr-21,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,36,Scheduled,119,Scheduled,234,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,742,Positive,Adult,,Post-1st,26-May-21,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,105,2,May,2021,30,,,,Completed,250-999,N/A,36,Scheduled,119,Scheduled,234,30,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,2180,Positive,Adult,,Post-2nd (1-8 Weeks),15-Jul-21,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,310,3,July,2021,,44,,,Completed,1000-4999,N/A,36,Scheduled,119,Scheduled,234,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,24192,Positive,Adult,,Post-3rd (1-8 Weeks),29-Oct-21,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3435,4,October,2021,,,31,,Completed,10000+,N/A,36,Scheduled,119,Scheduled,234,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,1922,Positive,Adult,,Post-3rd (8+ Weeks),28-Mar-22,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,273,5,March,2022,,,181,,Completed,1000-4999,N/A,36,Scheduled,119,Scheduled,234,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,,,,,0.78,Positive,339,Positive,Adult,,,11-Feb-21,Suspected COVID-19/Symptomatic,,,,,,,,,,,34,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,1,February,2021,,,,,Completed,250-999,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,,,,,0.1,Negative,88,Positive,Adult,,,26-Aug-21,Suspected COVID-19/Symptomatic,,,,,,,,,,,35,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,2,August,2021,,,,,Completed,50-249,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,3,Negative,Adult,,Pre-1st,07-Apr-21,baseline,09-Apr-21,Pfizer,17-Jun-21,Pfizer,,,,,,,50,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,69,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,2,Negative,Adult,-352,Pre-1st,22-Apr-21,baseline,27-Apr-21,Moderna,21-Jun-21,Moderna,17-Jan-22,Moderna,,,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,55,Scheduled,210,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.1,Negative,4,Negative,Adult,,Pre-1st,08-Mar-21,baseline,30-Mar-21,Pfizer,11-Jun-21,Pfizer,,,,,,,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,73,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.09,Negative,1571,Positive,Adult,,Post-1st,07-May-21,baseline,30-Mar-21,Pfizer,11-Jun-21,Pfizer,,,,,,,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,223,2,May,2021,38,,,,Completed,1000-4999,N/A,73,Delayed,,Delayed,,38,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,14,Negative,Adult,,Pre-1st,08-Mar-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,47,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,2,1,March,2021,,,,,Completed,0-49,N/A,33,Scheduled,119,Scheduled,191,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,26979,Positive,Adult,,Post-2nd (1-8 Weeks),07-Jun-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,47,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,3831,2,June,2021,,32,,,Completed,10000+,N/A,33,Scheduled,119,Scheduled,191,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.06,Negative,24142,Positive,Adult,,Post-3rd (1-8 Weeks),23-Sep-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,47,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,3428,3,September,2021,,,21,,Completed,10000+,N/A,33,Scheduled,119,Scheduled,191,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.17,Negative,4194,Positive,Adult,,Post-3rd (8+ Weeks),09-Mar-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,48,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,596,4,March,2022,,,188,,Completed,1000-4999,N/A,33,Scheduled,119,Scheduled,191,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.19,Negative,12333,Positive,Adult,,Post-4th,09-Jun-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,48,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1751,5,June,2022,,,,89,Completed,10000+,N/A,33,Scheduled,119,Scheduled,191,,,,89,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1,Negative,Adult,,Pre-1st,03-Mar-21,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,81,Delayed,168,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,9237,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1312,2,July,2021,,36,,,Completed,,N/A,81,Delayed,168,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.41,Negative,14149,Positive,Adult,,Post-3rd (1-8 Weeks),11-Jan-22,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2009,3,January,2022,,,36,,Completed,10000+,N/A,81,Delayed,168,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.39,Negative,8081,Positive,Adult,,Post-3rd (8+ Weeks),04-Apr-22,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1148,4,April,2022,,,119,,Completed,,N/A,81,Delayed,168,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,2,Negative,Adult,,Pre-1st,05-Mar-21,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,34,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,1,March,2021,,,,,Completed,0-49,N/A,56,Scheduled,140,Delayed,229,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,1144,Positive,Adult,,Post-2nd (1-8 Weeks),18-Aug-21,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,35,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,162,2,August,2021,,42,,,Completed,1000-4999,N/A,56,Scheduled,140,Delayed,229,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,345,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,35,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,49,3,February,2022,,,71,,Completed,250-999,N/A,56,Scheduled,140,Delayed,229,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,386,Positive,Adult,,Post-3rd (8+ Weeks),25-May-22,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,35,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,55,4,May,2022,,,182,,Completed,250-999,N/A,56,Scheduled,140,Delayed,229,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,0,Negative,Adult,,Pre-1st,05-Mar-21,baseline,15-Apr-21,Pfizer,23-Jun-21,Pfizer,14-Sep-21,Pfizer,27-Jun-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,69,Delayed,83,Scheduled,286,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.8,Positive,2,Negative,Adult,-44,Pre-1st,29-Mar-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,64,Delayed,105,Scheduled,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.7,Positive,1297,Positive,Adult,0,Post-1st,12-May-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,184,2,May,2021,29,,,,Completed,1000-4999,N/A,64,Delayed,105,Scheduled,155,29,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.78,Positive,546,Positive,Adult,96,Post-2nd (8+ Weeks),16-Aug-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,78,3,August,2021,,61,,,Completed,250-999,N/A,64,Delayed,105,Scheduled,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.66,Negative,151,Positive,Adult,142,Post-2nd (8+ Weeks),01-Oct-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,21,4,October,2021,,107,,,Completed,50-249,N/A,64,Delayed,105,Scheduled,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.39,Negative,1113,Positive,Adult,265,Post-3rd (8+ Weeks),01-Feb-22,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,158,5,February,2022,,,125,,Completed,1000-4999,N/A,64,Delayed,105,Scheduled,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.72,Positive,24265,Positive,Adult,331,Post-4th,08-Apr-22,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3446,6,April,2022,,,,36,Completed,10000+,N/A,64,Delayed,105,Scheduled,155,,,,36,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.8,Positive,3597,Positive,Adult,404,Post-4th,20-Jun-22,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,511,7,June,2022,,,,109,Completed,1000-4999,N/A,64,Delayed,105,Scheduled,155,,,,109,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.14,Negative,30,Negative,Elderly,,Post-1st,19-May-21,baseline,05-Apr-21,Pfizer,23-Jun-21,Pfizer,29-Dec-21,Pfizer,06-Jul-22,Pfizer,,,69,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4,1,May,2021,44,,,,Completed,0-49,N/A,79,Delayed,189,Delayed,189,44,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.47,Negative,56,Positive,Adult,93,Pre-1st,06-Apr-21,covid,18-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,1,April,2021,,,,,Completed,50-249,N/A,45,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.19,Negative,9720,Positive,Adult,206,Post-2nd (1-8 Weeks),28-Jul-21,covid,18-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1380,2,July,2021,,26,,,Completed,,N/A,45,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Immunomodulator Only,,0.03,Negative,2117,Positive,Adult,-148,Post-2nd (8+ Weeks),25-Aug-21,Post Vaccine covid,23-Apr-21,Pfizer,17-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,301,1,August,2021,,69,,,Completed,1000-4999,N/A,55,Scheduled,207,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Immunomodulator Only,,0.28,Negative,40000,Positive,Adult,132,Post-3rd (8+ Weeks),01-Jun-22,Post Vaccine covid,23-Apr-21,Pfizer,17-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5680,2,June,2022,,,142,,Completed,10000+,N/A,55,Scheduled,207,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,7,Negative,Adult,,Pre-1st,09-Mar-21,baseline,09-Apr-21,Pfizer,03-May-21,Pfizer,28-Sep-21,Pfizer,,,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,24,Scheduled,148,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,10109,Positive,Adult,,Post-3rd (1-8 Weeks),18-Oct-21,baseline,09-Apr-21,Pfizer,03-May-21,Pfizer,28-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1435,2,October,2021,,,20,,Completed,10000+,N/A,24,Scheduled,148,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.17,Negative,1284,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,09-Apr-21,Pfizer,03-May-21,Pfizer,28-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,182,3,February,2022,,,133,,Completed,1000-4999,N/A,24,Scheduled,148,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,136,Positive,Adult,-232,Post-1st,22-Feb-21,Post Vaccine covid,13-Jan-21,Pfizer,23-Feb-21,Pfizer,09-Oct-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,19,1,February,2021,40,,,,Completed,50-249,N/A,41,Scheduled,228,Delayed,,40,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,658,Positive,Adult,-227,Post-1st,22-May-21,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,93,1,May,2021,30,,,,Completed,250-999,N/A,57,Delayed,238,Delayed,,30,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,8046,Positive,Adult,-154,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1142,2,August,2021,,46,,,Completed,,N/A,57,Delayed,238,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.18,Negative,711,Positive,Adult,-5,Post-2nd (8+ Weeks),30-Dec-21,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,101,3,December,2021,,195,,,Completed,250-999,N/A,57,Delayed,238,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.44,Positive,40000,Positive,Adult,129,Post-3rd (8+ Weeks),13-May-22,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5680,4,May,2022,,,91,,Completed,10000+,N/A,57,Delayed,238,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,,,,,0.05,Negative,0,Negative,Adult,-102,,14-Sep-21,Baseline to COVID,,,,,,,,,,,47,40-49,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,September,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.81,Positive,90,Positive,Adult,164,Pre-1st,28-Jan-21,covid,06-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,31,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,1,January,2021,,,,,Completed,50-249,N/A,57,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,4.7,Positive,17865,Positive,Adult,682,Post-2nd (8+ Weeks),30-Jun-22,covid,06-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2537,2,June,2022,,363,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,2932,Positive,Adult,-223,Post-2nd (8+ Weeks),12-Aug-21,baseline,11-Apr-21,Pfizer,16-Jun-21,Pfizer,11-Oct-21,Pfizer,07-Jul-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,416,1,August,2021,,57,,,Completed,1000-4999,N/A,66,Delayed,117,Scheduled,269,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,11661,Positive,Adult,-125,Post-3rd (1-8 Weeks),18-Nov-21,baseline,11-Apr-21,Pfizer,16-Jun-21,Pfizer,11-Oct-21,Pfizer,07-Jul-22,Pfizer,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1656,2,November,2021,,,38,,Completed,10000+,N/A,66,Delayed,117,Scheduled,269,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,185,Positive,Adult,,Post-2nd (8+ Weeks),26-May-21,baseline,13-Jan-21,Pfizer,19-Feb-21,Pfizer,17-Jan-22,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,1,May,2021,,96,,,Completed,50-249,N/A,37,Scheduled,332,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,59,Positive,Adult,,Post-2nd (8+ Weeks),10-Sep-21,baseline,13-Jan-21,Pfizer,19-Feb-21,Pfizer,17-Jan-22,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8,2,September,2021,,203,,,Completed,50-249,N/A,37,Scheduled,332,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1910,Positive,Adult,,Post-3rd (8+ Weeks),17-Jun-22,baseline,13-Jan-21,Pfizer,19-Feb-21,Pfizer,17-Jan-22,Pfizer,,,,,46,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,271,3,June,2022,,,151,,Completed,1000-4999,N/A,37,Scheduled,332,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,7,Negative,Adult,,Pre-1st,03-Mar-21,baseline,10-Apr-21,Pfizer,19-Jun-21,Pfizer,02-Nov-21,Pfizer,15-Jun-22,Pfizer,,,36,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,70,Delayed,136,Delayed,225,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,25287,Positive,Adult,,Post-2nd (8+ Weeks),18-Aug-21,baseline,10-Apr-21,Pfizer,19-Jun-21,Pfizer,02-Nov-21,Pfizer,15-Jun-22,Pfizer,,,36,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,3591,2,August,2021,,60,,,Completed,10000+,N/A,70,Delayed,136,Delayed,225,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.1,Negative,18823,Positive,Adult,,Post-3rd (8+ Weeks),01-Feb-22,baseline,10-Apr-21,Pfizer,19-Jun-21,Pfizer,02-Nov-21,Pfizer,15-Jun-22,Pfizer,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,2673,3,February,2022,,,91,,Completed,10000+,N/A,70,Delayed,136,Delayed,225,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,5191,Positive,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,07-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,31-May-22,Moderna,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,737,1,July,2021,,55,,,Completed,,N/A,35,Scheduled,134,Delayed,250,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,1949,Positive,Adult,,Post-2nd (8+ Weeks),23-Sep-21,baseline,07-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,31-May-22,Moderna,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,277,2,September,2021,,134,,,Completed,1000-4999,N/A,35,Scheduled,134,Delayed,250,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,4027,Positive,Adult,,Post-3rd (8+ Weeks),24-Feb-22,baseline,07-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,31-May-22,Moderna,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,572,3,February,2022,,,154,,Completed,1000-4999,N/A,35,Scheduled,134,Delayed,250,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,,,0.16,Negative,4,Negative,Adult,,Pre-1st,24-Mar-21,baseline,06-Oct-21,Moderna,03-Nov-21,Moderna,,,,,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,,,0.17,Negative,4,Negative,Adult,,Pre-1st,14-Jul-21,baseline,06-Oct-21,Moderna,03-Nov-21,Moderna,,,,,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,July,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,45,Negative,Elderly,,Post-1st,31-Mar-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,83,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,March,2021,31,,,,Completed,0-49,N/A,44,Scheduled,177,Delayed,,31,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,618,Positive,Elderly,,Post-2nd (1-8 Weeks),12-May-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,83,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,88,2,May,2021,,29,,,Completed,250-999,N/A,44,Scheduled,177,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,37,Negative,Elderly,,Post-2nd (8+ Weeks),27-Aug-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,84,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,3,August,2021,,136,,,Completed,0-49,N/A,44,Scheduled,177,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,622,Positive,Elderly,,Post-3rd (8+ Weeks),15-Dec-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,84,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,88,4,December,2021,,,69,,Completed,250-999,N/A,44,Scheduled,177,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,253,Positive,Elderly,,Post-3rd (8+ Weeks),17-Feb-22,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,84,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,36,5,February,2022,,,133,,Completed,250-999,N/A,44,Scheduled,177,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,,,6.71,Positive,1494,Positive,Adult,52,Pre-1st,14-May-21,Baseline to COVID,07-Jul-21,Moderna,03-Nov-21,Moderna,,,,,,,30,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,212,1,May,2021,,,,,Completed,1000-4999,52 Days Before Collection Days After Collection,119,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,1.34,Positive,38883,Positive,Elderly,329,Post-2nd (1-8 Weeks),25-Feb-21,covid,31-Dec-20,Pfizer,07-Feb-21,Pfizer,07-Oct-21,Pfizer,,,,,67,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5521,1,February,2021,,18,,,Completed,10000+,N/A,38,Scheduled,242,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.33,Negative,5177,Positive,Elderly,537,Post-2nd (8+ Weeks),21-Sep-21,covid,31-Dec-20,Pfizer,07-Feb-21,Pfizer,07-Oct-21,Pfizer,,,,,68,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,735,2,September,2021,,226,,,Completed,,N/A,38,Scheduled,242,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.3,Negative,8102,Positive,Elderly,664,Post-3rd (8+ Weeks),26-Jan-22,covid,31-Dec-20,Pfizer,07-Feb-21,Pfizer,07-Oct-21,Pfizer,,,,,68,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1150,3,January,2022,,,111,,Completed,,N/A,38,Scheduled,242,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,13,Negative,Adult,,Pre-1st,18-Aug-21,baseline,27-Oct-21,Pfizer,26-Nov-21,Pfizer,,,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,August,2021,,,,,Completed,0-49,N/A,30,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,6,Negative,Adult,,Pre-1st,13-Apr-21,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,33,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,4140,Positive,Adult,,Post-2nd (1-8 Weeks),18-Jun-21,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,588,2,June,2021,,31,,,Completed,1000-4999,N/A,33,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,2094,Positive,Adult,,Post-2nd (8+ Weeks),22-Sep-21,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,297,3,September,2021,,127,,,Completed,1000-4999,N/A,33,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.17,Negative,80000,Positive,Adult,,Post-3rd (1-8 Weeks),27-Jan-22,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,4,January,2022,,,23,,Completed,10000+,N/A,33,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.56,Negative,40000,Positive,Adult,,Post-3rd (8+ Weeks),17-May-22,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5680,5,May,2022,,,133,,Completed,10000+,N/A,33,Scheduled,231,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.25,Negative,17211,Positive,Adult,-191,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2444,1,August,2021,,18,,,Completed,10000+,N/A,98,Delayed,66,Scheduled,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.4,Negative,8480,Positive,Adult,-13,Post-3rd (8+ Weeks),28-Jan-22,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1204,2,January,2022,,,130,,Completed,,N/A,98,Delayed,66,Scheduled,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2,Positive,80000,Positive,Adult,42,Post-4th,24-Mar-22,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,3,March,2022,,,,28,Completed,10000+,N/A,98,Delayed,66,Scheduled,157,,,,28,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.84,Positive,80000,Positive,Adult,160,Post-4th,20-Jul-22,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,4,July,2022,,,,146,Completed,10000+,N/A,98,Delayed,66,Scheduled,157,,,,146,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.45,Negative,231,Positive,Adult,-337,Post-1st,22-May-21,baseline,10-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,14-Apr-22,Pfizer,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,33,1,May,2021,42,,,,Completed,50-249,N/A,65,Delayed,85,Scheduled,219,42,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.35,Negative,1431,Positive,Adult,-304,Post-2nd (1-8 Weeks),24-Jun-21,baseline,10-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,14-Apr-22,Pfizer,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,203,2,June,2021,,10,,,Completed,1000-4999,N/A,65,Delayed,85,Scheduled,219,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,1,Negative,Adult,,Pre-1st,26-Mar-21,baseline,29-Apr-21,Pfizer,09-Jun-21,Pfizer,26-Sep-21,Pfizer,26-Feb-22,Pfizer,,,19,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,41,Scheduled,109,Scheduled,153,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,10805,Positive,Adult,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,29-Apr-21,Pfizer,09-Jun-21,Pfizer,26-Sep-21,Pfizer,26-Feb-22,Pfizer,,,20,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1534,2,July,2021,,41,,,Completed,10000+,N/A,41,Scheduled,109,Scheduled,153,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,1311,Positive,Adult,,Post-2nd (1-8 Weeks),20-Sep-21,baseline,02-Jul-21,Moderna,01-Aug-21,Moderna,,,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,186,1,September,2021,,50,,,Completed,1000-4999,N/A,30,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,18,Negative,Adult,,Post-1st,13-May-21,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,3,1,May,2021,19,,,,Completed,0-49,N/A,68,Delayed,205,Delayed,,19,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,893,Positive,Adult,,Post-2nd (8+ Weeks),28-Sep-21,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,127,2,September,2021,,89,,,Completed,250-999,N/A,68,Delayed,205,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,14853,Positive,Adult,,Post-3rd (1-8 Weeks),15-Feb-22,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2109,3,February,2022,,,24,,Completed,10000+,N/A,68,Delayed,205,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,3079,Positive,Adult,,Post-3rd (8+ Weeks),05-Jul-22,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,437,4,July,2022,,,164,,Completed,1000-4999,N/A,68,Delayed,205,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.42,Negative,1,Negative,Adult,,Pre-1st,16-Mar-21,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,82,Delayed,97,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.45,Negative,433,Positive,Adult,,Post-1st,28-May-21,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,62,2,May,2021,55,,,,Completed,250-999,N/A,82,Delayed,97,Scheduled,,55,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.26,Negative,11011,Positive,Adult,,Post-2nd (1-8 Weeks),17-Aug-21,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1564,3,August,2021,,54,,,Completed,10000+,N/A,82,Delayed,97,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.29,Negative,2196,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,312,4,February,2022,,,132,,Completed,1000-4999,N/A,82,Delayed,97,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1,Negative,Adult,-251,Pre-1st,03-May-21,baseline,03-May-21,Pfizer,28-Jun-21,Pfizer,21-Sep-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,May,2021,,,,,Completed,0-49,N/A,56,Scheduled,85,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,121,Positive,Adult,-209,Post-1st,14-Jun-21,baseline,03-May-21,Pfizer,28-Jun-21,Pfizer,21-Sep-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,2,June,2021,42,,,,Completed,50-249,N/A,56,Scheduled,85,Scheduled,,42,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,7011,Positive,Adult,-181,Post-2nd (1-8 Weeks),12-Jul-21,baseline,03-May-21,Pfizer,28-Jun-21,Pfizer,21-Sep-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,996,3,July,2021,,14,,,Completed,,N/A,56,Scheduled,85,Scheduled,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,6.22,Positive,5467,Positive,Adult,39,Post-1st,21-May-21,Baseline to COVID,05-May-21,Pfizer,20-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,776,1,May,2021,16,,,,Completed,,N/A,76,Delayed,,Delayed,,16,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.98,Positive,6333,Positive,Adult,120,Post-2nd (1-8 Weeks),10-Aug-21,Baseline to COVID,05-May-21,Pfizer,20-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,899,2,August,2021,,21,,,Completed,,N/A,76,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,1,Negative,Adult,,Post-1st,01-May-21,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,May,2021,23,,,,Completed,0-49,N/A,85,Delayed,80,Scheduled,166,23,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,797,Positive,Adult,,Post-2nd (1-8 Weeks),24-Jul-21,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,113,2,July,2021,,22,,,Completed,250-999,N/A,85,Delayed,80,Scheduled,166,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,5941,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,844,3,October,2021,,,25,,Completed,,N/A,85,Delayed,80,Scheduled,166,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,385,Positive,Adult,,Post-3rd (8+ Weeks),21-Jan-22,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,55,4,January,2022,,,123,,Completed,250-999,N/A,85,Delayed,80,Scheduled,166,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.2,Negative,10522,Positive,Adult,,Post-4th,02-Apr-22,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1494,5,April,2022,,,,28,Completed,10000+,N/A,85,Delayed,80,Scheduled,166,,,,28,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,1205,Positive,Adult,,Post-4th,06-Jul-22,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,171,6,July,2022,,,,123,Completed,1000-4999,N/A,85,Delayed,80,Scheduled,166,,,,123,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,46530,Positive,Adult,-222,Post-2nd (1-8 Weeks),22-Mar-21,Post Vaccine covid,13-Jan-21,Pfizer,20-Feb-21,Pfizer,28-Nov-21,Pfizer,,,,,27,18-29,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6607,1,March,2021,,30,,,Completed,10000+,N/A,38,Scheduled,281,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.54,Negative,80000,Positive,Adult,115,Post-3rd (8+ Weeks),22-Feb-22,Post Vaccine covid,13-Jan-21,Pfizer,20-Feb-21,Pfizer,28-Nov-21,Pfizer,,,,,28,18-29,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,2,February,2022,,,86,,Completed,10000+,N/A,38,Scheduled,281,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.25,Negative,1306,Positive,Adult,98,Post-1st,18-May-21,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,185,1,May,2021,41,,,,Completed,1000-4999,N/A,51,Scheduled,161,Delayed,176,41,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.09,Negative,5810,Positive,Adult,213,Post-2nd (8+ Weeks),10-Sep-21,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,825,2,September,2021,,105,,,Completed,,N/A,51,Scheduled,161,Delayed,176,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,35410,Positive,Adult,324,Post-3rd (1-8 Weeks),30-Dec-21,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,5028,3,December,2021,,,55,,Completed,10000+,N/A,51,Scheduled,161,Delayed,176,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.11,Negative,10143,Positive,Adult,435,Post-3rd (8+ Weeks),20-Apr-22,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,1440,4,April,2022,,,166,,Completed,10000+,N/A,51,Scheduled,161,Delayed,176,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.14,Negative,34058,Positive,Adult,462,Post-4th,17-May-22,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,4836,5,May,2022,,,,17,Completed,10000+,N/A,51,Scheduled,161,Delayed,176,,,,17,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,7079,Positive,Adult,,Post-2nd (1-8 Weeks),25-May-21,baseline,14-Apr-21,Pfizer,06-May-21,Pfizer,09-Dec-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1005,1,May,2021,,19,,,Completed,,N/A,22,Scheduled,217,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,30138,Positive,Adult,,Post-3rd (1-8 Weeks),21-Dec-21,baseline,14-Apr-21,Pfizer,06-May-21,Pfizer,09-Dec-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4280,2,December,2021,,,12,,Completed,10000+,N/A,22,Scheduled,217,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,0,Negative,Adult,,Pre-1st,13-Apr-21,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,53,Scheduled,229,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,80,Positive,Adult,,Post-1st,09-Jun-21,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,2,June,2021,30,,,,Completed,50-249,N/A,53,Scheduled,229,Delayed,,30,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,8465,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1202,3,July,2021,,20,,,Completed,,N/A,53,Scheduled,229,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,735,Positive,Adult,,Post-2nd (8+ Weeks),14-Feb-22,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,104,4,February,2022,,227,,,Completed,250-999,N/A,53,Scheduled,229,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,14762,Positive,Adult,,Post-3rd (1-8 Weeks),15-Mar-22,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2096,5,March,2022,,,27,,Completed,10000+,N/A,53,Scheduled,229,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,3730,Positive,Adult,,Post-3rd (8+ Weeks),23-Jun-22,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,53,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,530,6,June,2022,,,127,,Completed,1000-4999,N/A,53,Scheduled,229,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,2,Negative,Adult,,Pre-1st,16-Apr-21,baseline,12-Apr-21,Moderna,22-May-21,Moderna,,,,,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,40,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,604,Positive,Adult,,Post-1st,10-May-21,baseline,11-Apr-21,Pfizer,26-Jul-21,Pfizer,29-Dec-21,Pfizer,,,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,86,1,May,2021,29,,,,Completed,250-999,N/A,106,Delayed,156,Delayed,,29,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,16150,Positive,Adult,,Post-1st,30-Jul-21,baseline,11-Apr-21,Pfizer,26-Jul-21,Pfizer,29-Dec-21,Pfizer,,,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2293,2,July,2021,110,,,,Completed,10000+,N/A,106,Delayed,156,Delayed,,110,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.6,Negative,68644,Positive,Adult,,Post-3rd (1-8 Weeks),11-Jan-22,baseline,11-Apr-21,Pfizer,26-Jul-21,Pfizer,29-Dec-21,Pfizer,,,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9747,3,January,2022,,,13,,Completed,10000+,N/A,106,Delayed,156,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,,,,,,,,,Adult,,,10-Sep-21,baseline,,,,,,,,,,,46,40-49,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,September,2021,,,,,Processed,,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,30269,Positive,Adult,-180,Post-3rd (1-8 Weeks),25-Oct-21,baseline,07-Apr-21,Pfizer,04-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,24,18-29,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,4298,1,October,2021,,,24,,Completed,10000+,N/A,58,Delayed,119,Scheduled,,,,,,
University of Calgary,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2,Negative,Adult,-435,Pre-1st,01-Mar-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,37,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,60,Delayed,117,Scheduled,153,,,,,
University of Calgary,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2297,Positive,Adult,-355,Post-1st,20-May-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,326,2,May,2021,40,,,,Completed,1000-4999,N/A,60,Delayed,117,Scheduled,153,40,,,,
University of Calgary,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,28060,Positive,Adult,-319,Post-2nd (1-8 Weeks),25-Jun-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3985,3,June,2021,,16,,,Completed,10000+,N/A,60,Delayed,117,Scheduled,153,,,,,
University of Calgary,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,61731,Positive,Adult,-194,Post-3rd (1-8 Weeks),28-Oct-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,8766,4,October,2021,,,24,,Completed,10000+,N/A,60,Delayed,117,Scheduled,153,,,,,
University of Calgary,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,10337,Positive,Adult,-83,Post-3rd (8+ Weeks),16-Feb-22,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1468,5,February,2022,,,135,,Completed,10000+,N/A,60,Delayed,117,Scheduled,153,,,,,
University of Calgary,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,57844,Positive,Adult,-27,Post-4th,13-Apr-22,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,8214,6,April,2022,,,,38,Completed,10000+,N/A,60,Delayed,117,Scheduled,153,,,,38,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,1077,Positive,Elderly,,Post-2nd (1-8 Weeks),30-Apr-21,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,153,1,April,2021,,8,,,Completed,1000-4999,N/A,42,Scheduled,169,Delayed,166,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,517,Positive,Elderly,,Post-2nd (8+ Weeks),17-Sep-21,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,73,2,September,2021,,148,,,Completed,250-999,N/A,42,Scheduled,169,Delayed,166,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.28,Negative,19665,Positive,Elderly,,Post-3rd (1-8 Weeks),26-Oct-21,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2792,3,October,2021,,,18,,Completed,10000+,N/A,42,Scheduled,169,Delayed,166,,,,,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,17677,Positive,Elderly,,Post-4th,12-Apr-22,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2510,4,April,2022,,,,20,Completed,10000+,N/A,42,Scheduled,169,Delayed,166,,,,20,
University of Calgary,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.95,Positive,40000,Positive,Elderly,,Post-4th,06-Jul-22,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,5680,5,July,2022,,,,105,Completed,10000+,N/A,42,Scheduled,169,Delayed,166,,,,105,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,6076,Positive,Elderly,-340,Post-2nd (1-8 Weeks),16-Apr-21,baseline,11-Mar-21,Pfizer,03-Apr-21,Pfizer,06-Oct-21,Pfizer,10-Jun-22,Pfizer,,,81,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,863,1,April,2021,,13,,,Completed,,N/A,23,Scheduled,186,Delayed,247,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,0.09,Negative,883,Positive,Elderly,-315,Post-2nd (1-8 Weeks),11-May-21,baseline,11-Mar-21,Pfizer,03-Apr-21,Pfizer,06-Oct-21,Pfizer,10-Jun-22,Pfizer,,,81,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,125,2,May,2021,,38,,,Completed,250-999,N/A,23,Scheduled,186,Delayed,247,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,0.08,Negative,422,Positive,Elderly,-203,Post-2nd (8+ Weeks),31-Aug-21,baseline,11-Mar-21,Pfizer,03-Apr-21,Pfizer,06-Oct-21,Pfizer,10-Jun-22,Pfizer,,,81,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,60,3,August,2021,,150,,,Completed,250-999,N/A,23,Scheduled,186,Delayed,247,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,0.08,Negative,2601,Positive,Elderly,-143,Post-3rd (1-8 Weeks),30-Oct-21,baseline,11-Mar-21,Pfizer,03-Apr-21,Pfizer,06-Oct-21,Pfizer,10-Jun-22,Pfizer,,,82,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,369,4,October,2021,,,24,,Completed,1000-4999,N/A,23,Scheduled,186,Delayed,247,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,361,Positive,Adult,,Post-2nd (8+ Weeks),25-Aug-21,baseline,12-Apr-21,Pfizer,11-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,51,1,August,2021,,75,,,Completed,250-999,N/A,60,Delayed,174,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1760,Positive,Adult,,Post-3rd (8+ Weeks),17-Feb-22,baseline,12-Apr-21,Pfizer,11-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,250,2,February,2022,,,77,,Completed,1000-4999,N/A,60,Delayed,174,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,812,Positive,Adult,,Post-3rd (8+ Weeks),05-Apr-22,baseline,12-Apr-21,Pfizer,11-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,115,3,April,2022,,,124,,Completed,250-999,N/A,60,Delayed,174,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,4.12,Positive,182,Positive,Adult,12,Pre-1st,18-Jan-21,covid,22-Apr-21,Pfizer,26-Jul-21,Pfizer,,,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,1,January,2021,,,,,Completed,50-249,N/A,95,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,1.35,Positive,342,Positive,Adult,68,Pre-1st,15-Mar-21,covid,22-Apr-21,Pfizer,26-Jul-21,Pfizer,,,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,2,March,2021,,,,,Completed,250-999,N/A,95,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,997,Positive,Adult,,Post-1st,31-May-21,baseline,13-Apr-21,Moderna,07-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,142,1,May,2021,48,,,,Completed,250-999,N/A,55,Scheduled,204,Delayed,,48,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,11,Negative,Adult,,Pre-1st,08-Mar-21,baseline,10-Apr-21,Pfizer,15-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,34,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,1,March,2021,,,,,Completed,0-49,N/A,66,Delayed,182,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,1168,Positive,Adult,,Post-1st,03-May-21,baseline,10-Apr-21,Pfizer,15-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,34,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,166,2,May,2021,23,,,,Completed,1000-4999,N/A,66,Delayed,182,Delayed,,23,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,8755,Positive,Adult,,Post-2nd (8+ Weeks),18-Aug-21,baseline,10-Apr-21,Pfizer,15-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1243,3,August,2021,,64,,,Completed,,N/A,66,Delayed,182,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.48,Negative,109,Positive,Adult,103,Pre-1st,12-Mar-21,covid,21-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,1,March,2021,,,,,Completed,50-249,N/A,65,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,3.75,Positive,20944,Positive,Adult,87,Post-1st,10-Feb-21,covid,14-Jan-21,Pfizer,22-Feb-21,Pfizer,06-Dec-21,Pfizer,,,,,47,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2974,1,February,2021,27,,,,Completed,10000+,N/A,39,Scheduled,287,Delayed,,27,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.37,Negative,1791,Positive,Adult,341,Post-2nd (8+ Weeks),22-Oct-21,covid,14-Jan-21,Pfizer,22-Feb-21,Pfizer,06-Dec-21,Pfizer,,,,,48,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,254,2,October,2021,,242,,,Completed,1000-4999,N/A,39,Scheduled,287,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,1,Negative,Adult,,Pre-1st,06-Apr-21,baseline,02-Apr-21,Pfizer,28-May-21,Pfizer,17-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,56,Scheduled,203,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,1501,Positive,Adult,,Post-2nd (8+ Weeks),24-Aug-21,baseline,02-Apr-21,Pfizer,28-May-21,Pfizer,17-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,213,2,August,2021,,88,,,Completed,1000-4999,N/A,56,Scheduled,203,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,9959,Positive,Adult,,Post-3rd (1-8 Weeks),10-Feb-22,baseline,02-Apr-21,Pfizer,28-May-21,Pfizer,17-Dec-21,Pfizer,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1414,3,February,2022,,,55,,Completed,,N/A,56,Scheduled,203,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,0,Negative,Adult,,Pre-1st,17-Mar-21,baseline,24-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,25,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,49,Scheduled,198,Delayed,,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,313,Positive,Adult,,Post-1st,12-Jun-21,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,37,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,44,1,June,2021,45,,,,Completed,250-999,N/A,51,Scheduled,145,Delayed,,45,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,32029,Positive,Adult,,Post-2nd (1-8 Weeks),11-Jul-21,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,37,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,4548,2,July,2021,,23,,,Completed,10000+,N/A,51,Scheduled,145,Delayed,,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.24,Negative,25492,Positive,Adult,,Post-3rd (1-8 Weeks),07-Dec-21,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,38,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,3620,3,December,2021,,,27,,Completed,10000+,N/A,51,Scheduled,145,Delayed,,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.32,Negative,6186,Positive,Adult,,Post-3rd (8+ Weeks),27-Mar-22,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,38,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,878,4,March,2022,,,137,,Completed,,N/A,51,Scheduled,145,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,0,Negative,Adult,,Pre-1st,25-Mar-21,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,62,Delayed,190,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,212,Positive,Adult,,Post-1st,17-May-21,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,2,May,2021,37,,,,Completed,50-249,N/A,62,Delayed,190,Delayed,,37,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.19,Negative,505,Positive,Adult,,Post-2nd (8+ Weeks),16-Dec-21,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,72,3,December,2021,,188,,,Completed,250-999,N/A,62,Delayed,190,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.14,Negative,8246,Positive,Adult,,Post-3rd (1-8 Weeks),25-Jan-22,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1171,4,January,2022,,,38,,Completed,,N/A,62,Delayed,190,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.26,Negative,1670,Positive,Adult,,Post-3rd (8+ Weeks),26-May-22,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,237,5,May,2022,,,159,,Completed,1000-4999,N/A,62,Delayed,190,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.35,Negative,344,Positive,Adult,215,Pre-1st,22-Feb-21,covid,28-Jul-21,Pfizer,28-Aug-21,Pfizer,,,,,,,32,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,1,February,2021,,,,,Completed,250-999,N/A,31,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,0,Negative,Adult,-306,Pre-1st,03-Apr-21,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,April,2021,,,,,Completed,0-49,N/A,57,Delayed,138,Delayed,199,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,3,Negative,Adult,-231,Post-1st,17-Jun-21,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,2,June,2021,36,,,,Completed,0-49,N/A,57,Delayed,138,Delayed,199,36,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,41,Negative,Adult,-196,Post-2nd (1-8 Weeks),22-Jul-21,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,6,3,July,2021,,14,,,Completed,0-49,N/A,57,Delayed,138,Delayed,199,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,351,Positive,Adult,-30,Post-3rd (1-8 Weeks),04-Jan-22,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,50,4,January,2022,,,42,,Completed,250-999,N/A,57,Delayed,138,Delayed,199,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,2075,Positive,Adult,91,Post-3rd (8+ Weeks),05-May-22,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,295,5,May,2022,,,163,,Completed,1000-4999,N/A,57,Delayed,138,Delayed,199,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.09,Negative,437,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,09-Apr-21,Pfizer,30-May-21,Pfizer,03-Sep-21,Pfizer,15-Feb-22,Pfizer,,,26,18-29,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,62,1,July,2021,,40,,,Completed,250-999,N/A,51,Scheduled,96,Scheduled,165,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,446,Positive,Adult,,Post-3rd (8+ Weeks),07-Jan-22,baseline,09-Apr-21,Pfizer,30-May-21,Pfizer,03-Sep-21,Pfizer,15-Feb-22,Pfizer,,,27,18-29,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,63,2,January,2022,,,126,,Completed,250-999,N/A,51,Scheduled,96,Scheduled,165,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,849,Positive,Adult,,Post-4th,21-May-22,baseline,09-Apr-21,Pfizer,30-May-21,Pfizer,03-Sep-21,Pfizer,15-Feb-22,Pfizer,,,27,18-29,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,121,3,May,2022,,,,95,Completed,250-999,N/A,51,Scheduled,96,Scheduled,165,,,,95,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,0,Negative,Adult,-28,Pre-1st,14-Mar-21,Baseline to COVID,19-May-21,Pfizer,01-Aug-21,Moderna,24-Jan-22,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,74,Delayed,176,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,0,Negative,Adult,,Pre-1st,12-Mar-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,33,Scheduled,134,Delayed,229,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,514,Positive,Adult,,Post-1st,07-May-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,73,2,May,2021,28,,,,Completed,250-999,N/A,33,Scheduled,134,Delayed,229,28,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,3692,Positive,Adult,,Post-2nd (8+ Weeks),16-Aug-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,524,3,August,2021,,96,,,Completed,1000-4999,N/A,33,Scheduled,134,Delayed,229,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,9253,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1314,4,February,2022,,,133,,Completed,,N/A,33,Scheduled,134,Delayed,229,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,3,Negative,Adult,,Pre-1st,16-Mar-21,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,66,Delayed,179,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,44,Negative,Adult,,Post-1st,28-May-21,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,2,May,2021,38,,,,Completed,0-49,N/A,66,Delayed,179,Delayed,,38,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,10169,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1444,3,July,2021,,24,,,Completed,10000+,N/A,66,Delayed,179,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.32,Negative,530,Positive,Adult,,Post-2nd (8+ Weeks),16-Dec-21,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,75,4,December,2021,,174,,,Completed,250-999,N/A,66,Delayed,179,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.33,Negative,10602,Positive,Adult,,Post-3rd (1-8 Weeks),17-Jan-22,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1505,5,January,2022,,,27,,Completed,10000+,N/A,66,Delayed,179,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.89,Positive,1309,Positive,Adult,,Post-3rd (8+ Weeks),22-Apr-22,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,186,6,April,2022,,,122,,Completed,1000-4999,N/A,66,Delayed,179,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,182,Positive,Adult,,Post-1st,30-Mar-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,26,1,March,2021,38,,,,Completed,50-249,N/A,38,Scheduled,156,Delayed,144,38,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,447,Positive,Adult,,Post-2nd (8+ Weeks),02-Jun-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,63,2,June,2021,,64,,,Completed,250-999,N/A,38,Scheduled,156,Delayed,144,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,152,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,22,3,September,2021,,156,,,Completed,50-249,N/A,38,Scheduled,156,Delayed,144,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,405,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,57,4,January,2022,,,140,,Completed,250-999,N/A,38,Scheduled,156,Delayed,144,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,2201,Positive,Adult,,Post-4th,24-Mar-22,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,312,5,March,2022,,,,59,Completed,1000-4999,N/A,38,Scheduled,156,Delayed,144,,,,59,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,6.3,Positive,9005,Positive,Adult,51,Pre-1st,10-Feb-21,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,48,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1279,1,February,2021,,,,,Completed,,N/A,67,Delayed,167,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.3,Positive,38645,Positive,Adult,147,Post-1st,17-May-21,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5488,2,May,2021,36,,,,Completed,10000+,N/A,67,Delayed,167,Delayed,,36,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.35,Negative,10096,Positive,Adult,234,Post-2nd (8+ Weeks),12-Aug-21,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1434,3,August,2021,,56,,,Completed,10000+,N/A,67,Delayed,167,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.41,Negative,19486,Positive,Adult,399,Post-3rd (1-8 Weeks),24-Jan-22,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2767,4,January,2022,,,54,,Completed,10000+,N/A,67,Delayed,167,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.4,Negative,11469,Positive,Adult,491,Post-3rd (8+ Weeks),26-Apr-22,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1629,5,April,2022,,,146,,Completed,10000+,N/A,67,Delayed,167,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,3.77,Positive,816,Positive,Adult,76,Pre-1st,16-Feb-21,covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,116,1,February,2021,,,,,Completed,250-999,N/A,54,Scheduled,187,Delayed,,,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,1.04,Positive,24684,Positive,Adult,175,Post-1st,26-May-21,covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3505,2,May,2021,34,,,,Completed,10000+,N/A,54,Scheduled,187,Delayed,,34,,,,
University of Calgary,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.47,Negative,14568,Positive,Adult,271,Post-2nd (8+ Weeks),30-Aug-21,covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2069,3,August,2021,,76,,,Completed,10000+,N/A,54,Scheduled,187,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,26,Negative,Adult,,Post-1st,20-Apr-21,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,1,April,2021,13,,,,Completed,0-49,N/A,69,Delayed,185,Delayed,,13,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,2199,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,312,2,August,2021,,50,,,Completed,1000-4999,N/A,69,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,5211,Positive,Adult,,Post-3rd (1-8 Weeks),25-Jan-22,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,740,3,January,2022,,,39,,Completed,,N/A,69,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,1.7,Positive,7098,Positive,Adult,,Post-3rd (8+ Weeks),02-Jun-22,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1008,4,June,2022,,,167,,Completed,,N/A,69,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,0,Negative,Elderly,,Pre-1st,24-Mar-21,baseline,05-Apr-21,Pfizer,15-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,170,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,14204,Positive,Elderly,,Post-2nd (8+ Weeks),19-Aug-21,baseline,05-Apr-21,Pfizer,15-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2017,2,August,2021,,65,,,Completed,10000+,N/A,71,Delayed,170,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,28529,Positive,Elderly,,Post-3rd (8+ Weeks),07-Feb-22,baseline,05-Apr-21,Pfizer,15-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4051,3,February,2022,,,67,,Completed,10000+,N/A,71,Delayed,170,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,6552,Positive,Elderly,,Post-3rd (8+ Weeks),20-May-22,baseline,05-Apr-21,Pfizer,15-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,930,4,May,2022,,,169,,Completed,,N/A,71,Delayed,170,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,176,Positive,Adult,-412,Post-1st,11-Feb-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,1,February,2021,30,,,,Completed,50-249,N/A,31,Scheduled,245,Delayed,,30,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,,Adult,-376,Post-2nd (1-8 Weeks),19-Mar-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,March,2021,,35,,,Processed,,N/A,31,Scheduled,245,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.27,Negative,1171,Positive,Adult,-216,Post-2nd (8+ Weeks),26-Aug-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,166,3,August,2021,,195,,,Completed,1000-4999,N/A,31,Scheduled,245,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.33,Negative,4423,Positive,Adult,-78,Post-3rd (8+ Weeks),11-Jan-22,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,628,4,January,2022,,,88,,Completed,1000-4999,N/A,31,Scheduled,245,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.04,Negative,4,Negative,Adult,,Pre-1st,19-Mar-21,baseline,04-Jun-21,Pfizer,04-Jul-21,Pfizer,,,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,30,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,226,Positive,Adult,-223,Post-1st,21-May-21,Post Vaccine covid,31-Mar-21,Pfizer,02-Jun-21,Pfizer,26-Oct-21,Pfizer,,,,,19,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,32,1,May,2021,51,,,,Completed,50-249,N/A,63,Delayed,146,Delayed,,51,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.13,Negative,1165,Positive,Adult,-175,Post-2nd (1-8 Weeks),08-Jul-21,Post Vaccine covid,31-Mar-21,Pfizer,02-Jun-21,Pfizer,26-Oct-21,Pfizer,,,,,19,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,165,2,July,2021,,36,,,Completed,1000-4999,N/A,63,Delayed,146,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,2491,Positive,Adult,,Post-2nd (1-8 Weeks),10-Aug-21,baseline,07-May-21,Pfizer,17-Jun-21,Pfizer,,,,,,,22,18-29,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,354,1,August,2021,,54,,,Completed,1000-4999,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,121,Positive,Adult,-205,Post-1st,02-Jun-21,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,1,June,2021,34,,,,Completed,50-249,N/A,48,Scheduled,227,Delayed,,34,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,3792,Positive,Adult,-151,Post-2nd (1-8 Weeks),26-Jul-21,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,538,2,July,2021,,40,,,Completed,1000-4999,N/A,48,Scheduled,227,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.98,Positive,16406,Positive,Adult,35,Post-2nd (8+ Weeks),28-Jan-22,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2330,3,January,2022,,226,,,Completed,10000+,N/A,48,Scheduled,227,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.26,Negative,19766,Positive,Adult,62,Post-3rd (1-8 Weeks),24-Feb-22,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2807,4,February,2022,,,26,,Completed,10000+,N/A,48,Scheduled,227,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,6975,Positive,Adult,152,Post-3rd (8+ Weeks),25-May-22,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,990,5,May,2022,,,116,,Completed,,N/A,48,Scheduled,227,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Ustekinumab Only,Ustekinumab Only,,,5.88,Positive,564,Positive,Adult,19,Pre-1st,13-Feb-21,covid,07-Sep-21,Pfizer,05-Nov-21,Pfizer,,,,,,,45,40-49,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80,1,February,2021,,,,,Completed,250-999,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.32,Negative,8,Negative,Adult,121,Pre-1st,15-Mar-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,121 Days Before Collection Days After Collection,57,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.13,Negative,483,Positive,Adult,213,Post-1st,15-Jun-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69,2,June,2021,56,,,,Completed,250-999,213 Days Before Collection Days After Collection,57,Delayed,,Delayed,,56,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.08,Negative,102,Positive,Adult,398,Post-2nd (8+ Weeks),17-Dec-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,3,December,2021,,184,,,Completed,50-249,398 Days Before Collection Days After Collection,57,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,0,Negative,Adult,,Pre-1st,15-Apr-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,40,Scheduled,117,Scheduled,236,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,1848,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,262,2,June,2021,,33,,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,1860,Positive,Adult,,Post-2nd (1-8 Weeks),02-Jul-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,264,3,July,2021,,35,,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,12703,Positive,Adult,,Post-3rd (1-8 Weeks),05-Oct-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1804,4,October,2021,,,13,,Completed,10000+,N/A,40,Scheduled,117,Scheduled,236,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.21,Negative,1142,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,162,5,February,2022,,,145,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,411,Positive,Adult,-531,Post-1st,10-Feb-21,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,58,1,February,2021,41,,,,Completed,250-999,N/A,40,Scheduled,204,Delayed,187,41,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5755,Positive,Adult,-470,Post-2nd (8+ Weeks),12-Apr-21,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,817,2,April,2021,,62,,,Completed,,N/A,40,Scheduled,204,Delayed,187,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.17,Negative,9708,Positive,Adult,-274,Post-3rd (1-8 Weeks),25-Oct-21,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1379,3,October,2021,,,54,,Completed,,N/A,40,Scheduled,204,Delayed,187,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,4214,Positive,Adult,-193,Post-3rd (8+ Weeks),14-Jan-22,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,598,4,January,2022,,,135,,Completed,1000-4999,N/A,40,Scheduled,204,Delayed,187,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.18,Negative,13966,Positive,Adult,-88,Post-4th,29-Apr-22,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1983,5,April,2022,,,,53,Completed,10000+,N/A,40,Scheduled,204,Delayed,187,,,,53,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.06,Negative,13170,Positive,Adult,-132,Post-2nd (1-8 Weeks),25-Aug-21,Post Vaccine covid,05-May-21,Pfizer,03-Jul-21,Pfizer,,,,,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1870,1,August,2021,,53,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.07,Negative,2,Negative,Adult,-329,Pre-1st,02-Mar-21,Post Vaccine covid,30-Apr-21,Pfizer,29-Sep-21,Pfizer,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,152,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,5644,Positive,Adult,-320,Post-2nd (1-8 Weeks),23-Feb-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,801,1,February,2021,,47,,,Completed,,N/A,21,Scheduled,245,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,1401,Positive,Adult,-238,Post-2nd (8+ Weeks),16-May-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,199,2,May,2021,,129,,,Completed,1000-4999,N/A,21,Scheduled,245,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,15530,Positive,Adult,-87,Post-3rd (1-8 Weeks),14-Oct-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2205,3,October,2021,,,35,,Completed,10000+,N/A,21,Scheduled,245,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.41,Negative,16636,Positive,Adult,11,Post-3rd (8+ Weeks),20-Jan-22,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2362,4,January,2022,,,133,,Completed,10000+,N/A,21,Scheduled,245,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,2.07,Positive,1271,Positive,Adult,100,Pre-1st,30-Apr-21,covid,26-May-21,Pfizer,29-Jun-21,Pfizer,,,,,,,51,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,180,1,April,2021,,,,,Completed,1000-4999,100 Days Before Collection Days After Collection,34,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,4,Negative,Adult,,Pre-1st,01-Mar-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,1,March,2021,,,,,Completed,0-49,N/A,49,Scheduled,154,Delayed,156,,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,,,,Adult,,Post-1st,19-Apr-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,,2,April,2021,47,,,,Processed,,N/A,49,Scheduled,154,Delayed,156,47,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,468,Positive,Adult,,Post-2nd (8+ Weeks),17-Jun-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,66,3,June,2021,,57,,,Completed,250-999,N/A,49,Scheduled,154,Delayed,156,,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,515,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,73,4,August,2021,,121,,,Completed,250-999,N/A,49,Scheduled,154,Delayed,156,,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,9428,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1339,5,November,2021,,,42,,Completed,,N/A,49,Scheduled,154,Delayed,156,,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,1225,Positive,Adult,,Post-3rd (8+ Weeks),25-Jan-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,174,6,January,2022,,,125,,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.05,Negative,1471,Positive,Adult,,Post-4th,14-Mar-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,209,7,March,2022,,,,17,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,17,
University of Calgary,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,1018,Positive,Adult,,Post-4th,04-Jul-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,145,8,July,2022,,,,129,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,129,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,52,Positive,Adult,,Post-1st,23-Feb-21,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,40,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,7,1,February,2021,37,,,,Completed,50-249,N/A,38,Scheduled,274,Delayed,,37,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,2664,Positive,Adult,,Post-2nd (1-8 Weeks),24-Mar-21,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,40,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,378,2,March,2021,,28,,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,46,Negative,Adult,,Post-2nd (8+ Weeks),16-Sep-21,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,7,3,September,2021,,204,,,Completed,0-49,N/A,38,Scheduled,274,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,4866,Positive,Adult,,Post-3rd (8+ Weeks),28-Jun-22,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,691,4,June,2022,,,215,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.09,Negative,322,Positive,Adult,209,Pre-1st,10-Feb-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46,1,February,2021,,,,,Completed,250-999,209 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.04,Negative,5996,Positive,Adult,282,Post-2nd (1-8 Weeks),24-Apr-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,851,2,April,2021,,25,,,Completed,,282 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.11,Negative,4861,Positive,Adult,393,Post-2nd (8+ Weeks),13-Aug-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,690,3,August,2021,,136,,,Completed,1000-4999,393 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.05,Negative,9674,Positive,Adult,525,Post-2nd (8+ Weeks),23-Dec-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1374,4,December,2021,,268,,,Completed,,525 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,3.87,Positive,4335,Positive,Adult,634,Post-3rd (8+ Weeks),11-Apr-22,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,615,5,April,2022,,,102,,Completed,1000-4999,634 Days Before Collection Days Before Collection,40,Scheduled,275,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,1014,Positive,Adult,-309,Post-1st,24-Mar-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,144,1,March,2021,33,,,,Completed,1000-4999,N/A,38,Scheduled,158,Delayed,286,33,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,9554,Positive,Adult,-253,Post-2nd (1-8 Weeks),19-May-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1357,2,May,2021,,51,,,Completed,,N/A,38,Scheduled,158,Delayed,286,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2620,Positive,Adult,-155,Post-2nd (8+ Weeks),25-Aug-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,372,3,August,2021,,149,,,Completed,1000-4999,N/A,38,Scheduled,158,Delayed,286,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,6700,Positive,Adult,-70,Post-3rd (8+ Weeks),18-Nov-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,951,4,November,2021,,,76,,Completed,,N/A,38,Scheduled,158,Delayed,286,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.95,Positive,13174,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,25-Apr-21,Moderna,21-Jun-21,Moderna,,,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1871,1,July,2021,,35,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,,,,,5.85,Positive,14821,Positive,Elderly,22,,18-Feb-21,covid,,,,,,,,,,,73,70+,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2105,1,February,2021,,,,,Completed,10000+,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,,,,,1.24,Positive,982,Positive,Elderly,190,,05-Aug-21,covid,,,,,,,,,,,73,70+,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139,2,August,2021,,,,,Completed,250-999,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.02,Negative,2,Negative,Adult,,Pre-1st,02-Mar-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,28,Scheduled,141,Delayed,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.02,Negative,1566,Positive,Adult,,Post-2nd (1-8 Weeks),13-May-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,222,2,May,2021,,17,,,Completed,1000-4999,N/A,28,Scheduled,141,Delayed,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.07,Negative,56,Positive,Adult,,Post-2nd (8+ Weeks),26-Aug-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,8,3,August,2021,,122,,,Completed,50-249,N/A,28,Scheduled,141,Delayed,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.03,Negative,380,Positive,Adult,,Post-3rd (8+ Weeks),30-Nov-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,54,4,November,2021,,,77,,Completed,250-999,N/A,28,Scheduled,141,Delayed,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.13,Negative,3656,Positive,Adult,,Post-4th,28-Feb-22,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,519,5,February,2022,,,,13,Completed,1000-4999,N/A,28,Scheduled,141,Delayed,154,,,,13,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.93,Positive,1333,Positive,Adult,93,Pre-1st,08-Mar-21,covid,29-Aug-21,Pfizer,01-Oct-21,Pfizer,,,,,,,47,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,189,1,March,2021,,,,,Completed,1000-4999,N/A,33,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.39,Negative,31543,Positive,Adult,333,Post-2nd (1-8 Weeks),03-Nov-21,covid,29-Aug-21,Pfizer,01-Oct-21,Pfizer,,,,,,,48,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4479,2,November,2021,,33,,,Completed,10000+,N/A,33,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,5564,Positive,Adult,,Post-2nd (1-8 Weeks),12-Mar-21,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,790,1,March,2021,,28,,,Completed,,N/A,38,Scheduled,238,Delayed,161,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,137,Positive,Adult,,Post-2nd (8+ Weeks),13-Sep-21,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,19,2,September,2021,,213,,,Completed,50-249,N/A,38,Scheduled,238,Delayed,161,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,29594,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4202,3,November,2021,,,26,,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.44,Negative,10892,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1547,4,February,2022,,,118,,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.59,Negative,23601,Positive,Adult,,Post-4th,04-Apr-22,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3351,5,April,2022,,,,17,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,17,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,3,Negative,Elderly,,Pre-1st,14-Mar-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,98,Scheduled,159,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,221,Positive,Elderly,,Post-1st,27-Apr-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,31,2,April,2021,33,,,,Completed,50-249,N/A,71,Delayed,98,Scheduled,159,33,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,4674,Positive,Elderly,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,664,3,June,2021,,26,,,Completed,1000-4999,N/A,71,Delayed,98,Scheduled,159,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.14,Negative,18765,Positive,Elderly,,Post-3rd (1-8 Weeks),27-Sep-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2665,4,September,2021,,,17,,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,4296,Positive,Elderly,,Post-3rd (8+ Weeks),12-Jan-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,610,5,January,2022,,,124,,Completed,1000-4999,N/A,71,Delayed,98,Scheduled,159,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,21765,Positive,Elderly,,Post-4th,17-Mar-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3091,6,March,2022,,,,29,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,29,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.13,Positive,80000,Positive,Elderly,,Post-4th,17-Jun-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,7,June,2022,,,,121,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,121,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.41,Negative,112,Positive,Adult,100,Pre-1st,13-Mar-21,covid,10-Jun-21,Pfizer,04-Jul-21,Pfizer,11-Jan-22,Pfizer,,,,,25,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,1,March,2021,,,,,Completed,50-249,N/A,24,Scheduled,191,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,4,Negative,Adult,,Pre-1st,12-Apr-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,62,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,1,April,2021,,,,,Completed,0-49,N/A,29,Scheduled,144,Delayed,259,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,6333,Positive,Adult,,Post-2nd (1-8 Weeks),31-May-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,62,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,899,2,May,2021,,10,,,Completed,,N/A,29,Scheduled,144,Delayed,259,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,11555,Positive,Adult,,Post-3rd (1-8 Weeks),15-Nov-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,63,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1641,3,November,2021,,,34,,Completed,10000+,N/A,29,Scheduled,144,Delayed,259,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,5,Negative,Adult,,Pre-1st,25-Mar-21,baseline,06-Apr-21,Pfizer,10-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,34,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,65,Delayed,201,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,133,Positive,Adult,,Post-1st,19-May-21,baseline,06-Apr-21,Pfizer,10-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,34,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,2,May,2021,43,,,,Completed,50-249,N/A,65,Delayed,201,Delayed,,43,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,7.39,Positive,671,Positive,Elderly,22,Pre-1st,18-Feb-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,95,1,February,2021,,,,,Completed,250-999,N/A,77,Delayed,129,Delayed,190,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,6.73,Positive,14619,Positive,Elderly,83,Post-1st,20-Apr-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2076,2,April,2021,28,,,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,28,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,3.29,Positive,20380,Positive,Elderly,174,Post-2nd (1-8 Weeks),20-Jul-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2894,3,July,2021,,42,,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.64,Positive,32231,Positive,Elderly,282,Post-3rd (1-8 Weeks),05-Nov-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4577,4,November,2021,,,21,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.66,Positive,10441,Positive,Elderly,407,Post-3rd (8+ Weeks),10-Mar-22,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1483,5,March,2022,,,146,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.7,Positive,37287,Positive,Elderly,465,Post-4th,07-May-22,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5295,6,May,2022,,,,14,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,14,
University of Calgary,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,,6.44,Positive,714,Positive,Adult,49,Pre-1st,01-Apr-21,covid,01-May-21,Pfizer,10-Jul-21,Pfizer,,,,,,,29,18-29,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101,1,April,2021,,,,,Completed,250-999,N/A,70,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,2,Negative,Adult,-285,Pre-1st,16-Mar-21,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,58,Delayed,231,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,228,Positive,Adult,-208,Post-1st,01-Jun-21,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,2,June,2021,51,,,,Completed,50-249,N/A,58,Delayed,231,Delayed,,51,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,5238,Positive,Adult,-180,Post-2nd (1-8 Weeks),29-Jun-21,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,744,3,June,2021,,21,,,Completed,,N/A,58,Delayed,231,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,6.47,Positive,36858,Positive,Adult,24,Post-2nd (8+ Weeks),19-Jan-22,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5234,4,January,2022,,225,,,Completed,10000+,N/A,58,Delayed,231,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.64,Positive,28320,Positive,Adult,99,Post-3rd (8+ Weeks),04-Apr-22,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4021,5,April,2022,,,69,,Completed,10000+,N/A,58,Delayed,231,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2,Negative,Adult,,Pre-1st,10-Mar-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,52,Scheduled,109,Scheduled,175,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,82,Positive,Adult,,Post-1st,31-May-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,12,2,May,2021,35,,,,Completed,50-249,N/A,52,Scheduled,109,Scheduled,175,35,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2231,Positive,Adult,,Post-2nd (8+ Weeks),16-Sep-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,317,3,September,2021,,91,,,Completed,1000-4999,N/A,52,Scheduled,109,Scheduled,175,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,10645,Positive,Adult,,Post-3rd (1-8 Weeks),18-Oct-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1512,4,October,2021,,,14,,Completed,10000+,N/A,52,Scheduled,109,Scheduled,175,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,1264,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,179,5,February,2022,,,133,,Completed,1000-4999,N/A,52,Scheduled,109,Scheduled,175,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,10751,Positive,Adult,,Post-4th,20-Apr-22,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1527,6,April,2022,,,,23,Completed,10000+,N/A,52,Scheduled,109,Scheduled,175,,,,23,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,6428,Positive,Adult,,Post-2nd (1-8 Weeks),05-Mar-21,baseline,13-Jan-21,Pfizer,20-Feb-21,Pfizer,22-Sep-21,Moderna,04-Apr-22,Pfizer,,,52,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,913,1,March,2021,,13,,,Completed,,N/A,38,Scheduled,214,Delayed,194,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,666,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Jan-21,Pfizer,20-Feb-21,Pfizer,22-Sep-21,Moderna,04-Apr-22,Pfizer,,,53,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,95,2,September,2021,,201,,,Completed,250-999,N/A,38,Scheduled,214,Delayed,194,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,2918,Positive,Adult,,Post-3rd (8+ Weeks),31-Jan-22,baseline,13-Jan-21,Pfizer,20-Feb-21,Pfizer,22-Sep-21,Moderna,04-Apr-22,Pfizer,,,53,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,414,3,January,2022,,,131,,Completed,1000-4999,N/A,38,Scheduled,214,Delayed,194,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,476,Positive,Adult,-401,Post-1st,05-Apr-21,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,68,1,April,2021,34,,,,Completed,250-999,N/A,42,Scheduled,260,Delayed,,34,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,927,Positive,Adult,-338,Post-2nd (1-8 Weeks),07-Jun-21,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,132,2,June,2021,,55,,,Completed,250-999,N/A,42,Scheduled,260,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,419,Positive,Adult,-267,Post-2nd (8+ Weeks),17-Aug-21,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,59,3,August,2021,,126,,,Completed,250-999,N/A,42,Scheduled,260,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,16828,Positive,Adult,-112,Post-3rd (1-8 Weeks),19-Jan-22,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2390,4,January,2022,,,21,,Completed,10000+,N/A,42,Scheduled,260,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,6505,Positive,Adult,9,Post-3rd (8+ Weeks),20-May-22,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,924,5,May,2022,,,142,,Completed,,N/A,42,Scheduled,260,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,1295,Positive,Adult,,Post-2nd (1-8 Weeks),18-Mar-21,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,184,1,March,2021,,39,,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,191,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,191,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,27,2,September,2021,,207,,,Completed,50-249,N/A,38,Scheduled,274,Delayed,191,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,2494,Positive,Adult,,Post-3rd (8+ Weeks),09-Feb-22,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,354,3,February,2022,,,93,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,191,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,98,Positive,Adult,-127,Post-1st,13-May-21,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,1,May,2021,35,,,,Completed,50-249,N/A,100,Delayed,96,Scheduled,,35,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.15,Negative,15371,Positive,Adult,112,Post-3rd (8+ Weeks),07-Jan-22,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2183,2,January,2022,,,78,,Completed,10000+,N/A,100,Delayed,96,Scheduled,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,4128,Positive,Adult,153,Post-3rd (8+ Weeks),17-Feb-22,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,586,3,February,2022,,,119,,Completed,1000-4999,N/A,100,Delayed,96,Scheduled,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,6783,Positive,Adult,-177,Post-3rd (1-8 Weeks),06-Oct-21,baseline,07-Apr-21,Pfizer,11-May-21,Pfizer,05-Sep-21,Pfizer,26-Jul-22,Pfizer,,,36,30-39,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,963,1,October,2021,,,31,,Completed,,N/A,34,Scheduled,117,Scheduled,324,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,0,Negative,Adult,,Pre-1st,26-Mar-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,77,Delayed,139,Delayed,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,43,Negative,Adult,,Post-1st,06-May-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,6,2,May,2021,22,,,,Completed,0-49,N/A,77,Delayed,139,Delayed,155,22,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,9573,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1359,3,July,2021,,30,,,Completed,,N/A,77,Delayed,139,Delayed,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,9865,Positive,Adult,,Post-3rd (1-8 Weeks),29-Dec-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1401,4,December,2021,,,43,,Completed,,N/A,77,Delayed,139,Delayed,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,3947,Positive,Adult,,Post-3rd (8+ Weeks),23-Mar-22,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,561,5,March,2022,,,127,,Completed,1000-4999,N/A,77,Delayed,139,Delayed,155,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,11142,Positive,Adult,,Post-4th,20-May-22,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1582,6,May,2022,,,,30,Completed,10000+,N/A,77,Delayed,139,Delayed,155,,,,30,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.23,Negative,6049,Positive,Elderly,,Post-1st,18-May-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,859,1,May,2021,31,,,,Completed,,N/A,73,Delayed,112,Scheduled,,31,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.32,Negative,27416,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3893,2,September,2021,,78,,,Completed,10000+,N/A,73,Delayed,112,Scheduled,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.54,Negative,67229,Positive,Elderly,,Post-3rd (1-8 Weeks),16-Nov-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9547,3,November,2021,,,28,,Completed,10000+,N/A,73,Delayed,112,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,1,Negative,Adult,,Pre-1st,16-Mar-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,79,Delayed,93,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,186,Positive,Adult,,Post-1st,06-May-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,26,2,May,2021,33,,,,Completed,50-249,N/A,79,Delayed,93,Scheduled,154,33,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,1012,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,144,3,July,2021,,36,,,Completed,1000-4999,N/A,79,Delayed,93,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.11,Negative,13551,Positive,Adult,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1924,4,October,2021,,,22,,Completed,10000+,N/A,79,Delayed,93,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,731,Positive,Adult,,Post-3rd (8+ Weeks),19-Feb-22,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,104,5,February,2022,,,150,,Completed,250-999,N/A,79,Delayed,93,Scheduled,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,4012,Positive,Adult,,Post-4th,18-Mar-22,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,570,6,March,2022,,,,23,Completed,1000-4999,N/A,79,Delayed,93,Scheduled,154,,,,23,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,10,Negative,Adult,-482,Pre-1st,12-Mar-21,baseline,22-Apr-21,Pfizer,22-Jun-21,Moderna,05-Feb-22,Moderna,,,,,36,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,61,Delayed,228,Delayed,,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,8472,Positive,Adult,-126,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1203,1,August,2021,,64,,,Completed,,N/A,61,Delayed,214,Delayed,,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,1.11,Positive,80000,Positive,Adult,99,Post-3rd (8+ Weeks),30-Mar-22,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11360,2,March,2022,,,75,,Completed,10000+,N/A,61,Delayed,214,Delayed,,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.5,Negative,80000,Positive,Adult,155,Post-3rd (8+ Weeks),25-May-22,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11360,3,May,2022,,,131,,Completed,10000+,N/A,61,Delayed,214,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,1,Negative,Elderly,,Pre-1st,16-Mar-21,baseline,23-Mar-21,Pfizer,06-May-21,Pfizer,12-Nov-21,Pfizer,06-May-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,44,Scheduled,190,Delayed,175,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,538,Positive,Elderly,,Post-3rd (8+ Weeks),24-Jan-22,baseline,23-Mar-21,Pfizer,06-May-21,Pfizer,12-Nov-21,Pfizer,06-May-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,76,2,January,2022,,,73,,Completed,250-999,N/A,44,Scheduled,190,Delayed,175,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,3,Negative,Adult,,Pre-1st,13-Mar-21,baseline,08-Apr-21,Pfizer,20-Jun-21,Pfizer,17-Jan-22,Pfizer,20-Jul-22,Pfizer,,,40,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,73,Delayed,211,Delayed,184,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,1074,Positive,Adult,,Post-2nd (1-8 Weeks),01-Aug-21,baseline,08-Apr-21,Pfizer,20-Jun-21,Pfizer,17-Jan-22,Pfizer,20-Jul-22,Pfizer,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,152,2,August,2021,,42,,,Completed,1000-4999,N/A,73,Delayed,211,Delayed,184,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2,Negative,Adult,-297,Pre-1st,08-Mar-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,54,Scheduled,136,Delayed,164,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,140,Positive,Adult,-224,Post-1st,20-May-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,20,2,May,2021,28,,,,Completed,50-249,N/A,54,Scheduled,136,Delayed,164,28,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,2220,Positive,Adult,-174,Post-2nd (1-8 Weeks),09-Jul-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,315,3,July,2021,,24,,,Completed,1000-4999,N/A,54,Scheduled,136,Delayed,164,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,8842,Positive,Adult,-20,Post-3rd (1-8 Weeks),10-Dec-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1255,4,December,2021,,,42,,Completed,,N/A,54,Scheduled,136,Delayed,164,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.16,Negative,22989,Positive,Adult,76,Post-3rd (8+ Weeks),16-Mar-22,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3264,5,March,2022,,,138,,Completed,10000+,N/A,54,Scheduled,136,Delayed,164,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.3,Negative,40000,Positive,Adult,132,Post-4th,11-May-22,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5680,6,May,2022,,,,30,Completed,10000+,N/A,54,Scheduled,136,Delayed,164,,,,30,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.17,Negative,2,Negative,Elderly,,Pre-1st,25-Mar-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,75,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,178,Positive,Elderly,,Post-1st,08-May-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,2,May,2021,42,,,,Completed,50-249,N/A,75,Delayed,185,Delayed,,42,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.13,Negative,15515,Positive,Elderly,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2203,3,July,2021,,26,,,Completed,10000+,N/A,75,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.24,Negative,1077,Positive,Elderly,,Post-2nd (8+ Weeks),03-Dec-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,153,4,December,2021,,176,,,Completed,1000-4999,N/A,75,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.19,Negative,50963,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Jan-22,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7237,5,January,2022,,,22,,Completed,10000+,N/A,75,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.34,Negative,8682,Positive,Elderly,,Post-3rd (8+ Weeks),25-Apr-22,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1233,6,April,2022,,,134,,Completed,,N/A,75,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2,Negative,Adult,,Pre-1st,02-Mar-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,24,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,61,Delayed,104,Scheduled,153,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,6595,Positive,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,24,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,937,2,July,2021,,26,,,Completed,,N/A,61,Delayed,104,Scheduled,153,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,5500,Positive,Adult,,Post-3rd (8+ Weeks),23-Dec-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,25,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,781,3,December,2021,,,92,,Completed,,N/A,61,Delayed,104,Scheduled,153,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,4347,Positive,Adult,,Post-4th,17-Mar-22,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,25,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,617,4,March,2022,,,,23,Completed,1000-4999,N/A,61,Delayed,104,Scheduled,153,,,,23,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,4626,Positive,Adult,-377,Post-2nd (8+ Weeks),19-Apr-21,baseline,29-Dec-20,Pfizer,21-Jan-21,Pfizer,19-Oct-21,Pfizer,,,,,40,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,657,1,April,2021,,88,,,Completed,1000-4999,N/A,23,Scheduled,271,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,934,Positive,Adult,,Post-1st,14-May-21,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,53,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,133,1,May,2021,23,,,,Completed,250-999,N/A,48,Scheduled,212,Delayed,,23,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.72,Positive,38283,Positive,Adult,,Post-3rd (1-8 Weeks),01-Feb-22,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5436,2,February,2022,,,26,,Completed,10000+,N/A,48,Scheduled,212,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.58,Positive,70589,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10024,3,June,2022,,,160,,Completed,10000+,N/A,48,Scheduled,212,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,1490,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,04-May-21,Pfizer,15-Jun-21,Pfizer,,,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,212,1,August,2021,,66,,,Completed,1000-4999,N/A,42,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,1,Negative,Adult,,Pre-1st,25-Mar-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,30,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,68,Delayed,140,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,111,Positive,Adult,,Post-1st,18-May-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,16,2,May,2021,42,,,,Completed,50-249,N/A,68,Delayed,140,Delayed,,42,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,6624,Positive,Adult,,Post-2nd (8+ Weeks),12-Aug-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,941,3,August,2021,,60,,,Completed,,N/A,68,Delayed,140,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.2,Negative,10109,Positive,Adult,,Post-3rd (8+ Weeks),26-Jan-22,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,1435,4,January,2022,,,87,,Completed,10000+,N/A,68,Delayed,140,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.18,Negative,20064,Positive,Elderly,243,Post-2nd (1-8 Weeks),18-Aug-21,covid,29-May-21,Moderna,07-Jul-21,Moderna,,,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2849,1,August,2021,,42,,,Completed,10000+,N/A,39,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,4.21,Positive,965,Positive,Adult,113,Pre-1st,26-Feb-21,covid,16-Jul-21,Pfizer,12-Aug-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,137,1,February,2021,,,,,Completed,250-999,N/A,27,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,924,Positive,Adult,-214,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,14-May-21,Pfizer,24-Jun-21,Pfizer,19-Jan-22,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,131,1,August,2021,,40,,,Completed,250-999,N/A,41,Scheduled,209,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.07,Negative,2,Negative,Adult,,Pre-1st,23-Mar-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,54,Scheduled,116,Scheduled,211,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,2840,Positive,Adult,,Post-2nd (8+ Weeks),09-Aug-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,403,2,August,2021,,67,,,Completed,1000-4999,N/A,54,Scheduled,116,Scheduled,211,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,12401,Positive,Adult,,Post-3rd (1-8 Weeks),20-Oct-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,1761,3,October,2021,,,23,,Completed,10000+,N/A,54,Scheduled,116,Scheduled,211,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.11,Negative,1988,Positive,Adult,,Post-3rd (8+ Weeks),17-Feb-22,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,282,4,February,2022,,,143,,Completed,1000-4999,N/A,54,Scheduled,116,Scheduled,211,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,17073,Positive,Adult,,Post-4th,20-May-22,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,2424,5,May,2022,,,,24,Completed,10000+,N/A,54,Scheduled,116,Scheduled,211,,,,24,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,1,Negative,Adult,,Pre-1st,19-Apr-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,4988,Positive,Adult,,Post-2nd (1-8 Weeks),09-Aug-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,708,2,August,2021,,49,,,Completed,1000-4999,N/A,60,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.09,Negative,9900,Positive,Adult,,Post-3rd (8+ Weeks),10-May-22,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1406,3,May,2022,,,139,,Completed,,N/A,60,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.01,Negative,69,Positive,Elderly,,Post-1st,12-Apr-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,10,1,April,2021,38,,,,Completed,50-249,N/A,38,Scheduled,189,Delayed,152,38,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,,,,Elderly,,Post-2nd (1-8 Weeks),04-May-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,,2,May,2021,,22,,,Processed,,N/A,38,Scheduled,189,Delayed,152,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,421,Positive,Elderly,,Post-2nd (8+ Weeks),13-Aug-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,60,3,August,2021,,123,,,Completed,250-999,N/A,38,Scheduled,189,Delayed,152,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.01,Negative,18000,Positive,Elderly,,Post-3rd (1-8 Weeks),01-Nov-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2556,4,November,2021,,,14,,Completed,10000+,N/A,38,Scheduled,189,Delayed,152,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.04,Negative,5391,Positive,Elderly,,Post-3rd (8+ Weeks),17-Feb-22,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,765,5,February,2022,,,122,,Completed,,N/A,38,Scheduled,189,Delayed,152,,,,,
University of Calgary,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.07,Negative,20522,Positive,Elderly,,Post-4th,07-Apr-22,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2914,6,April,2022,,,,19,Completed,10000+,N/A,38,Scheduled,189,Delayed,152,,,,19,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.05,Negative,499,Positive,Elderly,,Post-1st,19-Apr-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71,1,April,2021,29,,,,Completed,250-999,N/A,39,Scheduled,286,Delayed,,29,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.04,Negative,1736,Positive,Elderly,,Post-2nd (1-8 Weeks),20-May-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,247,2,May,2021,,21,,,Completed,1000-4999,N/A,39,Scheduled,286,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.18,Negative,86,Positive,Elderly,,Post-2nd (8+ Weeks),17-Dec-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,3,December,2021,,232,,,Completed,50-249,N/A,39,Scheduled,286,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.01,Negative,82,Positive,Elderly,,Post-1st,05-Apr-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,12,1,April,2021,37,,,,Completed,50-249,N/A,40,Scheduled,168,Delayed,153,37,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.02,Negative,946,Positive,Elderly,,Post-2nd (1-8 Weeks),25-May-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,134,2,May,2021,,47,,,Completed,250-999,N/A,40,Scheduled,168,Delayed,153,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.01,Negative,171,Positive,Elderly,,Post-2nd (8+ Weeks),30-Aug-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,24,3,August,2021,,144,,,Completed,50-249,N/A,40,Scheduled,168,Delayed,153,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.04,Negative,7896,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1121,4,November,2021,,,41,,Completed,,N/A,40,Scheduled,168,Delayed,153,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.04,Negative,7007,Positive,Elderly,,Post-3rd (8+ Weeks),24-Jan-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,995,5,January,2022,,,123,,Completed,,N/A,40,Scheduled,168,Delayed,153,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.08,Negative,11570,Positive,Elderly,,Post-4th,21-Mar-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1643,6,March,2022,,,,26,Completed,10000+,N/A,40,Scheduled,168,Delayed,153,,,,26,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.1,Negative,2560,Positive,Elderly,,Post-4th,04-Jul-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,76,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,364,7,July,2022,,,,131,Completed,1000-4999,N/A,40,Scheduled,168,Delayed,153,,,,131,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.12,Negative,117,Positive,Adult,,Post-1st,18-Jun-21,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,1,June,2021,56,,,,Completed,50-249,N/A,70,Delayed,,Delayed,,56,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.14,Negative,7931,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1126,2,August,2021,,34,,,Completed,,N/A,70,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,2.35,Positive,38342,Positive,Adult,,Post-2nd (8+ Weeks),17-Feb-22,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5445,3,February,2022,,230,,,Completed,10000+,N/A,70,Delayed,,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.96,Positive,29192,Positive,Adult,,Post-2nd (8+ Weeks),14-Jul-22,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,56,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4145,4,July,2022,,377,,,Completed,10000+,N/A,70,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,57,Positive,Elderly,,Post-1st,13-Apr-21,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,1,April,2021,43,,,,Completed,50-249,N/A,40,Scheduled,198,Delayed,,43,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,3011,Positive,Elderly,,Post-2nd (8+ Weeks),08-Jun-21,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,428,2,June,2021,,59,,,Completed,1000-4999,N/A,40,Scheduled,198,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,4979,Positive,Elderly,,Post-3rd (8+ Weeks),11-May-22,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,79,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,707,3,May,2022,,,198,,Completed,1000-4999,N/A,40,Scheduled,198,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,2901,Positive,Adult,-306,Post-2nd (1-8 Weeks),09-Apr-21,Post Vaccine covid,15-Jan-21,Pfizer,24-Feb-21,Pfizer,03-Oct-21,Pfizer,,,,,28,18-29,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,412,1,April,2021,,44,,,Completed,1000-4999,N/A,40,Scheduled,221,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,8632,Positive,Adult,-106,Post-3rd (1-8 Weeks),26-Oct-21,Post Vaccine covid,15-Jan-21,Pfizer,24-Feb-21,Pfizer,03-Oct-21,Pfizer,,,,,29,18-29,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1226,2,October,2021,,,23,,Completed,,N/A,40,Scheduled,221,Delayed,,,,,,
University of Calgary,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,1995,Positive,Adult,,Post-2nd (8+ Weeks),23-Jul-21,baseline,23-Mar-21,Pfizer,29-Apr-21,Pfizer,19-Jan-22,Pfizer,,,,,56,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,283,1,July,2021,,85,,,Completed,1000-4999,N/A,37,Scheduled,265,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,366,Positive,Adult,-429,Post-1st,30-Mar-21,baseline,22-Feb-21,Pfizer,01-Apr-21,Pfizer,25-Nov-21,Pfizer,,,,,25,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,52,1,March,2021,36,,,,Completed,250-999,N/A,38,Scheduled,238,Delayed,,36,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.09,Negative,1662,Positive,Adult,-34,Post-3rd (8+ Weeks),29-Apr-22,baseline,22-Feb-21,Pfizer,01-Apr-21,Pfizer,25-Nov-21,Pfizer,,,,,26,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,236,2,April,2022,,,155,,Completed,1000-4999,N/A,38,Scheduled,238,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,609,Positive,Elderly,,Post-1st,09-Apr-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,87,1,April,2021,28,,,,Completed,250-999,N/A,35,Scheduled,140,Delayed,161,28,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,1769,Positive,Elderly,,Post-2nd (1-8 Weeks),12-May-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,251,2,May,2021,,26,,,Completed,1000-4999,N/A,35,Scheduled,140,Delayed,161,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,684,Positive,Elderly,,Post-2nd (8+ Weeks),03-Sep-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,97,3,September,2021,,140,,,Completed,250-999,N/A,35,Scheduled,140,Delayed,161,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,3592,Positive,Elderly,,Post-3rd (8+ Weeks),29-Oct-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,510,4,October,2021,,,56,,Completed,1000-4999,N/A,35,Scheduled,140,Delayed,161,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,5820,Positive,Elderly,,Post-4th,19-Apr-22,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,76,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,826,5,April,2022,,,,67,Completed,,N/A,35,Scheduled,140,Delayed,161,,,,67,
University of Calgary,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,2,Negative,Adult,-359,Pre-1st,09-Mar-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,35,Scheduled,56,Scheduled,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.31,Negative,59,Positive,Adult,-209,Post-1st,06-Aug-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,8,2,August,2021,29,,,,Completed,50-249,N/A,35,Scheduled,56,Scheduled,,29,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.1,Negative,11541,Positive,Adult,-113,Post-3rd (1-8 Weeks),10-Nov-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1639,3,November,2021,,,34,,Completed,10000+,N/A,35,Scheduled,56,Scheduled,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,8,Positive,69068,Positive,Adult,4,Post-3rd (8+ Weeks),07-Mar-22,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9808,4,March,2022,,,151,,Completed,10000+,N/A,35,Scheduled,56,Scheduled,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.09,Negative,5,Negative,Adult,,Pre-1st,07-Apr-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,24,Scheduled,129,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.08,Negative,41,Negative,Adult,,Post-1st,06-May-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,6,2,May,2021,23,,,,Completed,0-49,N/A,24,Scheduled,129,Delayed,,23,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.07,Negative,1607,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,228,3,June,2021,,47,,,Completed,1000-4999,N/A,24,Scheduled,129,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,1834,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,260,4,September,2021,,125,,,Completed,1000-4999,N/A,24,Scheduled,129,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,12398,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1761,5,October,2021,,,32,,Completed,10000+,N/A,24,Scheduled,129,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,2126,Positive,Adult,,Post-3rd (8+ Weeks),10-Feb-22,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,302,6,February,2022,,,150,,Completed,1000-4999,N/A,24,Scheduled,129,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,959,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,136,1,June,2021,,34,,,Completed,250-999,N/A,55,Scheduled,107,Scheduled,181,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,1497,Positive,Elderly,,Post-2nd (8+ Weeks),24-Aug-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,213,2,August,2021,,98,,,Completed,1000-4999,N/A,55,Scheduled,107,Scheduled,181,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,8046,Positive,Elderly,,Post-3rd (1-8 Weeks),22-Sep-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1143,3,September,2021,,,20,,Completed,,N/A,55,Scheduled,107,Scheduled,181,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,929,Positive,Elderly,,Post-3rd (8+ Weeks),09-Feb-22,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,132,4,February,2022,,,160,,Completed,250-999,N/A,55,Scheduled,107,Scheduled,181,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,10268,Positive,Elderly,,Post-4th,04-Apr-22,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1458,5,April,2022,,,,33,Completed,10000+,N/A,55,Scheduled,107,Scheduled,181,,,,33,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,9369,Positive,Elderly,,Post-1st,30-Apr-21,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,76,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1330,1,April,2021,29,,,,Completed,,N/A,23,Scheduled,213,Delayed,199,29,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.38,Negative,720,Positive,Elderly,,Post-2nd (8+ Weeks),23-Oct-21,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,102,2,October,2021,,182,,,Completed,250-999,N/A,23,Scheduled,213,Delayed,199,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.19,Negative,5345,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,759,3,February,2022,,,72,,Completed,,N/A,23,Scheduled,213,Delayed,199,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.7,Positive,7128,Positive,Elderly,,Post-3rd (8+ Weeks),09-May-22,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1012,4,May,2022,,,167,,Completed,,N/A,23,Scheduled,213,Delayed,199,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,232,Positive,Adult,-268,Post-1st,08-Apr-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,1,April,2021,40,,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,40,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,412,Positive,Adult,-164,Post-2nd (8+ Weeks),21-Jul-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59,2,July,2021,,103,,,Completed,250-999,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,139,Positive,Adult,-72,Post-2nd (8+ Weeks),21-Oct-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,3,October,2021,,195,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.2,Negative,13481,Positive,Adult,31,Post-2nd (8+ Weeks),01-Feb-22,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1914,4,February,2022,,298,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,110,Positive,Adult,53,Post-2nd (8+ Weeks),23-Feb-22,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,5,February,2022,,320,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.02,Negative,1,Negative,Adult,,Pre-1st,29-Mar-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,94,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.06,Negative,1207,Positive,Adult,,Post-1st,13-May-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,171,2,May,2021,23,,,,Completed,1000-4999,N/A,94,Delayed,,Delayed,,23,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.03,Negative,36676,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5208,3,August,2021,,14,,,Completed,10000+,N/A,94,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.19,Negative,41828,Positive,Adult,,Post-2nd (8+ Weeks),19-Jul-22,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5940,4,July,2022,,361,,,Completed,10000+,N/A,94,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,550,Positive,Adult,,Post-1st,10-Jun-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,78,1,June,2021,47,,,,Completed,250-999,N/A,65,Delayed,169,Delayed,,47,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,3076,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,437,2,August,2021,,39,,,Completed,1000-4999,N/A,65,Delayed,169,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,490,Positive,Adult,,Post-2nd (8+ Weeks),30-Nov-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,70,3,November,2021,,155,,,Completed,250-999,N/A,65,Delayed,169,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,4.98,Positive,20241,Positive,Adult,,Post-3rd (8+ Weeks),10-May-22,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2874,4,May,2022,,,147,,Completed,10000+,N/A,65,Delayed,169,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,128,Positive,Elderly,,Post-1st,12-Apr-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,April,2021,36,,,,Completed,50-249,N/A,38,Scheduled,192,Delayed,175,36,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,5756,Positive,Elderly,,Post-2nd (1-8 Weeks),06-May-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,817,2,May,2021,,22,,,Completed,,N/A,38,Scheduled,192,Delayed,175,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,995,Positive,Elderly,,Post-2nd (8+ Weeks),03-Sep-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,141,3,September,2021,,142,,,Completed,250-999,N/A,38,Scheduled,192,Delayed,175,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.35,Negative,5455,Positive,Elderly,,Post-3rd (8+ Weeks),30-Dec-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,775,4,December,2021,,,68,,Completed,,N/A,38,Scheduled,192,Delayed,175,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.34,Negative,2339,Positive,Elderly,,Post-3rd (8+ Weeks),28-Mar-22,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,332,5,March,2022,,,156,,Completed,1000-4999,N/A,38,Scheduled,192,Delayed,175,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.51,Negative,24158,Positive,Elderly,,Post-4th,16-May-22,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3430,6,May,2022,,,,30,Completed,10000+,N/A,38,Scheduled,192,Delayed,175,,,,30,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,3,Negative,Adult,,Pre-1st,07-Mar-21,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,23,Scheduled,142,Delayed,185,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,285,Positive,Adult,,Post-2nd (8+ Weeks),14-Aug-21,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,41,2,August,2021,,101,,,Completed,250-999,N/A,23,Scheduled,142,Delayed,185,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,8781,Positive,Adult,,Post-3rd (1-8 Weeks),26-Oct-21,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1247,3,October,2021,,,32,,Completed,,N/A,23,Scheduled,142,Delayed,185,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,4134,Positive,Adult,,Post-3rd (8+ Weeks),11-Jan-22,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,587,4,January,2022,,,109,,Completed,1000-4999,N/A,23,Scheduled,142,Delayed,185,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,15154,Positive,Adult,,Post-4th,09-May-22,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2152,5,May,2022,,,,42,Completed,10000+,N/A,23,Scheduled,142,Delayed,185,,,,42,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,3,Negative,Adult,-277,Pre-1st,31-Mar-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,60,Delayed,183,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,97,Positive,Adult,-221,Post-1st,26-May-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,2,May,2021,42,,,,Completed,50-249,N/A,60,Delayed,183,Delayed,,42,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1842,Positive,Adult,-165,Post-2nd (1-8 Weeks),21-Jul-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,262,3,July,2021,,38,,,Completed,1000-4999,N/A,60,Delayed,183,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.2,Negative,127,Positive,Adult,-53,Post-2nd (8+ Weeks),10-Nov-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,4,November,2021,,150,,,Completed,50-249,N/A,60,Delayed,183,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.87,Positive,38554,Positive,Adult,29,Post-3rd (1-8 Weeks),31-Jan-22,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5475,5,January,2022,,,49,,Completed,10000+,N/A,60,Delayed,183,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.64,Negative,9513,Positive,Adult,128,Post-3rd (8+ Weeks),10-May-22,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1351,6,May,2022,,,148,,Completed,,N/A,60,Delayed,183,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,592,Positive,Adult,-341,Post-1st,04-Jun-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,84,1,June,2021,37,,,,Completed,250-999,N/A,52,Scheduled,178,Delayed,,37,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,10271,Positive,Adult,-309,Post-2nd (1-8 Weeks),06-Jul-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1458,2,July,2021,,17,,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.31,Negative,2628,Positive,Adult,-152,Post-2nd (8+ Weeks),10-Dec-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,373,3,December,2021,,174,,,Completed,1000-4999,N/A,52,Scheduled,178,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.27,Negative,30815,Positive,Adult,-125,Post-3rd (1-8 Weeks),06-Jan-22,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,4376,4,January,2022,,,23,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,5.05,Positive,24886,Positive,Adult,16,Post-3rd (8+ Weeks),27-May-22,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,38,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,3534,5,May,2022,,,164,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,22,Negative,Elderly,,Post-1st,24-Apr-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,70,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,3,1,April,2021,29,,,,Completed,0-49,N/A,71,Delayed,183,Delayed,155,29,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,3246,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,70,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,461,2,June,2021,,16,,,Completed,1000-4999,N/A,71,Delayed,183,Delayed,155,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,789,Positive,Elderly,,Post-2nd (8+ Weeks),01-Oct-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,70,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,112,3,October,2021,,118,,,Completed,250-999,N/A,71,Delayed,183,Delayed,155,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.06,Negative,12938,Positive,Elderly,,Post-3rd (1-8 Weeks),22-Dec-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1837,4,December,2021,,,17,,Completed,10000+,N/A,71,Delayed,183,Delayed,155,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.13,Negative,7641,Positive,Elderly,,Post-3rd (8+ Weeks),05-Apr-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1085,5,April,2022,,,121,,Completed,,N/A,71,Delayed,183,Delayed,155,,,,,
University of Calgary,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.12,Negative,15739,Positive,Elderly,,Post-4th,30-May-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2235,6,May,2022,,,,21,Completed,10000+,N/A,71,Delayed,183,Delayed,155,,,,21,
University of Calgary,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,3,Negative,Adult,,Pre-1st,30-Mar-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,70,Delayed,72,Scheduled,154,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,1626,Positive,Adult,,Post-1st,25-May-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,231,2,May,2021,42,,,,Completed,1000-4999,N/A,70,Delayed,72,Scheduled,154,42,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,26157,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,3714,3,July,2021,,30,,,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,5778,Positive,Adult,,Post-3rd (8+ Weeks),09-Nov-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,820,4,November,2021,,,68,,Completed,,N/A,70,Delayed,72,Scheduled,154,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,10429,Positive,Adult,,Post-3rd (8+ Weeks),27-Jan-22,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1481,5,January,2022,,,147,,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,20932,Positive,Adult,,Post-4th,06-Jun-22,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,2972,6,June,2022,,,,123,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,123,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,8212,Positive,Adult,,Post-2nd (1-8 Weeks),15-Mar-21,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1166,1,March,2021,,36,,,Completed,,N/A,35,Scheduled,296,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.23,Negative,1990,Positive,Adult,,Post-2nd (8+ Weeks),09-Nov-21,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,283,2,November,2021,,275,,,Completed,1000-4999,N/A,35,Scheduled,296,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.48,Negative,30929,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,38,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,4392,3,February,2022,,,76,,Completed,10000+,N/A,35,Scheduled,296,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.08,Negative,2,Negative,Adult,-383,Pre-1st,09-Apr-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,106,Scheduled,281,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.1,Negative,244,Positive,Adult,-327,Post-1st,04-Jun-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,2,June,2021,26,,,,Completed,50-249,N/A,60,Delayed,106,Scheduled,281,26,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.1,Negative,12709,Positive,Adult,-271,Post-2nd (1-8 Weeks),30-Jul-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1805,3,July,2021,,22,,,Completed,10000+,N/A,60,Delayed,106,Scheduled,281,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.24,Negative,16349,Positive,Adult,-166,Post-3rd (1-8 Weeks),12-Nov-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2322,4,November,2021,,,21,,Completed,10000+,N/A,60,Delayed,106,Scheduled,281,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.3,Negative,1979,Positive,Adult,-48,Post-3rd (8+ Weeks),10-Mar-22,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,281,5,March,2022,,,139,,Completed,1000-4999,N/A,60,Delayed,106,Scheduled,281,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5,Negative,Adult,-299,Pre-1st,10-Mar-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,40,Scheduled,145,Delayed,185,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,127,Positive,Adult,-242,Post-1st,06-May-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,18,2,May,2021,30,,,,Completed,50-249,N/A,40,Scheduled,145,Delayed,185,30,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,662,Positive,Adult,-139,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,94,3,August,2021,,93,,,Completed,250-999,N/A,40,Scheduled,145,Delayed,185,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,6859,Positive,Adult,-59,Post-3rd (1-8 Weeks),05-Nov-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,974,4,November,2021,,,28,,Completed,,N/A,40,Scheduled,145,Delayed,185,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.47,Negative,30861,Positive,Adult,52,Post-3rd (8+ Weeks),24-Feb-22,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4382,5,February,2022,,,139,,Completed,10000+,N/A,40,Scheduled,145,Delayed,185,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,37297,Positive,Adult,130,Post-4th,13-May-22,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5296,6,May,2022,,,,32,Completed,10000+,N/A,40,Scheduled,145,Delayed,185,,,,32,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,40,Negative,Adult,,Post-1st,04-May-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,6,1,May,2021,27,,,,Completed,0-49,N/A,65,Delayed,202,Delayed,,27,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,61,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9,2,July,2021,,49,,,Completed,50-249,N/A,65,Delayed,202,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.08,Negative,4895,Positive,Adult,,Post-3rd (1-8 Weeks),17-Jan-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,695,3,January,2022,,,18,,Completed,1000-4999,N/A,65,Delayed,202,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.92,Positive,21918,Positive,Adult,,Post-3rd (8+ Weeks),03-May-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,3112,4,May,2022,,,124,,Completed,10000+,N/A,65,Delayed,202,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,976,Positive,Adult,,Post-1st,07-Jul-21,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,34,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,139,1,July,2021,47,,,,Completed,250-999,N/A,50,Scheduled,231,Delayed,,47,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,32337,Positive,Adult,,Post-2nd (1-8 Weeks),24-Jul-21,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,34,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4592,2,July,2021,,14,,,Completed,10000+,N/A,50,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.13,Negative,11144,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1582,3,December,2021,,165,,,Completed,10000+,N/A,50,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.16,Negative,27802,Positive,Adult,,Post-3rd (8+ Weeks),08-Jun-22,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3948,4,June,2022,,,102,,Completed,10000+,N/A,50,Scheduled,231,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.04,Negative,73,Positive,Adult,-356,Post-1st,13-May-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,41,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,10,1,May,2021,21,,,,Completed,50-249,N/A,28,Scheduled,112,Scheduled,215,21,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.03,Negative,157,Positive,Adult,-328,Post-2nd (1-8 Weeks),10-Jun-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,41,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,22,2,June,2021,,21,,,Completed,50-249,N/A,28,Scheduled,112,Scheduled,215,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.13,Negative,8216,Positive,Adult,-211,Post-3rd (1-8 Weeks),05-Oct-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1167,3,October,2021,,,26,,Completed,,N/A,28,Scheduled,112,Scheduled,215,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.12,Negative,1692,Positive,Adult,-83,Post-3rd (8+ Weeks),10-Feb-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,240,4,February,2022,,,154,,Completed,1000-4999,N/A,28,Scheduled,112,Scheduled,215,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.14,Negative,932,Positive,Adult,-55,Post-3rd (8+ Weeks),10-Mar-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,132,5,March,2022,,,182,,Completed,250-999,N/A,28,Scheduled,112,Scheduled,215,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,2.76,Positive,79163,Positive,Adult,22,Post-4th,26-May-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,11241,6,May,2022,,,,44,Completed,10000+,N/A,28,Scheduled,112,Scheduled,215,,,,44,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,105,Positive,Adult,-220,Post-1st,25-May-21,Post Vaccine covid,04-May-21,Pfizer,19-Jun-21,Pfizer,27-Feb-22,Moderna,,,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,1,May,2021,21,,,,Completed,50-249,-220 Days After Collection Days After Collection,46,Scheduled,253,Delayed,,21,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2716,Positive,Adult,-106,Post-2nd (8+ Weeks),16-Sep-21,Post Vaccine covid,04-May-21,Pfizer,19-Jun-21,Pfizer,27-Feb-22,Moderna,,,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,386,2,September,2021,,89,,,Completed,1000-4999,-106 Days After Collection Days After Collection,46,Scheduled,253,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,78,Positive,Elderly,-232,Post-1st,17-May-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,1,May,2021,44,,,,Completed,50-249,N/A,83,Delayed,75,Scheduled,,44,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,4172,Positive,Elderly,-151,Post-2nd (1-8 Weeks),06-Aug-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,592,2,August,2021,,42,,,Completed,1000-4999,N/A,83,Delayed,75,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,3631,Positive,Elderly,-62,Post-3rd (8+ Weeks),03-Nov-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,516,3,November,2021,,,56,,Completed,1000-4999,N/A,83,Delayed,75,Scheduled,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.02,Positive,20559,Positive,Elderly,16,Post-3rd (8+ Weeks),20-Jan-22,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2919,4,January,2022,,,134,,Completed,10000+,N/A,83,Delayed,75,Scheduled,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,1,Negative,Adult,,Pre-1st,15-Mar-21,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,61,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,March,2021,,,,,Completed,0-49,N/A,52,Scheduled,192,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,3465,Positive,Adult,,Post-2nd (1-8 Weeks),16-Aug-21,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,62,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,492,2,August,2021,,28,,,Completed,1000-4999,N/A,52,Scheduled,192,Delayed,,,,,,
University of Calgary,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.9,Positive,16258,Positive,Adult,,Post-3rd (8+ Weeks),13-Jun-22,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,63,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,2309,3,June,2022,,,137,,Completed,10000+,N/A,52,Scheduled,192,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.11,Negative,2795,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,28-Jan-22,Pfizer,,,62,60-69,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,397,1,July,2021,,34,,,Completed,1000-4999,N/A,80,Delayed,97,Scheduled,140,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,947,Positive,Elderly,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,06-Apr-21,Pfizer,29-Jun-21,Pfizer,03-Nov-21,Pfizer,02-May-22,Pfizer,,,70,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,134,1,August,2021,,36,,,Completed,250-999,N/A,84,Delayed,127,Delayed,180,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,760,Positive,Elderly,,Post-3rd (8+ Weeks),22-Feb-22,baseline,06-Apr-21,Pfizer,29-Jun-21,Pfizer,03-Nov-21,Pfizer,02-May-22,Pfizer,,,71,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,108,2,February,2022,,,111,,Completed,250-999,N/A,84,Delayed,127,Delayed,180,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,5155,Positive,Adult,-279,Post-2nd (8+ Weeks),16-Jul-21,baseline,07-Apr-21,Pfizer,01-May-21,Pfizer,10-Sep-21,Pfizer,18-Feb-22,Moderna,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,732,1,July,2021,,76,,,Completed,,N/A,24,Scheduled,132,Delayed,161,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,9640,Positive,Elderly,-97,Post-3rd (8+ Weeks),14-Jan-22,baseline,07-Apr-21,Pfizer,01-May-21,Pfizer,10-Sep-21,Pfizer,18-Feb-22,Moderna,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,1369,2,January,2022,,,126,,Completed,,N/A,24,Scheduled,132,Delayed,161,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,5.54,Positive,33181,Positive,Elderly,15,Post-4th,06-May-22,baseline,07-Apr-21,Pfizer,01-May-21,Pfizer,10-Sep-21,Pfizer,18-Feb-22,Moderna,,,65,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,4712,3,May,2022,,,,77,Completed,10000+,N/A,24,Scheduled,132,Delayed,161,,,,77,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,63,Positive,Elderly,,Post-1st,06-May-21,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,9,1,May,2021,42,,,,Completed,50-249,N/A,77,Delayed,159,Delayed,160,42,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,9978,Positive,Elderly,,Post-3rd (8+ Weeks),17-Jan-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1417,2,January,2022,,,62,,Completed,,N/A,77,Delayed,159,Delayed,160,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,2082,Positive,Elderly,,Post-3rd (8+ Weeks),11-Apr-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,296,3,April,2022,,,146,,Completed,1000-4999,N/A,77,Delayed,159,Delayed,160,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,23285,Positive,Elderly,,Post-4th,26-May-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3306,4,May,2022,,,,31,Completed,10000+,N/A,77,Delayed,159,Delayed,160,,,,31,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.05,Negative,20,Negative,Adult,,Post-1st,05-Apr-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,1,April,2021,24,,,,Completed,0-49,N/A,99,Delayed,188,Delayed,,24,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.05,Negative,142,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,2,June,2021,,9,,,Completed,50-249,N/A,99,Delayed,188,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.22,Negative,356,Positive,Elderly,,Post-2nd (8+ Weeks),09-Dec-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,51,3,December,2021,,173,,,Completed,250-999,N/A,99,Delayed,188,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.56,Negative,65420,Positive,Elderly,,Post-3rd (1-8 Weeks),18-Jan-22,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9290,4,January,2022,,,25,,Completed,10000+,N/A,99,Delayed,188,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.37,Negative,10100,Positive,Elderly,,Post-3rd (8+ Weeks),11-May-22,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1434,5,May,2022,,,138,,Completed,10000+,N/A,99,Delayed,188,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.38,Negative,324,Positive,Adult,124,Pre-1st,25-Mar-21,covid,22-Sep-21,Pfizer,13-Oct-21,Pfizer,,,,,,,33,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,1,March,2021,,,,,Completed,250-999,N/A,21,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,607,Positive,Adult,,Post-1st,26-May-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,86,1,May,2021,42,,,,Completed,250-999,N/A,58,Delayed,155,Delayed,153,42,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,3205,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,455,2,July,2021,,42,,,Completed,1000-4999,N/A,58,Delayed,155,Delayed,153,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,1023,Positive,Adult,,Post-2nd (8+ Weeks),06-Nov-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,145,3,November,2021,,148,,,Completed,1000-4999,N/A,58,Delayed,155,Delayed,153,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,27081,Positive,Adult,,Post-3rd (1-8 Weeks),30-Nov-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3846,4,November,2021,,,17,,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.25,Positive,38297,Positive,Adult,,Post-3rd (8+ Weeks),28-Mar-22,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5438,5,March,2022,,,135,,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.86,Positive,80000,Positive,Adult,,Post-4th,03-May-22,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,6,May,2022,,,,18,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,18,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.06,Negative,5,Negative,Elderly,-400,Post-2nd (1-8 Weeks),15-Mar-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,64,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,1,1,March,2021,,16,,,Completed,0-49,N/A,40,Scheduled,187,Delayed,144,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.14,Negative,7,Negative,Elderly,-281,Post-2nd (8+ Weeks),12-Jul-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,1,2,July,2021,,135,,,Completed,0-49,N/A,40,Scheduled,187,Delayed,144,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.16,Negative,667,Positive,Elderly,-155,Post-3rd (8+ Weeks),15-Nov-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,95,3,November,2021,,,74,,Completed,250-999,N/A,40,Scheduled,187,Delayed,144,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.24,Negative,392,Positive,Elderly,-89,Post-3rd (8+ Weeks),20-Jan-22,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,56,4,January,2022,,,140,,Completed,250-999,N/A,40,Scheduled,187,Delayed,144,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.19,Negative,1255,Positive,Elderly,-8,Post-4th,11-Apr-22,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,178,5,April,2022,,,,77,Completed,1000-4999,N/A,40,Scheduled,187,Delayed,144,,,,77,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,4398,Positive,Elderly,,Post-2nd (1-8 Weeks),31-May-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,625,1,May,2021,,22,,,Completed,1000-4999,N/A,23,Scheduled,205,Delayed,181,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,434,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,2,September,2021,,123,,,Completed,250-999,N/A,23,Scheduled,205,Delayed,181,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,14324,Positive,Elderly,,Post-3rd (1-8 Weeks),20-Dec-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2034,3,December,2021,,,20,,Completed,10000+,N/A,23,Scheduled,205,Delayed,181,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,5352,Positive,Elderly,,Post-3rd (8+ Weeks),01-Apr-22,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,760,4,April,2022,,,122,,Completed,,N/A,23,Scheduled,205,Delayed,181,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,13972,Positive,Elderly,,Post-4th,10-Jun-22,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1984,5,June,2022,,,,11,Completed,10000+,N/A,23,Scheduled,205,Delayed,181,,,,11,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,7,Negative,Elderly,,Post-1st,10-May-21,baseline,16-Mar-21,Moderna,14-Jun-21,Moderna,17-Nov-21,Pfizer,20-Apr-22,Moderna ,,,67,60-69,1,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,May,2021,55,,,,Completed,0-49,N/A,90,Delayed,156,Delayed,154,55,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.07,Negative,273,Positive,Elderly,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,16-Mar-21,Moderna,14-Jun-21,Moderna,17-Nov-21,Pfizer,20-Apr-22,Moderna ,,,67,60-69,1,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,39,2,July,2021,,21,,,Completed,250-999,N/A,90,Delayed,156,Delayed,154,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,813,Positive,Elderly,,Post-3rd (1-8 Weeks),24-Nov-21,baseline,16-Mar-21,Moderna,14-Jun-21,Moderna,17-Nov-21,Pfizer,20-Apr-22,Moderna ,,,67,60-69,1,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,115,3,November,2021,,,7,,Completed,250-999,N/A,90,Delayed,156,Delayed,154,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,43,Negative,Elderly,,Post-1st,07-May-21,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,6,1,May,2021,45,,,,Completed,0-49,N/A,55,Scheduled,118,Scheduled,185,45,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,2917,Positive,Elderly,,Post-2nd (1-8 Weeks),08-Jun-21,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,414,2,June,2021,,22,,,Completed,1000-4999,N/A,55,Scheduled,118,Scheduled,185,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,3010,Positive,Elderly,,Post-3rd (1-8 Weeks),25-Oct-21,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,427,3,October,2021,,,43,,Completed,1000-4999,N/A,55,Scheduled,118,Scheduled,185,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.09,Negative,513,Positive,Elderly,,Post-3rd (8+ Weeks),08-Feb-22,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,73,4,February,2022,,,149,,Completed,250-999,N/A,55,Scheduled,118,Scheduled,185,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.09,Negative,6064,Positive,Elderly,,Post-4th,21-Apr-22,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,861,5,April,2022,,,,36,Completed,,N/A,55,Scheduled,118,Scheduled,185,,,,36,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,680,Positive,Adult,,Post-1st,10-May-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,97,1,May,2021,28,,,,Completed,250-999,N/A,52,Scheduled,196,Delayed,,28,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,4141,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,588,2,June,2021,,18,,,Completed,1000-4999,N/A,52,Scheduled,196,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,426,Positive,Adult,,Post-2nd (8+ Weeks),01-Oct-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,60,3,October,2021,,120,,,Completed,250-999,N/A,52,Scheduled,196,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,17436,Positive,Adult,,Post-3rd (1-8 Weeks),07-Jan-22,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2476,4,January,2022,,,22,,Completed,10000+,N/A,52,Scheduled,196,Delayed,,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,351,Positive,Adult,,Post-1st,28-May-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,50,1,May,2021,54,,,,Completed,250-999,N/A,68,Delayed,128,Delayed,186,54,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,12090,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1717,2,July,2021,,24,,,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.57,Negative,14068,Positive,Elderly,,Post-3rd (1-8 Weeks),24-Nov-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1998,3,November,2021,,,38,,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.71,Positive,3190,Positive,Elderly,,Post-3rd (8+ Weeks),15-Mar-22,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,453,4,March,2022,,,149,,Completed,1000-4999,N/A,68,Delayed,128,Delayed,186,,,,,
University of Calgary,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.41,Positive,45938,Positive,Elderly,,Post-4th,09-May-22,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,6523,5,May,2022,,,,18,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,18,
University of Calgary,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.02,Negative,675,Positive,Elderly,,Post-1st,19-Apr-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,96,1,April,2021,32,,,,Completed,250-999,N/A,35,Scheduled,166,Delayed,,32,,,,
University of Calgary,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.02,Negative,1511,Positive,Elderly,,Post-2nd (8+ Weeks),22-Jul-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,215,2,July,2021,,91,,,Completed,1000-4999,N/A,35,Scheduled,166,Delayed,,,,,,
University of Calgary,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.02,Negative,19256,Positive,Elderly,,Post-3rd (1-8 Weeks),02-Nov-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,2734,3,November,2021,,,28,,Completed,10000+,N/A,35,Scheduled,166,Delayed,,,,,,
University of Calgary,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.04,Negative,4794,Positive,Elderly,,Post-3rd (8+ Weeks),07-Apr-22,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,79,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,681,4,April,2022,,,184,,Completed,1000-4999,N/A,35,Scheduled,166,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,,,0.08,Negative,2111,Positive,Adult,-174,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,11-Apr-21,Pfizer,08-May-21,Pfizer,,,,,,,56,50-59,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,300,1,August,2021,,101,,,Completed,1000-4999,N/A,27,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.02,Negative,105,Positive,Elderly,,Post-1st,09-Jun-21,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,1,June,2021,72,,,,Completed,50-249,N/A,80,Delayed,185,Delayed,,72,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.07,Negative,25814,Positive,Elderly,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3666,2,June,2021,,13,,,Completed,10000+,N/A,80,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.02,Negative,1660,Positive,Elderly,,Post-2nd (8+ Weeks),12-Nov-21,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,236,3,November,2021,,148,,,Completed,1000-4999,N/A,80,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.07,Negative,3585,Positive,Elderly,,Post-3rd (8+ Weeks),12-May-22,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,509,4,May,2022,,,144,,Completed,1000-4999,N/A,80,Delayed,185,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,27,Negative,Elderly,,Post-1st,12-May-21,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,72,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,4,1,May,2021,50,,,,Completed,0-49,N/A,79,Delayed,118,Scheduled,,50,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.08,Negative,465,Positive,Elderly,,Post-2nd (8+ Weeks),13-Aug-21,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,72,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,66,2,August,2021,,64,,,Completed,250-999,N/A,79,Delayed,118,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.07,Negative,4818,Positive,Elderly,,Post-3rd (1-8 Weeks),04-Nov-21,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,73,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,684,3,November,2021,,,29,,Completed,1000-4999,N/A,79,Delayed,118,Scheduled,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.12,Negative,489,Positive,Elderly,,Post-3rd (8+ Weeks),23-Feb-22,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,73,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,69,4,February,2022,,,140,,Completed,250-999,N/A,79,Delayed,118,Scheduled,,,,,,
University of Calgary,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.09,Negative,511,Positive,Adult,,Post-1st,13-May-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,73,1,May,2021,36,,,,Completed,250-999,N/A,76,Delayed,153,Delayed,,36,,,,
University of Calgary,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.08,Negative,11244,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1597,2,July,2021,,30,,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.08,Negative,1991,Positive,Elderly,,Post-2nd (8+ Weeks),09-Nov-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,283,3,November,2021,,140,,,Completed,1000-4999,N/A,76,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.09,Negative,50256,Positive,Elderly,,Post-3rd (8+ Weeks),11-Feb-22,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7136,4,February,2022,,,81,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,4.9,Positive,80000,Positive,Elderly,,Post-3rd (8+ Weeks),14-Apr-22,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,65,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,5,April,2022,,,143,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,2402,Positive,Adult,,Post-1st,30-Apr-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,341,1,April,2021,29,,,,Completed,1000-4999,N/A,57,Delayed,132,Delayed,151,29,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,35266,Positive,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5008,2,June,2021,,28,,,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.08,Negative,80000,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,3,October,2021,,,8,,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,80000,Positive,Adult,,Post-4th,01-Apr-22,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,4,April,2022,,,,25,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,25,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,367,Positive,Adult,,Post-1st,11-Jun-21,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,52,1,June,2021,47,,,,Completed,250-999,N/A,52,Scheduled,84,Scheduled,157,47,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,7113,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1010,2,July,2021,,23,,,Completed,,N/A,52,Scheduled,84,Scheduled,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,1970,Positive,Adult,,Post-3rd (8+ Weeks),18-Feb-22,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,26,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,280,3,February,2022,,,163,,Completed,1000-4999,N/A,52,Scheduled,84,Scheduled,157,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.27,Negative,14148,Positive,Adult,,Post-4th,23-Mar-22,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,26,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,2009,4,March,2022,,,,39,Completed,10000+,N/A,52,Scheduled,84,Scheduled,157,,,,39,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,219,Positive,Elderly,,Post-1st,21-Apr-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,1,April,2021,28,,,,Completed,50-249,N/A,79,Delayed,199,Delayed,,28,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,3515,Positive,Elderly,,Post-2nd (1-8 Weeks),07-Jul-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,499,2,July,2021,,26,,,Completed,1000-4999,N/A,79,Delayed,199,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.37,Negative,756,Positive,Elderly,,Post-2nd (8+ Weeks),17-Dec-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107,3,December,2021,,189,,,Completed,250-999,N/A,79,Delayed,199,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.21,Negative,22535,Positive,Elderly,,Post-3rd (1-8 Weeks),21-Jan-22,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3200,4,January,2022,,,25,,Completed,10000+,N/A,79,Delayed,199,Delayed,,,,,,
University of Calgary,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.85,Positive,6030,Positive,Elderly,,Post-3rd (8+ Weeks),09-May-22,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,67,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,856,5,May,2022,,,133,,Completed,,N/A,79,Delayed,199,Delayed,,,,,,
University of Calgary,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.01,Negative,692,Positive,Adult,,Post-1st,21-May-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,59,50-59,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,98,1,May,2021,42,,,,Completed,250-999,N/A,63,Delayed,185,Delayed,,42,,,,
University of Calgary,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.01,Negative,11614,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,59,50-59,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1649,2,August,2021,,54,,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,24799,Positive,Adult,,Post-3rd (1-8 Weeks),27-Jan-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,3521,3,January,2022,,,45,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,10229,Positive,Adult,,Post-3rd (8+ Weeks),08-Apr-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1452,4,April,2022,,,116,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.02,Negative,180,Positive,Adult,,Pre-1st,23-Mar-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,25,1,March,2021,,,,,Completed,50-249,N/A,27,Scheduled,125,Delayed,153,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.02,Negative,77,Positive,Adult,,Post-1st,05-May-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,11,2,May,2021,26,,,,Completed,50-249,N/A,27,Scheduled,125,Delayed,153,26,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.02,Negative,376,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,53,3,June,2021,,48,,,Completed,250-999,N/A,27,Scheduled,125,Delayed,153,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.02,Negative,18020,Positive,Adult,,Post-3rd (1-8 Weeks),30-Sep-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,2559,4,September,2021,,,22,,Completed,10000+,N/A,27,Scheduled,125,Delayed,153,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.02,Negative,7515,Positive,Adult,,Post-4th,01-Mar-22,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,1067,5,March,2022,,,,21,Completed,,N/A,27,Scheduled,125,Delayed,153,,,,21,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.03,Negative,3702,Positive,Adult,,Post-4th,03-Jun-22,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,526,6,June,2022,,,,115,Completed,1000-4999,N/A,27,Scheduled,125,Delayed,153,,,,115,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,5.05,Positive,53,Positive,Adult,-44,Pre-1st,06-May-21,covid,26-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,1,May,2021,,,,,Completed,50-249,N/A,43,Scheduled,,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,1.5,Positive,4699,Positive,Adult,0,Post-1st,19-Jun-21,covid,26-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,667,2,June,2021,24,,,,Completed,1000-4999,N/A,43,Scheduled,,Delayed,,24,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.01,Negative,427,Positive,Adult,,Post-1st,26-May-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,27,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,61,1,May,2021,33,,,,Completed,250-999,N/A,67,Delayed,191,Delayed,,33,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.02,Negative,7375,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,27,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,1047,2,July,2021,,22,,,Completed,,N/A,67,Delayed,191,Delayed,,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.03,Negative,1739,Positive,Adult,,Post-2nd (8+ Weeks),21-Dec-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,247,3,December,2021,,175,,,Completed,1000-4999,N/A,67,Delayed,191,Delayed,,,,,,
University of Calgary,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.03,Negative,10135,Positive,Adult,,Post-3rd (1-8 Weeks),31-Jan-22,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,1439,4,January,2022,,,25,,Completed,10000+,N/A,67,Delayed,191,Delayed,,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,18195,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,70,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,2584,1,May,2021,,12,,,Completed,10000+,N/A,59,Delayed,140,Delayed,199,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,2020,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,71,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,287,2,September,2021,,124,,,Completed,1000-4999,N/A,59,Delayed,140,Delayed,199,,,,,
University of Calgary,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.88,Positive,3697,Positive,Elderly,,Post-3rd (8+ Weeks),04-Mar-22,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,71,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,525,3,March,2022,,,154,,Completed,1000-4999,N/A,59,Delayed,140,Delayed,199,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.04,Negative,907,Positive,Adult,-396,Post-1st,15-Jun-21,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,129,1,June,2021,44,,,,Completed,250-999,N/A,78,Delayed,92,Scheduled,169,44,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.05,Negative,20206,Positive,Adult,-229,Post-3rd (1-8 Weeks),29-Nov-21,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,2869,2,November,2021,,,41,,Completed,10000+,N/A,78,Delayed,92,Scheduled,169,,,,,
University of Calgary,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.06,Negative,647,Positive,Adult,-117,Post-3rd (8+ Weeks),21-Mar-22,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,92,3,March,2022,,,153,,Completed,250-999,N/A,78,Delayed,92,Scheduled,169,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,,Elderly,,Post-1st,26-Apr-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,April,2021,45,,,,Processed,,N/A,87,Delayed,183,Delayed,,45,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.11,Negative,15339,Positive,Elderly,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2178,2,June,2021,,21,,,Completed,10000+,N/A,87,Delayed,183,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.16,Negative,40996,Positive,Elderly,,Post-3rd (1-8 Weeks),29-Dec-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5821,3,December,2021,,,22,,Completed,10000+,N/A,87,Delayed,183,Delayed,,,,,,
University of Calgary,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,7587,Positive,Elderly,,Post-3rd (8+ Weeks),27-Apr-22,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1077,4,April,2022,,,141,,Completed,,N/A,87,Delayed,183,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,791,Positive,Elderly,,Post-1st,21-Jul-21,baseline,08-May-21,Moderna,01-Oct-21,Pfizer,07-Jul-22,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,112,1,July,2021,74,,,,Completed,250-999,N/A,146,Delayed,279,Delayed,,74,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Combination Therapy,Vedolizumab Only,,,0.02,Negative,449,Positive,Adult,,Post-1st,31-May-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,,,,,,,26,18-29,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64,1,May,2021,22,,,,Completed,250-999,N/A,59,Delayed,,Delayed,,22,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Combination Therapy,Vedolizumab Only,,,0.02,Negative,13978,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,,,,,,,26,18-29,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1985,2,July,2021,,12,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Female,UC,Immunomodulator Only,Combination Therapy,Vedolizumab Only,,,0.02,Negative,3192,Positive,Adult,,Post-2nd (8+ Weeks),12-Nov-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,,,,,,,27,18-29,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,453,3,November,2021,,128,,,Completed,1000-4999,N/A,59,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,0,Negative,Adult,,Post-1st,03-May-21,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,May,2021,33,,,,Completed,0-49,N/A,78,Delayed,183,Delayed,,33,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,74,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,11,2,July,2021,,39,,,Completed,50-249,N/A,78,Delayed,183,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,956,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,136,3,January,2022,,,20,,Completed,250-999,N/A,78,Delayed,183,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,22319,Positive,Adult,-300,Post-2nd (1-8 Weeks),06-May-21,baseline,04-Apr-21,Pfizer,26-Apr-21,Pfizer,13-Nov-21,Pfizer,,,,,26,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3169,1,May,2021,,10,,,Completed,10000+,N/A,22,Scheduled,201,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,4330,Positive,Adult,-182,Post-2nd (8+ Weeks),01-Sep-21,baseline,04-Apr-21,Pfizer,26-Apr-21,Pfizer,13-Nov-21,Pfizer,,,,,27,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,615,2,September,2021,,128,,,Completed,1000-4999,N/A,22,Scheduled,201,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,44,Negative,Adult,-119,Post-1st,27-May-21,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,6,1,May,2021,28,,,,Completed,0-49,N/A,46,Scheduled,215,Delayed,,28,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,2299,Positive,Adult,-79,Post-2nd (1-8 Weeks),06-Jul-21,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,327,2,July,2021,,22,,,Completed,1000-4999,N/A,46,Scheduled,215,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.13,Positive,36208,Positive,Adult,133,Post-3rd (1-8 Weeks),03-Feb-22,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,5142,3,February,2022,,,19,,Completed,10000+,N/A,46,Scheduled,215,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.54,Negative,5534,Positive,Adult,259,Post-3rd (8+ Weeks),09-Jun-22,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,786,4,June,2022,,,145,,Completed,,N/A,46,Scheduled,215,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.12,Negative,683,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jun-21,baseline,15-Apr-21,Pfizer,08-May-21,Pfizer,30-Sep-21,Pfizer,02-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,97,1,June,2021,,49,,,Completed,250-999,N/A,23,Scheduled,145,Delayed,153,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.14,Negative,439,Positive,Adult,,Post-2nd (8+ Weeks),18-Sep-21,baseline,15-Apr-21,Pfizer,08-May-21,Pfizer,30-Sep-21,Pfizer,02-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,62,2,September,2021,,133,,,Completed,250-999,N/A,23,Scheduled,145,Delayed,153,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,12,Negative,Adult,,Post-1st,10-Jun-21,baseline,13-May-21,Moderna,12-Jul-21,Moderna,,,,,,,25,18-29,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,June,2021,28,,,,Completed,0-49,N/A,60,Delayed,,Delayed,,28,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,379,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,13-May-21,Moderna,12-Jul-21,Moderna,,,,,,,25,18-29,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54,2,August,2021,,24,,,Completed,250-999,N/A,60,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,95,Positive,Elderly,-341,Post-2nd (8+ Weeks),26-Apr-21,baseline,15-Jan-21,Pfizer,12-Feb-21,Pfizer,27-Sep-21,Pfizer,10-May-22,Pfizer,,,83,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,13,1,April,2021,,73,,,Completed,50-249,N/A,28,Scheduled,227,Delayed,225,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.13,Negative,3316,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Apr-21,baseline,03-Mar-21,Pfizer,12-Apr-21,Pfizer,13-Oct-21,Pfizer,02-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,471,1,April,2021,,9,,,Completed,1000-4999,N/A,40,Scheduled,184,Delayed,201,,,,,
University of Calgary,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.13,Negative,99,Positive,Elderly,,Post-2nd (8+ Weeks),07-Oct-21,baseline,03-Mar-21,Pfizer,12-Apr-21,Pfizer,13-Oct-21,Pfizer,02-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,14,2,October,2021,,178,,,Completed,50-249,N/A,40,Scheduled,184,Delayed,201,,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,65,Positive,Adult,,Post-1st,11-May-21,baseline,08-Apr-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,52,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,1,May,2021,33,,,,Completed,50-249,N/A,61,Delayed,182,Delayed,,33,,,,
University of Calgary,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,2472,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,08-Apr-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,52,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,351,2,July,2021,,38,,,Completed,1000-4999,N/A,61,Delayed,182,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,3335,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jun-21,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,474,1,June,2021,,15,,,Completed,1000-4999,N/A,60,Delayed,88,Scheduled,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.16,Negative,9061,Positive,Adult,,Post-3rd (1-8 Weeks),04-Oct-21,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1287,2,October,2021,,,24,,Completed,,N/A,60,Delayed,88,Scheduled,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.27,Negative,1227,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,174,3,January,2022,,,132,,Completed,1000-4999,N/A,60,Delayed,88,Scheduled,154,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.45,Negative,6920,Positive,Adult,,Post-4th,26-Apr-22,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,983,4,April,2022,,,,74,Completed,,N/A,60,Delayed,88,Scheduled,154,,,,74,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,183,Positive,Adult,,Post-1st,21-May-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,1,May,2021,66,,,,Completed,50-249,N/A,95,Delayed,201,Delayed,,66,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,2181,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,310,2,July,2021,,38,,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.2,Negative,1345,Positive,Adult,,Post-2nd (8+ Weeks),16-Nov-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,191,3,November,2021,,150,,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.39,Negative,7845,Positive,Adult,,Post-3rd (8+ Weeks),18-Mar-22,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1114,4,March,2022,,,71,,Completed,,N/A,95,Delayed,201,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.54,Negative,2514,Positive,Adult,,Post-3rd (8+ Weeks),17-May-22,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,357,5,May,2022,,,131,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
University of Calgary,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.6,Negative,66923,Positive,Adult,,Post-2nd (8+ Weeks),20-Apr-22,baseline,05-May-21,Pfizer,06-Jul-21,Pfizer,,,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9503,1,April,2022,,288,,,Completed,10000+,N/A,62,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.01,Negative,3,Negative,Adult,,Post-1st,10-May-21,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,33,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,May,2021,26,,,,Completed,0-49,N/A,28,Scheduled,113,Scheduled,158,26,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.01,Negative,3289,Positive,Adult,,Post-2nd (1-8 Weeks),31-May-21,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,33,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,467,2,May,2021,,19,,,Completed,1000-4999,N/A,28,Scheduled,113,Scheduled,158,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.01,Negative,3392,Positive,Adult,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,482,3,September,2021,,,27,,Completed,1000-4999,N/A,28,Scheduled,113,Scheduled,158,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.01,Negative,520,Positive,Adult,,Post-3rd (8+ Weeks),05-Jan-22,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,74,4,January,2022,,,125,,Completed,250-999,N/A,28,Scheduled,113,Scheduled,158,,,,,
University of Calgary,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.02,Negative,903,Positive,Adult,,Post-4th,24-May-22,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,128,5,May,2022,,,,106,Completed,250-999,N/A,28,Scheduled,113,Scheduled,158,,,,106,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.21,Negative,452,Positive,Adult,-292,Post-1st,19-May-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,64,1,May,2021,36,,,,Completed,250-999,N/A,43,Scheduled,175,Delayed,202,36,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,,,Adult,-229,Post-2nd (8+ Weeks),21-Jul-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,2,July,2021,,56,,,Processed,,N/A,43,Scheduled,175,Delayed,202,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.21,Negative,1927,Positive,Adult,-138,Post-2nd (8+ Weeks),20-Oct-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,274,3,October,2021,,147,,,Completed,1000-4999,N/A,43,Scheduled,175,Delayed,202,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.18,Negative,16035,Positive,Adult,-26,Post-3rd (8+ Weeks),09-Feb-22,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2277,4,February,2022,,,84,,Completed,10000+,N/A,43,Scheduled,175,Delayed,202,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,228,Positive,Adult,-229,Post-1st,25-May-21,Post Vaccine covid,21-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,1,May,2021,34,,,,Completed,50-249,N/A,59,Delayed,130,Delayed,,34,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,3140,Positive,Adult,-179,Post-2nd (1-8 Weeks),14-Jul-21,Post Vaccine covid,21-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,446,2,July,2021,,25,,,Completed,1000-4999,N/A,59,Delayed,130,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,85,Positive,Adult,-337,Post-1st,17-May-21,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,1,May,2021,19,,,,Completed,50-249,N/A,45,Scheduled,198,Delayed,,19,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,3913,Positive,Adult,-252,Post-2nd (8+ Weeks),10-Aug-21,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,556,2,August,2021,,59,,,Completed,1000-4999,N/A,45,Scheduled,198,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,80000,Positive,Adult,-85,Post-3rd (1-8 Weeks),24-Jan-22,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,January,2022,,,28,,Completed,10000+,N/A,45,Scheduled,198,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.76,Positive,12844,Positive,Adult,52,Post-3rd (8+ Weeks),10-Jun-22,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1824,4,June,2022,,,165,,Completed,10000+,N/A,45,Scheduled,198,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,30850,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,19-Apr-21,Pfizer,14-Jun-21,Pfizer,02-Jan-22,Pfizer,,,,,22,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4381,1,June,2021,,7,,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,3.26,Positive,80000,Positive,Adult,,Post-3rd (1-8 Weeks),08-Feb-22,baseline,19-Apr-21,Pfizer,14-Jun-21,Pfizer,02-Jan-22,Pfizer,,,,,22,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,2,February,2022,,,37,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,4176,Positive,Adult,,Post-2nd (1-8 Weeks),18-May-21,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,60,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,593,1,May,2021,,8,,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,2128,Positive,Adult,,Post-2nd (8+ Weeks),15-Sep-21,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,60,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,302,2,September,2021,,128,,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,3207,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,61,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,455,3,June,2022,,,155,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,19199,Positive,Adult,,Post-2nd (1-8 Weeks),20-May-21,baseline,06-Apr-21,Pfizer,08-May-21,Pfizer,07-Jan-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2726,1,May,2021,,12,,,Completed,10000+,N/A,32,Scheduled,244,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.1,Negative,3650,Positive,Adult,,Post-2nd (8+ Weeks),04-Oct-21,baseline,06-Apr-21,Pfizer,08-May-21,Pfizer,07-Jan-22,Pfizer,,,,,36,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,518,2,October,2021,,149,,,Completed,1000-4999,N/A,32,Scheduled,244,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.78,Positive,982,Positive,Adult,0,Post-1st,12-May-21,baseline,02-Apr-21,Pfizer,03-Jun-21,Pfizer,,,,,,,30,30-39,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139,1,May,2021,40,,,,Completed,250-999,N/A,62,Delayed,,Delayed,,40,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.77,Positive,6100,Positive,Adult,85,Post-2nd (8+ Weeks),05-Aug-21,baseline,02-Apr-21,Pfizer,03-Jun-21,Pfizer,,,,,,,30,30-39,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,866,2,August,2021,,63,,,Completed,,N/A,62,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,666,Positive,Adult,,Post-1st,11-Jun-21,baseline,22-Apr-21,Pfizer,18-Jun-21,Pfizer,22-Oct-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,95,1,June,2021,50,,,,Completed,250-999,N/A,57,Delayed,126,Delayed,,50,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,2985,Positive,Adult,,Post-2nd (8+ Weeks),14-Sep-21,baseline,22-Apr-21,Pfizer,18-Jun-21,Pfizer,22-Oct-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,424,2,September,2021,,88,,,Completed,1000-4999,N/A,57,Delayed,126,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,7684,Positive,Adult,,Post-3rd (8+ Weeks),22-Mar-22,baseline,22-Apr-21,Pfizer,18-Jun-21,Pfizer,22-Oct-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1091,3,March,2022,,,151,,Completed,,N/A,57,Delayed,126,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,53759,Positive,Adult,,Post-2nd (1-8 Weeks),18-May-21,baseline,23-Mar-21,Pfizer,04-May-21,Pfizer,,,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7634,1,May,2021,,14,,,Completed,10000+,N/A,42,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,2184,Positive,Adult,,Post-2nd (8+ Weeks),21-Sep-21,baseline,23-Mar-21,Pfizer,04-May-21,Pfizer,,,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,310,2,September,2021,,140,,,Completed,1000-4999,N/A,42,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,2387,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,339,1,July,2021,,23,,,Completed,1000-4999,N/A,79,Delayed,217,Delayed,0,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,74,Positive,Adult,,Post-2nd (8+ Weeks),29-Oct-21,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,11,2,October,2021,,121,,,Completed,50-249,N/A,79,Delayed,217,Delayed,0,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,5340,Positive,Adult,,Post-4th,24-Feb-22,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,758,3,February,2022,,,,22,Completed,,N/A,79,Delayed,217,Delayed,0,,,,22,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.28,Positive,1754,Positive,Adult,,Post-4th,29-Jun-22,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,249,4,June,2022,,,,147,Completed,1000-4999,N/A,79,Delayed,217,Delayed,0,,,,147,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,17299,Positive,Adult,,Post-2nd (1-8 Weeks),28-May-21,baseline,06-Apr-21,Moderna,10-May-21,Moderna,02-Sep-21,Moderna,04-Feb-22,Moderna,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2456,1,May,2021,,18,,,Completed,10000+,N/A,34,Scheduled,115,Scheduled,155,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,27869,Positive,Adult,,Post-3rd (1-8 Weeks),08-Oct-21,baseline,06-Apr-21,Moderna,10-May-21,Moderna,02-Sep-21,Moderna,04-Feb-22,Moderna,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3957,2,October,2021,,,36,,Completed,10000+,N/A,34,Scheduled,115,Scheduled,155,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,99,Positive,Adult,-269,Post-1st,07-May-21,Post Vaccine covid,04-Apr-21,Pfizer,29-May-21,Pfizer,27-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,1,May,2021,33,,,,Completed,50-249,N/A,55,Scheduled,121,Delayed,,33,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,1010,Positive,Adult,-223,Post-2nd (1-8 Weeks),22-Jun-21,Post Vaccine covid,04-Apr-21,Pfizer,29-May-21,Pfizer,27-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,143,2,June,2021,,24,,,Completed,1000-4999,N/A,55,Scheduled,121,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,,,,,0.07,Negative,0,Negative,Adult,,,19-May-21,baseline,,,,,,,,,,,36,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,May,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,,,,,0.08,Negative,3,Negative,Adult,,,13-Sep-21,baseline,,,,,,,,,,,37,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,September,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,780,Positive,Adult,,Post-1st,20-May-21,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,111,1,May,2021,38,,,,Completed,250-999,N/A,62,Delayed,184,Delayed,,38,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,3302,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,469,2,July,2021,,46,,,Completed,1000-4999,N/A,62,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,80000,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,3,January,2022,,,23,,Completed,10000+,N/A,62,Delayed,184,Delayed,,,,,,
University of Calgary,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,25204,Positive,Adult,,Post-3rd (8+ Weeks),13-Apr-22,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3579,4,April,2022,,,120,,Completed,10000+,N/A,62,Delayed,184,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.82,Positive,139,Positive,Adult,31,Pre-1st,19-Apr-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,20,1,April,2021,,,,,Completed,50-249,31 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.99,Positive,7161,Positive,Adult,60,Post-1st,18-May-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1017,2,May,2021,20,,,,Completed,,60 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,20,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.17,Negative,1913,Positive,Adult,157,Post-2nd (8+ Weeks),23-Aug-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,272,3,August,2021,,96,,,Completed,1000-4999,157 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,513,Positive,Adult,236,Post-2nd (8+ Weeks),10-Nov-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,73,4,November,2021,,175,,,Completed,250-999,236 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,3377,Positive,Adult,328,Post-3rd (8+ Weeks),10-Feb-22,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,480,5,February,2022,,,65,,Completed,1000-4999,328 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,33,Negative,Adult,,Post-1st,10-Jun-21,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,June,2021,55,,,,Completed,0-49,N/A,58,Delayed,136,Delayed,,55,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,4678,Positive,Adult,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,664,2,July,2021,,37,,,Completed,1000-4999,N/A,58,Delayed,136,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,14962,Positive,Adult,,Post-3rd (1-8 Weeks),26-Nov-21,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2125,3,November,2021,,,30,,Completed,10000+,N/A,58,Delayed,136,Delayed,,,,,,
University of Calgary,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,1651,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,234,4,February,2022,,,111,,Completed,1000-4999,N/A,58,Delayed,136,Delayed,,,,,,
University of Calgary,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,5.78,Positive,93,Positive,Adult,55,Pre-1st,30-Mar-21,covid,09-Apr-21,Pfizer,04-May-21,Pfizer,22-Dec-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,13,1,March,2021,,,,,Completed,50-249,N/A,25,Scheduled,232,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,197,Positive,Elderly,,Post-1st,21-Apr-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,28,1,April,2021,35,,,,Completed,50-249,N/A,71,Delayed,99,Scheduled,152,35,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,165,Positive,Elderly,,Post-1st,26-May-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,23,2,May,2021,70,,,,Completed,50-249,N/A,71,Delayed,99,Scheduled,152,70,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,1775,Positive,Elderly,,Post-2nd (8+ Weeks),23-Jul-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,252,3,July,2021,,57,,,Completed,1000-4999,N/A,71,Delayed,99,Scheduled,152,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,11062,Positive,Elderly,,Post-3rd (1-8 Weeks),23-Sep-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1571,4,September,2021,,,20,,Completed,10000+,N/A,71,Delayed,99,Scheduled,152,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.4,Negative,2380,Positive,Elderly,,Post-3rd (8+ Weeks),07-Jan-22,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,338,5,January,2022,,,126,,Completed,1000-4999,N/A,71,Delayed,99,Scheduled,152,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.57,Negative,23708,Positive,Elderly,,Post-4th,24-Feb-22,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,3367,6,February,2022,,,,22,Completed,10000+,N/A,71,Delayed,99,Scheduled,152,,,,22,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.82,Positive,2905,Positive,Elderly,,Post-4th,16-Jun-22,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,413,7,June,2022,,,,134,Completed,1000-4999,N/A,71,Delayed,99,Scheduled,152,,,,134,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,71,Positive,Adult,-219,Post-1st,07-Jun-21,Post Vaccine covid,27-Apr-21,Pfizer,23-Jun-21,Pfizer,,,,,,,34,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,1,June,2021,41,,,,Completed,50-249,N/A,57,Delayed,,Delayed,,41,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.07,Negative,6603,Positive,Adult,-184,Post-2nd (1-8 Weeks),12-Jul-21,Post Vaccine covid,27-Apr-21,Pfizer,23-Jun-21,Pfizer,,,,,,,34,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,938,2,July,2021,,19,,,Completed,,N/A,57,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,1.03,Positive,48786,Positive,Adult,75,Post-2nd (8+ Weeks),28-Mar-22,Post Vaccine covid,27-Apr-21,Pfizer,23-Jun-21,Pfizer,,,,,,,34,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6928,3,March,2022,,278,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,4381,Positive,Elderly,-237,Post-2nd (1-8 Weeks),27-Aug-21,baseline,10-Jun-21,Pfizer,07-Jul-21,Pfizer,29-Jan-22,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,622,1,August,2021,,51,,,Completed,1000-4999,N/A,27,Scheduled,206,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,4.21,Positive,61940,Positive,Elderly,40,Post-3rd (8+ Weeks),31-May-22,baseline,10-Jun-21,Pfizer,07-Jul-21,Pfizer,29-Jan-22,Pfizer,,,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8796,2,May,2022,,,122,,Completed,10000+,N/A,27,Scheduled,206,Delayed,,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.02,Negative,5423,Positive,Elderly,,Post-2nd (1-8 Weeks),21-May-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,770,1,May,2021,,23,,,Completed,,N/A,25,Scheduled,131,Delayed,193,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.02,Negative,214,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,30,2,September,2021,,134,,,Completed,50-249,N/A,25,Scheduled,131,Delayed,193,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.01,Negative,1210,Positive,Elderly,,Post-3rd (8+ Weeks),04-Nov-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,172,3,November,2021,,,59,,Completed,1000-4999,N/A,25,Scheduled,131,Delayed,193,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.02,Negative,120,Positive,Elderly,,Post-3rd (8+ Weeks),28-Jan-22,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,17,4,January,2022,,,144,,Completed,50-249,N/A,25,Scheduled,131,Delayed,193,,,,,
University of Calgary,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.06,Negative,6908,Positive,Elderly,,Post-4th,28-Apr-22,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,71,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,981,5,April,2022,,,,41,Completed,,N/A,25,Scheduled,131,Delayed,193,,,,41,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.13,Negative,2177,Positive,Adult,101,Post-1st,25-Jun-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,309,1,June,2021,53,,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,53,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,5525,Positive,Adult,155,Post-2nd (1-8 Weeks),18-Aug-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,785,2,August,2021,,48,,,Completed,,N/A,59,Delayed,343,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.11,Negative,2864,Positive,Adult,211,Post-2nd (8+ Weeks),13-Oct-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,407,3,October,2021,,104,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,,,,,
University of Calgary,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.1,Negative,2185,Positive,Adult,272,Post-2nd (8+ Weeks),13-Dec-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,310,4,December,2021,,165,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,3.32,Positive,22465,Positive,Adult,110,Post-1st,17-May-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3190,1,May,2021,35,,,,Completed,10000+,0,62,Delayed,115,Scheduled,289,35,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.99,Positive,10572,Positive,Adult,161,Post-2nd (1-8 Weeks),07-Jul-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1501,2,July,2021,,24,,,Completed,10000+,161 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.45,Negative,13498,Positive,Adult,273,Post-3rd (1-8 Weeks),27-Oct-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1917,3,October,2021,,,21,,Completed,10000+,273 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.34,Negative,7559,Positive,Adult,385,Post-3rd (8+ Weeks),16-Feb-22,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1073,4,February,2022,,,133,,Completed,,385 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,821,Positive,Adult,,Post-1st,18-May-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,117,1,May,2021,36,,,,Completed,250-999,N/A,44,Scheduled,,Delayed,,36,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,2844,Positive,Adult,,Post-2nd (8+ Weeks),27-Jul-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,404,2,July,2021,,62,,,Completed,1000-4999,N/A,44,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,1286,Positive,Adult,,Post-2nd (8+ Weeks),06-Oct-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,183,3,October,2021,,133,,,Completed,1000-4999,N/A,44,Scheduled,,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.02,Negative,4583,Positive,Adult,-316,Post-2nd (8+ Weeks),05-Apr-21,Post Vaccine covid,30-Dec-20,Pfizer,20-Jan-21,Pfizer,10-Sep-21,Pfizer,,,,,52,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,651,1,April,2021,,75,,,Completed,1000-4999,N/A,21,Scheduled,233,Delayed,,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,1.76,Positive,80000,Positive,Adult,29,Post-3rd (8+ Weeks),16-Mar-22,Post Vaccine covid,30-Dec-20,Pfizer,20-Jan-21,Pfizer,10-Sep-21,Pfizer,,,,,53,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,2,March,2022,,,187,,Completed,10000+,N/A,21,Scheduled,233,Delayed,,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.01,Negative,42,Negative,Elderly,-257,Post-1st,09-May-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,6,1,May,2021,39,,,,Completed,0-49,N/A,74,Delayed,94,Scheduled,221,39,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.01,Negative,1405,Positive,Elderly,-155,Post-2nd (8+ Weeks),19-Aug-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,199,2,August,2021,,67,,,Completed,1000-4999,N/A,74,Delayed,94,Scheduled,221,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.23,Negative,3824,Positive,Elderly,-76,Post-3rd (1-8 Weeks),06-Nov-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,543,3,November,2021,,,52,,Completed,1000-4999,N/A,74,Delayed,94,Scheduled,221,,,,,
University of Calgary,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,1.27,Positive,8781,Positive,Elderly,36,Post-3rd (8+ Weeks),26-Feb-22,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,1247,4,February,2022,,,164,,Completed,,N/A,74,Delayed,94,Scheduled,221,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,0.03,Negative,1165,Positive,Elderly,,Post-2nd (8+ Weeks),20-Aug-21,baseline,05-Mar-21,Pfizer,16-Apr-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,81,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,165,1,August,2021,,126,,,Completed,1000-4999,N/A,42,Scheduled,160,Delayed,201,,,,,
University of Calgary,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,0.03,Negative,611,Positive,Elderly,,Post-3rd (8+ Weeks),04-Feb-22,baseline,05-Mar-21,Pfizer,16-Apr-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,82,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,87,2,February,2022,,,134,,Completed,250-999,N/A,42,Scheduled,160,Delayed,201,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,411,Positive,Adult,-164,Post-1st,01-Jun-21,baseline,09-Apr-21,Moderna,18-Jun-21,Moderna,14-Oct-21,Moderna,24-Jun-22,Moderna,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,14,1,June,2021,53,,,,Completed,50-249,N/A,70,Delayed,118,Scheduled,253,53,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,10,Negative,Adult,0,Post-3rd (1-8 Weeks),12-Nov-21,baseline,09-Apr-21,Moderna,18-Jun-21,Moderna,14-Oct-21,Moderna,24-Jun-22,Moderna,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,776,2,November,2021,,,29,,Completed,,N/A,70,Delayed,118,Scheduled,253,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,14,Negative,Adult,105,Post-3rd (8+ Weeks),25-Feb-22,baseline,09-Apr-21,Moderna,18-Jun-21,Moderna,14-Oct-21,Moderna,24-Jun-22,Moderna,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,3,February,2022,,,134,,Completed,250-999,N/A,70,Delayed,118,Scheduled,253,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,5755,Positive,Adult,,Post-1st,13-May-21,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,9,1,May,2021,45,,,,Completed,50-249,N/A,64,Delayed,114,Scheduled,209,45,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,235,Positive,Adult,,Post-2nd (1-8 Weeks),24-Jun-21,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,479,2,June,2021,,23,,,Completed,1000-4999,N/A,64,Delayed,114,Scheduled,209,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,2,Negative,Adult,,Post-3rd (1-8 Weeks),27-Oct-21,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,331,3,October,2021,,,34,,Completed,1000-4999,N/A,64,Delayed,114,Scheduled,209,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,366,Positive,Adult,,Post-3rd (8+ Weeks),15-Jan-22,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,74,4,January,2022,,,114,,Completed,250-999,N/A,64,Delayed,114,Scheduled,209,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,4,Negative,Adult,,Post-4th,19-May-22,baseline,29-Mar-21,Pfizer,01-Jun-21,Pfizer,23-Sep-21,Pfizer,20-Apr-22,Pfizer,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,317,5,May,2022,,,,29,Completed,1000-4999,N/A,64,Delayed,114,Scheduled,209,,,,29,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,176,Positive,Adult,-299,Post-1st,30-Apr-21,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,287,1,April,2021,25,,,,Completed,1000-4999,N/A,47,Scheduled,132,Delayed,,25,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,1553,Positive,Adult,-233,Post-2nd (1-8 Weeks),05-Jul-21,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2404,2,July,2021,,44,,,Completed,10000+,N/A,47,Scheduled,132,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.13,Negative,476,Positive,Adult,-146,Post-2nd (8+ Weeks),30-Sep-21,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,729,3,September,2021,,131,,,Completed,,N/A,47,Scheduled,132,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,907,Positive,Adult,-27,Post-3rd (8+ Weeks),27-Jan-22,Post Vaccine covid,05-Apr-21,Pfizer,22-May-21,Pfizer,01-Oct-21,Pfizer,,,,,40,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2157,5,January,2022,,,118,,Completed,10000+,N/A,47,Scheduled,132,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.08,Negative,26073,Positive,Elderly,-341,Post-2nd (1-8 Weeks),20-May-21,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,84,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101,1,May,2021,,29,,,Completed,250-999,N/A,39,Scheduled,180,Delayed,177,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.13,Negative,404,Positive,Elderly,-138,Post-3rd (1-8 Weeks),09-Dec-21,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,85,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,266,3,December,2021,,,52,,Completed,1000-4999,N/A,39,Scheduled,180,Delayed,177,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,2,Negative,Elderly,-61,Post-3rd (8+ Weeks),24-Feb-22,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,85,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,111,4,February,2022,,,129,,Completed,250-999,N/A,39,Scheduled,180,Delayed,177,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.08,Negative,2,Negative,Elderly,30,Post-4th,26-May-22,baseline,13-Mar-21,Pfizer,21-Apr-21,Pfizer,18-Oct-21,Pfizer,13-Apr-22,Pfizer ,,,85,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,5,May,2022,,,,43,Completed,10000+,N/A,39,Scheduled,180,Delayed,177,,,,43,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.28,Negative,743,Positive,Adult,-390,Post-1st,19-May-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,57,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,240,1,May,2021,40,,,,Completed,1000-4999,N/A,63,Delayed,185,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.29,Negative,4626,Positive,Adult,-320,Post-2nd (1-8 Weeks),28-Jul-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,57,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2126,2,July,2021,,47,,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,,,Adult,-216,Post-2nd (8+ Weeks),09-Nov-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,58,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,533,3,November,2021,,151,,,Completed,1000-4999,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,121,Positive,Adult,-140,Post-3rd (1-8 Weeks),24-Jan-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,58,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7983,4,January,2022,,,42,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,1114,Positive,Adult,-68,Post-3rd (8+ Weeks),06-Apr-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,58,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3755,5,April,2022,,,114,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,34,Negative,Elderly,205,Post-1st,30-Apr-21,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,65,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,137,1,April,2021,31,,,,Completed,250-999,N/A,71,Delayed,184,Delayed,,31,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,164,Positive,Elderly,268,Post-2nd (1-8 Weeks),02-Jul-21,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,65,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,341,2,July,2021,,23,,,Completed,1000-4999,N/A,71,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,2,Negative,Elderly,457,Post-3rd (1-8 Weeks),07-Jan-22,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,65,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1790,3,January,2022,,,28,,Completed,10000+,N/A,71,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,118,Positive,Elderly,586,Post-3rd (8+ Weeks),16-May-22,covid,30-Mar-21,Pfizer,09-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,66,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5680,4,May,2022,,,157,,Completed,10000+,N/A,71,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,73,Positive,Adult,,Post-1st,28-May-21,baseline,05-Apr-21,Pfizer,30-May-21,Pfizer,,,,,,,19,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,1,May,2021,53,,,,Completed,250-999,N/A,55,Scheduled,,Delayed,,53,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,7692,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,02-Apr-21,Pfizer,13-May-21,Pfizer,06-Oct-21,Pfizer,26-Jul-22,Moderna,,,51,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,245,2,July,2021,,53,,,Completed,1000-4999,N/A,41,Scheduled,146,Delayed,293,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,2,Negative,Adult,,Post-2nd (8+ Weeks),01-Oct-21,baseline,02-Apr-21,Pfizer,13-May-21,Pfizer,06-Oct-21,Pfizer,26-Jul-22,Moderna,,,52,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,39,3,October,2021,,141,,,Completed,250-999,N/A,41,Scheduled,146,Delayed,293,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,2,Negative,Adult,,Post-3rd (1-8 Weeks),05-Nov-21,baseline,02-Apr-21,Pfizer,13-May-21,Pfizer,06-Oct-21,Pfizer,26-Jul-22,Moderna,,,52,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,824,4,November,2021,,,30,,Completed,,N/A,41,Scheduled,146,Delayed,293,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,31026,Positive,Adult,,Post-1st,26-May-21,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,15,1,May,2021,50,,,,Completed,50-249,N/A,78,Delayed,153,Delayed,,50,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,211,Positive,Adult,,Post-2nd (8+ Weeks),03-Nov-21,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,44,3,November,2021,,133,,,Completed,250-999,N/A,78,Delayed,153,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,713,Positive,Adult,,Post-3rd (1-8 Weeks),15-Dec-21,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,44,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,718,4,December,2021,,,22,,Completed,,N/A,78,Delayed,153,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,592,Positive,Adult,,Post-3rd (8+ Weeks),13-Apr-22,baseline,06-Apr-21,Pfizer,23-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,45,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,111,5,April,2022,,,141,,Completed,250-999,N/A,78,Delayed,153,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,95,Positive,Adult,,Post-2nd (8+ Weeks),24-Apr-21,baseline,14-Jan-21,Pfizer,22-Feb-21,Pfizer,08-Oct-21,Moderna,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,165,1,April,2021,,61,,,Completed,1000-4999,N/A,39,Scheduled,228,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.47,Negative,6076,Positive,Adult,-240,Post-1st,10-May-21,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,1,May,2021,54,,,,Completed,250-999,N/A,80,Delayed,97,Scheduled,,54,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,927,Positive,Adult,-187,Post-2nd (1-8 Weeks),02-Jul-21,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,348,2,July,2021,,27,,,Completed,1000-4999,N/A,80,Delayed,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,3671,Positive,Adult,-96,Post-3rd (1-8 Weeks),01-Oct-21,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2393,3,October,2021,,,21,,Completed,10000+,N/A,80,Delayed,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.01,Negative,231,Positive,Adult,9,Post-3rd (8+ Weeks),14-Jan-22,Post Vaccine covid,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3072,4,January,2022,,,126,,Completed,10000+,N/A,80,Delayed,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,85,Positive,Adult,-90,Post-2nd (1-8 Weeks),31-May-21,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,48,1,May,2021,,34,,,Completed,250-999,N/A,26,Scheduled,148,Delayed,205,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,456,Positive,Adult,-5,Post-2nd (8+ Weeks),24-Aug-21,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,5,2,August,2021,,119,,,Completed,0-49,N/A,26,Scheduled,148,Delayed,205,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,2,Negative,Adult,38,Post-3rd (1-8 Weeks),06-Oct-21,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,5633,3,October,2021,,,14,,Completed,10000+,N/A,26,Scheduled,148,Delayed,205,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,157,Positive,Adult,169,Post-3rd (8+ Weeks),14-Feb-22,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1242,4,February,2022,,,145,,Completed,,N/A,26,Scheduled,148,Delayed,205,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,244,Positive,Adult,291,Post-4th,16-Jun-22,Post Vaccine covid,01-Apr-21,Pfizer,27-Apr-21,Pfizer,22-Sep-21,Pfizer,15-Apr-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2628,5,June,2022,,,,62,Completed,10000+,N/A,26,Scheduled,148,Delayed,205,,,,62,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.01,Negative,965,Positive,Adult,,Post-1st,05-May-21,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,143,1,May,2021,30,,,,Completed,1000-4999,N/A,59,Delayed,203,Delayed,218,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.01,Negative,1613,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jun-21,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1598,2,June,2021,,11,,,Completed,10000+,N/A,59,Delayed,203,Delayed,218,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.01,Negative,14975,Positive,Adult,,Post-2nd (8+ Weeks),18-Oct-21,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,365,3,October,2021,,137,,,Completed,1000-4999,N/A,59,Delayed,203,Delayed,218,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.31,Negative,5644,Positive,Adult,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,05-Apr-21,Pfizer,03-Jun-21,Pfizer,23-Dec-21,Pfizer,29-Jul-22,Pfizer,,,38,30-39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1239,4,February,2022,,,42,,Completed,,N/A,59,Delayed,203,Delayed,218,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,28060,Positive,Elderly,,Post-1st,29-Apr-21,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,8,1,April,2021,48,,,,Completed,50-249,N/A,83,Delayed,161,Delayed,153,48,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,4583,Positive,Elderly,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,,2,July,2021,,46,,,Processed,,N/A,83,Delayed,161,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,883,Positive,Elderly,,Post-3rd (1-8 Weeks),23-Nov-21,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,73,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,588,3,November,2021,,,12,,Completed,1000-4999,N/A,83,Delayed,161,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,1.82,Positive,2323,Positive,Elderly,,Post-3rd (8+ Weeks),01-Apr-22,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,73,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,36,4,April,2022,,,141,,Completed,250-999,N/A,83,Delayed,161,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,1.82,Positive,1014,Positive,Elderly,,Post-4th,16-May-22,baseline,12-Mar-21,Pfizer,03-Jun-21,Pfizer,11-Nov-21,Pfizer,13-Apr-22,Pfizer,,,73,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,3424,5,May,2022,,,,33,Completed,10000+,N/A,83,Delayed,161,Delayed,153,,,,33,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.01,Negative,10271,Positive,Adult,,Post-1st,11-May-21,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,61,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,398,1,May,2021,19,,,,Completed,1000-4999,N/A,28,Scheduled,204,Delayed,186,19,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.02,Negative,6,Negative,Adult,,Post-2nd (1-8 Weeks),09-Jun-21,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,61,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,7356,2,June,2021,,20,,,Completed,10000+,N/A,28,Scheduled,204,Delayed,186,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.02,Negative,1648,Positive,Adult,,Post-2nd (8+ Weeks),22-Sep-21,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,62,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,443,3,September,2021,,125,,,Completed,1000-4999,N/A,28,Scheduled,204,Delayed,186,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.02,Negative,652,Positive,Adult,,Post-3rd (1-8 Weeks),02-Feb-22,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,62,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,3016,4,February,2022,,,54,,Completed,10000+,N/A,28,Scheduled,204,Delayed,186,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Combination Therapy,Anti-TNF Only,0.02,Negative,0,Negative,Adult,,Post-3rd (8+ Weeks),19-Apr-22,baseline,22-Apr-21,Moderna,20-May-21,Moderna,10-Dec-21,Moderna,14-Jun-22,Pfizer,,,62,60-69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1717,5,April,2022,,,130,,Completed,10000+,N/A,28,Scheduled,204,Delayed,186,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.02,Negative,2901,Positive,Adult,,Post-1st,21-May-21,baseline,17-Apr-21,Pfizer,05-Jun-21,Pfizer,,,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,1,May,2021,34,,,,Completed,250-999,N/A,49,Scheduled,,Delayed,,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.02,Negative,136,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,17-Apr-21,Pfizer,05-Jun-21,Pfizer,,,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,764,2,July,2021,,55,,,Completed,,N/A,49,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,3698,Positive,Adult,-262,Post-1st,17-May-21,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,38,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,65,1,May,2021,31,,,,Completed,250-999,N/A,58,Delayed,198,Delayed,,31,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,7424,Positive,Adult,-77,Post-2nd (8+ Weeks),18-Nov-21,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,174,3,November,2021,,158,,,Completed,1000-4999,N/A,58,Delayed,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.08,Negative,124,Positive,Adult,-23,Post-3rd (1-8 Weeks),11-Jan-22,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3504,4,January,2022,,,14,,Completed,10000+,N/A,58,Delayed,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,1,Negative,Adult,85,Post-3rd (8+ Weeks),29-Apr-22,Post Vaccine covid,16-Apr-21,Pfizer,13-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3935,5,April,2022,,,122,,Completed,10000+,N/A,58,Delayed,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,4866,Positive,Adult,-401,Post-1st,19-May-21,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,30,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,221,1,May,2021,28,,,,Completed,1000-4999,N/A,56,Scheduled,213,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.35,Negative,22319,Positive,Adult,-350,Post-2nd (1-8 Weeks),09-Jul-21,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,30,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,4406,2,July,2021,,23,,,Completed,10000+,N/A,56,Scheduled,213,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,4.09,Positive,2021,Positive,Adult,-210,Post-2nd (8+ Weeks),26-Nov-21,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,30,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1392,3,November,2021,,163,,,Completed,,N/A,56,Scheduled,213,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.28,Negative,5,Negative,Adult,-39,Post-3rd (8+ Weeks),16-May-22,baseline,21-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,31,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2280,4,May,2022,,,121,,Completed,10000+,N/A,56,Scheduled,213,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,2,Negative,Adult,,Post-1st,30-May-21,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,225,1,May,2021,43,,,,Completed,1000-4999,N/A,56,Scheduled,217,Delayed,,43,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,6595,Positive,Adult,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2810,2,July,2021,,26,,,Completed,10000+,N/A,56,Scheduled,217,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1873,Positive,Adult,,Post-2nd (8+ Weeks),03-Jan-22,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,92,3,January,2022,,205,,,Completed,250-999,N/A,56,Scheduled,217,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,860,Positive,Adult,,Post-3rd (1-8 Weeks),04-Feb-22,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7806,4,February,2022,,,20,,Completed,10000+,N/A,56,Scheduled,217,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,452,Positive,Adult,,Post-3rd (8+ Weeks),22-May-22,baseline,17-Apr-21,Pfizer,12-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3035,5,May,2022,,,127,,Completed,10000+,N/A,56,Scheduled,217,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,8761,Positive,Adult,,Post-1st,06-May-21,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,4,1,May,2021,33,,,,Completed,0-49,N/A,83,Delayed,98,Scheduled,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.11,Negative,9143,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,2,July,2021,,26,,,Processed,,N/A,83,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,31538,Positive,Adult,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2789,3,October,2021,,,13,,Completed,10000+,N/A,83,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,7097,Positive,Adult,,Post-3rd (8+ Weeks),23-Feb-22,baseline,03-Apr-21,Pfizer,25-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,222,4,February,2022,,,145,,Completed,1000-4999,N/A,83,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,2.65,Positive,2,Negative,Adult,,Post-1st,11-May-21,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,9,1,May,2021,28,,,,Completed,50-249,N/A,44,Scheduled,203,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,7,Negative,Adult,,Post-2nd (8+ Weeks),03-Oct-21,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,42,3,October,2021,,129,,,Completed,250-999,N/A,44,Scheduled,203,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,135,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2374,4,January,2022,,,21,,Completed,10000+,N/A,44,Scheduled,203,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,6.44,Positive,1,Negative,Adult,,Post-3rd (8+ Weeks),27-Apr-22,baseline,13-Apr-21,Pfizer,27-May-21,Pfizer,16-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,10535,5,April,2022,,,132,,Completed,10000+,N/A,44,Scheduled,203,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,6.44,Positive,19233,Positive,Elderly,,Post-1st,31-May-21,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,72,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,1,May,2021,55,,,,Completed,0-49,N/A,83,Delayed,127,Delayed,153,55,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.11,Negative,5155,Positive,Elderly,,Post-2nd (8+ Weeks),25-Aug-21,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,72,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,2,2,August,2021,,58,,,Completed,0-49,N/A,83,Delayed,127,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.03,Negative,394,Positive,Elderly,,Post-3rd (8+ Weeks),02-Mar-22,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,73,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,4,March,2022,,,120,,Completed,0-49,N/A,83,Delayed,127,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Combination Therapy,Corticosteroids,Corticosteroids,Corticosteroids,0.01,Negative,377,Positive,Elderly,,Post-4th,06-Jun-22,baseline,06-Apr-21,Moderna,28-Jun-21,Moderna,02-Nov-21,Pfizer,04-Apr-22,Moderna ,,,73,70+,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,5,5,June,2022,,,,63,Completed,0-49,N/A,83,Delayed,127,Delayed,153,,,,63,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,9708,Positive,Elderly,-112,Post-1st,27-Apr-21,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4,1,April,2021,40,,,,Completed,0-49,N/A,73,Delayed,201,Delayed,208,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,1,Negative,Elderly,-26,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,84,2,July,2021,,53,,,Completed,250-999,N/A,73,Delayed,201,Delayed,208,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,86,Positive,Elderly,48,Post-2nd (8+ Weeks),04-Oct-21,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,28,3,October,2021,,127,,,Completed,50-249,N/A,73,Delayed,201,Delayed,208,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,2.92,Positive,9853,Positive,Elderly,162,Post-3rd (1-8 Weeks),26-Jan-22,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,70,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,744,4,January,2022,,,40,,Completed,,N/A,73,Delayed,201,Delayed,208,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.51,Negative,0,Negative,Elderly,245,Post-3rd (8+ Weeks),19-Apr-22,Post Vaccine covid,18-Mar-21,Pfizer,30-May-21,Pfizer,17-Dec-21,Pfizer,13-Jul-22,Pfizer,,,70,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,107,5,April,2022,,,123,,Completed,250-999,N/A,73,Delayed,201,Delayed,208,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.19,Negative,12709,Positive,Adult,-275,Post-1st,10-May-21,baseline,03-Apr-21,Pfizer,07-May-21,Pfizer,03-Sep-21,Pfizer,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,56,1,May,2021,37,,,,Completed,250-999,N/A,34,Scheduled,119,Scheduled,,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.19,Negative,99,Positive,Elderly,,Post-2nd (1-8 Weeks),17-May-21,baseline,07-Apr-21,Pfizer,30-Apr-21,Pfizer,21-Oct-21,Pfizer,07-Apr-22,Pfizer,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1331,1,May,2021,,17,,,Completed,,N/A,23,Scheduled,174,Delayed,168,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,2.07,Positive,8076,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,07-Apr-21,Pfizer,30-Apr-21,Pfizer,21-Oct-21,Pfizer,07-Apr-22,Pfizer,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,268,2,September,2021,,132,,,Completed,1000-4999,N/A,23,Scheduled,174,Delayed,168,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,2.07,Positive,232,Positive,Elderly,,Post-3rd (8+ Weeks),08-Mar-22,baseline,07-Apr-21,Pfizer,30-Apr-21,Pfizer,21-Oct-21,Pfizer,07-Apr-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,541,3,March,2022,,,138,,Completed,1000-4999,N/A,23,Scheduled,174,Delayed,168,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.89,Positive,458,Positive,Elderly,,Post-2nd (1-8 Weeks),02-Jul-21,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,70,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,527,2,July,2021,,18,,,Completed,1000-4999,N/A,80,Delayed,183,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.04,Negative,681,Positive,Elderly,,Post-3rd (1-8 Weeks),18-Jan-22,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,71,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2032,4,January,2022,,,35,,Completed,10000+,N/A,80,Delayed,183,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,12249,Positive,Elderly,,Post-3rd (8+ Weeks),04-May-22,Suspected COVID-19/Symptomatic,26-Mar-21,Pfizer,14-Jun-21,Pfizer,14-Dec-21,Pfizer,18-May-22,Pfizer,,,71,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,741,5,May,2022,,,141,,Completed,,N/A,80,Delayed,183,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,42,Negative,Adult,-265,Post-1st,12-May-21,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,1,May,2021,34,,,,Processed,,N/A,64,Delayed,98,Scheduled,241,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,9554,Positive,Adult,-209,Post-2nd (1-8 Weeks),07-Jul-21,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,818,2,July,2021,,26,,,Completed,,N/A,64,Delayed,98,Scheduled,241,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,3913,Positive,Adult,-125,Post-3rd (1-8 Weeks),29-Sep-21,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2993,3,September,2021,,,12,,Completed,10000+,N/A,64,Delayed,98,Scheduled,241,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,18776,Positive,Adult,-13,Post-3rd (8+ Weeks),19-Jan-22,Post Vaccine covid,08-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,16-May-22,Pfizer,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,135,4,January,2022,,,124,,Completed,250-999,N/A,64,Delayed,98,Scheduled,241,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.07,Negative,84,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,26,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2683,1,July,2021,,25,,,Completed,10000+,N/A,47,Scheduled,104,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.07,Negative,1,Negative,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,26,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2360,2,October,2021,,,36,,Completed,10000+,N/A,47,Scheduled,104,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.03,Negative,15,Negative,Adult,,Post-3rd (8+ Weeks),18-Feb-22,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,174,3,February,2022,,,149,,Completed,1000-4999,N/A,47,Scheduled,104,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.09,Negative,1961,Positive,Adult,,Post-4th,14-Apr-22,baseline,24-Apr-21,Moderna,10-Jun-21,Moderna,22-Sep-21,Moderna,23-Feb-22,Moderna,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,696,4,April,2022,,,,50,Completed,1000-4999,N/A,47,Scheduled,104,Scheduled,154,,,,50,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.09,Negative,9147,Positive,Adult,,Post-1st,21-May-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,1,May,2021,39,,,,Completed,250-999,N/A,99,Delayed,,Delayed,,39,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.13,Negative,357,Positive,Adult,,Post-1st,14-Jul-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,2,July,2021,93,,,,Completed,50-249,N/A,99,Delayed,,Delayed,,93,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.13,Negative,127,Positive,Adult,,Post-1st,14-Jul-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,3,July,2021,93,,,,Completed,50-249,N/A,99,Delayed,,Delayed,,93,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,347,Positive,Adult,,Post-2nd (1-8 Weeks),13-Aug-21,baseline,12-Apr-21,Pfizer,20-Jul-21,Pfizer,,,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,925,4,August,2021,,24,,,Completed,,N/A,99,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.18,Negative,87,Positive,Adult,,Post-1st,07-May-21,baseline,11-Apr-21,Pfizer,24-May-21,Pfizer,09-Oct-21,Pfizer,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,148,1,May,2021,26,,,,Completed,1000-4999,N/A,43,Scheduled,138,Delayed,,26,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,614,Positive,Adult,,Post-3rd (1-8 Weeks),22-Oct-21,baseline,11-Apr-21,Pfizer,24-May-21,Pfizer,09-Oct-21,Pfizer,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2707,3,October,2021,,,13,,Completed,10000+,N/A,43,Scheduled,138,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Vedolizumab Only,3.87,Positive,1401,Positive,Adult,,Post-2nd (1-8 Weeks),09-Aug-21,baseline,10-Apr-21,Pfizer,26-Jun-21,Pfizer,23-Sep-21,Pfizer,14-Apr-22,Pfizer,,,54,50-59,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,2860,2,August,2021,,44,,,Completed,10000+,N/A,77,Delayed,89,Scheduled,203,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Vedolizumab Only,3.87,Positive,1296,Positive,Adult,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,10-Apr-21,Pfizer,26-Jun-21,Pfizer,23-Sep-21,Pfizer,14-Apr-22,Pfizer,,,54,50-59,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,1201,3,October,2021,,,21,,Completed,,N/A,77,Delayed,89,Scheduled,203,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Vedolizumab Only,0.03,Negative,4381,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,10-Apr-21,Pfizer,26-Jun-21,Pfizer,23-Sep-21,Pfizer,14-Apr-22,Pfizer,,,55,50-59,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,166,4,February,2022,,,145,,Completed,1000-4999,N/A,77,Delayed,89,Scheduled,203,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,1980,Positive,Adult,,Post-1st,25-May-21,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,52,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,224,1,May,2021,32,,,,Completed,1000-4999,N/A,63,Delayed,193,Delayed,133,32,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,113,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,52,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4147,2,July,2021,,21,,,Completed,10000+,N/A,63,Delayed,193,Delayed,133,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,16932,Positive,Adult,,Post-3rd (1-8 Weeks),28-Jan-22,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,52,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10325,3,January,2022,,,24,,Completed,10000+,N/A,63,Delayed,193,Delayed,133,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,516,Positive,Adult,,Post-4th,13-Jun-22,baseline,23-Apr-21,Moderna,25-Jun-21,Moderna,04-Jan-22,Moderna,17-May-22,Moderna,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11343,4,June,2022,,,,27,Completed,10000+,N/A,63,Delayed,193,Delayed,133,,,,27,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,136,Positive,Adult,,Post-1st,06-May-21,baseline,11-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,17-Dec-21,Pfizer,,,,,64,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,1,May,2021,56,,,,Completed,250-999,N/A,97,Delayed,184,Delayed,,56,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,78,Positive,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,11-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,17-Dec-21,Pfizer,,,,,64,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,586,2,July,2021,,40,,,Completed,1000-4999,N/A,97,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.1,Negative,3,Negative,Adult,-390,Post-1st,24-Apr-21,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,57,1,April,2021,25,,,,Completed,250-999,N/A,51,Scheduled,113,Scheduled,,25,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.1,Negative,13359,Positive,Adult,-300,Post-2nd (8+ Weeks),23-Jul-21,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,691,2,July,2021,,64,,,Completed,1000-4999,N/A,51,Scheduled,113,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.1,Negative,20206,Positive,Adult,-185,Post-3rd (8+ Weeks),15-Nov-21,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2789,3,November,2021,,,66,,Completed,10000+,N/A,51,Scheduled,113,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,,,Adult,-73,Post-3rd (8+ Weeks),07-Mar-22,baseline,30-Mar-21,Pfizer,20-May-21,Pfizer,10-Sep-21,Pfizer,,,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,379,4,March,2022,,,178,,Completed,1000-4999,N/A,51,Scheduled,113,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,228,Positive,Elderly,,Post-1st,29-Apr-21,baseline,14-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Dec-21,Pfizer,,,,,74,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,1,April,2021,46,,,,Completed,50-249,N/A,88,Delayed,197,Delayed,,46,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,658,Positive,Elderly,,Post-2nd (8+ Weeks),12-Nov-21,baseline,14-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Dec-21,Pfizer,,,,,74,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,710,2,November,2021,,155,,,Completed,1000-4999,N/A,88,Delayed,197,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.06,Negative,3914,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,14-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Dec-21,Pfizer,,,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8874,3,February,2022,,,41,,Completed,10000+,N/A,88,Delayed,197,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,17,Negative,Adult,-237,Post-1st,07-May-21,Post Vaccine covid,09-Apr-21,Pfizer,02-Jun-21,Pfizer,13-Oct-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,184,1,May,2021,28,,,,Completed,1000-4999,N/A,54,Scheduled,133,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,17,Negative,Adult,-162,Post-2nd (1-8 Weeks),21-Jul-21,Post Vaccine covid,09-Apr-21,Pfizer,02-Jun-21,Pfizer,13-Oct-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,358,2,July,2021,,49,,,Completed,1000-4999,N/A,54,Scheduled,133,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.28,Negative,5778,Positive,Adult,-50,Post-3rd (1-8 Weeks),10-Nov-21,Post Vaccine covid,09-Apr-21,Pfizer,02-Jun-21,Pfizer,13-Oct-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,989,3,November,2021,,,28,,Completed,,N/A,54,Scheduled,133,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,140,Positive,Elderly,,Post-1st,08-Jun-21,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,73,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2,1,June,2021,62,,,,Completed,0-49,N/A,82,Delayed,205,Delayed,,62,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,2,Negative,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,73,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,,2,July,2021,,28,,,Processed,,N/A,82,Delayed,205,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.09,Negative,2932,Positive,Elderly,,Post-2nd (8+ Weeks),08-Dec-21,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,73,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,12,3,December,2021,,163,,,Completed,50-249,N/A,82,Delayed,205,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.09,Negative,226,Positive,Elderly,,Post-3rd (8+ Weeks),07-Jun-22,baseline,07-Apr-21,Pfizer,28-Jun-21,Pfizer,19-Jan-22,Pfizer,,Ustekinumab,,,74,70+,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,455,4,June,2022,,,139,,Completed,1000-4999,N/A,82,Delayed,205,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.1,Negative,46530,Positive,Adult,-169,Post-2nd (1-8 Weeks),11-Aug-21,Post Vaccine covid,03-Apr-21,Pfizer,18-Jun-21,Pfizer,,,,,,,56,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,308,2,August,2021,,54,,,Completed,1000-4999,N/A,76,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.06,Negative,2493,Positive,Adult,-8,Post-2nd (8+ Weeks),19-Jan-22,Post Vaccine covid,03-Apr-21,Pfizer,18-Jun-21,Pfizer,,,,,,,57,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70,3,January,2022,,215,,,Completed,250-999,N/A,76,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,97,Positive,Adult,-345,Post-1st,29-Apr-21,baseline,05-Apr-21,Pfizer,26-May-21,Pfizer,23-Sep-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,40,1,April,2021,24,,,,Completed,250-999,N/A,51,Scheduled,120,Scheduled,,24,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.45,Negative,4893,Positive,Adult,-302,Post-2nd (1-8 Weeks),11-Jun-21,baseline,05-Apr-21,Pfizer,26-May-21,Pfizer,23-Sep-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1054,2,June,2021,,16,,,Completed,,N/A,51,Scheduled,120,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.45,Negative,17240,Positive,Adult,-187,Post-3rd (1-8 Weeks),04-Oct-21,baseline,05-Apr-21,Pfizer,26-May-21,Pfizer,23-Sep-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1760,3,October,2021,,,11,,Completed,10000+,N/A,51,Scheduled,120,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.13,Negative,105,Positive,Adult,,Post-1st,11-May-21,baseline,26-Apr-21,Pfizer,23-Jun-21,Pfizer,09-Jan-22,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,1,May,2021,15,,,,Completed,50-249,N/A,58,Delayed,200,Delayed,,15,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.13,Negative,71,Positive,Adult,,Post-3rd (8+ Weeks),02-May-22,baseline,26-Apr-21,Pfizer,23-Jun-21,Pfizer,09-Jan-22,Pfizer,,,,,49,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,605,2,May,2022,,,113,,Completed,1000-4999,N/A,58,Delayed,200,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,17788,Positive,Adult,,Post-1st,28-Apr-21,baseline,17-Mar-21,AstraZeneca,02-Jun-21,Moderna,25-Oct-21,Moderna,,,,,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,1,April,2021,42,,,,Processed,,N/A,77,Delayed,145,Delayed,,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.39,Negative,6831,Positive,Adult,,Post-2nd (8+ Weeks),10-Aug-21,baseline,17-Mar-21,AstraZeneca,02-Jun-21,Moderna,25-Oct-21,Moderna,,,,,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,647,2,August,2021,,69,,,Completed,1000-4999,N/A,77,Delayed,145,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.18,Negative,432,Positive,Adult,,Post-3rd (8+ Weeks),18-Feb-22,baseline,17-Mar-21,AstraZeneca,02-Jun-21,Moderna,25-Oct-21,Moderna,,,,,64,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,3,February,2022,,,116,,Completed,10000+,N/A,77,Delayed,145,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.34,Negative,10986,Positive,Elderly,,Post-2nd (8+ Weeks),01-Sep-21,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,154,2,September,2021,,142,,,Completed,1000-4999,N/A,41,Scheduled,227,Delayed,145,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.34,Negative,10291,Positive,Elderly,,Post-3rd (1-8 Weeks),18-Jan-22,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,606,3,January,2022,,,54,,Completed,1000-4999,N/A,41,Scheduled,227,Delayed,145,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,1171,Positive,Elderly,,Post-3rd (8+ Weeks),16-Mar-22,baseline,02-Mar-21,Pfizer,12-Apr-21,Pfizer,25-Nov-21,Pfizer,19-Apr-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,83,4,March,2022,,,111,,Completed,250-999,N/A,41,Scheduled,227,Delayed,145,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,,0.05,Negative,924,Positive,Elderly,23,Post-1st,10-May-21,Post Vaccine covid,25-Mar-21,Pfizer,05-May-21,Pfizer,02-Dec-21,Pfizer,,,,,66,60-69,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,678,1,May,2021,46,,,,Completed,1000-4999,N/A,41,Scheduled,211,Delayed,,46,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,,0.23,Negative,4255,Positive,Elderly,108,Post-2nd (8+ Weeks),03-Aug-21,Post Vaccine covid,25-Mar-21,Pfizer,05-May-21,Pfizer,02-Dec-21,Pfizer,,,,,67,60-69,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,522,2,August,2021,,90,,,Completed,1000-4999,N/A,41,Scheduled,211,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,,0.11,Negative,2168,Positive,Elderly,243,Post-3rd (1-8 Weeks),16-Dec-21,Post Vaccine covid,25-Mar-21,Pfizer,05-May-21,Pfizer,02-Dec-21,Pfizer,,,,,67,60-69,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7458,3,December,2021,,,14,,Completed,10000+,N/A,41,Scheduled,211,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,9806,Positive,Elderly,-137,Post-2nd (8+ Weeks),09-Aug-21,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,68,2,August,2021,,61,,,Completed,250-999,N/A,56,Scheduled,107,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1,Negative,Elderly,-64,Post-3rd (1-8 Weeks),21-Oct-21,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,134,3,October,2021,,,27,,Completed,250-999,N/A,56,Scheduled,107,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,5757,Positive,Elderly,25,Post-3rd (8+ Weeks),18-Jan-22,Post Vaccine covid,14-Apr-21,Pfizer,09-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,72,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5430,4,January,2022,,,116,,Completed,10000+,N/A,56,Scheduled,107,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.13,Negative,970,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jun-21,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,45,2,June,2021,,19,,,Completed,250-999,N/A,61,Delayed,119,Scheduled,182,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.08,Negative,228,Positive,Adult,,Post-3rd (1-8 Weeks),29-Oct-21,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,114,3,October,2021,,,29,,Completed,250-999,N/A,61,Delayed,119,Scheduled,182,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.2,Negative,41,Negative,Adult,,Post-3rd (8+ Weeks),28-Jan-22,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,82,4,January,2022,,,120,,Completed,250-999,N/A,61,Delayed,119,Scheduled,182,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.06,Negative,121,Positive,Adult,,Post-4th,28-Apr-22,baseline,03-Apr-21,Pfizer,03-Jun-21,Pfizer,30-Sep-21,Pfizer,31-Mar-22,Pfizer,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,517,5,April,2022,,,,28,Completed,1000-4999,N/A,61,Delayed,119,Scheduled,182,,,,28,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,3685,Positive,Adult,,Post-2nd (1-8 Weeks),07-Jul-21,baseline,19-Apr-21,Pfizer,16-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1053,1,July,2021,,21,,,Completed,,N/A,58,Delayed,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.4,Negative,422,Positive,Adult,,Post-1st,01-Jun-21,baseline,04-Apr-21,Pfizer,09-Jun-21,Pfizer,06-Dec-21,Pfizer,27-May-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,23,1,June,2021,58,,,,Completed,50-249,N/A,66,Delayed,180,Delayed,172,58,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,4070,Positive,Adult,,Post-3rd (8+ Weeks),11-Mar-22,baseline,04-Apr-21,Pfizer,09-Jun-21,Pfizer,06-Dec-21,Pfizer,27-May-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,597,2,March,2022,,,95,,Completed,1000-4999,N/A,66,Delayed,180,Delayed,172,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,31280,Positive,Elderly,,Post-1st,23-Apr-21,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,68,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,68,1,April,2021,28,,,,Completed,250-999,N/A,85,Delayed,183,Delayed,213,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,807,Positive,Elderly,,Post-2nd (1-8 Weeks),12-Jul-21,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,68,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,804,2,July,2021,,23,,,Completed,,N/A,85,Delayed,183,Delayed,213,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.18,Negative,2755,Positive,Elderly,,Post-2nd (8+ Weeks),05-Nov-21,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,379,3,November,2021,,139,,,Completed,1000-4999,N/A,85,Delayed,183,Delayed,213,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.18,Negative,167,Positive,Elderly,,Post-3rd (1-8 Weeks),04-Jan-22,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2066,4,January,2022,,,16,,Completed,10000+,N/A,85,Delayed,183,Delayed,213,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,6.73,Positive,365,Positive,Elderly,,Post-3rd (8+ Weeks),21-Apr-22,baseline,26-Mar-21,Pfizer,19-Jun-21,Pfizer,19-Dec-21,Pfizer,20-Jul-22,Pfizer,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,841,5,April,2022,,,123,,Completed,,N/A,85,Delayed,183,Delayed,213,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,6.73,Positive,10012,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,05-Apr-21,Pfizer,20-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1295,1,July,2021,,32,,,Completed,,N/A,76,Delayed,94,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,2.01,Positive,4194,Positive,Adult,,Post-3rd (1-8 Weeks),12-Nov-21,baseline,05-Apr-21,Pfizer,20-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1478,2,November,2021,,,51,,Completed,10000+,N/A,76,Delayed,94,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.19,Negative,41,Negative,Adult,,Post-3rd (8+ Weeks),13-Jan-22,baseline,05-Apr-21,Pfizer,20-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,215,3,January,2022,,,113,,Completed,1000-4999,N/A,76,Delayed,94,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.07,Negative,162,Positive,Adult,-359,Post-1st,04-May-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,5,1,May,2021,34,,,,Completed,0-49,N/A,35,Scheduled,120,Scheduled,153,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.07,Negative,61731,Positive,Adult,-304,Post-2nd (1-8 Weeks),28-Jun-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,19,2,June,2021,,54,,,Completed,50-249,N/A,35,Scheduled,120,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.96,Positive,13848,Positive,Adult,-239,Post-2nd (8+ Weeks),01-Sep-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,12,3,September,2021,,119,,,Completed,50-249,N/A,35,Scheduled,120,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.59,Negative,4214,Positive,Adult,-220,Post-3rd (1-8 Weeks),20-Sep-21,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,695,4,September,2021,,,18,,Completed,1000-4999,N/A,35,Scheduled,120,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.59,Negative,3990,Positive,Adult,-112,Post-3rd (8+ Weeks),06-Jan-22,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,176,5,January,2022,,,126,,Completed,1000-4999,N/A,35,Scheduled,120,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,2.91,Positive,1356,Positive,Adult,-50,Post-4th,09-Mar-22,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,3850,6,March,2022,,,,35,Completed,10000+,N/A,35,Scheduled,120,Scheduled,153,,,,35,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,0.72,Positive,17211,Positive,Adult,40,Post-4th,07-Jun-22,baseline,31-Mar-21,Pfizer,05-May-21,Pfizer,02-Sep-21,Pfizer,02-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,6910,7,June,2022,,,,125,Completed,10000+,N/A,35,Scheduled,120,Scheduled,153,,,,125,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,2164,Positive,Adult,,Post-1st,07-Jun-21,baseline,04-May-21,Moderna,20-Jun-21,Moderna,30-Sep-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,84,1,June,2021,34,,,,Completed,250-999,N/A,47,Scheduled,102,Scheduled,,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,47,Negative,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,04-May-21,Moderna,20-Jun-21,Moderna,30-Sep-21,Moderna,,,,,40,40-49,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,2211,2,November,2021,,,34,,Completed,10000+,N/A,47,Scheduled,102,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.14,Negative,13847,Positive,Adult,,Post-3rd (8+ Weeks),26-Jan-22,baseline,04-May-21,Moderna,20-Jun-21,Moderna,30-Sep-21,Moderna,,,,,40,40-49,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,11360,3,January,2022,,,118,,Completed,10000+,N/A,47,Scheduled,102,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.61,Negative,4,Negative,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,09-Apr-21,Pfizer,12-Jun-21,Pfizer,06-Sep-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,709,2,July,2021,,24,,,Completed,1000-4999,N/A,64,Delayed,86,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.24,Positive,2448,Positive,Adult,,Post-3rd (8+ Weeks),23-Dec-21,baseline,09-Apr-21,Pfizer,12-Jun-21,Pfizer,06-Sep-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,250,3,December,2021,,,108,,Completed,1000-4999,N/A,64,Delayed,86,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,No Immunosuppressives,Ustekinumab Only,Ustekinumab Only,,1.64,Positive,12395,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,25-Apr-21,Pfizer,30-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2588,1,July,2021,,16,,,Completed,10000+,N/A,66,Delayed,196,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,No Immunosuppressives,Ustekinumab Only,Ustekinumab Only,,1.64,Positive,19643,Positive,Adult,,Post-3rd (1-8 Weeks),10-Feb-22,baseline,25-Apr-21,Pfizer,30-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4389,2,February,2022,,,29,,Completed,10000+,N/A,66,Delayed,196,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,No Immunosuppressives,Ustekinumab Only,Ustekinumab Only,,3.9,Positive,137,Positive,Adult,,Post-3rd (8+ Weeks),30-May-22,baseline,25-Apr-21,Pfizer,30-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,530,3,May,2022,,,138,,Completed,1000-4999,N/A,66,Delayed,196,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.04,Negative,6603,Positive,Adult,,Post-1st,15-Jun-21,baseline,13-Apr-21,Pfizer,29-Jun-21,Pfizer,26-Nov-21,Pfizer,,,,,45,40-49,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,39,1,June,2021,63,,,,Completed,250-999,N/A,77,Delayed,150,Delayed,,63,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.18,Negative,4330,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,13-Apr-21,Pfizer,29-Jun-21,Pfizer,26-Nov-21,Pfizer,,,,,45,40-49,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,,2,July,2021,,24,,,Processed,,N/A,77,Delayed,150,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.6,Negative,4069,Positive,Adult,,Post-3rd (1-8 Weeks),31-Dec-21,baseline,13-Apr-21,Pfizer,29-Jun-21,Pfizer,26-Nov-21,Pfizer,,,,,46,40-49,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,8718,3,December,2021,,,35,,Completed,10000+,N/A,77,Delayed,150,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.6,Negative,7011,Positive,Adult,-217,Post-1st,25-May-21,Post Vaccine covid,14-Apr-21,Pfizer,20-Jun-21,Pfizer,,,,,,,36,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,1,May,2021,41,,,,Completed,250-999,N/A,67,Delayed,,Delayed,,41,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.68,Negative,30269,Positive,Adult,57,Post-2nd (8+ Weeks),23-Feb-22,Post Vaccine covid,14-Apr-21,Pfizer,20-Jun-21,Pfizer,,,,,,,37,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2431,2,February,2022,,248,,,Completed,10000+,N/A,67,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.62,Negative,5238,Positive,Elderly,,Post-1st,08-Jun-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,66,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,384,1,June,2021,74,,,,Completed,1000-4999,N/A,71,Delayed,110,Scheduled,155,74,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,3140,Positive,Elderly,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1516,2,October,2021,,,35,,Completed,10000+,N/A,71,Delayed,110,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.79,Positive,14754,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,191,3,February,2022,,,133,,Completed,1000-4999,N/A,71,Delayed,110,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.95,Positive,6783,Positive,Elderly,,Post-4th,26-May-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,23-Sep-21,Pfizer,25-Feb-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,574,4,May,2022,,,,90,Completed,1000-4999,N/A,71,Delayed,110,Scheduled,155,,,,90,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,3706,Positive,Adult,-354,Post-2nd (1-8 Weeks),17-Jun-21,baseline,12-Apr-21,Moderna,25-May-21,Moderna,26-Sep-21,Moderna,,,,,20,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1092,1,June,2021,,23,,,Completed,,N/A,43,Scheduled,124,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,4.9,Positive,1165,Positive,Adult,-230,Post-3rd (1-8 Weeks),19-Oct-21,baseline,12-Apr-21,Moderna,25-May-21,Moderna,26-Sep-21,Moderna,,,,,21,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1897,2,October,2021,,,23,,Completed,10000+,N/A,43,Scheduled,124,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,8423,Positive,Adult,-94,Post-3rd (8+ Weeks),04-Mar-22,baseline,12-Apr-21,Moderna,25-May-21,Moderna,26-Sep-21,Moderna,,,,,21,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,517,3,March,2022,,,159,,Completed,1000-4999,N/A,43,Scheduled,124,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,4.9,Positive,2220,Positive,Adult,,Post-1st,18-Jun-21,baseline,13-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Sep-21,Pfizer,22-Jun-22,Pfizer,,,44,40-49,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,12,1,June,2021,66,,,,Completed,50-249,N/A,66,Delayed,84,Scheduled,285,66,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.07,Negative,2111,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,13-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Sep-21,Pfizer,22-Jun-22,Pfizer,,,44,40-49,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,149,2,July,2021,,28,,,Completed,1000-4999,N/A,66,Delayed,84,Scheduled,285,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,,3210,Positive,Adult,,Post-3rd (8+ Weeks),07-Feb-22,baseline,13-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Sep-21,Pfizer,22-Jun-22,Pfizer,,,45,40-49,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,208,3,February,2022,,,150,,Completed,1000-4999,N/A,66,Delayed,84,Scheduled,285,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,,,2801,Positive,Adult,,Post-1st,12-May-21,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,52,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,24,1,May,2021,29,,,,Completed,50-249,N/A,60,Delayed,212,Delayed,,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,,,2172,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,52,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,141,2,August,2021,,55,,,Completed,250-999,N/A,60,Delayed,212,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,,,9329,Positive,Adult,,Post-2nd (8+ Weeks),24-Nov-21,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,52,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,69,3,November,2021,,165,,,Completed,250-999,N/A,60,Delayed,212,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,,,5467,Positive,Adult,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,53,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2292,4,February,2022,,,24,,Completed,10000+,N/A,60,Delayed,212,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.16,Negative,16349,Positive,Adult,,Post-3rd (8+ Weeks),25-May-22,baseline,13-Apr-21,Pfizer,12-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,53,50-59,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3591,5,May,2022,,,135,,Completed,10000+,N/A,60,Delayed,212,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,659,Positive,Adult,-304,Post-2nd (1-8 Weeks),07-Jul-21,baseline,03-May-21,Pfizer,12-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,39,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,525,1,July,2021,,25,,,Completed,1000-4999,N/A,40,Scheduled,104,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1842,Positive,Adult,-135,Post-3rd (8+ Weeks),23-Dec-21,baseline,03-May-21,Pfizer,12-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1038,2,December,2021,,,90,,Completed,,N/A,40,Scheduled,104,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,96,Positive,Elderly,-181,Post-2nd (1-8 Weeks),24-Jun-21,Post Vaccine covid,28-Mar-21,Pfizer,04-Jun-21,Pfizer,09-Nov-21,Pfizer,17-May-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,578,1,June,2021,,20,,,Completed,1000-4999,N/A,68,Delayed,158,Delayed,189,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,412,Positive,Elderly,0,Post-3rd (1-8 Weeks),22-Dec-21,Post Vaccine covid,28-Mar-21,Pfizer,04-Jun-21,Pfizer,09-Nov-21,Pfizer,17-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,6201,2,December,2021,,,43,,Completed,10000+,N/A,68,Delayed,158,Delayed,189,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,2313,Positive,Elderly,91,Post-3rd (8+ Weeks),23-Mar-22,Post Vaccine covid,28-Mar-21,Pfizer,04-Jun-21,Pfizer,09-Nov-21,Pfizer,17-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3472,3,March,2022,,,134,,Completed,10000+,N/A,68,Delayed,158,Delayed,189,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,Combination Therapy,0.03,Negative,2520,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,10-Apr-21,Pfizer,17-Jun-21,Pfizer,05-Oct-21,Pfizer,07-Apr-22,Pfizer,,,34,30-39,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,935,1,July,2021,,22,,,Completed,,N/A,68,Delayed,110,Scheduled,184,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,Combination Therapy,0.07,Negative,6055,Positive,Adult,,Post-3rd (1-8 Weeks),05-Nov-21,baseline,10-Apr-21,Pfizer,17-Jun-21,Pfizer,05-Oct-21,Pfizer,07-Apr-22,Pfizer,,,34,30-39,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1395,2,November,2021,,,31,,Completed,,N/A,68,Delayed,110,Scheduled,184,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,Combination Therapy,0.31,Negative,317,Positive,Adult,,Post-4th,06-May-22,baseline,10-Apr-21,Pfizer,17-Jun-21,Pfizer,05-Oct-21,Pfizer,07-Apr-22,Pfizer,,,35,30-39,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,3214,3,May,2022,,,,29,Completed,10000+,N/A,68,Delayed,110,Scheduled,184,,,,29,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Corticosteroids,Anti-TNF Only,Corticosteroids,Anti-TNF Only,,0.07,Negative,358,Positive,Adult,-189,Post-2nd (8+ Weeks),22-Jun-21,Post Vaccine covid,24-Feb-21,Pfizer,06-Apr-21,Pfizer,10-Nov-21,Pfizer,,,,,52,50-59,0,1,0,0,0,1,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,50,1,June,2021,,77,,,Completed,250-999,N/A,41,Scheduled,218,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Corticosteroids,Anti-TNF Only,Corticosteroids,Anti-TNF Only,,0.31,Negative,10164,Positive,Adult,-132,Post-2nd (8+ Weeks),18-Aug-21,Post Vaccine covid,24-Feb-21,Pfizer,06-Apr-21,Pfizer,10-Nov-21,Pfizer,,,,,52,50-59,0,1,0,0,0,1,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,36,2,August,2021,,134,,,Completed,250-999,N/A,41,Scheduled,218,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Corticosteroids,Anti-TNF Only,Corticosteroids,Anti-TNF Only,,0.02,Negative,2620,Positive,Adult,98,Post-3rd (8+ Weeks),05-Apr-22,Post Vaccine covid,24-Feb-21,Pfizer,06-Apr-21,Pfizer,10-Nov-21,Pfizer,,,,,53,50-59,0,1,0,0,0,1,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9646,3,April,2022,,,146,,Completed,10000+,N/A,41,Scheduled,218,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.1,Negative,667,Positive,Adult,,Post-1st,19-May-21,baseline,08-Apr-21,Moderna,26-Jun-21,Moderna,18-Jan-22,Moderna,21-Jun-22,Moderna,,,60,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89,1,May,2021,41,,,,Completed,250-999,N/A,79,Delayed,206,Delayed,154,41,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,8046,Positive,Adult,,Post-3rd (8+ Weeks),17-Mar-22,baseline,08-Apr-21,Moderna,26-Jun-21,Moderna,18-Jan-22,Moderna,21-Jun-22,Moderna,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7982,3,March,2022,,,58,,Completed,10000+,N/A,79,Delayed,206,Delayed,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,2628,Positive,Adult,,Post-3rd (8+ Weeks),31-May-22,baseline,08-Apr-21,Moderna,26-Jun-21,Moderna,18-Jan-22,Moderna,21-Jun-22,Moderna,,,61,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3666,4,May,2022,,,133,,Completed,10000+,N/A,79,Delayed,206,Delayed,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,3792,Positive,Adult,,Post-1st,18-May-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,72,1,May,2021,40,,,,Completed,250-999,N/A,69,Delayed,91,Scheduled,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,4172,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,775,2,August,2021,,49,,,Completed,,N/A,69,Delayed,91,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,322,Positive,Adult,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2881,3,September,2021,,,14,,Completed,10000+,N/A,69,Delayed,91,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.24,Negative,2117,Positive,Adult,,Post-3rd (8+ Weeks),29-Jan-22,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,15-Sep-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,383,4,January,2022,,,136,,Completed,1000-4999,N/A,69,Delayed,91,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.24,Negative,5131,Positive,Elderly,-231,Post-1st,17-Jun-21,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,7,1,June,2021,71,,,,Completed,0-49,N/A,89,Delayed,122,Delayed,171,71,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2601,Positive,Elderly,-199,Post-2nd (1-8 Weeks),19-Jul-21,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4442,2,July,2021,,14,,,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,797,Positive,Elderly,-63,Post-3rd (1-8 Weeks),02-Dec-21,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1706,3,December,2021,,,28,,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,56221,Positive,Elderly,49,Post-3rd (8+ Weeks),24-Mar-22,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5220,4,March,2022,,,140,,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,662,Positive,Elderly,105,Post-4th,19-May-22,Post Vaccine covid,07-Apr-21,Pfizer,05-Jul-21,Pfizer,04-Nov-21,Pfizer,24-Apr-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5680,5,May,2022,,,,25,Completed,10000+,N/A,89,Delayed,122,Delayed,171,,,,25,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.06,Negative,1873,Positive,Adult,,Post-1st,03-May-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,May,2021,30,,,,Completed,0-49,N/A,33,Scheduled,124,Delayed,153,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,1927,Positive,Adult,,Post-2nd (1-8 Weeks),21-May-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,19,2,May,2021,,15,,,Completed,50-249,N/A,33,Scheduled,124,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,4679,Positive,Adult,,Post-3rd (8+ Weeks),11-Jan-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1020,4,January,2022,,,126,,Completed,,N/A,33,Scheduled,124,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,7312,Positive,Adult,,Post-4th,24-Feb-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,55,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,4380,5,February,2022,,,,17,Completed,10000+,N/A,33,Scheduled,124,Delayed,153,,,,17,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,883,Positive,Adult,,Post-4th,23-Jun-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,07-Sep-21,Pfizer,07-Feb-22,Moderna,,,56,50-59,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,6952,6,June,2022,,,,136,Completed,10000+,N/A,33,Scheduled,124,Delayed,153,,,,136,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,3525,Positive,Elderly,,Post-1st,20-May-21,baseline,06-Apr-21,Pfizer,26-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,69,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,May,2021,44,,,,Completed,0-49,N/A,81,Delayed,94,Scheduled,,44,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,12399,Positive,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,06-Apr-21,Pfizer,26-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,69,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,332,2,July,2021,,30,,,Completed,1000-4999,N/A,81,Delayed,94,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,20059,Positive,Elderly,,Post-3rd (1-8 Weeks),08-Nov-21,baseline,06-Apr-21,Pfizer,26-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,69,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,180,3,November,2021,,,41,,Completed,1000-4999,N/A,81,Delayed,94,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.03,Negative,3273,Positive,Elderly,,Post-1st,12-Jun-21,baseline,26-Apr-21,Moderna,24-Jun-21,Moderna,,,,,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,1,June,2021,47,,,,Completed,50-249,N/A,59,Delayed,,Delayed,,47,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.08,Negative,55364,Positive,Elderly,,Post-2nd (8+ Weeks),09-Feb-22,baseline,26-Apr-21,Moderna,24-Jun-21,Moderna,,,,,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,103,2,February,2022,,230,,,Completed,250-999,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.08,Negative,254,Positive,Adult,,Post-2nd (8+ Weeks),14-Aug-21,baseline,14-Apr-21,Moderna,19-Jun-21,Moderna,05-Dec-21,Moderna,,,,,25,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4481,1,August,2021,,56,,,Completed,10000+,N/A,66,Delayed,169,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,13170,Positive,Adult,,Post-3rd (8+ Weeks),12-Apr-22,baseline,14-Apr-21,Moderna,19-Jun-21,Moderna,05-Dec-21,Moderna,,,,,26,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,2,April,2022,,,128,,Completed,10000+,N/A,66,Delayed,169,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.01,Negative,848,Positive,Adult,,Post-1st,25-May-21,baseline,03-Apr-21,Pfizer,14-Jun-21,Pfizer,11-Jan-22,Pfizer,,,,,22,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,May,2021,52,,,,Processed,,N/A,72,Delayed,211,Delayed,,52,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.03,Negative,558,Positive,Adult,,Post-2nd (8+ Weeks),30-Aug-21,baseline,03-Apr-21,Pfizer,14-Jun-21,Pfizer,11-Jan-22,Pfizer,,,,,22,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,286,2,August,2021,,77,,,Completed,1000-4999,N/A,72,Delayed,211,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,358,Positive,Adult,-205,Post-1st,10-Jun-21,baseline,26-Apr-21,Pfizer,02-Jul-21,Moderna,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,June,2021,45,,,,Completed,0-49,N/A,67,Delayed,,Delayed,,45,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,98,Positive,Adult,-157,Post-2nd (1-8 Weeks),28-Jul-21,baseline,26-Apr-21,Pfizer,02-Jul-21,Moderna,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,860,2,July,2021,,26,,,Completed,,N/A,67,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,8472,Positive,Adult,-26,Post-2nd (8+ Weeks),06-Dec-21,baseline,26-Apr-21,Pfizer,02-Jul-21,Moderna,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,3,December,2021,,157,,,Completed,50-249,N/A,67,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.78,Positive,21080,Positive,Elderly,,Post-1st,25-May-21,baseline,05-May-21,Pfizer,22-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,20,1,May,2021,20,,,,Completed,50-249,N/A,48,Scheduled,168,Delayed,,20,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.04,Negative,11661,Positive,Elderly,,Post-3rd (8+ Weeks),11-Mar-22,baseline,05-May-21,Pfizer,22-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,592,2,March,2022,,,94,,Completed,1000-4999,N/A,48,Scheduled,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,30815,Positive,Adult,,Post-2nd (1-8 Weeks),26-May-21,baseline,29-Mar-21,Pfizer,01-May-21,Pfizer,03-Sep-21,Pfizer,02-Feb-22,Moderna,,,42,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,277,1,May,2021,,25,,,Completed,1000-4999,N/A,33,Scheduled,125,Delayed,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,15623,Positive,Adult,,Post-4th,08-Jun-22,baseline,29-Mar-21,Pfizer,01-May-21,Pfizer,03-Sep-21,Pfizer,02-Feb-22,Moderna,,,43,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,732,2,June,2022,,,,126,Completed,,N/A,33,Scheduled,125,Delayed,152,,,,126,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Ustekinumab Only,,0.05,Negative,6698,Positive,Adult,,Post-1st,20-May-21,baseline,14-Apr-21,Pfizer,14-Jun-21,Pfizer,27-Feb-22,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,1,May,2021,36,,,,Completed,50-249,N/A,61,Delayed,258,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Ustekinumab Only,,0.02,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),09-Aug-21,baseline,14-Apr-21,Pfizer,14-Jun-21,Pfizer,27-Feb-22,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1039,2,August,2021,,56,,,Completed,,N/A,61,Delayed,258,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,44,Negative,Adult,-268,Post-2nd (1-8 Weeks),27-May-21,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1147,1,May,2021,,17,,,Completed,,N/A,29,Scheduled,140,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,647,Positive,Adult,-157,Post-2nd (8+ Weeks),15-Sep-21,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,45,2,September,2021,,128,,,Completed,250-999,N/A,29,Scheduled,140,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,6596,Positive,Adult,-124,Post-3rd (1-8 Weeks),18-Oct-21,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2218,3,October,2021,,,21,,Completed,10000+,N/A,29,Scheduled,140,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,11541,Positive,Adult,-18,Post-3rd (8+ Weeks),01-Feb-22,baseline,11-Apr-21,Pfizer,10-May-21,Pfizer,27-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,239,4,February,2022,,,127,,Completed,1000-4999,N/A,29,Scheduled,140,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.24,Positive,28,Negative,Adult,,Post-1st,08-Jun-21,baseline,23-Apr-21,Pfizer,11-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,50,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,74,1,June,2021,46,,,,Completed,250-999,N/A,49,Scheduled,204,Delayed,,46,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.24,Positive,1241,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,23-Apr-21,Pfizer,11-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,50,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1093,2,July,2021,,38,,,Completed,,N/A,49,Scheduled,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,16828,Positive,Adult,,Post-1st,17-Jun-21,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,56,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,1,June,2021,35,,,,Completed,50-249,N/A,51,Scheduled,187,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.09,Negative,1924,Positive,Adult,,Post-2nd (1-8 Weeks),17-Jul-21,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,56,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2318,2,July,2021,,14,,,Completed,10000+,N/A,51,Scheduled,187,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,8632,Positive,Adult,,Post-3rd (8+ Weeks),13-May-22,baseline,13-May-21,Pfizer,03-Jul-21,Pfizer,06-Jan-22,Pfizer,,,,,57,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,914,5,May,2022,,,127,,Completed,,N/A,51,Scheduled,187,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,2716,Positive,Adult,,Post-1st,26-May-21,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,35,1,May,2021,43,,,,Completed,50-249,N/A,48,Scheduled,115,Scheduled,147,43,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,4787,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,77,2,September,2021,,101,,,Completed,250-999,N/A,48,Scheduled,115,Scheduled,147,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3560,Positive,Adult,,Post-3rd (8+ Weeks),15-Dec-21,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,233,3,December,2021,,,83,,Completed,1000-4999,N/A,48,Scheduled,115,Scheduled,147,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,4330,Positive,Adult,,Post-3rd (8+ Weeks),14-Jan-22,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,164,4,January,2022,,,113,,Completed,1000-4999,N/A,48,Scheduled,115,Scheduled,147,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,7730,Positive,Adult,,Post-4th,28-Feb-22,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2086,5,February,2022,,,,11,Completed,10000+,N/A,48,Scheduled,115,Scheduled,147,,,,11,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,0,Negative,Adult,,Post-4th,20-Jun-22,baseline,13-Apr-21,Pfizer,31-May-21,Pfizer,23-Sep-21,Pfizer,17-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,272,6,June,2022,,,,123,Completed,1000-4999,N/A,48,Scheduled,115,Scheduled,147,,,,123,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,,0.27,Negative,625,Positive,Adult,,Post-1st,10-Jun-21,baseline,08-May-21,Pfizer,11-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,36,30-39,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,24,1,June,2021,33,,,,Completed,50-249,N/A,34,Scheduled,165,Delayed,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,,0.27,Negative,131,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,08-May-21,Pfizer,11-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,36,30-39,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,283,2,July,2021,,28,,,Completed,1000-4999,N/A,34,Scheduled,165,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Combination Therapy,,0.01,Negative,,,Adult,,Post-3rd (8+ Weeks),22-Jan-22,baseline,08-May-21,Pfizer,11-Jun-21,Pfizer,23-Nov-21,Pfizer,,,,,36,30-39,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,2250,3,January,2022,,,60,,Completed,10000+,N/A,34,Scheduled,165,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,143,Positive,Adult,,Post-1st,08-Jun-21,baseline,09-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Dec-21,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,16,1,June,2021,60,,,,Completed,50-249,N/A,63,Delayed,201,Delayed,,60,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1770,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,09-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Dec-21,Pfizer,,,,,46,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,859,2,August,2021,,55,,,Completed,,N/A,63,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,9640,Positive,Adult,,Post-1st,15-Jun-21,baseline,03-May-21,Pfizer,02-Jul-21,Pfizer,06-Mar-22,Pfizer,,,,,23,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,151,1,June,2021,43,,,,Completed,1000-4999,N/A,60,Delayed,247,Delayed,,43,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.06,Negative,3644,Positive,Elderly,,Post-2nd (8+ Weeks),16-Aug-21,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,645,2,August,2021,,114,,,Completed,1000-4999,N/A,21,Scheduled,147,Delayed,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.04,Negative,60,Positive,Elderly,,Post-3rd (1-8 Weeks),01-Oct-21,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,October,2021,,,13,,Completed,10000+,N/A,21,Scheduled,147,Delayed,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.04,Negative,4404,Positive,Elderly,,Post-4th,08-Mar-22,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6002,5,March,2022,,,,14,Completed,10000+,N/A,21,Scheduled,147,Delayed,157,,,,14,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.04,Negative,336,Positive,Elderly,,Post-4th,22-Jun-22,baseline,03-Apr-21,Pfizer,24-Apr-21,Pfizer,18-Sep-21,Pfizer,22-Feb-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1114,6,June,2022,,,,120,Completed,,N/A,21,Scheduled,147,Delayed,157,,,,120,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.17,Negative,16613,Positive,Adult,-325,Post-1st,02-Jun-21,baseline,23-Apr-21,Moderna,18-Jun-21,Moderna,11-Feb-22,Moderna,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,137,1,June,2021,40,,,,Completed,250-999,N/A,56,Scheduled,238,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.17,Negative,2936,Positive,Adult,-285,Post-2nd (1-8 Weeks),12-Jul-21,baseline,23-Apr-21,Moderna,18-Jun-21,Moderna,11-Feb-22,Moderna,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1008,2,July,2021,,24,,,Completed,,N/A,56,Scheduled,238,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.09,Negative,392,Positive,Adult,-130,Post-2nd (8+ Weeks),14-Dec-21,baseline,23-Apr-21,Moderna,18-Jun-21,Moderna,11-Feb-22,Moderna,,,,,44,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,120,3,December,2021,,179,,,Completed,250-999,N/A,56,Scheduled,238,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.2,Negative,13966,Positive,Elderly,,Post-2nd (1-8 Weeks),22-Jun-21,baseline,03-Mar-21,Pfizer,04-May-21,Pfizer,04-Dec-21,Pfizer,,,,,78,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,234,1,June,2021,,49,,,Completed,1000-4999,N/A,62,Delayed,214,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.08,Negative,15530,Positive,Adult,39,Pre-1st,26-May-21,covid,01-Jun-21,Moderna,20-Jul-21,Moderna,,,,,,,35,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1816,1,May,2021,,,,,Completed,10000+,N/A,49,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.08,Negative,5335,Positive,Adult,-310,Post-1st,09-Jun-21,baseline,27-Apr-21,Pfizer,16-Jun-21,Pfizer,23-Oct-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,330,1,June,2021,43,,,,Completed,1000-4999,N/A,50,Scheduled,129,Delayed,,43,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.03,Negative,80000,Positive,Adult,-308,Post-1st,21-May-21,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,May,2021,35,,,,Completed,0-49,N/A,70,Delayed,193,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.05,Negative,6233,Positive,Adult,-249,Post-2nd (1-8 Weeks),19-Jul-21,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,278,2,July,2021,,24,,,Completed,1000-4999,N/A,70,Delayed,193,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.05,Negative,28529,Positive,Adult,-57,Post-3rd (1-8 Weeks),27-Jan-22,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,54,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1715,3,January,2022,,,23,,Completed,10000+,N/A,70,Delayed,193,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.03,Negative,10337,Positive,Adult,63,Post-3rd (8+ Weeks),27-May-22,baseline,16-Apr-21,Pfizer,25-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,55,50-59,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6476,4,May,2022,,,143,,Completed,10000+,N/A,70,Delayed,193,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,1692,Positive,Adult,-208,Post-1st,31-May-21,Post Vaccine covid,25-Apr-21,Moderna,14-Jun-21,Moderna,22-Apr-22,Pfizer,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,138,1,May,2021,36,,,,Completed,250-999,N/A,50,Scheduled,312,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,597,Positive,Adult,-156,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,25-Apr-21,Moderna,14-Jun-21,Moderna,22-Apr-22,Pfizer,,,,,36,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1443,2,July,2021,,38,,,Completed,10000+,N/A,50,Scheduled,312,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,561,Positive,Adult,-2,Post-2nd (8+ Weeks),23-Dec-21,Post Vaccine covid,25-Apr-21,Moderna,14-Jun-21,Moderna,22-Apr-22,Pfizer,,,,,36,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,333,3,December,2021,,192,,,Completed,1000-4999,N/A,50,Scheduled,312,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,4423,Positive,Adult,,Post-1st,29-May-21,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2,1,May,2021,42,,,,Completed,0-49,N/A,55,Scheduled,85,Scheduled,149,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,1224,Positive,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1102,2,June,2021,,14,,,Completed,,N/A,55,Scheduled,85,Scheduled,149,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,3824,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,219,3,October,2021,,,54,,Completed,1000-4999,N/A,55,Scheduled,85,Scheduled,149,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,544,Positive,Adult,,Post-4th,04-Jul-22,baseline,17-Apr-21,Pfizer,11-Jun-21,Pfizer,04-Sep-21,Pfizer,31-Jan-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,108,4,July,2022,,,,154,Completed,250-999,N/A,55,Scheduled,85,Scheduled,149,,,,154,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.54,Negative,7548,Positive,Adult,,Post-2nd (8+ Weeks),10-Aug-21,New biologic/Tofacitinib start,20-Apr-21,Pfizer,10-Jun-21,Pfizer,18-Nov-21,Pfizer,14-Jun-22,Pfizer,,,33,30-39,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,237,1,August,2021,,61,,,Completed,1000-4999,N/A,51,Scheduled,161,Delayed,208,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,2668,Positive,Adult,,Post-3rd (8+ Weeks),03-Mar-22,New biologic/Tofacitinib start,20-Apr-21,Pfizer,10-Jun-21,Pfizer,18-Nov-21,Pfizer,14-Jun-22,Pfizer,,,34,30-39,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,446,2,March,2022,,,105,,Completed,1000-4999,N/A,51,Scheduled,161,Delayed,208,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,139,Positive,Adult,,Post-2nd (1-8 Weeks),07-Aug-21,baseline,15-Apr-21,Pfizer,24-Jun-21,Pfizer,23-Dec-21,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1566,2,August,2021,,44,,,Completed,10000+,N/A,70,Delayed,182,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,50221,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,15-Apr-21,Pfizer,24-Jun-21,Pfizer,23-Dec-21,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,335,3,December,2021,,181,,,Completed,1000-4999,N/A,70,Delayed,182,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,,,Adult,-202,Post-2nd (1-8 Weeks),14-Jun-21,Post Vaccine covid,20-Mar-21,Pfizer,24-Apr-21,Pfizer,,,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,578,1,June,2021,,51,,,Completed,1000-4999,N/A,35,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.17,Negative,6700,Positive,Adult,-130,Post-2nd (8+ Weeks),25-Aug-21,Post Vaccine covid,20-Mar-21,Pfizer,24-Apr-21,Pfizer,,,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79,2,August,2021,,123,,,Completed,250-999,N/A,35,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.15,Negative,5102,Positive,Adult,,Post-1st,02-Jun-21,baseline,22-Apr-21,Pfizer,02-Jul-21,Pfizer,03-Jan-22,Moderna,,,,,34,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,18,1,June,2021,41,,,,Completed,50-249,N/A,71,Delayed,185,Delayed,,41,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,26446,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jul-21,baseline,22-Apr-21,Pfizer,02-Jul-21,Pfizer,03-Jan-22,Moderna,,,,,34,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,382,2,July,2021,,26,,,Completed,1000-4999,N/A,71,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,4015,Positive,Adult,,Post-3rd (8+ Weeks),11-Mar-22,baseline,22-Apr-21,Pfizer,02-Jul-21,Pfizer,03-Jan-22,Moderna,,,,,35,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2993,3,March,2022,,,67,,Completed,10000+,N/A,71,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.32,Negative,942,Positive,Adult,,Post-1st,16-Jun-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,1,June,2021,38,,,,Completed,50-249,N/A,59,Delayed,179,Delayed,,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.26,Positive,736,Positive,Adult,,Post-2nd (8+ Weeks),22-Sep-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,61,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,552,2,September,2021,,77,,,Completed,1000-4999,N/A,59,Delayed,179,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,18888,Positive,Adult,,Post-3rd (1-8 Weeks),21-Jan-22,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,61,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5031,3,January,2022,,,19,,Completed,10000+,N/A,59,Delayed,179,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,12014,Positive,Adult,,Post-3rd (8+ Weeks),29-Jun-22,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,02-Jan-22,Pfizer,,,,,62,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1174,4,June,2022,,,178,,Completed,,N/A,59,Delayed,179,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,,0.01,Negative,3631,Positive,Adult,,Post-2nd (8+ Weeks),31-Aug-21,baseline,15-Apr-21,Pfizer,17-Jun-21,Pfizer,02-Jan-22,Moderna,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,310,1,August,2021,,75,,,Completed,1000-4999,N/A,63,Delayed,199,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.01,Negative,780,Positive,Adult,,Post-1st,02-Jun-21,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,58,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,12,1,June,2021,35,,,,Completed,50-249,N/A,43,Scheduled,189,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.02,Negative,6859,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,58,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,263,2,July,2021,,25,,,Completed,1000-4999,N/A,43,Scheduled,189,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.02,Negative,12074,Positive,Adult,,Post-2nd (8+ Weeks),09-Aug-21,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,58,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,139,3,August,2021,,60,,,Completed,250-999,N/A,43,Scheduled,189,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.03,Negative,5508,Positive,Adult,,Post-3rd (8+ Weeks),09-May-22,baseline,28-Apr-21,Pfizer,10-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,59,50-59,0,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,0,0,0,0,0,0,1498,5,May,2022,,,144,,Completed,10000+,N/A,43,Scheduled,189,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,76704,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jun-21,baseline,01-May-21,Moderna,29-May-21,Moderna,10-Sep-21,Moderna,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,367,1,June,2021,,11,,,Completed,1000-4999,N/A,28,Scheduled,104,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,932,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,01-May-21,Moderna,29-May-21,Moderna,10-Sep-21,Moderna,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,403,2,September,2021,,96,,,Completed,1000-4999,N/A,28,Scheduled,104,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,6967,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,01-May-21,Moderna,29-May-21,Moderna,10-Sep-21,Moderna,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,560,4,February,2022,,,151,,Completed,1000-4999,N/A,28,Scheduled,104,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,27116,Positive,Adult,,Post-1st,31-May-21,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,12,1,May,2021,45,,,,Completed,50-249,N/A,65,Delayed,116,Scheduled,155,45,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,5783,Positive,Elderly,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,91,2,July,2021,,39,,,Completed,250-999,N/A,65,Delayed,116,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,1979,Positive,Elderly,,Post-3rd (1-8 Weeks),12-Nov-21,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,302,3,November,2021,,,29,,Completed,1000-4999,N/A,65,Delayed,116,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,2,Negative,Elderly,,Post-3rd (8+ Weeks),07-Feb-22,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,108,4,February,2022,,,116,,Completed,250-999,N/A,65,Delayed,116,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,53,Positive,Elderly,,Post-4th,04-Apr-22,baseline,16-Apr-21,Pfizer,20-Jun-21,Pfizer,14-Oct-21,Pfizer,18-Mar-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,604,5,April,2022,,,,17,Completed,1000-4999,N/A,65,Delayed,116,Scheduled,155,,,,17,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,18547,Positive,Adult,28,Pre-1st,27-May-21,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,921,1,May,2021,,,,,Completed,,N/A,41,Scheduled,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,189,Positive,Adult,69,Post-1st,07-Jul-21,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3676,2,July,2021,40,,,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.06,Negative,16056,Positive,Adult,84,Post-2nd (1-8 Weeks),22-Jul-21,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7259,3,July,2021,,14,,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,1380,Positive,Adult,252,Post-2nd (8+ Weeks),06-Jan-22,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2085,4,January,2022,,182,,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.77,Positive,2321,Positive,Adult,272,Post-3rd (1-8 Weeks),26-Jan-22,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,58,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3407,5,January,2022,,,19,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.77,Positive,327,Positive,Adult,383,Post-3rd (8+ Weeks),17-May-22,covid,28-May-21,Pfizer,08-Jul-21,Pfizer,07-Jan-22,Moderna,,,,,59,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2338,6,May,2022,,,130,,Completed,10000+,N/A,41,Scheduled,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,,,0.98,Positive,1662,Positive,Adult,,Post-1st,03-Jun-21,baseline,28-Apr-21,Pfizer,25-Jul-21,Pfizer,,,,,,,20,18-29,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68,1,June,2021,36,,,,Completed,250-999,N/A,88,Delayed,,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,135,Positive,Adult,25,Post-2nd (8+ Weeks),24-Sep-21,Post Vaccine covid,01-Apr-21,Pfizer,13-May-21,Pfizer,23-Dec-21,Pfizer,,,,,45,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10902,2,September,2021,,134,,,Completed,10000+,N/A,42,Scheduled,224,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,351,Positive,Adult,176,Post-3rd (8+ Weeks),22-Feb-22,Post Vaccine covid,01-Apr-21,Pfizer,13-May-21,Pfizer,23-Dec-21,Pfizer,,,,,46,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4406,3,February,2022,,,61,,Completed,10000+,N/A,42,Scheduled,224,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1719,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,33,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,554,1,July,2021,,30,,,Completed,1000-4999,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.5,Negative,0,Negative,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,104,2,December,2021,,196,,,Completed,250-999,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.14,Negative,15190,Positive,Adult,,Post-3rd (1-8 Weeks),18-Feb-22,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3508,3,February,2022,,,52,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.14,Negative,57844,Positive,Adult,,Post-3rd (8+ Weeks),10-Jun-22,baseline,14-Apr-21,Moderna,09-Jun-21,Moderna,28-Dec-21,Moderna,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5043,4,June,2022,,,164,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,592,Positive,Adult,,Post-1st,08-Jun-21,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,49,1,June,2021,19,,,,Completed,250-999,N/A,21,Scheduled,239,Delayed,,19,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,198,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,625,2,June,2021,,18,,,Completed,1000-4999,N/A,21,Scheduled,239,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,16035,Positive,Adult,,Post-3rd (1-8 Weeks),23-Mar-22,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2851,3,March,2022,,,47,,Completed,10000+,N/A,21,Scheduled,239,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,24677,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,20-May-21,Moderna,10-Jun-21,Moderna,04-Feb-22,Moderna,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1024,4,June,2022,,,131,,Completed,,N/A,21,Scheduled,239,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.01,Negative,13263,Positive,Adult,,Post-1st,15-Jun-21,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,4,1,June,2021,45,,,,Completed,0-49,N/A,55,Scheduled,127,Delayed,196,45,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.35,Negative,8842,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,789,2,July,2021,,34,,,Completed,,N/A,55,Scheduled,127,Delayed,196,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.02,Negative,1682,Positive,Adult,,Post-3rd (1-8 Weeks),17-Nov-21,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,1296,3,November,2021,,,18,,Completed,,N/A,55,Scheduled,127,Delayed,196,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,0.26,Negative,10208,Positive,Adult,,Post-3rd (8+ Weeks),09-Mar-22,baseline,01-May-21,Pfizer,25-Jun-21,Pfizer,30-Oct-21,Pfizer,14-May-22,Pfizer,,,26,18-29,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1,0,1,140,4,March,2022,,,130,,Completed,250-999,N/A,55,Scheduled,127,Delayed,196,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,0.02,Negative,953,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,11-Apr-21,Pfizer,22-May-21,Pfizer,17-Sep-21,Pfizer,04-Jul-22,Moderna,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,376,1,June,2021,,37,,,Completed,1000-4999,N/A,41,Scheduled,118,Scheduled,290,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Ustekinumab Only,0.01,Negative,8480,Positive,Adult,,Post-3rd (8+ Weeks),18-Nov-21,baseline,11-Apr-21,Pfizer,22-May-21,Pfizer,17-Sep-21,Pfizer,04-Jul-22,Moderna,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,63,2,November,2021,,,62,,Completed,250-999,N/A,41,Scheduled,118,Scheduled,290,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,2497,Positive,Adult,90,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,08-Apr-21,Pfizer,10-Jun-21,Pfizer,26-Sep-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,,2,August,2021,,54,,,Processed,,N/A,63,Delayed,108,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.28,Negative,495,Positive,Adult,184,Post-3rd (1-8 Weeks),05-Nov-21,Post Vaccine covid,08-Apr-21,Pfizer,10-Jun-21,Pfizer,26-Sep-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,8519,3,November,2021,,,40,,Completed,10000+,N/A,63,Delayed,108,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,1255,Positive,Adult,302,Post-3rd (8+ Weeks),03-Mar-22,Post Vaccine covid,08-Apr-21,Pfizer,10-Jun-21,Pfizer,26-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,2656,4,March,2022,,,158,,Completed,10000+,N/A,63,Delayed,108,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,465,Positive,Adult,,Post-1st,03-Jun-21,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,1,June,2021,42,,,,Completed,250-999,N/A,44,Scheduled,123,Delayed,156,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,39,Negative,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1870,2,June,2021,,20,,,Completed,10000+,N/A,44,Scheduled,123,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.47,Negative,711,Positive,Adult,,Post-3rd (1-8 Weeks),29-Oct-21,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3553,3,October,2021,,,23,,Completed,10000+,N/A,44,Scheduled,123,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.25,Negative,2374,Positive,Adult,,Post-3rd (8+ Weeks),17-Feb-22,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,168,4,February,2022,,,134,,Completed,1000-4999,N/A,44,Scheduled,123,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,7109,Positive,Adult,,Post-4th,31-Mar-22,baseline,22-Apr-21,Pfizer,05-Jun-21,Pfizer,06-Oct-21,Pfizer,11-Mar-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,426,5,March,2022,,,,20,Completed,1000-4999,N/A,44,Scheduled,123,Delayed,156,,,,20,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.18,Negative,2345,Positive,Adult,-238,Post-1st,15-Jun-21,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,42,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,87,1,June,2021,39,,,,Completed,250-999,N/A,63,Delayed,67,Scheduled,,39,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.18,Negative,5465,Positive,Adult,-193,Post-2nd (1-8 Weeks),30-Jul-21,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,42,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1966,2,July,2021,,21,,,Completed,10000+,N/A,63,Delayed,67,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,43671,Positive,Adult,-102,Post-3rd (1-8 Weeks),29-Oct-21,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,42,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1098,3,October,2021,,,45,,Completed,,N/A,63,Delayed,67,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,1655,Positive,Adult,-4,Post-3rd (8+ Weeks),04-Feb-22,Post Vaccine covid,07-May-21,Pfizer,09-Jul-21,Pfizer,14-Sep-21,Moderna,,,,,43,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,337,4,February,2022,,,143,,Completed,1000-4999,N/A,63,Delayed,67,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.12,Negative,1832,Positive,Adult,,Post-2nd (1-8 Weeks),02-Jun-21,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,54,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1476,1,June,2021,,13,,,Completed,10000+,N/A,37,Scheduled,184,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,653,Positive,Adult,,Post-2nd (8+ Weeks),29-Sep-21,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,54,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,130,2,September,2021,,132,,,Completed,250-999,N/A,37,Scheduled,184,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,1618,Positive,Adult,,Post-3rd (1-8 Weeks),03-Dec-21,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,55,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3366,3,December,2021,,,13,,Completed,10000+,N/A,37,Scheduled,184,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,80000,Positive,Adult,,Post-3rd (8+ Weeks),17-Mar-22,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,55,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,483,4,March,2022,,,117,,Completed,1000-4999,N/A,37,Scheduled,184,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,25663,Positive,Adult,,Post-4th,14-Jun-22,baseline,13-Apr-21,Pfizer,20-May-21,Pfizer,20-Nov-21,Pfizer,03-May-22,Pfizer,,,55,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2898,5,June,2022,,,,42,Completed,10000+,N/A,37,Scheduled,184,Delayed,164,,,,42,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,,107,Positive,Adult,31,Post-1st,08-Jun-21,covid,22-May-21,Pfizer,25-Aug-21,Pfizer,08-Jun-22,Pfizer,,,,,18,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,696,1,June,2021,17,,,,Completed,1000-4999,N/A,95,Delayed,287,Delayed,,17,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,,,1297,Positive,Adult,,Post-1st,07-Jul-21,baseline,20-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78,1,July,2021,48,,,,Completed,250-999,N/A,49,Scheduled,,Delayed,,48,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,2.88,Positive,4699,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,20-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,941,2,September,2021,,56,,,Completed,,N/A,49,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,982,Positive,Adult,,Post-2nd (8+ Weeks),23-Dec-21,baseline,20-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,44,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,3,December,2021,,168,,,Completed,250-999,N/A,49,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,69068,Positive,Adult,,Post-1st,31-May-21,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,17,1,May,2021,38,,,,Completed,50-249,N/A,52,Scheduled,85,Scheduled,206,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,14403,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1541,2,July,2021,,39,,,Completed,10000+,N/A,52,Scheduled,85,Scheduled,206,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.18,Negative,14106,Positive,Adult,,Post-3rd (1-8 Weeks),30-Sep-21,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1839,3,September,2021,,,23,,Completed,10000+,N/A,52,Scheduled,85,Scheduled,206,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.18,Negative,23620,Positive,Adult,,Post-3rd (8+ Weeks),07-Jan-22,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,614,4,January,2022,,,122,,Completed,1000-4999,N/A,52,Scheduled,85,Scheduled,206,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,21633,Positive,Adult,,Post-4th,29-Apr-22,baseline,23-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,01-Apr-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1823,5,April,2022,,,,28,Completed,10000+,N/A,52,Scheduled,85,Scheduled,206,,,,28,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,6505,Positive,Adult,,Post-2nd (1-8 Weeks),20-May-21,baseline,31-Mar-21,Pfizer,26-Apr-21,Pfizer,16-Nov-21,Pfizer,,,,,64,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,74,1,May,2021,,24,,,Completed,250-999,N/A,26,Scheduled,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,10049,Positive,Elderly,,Post-2nd (8+ Weeks),07-Sep-21,baseline,31-Mar-21,Pfizer,26-Apr-21,Pfizer,16-Nov-21,Pfizer,,,,,64,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,2,September,2021,,134,,,Completed,0-49,N/A,26,Scheduled,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,14741,Positive,Adult,,Post-1st,28-Jun-21,baseline,13-May-21,Moderna,23-Jun-21,Moderna,02-Jan-22,Moderna,,,,,47,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,June,2021,46,,,,Completed,0-49,N/A,41,Scheduled,193,Delayed,,46,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.01,Negative,182,Positive,Elderly,,Post-2nd (1-8 Weeks),16-Jun-21,baseline,29-Mar-21,Pfizer,03-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,68,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2412,1,June,2021,,13,,,Completed,10000+,N/A,66,Delayed,186,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.12,Negative,17139,Positive,Elderly,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,29-Mar-21,Pfizer,03-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,69,60-69,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10912,2,January,2022,,,31,,Completed,10000+,N/A,66,Delayed,186,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,39388,Positive,Adult,,Post-1st,17-May-21,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4,1,May,2021,24,,,,Completed,0-49,N/A,59,Delayed,75,Scheduled,153,24,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.22,Negative,29255,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,369,2,July,2021,,31,,,Completed,1000-4999,N/A,59,Delayed,75,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.22,Negative,17930,Positive,Adult,,Post-3rd (8+ Weeks),30-Dec-21,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,442,3,December,2021,,,117,,Completed,1000-4999,N/A,59,Delayed,75,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.08,Negative,33181,Positive,Adult,,Post-4th,20-Jun-22,baseline,23-Apr-21,AstraZeneca,21-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,29-Jul-22,Moderna,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,4,June,2022,,,,136,Completed,10000+,N/A,59,Delayed,75,Scheduled,153,,,,136,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.52,Negative,24886,Positive,Elderly,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,10-Dec-21,Pfizer,25-May-22,Pfizer,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2084,1,July,2021,,49,,,Completed,10000+,N/A,77,Delayed,183,Delayed,166,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.19,Negative,20559,Positive,Elderly,,Post-3rd (8+ Weeks),23-Feb-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,10-Dec-21,Pfizer,25-May-22,Pfizer,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1080,2,February,2022,,,75,,Completed,,N/A,77,Delayed,183,Delayed,166,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,39003,Positive,Elderly,,Post-4th,13-Jun-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,10-Dec-21,Pfizer,25-May-22,Pfizer,,,73,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5630,3,June,2022,,,,19,Completed,10000+,N/A,77,Delayed,183,Delayed,166,,,,19,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.03,Negative,74,Positive,Adult,66,Post-2nd (1-8 Weeks),21-Jul-21,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1625,1,July,2021,,47,,,Completed,10000+,N/A,55,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.18,Negative,39359,Positive,Adult,243,Post-2nd (8+ Weeks),14-Jan-22,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,75,2,January,2022,,224,,,Completed,250-999,N/A,55,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,0.11,Negative,564,Positive,Adult,267,Post-3rd (1-8 Weeks),07-Feb-22,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,5539,3,February,2022,,,17,,Completed,10000+,N/A,55,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,,7.35,Positive,25446,Positive,Adult,386,Post-3rd (8+ Weeks),06-Jun-22,Post Vaccine covid,10-Apr-21,Pfizer,04-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,853,4,June,2022,,,136,,Completed,,N/A,55,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.37,Negative,36168,Positive,Adult,,Post-2nd (1-8 Weeks),25-May-21,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,61,1,May,2021,,49,,,Completed,250-999,N/A,21,Scheduled,150,Delayed,227,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.37,Negative,11154,Positive,Adult,,Post-2nd (8+ Weeks),16-Jul-21,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,16,2,July,2021,,101,,,Completed,50-249,N/A,21,Scheduled,150,Delayed,227,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,14821,Positive,Adult,,Post-3rd (1-8 Weeks),20-Sep-21,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,845,3,September,2021,,,17,,Completed,,N/A,21,Scheduled,150,Delayed,227,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,671,Positive,Adult,,Post-3rd (8+ Weeks),14-Jan-22,baseline,16-Mar-21,Pfizer,06-Apr-21,Pfizer,03-Sep-21,Pfizer,18-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,847,4,January,2022,,,133,,Completed,,N/A,21,Scheduled,150,Delayed,227,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.24,Negative,79163,Positive,Adult,-191,Post-1st,13-Jul-21,Post Vaccine covid,03-Jun-21,Pfizer,16-Aug-21,Pfizer,,,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,193,1,July,2021,40,,,,Completed,1000-4999,N/A,74,Delayed,,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.24,Negative,4771,Positive,Adult,-86,Post-2nd (8+ Weeks),26-Oct-21,Post Vaccine covid,03-Jun-21,Pfizer,16-Aug-21,Pfizer,,,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,758,2,October,2021,,71,,,Completed,,N/A,74,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.14,Negative,406,Positive,Adult,8,Post-2nd (8+ Weeks),28-Jan-22,Post Vaccine covid,03-Jun-21,Pfizer,16-Aug-21,Pfizer,,,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3354,3,January,2022,,165,,,Completed,10000+,N/A,74,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.81,Positive,80000,Positive,Adult,,Post-1st,17-Jun-21,baseline,23-Apr-21,Moderna,22-Jun-21,Moderna,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,78,1,June,2021,55,,,,Completed,250-999,N/A,60,Delayed,,Delayed,,55,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.11,Negative,36858,Positive,Adult,,Post-2nd (8+ Weeks),26-Aug-21,baseline,23-Apr-21,Moderna,22-Jun-21,Moderna,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,505,2,August,2021,,65,,,Completed,1000-4999,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,1.11,Positive,38242,Positive,Adult,,Post-2nd (8+ Weeks),19-Nov-21,baseline,23-Apr-21,Moderna,22-Jun-21,Moderna,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,127,3,November,2021,,150,,,Completed,250-999,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,76775,Positive,Elderly,,Post-2nd (8+ Weeks),07-Jun-21,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,80,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,15,1,June,2021,,59,,,Completed,50-249,N/A,39,Scheduled,139,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,9844,Positive,Elderly,,Post-3rd (8+ Weeks),18-Jan-22,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,80,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,52,3,January,2022,,,145,,Completed,250-999,N/A,39,Scheduled,139,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,6488,Positive,Elderly,,Post-4th,14-Mar-22,baseline,01-Mar-21,Pfizer,09-Apr-21,Pfizer,26-Aug-21,Pfizer,06-Feb-22,Pfizer,,,80,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1062,4,March,2022,,,,36,Completed,,N/A,39,Scheduled,139,Delayed,164,,,,36,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),11-Sep-21,baseline,16-May-21,Pfizer,02-Jul-21,Pfizer,07-Jun-22,Pfizer,,,,,46,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,27,1,September,2021,,71,,,Completed,50-249,N/A,47,Scheduled,340,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.05,Negative,80000,Positive,Adult,,Post-1st,17-Jun-21,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,62,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,11,1,June,2021,89,,,,Completed,50-249,N/A,88,Delayed,145,Delayed,31,89,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.05,Negative,640,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,62,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,36,2,August,2021,,50,,,Completed,250-999,N/A,88,Delayed,145,Delayed,31,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.1,Negative,4902,Positive,Adult,,Post-4th,29-Dec-21,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,4864,3,December,2021,,,,20,Completed,10000+,N/A,88,Delayed,145,Delayed,31,,,,20,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.1,Negative,1468,Positive,Adult,,Post-5th,02-May-22,baseline,20-Mar-21,AstraZeneca,16-Jun-21,AstraZeneca,08-Nov-21,Pfizer,09-Dec-21,Pfizer ,23-Apr-22,Pfizer,63,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,5294,4,May,2022,,,,,Completed,10000+,N/A,88,Delayed,145,Delayed,31,,,,,9
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,139,Positive,Adult,52,Post-2nd (1-8 Weeks),17-Jun-21,Post Vaccine covid,07-Apr-21,Pfizer,07-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,337,1,June,2021,,10,,,Completed,1000-4999,52 Days Before Collection Days After Collection,61,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,10160,Positive,Adult,217,Post-2nd (8+ Weeks),29-Nov-21,Post Vaccine covid,07-Apr-21,Pfizer,07-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,35,2,November,2021,,175,,,Completed,50-249,217 Days Before Collection Days After Collection,61,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,16406,Positive,Adult,393,Post-3rd (8+ Weeks),24-May-22,Post Vaccine covid,07-Apr-21,Pfizer,07-Jun-21,Pfizer,16-Dec-21,Pfizer,,,,,41,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,533,3,May,2022,,,159,,Completed,1000-4999,393 Days Before Collection Days Before Collection,61,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.31,Negative,31010,Positive,Adult,38,Pre-1st,15-Jun-21,covid,16-Jun-21,Pfizer,03-Sep-21,Pfizer,,,,,,,21,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,1,June,2021,,,,,Completed,50-249,N/A,79,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.31,Negative,80000,Positive,Adult,117,Post-1st,02-Sep-21,covid,16-Jun-21,Pfizer,03-Sep-21,Pfizer,,,,,,,21,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,955,2,September,2021,78,,,,Completed,,N/A,79,Delayed,,Delayed,,78,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.68,Negative,8781,Positive,Adult,265,Post-2nd (8+ Weeks),28-Jan-22,covid,16-Jun-21,Pfizer,03-Sep-21,Pfizer,,,,,,,22,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,555,3,January,2022,,147,,,Completed,1000-4999,N/A,79,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,195,Positive,Adult,,Post-1st,15-Jun-21,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,41,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,63,1,June,2021,53,,,,Completed,250-999,N/A,61,Delayed,162,Delayed,,53,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.52,Negative,485,Positive,Adult,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,41,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,2,July,2021,,15,,,Completed,10000+,N/A,61,Delayed,162,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,39669,Positive,Adult,,Post-2nd (8+ Weeks),01-Nov-21,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,504,3,November,2021,,131,,,Completed,1000-4999,N/A,61,Delayed,162,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,78,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4153,4,January,2022,,,35,,Completed,10000+,N/A,61,Delayed,162,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,12789,Positive,Adult,,Post-3rd (8+ Weeks),28-Apr-22,baseline,23-Apr-21,Pfizer,23-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1172,5,April,2022,,,147,,Completed,,N/A,61,Delayed,162,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.35,Negative,5467,Positive,Adult,,Post-1st,30-Jun-21,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,1,June,2021,32,,,,Completed,50-249,N/A,39,Scheduled,168,Delayed,,32,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.35,Negative,48659,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1539,2,August,2021,,29,,,Completed,10000+,N/A,39,Scheduled,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),17-Nov-21,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,53,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,169,3,November,2021,,133,,,Completed,1000-4999,N/A,39,Scheduled,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,41323,Positive,Adult,,Post-3rd (1-8 Weeks),10-Feb-22,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,54,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2445,4,February,2022,,,50,,Completed,10000+,N/A,39,Scheduled,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,3430,Positive,Adult,,Post-3rd (8+ Weeks),06-May-22,baseline,29-May-21,Pfizer,07-Jul-21,Pfizer,22-Dec-21,Pfizer,,,,,54,50-59,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1269,5,May,2022,,,135,,Completed,,N/A,39,Scheduled,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,61940,Positive,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,11-Apr-21,Pfizer,19-Jun-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,27,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1106,1,July,2021,,17,,,Completed,,N/A,69,Delayed,96,Scheduled,201,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,29326,Positive,Adult,-294,Post-2nd (1-8 Weeks),16-Jun-21,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,936,1,June,2021,,19,,,Completed,,N/A,37,Scheduled,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,80000,Positive,Adult,-197,Post-2nd (8+ Weeks),21-Sep-21,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,2,September,2021,,116,,,Completed,50-249,N/A,37,Scheduled,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,80000,Positive,Adult,-111,Post-3rd (1-8 Weeks),16-Dec-21,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,273,3,December,2021,,,54,,Completed,1000-4999,N/A,37,Scheduled,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,12,Negative,Adult,-34,Post-3rd (8+ Weeks),03-Mar-22,baseline,21-Apr-21,Moderna,28-May-21,Moderna,23-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,46,4,March,2022,,,131,,Completed,250-999,N/A,37,Scheduled,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,200,Positive,Adult,,Post-3rd (8+ Weeks),07-Apr-22,baseline,10-Apr-21,Pfizer,07-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,57,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,547,2,April,2022,,,115,,Completed,1000-4999,N/A,58,Delayed,189,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,,0.02,Negative,36757,Positive,Adult,,Post-2nd (8+ Weeks),10-Aug-21,baseline,30-Mar-21,Pfizer,03-Jun-21,Pfizer,20-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,0,0,0,0,0,0,0,31,1,August,2021,,68,,,Completed,50-249,N/A,65,Delayed,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Corticosteroids,,0.02,Negative,714,Positive,Adult,,Post-3rd (8+ Weeks),03-Jun-22,baseline,30-Mar-21,Pfizer,03-Jun-21,Pfizer,20-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,0,0,0,0,0,0,0,123,2,June,2022,,,134,,Completed,250-999,N/A,65,Delayed,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,9005,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,03-Sep-21,Pfizer,07-Feb-22,Moderna,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1075,1,June,2021,,19,,,Completed,,N/A,65,Delayed,84,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,2371,Positive,Adult,,Post-3rd (1-8 Weeks),24-Sep-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,03-Sep-21,Pfizer,07-Feb-22,Moderna,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,8246,2,September,2021,,,21,,Completed,10000+,N/A,65,Delayed,84,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,1494,Positive,Adult,,Post-4th,03-Mar-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,03-Sep-21,Pfizer,07-Feb-22,Moderna,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,6493,3,March,2022,,,,24,Completed,10000+,N/A,65,Delayed,84,Scheduled,157,,,,24,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.46,Negative,12844,Positive,Adult,,Post-2nd (8+ Weeks),16-Aug-21,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,384,1,August,2021,,60,,,Completed,1000-4999,N/A,57,Delayed,218,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,110,Positive,Adult,-199,Post-2nd (8+ Weeks),23-Jul-21,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,115,1,July,2021,,70,,,Completed,250-999,N/A,42,Scheduled,126,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,4028,Positive,Adult,-157,Post-2nd (8+ Weeks),03-Sep-21,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,51,2,September,2021,,112,,,Completed,250-999,N/A,42,Scheduled,126,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.24,Negative,93,Positive,Adult,-69,Post-3rd (8+ Weeks),30-Nov-21,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1028,3,November,2021,,,74,,Completed,,N/A,42,Scheduled,126,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,11065,Positive,Adult,11,Post-3rd (8+ Weeks),18-Feb-22,Post Vaccine covid,02-Apr-21,Pfizer,14-May-21,Pfizer,17-Sep-21,Pfizer,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,174,4,February,2022,,,154,,Completed,1000-4999,N/A,42,Scheduled,126,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.06,Negative,16667,Positive,Elderly,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,02-May-21,Moderna,30-Jun-21,Moderna,07-Jan-22,Moderna,,,,,64,60-69,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4810,1,July,2021,,20,,,Completed,10000+,N/A,59,Delayed,191,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.69,Negative,17117,Positive,Elderly,,Post-3rd (8+ Weeks),11-May-22,baseline,02-May-21,Moderna,30-Jun-21,Moderna,07-Jan-22,Moderna,,,,,65,60-69,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4461,2,May,2022,,,124,,Completed,10000+,N/A,59,Delayed,191,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,148,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,21-Apr-21,Pfizer,27-May-21,Pfizer,16-Nov-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1199,1,July,2021,,43,,,Completed,,N/A,36,Scheduled,173,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.07,Negative,9914,Positive,Adult,,Post-2nd (1-8 Weeks),04-Jun-21,baseline,29-Mar-21,Pfizer,20-May-21,Pfizer,02-Sep-21,Pfizer,,,,,45,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2153,1,June,2021,,15,,,Completed,10000+,N/A,52,Scheduled,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.24,Negative,5941,Positive,Adult,,Post-3rd (8+ Weeks),25-Nov-21,baseline,29-Mar-21,Pfizer,20-May-21,Pfizer,02-Sep-21,Pfizer,,,,,46,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1751,2,November,2021,,,84,,Completed,10000+,N/A,52,Scheduled,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.1,Negative,10406,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,29-Mar-21,Pfizer,20-May-21,Pfizer,02-Sep-21,Pfizer,,,,,46,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1246,3,January,2022,,,140,,Completed,,N/A,52,Scheduled,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.07,Negative,980,Positive,Adult,-226,Post-2nd (1-8 Weeks),18-Jun-21,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,556,1,June,2021,,20,,,Completed,1000-4999,N/A,40,Scheduled,186,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.32,Negative,7161,Positive,Adult,-82,Post-2nd (8+ Weeks),09-Nov-21,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,85,2,November,2021,,164,,,Completed,250-999,N/A,40,Scheduled,186,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,40116,Positive,Adult,-41,Post-3rd (1-8 Weeks),20-Dec-21,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2634,3,December,2021,,,19,,Completed,10000+,N/A,40,Scheduled,186,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.1,Negative,19766,Positive,Adult,79,Post-3rd (8+ Weeks),19-Apr-22,Post Vaccine covid,19-Apr-21,Pfizer,29-May-21,Pfizer,01-Dec-21,Pfizer,,,,,41,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,4,April,2022,,,139,,Completed,10000+,N/A,40,Scheduled,186,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.11,Negative,45607,Positive,Elderly,,Post-2nd (8+ Weeks),20-Jul-21,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,105,1,July,2021,,76,,,Completed,250-999,N/A,36,Scheduled,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.16,Negative,31079,Positive,Elderly,,Post-2nd (8+ Weeks),30-Sep-21,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,2,September,2021,,148,,,Completed,250-999,N/A,36,Scheduled,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.16,Negative,11447,Positive,Elderly,,Post-3rd (1-8 Weeks),13-Dec-21,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,968,3,December,2021,,,38,,Completed,,N/A,36,Scheduled,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.08,Positive,10002,Positive,Elderly,,Post-3rd (8+ Weeks),04-Apr-22,baseline,30-Mar-21,Pfizer,05-May-21,Pfizer,05-Nov-21,Pfizer,,,,,73,70+,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,392,4,April,2022,,,150,,Completed,1000-4999,N/A,36,Scheduled,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,1.57,Positive,25891,Positive,Adult,,Post-3rd (1-8 Weeks),22-Jan-22,baseline,12-Apr-21,Moderna,05-Jun-21,Moderna,28-Dec-21,Pfizer,22-Jul-22,Pfizer,,,57,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,7794,2,January,2022,,,25,,Completed,10000+,N/A,54,Scheduled,206,Delayed,206,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.19,Negative,117,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,20-Apr-21,Moderna,21-Jun-21,Moderna,12-Feb-22,Moderna,,,,,61,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2984,1,July,2021,,23,,,Completed,10000+,N/A,62,Delayed,236,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,9581,Positive,Adult,,Post-2nd (8+ Weeks),23-Dec-21,baseline,20-Apr-21,Moderna,21-Jun-21,Moderna,12-Feb-22,Moderna,,,,,62,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,425,2,December,2021,,185,,,Completed,1000-4999,N/A,62,Delayed,236,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,450,Positive,Adult,,Post-3rd (1-8 Weeks),28-Feb-22,baseline,20-Apr-21,Moderna,21-Jun-21,Moderna,12-Feb-22,Moderna,,,,,62,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,February,2022,,,16,,Completed,10000+,N/A,62,Delayed,236,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,22989,Positive,Elderly,,Post-3rd (1-8 Weeks),17-Sep-21,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,73,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,,2,September,2021,,,15,,Processed,,N/A,29,Scheduled,124,Delayed,193,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.61,Negative,1672,Positive,Elderly,,Post-3rd (8+ Weeks),23-Feb-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,February,2022,,,174,,Completed,0-49,N/A,29,Scheduled,124,Delayed,193,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,16757,Positive,Elderly,,Post-4th,11-Jul-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,14-Mar-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,July,2022,,,,119,Completed,0-49,N/A,29,Scheduled,124,Delayed,193,,,,119,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.4,Negative,1423,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,98,1,July,2021,,38,,,Completed,250-999,N/A,75,Delayed,180,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,0,Negative,Adult,,Post-2nd (8+ Weeks),02-Dec-21,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,2,December,2021,,172,,,Completed,50-249,N/A,75,Delayed,180,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,14619,Positive,Adult,,Post-3rd (8+ Weeks),24-Feb-22,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,337,3,February,2022,,,76,,Completed,1000-4999,N/A,75,Delayed,180,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,51122,Positive,Adult,,Post-3rd (8+ Weeks),16-May-22,baseline,30-Mar-21,Pfizer,13-Jun-21,Pfizer,10-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,264,4,May,2022,,,157,,Completed,1000-4999,N/A,75,Delayed,180,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,27712,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jun-21,baseline,22-Mar-21,AstraZeneca,10-Jun-21,Pfizer,15-Dec-21,Pfizer,,,,,61,60-69,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1084,1,June,2021,,19,,,Completed,,N/A,80,Delayed,188,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,0.03,Negative,6100,Positive,Elderly,,Post-1st,15-Jun-21,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,71,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,June,2021,31,,,,Completed,0-49,N/A,60,Delayed,,Delayed,,31,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,0.05,Negative,20944,Positive,Elderly,,Post-2nd (1-8 Weeks),10-Aug-21,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,71,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,August,2021,,27,,,Processed,,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,0.05,Negative,,,Elderly,,Post-2nd (8+ Weeks),30-Nov-21,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,71,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,3,November,2021,,139,,,Completed,0-49,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,,,0.04,Negative,10390,Positive,Elderly,,Post-2nd (8+ Weeks),14-Jul-22,baseline,15-May-21,Pfizer,14-Jul-21,Pfizer,,,,,,,72,70+,1,1,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,July,2022,,365,,,Completed,0-49,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.49,Negative,2075,Positive,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,20-Apr-21,Moderna,03-Jun-21,Moderna,20-Oct-21,Moderna,,,,,36,30-39,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,665,1,June,2021,,22,,,Completed,1000-4999,N/A,44,Scheduled,139,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.09,Negative,6868,Positive,Adult,,Post-3rd (8+ Weeks),25-Mar-22,baseline,20-Apr-21,Moderna,03-Jun-21,Moderna,20-Oct-21,Moderna,,,,,37,30-39,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,3600,2,March,2022,,,156,,Completed,10000+,N/A,44,Scheduled,139,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,14007,Positive,Adult,,Post-2nd (8+ Weeks),30-Jun-21,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,15,1,June,2021,,60,,,Completed,50-249,N/A,29,Scheduled,124,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.78,Positive,56,Positive,Adult,,Post-3rd (1-8 Weeks),22-Sep-21,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,181,2,September,2021,,,20,,Completed,1000-4999,N/A,29,Scheduled,124,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,1333,Positive,Adult,,Post-3rd (8+ Weeks),24-Jan-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,32,3,January,2022,,,144,,Completed,50-249,N/A,29,Scheduled,124,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.35,Negative,546,Positive,Adult,,Post-4th,19-Mar-22,baseline,02-Apr-21,Pfizer,01-May-21,Pfizer,02-Sep-21,Pfizer,09-Feb-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,56,4,March,2022,,,,38,Completed,250-999,N/A,29,Scheduled,124,Delayed,160,,,,38,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,67933,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,02-May-21,Pfizer,12-Jul-21,Moderna,,,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3895,1,July,2021,,14,,,Completed,10000+,N/A,71,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,1306,Positive,Adult,,Post-2nd (8+ Weeks),10-Jan-22,baseline,02-May-21,Pfizer,12-Jul-21,Moderna,,,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,303,2,January,2022,,182,,,Completed,1000-4999,N/A,71,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.52,Negative,28320,Positive,Adult,,Post-2nd (8+ Weeks),15-Jul-21,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,321,1,July,2021,,60,,,Completed,1000-4999,N/A,39,Scheduled,108,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,80000,Positive,Adult,,Post-3rd (1-8 Weeks),15-Sep-21,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1732,2,September,2021,,,14,,Completed,10000+,N/A,39,Scheduled,108,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.12,Negative,1271,Positive,Adult,,Post-3rd (8+ Weeks),12-Jan-22,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,294,3,January,2022,,,133,,Completed,1000-4999,N/A,39,Scheduled,108,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.12,Negative,112,Positive,Adult,,Post-3rd (8+ Weeks),14-Jan-22,baseline,07-Apr-21,Pfizer,16-May-21,Pfizer,01-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,269,4,January,2022,,,135,,Completed,1000-4999,N/A,39,Scheduled,108,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.09,Negative,2177,Positive,Adult,,Post-2nd (1-8 Weeks),09-Sep-21,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1104,2,September,2021,,39,,,Completed,,N/A,101,Delayed,65,Scheduled,162,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.09,Negative,109,Positive,Adult,,Post-3rd (1-8 Weeks),05-Nov-21,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1734,3,November,2021,,,31,,Completed,10000+,N/A,101,Delayed,65,Scheduled,162,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,5.88,Positive,433,Positive,Adult,,Post-3rd (8+ Weeks),23-Feb-22,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,459,4,February,2022,,,141,,Completed,1000-4999,N/A,101,Delayed,65,Scheduled,162,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,5.88,Positive,40000,Positive,Adult,,Post-4th,15-Jun-22,baseline,22-Apr-21,Pfizer,01-Aug-21,Pfizer,05-Oct-21,Pfizer,16-Mar-22,Pfizer,,,23,18-29,0,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,1,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,2040,5,June,2022,,,,91,Completed,10000+,N/A,101,Delayed,65,Scheduled,162,,,,91,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.03,Negative,3676,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,19-Apr-21,Moderna,14-Jun-21,Moderna,28-Sep-21,Moderna,,,,,40,40-49,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,344,1,July,2021,,38,,,Completed,1000-4999,N/A,56,Scheduled,106,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.03,Negative,22465,Positive,Adult,,Post-3rd (1-8 Weeks),29-Oct-21,baseline,19-Apr-21,Moderna,14-Jun-21,Moderna,28-Sep-21,Moderna,,,,,41,40-49,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1381,2,October,2021,,,31,,Completed,,N/A,56,Scheduled,106,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.05,Negative,16237,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,19-Apr-21,Moderna,14-Jun-21,Moderna,28-Sep-21,Moderna,,,,,41,40-49,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,218,3,February,2022,,,133,,Completed,1000-4999,N/A,56,Scheduled,106,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,,,,,0.14,Negative,15371,Positive,Adult,-98,,24-Sep-21,Baseline to COVID,,,,,,,,,,,41,40-49,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,September,2021,,,,,Processed,,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,1.16,Positive,965,Positive,Adult,,Post-1st,19-Aug-21,baseline,27-Jul-21,Pfizer,24-Aug-21,Pfizer,,,,,,,62,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,151,1,August,2021,23,,,,Completed,1000-4999,N/A,28,Scheduled,,Delayed,,23,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,80000,Positive,Adult,,Post-2nd (1-8 Weeks),16-Sep-21,baseline,27-Jul-21,Pfizer,24-Aug-21,Pfizer,,,,,,,62,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6896,2,September,2021,,23,,,Completed,10000+,N/A,28,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.04,Negative,11021,Positive,Adult,,Post-2nd (8+ Weeks),27-Jan-22,baseline,27-Jul-21,Pfizer,24-Aug-21,Pfizer,,,,,,,63,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,602,3,January,2022,,156,,,Completed,1000-4999,N/A,28,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,6723,Positive,Adult,-135,Post-2nd (8+ Weeks),14-Sep-21,Post Vaccine covid,17-Mar-21,AstraZeneca,08-Jun-21,Pfizer,16-Oct-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,125,1,September,2021,,98,,,Completed,250-999,N/A,83,Delayed,130,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,983,Positive,Adult,-84,Post-3rd (1-8 Weeks),04-Nov-21,Post Vaccine covid,17-Mar-21,AstraZeneca,08-Jun-21,Pfizer,16-Oct-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,885,2,November,2021,,,19,,Completed,,N/A,83,Delayed,130,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,40000,Positive,Adult,40,Post-3rd (8+ Weeks),08-Mar-22,Post Vaccine covid,17-Mar-21,AstraZeneca,08-Jun-21,Pfizer,16-Oct-21,Pfizer,,,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,March,2022,,,143,,Completed,10000+,N/A,83,Delayed,130,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,6333,Positive,Adult,,Post-2nd (8+ Weeks),03-Sep-21,baseline,06-May-21,Pfizer,27-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,336,1,September,2021,,68,,,Completed,1000-4999,N/A,52,Scheduled,188,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,8,Negative,Adult,,Post-3rd (8+ Weeks),28-Feb-22,baseline,06-May-21,Pfizer,27-Jun-21,Pfizer,01-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3010,2,February,2022,,,58,,Completed,10000+,N/A,52,Scheduled,188,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.06,Negative,324,Positive,Adult,,Post-3rd (1-8 Weeks),12-Nov-21,baseline,12-May-21,Pfizer,24-Jul-21,Pfizer,19-Oct-21,Pfizer,19-Apr-22,Pfizer,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,894,2,November,2021,,,24,,Completed,,N/A,73,Delayed,87,Scheduled,182,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,3.77,Positive,9513,Positive,Adult,,Post-3rd (8+ Weeks),07-Apr-22,baseline,12-May-21,Pfizer,24-Jul-21,Pfizer,19-Oct-21,Pfizer,19-Apr-22,Pfizer,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,106,3,April,2022,,,170,,Completed,250-999,N/A,73,Delayed,87,Scheduled,182,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Corticosteroids,Combination Therapy,Combination Therapy,0.05,Negative,40000,Positive,Adult,,Post-4th,12-May-22,baseline,12-May-21,Pfizer,24-Jul-21,Pfizer,19-Oct-21,Pfizer,19-Apr-22,Pfizer,,,31,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,841,4,May,2022,,,,23,Completed,,N/A,73,Delayed,87,Scheduled,182,,,,23,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.09,Negative,37297,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,22-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Sep-21,Pfizer,04-Apr-22,Pfizer,,,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1001,1,September,2021,,83,,,Completed,,N/A,50,Scheduled,110,Scheduled,187,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.09,Negative,40000,Positive,Adult,,Post-3rd (1-8 Weeks),19-Oct-21,baseline,22-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Sep-21,Pfizer,04-Apr-22,Pfizer,,,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,8001,2,October,2021,,,20,,Completed,10000+,N/A,50,Scheduled,110,Scheduled,187,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,4.21,Positive,40000,Positive,Adult,,Post-4th,27-Apr-22,baseline,22-Apr-21,Pfizer,11-Jun-21,Pfizer,29-Sep-21,Pfizer,04-Apr-22,Pfizer,,,57,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5701,3,April,2022,,,,23,Completed,10000+,N/A,50,Scheduled,110,Scheduled,187,,,,23,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,4.21,Positive,900,Positive,Adult,62,Post-3rd (1-8 Weeks),01-Nov-21,Post Vaccine covid,28-Apr-21,Pfizer,06-Jun-21,Pfizer,30-Sep-21,Pfizer,,,,,23,18-29,1,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5696,2,November,2021,,,32,,Completed,10000+,N/A,39,Scheduled,116,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.39,Negative,34,Negative,Adult,181,Post-3rd (8+ Weeks),28-Feb-22,Post Vaccine covid,28-Apr-21,Pfizer,06-Jun-21,Pfizer,30-Sep-21,Pfizer,,,,,23,18-29,1,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5514,3,February,2022,,,151,,Completed,10000+,N/A,39,Scheduled,116,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.21,Negative,151,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,26-Apr-21,Moderna,14-Jul-21,Moderna,14-Jan-22,,,,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,265,1,September,2021,,63,,,Completed,1000-4999,N/A,79,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.21,Negative,6023,Positive,Adult,36,Post-2nd (8+ Weeks),16-Nov-21,Post Vaccine covid,09-Apr-21,Pfizer,12-Jun-21,Pfizer,12-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,11360,1,November,2021,,157,,,Completed,10000+,N/A,64,Delayed,214,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,38645,Positive,Adult,,Post-3rd (8+ Weeks),27-Jan-22,baseline,01-May-21,Pfizer,22-Jul-21,Pfizer,29-Oct-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5800,1,January,2022,,,90,,Completed,10000+,N/A,82,Delayed,99,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,10169,Positive,Elderly,,Post-1st,11-May-21,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,68,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,52,1,May,2021,38,,,,Completed,250-999,N/A,52,Scheduled,111,Scheduled,195,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.24,Negative,6975,Positive,Elderly,,Post-2nd (1-8 Weeks),11-Jun-21,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,68,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,3398,2,June,2021,,17,,,Completed,10000+,N/A,52,Scheduled,111,Scheduled,195,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,4128,Positive,Elderly,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,68,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5345,3,September,2021,,,16,,Completed,10000+,N/A,52,Scheduled,111,Scheduled,195,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,80000,Positive,Elderly,,Post-3rd (8+ Weeks),13-Jan-22,baseline,03-Apr-21,Pfizer,25-May-21,Pfizer,13-Sep-21,Pfizer,27-Mar-22,Pfizer,,,69,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,597,4,January,2022,,,122,,Completed,1000-4999,N/A,52,Scheduled,111,Scheduled,195,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,5525,Positive,Adult,-357,Post-1st,04-May-21,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,48,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,17,1,May,2021,29,,,,Completed,50-249,N/A,59,Delayed,93,Scheduled,153,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,40000,Positive,Adult,-306,Post-2nd (1-8 Weeks),24-Jun-21,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,48,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,93,2,June,2021,,21,,,Completed,250-999,N/A,59,Delayed,93,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.17,Negative,1913,Positive,Adult,-94,Post-3rd (8+ Weeks),22-Jan-22,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,49,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,9,3,January,2022,,,140,,Completed,50-249,N/A,59,Delayed,93,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,23,Negative,Adult,55,Post-4th,20-Jun-22,baseline,05-Apr-21,Moderna,03-Jun-21,Moderna,04-Sep-21,Moderna,04-Feb-22,Moderna,,,49,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,1,572,5,June,2022,,,,136,Completed,1000-4999,N/A,59,Delayed,93,Scheduled,153,,,,136,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,250,Positive,Adult,30,Pre-1st,06-Apr-21,Baseline to COVID,22-Apr-21,Pfizer,27-May-21,Pfizer,27-Sep-21,Pfizer,06-Jun-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,91,1,April,2021,,,,,Completed,250-999,N/A,35,Scheduled,123,Delayed,252,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,80000,Positive,Adult,395,Post-3rd (8+ Weeks),06-Apr-22,Baseline to COVID,22-Apr-21,Pfizer,27-May-21,Pfizer,27-Sep-21,Pfizer,06-Jun-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3443,2,April,2022,,,191,,Completed,10000+,N/A,35,Scheduled,123,Delayed,252,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,10572,Positive,Adult,,Post-1st,10-Sep-21,baseline,17-Jun-21,Moderna,29-Sep-21,Moderna,,,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,138,1,September,2021,85,,,,Completed,250-999,N/A,104,Delayed,,Delayed,,85,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.14,Negative,5240,Positive,Adult,,Post-2nd (1-8 Weeks),08-Oct-21,baseline,17-Jun-21,Moderna,29-Sep-21,Moderna,,,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4281,2,October,2021,,9,,,Completed,10000+,N/A,104,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.08,Negative,90,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,,,,,,,31,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1654,1,July,2021,,30,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.08,Negative,21748,Positive,Adult,-259,Post-1st,07-May-21,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,97,1,May,2021,34,,,,Completed,250-999,N/A,35,Scheduled,134,Delayed,268,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,4.65,Positive,20380,Positive,Adult,-135,Post-2nd (8+ Weeks),08-Sep-21,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,500,3,September,2021,,123,,,Completed,1000-4999,N/A,35,Scheduled,134,Delayed,268,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.08,Negative,24684,Positive,Adult,-4,Post-3rd (8+ Weeks),17-Jan-22,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1010,4,January,2022,,,120,,Completed,,N/A,35,Scheduled,134,Delayed,268,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.12,Negative,31029,Positive,Adult,18,Post-3rd (8+ Weeks),08-Feb-22,baseline,03-Apr-21,Pfizer,08-May-21,Pfizer,19-Sep-21,Pfizer,14-Jun-22,Pfizer,,,42,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5538,5,February,2022,,,142,,Completed,10000+,N/A,35,Scheduled,134,Delayed,268,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.12,Negative,2464,Positive,Adult,,Post-1st,07-Jun-21,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,85,1,June,2021,55,,,,Completed,250-999,N/A,68,Delayed,166,Delayed,,55,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,59991,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3001,2,August,2021,,61,,,Completed,10000+,N/A,68,Delayed,166,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.09,Negative,17803,Positive,Adult,,Post-2nd (8+ Weeks),01-Dec-21,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,660,3,December,2021,,164,,,Completed,1000-4999,N/A,68,Delayed,166,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,982,Positive,Adult,,Post-3rd (8+ Weeks),15-Mar-22,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1400,4,March,2022,,,102,,Completed,,N/A,68,Delayed,166,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.08,Negative,19260,Positive,Adult,,Post-3rd (8+ Weeks),08-Jun-22,baseline,13-Apr-21,Moderna,20-Jun-21,Moderna,03-Dec-21,Moderna,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1579,5,June,2022,,,187,,Completed,10000+,N/A,68,Delayed,166,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,,0.08,Negative,886,Positive,Adult,,Post-2nd (1-8 Weeks),07-Jul-21,baseline,19-Apr-21,Pfizer,15-Jun-21,Pfizer,09-Feb-22,Pfizer,,,,,53,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,861,1,July,2021,,22,,,Completed,,N/A,57,Delayed,239,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,,0.11,Negative,25010,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,19-Apr-21,Pfizer,15-Jun-21,Pfizer,09-Feb-22,Pfizer,,,,,53,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,64,2,December,2021,,190,,,Completed,250-999,N/A,57,Delayed,239,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.11,Negative,566,Positive,Adult,,Post-1st,30-Mar-21,baseline,23-Feb-21,Pfizer,05-Apr-21,Pfizer,07-Dec-21,Pfizer,,,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,88,1,March,2021,35,,,,Completed,250-999,N/A,41,Scheduled,246,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,963,Positive,Adult,,Post-2nd (1-8 Weeks),26-May-21,baseline,23-Feb-21,Pfizer,05-Apr-21,Pfizer,07-Dec-21,Pfizer,,,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,607,2,May,2021,,51,,,Completed,1000-4999,N/A,41,Scheduled,246,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,322,Positive,Adult,,Post-3rd (8+ Weeks),14-Mar-22,baseline,23-Feb-21,Pfizer,05-Apr-21,Pfizer,07-Dec-21,Pfizer,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,281,4,March,2022,,,97,,Completed,1000-4999,N/A,41,Scheduled,246,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.29,Negative,12636,Positive,Adult,,Post-2nd (1-8 Weeks),04-Sep-21,baseline,18-Jun-21,Pfizer,20-Jul-21,Pfizer,29-Oct-21,Pfizer,31-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,49,1,September,2021,,46,,,Completed,250-999,N/A,32,Scheduled,101,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,2864,Positive,Adult,,Post-3rd (8+ Weeks),15-Jan-22,baseline,18-Jun-21,Pfizer,20-Jul-21,Pfizer,29-Oct-21,Pfizer,31-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,88,2,January,2022,,,78,,Completed,250-999,N/A,32,Scheduled,101,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,953,Positive,Adult,,Post-4th,09-Apr-22,baseline,18-Jun-21,Pfizer,20-Jul-21,Pfizer,29-Oct-21,Pfizer,31-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,647,3,April,2022,,,,9,Completed,1000-4999,N/A,32,Scheduled,101,Scheduled,153,,,,9,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,5810,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,22-Apr-21,Pfizer,17-Jun-21,Pfizer,12-Oct-21,Pfizer,05-May-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,150,1,July,2021,,18,,,Completed,1000-4999,N/A,56,Scheduled,117,Scheduled,205,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,483,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,22-Apr-21,Pfizer,17-Jun-21,Pfizer,12-Oct-21,Pfizer,05-May-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,608,2,November,2021,,,22,,Completed,1000-4999,N/A,56,Scheduled,117,Scheduled,205,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,344,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,22-Apr-21,Pfizer,17-Jun-21,Pfizer,12-Oct-21,Pfizer,05-May-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,3,February,2022,,,125,,Completed,250-999,N/A,56,Scheduled,117,Scheduled,205,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.81,Positive,246,Positive,Adult,,Post-2nd (8+ Weeks),29-Nov-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,09-Dec-21,Pfizer,09-Dec-21,Pfizer ,,,34,30-39,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,98,1,November,2021,,244,,,Completed,250-999,N/A,38,Scheduled,254,Delayed,0,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.07,Negative,7074,Positive,Adult,,Post-4th,10-Mar-22,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,09-Dec-21,Pfizer,09-Dec-21,Pfizer ,,,35,30-39,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1797,2,March,2022,,,,91,Completed,10000+,N/A,38,Scheduled,254,Delayed,0,,,,91,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,,,Adult,,Post-2nd (1-8 Weeks),22-Jun-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,100,1,June,2021,,41,,,Completed,250-999,N/A,33,Scheduled,133,Delayed,197,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,3486,Positive,Adult,,Post-2nd (8+ Weeks),17-Aug-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,72,2,August,2021,,97,,,Completed,250-999,N/A,33,Scheduled,133,Delayed,197,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,791,Positive,Adult,,Post-3rd (8+ Weeks),07-Dec-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,551,3,December,2021,,,76,,Completed,1000-4999,N/A,33,Scheduled,133,Delayed,197,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,2094,Positive,Adult,,Post-4th,24-May-22,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,22-Sep-21,Pfizer,07-Apr-22,Pfizer,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,920,4,May,2022,,,,47,Completed,,N/A,33,Scheduled,133,Delayed,197,,,,47,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.13,Negative,10096,Positive,Elderly,-344,Post-1st,03-May-21,baseline,27-Mar-21,Pfizer,14-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,30,1,May,2021,37,,,,Completed,50-249,N/A,79,Delayed,206,Delayed,,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,2,Negative,Elderly,-111,Post-2nd (8+ Weeks),22-Dec-21,baseline,27-Mar-21,Pfizer,14-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,153,3,December,2021,,191,,,Completed,1000-4999,N/A,79,Delayed,206,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,5111,Positive,Adult,-55,Post-2nd (1-8 Weeks),30-Jun-21,Post Vaccine covid,08-Apr-21,Pfizer,15-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,30,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,782,1,June,2021,,15,,,Completed,,N/A,68,Delayed,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,52521,Positive,Adult,-249,Post-2nd (1-8 Weeks),12-May-21,Post Vaccine covid,07-Apr-21,Pfizer,01-May-21,Pfizer,30-Sep-21,Pfizer,06-May-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1299,1,May,2021,,11,,,Completed,,N/A,24,Scheduled,152,Delayed,218,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,20064,Positive,Adult,40,Post-3rd (8+ Weeks),25-Feb-22,Post Vaccine covid,07-Apr-21,Pfizer,01-May-21,Pfizer,30-Sep-21,Pfizer,06-May-22,Pfizer,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5868,3,February,2022,,,148,,Completed,10000+,N/A,24,Scheduled,152,Delayed,218,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,757,Positive,Adult,,Post-1st,18-May-21,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,89,1,May,2021,27,,,,Completed,250-999,N/A,57,Delayed,228,Delayed,,27,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,61528,Positive,Adult,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4047,2,July,2021,,33,,,Completed,10000+,N/A,57,Delayed,228,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,14685,Positive,Adult,,Post-2nd (8+ Weeks),04-Jan-22,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,242,3,January,2022,,201,,,Completed,1000-4999,N/A,57,Delayed,228,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,461,Positive,Adult,,Post-3rd (8+ Weeks),02-Jun-22,baseline,21-Apr-21,Pfizer,17-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2814,4,June,2022,,,122,,Completed,10000+,N/A,57,Delayed,228,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.19,Negative,5836,Positive,Adult,-220,Post-2nd (1-8 Weeks),21-Jun-21,Post Vaccine covid,14-Apr-21,Moderna,28-May-21,Moderna,21-Oct-21,Moderna,,,,,42,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2448,1,June,2021,,24,,,Completed,10000+,N/A,44,Scheduled,146,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.19,Negative,6765,Positive,Adult,-71,Post-3rd (1-8 Weeks),17-Nov-21,Post Vaccine covid,14-Apr-21,Moderna,28-May-21,Moderna,21-Oct-21,Moderna,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7131,2,November,2021,,,27,,Completed,10000+,N/A,44,Scheduled,146,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,5534,Positive,Adult,41,Post-3rd (8+ Weeks),09-Mar-22,Post Vaccine covid,14-Apr-21,Moderna,28-May-21,Moderna,21-Oct-21,Moderna,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4164,3,March,2022,,,139,,Completed,10000+,N/A,44,Scheduled,146,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,47,Negative,Elderly,,Post-2nd (1-8 Weeks),26-Jul-21,New biologic/Tofacitinib start,13-Apr-21,Pfizer,26-Jun-21,Pfizer,26-Oct-21,Pfizer,28-Mar-22,Pfizer ,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,349,1,July,2021,,30,,,Completed,1000-4999,N/A,74,Delayed,122,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,3907,Positive,Elderly,,Post-3rd (8+ Weeks),10-Jan-22,New biologic/Tofacitinib start,13-Apr-21,Pfizer,26-Jun-21,Pfizer,26-Oct-21,Pfizer,28-Mar-22,Pfizer ,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,193,2,January,2022,,,76,,Completed,1000-4999,N/A,74,Delayed,122,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,1113,Positive,Adult,18,Pre-1st,25-May-21,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,1,May,2021,,,,,Completed,50-249,N/A,40,Scheduled,216,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,39004,Positive,Adult,59,Post-1st,05-Jul-21,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1478,2,July,2021,40,,,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2403,Positive,Adult,82,Post-2nd (1-8 Weeks),28-Jul-21,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2380,3,July,2021,,23,,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,185,Positive,Adult,294,Post-3rd (1-8 Weeks),25-Feb-22,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2250,4,February,2022,,,19,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.34,Negative,14568,Positive,Adult,405,Post-3rd (8+ Weeks),16-Jun-22,Baseline to COVID,26-May-21,Moderna,05-Jul-21,Moderna,06-Feb-22,Moderna,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1624,5,June,2022,,,130,,Completed,10000+,N/A,40,Scheduled,216,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.34,Negative,2185,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,09-Apr-21,Pfizer,20-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,July,2021,,24,,,Processed,,N/A,72,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,12233,Positive,Adult,,Post-3rd (8+ Weeks),24-Feb-22,baseline,09-Apr-21,Pfizer,20-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,42,3,February,2022,,,153,,Completed,250-999,N/A,72,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,,5.88,Positive,,,Elderly,265,Post-1st,01-Oct-21,Baseline to COVID,16-Sep-21,Pfizer,06-Nov-21,Pfizer,,,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,2,October,2021,15,,,,Completed,10000+,265 Days Before Collection Days Before Collection,51,Scheduled,,Delayed,,15,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,,0.06,Negative,5996,Positive,Elderly,331,Post-2nd (1-8 Weeks),06-Dec-21,Baseline to COVID,16-Sep-21,Pfizer,06-Nov-21,Pfizer,,,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3882,3,December,2021,,30,,,Completed,10000+,331 Days Before Collection Days Before Collection,51,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.6,Negative,32231,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,23-Apr-21,Pfizer,04-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,26,18-29,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1445,1,July,2021,,48,,,Completed,10000+,N/A,42,Scheduled,197,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,1.27,Positive,18507,Positive,Adult,,Post-3rd (1-8 Weeks),11-Jan-22,baseline,23-Apr-21,Pfizer,04-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,27,18-29,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6015,2,January,2022,,,24,,Completed,10000+,N/A,42,Scheduled,197,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,1.27,Positive,1293,Positive,Adult,,Post-3rd (8+ Weeks),07-May-22,baseline,23-Apr-21,Pfizer,04-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,27,18-29,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1329,3,May,2022,,,140,,Completed,,N/A,42,Scheduled,197,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,6.3,Positive,20683,Positive,Adult,-218,Post-2nd (8+ Weeks),01-Sep-21,baseline,08-Apr-21,Moderna,05-Jun-21,Moderna,09-Oct-21,Pfizer,,,,,37,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,970,1,September,2021,,88,,,Completed,,N/A,58,Delayed,126,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,15844,Positive,Adult,-135,Post-3rd (1-8 Weeks),23-Nov-21,baseline,08-Apr-21,Moderna,05-Jun-21,Moderna,09-Oct-21,Pfizer,,,,,37,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1761,2,November,2021,,,45,,Completed,10000+,N/A,58,Delayed,126,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.81,Positive,2512,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,21-Apr-21,Pfizer,11-Jun-21,Pfizer,07-Sep-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1969,1,June,2021,,19,,,Completed,10000+,N/A,51,Scheduled,88,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,1.3,Positive,18702,Positive,Adult,-290,Post-2nd (1-8 Weeks),07-Jul-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,20-Sep-21,Pfizer,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1244,1,July,2021,,21,,,Completed,,N/A,69,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,2458,Positive,Adult,-177,Post-3rd (1-8 Weeks),28-Oct-21,baseline,08-Apr-21,Pfizer,16-Jun-21,Pfizer,20-Sep-21,Pfizer,,,,,43,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2095,2,October,2021,,,38,,Completed,10000+,N/A,69,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.44,Negative,35410,Positive,Adult,,Post-2nd (1-8 Weeks),07-Aug-21,baseline,08-May-21,Pfizer,04-Jul-21,Pfizer,24-Sep-21,Pfizer,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,414,1,August,2021,,34,,,Completed,1000-4999,N/A,57,Delayed,82,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.44,Negative,3377,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,17-Jan-22,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,455,1,August,2021,,49,,,Completed,1000-4999,N/A,68,Delayed,215,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.17,Negative,38883,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,55,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,3062,1,July,2021,,15,,,Completed,10000+,N/A,28,Scheduled,99,Scheduled,138,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.2,Negative,2992,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,56,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,118,3,February,2022,,,125,,Completed,250-999,N/A,28,Scheduled,99,Scheduled,138,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.2,Negative,24265,Positive,Adult,,Post-4th,03-Mar-22,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,56,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,11360,4,March,2022,,,,15,Completed,10000+,N/A,28,Scheduled,99,Scheduled,138,,,,15,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.19,Negative,31543,Positive,Adult,,Post-4th,24-Jun-22,baseline,27-May-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Moderna,16-Feb-22,Moderna,,,56,50-59,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,4137,5,June,2022,,,,128,Completed,10000+,N/A,28,Scheduled,99,Scheduled,138,,,,128,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.55,Negative,1791,Positive,Adult,,Post-3rd (8+ Weeks),09-Dec-21,baseline,29-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,38,30-39,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1960,2,December,2021,,,72,,Completed,10000+,N/A,47,Scheduled,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,,5.85,Positive,19615,Positive,Adult,203,Pre-1st,15-Mar-21,covid,15-Apr-21,Moderna,13-Jun-21,Moderna,31-Dec-21,Moderna,,,,,28,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,80,1,March,2021,,,,,Completed,250-999,N/A,59,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,,5.85,Positive,18323,Positive,Adult,522,Post-3rd (1-8 Weeks),28-Jan-22,covid,15-Apr-21,Moderna,13-Jun-21,Moderna,31-Dec-21,Moderna,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1370,2,January,2022,,,28,,Completed,,N/A,59,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.18,Negative,18083,Positive,Adult,123,Pre-1st,10-Feb-21,Post Vaccine covid,31-Mar-21,Pfizer,11-Jun-21,Pfizer,02-Sep-21,Pfizer,31-Mar-22,Pfizer,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,February,2021,,,,,Completed,0-49,123 Days Before Collection Days After Collection,72,Delayed,83,Scheduled,210,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,10603,Positive,Adult,142,Pre-1st,25-Feb-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,February,2021,,,,,Completed,0-49,N/A,51,Scheduled,208,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.2,Positive,59800,Positive,Adult,225,Post-1st,19-May-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,495,2,May,2021,33,,,,Completed,1000-4999,N/A,51,Scheduled,208,Delayed,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,2.02,Positive,38382,Positive,Adult,282,Post-2nd (1-8 Weeks),15-Jul-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,3,July,2021,,39,,,Processed,,N/A,51,Scheduled,208,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.18,Negative,12262,Positive,Adult,444,Post-2nd (8+ Weeks),24-Dec-21,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,30,4,December,2021,,201,,,Completed,50-249,N/A,51,Scheduled,208,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.18,Negative,16462,Positive,Adult,470,Post-3rd (1-8 Weeks),19-Jan-22,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,308,5,January,2022,,,19,,Completed,1000-4999,N/A,51,Scheduled,208,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.83,Positive,7559,Positive,Adult,582,Post-3rd (8+ Weeks),11-May-22,Post Vaccine covid,16-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Dec-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,521,6,May,2022,,,131,,Completed,1000-4999,N/A,51,Scheduled,208,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,1.24,Positive,6005,Positive,Adult,,Post-3rd (8+ Weeks),06-Jul-22,baseline,27-Apr-21,Moderna,11-Jun-21,Moderna,21-Dec-21,Moderna,,,,,40,40-49,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9634,1,July,2022,,,197,,Completed,10000+,N/A,45,Scheduled,193,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,1.02,Positive,20473,Positive,Adult,18,Post-3rd (8+ Weeks),27-Apr-22,baseline,30-Apr-21,Pfizer,27-Jun-21,Moderna,03-Jan-22,Moderna,,,,,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5589,2,April,2022,,,114,,Completed,10000+,N/A,58,Delayed,190,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.69,Positive,4861,Positive,Adult,-301,Post-1st,13-Apr-21,baseline,30-Mar-21,Pfizer,06-May-21,Pfizer,19-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,April,2021,14,,,,Completed,50-249,N/A,37,Scheduled,136,Delayed,,14,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,24248,Positive,Adult,-124,Post-3rd (1-8 Weeks),07-Oct-21,baseline,30-Mar-21,Pfizer,06-May-21,Pfizer,19-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,951,2,October,2021,,,18,,Completed,,N/A,37,Scheduled,136,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,3.75,Positive,1216,Positive,Adult,-224,Post-2nd (1-8 Weeks),24-Jun-21,Post Vaccine covid,03-Apr-21,Pfizer,17-May-21,Pfizer,03-Sep-21,Pfizer,17-Feb-22,Pfizer,,,25,18-29,1,1,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,820,1,June,2021,,38,,,Completed,,N/A,44,Scheduled,109,Scheduled,167,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,19486,Positive,Adult,-294,Post-1st,12-Feb-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,266,1,February,2021,40,,,,Completed,1000-4999,N/A,40,Scheduled,294,Delayed,147,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,4569,Positive,Adult,-287,Post-2nd (1-8 Weeks),19-Feb-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4478,2,February,2021,,7,,,Completed,10000+,N/A,40,Scheduled,294,Delayed,147,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.57,Negative,3597,Positive,Adult,0,Post-2nd (8+ Weeks),03-Dec-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,235,3,December,2021,,294,,,Completed,1000-4999,N/A,40,Scheduled,294,Delayed,147,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.57,Negative,11438,Positive,Adult,5,Post-2nd (8+ Weeks),08-Dec-21,baseline,03-Jan-21,Pfizer,12-Feb-21,Pfizer,03-Dec-21,Moderna,29-Apr-22,Pfizer,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,2045,4,December,2021,,299,,,Completed,10000+,N/A,40,Scheduled,294,Delayed,147,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,2.11,Positive,10441,Positive,Adult,25,Pre-1st,09-Dec-20,covid,06-Jul-21,Moderna,28-Sep-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107,1,December,2020,,,,,Completed,250-999,N/A,84,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,1.31,Positive,929,Positive,Adult,304,Post-1st,14-Sep-21,covid,06-Jul-21,Moderna,28-Sep-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,348,2,September,2021,70,,,,Completed,1000-4999,N/A,84,Delayed,,Delayed,,70,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.26,Negative,7953,Positive,Adult,238,Pre-1st,18-Jan-21,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,January,2021,,,,,Completed,0-49,N/A,62,Delayed,183,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,10143,Positive,Adult,590,Post-3rd (1-8 Weeks),05-Jan-22,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,950,3,January,2022,,,27,,Completed,,N/A,62,Delayed,183,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,3.33,Positive,213,Positive,Adult,696,Post-3rd (8+ Weeks),21-Apr-22,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,285,4,April,2022,,,133,,Completed,1000-4999,N/A,62,Delayed,183,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.52,Negative,7207,Positive,Adult,738,Post-4th,02-Jun-22,covid,08-Apr-21,Pfizer,09-Jun-21,Pfizer,09-Dec-21,Pfizer,09-May-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,833,5,June,2022,,,,24,Completed,,N/A,62,Delayed,183,Delayed,151,,,,24,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,34058,Positive,Adult,273,Post-2nd (8+ Weeks),17-Aug-21,covid,22-Apr-21,Pfizer,20-Jun-21,Pfizer,,,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1737,2,August,2021,,58,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.48,Negative,21234,Positive,Adult,119,Pre-1st,24-Mar-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,46,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,140,1,March,2021,,,,,Completed,250-999,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.48,Negative,37287,Positive,Adult,199,Post-1st,12-Jun-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,46,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3551,2,June,2021,20,,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,20,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.27,Negative,2168,Positive,Adult,238,Post-2nd (1-8 Weeks),21-Jul-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,46,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11101,3,July,2021,,18,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Vedolizumab Only,Vedolizumab Only,,,0.04,Negative,6379,Positive,Adult,378,Post-2nd (8+ Weeks),08-Dec-21,covid,23-May-21,Pfizer,03-Jul-21,Moderna,,,,,,,47,40-49,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1741,4,December,2021,,158,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.13,Positive,22139,Positive,Adult,-359,Post-1st,12-May-21,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,23,1,May,2021,32,,,,Completed,50-249,N/A,49,Scheduled,206,Delayed,,32,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.13,Positive,21450,Positive,Adult,-319,Post-2nd (1-8 Weeks),21-Jun-21,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,164,2,June,2021,,23,,,Completed,1000-4999,N/A,49,Scheduled,206,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.72,Positive,3391,Positive,Adult,-239,Post-2nd (8+ Weeks),09-Sep-21,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,3,September,2021,,103,,,Completed,50-249,N/A,49,Scheduled,206,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.72,Positive,11469,Positive,Adult,-105,Post-3rd (1-8 Weeks),21-Jan-22,baseline,10-Apr-21,Pfizer,29-May-21,Pfizer,21-Dec-21,Pfizer,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,680,4,January,2022,,,31,,Completed,1000-4999,N/A,49,Scheduled,206,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,2.35,Positive,14853,Positive,Adult,-236,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,281,1,July,2021,,40,,,Completed,1000-4999,N/A,57,Delayed,210,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,2.35,Positive,9647,Positive,Adult,-98,Post-2nd (8+ Weeks),07-Dec-21,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,20,2,December,2021,,178,,,Completed,50-249,N/A,57,Delayed,210,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.27,Negative,9674,Positive,Adult,-32,Post-3rd (1-8 Weeks),11-Feb-22,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,937,3,February,2022,,,34,,Completed,,N/A,57,Delayed,210,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,3.19,Positive,42067,Positive,Adult,73,Post-3rd (8+ Weeks),27-May-22,Post Vaccine covid,16-Apr-21,Pfizer,12-Jun-21,Pfizer,08-Jan-22,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1361,4,May,2022,,,139,,Completed,,N/A,57,Delayed,210,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.34,Positive,5177,Positive,Adult,,Pre-1st,01-Mar-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,125,Delayed,244,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,3.03,Positive,3274,Positive,Adult,,Post-1st,03-May-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,23,2,May,2021,51,,,,Completed,50-249,N/A,71,Delayed,125,Delayed,244,51,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.47,Negative,6189,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,269,3,July,2021,,43,,,Completed,1000-4999,N/A,71,Delayed,125,Delayed,244,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,7.25,Positive,1124,Positive,Adult,,Post-2nd (8+ Weeks),03-Sep-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,113,4,September,2021,,103,,,Completed,250-999,N/A,71,Delayed,125,Delayed,244,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,2.3,Positive,3666,Positive,Adult,,Post-3rd (1-8 Weeks),12-Oct-21,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,7736,5,October,2021,,,17,,Completed,10000+,N/A,71,Delayed,125,Delayed,244,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,40000,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,13-Mar-21,AstraZeneca,23-May-21,AstraZeneca,25-Sep-21,Pfizer,27-May-22,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,297,6,February,2022,,,143,,Completed,1000-4999,N/A,71,Delayed,125,Delayed,244,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.09,Negative,47180,Positive,Adult,-198,Post-2nd (1-8 Weeks),04-Aug-21,Post Vaccine covid,20-Apr-21,Moderna,30-Jun-21,Moderna,26-Mar-22,Moderna,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,391,1,August,2021,,35,,,Completed,1000-4999,N/A,71,Delayed,269,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,4.31,Positive,6561,Positive,Adult,21,Post-2nd (8+ Weeks),11-Mar-22,Post Vaccine covid,20-Apr-21,Moderna,30-Jun-21,Moderna,26-Mar-22,Moderna,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1584,2,March,2022,,254,,,Completed,10000+,N/A,71,Delayed,269,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.23,Negative,4335,Positive,Adult,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,34,1,July,2021,,22,,,Completed,50-249,N/A,65,Delayed,104,Scheduled,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,3.89,Positive,17865,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,20,3,February,2022,,,128,,Completed,50-249,N/A,65,Delayed,104,Scheduled,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.66,Negative,2010,Positive,Adult,,Post-4th,04-Apr-22,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,305,4,April,2022,,,,27,Completed,1000-4999,N/A,65,Delayed,104,Scheduled,161,,,,27,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.78,Positive,5866,Positive,Adult,,Post-4th,20-Jul-22,baseline,12-Apr-21,Pfizer,16-Jun-21,Pfizer,28-Sep-21,Pfizer,08-Mar-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,53,5,July,2022,,,,134,Completed,250-999,N/A,65,Delayed,104,Scheduled,161,,,,134,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.54,Negative,64,Positive,Adult,-220,Pre-1st,14-Dec-20,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,December,2020,,,,,Completed,0-49,N/A,60,Delayed,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,3.26,Positive,3374,Positive,Adult,-71,Post-1st,12-May-21,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,May,2021,26,,,,Processed,,N/A,60,Delayed,105,Scheduled,,26,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,3.26,Positive,2332,Positive,Adult,0,Post-2nd (1-8 Weeks),22-Jul-21,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,260,3,July,2021,,37,,,Completed,1000-4999,N/A,60,Delayed,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,521,Positive,Adult,93,Post-3rd (1-8 Weeks),23-Oct-21,Post Vaccine covid,16-Apr-21,Pfizer,15-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,61,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,975,4,October,2021,,,25,,Completed,,N/A,60,Delayed,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.93,Positive,2230,Positive,Adult,37,Pre-1st,06-Jan-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,28,1,January,2021,,,,,Completed,50-249,N/A,33,Scheduled,132,Delayed,210,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.56,Positive,83,Positive,Adult,183,Post-2nd (1-8 Weeks),01-Jun-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,350,3,June,2021,,11,,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.23,Negative,1723,Positive,Adult,233,Post-2nd (8+ Weeks),21-Jul-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,297,4,July,2021,,61,,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,274,Positive,Adult,291,Post-2nd (8+ Weeks),17-Sep-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,184,5,September,2021,,119,,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.54,Negative,5799,Positive,Adult,395,Post-3rd (8+ Weeks),30-Dec-21,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,173,6,December,2021,,,91,,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.81,Positive,105,Positive,Adult,540,Post-4th,24-May-22,covid,18-Apr-21,Pfizer,21-May-21,Pfizer,30-Sep-21,Pfizer,28-Apr-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,465,7,May,2022,,,,26,Completed,1000-4999,N/A,33,Scheduled,132,Delayed,210,,,,26,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.32,Negative,422,Positive,Elderly,-321,Post-2nd (1-8 Weeks),07-Jul-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,07-Sep-21,Pfizer,21-Apr-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,229,1,July,2021,,27,,,Completed,1000-4999,N/A,75,Delayed,89,Scheduled,226,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.02,Negative,307,Positive,Elderly,-197,Post-3rd (8+ Weeks),08-Nov-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,07-Sep-21,Pfizer,21-Apr-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,52,2,November,2021,,,62,,Completed,250-999,N/A,75,Delayed,89,Scheduled,226,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,784,Positive,Adult,,Post-2nd (1-8 Weeks),12-Jul-21,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,414,1,July,2021,,26,,,Completed,1000-4999,N/A,68,Delayed,86,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,1163,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,645,2,November,2021,,,54,,Completed,1000-4999,N/A,68,Delayed,86,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.22,Negative,1004,Positive,Adult,,Post-3rd (8+ Weeks),18-Jan-22,baseline,09-Apr-21,Pfizer,16-Jun-21,Pfizer,10-Sep-21,Pfizer,,,,,48,40-49,1,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,300,3,January,2022,,,130,,Completed,1000-4999,N/A,68,Delayed,86,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,2568,Positive,Elderly,-203,Post-2nd (1-8 Weeks),10-Jul-21,Post Vaccine covid,25-Mar-21,Pfizer,19-Jun-21,Pfizer,,,,,,,65,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,523,2,July,2021,,21,,,Completed,1000-4999,N/A,86,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.1,Negative,8725,Positive,Elderly,-75,Post-2nd (8+ Weeks),15-Nov-21,Post Vaccine covid,25-Mar-21,Pfizer,19-Jun-21,Pfizer,,,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77,3,November,2021,,149,,,Completed,250-999,N/A,86,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,4.12,Positive,6692,Positive,Elderly,158,Post-2nd (8+ Weeks),06-Jul-22,Post Vaccine covid,25-Mar-21,Pfizer,19-Jun-21,Pfizer,,,,,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3904,4,July,2022,,382,,,Completed,10000+,N/A,86,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,2.93,Positive,57,Positive,Adult,,Post-2nd (1-8 Weeks),09-Aug-21,baseline,09-Apr-21,Pfizer,18-Jun-21,Pfizer,07-Dec-21,Pfizer,09-May-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,144,1,August,2021,,52,,,Completed,1000-4999,N/A,70,Delayed,172,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,,,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,09-Apr-21,Pfizer,18-Jun-21,Pfizer,07-Dec-21,Pfizer,09-May-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2324,2,February,2022,,,63,,Completed,10000+,N/A,70,Delayed,172,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.48,Negative,4141,Positive,Adult,-185,Post-2nd (1-8 Weeks),29-Jul-21,Post Vaccine covid,23-Mar-21,AstraZeneca,07-Jun-21,Pfizer,04-Sep-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,19,1,July,2021,,52,,,Completed,50-249,N/A,76,Delayed,89,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,251,Positive,Adult,-93,Post-3rd (1-8 Weeks),29-Oct-21,Post Vaccine covid,23-Mar-21,AstraZeneca,07-Jun-21,Pfizer,04-Sep-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,88,2,October,2021,,,55,,Completed,250-999,N/A,76,Delayed,89,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.24,Negative,24113,Positive,Adult,-10,Post-3rd (8+ Weeks),20-Jan-22,Post Vaccine covid,23-Mar-21,AstraZeneca,07-Jun-21,Pfizer,04-Sep-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,16,3,January,2022,,,138,,Completed,50-249,N/A,76,Delayed,89,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.24,Negative,2803,Positive,Adult,,Pre-1st,16-Mar-21,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,57,Delayed,100,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,51805,Positive,Adult,,Post-3rd (1-8 Weeks),27-Oct-21,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,877,2,October,2021,,,30,,Completed,,N/A,57,Delayed,100,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3123,Positive,Adult,,Post-3rd (8+ Weeks),22-Feb-22,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,110,3,February,2022,,,148,,Completed,250-999,N/A,57,Delayed,100,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,21242,Positive,Adult,,Post-4th,19-Apr-22,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,813,4,April,2022,,,,47,Completed,,N/A,57,Delayed,100,Scheduled,157,,,,47,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,12092,Positive,Adult,,Post-4th,21-Jul-22,baseline,23-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Mar-22,Pfizer,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,291,5,July,2022,,,,140,Completed,1000-4999,N/A,57,Delayed,100,Scheduled,157,,,,140,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,5380,Positive,Adult,-137,Post-3rd (1-8 Weeks),17-Nov-21,baseline,30-Mar-21,Pfizer,06-May-21,Pfizer,25-Sep-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,664,2,November,2021,,,53,,Completed,1000-4999,N/A,37,Scheduled,142,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,1582,Positive,Adult,159,Pre-1st,13-May-21,covid,04-Jun-21,Pfizer,03-Jul-21,Pfizer,23-Dec-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,May,2021,,,,,Completed,0-49,N/A,29,Scheduled,173,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,650,Positive,Adult,414,Post-3rd (1-8 Weeks),23-Jan-22,covid,04-Jun-21,Pfizer,03-Jul-21,Pfizer,23-Dec-21,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,696,3,January,2022,,,31,,Completed,1000-4999,N/A,29,Scheduled,173,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.09,Negative,54975,Positive,Adult,,Post-2nd (1-8 Weeks),17-Jul-21,baseline,30-Apr-21,Pfizer,28-Jun-21,Pfizer,,,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,July,2021,,19,,,Processed,,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.5,Negative,21373,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Sep-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,978,1,July,2021,,32,,,Completed,,N/A,60,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,31,Negative,Adult,,Post-3rd (1-8 Weeks),11-Nov-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Sep-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,331,2,November,2021,,,47,,Completed,1000-4999,N/A,60,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,,,Adult,,Post-3rd (8+ Weeks),09-Feb-22,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Sep-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2187,3,February,2022,,,137,,Completed,10000+,N/A,60,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,19640,Positive,Adult,-211,Post-2nd (1-8 Weeks),18-Jun-21,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,543,1,June,2021,,47,,,Completed,1000-4999,N/A,48,Scheduled,126,Delayed,234,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.9,Positive,1565,Positive,Adult,-133,Post-2nd (8+ Weeks),04-Sep-21,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,465,2,September,2021,,125,,,Completed,1000-4999,N/A,48,Scheduled,126,Delayed,234,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,63,Positive,Adult,-69,Post-3rd (8+ Weeks),07-Nov-21,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,725,3,November,2021,,,63,,Completed,,N/A,48,Scheduled,126,Delayed,234,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,1447,Positive,Adult,-9,Post-3rd (8+ Weeks),06-Jan-22,Post Vaccine covid,15-Mar-21,AstraZeneca,02-May-21,AstraZeneca,05-Sep-21,Pfizer,27-Apr-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,355,4,January,2022,,,123,,Completed,1000-4999,N/A,48,Scheduled,126,Delayed,234,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,293,Positive,Adult,-292,Post-1st,19-Jun-21,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,122,1,June,2021,44,,,,Completed,250-999,N/A,63,Delayed,123,Delayed,,44,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,16718,Positive,Adult,-251,Post-2nd (1-8 Weeks),30-Jul-21,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2666,2,July,2021,,22,,,Completed,10000+,N/A,63,Delayed,123,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.14,Negative,74193,Positive,Adult,-133,Post-3rd (1-8 Weeks),25-Nov-21,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7862,3,November,2021,,,17,,Completed,10000+,N/A,63,Delayed,123,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,6,Negative,Adult,-17,Post-3rd (8+ Weeks),21-Mar-22,baseline,06-May-21,Pfizer,08-Jul-21,Pfizer,08-Nov-21,Pfizer,,,,,49,40-49,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1449,4,March,2022,,,133,,Completed,10000+,N/A,63,Delayed,123,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,183,Positive,Adult,293,Post-2nd (1-8 Weeks),16-Jul-21,covid,02-May-21,Pfizer,28-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,37,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2937,2,July,2021,,18,,,Completed,10000+,N/A,57,Delayed,207,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.15,Negative,10,Negative,Adult,607,Post-3rd (8+ Weeks),26-May-22,covid,02-May-21,Pfizer,28-Jun-21,Pfizer,21-Jan-22,Pfizer,,,,,37,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6700,3,May,2022,,,125,,Completed,10000+,N/A,57,Delayed,207,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.51,Positive,36,Negative,Adult,57,Pre-1st,26-Jan-21,covid,21-Apr-21,Pfizer,11-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,21,1,January,2021,,,,,Completed,50-249,N/A,51,Scheduled,89,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,9370,Positive,Adult,226,Post-2nd (1-8 Weeks),14-Jul-21,covid,21-Apr-21,Pfizer,11-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,112,2,July,2021,,33,,,Completed,250-999,N/A,51,Scheduled,89,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.27,Negative,3808,Positive,Adult,217,Post-1st,28-Jun-21,covid,26-Apr-21,Moderna,26-Jun-21,Moderna,14-Dec-21,Pfizer,,,,,50,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1005,2,June,2021,63,,,,Completed,,N/A,61,Delayed,171,Delayed,,63,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,28166,Positive,Adult,240,Post-2nd (1-8 Weeks),21-Jul-21,covid,26-Apr-21,Moderna,26-Jun-21,Moderna,14-Dec-21,Pfizer,,,,,50,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,726,3,July,2021,,25,,,Completed,,N/A,61,Delayed,171,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.27,Negative,613,Positive,Adult,336,Post-2nd (8+ Weeks),25-Oct-21,covid,26-Apr-21,Moderna,26-Jun-21,Moderna,14-Dec-21,Pfizer,,,,,50,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,163,4,October,2021,,121,,,Completed,1000-4999,N/A,61,Delayed,171,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.07,Negative,3709,Positive,Adult,78,Pre-1st,01-Feb-21,covid,16-Apr-21,Pfizer,08-May-21,Pfizer,07-Oct-21,Pfizer,,,,,53,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,237,1,February,2021,,,,,Completed,1000-4999,N/A,22,Scheduled,152,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.12,Negative,1342,Positive,Adult,257,Post-2nd (8+ Weeks),30-Jul-21,covid,16-Apr-21,Pfizer,08-May-21,Pfizer,07-Oct-21,Pfizer,,,,,53,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,961,2,July,2021,,83,,,Completed,,N/A,22,Scheduled,152,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,5220,Positive,Adult,491,Post-3rd (8+ Weeks),21-Mar-22,covid,16-Apr-21,Pfizer,08-May-21,Pfizer,07-Oct-21,Pfizer,,,,,54,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,481,4,March,2022,,,165,,Completed,1000-4999,N/A,22,Scheduled,152,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,18891,Positive,Adult,,Pre-1st,30-Dec-20,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,54,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,1,1,December,2020,,,,,Completed,0-49,N/A,64,Delayed,185,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,16622,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,55,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,520,2,July,2021,,31,,,Completed,1000-4999,N/A,64,Delayed,185,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.16,Negative,1228,Positive,Adult,,Post-3rd (1-8 Weeks),19-Jan-22,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,55,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,7095,3,January,2022,,,35,,Completed,10000+,N/A,64,Delayed,185,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,4900,Positive,Adult,,Post-3rd (8+ Weeks),19-May-22,baseline,10-Apr-21,Pfizer,13-Jun-21,Pfizer,15-Dec-21,Pfizer,17-May-22,Pfizer,,,55,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,5680,4,May,2022,,,155,,Completed,10000+,N/A,64,Delayed,185,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,252,Positive,Adult,-64,Post-3rd (8+ Weeks),19-Jan-22,baseline,12-Apr-21,Moderna,12-May-21,Moderna,22-Sep-21,Moderna,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,104,1,January,2022,,,119,,Completed,250-999,N/A,30,Scheduled,133,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,158,Positive,Adult,-176,Post-2nd (1-8 Weeks),30-Jul-21,Post Vaccine covid,19-Apr-21,Moderna,15-Jun-21,Moderna,05-Jan-22,Moderna,,,,,41,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,526,1,July,2021,,45,,,Completed,1000-4999,N/A,57,Delayed,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,61,Positive,Adult,10,Post-3rd (1-8 Weeks),01-Feb-22,Post Vaccine covid,19-Apr-21,Moderna,15-Jun-21,Moderna,05-Jan-22,Moderna,,,,,42,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1427,2,February,2022,,,27,,Completed,10000+,N/A,57,Delayed,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,6512,Positive,Elderly,,Post-1st,28-Apr-21,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3,1,April,2021,34,,,,Completed,0-49,N/A,81,Delayed,108,Scheduled,174,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,3761,Positive,Elderly,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1117,3,October,2021,,,28,,Completed,,N/A,81,Delayed,108,Scheduled,174,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,19063,Positive,Elderly,,Post-3rd (8+ Weeks),24-Feb-22,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,167,4,February,2022,,,147,,Completed,1000-4999,N/A,81,Delayed,108,Scheduled,174,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.4,Negative,18,Negative,Elderly,,Post-4th,20-Apr-22,baseline,25-Mar-21,Pfizer,14-Jun-21,Pfizer,30-Sep-21,Pfizer,23-Mar-22,Pfizer,,,69,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1493,5,April,2022,,,,28,Completed,10000+,N/A,81,Delayed,108,Scheduled,174,,,,28,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.4,Negative,20140,Positive,Adult,,Post-1st,18-Jun-21,baseline,24-Apr-21,Moderna,16-Jun-21,Moderna,15-Oct-21,Moderna,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,1,June,2021,55,,,,Completed,50-249,N/A,53,Scheduled,121,Delayed,,55,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,8460,Positive,Adult,,Post-2nd (8+ Weeks),08-Oct-21,baseline,24-Apr-21,Moderna,16-Jun-21,Moderna,15-Oct-21,Moderna,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,145,2,October,2021,,114,,,Completed,1000-4999,N/A,53,Scheduled,121,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.14,Negative,1579,Positive,Adult,-262,Post-3rd (1-8 Weeks),28-Oct-21,baseline,14-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,439,2,October,2021,,,29,,Completed,1000-4999,N/A,62,Delayed,106,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,29201,Positive,Adult,-165,Post-3rd (8+ Weeks),02-Feb-22,baseline,14-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,94,3,February,2022,,,126,,Completed,250-999,N/A,62,Delayed,106,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,72714,Positive,Adult,-259,Post-1st,14-Jun-21,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,23,1,June,2021,46,,,,Completed,50-249,N/A,53,Scheduled,157,Delayed,181,46,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.29,Negative,445,Positive,Adult,-101,Post-2nd (8+ Weeks),19-Nov-21,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,89,3,November,2021,,151,,,Completed,250-999,N/A,53,Scheduled,157,Delayed,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,4130,Positive,Adult,-68,Post-3rd (1-8 Weeks),22-Dec-21,baseline,29-Apr-21,Pfizer,21-Jun-21,Pfizer,25-Nov-21,Pfizer,25-May-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,570,4,December,2021,,,27,,Completed,1000-4999,N/A,53,Scheduled,157,Delayed,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,5.54,Positive,74,Positive,Adult,-173,Post-2nd (8+ Weeks),11-Aug-21,baseline,10-Apr-21,Pfizer,11-Jun-21,Pfizer,28-Sep-21,Pfizer,27-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,456,1,August,2021,,61,,,Completed,1000-4999,N/A,62,Delayed,109,Scheduled,241,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,4997,Positive,Adult,-89,Post-3rd (1-8 Weeks),03-Nov-21,baseline,10-Apr-21,Pfizer,11-Jun-21,Pfizer,28-Sep-21,Pfizer,27-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2359,2,November,2021,,,36,,Completed,10000+,N/A,62,Delayed,109,Scheduled,241,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,62495,Positive,Adult,14,Post-3rd (8+ Weeks),14-Feb-22,baseline,10-Apr-21,Pfizer,11-Jun-21,Pfizer,28-Sep-21,Pfizer,27-May-22,Moderna,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4154,3,February,2022,,,139,,Completed,10000+,N/A,62,Delayed,109,Scheduled,241,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Vedolizumab Only,,0.66,Negative,13,Negative,Adult,,Pre-1st,23-Mar-21,baseline,17-Apr-21,Pfizer,27-Aug-21,Pfizer,03-Nov-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,132,Delayed,68,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Vedolizumab Only,,0.02,Negative,,,Adult,,Post-1st,17-May-21,baseline,17-Apr-21,Pfizer,27-Aug-21,Pfizer,03-Nov-21,Pfizer,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,2,May,2021,30,,,,Completed,50-249,N/A,132,Delayed,68,Scheduled,,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,No Immunosuppressives,No Immunosuppressives,,,0.02,Negative,82,Positive,Adult,,Post-2nd (8+ Weeks),12-Jul-22,New biologic/Tofacitinib start,20-Apr-21,Pfizer,11-Jun-21,Pfizer,,,,,,,56,50-59,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,232,1,July,2022,,396,,,Completed,1000-4999,N/A,52,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,3205,Positive,Elderly,,Post-1st,26-Apr-21,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,110,1,April,2021,33,,,,Completed,250-999,N/A,50,Scheduled,186,Delayed,150,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,126,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,382,2,June,2021,,39,,,Completed,1000-4999,N/A,50,Scheduled,186,Delayed,150,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.36,Negative,,,Elderly,,Post-3rd (1-8 Weeks),13-Dec-21,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4719,4,December,2021,,,28,,Completed,10000+,N/A,50,Scheduled,186,Delayed,150,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,4554,Positive,Elderly,,Post-4th,30-May-22,baseline,24-Mar-21,Pfizer,13-May-21,Pfizer,15-Nov-21,Pfizer,14-Apr-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5680,5,May,2022,,,,46,Completed,10000+,N/A,50,Scheduled,186,Delayed,150,,,,46,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.03,Negative,80000,Positive,Elderly,,Post-1st,05-May-21,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,68,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,28,1,May,2021,28,,,,Completed,50-249,N/A,70,Delayed,229,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.03,Negative,3185,Positive,Elderly,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,68,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1118,2,July,2021,,23,,,Completed,,N/A,70,Delayed,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.33,Negative,1081,Positive,Elderly,,Post-3rd (1-8 Weeks),16-Feb-22,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,69,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11360,3,February,2022,,,16,,Completed,10000+,N/A,70,Delayed,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.33,Negative,4266,Positive,Elderly,,Post-3rd (8+ Weeks),29-Jun-22,baseline,07-Apr-21,Pfizer,16-Jun-21,Pfizer,31-Jan-22,Pfizer,,,,,69,60-69,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2055,4,June,2022,,,149,,Completed,10000+,N/A,70,Delayed,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,581,Positive,Adult,0,Post-2nd (1-8 Weeks),20-Jul-21,baseline,17-Apr-21,Pfizer,25-Jun-21,Pfizer,14-Dec-21,Pfizer,31-May-22,Pfizer,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,93,1,July,2021,,25,,,Completed,250-999,N/A,69,Delayed,172,Delayed,168,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,23929,Positive,Adult,252,Post-3rd (8+ Weeks),29-Mar-22,baseline,17-Apr-21,Pfizer,25-Jun-21,Pfizer,14-Dec-21,Pfizer,31-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,65,2,March,2022,,,105,,Completed,250-999,N/A,69,Delayed,172,Delayed,168,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,316,Positive,Adult,213,Post-2nd (8+ Weeks),12-Jul-21,Post Vaccine covid,17-Jan-21,Moderna,27-Feb-21,Moderna,12-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,135,2,July,2021,,135,,,Completed,250-999,N/A,41,Scheduled,319,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,805,Positive,Adult,473,Post-3rd (8+ Weeks),29-Mar-22,Post Vaccine covid,17-Jan-21,Moderna,27-Feb-21,Moderna,12-Jan-22,Moderna,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,906,3,March,2022,,,76,,Completed,,N/A,41,Scheduled,319,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.06,Negative,575,Positive,Adult,-273,Pre-1st,07-Apr-21,Post Vaccine covid,16-May-21,Pfizer,30-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,56,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,45,Scheduled,190,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,3641,Positive,Adult,119,Post-3rd (8+ Weeks),04-May-22,Post Vaccine covid,16-May-21,Pfizer,30-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,57,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5680,2,May,2022,,,118,,Completed,10000+,N/A,45,Scheduled,190,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,7418,Positive,Adult,-281,Pre-1st,15-Apr-21,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.01,Negative,164,Positive,Adult,-197,Post-2nd (1-8 Weeks),08-Jul-21,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1422,2,July,2021,,13,,,Completed,10000+,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,4202,Positive,Adult,-30,Post-2nd (8+ Weeks),22-Dec-21,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,3,December,2021,,180,,,Completed,50-249,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,,,0.08,Negative,477,Positive,Adult,7,Post-2nd (8+ Weeks),28-Jan-22,Post Vaccine covid,26-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2003,4,January,2022,,217,,,Completed,10000+,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.08,Negative,5664,Positive,Adult,,Post-2nd (8+ Weeks),14-Aug-21,baseline,12-Apr-21,Pfizer,19-Jun-21,Pfizer,03-Jan-22,Pfizer,17-Jun-22,Pfizer,,,34,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,486,1,August,2021,,56,,,Completed,1000-4999,N/A,68,Delayed,198,Delayed,165,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,0.16,Negative,2667,Positive,Adult,,Post-3rd (1-8 Weeks),29-Jan-22,baseline,12-Apr-21,Pfizer,19-Jun-21,Pfizer,03-Jan-22,Pfizer,17-Jun-22,Pfizer,,,34,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,5677,2,January,2022,,,26,,Completed,10000+,N/A,68,Delayed,198,Delayed,165,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,5926,Positive,Adult,-173,Post-2nd (1-8 Weeks),28-Jul-21,Post Vaccine covid,24-Apr-21,Pfizer,04-Jun-21,Pfizer,,,,,,,24,18-29,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,398,1,July,2021,,54,,,Completed,1000-4999,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,9120,Positive,Adult,-6,Post-2nd (8+ Weeks),11-Jan-22,Post Vaccine covid,24-Apr-21,Pfizer,04-Jun-21,Pfizer,,,,,,,25,18-29,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,66,2,January,2022,,221,,,Completed,250-999,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,10411,Positive,Elderly,,Post-2nd (1-8 Weeks),08-Jul-21,baseline,12-Apr-21,Pfizer,01-Jul-21,Pfizer,05-Jan-22,Pfizer,12-Jul-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,409,1,July,2021,,7,,,Completed,1000-4999,N/A,80,Delayed,188,Delayed,188,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.32,Negative,1512,Positive,Adult,37,Pre-1st,29-Dec-20,covid,18-Oct-21,Pfizer,17-Nov-21,Pfizer,16-May-22,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,69,1,December,2020,,,,,Completed,250-999,N/A,30,Scheduled,180,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.3,Negative,592,Positive,Adult,268,Pre-1st,17-Aug-21,covid,18-Oct-21,Pfizer,17-Nov-21,Pfizer,16-May-22,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,2,August,2021,,,,,Completed,50-249,N/A,30,Scheduled,180,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.14,Negative,15571,Positive,Adult,13,Post-2nd (8+ Weeks),18-Jan-22,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Feb-22,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2434,1,January,2022,,219,,,Completed,10000+,N/A,60,Delayed,240,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,,,,,0.4,Negative,308,Positive,Adult,,,07-Oct-21,baseline,,,,,,,,,,,55,50-59,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,October,2021,,,,,Processed,,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,,,,,0.05,Negative,4990,Positive,Adult,,,05-Apr-21,baseline,,,,,,,,,,,45,40-49,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,1761,Positive,Adult,-221,Post-2nd (1-8 Weeks),15-Jun-21,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,27,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,354,1,June,2021,,25,,,Completed,1000-4999,N/A,29,Scheduled,240,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,18225,Positive,Adult,-127,Post-2nd (8+ Weeks),17-Sep-21,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,51,2,September,2021,,119,,,Completed,250-999,N/A,29,Scheduled,240,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,30908,Positive,Adult,32,Post-3rd (1-8 Weeks),23-Feb-22,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1443,3,February,2022,,,38,,Completed,10000+,N/A,29,Scheduled,240,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,3732,Positive,Adult,151,Post-3rd (8+ Weeks),22-Jun-22,Post Vaccine covid,22-Apr-21,Pfizer,21-May-21,Pfizer,16-Jan-22,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1444,4,June,2022,,,157,,Completed,10000+,N/A,29,Scheduled,240,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,273,Positive,Elderly,,Post-1st,17-May-21,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,33,1,May,2021,58,,,,Completed,50-249,N/A,83,Delayed,185,Delayed,224,58,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.2,Negative,,,Elderly,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1635,2,July,2021,,46,,,Completed,10000+,N/A,83,Delayed,185,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.2,Negative,61393,Positive,Elderly,,Post-3rd (1-8 Weeks),26-Jan-22,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4083,3,January,2022,,,44,,Completed,10000+,N/A,83,Delayed,185,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2703,Positive,Elderly,,Post-3rd (8+ Weeks),20-Apr-22,baseline,20-Mar-21,Pfizer,11-Jun-21,Pfizer,13-Dec-21,Pfizer,25-Jul-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1111,4,April,2022,,,128,,Completed,,N/A,83,Delayed,185,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,10676,Positive,Adult,60,Pre-1st,08-Apr-21,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,139,1,April,2021,,,,,Completed,250-999,N/A,64,Delayed,221,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,1343,Positive,Adult,93,Post-1st,11-May-21,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1989,2,May,2021,37,,,,Completed,10000+,N/A,64,Delayed,221,Delayed,,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,4040,Positive,Adult,166,Post-2nd (1-8 Weeks),23-Jul-21,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3088,3,July,2021,,46,,,Completed,10000+,N/A,64,Delayed,221,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.16,Negative,85,Positive,Adult,331,Post-2nd (8+ Weeks),04-Jan-22,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,425,4,January,2022,,211,,,Completed,1000-4999,N/A,64,Delayed,221,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1051,Positive,Adult,370,Post-3rd (1-8 Weeks),12-Feb-22,covid,04-Apr-21,Pfizer,07-Jun-21,Pfizer,14-Jan-22,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5450,5,February,2022,,,29,,Completed,10000+,N/A,64,Delayed,221,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,169,Positive,Adult,,Pre-1st,23-Jul-21,baseline,28-Aug-21,Pfizer,20-Sep-21,Pfizer,,,,,,,48,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,July,2021,,,,,Completed,0-49,N/A,23,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.19,Negative,994,Positive,Adult,224,Post-2nd (1-8 Weeks),21-Jul-21,Post Vaccine covid,26-Apr-21,Moderna,13-Jun-21,Moderna,,,,,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,July,2021,,38,,,Processed,,224 Days Before Collection Days After Collection,48,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.08,Negative,488,Positive,Adult,400,Post-2nd (8+ Weeks),13-Jan-22,Post Vaccine covid,26-Apr-21,Moderna,13-Jun-21,Moderna,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,649,2,January,2022,,214,,,Completed,1000-4999,400 Days Before Collection Days Before Collection,48,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.41,Negative,16141,Positive,Adult,567,Post-2nd (8+ Weeks),29-Jun-22,Post Vaccine covid,26-Apr-21,Moderna,13-Jun-21,Moderna,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160,3,June,2022,,381,,,Completed,1000-4999,567 Days Before Collection Days Before Collection,48,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,25291,Positive,Elderly,,Post-1st,14-Apr-21,baseline,09-Mar-21,Pfizer,16-Apr-21,Pfizer,16-Oct-21,Pfizer,,,,,78,70+,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,26,1,April,2021,36,,,,Completed,50-249,N/A,38,Scheduled,183,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.2,Negative,6583,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,09-Mar-21,Pfizer,16-Apr-21,Pfizer,16-Oct-21,Pfizer,,,,,78,70+,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,713,2,May,2021,,40,,,Completed,,N/A,38,Scheduled,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,1.39,Positive,9821,Positive,Elderly,,Post-2nd (8+ Weeks),01-Sep-21,baseline,09-Mar-21,Pfizer,16-Apr-21,Pfizer,16-Oct-21,Pfizer,,,,,78,70+,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,84,3,September,2021,,138,,,Completed,250-999,N/A,38,Scheduled,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.21,Negative,626,Positive,Elderly,,Post-1st,05-Apr-21,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,85,1,April,2021,39,,,,Completed,250-999,N/A,41,Scheduled,195,Delayed,204,39,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.15,Negative,9869,Positive,Elderly,,Post-2nd (1-8 Weeks),27-May-21,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1662,2,May,2021,,50,,,Completed,10000+,N/A,41,Scheduled,195,Delayed,204,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.15,Negative,56212,Positive,Elderly,,Post-2nd (8+ Weeks),30-Aug-21,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,76,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,279,3,August,2021,,145,,,Completed,1000-4999,N/A,41,Scheduled,195,Delayed,204,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,25819,Positive,Elderly,,Post-3rd (8+ Weeks),04-Jan-22,baseline,25-Feb-21,Pfizer,07-Apr-21,Pfizer,19-Oct-21,Pfizer,11-May-22,Pfizer,,,76,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2963,4,January,2022,,,77,,Completed,10000+,N/A,41,Scheduled,195,Delayed,204,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.98,Positive,506,Positive,Adult,-335,Post-2nd (1-8 Weeks),10-Jun-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,19-Oct-21,Pfizer,,,,,28,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,65,1,June,2021,,20,,,Completed,250-999,N/A,29,Scheduled,151,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.98,Positive,5458,Positive,Adult,-251,Post-2nd (8+ Weeks),02-Sep-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,19-Oct-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,12,2,September,2021,,104,,,Completed,50-249,N/A,29,Scheduled,151,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.41,Negative,2696,Positive,Adult,-41,Post-3rd (8+ Weeks),31-Mar-22,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,19-Oct-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,27,4,March,2022,,,163,,Completed,50-249,N/A,29,Scheduled,151,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.41,Negative,131,Positive,Elderly,,Post-2nd (8+ Weeks),24-Aug-21,baseline,14-Mar-21,Pfizer,24-Apr-21,Pfizer,15-Oct-21,Pfizer,16-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,29,2,August,2021,,122,,,Completed,50-249,N/A,41,Scheduled,174,Delayed,213,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.11,Negative,5598,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,14-Mar-21,Pfizer,24-Apr-21,Pfizer,15-Oct-21,Pfizer,16-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,199,3,February,2022,,,111,,Completed,1000-4999,N/A,41,Scheduled,174,Delayed,213,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,7184,Positive,Elderly,,Post-1st,29-Apr-21,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,1,April,2021,34,,,,Completed,0-49,N/A,74,Delayed,182,Delayed,,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,30848,Positive,Elderly,,Post-2nd (1-8 Weeks),15-Jul-21,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,47,2,July,2021,,37,,,Completed,250-999,N/A,74,Delayed,182,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,4.84,Positive,48955,Positive,Elderly,,Post-3rd (8+ Weeks),03-Mar-22,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,678,3,March,2022,,,86,,Completed,1000-4999,N/A,74,Delayed,182,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,20,Negative,Elderly,,Post-3rd (8+ Weeks),12-May-22,baseline,26-Mar-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,376,4,May,2022,,,156,,Completed,1000-4999,N/A,74,Delayed,182,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,2338,Positive,Adult,,Post-1st,12-Jul-21,baseline,27-May-21,Pfizer,12-Jul-21,Pfizer,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,July,2021,46,,,,Completed,50-249,N/A,46,Scheduled,,Delayed,,46,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.41,Negative,1269,Positive,Adult,,Post-2nd (8+ Weeks),24-Dec-21,baseline,27-May-21,Pfizer,12-Jul-21,Pfizer,,,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81,2,December,2021,,165,,,Completed,250-999,N/A,46,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,70,Positive,Elderly,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1169,1,July,2021,,38,,,Completed,,N/A,61,Delayed,107,Scheduled,173,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.02,Positive,727,Positive,Elderly,,Post-3rd (1-8 Weeks),27-Oct-21,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3982,2,October,2021,,,30,,Completed,10000+,N/A,61,Delayed,107,Scheduled,173,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.02,Positive,31557,Positive,Elderly,,Post-3rd (8+ Weeks),29-Jan-22,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1571,3,January,2022,,,124,,Completed,10000+,N/A,61,Delayed,107,Scheduled,173,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.37,Negative,,,Elderly,,Post-4th,20-Jul-22,baseline,12-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Sep-21,Pfizer,19-Mar-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1398,5,July,2022,,,,123,Completed,,N/A,61,Delayed,107,Scheduled,173,,,,123,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,3.17,Positive,2012,Positive,Adult,,Post-2nd (8+ Weeks),23-Aug-21,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,51,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,39,1,August,2021,,87,,,Completed,250-999,N/A,52,Scheduled,97,Scheduled,196,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,0.21,Negative,140,Positive,Adult,,Post-3rd (1-8 Weeks),22-Sep-21,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,51,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,726,2,September,2021,,,20,,Completed,,N/A,52,Scheduled,97,Scheduled,196,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,0.21,Negative,4168,Positive,Adult,,Post-3rd (8+ Weeks),21-Jan-22,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,51,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,3,January,2022,,,141,,Completed,50-249,N/A,52,Scheduled,97,Scheduled,196,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Corticosteroids,0.47,Negative,1949,Positive,Adult,,Post-4th,26-Jun-22,baseline,06-Apr-21,Pfizer,28-May-21,Pfizer,02-Sep-21,Pfizer,17-Mar-22,Pfizer,,,52,50-59,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,85,4,June,2022,,,,101,Completed,250-999,N/A,52,Scheduled,97,Scheduled,196,,,,101,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,1.11,Positive,5158,Positive,Adult,-215,Post-2nd (8+ Weeks),11-Aug-21,baseline,11-Apr-21,Pfizer,06-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,163,1,August,2021,,66,,,Completed,1000-4999,N/A,56,Scheduled,147,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.66,Positive,85,Positive,Adult,,Post-2nd (1-8 Weeks),14-Jul-21,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11083,1,July,2021,,26,,,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,7320,Positive,Adult,,Post-3rd (8+ Weeks),11-Jan-22,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4204,2,January,2022,,,130,,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,520,Positive,Adult,,Post-4th,25-Mar-22,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5388,3,March,2022,,,,49,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,49,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,7700,Positive,Adult,,Post-4th,22-Jun-22,baseline,27-Apr-21,Moderna,18-Jun-21,Moderna,03-Sep-21,Moderna,04-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2572,4,June,2022,,,,138,Completed,10000+,N/A,52,Scheduled,77,Scheduled,154,,,,138,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,12499,Positive,Adult,-190,Post-2nd (8+ Weeks),20-Jul-21,Post Vaccine covid,17-Dec-20,Pfizer,07-Jan-21,Pfizer,22-Sep-21,Pfizer,,,,,43,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,1,July,2021,,194,,,Completed,0-49,N/A,21,Scheduled,258,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,190,Positive,Adult,13,Post-3rd (8+ Weeks),08-Feb-22,Post Vaccine covid,17-Dec-20,Pfizer,07-Jan-21,Pfizer,22-Sep-21,Pfizer,,,,,43,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5593,2,February,2022,,,139,,Completed,10000+,N/A,21,Scheduled,258,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.11,Negative,16325,Positive,Adult,-427,Pre-1st,19-Mar-21,baseline,11-Apr-21,Pfizer,27-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,77,Delayed,93,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.27,Negative,827,Positive,Adult,-371,Post-1st,14-May-21,baseline,11-Apr-21,Pfizer,27-Jun-21,Pfizer,28-Sep-21,Pfizer,,,,,27,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,2,May,2021,33,,,,Completed,50-249,N/A,77,Delayed,93,Scheduled,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,,,,,0.27,Negative,15533,Positive,Adult,,,12-Jul-21,baseline,,,,,,,,,,,36,30-39,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,July,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.06,Negative,6433,Positive,Elderly,,Post-2nd (1-8 Weeks),29-Apr-21,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,84,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,April,2021,,12,,,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.24,Negative,246,Positive,Elderly,,Post-2nd (1-8 Weeks),27-May-21,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,84,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,,2,May,2021,,40,,,Processed,,N/A,37,Scheduled,147,Delayed,177,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.04,Negative,540,Positive,Elderly,,Post-2nd (8+ Weeks),20-Aug-21,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,84,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,3,August,2021,,125,,,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,6.47,Positive,1644,Positive,Elderly,,Post-4th,24-Mar-22,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,85,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,4,March,2022,,,,17,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,17,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,6.47,Positive,1153,Positive,Elderly,,Post-4th,15-Jul-22,baseline,11-Mar-21,Pfizer,17-Apr-21,Pfizer,11-Sep-21,Pfizer,07-Mar-22,Pfizer,,,85,70+,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,5,July,2022,,,,130,Completed,0-49,N/A,37,Scheduled,147,Delayed,177,,,,130,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,1.41,Positive,14690,Positive,Elderly,,Post-1st,16-Apr-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,59,1,April,2021,29,,,,Completed,250-999,N/A,42,Scheduled,209,Delayed,,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.14,Negative,1914,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,843,2,May,2021,,27,,,Completed,,N/A,42,Scheduled,209,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.03,Positive,167,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,109,3,September,2021,,139,,,Completed,250-999,N/A,42,Scheduled,209,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.45,Negative,1993,Positive,Elderly,,Post-3rd (1-8 Weeks),21-Dec-21,baseline,18-Mar-21,Pfizer,29-Apr-21,Pfizer,24-Nov-21,Pfizer,,,,,69,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5213,4,December,2021,,,27,,Completed,10000+,N/A,42,Scheduled,209,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,15843,Positive,Adult,-272,Post-2nd (8+ Weeks),26-Aug-21,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,12,1,August,2021,,189,,,Completed,50-249,N/A,39,Scheduled,209,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,116,Positive,Adult,-216,Post-3rd (1-8 Weeks),21-Oct-21,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1560,2,October,2021,,,36,,Completed,10000+,N/A,39,Scheduled,209,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,6050,Positive,Adult,-104,Post-3rd (8+ Weeks),10-Feb-22,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,506,3,February,2022,,,148,,Completed,1000-4999,N/A,39,Scheduled,209,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,1061,Positive,Adult,-48,Post-4th,07-Apr-22,baseline,10-Jan-21,Pfizer,18-Feb-21,Pfizer,15-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,821,4,April,2022,,,,51,Completed,,N/A,39,Scheduled,209,Delayed,153,,,,51,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.11,Negative,23599,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,23-Apr-21,Pfizer,03-Jun-21,Pfizer,12-Jan-22,Moderna,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,98,1,September,2021,,98,,,Completed,250-999,N/A,41,Scheduled,223,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.56,Negative,4545,Positive,Adult,,Post-3rd (1-8 Weeks),14-Feb-22,baseline,23-Apr-21,Pfizer,03-Jun-21,Pfizer,12-Jan-22,Moderna,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1456,2,February,2022,,,33,,Completed,10000+,N/A,41,Scheduled,223,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.56,Negative,80000,Positive,Adult,,Post-2nd (1-8 Weeks),18-Jun-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,285,1,June,2021,,8,,,Completed,1000-4999,N/A,61,Delayed,109,Scheduled,249,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.6,Negative,13009,Positive,Adult,,Post-2nd (8+ Weeks),13-Aug-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,77,2,August,2021,,64,,,Completed,250-999,N/A,61,Delayed,109,Scheduled,249,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.22,Negative,42264,Positive,Adult,,Post-3rd (1-8 Weeks),15-Nov-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,899,3,November,2021,,,49,,Completed,,N/A,61,Delayed,109,Scheduled,249,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.14,Negative,7844,Positive,Adult,,Post-3rd (8+ Weeks),28-Jan-22,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,27-Sep-21,Pfizer,03-Jun-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,223,4,January,2022,,,123,,Completed,1000-4999,N/A,61,Delayed,109,Scheduled,249,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,1648,Positive,Adult,,Pre-1st,09-Mar-21,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,33,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,1,March,2021,,,,,Completed,0-49,N/A,28,Scheduled,121,Delayed,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,3.96,Positive,14,Negative,Adult,,Post-1st,03-May-21,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,33,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,15,2,May,2021,25,,,,Completed,50-249,N/A,28,Scheduled,121,Delayed,158,25,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,7763,Positive,Adult,,Post-2nd (1-8 Weeks),01-Jun-21,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,33,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,271,3,June,2021,,26,,,Completed,1000-4999,N/A,28,Scheduled,121,Delayed,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,1541,Positive,Adult,,Post-3rd (8+ Weeks),19-Jan-22,baseline,08-Apr-21,Pfizer,06-May-21,Pfizer,04-Sep-21,Pfizer,09-Feb-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,374,4,January,2022,,,137,,Completed,1000-4999,N/A,28,Scheduled,121,Delayed,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,762,Positive,Adult,-236,Post-2nd (8+ Weeks),24-Aug-21,baseline,15-Apr-21,Pfizer,09-May-21,Pfizer,23-Sep-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,16,1,August,2021,,107,,,Completed,50-249,N/A,24,Scheduled,137,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.03,Negative,1671,Positive,Adult,-166,Post-3rd (1-8 Weeks),02-Nov-21,baseline,15-Apr-21,Pfizer,09-May-21,Pfizer,23-Sep-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,776,2,November,2021,,,40,,Completed,,N/A,24,Scheduled,137,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,3138,Positive,Adult,,Pre-1st,15-Apr-21,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,64,Delayed,99,Scheduled,221,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.15,Negative,978,Positive,Adult,,Post-1st,26-May-21,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,328,2,May,2021,35,,,,Completed,1000-4999,N/A,64,Delayed,99,Scheduled,221,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2359,Positive,Adult,,Post-3rd (1-8 Weeks),22-Oct-21,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,9829,4,October,2021,,,21,,Completed,10000+,N/A,64,Delayed,99,Scheduled,221,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,126,Positive,Adult,,Post-3rd (8+ Weeks),16-Feb-22,baseline,21-Apr-21,Moderna,24-Jun-21,Moderna,01-Oct-21,Pfizer,10-May-22,Moderna,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1592,5,February,2022,,,138,,Completed,10000+,N/A,64,Delayed,99,Scheduled,221,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.19,Negative,2689,Positive,Adult,-280,Pre-1st,12-Mar-21,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,47,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,1,March,2021,,,,,Completed,0-49,N/A,62,Delayed,161,Delayed,202,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.48,Positive,21080,Positive,Adult,-141,Post-2nd (1-8 Weeks),29-Jul-21,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,47,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,113,2,July,2021,,48,,,Completed,250-999,N/A,62,Delayed,161,Delayed,202,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.17,Negative,120,Positive,Adult,0,Post-3rd (1-8 Weeks),17-Dec-21,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,48,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,230,3,December,2021,,,28,,Completed,1000-4999,N/A,62,Delayed,161,Delayed,202,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.14,Negative,3889,Positive,Adult,56,Post-3rd (8+ Weeks),11-Feb-22,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,48,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,2367,4,February,2022,,,84,,Completed,10000+,N/A,62,Delayed,161,Delayed,202,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.14,Negative,35432,Positive,Adult,194,Post-4th,29-Jun-22,Post Vaccine covid,10-Apr-21,Pfizer,11-Jun-21,Pfizer,19-Nov-21,Pfizer,09-Jun-22,Pfizer,,,48,40-49,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,2735,5,June,2022,,,,20,Completed,10000+,N/A,62,Delayed,161,Delayed,202,,,,20,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,2186,Positive,Adult,,Post-3rd (1-8 Weeks),19-Nov-21,baseline,11-Apr-21,Moderna,11-Jun-21,Moderna,06-Oct-21,Moderna,,,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,2168,2,November,2021,,,44,,Completed,10000+,N/A,61,Delayed,117,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,82,Positive,Adult,,Post-3rd (8+ Weeks),22-Feb-22,baseline,11-Apr-21,Moderna,11-Jun-21,Moderna,06-Oct-21,Moderna,,,,,48,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,263,3,February,2022,,,139,,Completed,1000-4999,N/A,61,Delayed,117,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,1856,Positive,Elderly,,Pre-1st,08-Mar-21,baseline,29-Mar-21,Pfizer,10-Jun-21,Pfizer,13-Sep-21,Pfizer,21-Mar-22,Pfizer,,,65,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,73,Delayed,95,Scheduled,189,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,979,Positive,Elderly,,Post-3rd (8+ Weeks),11-Nov-21,baseline,29-Mar-21,Pfizer,10-Jun-21,Pfizer,13-Sep-21,Pfizer,21-Mar-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,41,2,November,2021,,,59,,Completed,250-999,N/A,73,Delayed,95,Scheduled,189,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,53528,Positive,Elderly,,Post-3rd (8+ Weeks),24-Jan-22,baseline,29-Mar-21,Pfizer,10-Jun-21,Pfizer,13-Sep-21,Pfizer,21-Mar-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,8,3,January,2022,,,133,,Completed,50-249,N/A,73,Delayed,95,Scheduled,189,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.02,Negative,10547,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,06-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,594,1,July,2021,,38,,,Completed,1000-4999,N/A,66,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.04,Negative,2586,Positive,Adult,,Post-3rd (8+ Weeks),19-Jan-22,baseline,06-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,39,30-39,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3442,2,January,2022,,,124,,Completed,10000+,N/A,66,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,2836,Positive,Elderly,-380,Post-1st,17-May-21,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,105,1,May,2021,56,,,,Completed,250-999,N/A,77,Delayed,192,Delayed,,56,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,8790,Positive,Elderly,-337,Post-2nd (1-8 Weeks),29-Jun-21,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,521,2,June,2021,,22,,,Completed,1000-4999,N/A,77,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,3946,Positive,Elderly,-135,Post-3rd (1-8 Weeks),17-Jan-22,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2848,3,January,2022,,,32,,Completed,10000+,N/A,77,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,86,Positive,Elderly,-36,Post-3rd (8+ Weeks),26-Apr-22,baseline,22-Mar-21,Moderna,07-Jun-21,Moderna,16-Dec-21,Pfizer,,,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,330,4,April,2022,,,131,,Completed,1000-4999,N/A,77,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,2125,Positive,Adult,,Post-2nd (8+ Weeks),09-Nov-21,baseline,15-May-21,Pfizer,08-Jul-21,Pfizer,18-Dec-21,Pfizer,,,,,57,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,November,2021,,124,,,Completed,0-49,N/A,54,Scheduled,163,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,763,Positive,Adult,,Post-3rd (1-8 Weeks),18-Jan-22,baseline,15-May-21,Pfizer,08-Jul-21,Pfizer,18-Dec-21,Pfizer,,,,,57,50-59,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,784,3,January,2022,,,31,,Completed,,N/A,54,Scheduled,163,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,4252,Positive,Adult,,Post-1st,08-Jun-21,baseline,14-Apr-21,Pfizer,10-Jun-21,Pfizer,19-Nov-21,Pfizer,02-May-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,June,2021,55,,,,Completed,0-49,N/A,57,Delayed,162,Delayed,164,55,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,3901,Positive,Adult,,Post-3rd (8+ Weeks),15-Jan-22,baseline,14-Apr-21,Pfizer,10-Jun-21,Pfizer,19-Nov-21,Pfizer,02-May-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,770,3,January,2022,,,57,,Completed,,N/A,57,Delayed,162,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,734,Positive,Adult,,Post-3rd (8+ Weeks),02-May-22,baseline,14-Apr-21,Pfizer,10-Jun-21,Pfizer,19-Nov-21,Pfizer,02-May-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,434,4,May,2022,,,164,,Completed,1000-4999,N/A,57,Delayed,162,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,35511,Positive,Adult,-212,Post-3rd (1-8 Weeks),17-Sep-21,baseline,07-Apr-21,Pfizer,03-May-21,Pfizer,03-Sep-21,Pfizer,15-Apr-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,308,2,September,2021,,,14,,Completed,1000-4999,N/A,26,Scheduled,123,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,345,Positive,Adult,-100,Post-3rd (8+ Weeks),07-Jan-22,baseline,07-Apr-21,Pfizer,03-May-21,Pfizer,03-Sep-21,Pfizer,15-Apr-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,19,3,January,2022,,,126,,Completed,50-249,N/A,26,Scheduled,123,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,4403,Positive,Elderly,,Pre-1st,05-Mar-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,49,Scheduled,132,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,20077,Positive,Elderly,,Post-1st,29-Apr-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,12,2,April,2021,41,,,,Completed,50-249,N/A,49,Scheduled,132,Delayed,151,41,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,7213,Positive,Elderly,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,222,3,June,2021,,47,,,Completed,1000-4999,N/A,49,Scheduled,132,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,25,Negative,Elderly,,Post-2nd (8+ Weeks),14-Sep-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,107,4,September,2021,,130,,,Completed,250-999,N/A,49,Scheduled,132,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5556,Positive,Elderly,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3533,5,October,2021,,,28,,Completed,10000+,N/A,49,Scheduled,132,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,9128,Positive,Elderly,,Post-3rd (8+ Weeks),13-Jan-22,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,72,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,492,6,January,2022,,,119,,Completed,1000-4999,N/A,49,Scheduled,132,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.77,Positive,986,Positive,Elderly,,Post-4th,05-Apr-22,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,73,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,7,April,2022,,,,50,Completed,10000+,N/A,49,Scheduled,132,Delayed,151,,,,50,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,2648,Positive,Elderly,,Post-4th,05-Jul-22,baseline,19-Mar-21,Moderna,07-May-21,Moderna,16-Sep-21,Moderna,14-Feb-22,Moderna,,,73,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,8,July,2022,,,,141,Completed,10000+,N/A,49,Scheduled,132,Delayed,151,,,,141,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Anti-TNF Only,0.03,Negative,437,Positive,Adult,-89,Post-2nd (1-8 Weeks),15-Jul-21,baseline,15-Apr-21,Pfizer,19-Jun-21,Pfizer,30-Sep-21,Pfizer,24-Jan-22,Pfizer,,,24,18-29,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,0,417,2,July,2021,,26,,,Completed,1000-4999,N/A,65,Delayed,103,Scheduled,116,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Anti-TNF Only,0.04,Negative,13168,Positive,Adult,0,Post-3rd (1-8 Weeks),12-Oct-21,baseline,15-Apr-21,Pfizer,19-Jun-21,Pfizer,30-Sep-21,Pfizer,24-Jan-22,Pfizer,,,25,18-29,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,1,0,11360,3,October,2021,,,12,,Completed,10000+,N/A,65,Delayed,103,Scheduled,116,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,1180,Positive,Adult,,Post-1st,04-May-21,baseline,08-Apr-21,Pfizer,15-May-21,Pfizer,29-Sep-21,Pfizer,,,,,51,50-59,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,1,1,May,2021,26,,,,Completed,0-49,N/A,37,Scheduled,137,Delayed,,26,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,10395,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,08-Apr-21,Pfizer,15-May-21,Pfizer,29-Sep-21,Pfizer,,,,,51,50-59,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,156,3,October,2021,,,29,,Completed,1000-4999,N/A,37,Scheduled,137,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,917,Positive,Adult,,Post-3rd (8+ Weeks),27-Jan-22,baseline,08-Apr-21,Pfizer,15-May-21,Pfizer,29-Sep-21,Pfizer,,,,,52,50-59,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,26,4,January,2022,,,120,,Completed,50-249,N/A,37,Scheduled,137,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.58,Negative,23705,Positive,Adult,-224,Post-2nd (1-8 Weeks),18-Jun-21,Post Vaccine covid,12-Apr-21,Pfizer,09-May-21,Pfizer,02-Sep-21,Pfizer,30-Apr-22,Pfizer,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,1,June,2021,,40,,,Processed,,N/A,27,Scheduled,116,Scheduled,240,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.02,Negative,3399,Positive,Adult,-113,Post-3rd (1-8 Weeks),07-Oct-21,Post Vaccine covid,12-Apr-21,Pfizer,09-May-21,Pfizer,02-Sep-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,937,2,October,2021,,,35,,Completed,,N/A,27,Scheduled,116,Scheduled,240,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.1,Negative,20410,Positive,Adult,20,Post-3rd (8+ Weeks),17-Feb-22,Post Vaccine covid,12-Apr-21,Pfizer,09-May-21,Pfizer,02-Sep-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3613,3,February,2022,,,168,,Completed,10000+,N/A,27,Scheduled,116,Scheduled,240,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,549,Positive,Adult,-216,Post-2nd (1-8 Weeks),13-Jul-21,Post Vaccine covid,15-Apr-21,Pfizer,16-Jun-21,Pfizer,12-Oct-21,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1461,1,July,2021,,27,,,Completed,10000+,N/A,62,Delayed,118,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.69,Negative,6627,Positive,Adult,-104,Post-3rd (1-8 Weeks),02-Nov-21,Post Vaccine covid,15-Apr-21,Pfizer,16-Jun-21,Pfizer,12-Oct-21,Pfizer,,,,,55,50-59,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,615,2,November,2021,,,21,,Completed,1000-4999,N/A,62,Delayed,118,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,272,Positive,Adult,25,Post-3rd (8+ Weeks),11-Mar-22,Post Vaccine covid,15-Apr-21,Pfizer,16-Jun-21,Pfizer,12-Oct-21,Pfizer,,,,,56,50-59,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1398,3,March,2022,,,150,,Completed,,N/A,62,Delayed,118,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Corticosteroids,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,120,Positive,Elderly,,Post-2nd (8+ Weeks),28-Jul-21,baseline,21-Apr-21,Moderna,19-May-21,Moderna,22-Oct-21,Moderna,,,,,71,70+,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,July,2021,,70,,,Completed,0-49,N/A,28,Scheduled,156,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Corticosteroids,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,10851,Positive,Elderly,,Post-2nd (8+ Weeks),22-Sep-21,baseline,21-Apr-21,Moderna,19-May-21,Moderna,22-Oct-21,Moderna,,,,,71,70+,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,September,2021,,126,,,Completed,0-49,N/A,28,Scheduled,156,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Corticosteroids,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,12952,Positive,Elderly,,Post-3rd (8+ Weeks),12-Jan-22,baseline,21-Apr-21,Moderna,19-May-21,Moderna,22-Oct-21,Moderna,,,,,71,70+,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,75,3,January,2022,,,82,,Completed,250-999,N/A,28,Scheduled,156,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,12841,Positive,Adult,,Pre-1st,09-Mar-21,baseline,13-Apr-21,Moderna,27-May-21,Moderna,12-Nov-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,44,Scheduled,169,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,522,Positive,Adult,,Post-1st,18-May-21,baseline,13-Apr-21,Moderna,27-May-21,Moderna,12-Nov-21,Pfizer,,,,,32,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,525,2,May,2021,35,,,,Completed,1000-4999,N/A,44,Scheduled,169,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,46,Negative,Adult,,Post-3rd (8+ Weeks),31-May-22,baseline,13-Apr-21,Moderna,27-May-21,Moderna,12-Nov-21,Pfizer,,,,,33,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7462,3,May,2022,,,200,,Completed,10000+,N/A,44,Scheduled,169,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,6932,Positive,Adult,,Post-2nd (1-8 Weeks),15-Jun-21,baseline,26-Apr-21,Pfizer,27-May-21,Pfizer,25-Jun-21,Pfizer,01-Sep-21,Pfizer,21-Jul-22,Pfizer,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1226,1,June,2021,,19,,,Completed,,N/A,31,Scheduled,29,Scheduled,68,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,981,Positive,Adult,,Post-3rd (1-8 Weeks),13-Jul-21,baseline,26-Apr-21,Pfizer,27-May-21,Pfizer,25-Jun-21,Pfizer,01-Sep-21,Pfizer,21-Jul-22,Pfizer,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3978,2,July,2021,,,18,,Completed,10000+,N/A,31,Scheduled,29,Scheduled,68,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,42,Negative,Adult,,Post-4th,06-Oct-21,baseline,26-Apr-21,Pfizer,27-May-21,Pfizer,25-Jun-21,Pfizer,01-Sep-21,Pfizer,21-Jul-22,Pfizer,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2422,3,October,2021,,,,35,Completed,10000+,N/A,31,Scheduled,29,Scheduled,68,,,,35,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,,0.01,Negative,76847,Positive,Adult,,Post-1st,20-Apr-21,baseline,16-Mar-21,AstraZeneca,17-Jun-21,Pfizer,17-Feb-22,Pfizer,,,,,62,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,14,1,April,2021,35,,,,Completed,50-249,N/A,93,Delayed,245,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,,0.02,Negative,30,Negative,Adult,,Post-2nd (1-8 Weeks),15-Jul-21,baseline,16-Mar-21,AstraZeneca,17-Jun-21,Pfizer,17-Feb-22,Pfizer,,,,,63,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,348,2,July,2021,,28,,,Completed,1000-4999,N/A,93,Delayed,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,,0.13,Negative,2598,Positive,Adult,,Post-3rd (8+ Weeks),16-May-22,baseline,16-Mar-21,AstraZeneca,17-Jun-21,Pfizer,17-Feb-22,Pfizer,,,,,63,60-69,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1522,3,May,2022,,,88,,Completed,10000+,N/A,93,Delayed,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.13,Negative,3111,Positive,Adult,,Pre-1st,01-Mar-21,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,52,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,43,Scheduled,143,Delayed,150,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.19,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),27-Jul-21,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,53,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,435,2,July,2021,,73,,,Completed,1000-4999,N/A,43,Scheduled,143,Delayed,150,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.02,Negative,7607,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,53,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,425,4,February,2022,,,133,,Completed,1000-4999,N/A,43,Scheduled,143,Delayed,150,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Ustekinumab Only,0.04,Negative,39645,Positive,Adult,,Post-4th,01-Apr-22,baseline,02-Apr-21,Pfizer,15-May-21,Pfizer,05-Oct-21,Pfizer,04-Mar-22,Pfizer,,,53,50-59,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,3946,5,April,2022,,,,28,Completed,10000+,N/A,43,Scheduled,143,Delayed,150,,,,28,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,430,Positive,Elderly,,Post-2nd (8+ Weeks),12-Jul-21,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,113,1,July,2021,,101,,,Completed,250-999,N/A,23,Scheduled,152,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5952,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,960,3,February,2022,,,155,,Completed,,N/A,23,Scheduled,152,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,5966,Positive,Elderly,,Post-4th,23-Apr-22,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1823,4,April,2022,,,,78,Completed,10000+,N/A,23,Scheduled,152,Delayed,156,,,,78,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.32,Negative,546,Positive,Elderly,,Post-4th,21-Jun-22,baseline,10-Mar-21,Pfizer,02-Apr-21,Pfizer,01-Sep-21,Pfizer,04-Feb-22,Pfizer,03-Jul-22,Pfizer,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1272,5,June,2022,,,,137,Completed,,N/A,23,Scheduled,152,Delayed,156,,,,137,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,3558,Positive,Adult,,Post-1st,20-May-21,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,4,1,May,2021,28,,,,Completed,0-49,N/A,40,Scheduled,115,Scheduled,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,108,Positive,Adult,,Post-3rd (1-8 Weeks),01-Nov-21,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,358,3,November,2021,,,38,,Completed,1000-4999,N/A,40,Scheduled,115,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,3119,Positive,Adult,,Post-3rd (8+ Weeks),10-Jan-22,baseline,22-Apr-21,Pfizer,01-Jun-21,Pfizer,24-Sep-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,120,4,January,2022,,,108,,Completed,250-999,N/A,40,Scheduled,115,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,1.75,Positive,7480,Positive,Adult,263,Pre-1st,08-Jan-21,Post Vaccine covid,10-Jun-21,Pfizer,15-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,1,January,2021,,,,,Completed,0-49,N/A,35,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.04,Negative,983,Positive,Adult,490,Post-2nd (1-8 Weeks),23-Aug-21,Post Vaccine covid,10-Jun-21,Pfizer,15-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3046,2,August,2021,,39,,,Completed,10000+,N/A,35,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.08,Negative,191,Positive,Adult,634,Post-2nd (8+ Weeks),14-Jan-22,Post Vaccine covid,10-Jun-21,Pfizer,15-Jul-21,Pfizer,,,,,,,51,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,932,3,January,2022,,183,,,Completed,,N/A,35,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,75,Positive,Adult,,Pre-1st,02-Mar-21,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,255,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1224,2,July,2021,,42,,,Completed,,N/A,71,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,34251,Positive,Adult,,Post-3rd (1-8 Weeks),11-Feb-22,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3704,3,February,2022,,,46,,Completed,10000+,N/A,71,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,37283,Positive,Adult,,Post-3rd (8+ Weeks),13-Jul-22,baseline,30-Mar-21,Pfizer,09-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6021,4,July,2022,,,198,,Completed,10000+,N/A,71,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,4224,Positive,Adult,,Post-3rd (1-8 Weeks),08-Oct-21,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,01-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,106,1,October,2021,,,37,,Completed,250-999,N/A,28,Scheduled,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,441,Positive,Adult,,Post-3rd (8+ Weeks),09-Feb-22,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,01-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,2,February,2022,,,161,,Completed,50-249,N/A,28,Scheduled,105,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,80000,Positive,Adult,-307,Post-1st,21-May-21,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,234,1,May,2021,37,,,,Completed,1000-4999,N/A,48,Scheduled,211,Delayed,,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,3552,Positive,Adult,-280,Post-2nd (1-8 Weeks),17-Jun-21,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2731,2,June,2021,,16,,,Completed,10000+,N/A,48,Scheduled,211,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.18,Negative,29244,Positive,Adult,-98,Post-2nd (8+ Weeks),16-Dec-21,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,251,3,December,2021,,198,,,Completed,1000-4999,N/A,48,Scheduled,211,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,8252,Positive,Adult,-55,Post-3rd (1-8 Weeks),28-Jan-22,baseline,14-Apr-21,Moderna,01-Jun-21,Moderna,29-Dec-21,Moderna,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10892,4,January,2022,,,30,,Completed,10000+,N/A,48,Scheduled,211,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,10835,Positive,Adult,,Pre-1st,01-Mar-21,baseline,03-Feb-22,Moderna,07-Apr-22,Moderna,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,63,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,17220,Positive,Adult,,Pre-1st,28-Jan-22,baseline,03-Feb-22,Moderna,07-Apr-22,Moderna,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,January,2022,,,,,Completed,0-49,N/A,63,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,8937,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,533,1,July,2021,,39,,,Completed,1000-4999,N/A,57,Delayed,102,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,7789,Positive,Adult,,Post-3rd (1-8 Weeks),19-Oct-21,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,834,2,October,2021,,,27,,Completed,,N/A,57,Delayed,102,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,11629,Positive,Adult,,Post-3rd (8+ Weeks),24-Jan-22,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,290,3,January,2022,,,124,,Completed,1000-4999,N/A,57,Delayed,102,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,3849,Positive,Adult,,Post-4th,17-Mar-22,baseline,16-Apr-21,Pfizer,12-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,37,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,768,4,March,2022,,,,22,Completed,,N/A,57,Delayed,102,Scheduled,154,,,,22,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,869,Positive,Adult,,Post-3rd (8+ Weeks),22-Jan-22,baseline,30-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Oct-21,Pfizer,20-Mar-22,Pfizer ,,,62,60-69,1,1,1,0,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,1,136,2,January,2022,,,90,,Completed,250-999,N/A,72,Delayed,136,Delayed,147,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,7572,Positive,Adult,,Post-4th,30-May-22,baseline,30-Mar-21,Pfizer,10-Jun-21,Pfizer,24-Oct-21,Pfizer,20-Mar-22,Pfizer ,,,62,60-69,1,1,1,0,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,1,119,3,May,2022,,,,71,Completed,250-999,N/A,72,Delayed,136,Delayed,147,,,,71,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,45728,Positive,Adult,,Post-2nd (8+ Weeks),23-Sep-21,baseline,03-May-21,Pfizer,30-May-21,Pfizer,02-Oct-21,Pfizer,06-Jun-22,Pfizer,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,415,2,September,2021,,116,,,Completed,1000-4999,N/A,27,Scheduled,125,Delayed,247,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,8609,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,03-May-21,Pfizer,30-May-21,Pfizer,02-Oct-21,Pfizer,06-Jun-22,Pfizer,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2616,3,October,2021,,,26,,Completed,10000+,N/A,27,Scheduled,125,Delayed,247,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2701,Positive,Adult,,Post-3rd (8+ Weeks),07-Feb-22,baseline,03-May-21,Pfizer,30-May-21,Pfizer,02-Oct-21,Pfizer,06-Jun-22,Pfizer,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,752,4,February,2022,,,128,,Completed,,N/A,27,Scheduled,125,Delayed,247,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,0.01,Negative,33873,Positive,Adult,,Post-2nd (1-8 Weeks),17-Aug-21,baseline,17-May-21,Pfizer,16-Jul-21,Moderna,05-Oct-21,Pfizer,,,,,63,60-69,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,August,2021,,32,,,Completed,0-49,N/A,60,Delayed,81,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,12333,Positive,Adult,-190,Post-3rd (8+ Weeks),14-Jan-22,baseline,22-Apr-21,Moderna,12-Jun-21,Moderna,12-Nov-21,Pfizer,15-Apr-22,Moderna ,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1966,2,January,2022,,,63,,Completed,10000+,N/A,51,Scheduled,153,Delayed,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,8771,Positive,Adult,-64,Post-4th,20-May-22,baseline,22-Apr-21,Moderna,12-Jun-21,Moderna,12-Nov-21,Pfizer,15-Apr-22,Moderna ,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2682,3,May,2022,,,,35,Completed,10000+,N/A,51,Scheduled,153,Delayed,154,,,,35,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,742,Positive,Adult,23,Pre-1st,15-Apr-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,58,1,April,2021,,,,,Completed,250-999,N/A,44,Scheduled,98,Scheduled,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,361,Positive,Adult,58,Post-1st,20-May-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,844,2,May,2021,32,,,,Completed,,N/A,44,Scheduled,98,Scheduled,161,32,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,6816,Positive,Adult,90,Post-2nd (1-8 Weeks),21-Jun-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1475,3,June,2021,,20,,,Completed,10000+,N/A,44,Scheduled,98,Scheduled,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,2762,Positive,Adult,189,Post-3rd (1-8 Weeks),28-Sep-21,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2528,4,September,2021,,,21,,Completed,10000+,N/A,44,Scheduled,98,Scheduled,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,22184,Positive,Adult,300,Post-3rd (8+ Weeks),17-Jan-22,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,357,5,January,2022,,,132,,Completed,1000-4999,N/A,44,Scheduled,98,Scheduled,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,54888,Positive,Adult,350,Post-4th,08-Mar-22,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2568,6,March,2022,,,,21,Completed,10000+,N/A,44,Scheduled,98,Scheduled,161,,,,21,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,21016,Positive,Adult,450,Post-4th,16-Jun-22,Baseline to COVID,18-Apr-21,Pfizer,01-Jun-21,Pfizer,07-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1023,7,June,2022,,,,121,Completed,,N/A,44,Scheduled,98,Scheduled,161,,,,121,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.04,Negative,2990,Positive,Adult,,Pre-1st,16-Mar-21,baseline,09-Apr-21,Pfizer,02-May-21,Pfizer,22-Sep-21,Pfizer,02-Mar-22,Pfizer,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,23,Scheduled,143,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.11,Negative,80000,Positive,Adult,,Post-2nd (1-8 Weeks),11-May-21,baseline,09-Apr-21,Pfizer,02-May-21,Pfizer,22-Sep-21,Pfizer,02-Mar-22,Pfizer,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,836,2,May,2021,,9,,,Completed,,N/A,23,Scheduled,143,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.11,Negative,32041,Positive,Adult,,Post-3rd (8+ Weeks),22-Dec-21,baseline,09-Apr-21,Pfizer,02-May-21,Pfizer,22-Sep-21,Pfizer,02-Mar-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,350,3,December,2021,,,91,,Completed,1000-4999,N/A,23,Scheduled,143,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,0,Negative,Adult,,Pre-1st,30-Mar-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,64,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,0,Negative,Adult,,Post-2nd (1-8 Weeks),28-Jul-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,20,3,July,2021,,47,,,Completed,50-249,N/A,64,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,0,Negative,Adult,,Post-2nd (8+ Weeks),18-Aug-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,4,August,2021,,68,,,Completed,50-249,N/A,64,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,0,Negative,Adult,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,196,5,September,2021,,,12,,Completed,1000-4999,N/A,64,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,691,Positive,Adult,,Post-3rd (8+ Weeks),22-Feb-22,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,6,February,2022,,,158,,Completed,0-49,N/A,64,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,85,Positive,Adult,,Post-3rd (8+ Weeks),17-May-22,baseline,08-Apr-21,AstraZeneca,11-Jun-21,Pfizer,17-Sep-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,45,7,May,2022,,,242,,Completed,250-999,N/A,64,Delayed,98,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,2371,Positive,Adult,,Post-2nd (1-8 Weeks),17-Jul-21,baseline,16-Mar-21,AstraZeneca,13-Jun-21,AstraZeneca,21-Sep-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,175,1,July,2021,,34,,,Completed,1000-4999,N/A,89,Delayed,100,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1862,Positive,Adult,,Post-3rd (1-8 Weeks),28-Oct-21,baseline,16-Mar-21,AstraZeneca,13-Jun-21,AstraZeneca,21-Sep-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3870,2,October,2021,,,37,,Completed,10000+,N/A,89,Delayed,100,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,7636,Positive,Adult,,Post-3rd (8+ Weeks),23-Feb-22,baseline,16-Mar-21,AstraZeneca,13-Jun-21,AstraZeneca,21-Sep-21,Pfizer,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,336,3,February,2022,,,155,,Completed,1000-4999,N/A,89,Delayed,100,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1246,Positive,Adult,-353,Pre-1st,05-Mar-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,22,Scheduled,144,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,2,Negative,Adult,-272,Post-2nd (1-8 Weeks),25-May-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1399,2,May,2021,,11,,,Completed,,N/A,22,Scheduled,144,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,,,Adult,-150,Post-2nd (8+ Weeks),24-Sep-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,46,3,September,2021,,133,,,Completed,250-999,N/A,22,Scheduled,144,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,37,Negative,Adult,-108,Post-3rd (1-8 Weeks),05-Nov-21,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1550,4,November,2021,,,31,,Completed,10000+,N/A,22,Scheduled,144,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,0,Negative,Adult,14,Post-3rd (8+ Weeks),07-Mar-22,Post Vaccine covid,22-Apr-21,Pfizer,14-May-21,Pfizer,05-Oct-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2546,5,March,2022,,,153,,Completed,10000+,N/A,22,Scheduled,144,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,5580,Positive,Adult,,Post-1st,28-Apr-21,baseline,22-Mar-21,AstraZeneca,27-May-21,Pfizer,14-Sep-21,Pfizer,20-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,9,1,April,2021,37,,,,Completed,50-249,N/A,66,Delayed,110,Scheduled,159,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,4686,Positive,Adult,,Post-3rd (1-8 Weeks),13-Oct-21,baseline,22-Mar-21,AstraZeneca,27-May-21,Pfizer,14-Sep-21,Pfizer,20-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,361,2,October,2021,,,29,,Completed,1000-4999,N/A,66,Delayed,110,Scheduled,159,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,25349,Positive,Adult,,Post-4th,11-May-22,baseline,22-Mar-21,AstraZeneca,27-May-21,Pfizer,14-Sep-21,Pfizer,20-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,73,3,May,2022,,,,80,Completed,250-999,N/A,66,Delayed,110,Scheduled,159,,,,80,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,,,0.41,Negative,108,Positive,Adult,,Pre-1st,16-Aug-21,baseline,12-Oct-21,Pfizer,15-Nov-21,Pfizer,,,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,August,2021,,,,,Completed,0-49,N/A,34,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,1273,Positive,Adult,85,Pre-1st,15-Jan-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,165,1,January,2021,,,,,Completed,1000-4999,N/A,55,Scheduled,117,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,228,Positive,Adult,134,Pre-1st,05-Mar-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,128,2,March,2021,,,,,Completed,250-999,N/A,55,Scheduled,117,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,395,Positive,Adult,211,Post-1st,21-May-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1794,3,May,2021,32,,,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,32,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,27432,Positive,Adult,246,Post-2nd (1-8 Weeks),25-Jun-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,8737,4,June,2021,,12,,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2136,Positive,Adult,326,Post-2nd (8+ Weeks),13-Sep-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2310,5,September,2021,,92,,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2258,Positive,Adult,368,Post-3rd (1-8 Weeks),25-Oct-21,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,8492,6,October,2021,,,17,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,12198,Positive,Adult,494,Post-3rd (8+ Weeks),28-Feb-22,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2109,7,February,2022,,,143,,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,2073,Positive,Adult,527,Post-4th,02-Apr-22,covid,19-Apr-21,Pfizer,13-Jun-21,Pfizer,08-Oct-21,Pfizer,11-Mar-22,Pfizer,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,5974,8,April,2022,,,,22,Completed,10000+,N/A,55,Scheduled,117,Scheduled,154,,,,22,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,1897,Positive,Adult,-167,Post-2nd (1-8 Weeks),06-Aug-21,Post Vaccine covid,08-Apr-21,Pfizer,14-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,45,40-49,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1325,1,August,2021,,53,,,Completed,,N/A,67,Delayed,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,IBD-U,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,6800,Positive,Adult,12,Post-3rd (1-8 Weeks),01-Feb-22,Post Vaccine covid,08-Apr-21,Pfizer,14-Jun-21,Pfizer,04-Jan-22,Moderna,,,,,45,40-49,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,2093,2,February,2022,,,28,,Completed,10000+,N/A,67,Delayed,204,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.05,Negative,7774,Positive,Adult,,Pre-1st,09-Jan-21,baseline,01-Sep-21,Pfizer,29-Sep-21,Pfizer,,,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,January,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.26,Negative,12209,Positive,Adult,,Pre-1st,09-Jul-21,baseline,01-Sep-21,Pfizer,29-Sep-21,Pfizer,,,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,July,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,3235,Positive,Adult,-250,Post-1st,12-Jun-21,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,1,June,2021,38,,,,Completed,0-49,N/A,43,Scheduled,97,Scheduled,,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.1,Negative,14366,Positive,Adult,-196,Post-2nd (1-8 Weeks),05-Aug-21,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,596,2,August,2021,,49,,,Completed,1000-4999,N/A,43,Scheduled,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2426,Positive,Adult,-112,Post-3rd (1-8 Weeks),28-Oct-21,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,312,3,October,2021,,,36,,Completed,1000-4999,N/A,43,Scheduled,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,9724,Positive,Adult,-29,Post-3rd (8+ Weeks),19-Jan-22,Post Vaccine covid,05-May-21,Pfizer,17-Jun-21,Pfizer,22-Sep-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,244,4,January,2022,,,119,,Completed,1000-4999,N/A,43,Scheduled,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,1536,Positive,Adult,,Post-2nd (8+ Weeks),28-Jul-21,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,18-Dec-21,Pfizer,25-May-22,Moderna,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,136,1,July,2021,,70,,,Completed,250-999,N/A,28,Scheduled,213,Delayed,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,1064,Positive,Adult,,Post-2nd (8+ Weeks),08-Sep-21,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,18-Dec-21,Pfizer,25-May-22,Moderna,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,60,2,September,2021,,112,,,Completed,250-999,N/A,28,Scheduled,213,Delayed,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,48561,Positive,Adult,,Post-3rd (1-8 Weeks),15-Jan-22,baseline,21-Apr-21,Pfizer,19-May-21,Pfizer,18-Dec-21,Pfizer,25-May-22,Moderna,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,5010,3,January,2022,,,28,,Completed,10000+,N/A,28,Scheduled,213,Delayed,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,4242,Positive,Adult,-389,Pre-1st,16-Mar-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,40,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,55,Scheduled,85,Scheduled,173,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,2366,Positive,Adult,-301,Post-1st,12-Jun-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,2,June,2021,51,,,,Completed,0-49,N/A,55,Scheduled,85,Scheduled,173,51,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,21200,Positive,Adult,-274,Post-2nd (1-8 Weeks),09-Jul-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,54,3,July,2021,,23,,,Completed,250-999,N/A,55,Scheduled,85,Scheduled,173,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.08,Negative,4450,Positive,Adult,-192,Post-3rd (1-8 Weeks),29-Sep-21,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,567,4,September,2021,,,20,,Completed,1000-4999,N/A,55,Scheduled,85,Scheduled,173,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.25,Negative,6295,Positive,Adult,-79,Post-3rd (8+ Weeks),20-Jan-22,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,80,5,January,2022,,,133,,Completed,250-999,N/A,55,Scheduled,85,Scheduled,173,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,748,Positive,Adult,-23,Post-4th,17-Mar-22,baseline,22-Apr-21,Pfizer,16-Jun-21,Pfizer,09-Sep-21,Pfizer,01-Mar-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1883,6,March,2022,,,,16,Completed,10000+,N/A,55,Scheduled,85,Scheduled,173,,,,16,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,5921,Positive,Elderly,,Post-1st,23-Apr-21,baseline,19-Mar-21,Pfizer,30-Apr-21,Pfizer,23-Oct-21,Pfizer,,,,,70,70+,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,1,April,2021,35,,,,Completed,0-49,N/A,42,Scheduled,176,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,7049,Positive,Elderly,,Post-3rd (8+ Weeks),07-Feb-22,baseline,19-Mar-21,Pfizer,30-Apr-21,Pfizer,23-Oct-21,Pfizer,,,,,71,70+,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,297,2,February,2022,,,107,,Completed,1000-4999,N/A,42,Scheduled,176,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.16,Negative,56345,Positive,Adult,-479,Post-1st,11-Feb-21,baseline,07-Jan-21,Pfizer,15-Feb-21,Pfizer,15-Nov-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2,1,February,2021,35,,,,Completed,0-49,N/A,39,Scheduled,273,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,1864,Positive,Adult,-174,Post-3rd (1-8 Weeks),13-Dec-21,baseline,07-Jan-21,Pfizer,15-Feb-21,Pfizer,15-Nov-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1196,3,December,2021,,,28,,Completed,,N/A,39,Scheduled,273,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,40848,Positive,Adult,-72,Post-3rd (8+ Weeks),25-Mar-22,baseline,07-Jan-21,Pfizer,15-Feb-21,Pfizer,15-Nov-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,409,4,March,2022,,,130,,Completed,1000-4999,N/A,39,Scheduled,273,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,368,Positive,Adult,,Pre-1st,01-Apr-21,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,22,Scheduled,197,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,23927,Positive,Adult,,Post-2nd (8+ Weeks),17-Aug-21,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,120,2,August,2021,,92,,,Completed,250-999,N/A,22,Scheduled,197,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,37642,Positive,Adult,,Post-3rd (1-8 Weeks),14-Jan-22,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4480,3,January,2022,,,45,,Completed,10000+,N/A,22,Scheduled,197,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,4205,Positive,Adult,,Post-3rd (8+ Weeks),27-May-22,baseline,25-Apr-21,Pfizer,17-May-21,Pfizer,30-Nov-21,Pfizer,12-Jul-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5977,4,May,2022,,,178,,Completed,10000+,N/A,22,Scheduled,197,Delayed,224,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,971,Positive,Adult,-188,Pre-1st,23-Mar-21,baseline,09-Apr-21,Moderna,10-May-21,Moderna,03-Sep-21,Moderna,12-Mar-22,Moderna,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,31,Scheduled,116,Scheduled,190,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,30146,Positive,Adult,0,Post-3rd (1-8 Weeks),27-Sep-21,baseline,09-Apr-21,Moderna,10-May-21,Moderna,03-Sep-21,Moderna,12-Mar-22,Moderna,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3644,2,September,2021,,,24,,Completed,10000+,N/A,31,Scheduled,116,Scheduled,190,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,11649,Positive,Adult,57,Post-3rd (8+ Weeks),23-Nov-21,baseline,09-Apr-21,Moderna,10-May-21,Moderna,03-Sep-21,Moderna,12-Mar-22,Moderna,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1408,3,November,2021,,,81,,Completed,,N/A,31,Scheduled,116,Scheduled,190,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,597,Positive,Elderly,0,Post-1st,06-May-21,baseline,24-Mar-21,Pfizer,01-Jun-21,Pfizer,03-Dec-21,Pfizer,,,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,1,May,2021,43,,,,Completed,50-249,N/A,69,Delayed,185,Delayed,,43,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,4646,Positive,Elderly,348,Post-3rd (8+ Weeks),19-Apr-22,baseline,24-Mar-21,Pfizer,01-Jun-21,Pfizer,03-Dec-21,Pfizer,,,,,69,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2602,3,April,2022,,,137,,Completed,10000+,N/A,69,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.04,Negative,9861,Positive,Elderly,,Pre-1st,12-Mar-21,baseline,28-Mar-21,Pfizer,24-Apr-21,Pfizer,09-Nov-21,Pfizer,13-Apr-22,Pfizer,,,74,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,27,Scheduled,199,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,6062,Positive,Elderly,,Post-3rd (8+ Weeks),19-Apr-22,baseline,28-Mar-21,Pfizer,24-Apr-21,Pfizer,09-Nov-21,Pfizer,13-Apr-22,Pfizer,,,75,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,53,3,April,2022,,,161,,Completed,250-999,N/A,27,Scheduled,199,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.03,Negative,453,Positive,Elderly,,Post-4th,04-May-22,baseline,28-Mar-21,Pfizer,24-Apr-21,Pfizer,09-Nov-21,Pfizer,13-Apr-22,Pfizer,,,75,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1700,4,May,2022,,,,21,Completed,10000+,N/A,27,Scheduled,199,Delayed,155,,,,21,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,621,Positive,Adult,,Post-1st,14-May-21,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,200,1,May,2021,29,,,,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,747,Positive,Adult,,Post-3rd (8+ Weeks),03-Nov-21,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,668,3,November,2021,,,62,,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,1976,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,179,4,January,2022,,,140,,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,348,Positive,Adult,,Post-4th,20-Jun-22,baseline,15-Apr-21,Moderna,18-Jun-21,Pfizer,02-Sep-21,Pfizer,16-Feb-22,Pfizer,,,47,40-49,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,400,5,June,2022,,,,124,Completed,1000-4999,N/A,64,Delayed,76,Scheduled,167,,,,124,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,4553,Positive,Adult,,Post-2nd (8+ Weeks),26-Jul-21,baseline,03-Apr-21,Pfizer,19-May-21,Pfizer,04-Oct-21,Pfizer,12-May-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,165,2,July,2021,,68,,,Completed,1000-4999,N/A,46,Scheduled,138,Delayed,220,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,1056,Positive,Adult,,Post-3rd (1-8 Weeks),26-Oct-21,baseline,03-Apr-21,Pfizer,19-May-21,Pfizer,04-Oct-21,Pfizer,12-May-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,7585,3,October,2021,,,22,,Completed,10000+,N/A,46,Scheduled,138,Delayed,220,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,4282,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,03-Apr-21,Pfizer,19-May-21,Pfizer,04-Oct-21,Pfizer,12-May-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,961,4,February,2022,,,133,,Completed,,N/A,46,Scheduled,138,Delayed,220,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.12,Negative,435,Positive,Adult,,Post-2nd (8+ Weeks),23-Jul-21,baseline,12-Apr-21,Pfizer,10-May-21,Pfizer,06-Aug-21,Pfizer,30-Oct-21,Pfizer,10-Mar-22,Moderna ,50,50-59,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,64,1,July,2021,,74,,,Completed,250-999,N/A,28,Scheduled,88,Scheduled,85,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,691,Positive,Adult,393,Post-2nd (8+ Weeks),13-Apr-21,covid,04-Jan-21,Pfizer,11-Feb-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2907,1,April,2021,,61,,,Completed,10000+,N/A,38,Scheduled,293,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,12658,Positive,Elderly,,Post-1st,13-Apr-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,65,1,April,2021,28,,,,Completed,250-999,N/A,24,Scheduled,194,Delayed,160,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,702,Positive,Elderly,,Post-2nd (1-8 Weeks),04-May-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,303,2,May,2021,,25,,,Completed,1000-4999,N/A,24,Scheduled,194,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.11,Negative,504,Positive,Elderly,,Post-2nd (8+ Weeks),20-Jul-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,159,3,July,2021,,102,,,Completed,1000-4999,N/A,24,Scheduled,194,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,3880,Positive,Elderly,,Post-3rd (1-8 Weeks),16-Nov-21,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3547,4,November,2021,,,27,,Completed,10000+,N/A,24,Scheduled,194,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,6476,Positive,Elderly,,Post-3rd (8+ Weeks),02-Mar-22,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1236,5,March,2022,,,133,,Completed,,N/A,24,Scheduled,194,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,626,Positive,Elderly,,Post-4th,21-Apr-22,baseline,16-Mar-21,Pfizer,09-Apr-21,Pfizer,20-Oct-21,Pfizer,29-Mar-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,6,April,2022,,,,23,Completed,10000+,N/A,24,Scheduled,194,Delayed,160,,,,23,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,3.57,Positive,28498,Positive,Adult,,Post-2nd (8+ Weeks),22-Jul-21,baseline,28-Apr-21,Pfizer,19-May-21,Pfizer,29-Dec-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,135,1,July,2021,,64,,,Completed,250-999,N/A,21,Scheduled,224,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.99,Positive,1705,Positive,Adult,,Post-2nd (8+ Weeks),17-Sep-21,baseline,28-Apr-21,Pfizer,19-May-21,Pfizer,29-Dec-21,Pfizer,,,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,93,2,September,2021,,121,,,Completed,250-999,N/A,21,Scheduled,224,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.99,Positive,19817,Positive,Adult,,Post-3rd (1-8 Weeks),07-Jan-22,baseline,28-Apr-21,Pfizer,19-May-21,Pfizer,29-Dec-21,Pfizer,,,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,114,3,January,2022,,,9,,Completed,250-999,N/A,21,Scheduled,224,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,1358,Positive,Adult,,Pre-1st,17-Apr-21,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,59,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,5675,Positive,Adult,,Post-1st,10-Jun-21,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,June,2021,35,,,,Completed,0-49,N/A,59,Delayed,192,Delayed,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.08,Negative,125,Positive,Adult,,Post-2nd (1-8 Weeks),21-Aug-21,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,70,3,August,2021,,48,,,Completed,250-999,N/A,59,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.08,Negative,,,Adult,,Post-3rd (1-8 Weeks),03-Feb-22,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,97,4,February,2022,,,22,,Completed,250-999,N/A,59,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.39,Negative,295,Positive,Adult,,Post-3rd (8+ Weeks),10-Jun-22,baseline,06-May-21,Pfizer,04-Jul-21,Pfizer,12-Jan-22,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,17,5,June,2022,,,149,,Completed,50-249,N/A,59,Delayed,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,10178,Positive,Adult,,Post-1st,04-May-21,baseline,13-Apr-21,Moderna,15-Jul-21,Moderna,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,447,1,May,2021,21,,,,Completed,1000-4999,N/A,93,Delayed,,Delayed,,21,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,42358,Positive,Adult,,Post-2nd (1-8 Weeks),19-Aug-21,baseline,13-Apr-21,Moderna,15-Jul-21,Moderna,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2826,2,August,2021,,35,,,Completed,10000+,N/A,93,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.05,Negative,9357,Positive,Adult,,Post-2nd (8+ Weeks),17-Feb-22,baseline,13-Apr-21,Moderna,15-Jul-21,Moderna,,,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,551,3,February,2022,,217,,,Completed,1000-4999,N/A,93,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,13866,Positive,Adult,43,Pre-1st,05-Feb-21,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,2,1,February,2021,,,,,Completed,0-49,N/A,47,Scheduled,103,Scheduled,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,2919,Positive,Adult,159,Post-1st,01-Jun-21,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,35,2,June,2021,32,,,,Completed,50-249,N/A,47,Scheduled,103,Scheduled,158,32,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,3203,Positive,Adult,302,Post-3rd (1-8 Weeks),22-Oct-21,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,349,4,October,2021,,,25,,Completed,1000-4999,N/A,47,Scheduled,103,Scheduled,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.95,Positive,21561,Positive,Adult,411,Post-3rd (8+ Weeks),08-Feb-22,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,45,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1129,5,February,2022,,,134,,Completed,,N/A,47,Scheduled,103,Scheduled,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.95,Positive,21697,Positive,Adult,464,Post-4th,02-Apr-22,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,45,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,3015,6,April,2022,,,,29,Completed,10000+,N/A,47,Scheduled,103,Scheduled,158,,,,29,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,830,Positive,Adult,566,Post-4th,13-Jul-22,covid,30-Apr-21,Pfizer,16-Jun-21,Pfizer,27-Sep-21,Pfizer,04-Mar-22,Moderna,,,45,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,879,7,July,2022,,,,131,Completed,,N/A,47,Scheduled,103,Scheduled,158,,,,131,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),27-Aug-21,baseline,09-Apr-21,Pfizer,14-Jun-21,Pfizer,08-Dec-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,535,1,August,2021,,74,,,Completed,1000-4999,N/A,66,Delayed,177,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,29137,Positive,Adult,,Post-3rd (1-8 Weeks),20-Jan-22,baseline,09-Apr-21,Pfizer,14-Jun-21,Pfizer,08-Dec-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,603,2,January,2022,,,43,,Completed,1000-4999,N/A,66,Delayed,177,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,22215,Positive,Adult,,Post-3rd (8+ Weeks),28-Apr-22,baseline,09-Apr-21,Pfizer,14-Jun-21,Pfizer,08-Dec-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1415,3,April,2022,,,141,,Completed,,N/A,66,Delayed,177,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,67844,Positive,Adult,,Post-1st,26-May-21,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,105,2,May,2021,30,,,,Completed,250-999,N/A,36,Scheduled,119,Scheduled,234,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,3,Negative,Adult,,Post-2nd (1-8 Weeks),15-Jul-21,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,310,3,July,2021,,44,,,Completed,1000-4999,N/A,36,Scheduled,119,Scheduled,234,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,1897,Positive,Adult,,Post-3rd (8+ Weeks),28-Mar-22,baseline,26-Apr-21,Moderna,01-Jun-21,Moderna,28-Sep-21,Moderna,20-May-22,Moderna,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,273,5,March,2022,,,181,,Completed,1000-4999,N/A,36,Scheduled,119,Scheduled,234,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,,,,,0.02,Negative,795,Positive,Adult,,,11-Feb-21,Suspected COVID-19/Symptomatic,,,,,,,,,,,34,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,1,February,2021,,,,,Completed,250-999,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,,,,,0.03,Negative,54482,Positive,Adult,,,26-Aug-21,Suspected COVID-19/Symptomatic,,,,,,,,,,,35,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,2,August,2021,,,,,Completed,50-249,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,3.04,Positive,2089,Positive,Adult,,Pre-1st,07-Apr-21,baseline,09-Apr-21,Pfizer,17-Jun-21,Pfizer,,,,,,,50,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,69,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,31314,Positive,Adult,-352,Pre-1st,22-Apr-21,baseline,27-Apr-21,Moderna,21-Jun-21,Moderna,17-Jan-22,Moderna,,,,,44,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,55,Scheduled,210,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.04,Negative,240,Positive,Adult,,Pre-1st,08-Mar-21,baseline,30-Mar-21,Pfizer,11-Jun-21,Pfizer,,,,,,,55,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,73,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.45,Negative,1911,Positive,Adult,,Post-1st,07-May-21,baseline,30-Mar-21,Pfizer,11-Jun-21,Pfizer,,,,,,,56,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,223,2,May,2021,38,,,,Completed,1000-4999,N/A,73,Delayed,,Delayed,,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.08,Negative,138,Positive,Adult,,Pre-1st,08-Mar-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,47,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,2,1,March,2021,,,,,Completed,0-49,N/A,33,Scheduled,119,Scheduled,191,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.2,Negative,2150,Positive,Adult,,Post-2nd (1-8 Weeks),07-Jun-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,47,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,3831,2,June,2021,,32,,,Completed,10000+,N/A,33,Scheduled,119,Scheduled,191,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,3.29,Positive,373,Positive,Adult,,Post-3rd (1-8 Weeks),23-Sep-21,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,47,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,3428,3,September,2021,,,21,,Completed,10000+,N/A,33,Scheduled,119,Scheduled,191,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,3.29,Positive,2914,Positive,Adult,,Post-3rd (8+ Weeks),09-Mar-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,48,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,596,4,March,2022,,,188,,Completed,1000-4999,N/A,33,Scheduled,119,Scheduled,191,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Corticosteroids,0.06,Negative,4543,Positive,Adult,,Post-4th,09-Jun-22,baseline,03-Apr-21,Pfizer,06-May-21,Pfizer,02-Sep-21,Pfizer,12-Mar-22,Pfizer,,,48,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1751,5,June,2022,,,,89,Completed,10000+,N/A,33,Scheduled,119,Scheduled,191,,,,89,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.25,Negative,2112,Positive,Adult,,Pre-1st,03-Mar-21,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,81,Delayed,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,1014,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1312,2,July,2021,,36,,,Completed,,N/A,81,Delayed,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.56,Negative,16365,Positive,Adult,,Post-3rd (1-8 Weeks),11-Jan-22,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2009,3,January,2022,,,36,,Completed,10000+,N/A,81,Delayed,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,6.85,Positive,3,Negative,Adult,,Post-3rd (8+ Weeks),04-Apr-22,baseline,01-Apr-21,Pfizer,21-Jun-21,Pfizer,06-Dec-21,Pfizer,,,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1148,4,April,2022,,,119,,Completed,,N/A,81,Delayed,168,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.07,Negative,6178,Positive,Adult,,Pre-1st,05-Mar-21,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,34,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,1,March,2021,,,,,Completed,0-49,N/A,56,Scheduled,140,Delayed,229,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.07,Negative,777,Positive,Adult,,Post-2nd (1-8 Weeks),18-Aug-21,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,35,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,162,2,August,2021,,42,,,Completed,1000-4999,N/A,56,Scheduled,140,Delayed,229,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,5726,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,35,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,49,3,February,2022,,,71,,Completed,250-999,N/A,56,Scheduled,140,Delayed,229,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.33,Positive,2051,Positive,Adult,,Post-3rd (8+ Weeks),25-May-22,baseline,12-May-21,Pfizer,07-Jul-21,Pfizer,24-Nov-21,Pfizer,11-Jul-22,Pfizer,,,35,30-39,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,55,4,May,2022,,,182,,Completed,250-999,N/A,56,Scheduled,140,Delayed,229,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,,,Adult,,Pre-1st,05-Mar-21,baseline,15-Apr-21,Pfizer,23-Jun-21,Pfizer,14-Sep-21,Pfizer,27-Jun-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,69,Delayed,83,Scheduled,286,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,6888,Positive,Adult,-44,Pre-1st,29-Mar-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,64,Delayed,105,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.96,Positive,2329,Positive,Adult,0,Post-1st,12-May-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,184,2,May,2021,29,,,,Completed,1000-4999,N/A,64,Delayed,105,Scheduled,155,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.96,Positive,15402,Positive,Adult,96,Post-2nd (8+ Weeks),16-Aug-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,78,3,August,2021,,61,,,Completed,250-999,N/A,64,Delayed,105,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,199,Positive,Adult,142,Post-2nd (8+ Weeks),01-Oct-21,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,21,4,October,2021,,107,,,Completed,50-249,N/A,64,Delayed,105,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,7,Negative,Adult,265,Post-3rd (8+ Weeks),01-Feb-22,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,158,5,February,2022,,,125,,Completed,1000-4999,N/A,64,Delayed,105,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3665,Positive,Adult,331,Post-4th,08-Apr-22,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3446,6,April,2022,,,,36,Completed,10000+,N/A,64,Delayed,105,Scheduled,155,,,,36,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,49964,Positive,Adult,404,Post-4th,20-Jun-22,baseline,13-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Sep-21,Pfizer,03-Mar-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,511,7,June,2022,,,,109,Completed,1000-4999,N/A,64,Delayed,105,Scheduled,155,,,,109,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,40000,Positive,Elderly,,Post-1st,19-May-21,baseline,05-Apr-21,Pfizer,23-Jun-21,Pfizer,29-Dec-21,Pfizer,06-Jul-22,Pfizer,,,69,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,4,1,May,2021,44,,,,Completed,0-49,N/A,79,Delayed,189,Delayed,189,44,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.95,Positive,25,Negative,Adult,93,Pre-1st,06-Apr-21,covid,18-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,1,April,2021,,,,,Completed,50-249,N/A,45,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.19,Negative,1291,Positive,Adult,206,Post-2nd (1-8 Weeks),28-Jul-21,covid,18-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,23,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1380,2,July,2021,,26,,,Completed,,N/A,45,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Immunomodulator Only,,0.19,Negative,1173,Positive,Adult,132,Post-3rd (8+ Weeks),01-Jun-22,Post Vaccine covid,23-Apr-21,Pfizer,17-Jun-21,Pfizer,10-Jan-22,Moderna,,,,,43,40-49,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5680,2,June,2022,,,142,,Completed,10000+,N/A,55,Scheduled,207,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.1,Positive,10517,Positive,Adult,,Pre-1st,09-Mar-21,baseline,09-Apr-21,Pfizer,03-May-21,Pfizer,28-Sep-21,Pfizer,,,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,24,Scheduled,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,5.22,Positive,85,Positive,Adult,,Post-3rd (1-8 Weeks),18-Oct-21,baseline,09-Apr-21,Pfizer,03-May-21,Pfizer,28-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1435,2,October,2021,,,20,,Completed,10000+,N/A,24,Scheduled,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,3.13,Positive,1023,Positive,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,09-Apr-21,Pfizer,03-May-21,Pfizer,28-Sep-21,Pfizer,,,,,37,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,182,3,February,2022,,,133,,Completed,1000-4999,N/A,24,Scheduled,148,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,1,Negative,Adult,-232,Post-1st,22-Feb-21,Post Vaccine covid,13-Jan-21,Pfizer,23-Feb-21,Pfizer,09-Oct-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,19,1,February,2021,40,,,,Completed,50-249,N/A,41,Scheduled,228,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.54,Negative,73,Positive,Adult,-227,Post-1st,22-May-21,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,93,1,May,2021,30,,,,Completed,250-999,N/A,57,Delayed,238,Delayed,,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,1633,Positive,Adult,-154,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1142,2,August,2021,,46,,,Completed,,N/A,57,Delayed,238,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.28,Negative,774,Positive,Adult,-5,Post-2nd (8+ Weeks),30-Dec-21,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,35,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,101,3,December,2021,,195,,,Completed,250-999,N/A,57,Delayed,238,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.84,Positive,2690,Positive,Adult,129,Post-3rd (8+ Weeks),13-May-22,Post Vaccine covid,22-Apr-21,Pfizer,18-Jun-21,Pfizer,11-Feb-22,Pfizer,,,,,36,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5680,4,May,2022,,,91,,Completed,10000+,N/A,57,Delayed,238,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,,,,,,,1286,Positive,Adult,-102,,14-Sep-21,Baseline to COVID,,,,,,,,,,,47,40-49,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,September,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,33233,Positive,Adult,164,Pre-1st,28-Jan-21,covid,06-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,31,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,1,January,2021,,,,,Completed,50-249,N/A,57,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,,40000,Positive,Adult,682,Post-2nd (8+ Weeks),30-Jun-22,covid,06-May-21,Pfizer,02-Jul-21,Pfizer,,,,,,,32,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2537,2,June,2022,,363,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,197,Positive,Adult,-223,Post-2nd (8+ Weeks),12-Aug-21,baseline,11-Apr-21,Pfizer,16-Jun-21,Pfizer,11-Oct-21,Pfizer,07-Jul-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,416,1,August,2021,,57,,,Completed,1000-4999,N/A,66,Delayed,117,Scheduled,269,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,7874,Positive,Adult,-125,Post-3rd (1-8 Weeks),18-Nov-21,baseline,11-Apr-21,Pfizer,16-Jun-21,Pfizer,11-Oct-21,Pfizer,07-Jul-22,Pfizer,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1656,2,November,2021,,,38,,Completed,10000+,N/A,66,Delayed,117,Scheduled,269,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,80000,Positive,Adult,,Post-2nd (8+ Weeks),26-May-21,baseline,13-Jan-21,Pfizer,19-Feb-21,Pfizer,17-Jan-22,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,1,May,2021,,96,,,Completed,50-249,N/A,37,Scheduled,332,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,14475,Positive,Adult,,Post-2nd (8+ Weeks),10-Sep-21,baseline,13-Jan-21,Pfizer,19-Feb-21,Pfizer,17-Jan-22,Pfizer,,,,,45,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8,2,September,2021,,203,,,Completed,50-249,N/A,37,Scheduled,332,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,3421,Positive,Adult,,Post-3rd (8+ Weeks),17-Jun-22,baseline,13-Jan-21,Pfizer,19-Feb-21,Pfizer,17-Jan-22,Pfizer,,,,,46,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,271,3,June,2022,,,151,,Completed,1000-4999,N/A,37,Scheduled,332,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,2879,Positive,Adult,,Post-2nd (8+ Weeks),18-Aug-21,baseline,10-Apr-21,Pfizer,19-Jun-21,Pfizer,02-Nov-21,Pfizer,15-Jun-22,Pfizer,,,36,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,3591,2,August,2021,,60,,,Completed,10000+,N/A,70,Delayed,136,Delayed,225,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,5,Negative,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,07-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,31-May-22,Moderna,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,737,1,July,2021,,55,,,Completed,,N/A,35,Scheduled,134,Delayed,250,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,232,Positive,Adult,,Post-2nd (8+ Weeks),23-Sep-21,baseline,07-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,31-May-22,Moderna,,,37,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,277,2,September,2021,,134,,,Completed,1000-4999,N/A,35,Scheduled,134,Delayed,250,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,11516,Positive,Adult,,Post-3rd (8+ Weeks),24-Feb-22,baseline,07-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,31-May-22,Moderna,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,572,3,February,2022,,,154,,Completed,1000-4999,N/A,35,Scheduled,134,Delayed,250,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,,,0.03,Negative,28755,Positive,Adult,,Pre-1st,24-Mar-21,baseline,06-Oct-21,Moderna,03-Nov-21,Moderna,,,,,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,,,0.01,Negative,7827,Positive,Adult,,Pre-1st,14-Jul-21,baseline,06-Oct-21,Moderna,03-Nov-21,Moderna,,,,,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,July,2021,,,,,Completed,0-49,N/A,28,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,4,Negative,Elderly,,Post-1st,31-Mar-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,83,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,1,March,2021,31,,,,Completed,0-49,N/A,44,Scheduled,177,Delayed,,31,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,186,Positive,Elderly,,Post-2nd (1-8 Weeks),12-May-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,83,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,88,2,May,2021,,29,,,Completed,250-999,N/A,44,Scheduled,177,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,5019,Positive,Elderly,,Post-2nd (8+ Weeks),27-Aug-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,84,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,3,August,2021,,136,,,Completed,0-49,N/A,44,Scheduled,177,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,593,Positive,Elderly,,Post-3rd (8+ Weeks),15-Dec-21,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,84,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,88,4,December,2021,,,69,,Completed,250-999,N/A,44,Scheduled,177,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,8375,Positive,Elderly,,Post-3rd (8+ Weeks),17-Feb-22,baseline,28-Feb-21,Pfizer,13-Apr-21,Pfizer,07-Oct-21,Pfizer,,,,,84,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,36,5,February,2022,,,133,,Completed,250-999,N/A,44,Scheduled,177,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,,,0.06,Negative,597,Positive,Adult,52,Pre-1st,14-May-21,Baseline to COVID,07-Jul-21,Moderna,03-Nov-21,Moderna,,,,,,,30,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,212,1,May,2021,,,,,Completed,1000-4999,52 Days Before Collection Days After Collection,119,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,11702,Positive,Elderly,329,Post-2nd (1-8 Weeks),25-Feb-21,covid,31-Dec-20,Pfizer,07-Feb-21,Pfizer,07-Oct-21,Pfizer,,,,,67,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5521,1,February,2021,,18,,,Completed,10000+,N/A,38,Scheduled,242,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,1961,Positive,Elderly,537,Post-2nd (8+ Weeks),21-Sep-21,covid,31-Dec-20,Pfizer,07-Feb-21,Pfizer,07-Oct-21,Pfizer,,,,,68,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,735,2,September,2021,,226,,,Completed,,N/A,38,Scheduled,242,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,20865,Positive,Elderly,664,Post-3rd (8+ Weeks),26-Jan-22,covid,31-Dec-20,Pfizer,07-Feb-21,Pfizer,07-Oct-21,Pfizer,,,,,68,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1150,3,January,2022,,,111,,Completed,,N/A,38,Scheduled,242,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,1330,Positive,Adult,,Pre-1st,18-Aug-21,baseline,27-Oct-21,Pfizer,26-Nov-21,Pfizer,,,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,August,2021,,,,,Completed,0-49,N/A,30,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.92,Positive,206,Positive,Adult,,Pre-1st,13-Apr-21,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,48,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,33,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,1400,Positive,Adult,,Post-2nd (1-8 Weeks),18-Jun-21,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,588,2,June,2021,,31,,,Completed,1000-4999,N/A,33,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.87,Positive,17,Negative,Adult,,Post-2nd (8+ Weeks),22-Sep-21,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,297,3,September,2021,,127,,,Completed,1000-4999,N/A,33,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,4774,Positive,Adult,,Post-3rd (8+ Weeks),17-May-22,baseline,15-Apr-21,Pfizer,18-May-21,Pfizer,04-Jan-22,Moderna,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5680,5,May,2022,,,133,,Completed,10000+,N/A,33,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2646,Positive,Adult,-191,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2444,1,August,2021,,18,,,Completed,10000+,N/A,98,Delayed,66,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,129,Positive,Adult,-13,Post-3rd (8+ Weeks),28-Jan-22,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1204,2,January,2022,,,130,,Completed,,N/A,98,Delayed,66,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,574,Positive,Adult,42,Post-4th,24-Mar-22,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,3,March,2022,,,,28,Completed,10000+,N/A,98,Delayed,66,Scheduled,157,,,,28,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.64,Negative,8229,Positive,Adult,160,Post-4th,20-Jul-22,Post Vaccine covid,09-Apr-21,Pfizer,16-Jul-21,Pfizer,20-Sep-21,Pfizer,24-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,4,July,2022,,,,146,Completed,10000+,N/A,98,Delayed,66,Scheduled,157,,,,146,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,28042,Positive,Adult,-337,Post-1st,22-May-21,baseline,10-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,14-Apr-22,Pfizer,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,33,1,May,2021,42,,,,Completed,50-249,N/A,65,Delayed,85,Scheduled,219,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,11064,Positive,Adult,-304,Post-2nd (1-8 Weeks),24-Jun-21,baseline,10-Apr-21,Pfizer,14-Jun-21,Pfizer,07-Sep-21,Pfizer,14-Apr-22,Pfizer,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,203,2,June,2021,,10,,,Completed,1000-4999,N/A,65,Delayed,85,Scheduled,219,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,58542,Positive,Adult,,Pre-1st,26-Mar-21,baseline,29-Apr-21,Pfizer,09-Jun-21,Pfizer,26-Sep-21,Pfizer,26-Feb-22,Pfizer,,,19,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,41,Scheduled,109,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,9848,Positive,Adult,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,29-Apr-21,Pfizer,09-Jun-21,Pfizer,26-Sep-21,Pfizer,26-Feb-22,Pfizer,,,20,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1534,2,July,2021,,41,,,Completed,10000+,N/A,41,Scheduled,109,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,5113,Positive,Adult,,Post-1st,13-May-21,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,3,1,May,2021,19,,,,Completed,0-49,N/A,68,Delayed,205,Delayed,,19,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,183,Positive,Adult,,Post-2nd (8+ Weeks),28-Sep-21,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,127,2,September,2021,,89,,,Completed,250-999,N/A,68,Delayed,205,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,601,Positive,Adult,,Post-3rd (1-8 Weeks),15-Feb-22,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,2109,3,February,2022,,,24,,Completed,10000+,N/A,68,Delayed,205,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,78052,Positive,Adult,,Post-3rd (8+ Weeks),05-Jul-22,baseline,24-Apr-21,Moderna,01-Jul-21,Moderna,22-Jan-22,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,437,4,July,2022,,,164,,Completed,1000-4999,N/A,68,Delayed,205,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.12,Negative,29608,Positive,Adult,,Pre-1st,16-Mar-21,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,38,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,82,Delayed,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,37945,Positive,Adult,,Post-1st,28-May-21,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,62,2,May,2021,55,,,,Completed,250-999,N/A,82,Delayed,97,Scheduled,,55,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.12,Negative,18113,Positive,Adult,,Post-2nd (1-8 Weeks),17-Aug-21,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1564,3,August,2021,,54,,,Completed,10000+,N/A,82,Delayed,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,2,Negative,Adult,,Post-3rd (8+ Weeks),08-Feb-22,baseline,03-Apr-21,Pfizer,24-Jun-21,Pfizer,29-Sep-21,Pfizer,,,,,39,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,312,4,February,2022,,,132,,Completed,1000-4999,N/A,82,Delayed,97,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,5,Negative,Adult,-251,Pre-1st,03-May-21,baseline,03-May-21,Pfizer,28-Jun-21,Pfizer,21-Sep-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,May,2021,,,,,Completed,0-49,N/A,56,Scheduled,85,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,2,Negative,Adult,-181,Post-2nd (1-8 Weeks),12-Jul-21,baseline,03-May-21,Pfizer,28-Jun-21,Pfizer,21-Sep-21,Pfizer,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,996,3,July,2021,,14,,,Completed,,N/A,56,Scheduled,85,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.05,Negative,1,Negative,Adult,39,Post-1st,21-May-21,Baseline to COVID,05-May-21,Pfizer,20-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,776,1,May,2021,16,,,,Completed,,N/A,76,Delayed,,Delayed,,16,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.03,Negative,0,Negative,Adult,120,Post-2nd (1-8 Weeks),10-Aug-21,Baseline to COVID,05-May-21,Pfizer,20-Jul-21,Pfizer,,,,,,,50,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,899,2,August,2021,,21,,,Completed,,N/A,76,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,415,Positive,Adult,,Post-1st,01-May-21,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,May,2021,23,,,,Completed,0-49,N/A,85,Delayed,80,Scheduled,166,23,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,5937,Positive,Adult,,Post-2nd (1-8 Weeks),24-Jul-21,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,113,2,July,2021,,22,,,Completed,250-999,N/A,85,Delayed,80,Scheduled,166,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,770,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,844,3,October,2021,,,25,,Completed,,N/A,85,Delayed,80,Scheduled,166,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,36709,Positive,Adult,,Post-3rd (8+ Weeks),21-Jan-22,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,55,4,January,2022,,,123,,Completed,250-999,N/A,85,Delayed,80,Scheduled,166,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,690,Positive,Adult,,Post-4th,02-Apr-22,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1494,5,April,2022,,,,28,Completed,10000+,N/A,85,Delayed,80,Scheduled,166,,,,28,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,10254,Positive,Adult,,Post-4th,06-Jul-22,baseline,08-Apr-21,Pfizer,02-Jul-21,Pfizer,20-Sep-21,Pfizer,05-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,171,6,July,2022,,,,123,Completed,1000-4999,N/A,85,Delayed,80,Scheduled,166,,,,123,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,2004,Positive,Adult,-222,Post-2nd (1-8 Weeks),22-Mar-21,Post Vaccine covid,13-Jan-21,Pfizer,20-Feb-21,Pfizer,28-Nov-21,Pfizer,,,,,27,18-29,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6607,1,March,2021,,30,,,Completed,10000+,N/A,38,Scheduled,281,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,541,Positive,Adult,115,Post-3rd (8+ Weeks),22-Feb-22,Post Vaccine covid,13-Jan-21,Pfizer,20-Feb-21,Pfizer,28-Nov-21,Pfizer,,,,,28,18-29,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,2,February,2022,,,86,,Completed,10000+,N/A,38,Scheduled,281,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,1570,Positive,Adult,213,Post-2nd (8+ Weeks),10-Sep-21,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,825,2,September,2021,,105,,,Completed,,N/A,51,Scheduled,161,Delayed,176,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,5,Negative,Adult,324,Post-3rd (1-8 Weeks),30-Dec-21,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,5028,3,December,2021,,,55,,Completed,10000+,N/A,51,Scheduled,161,Delayed,176,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,108,Positive,Adult,435,Post-3rd (8+ Weeks),20-Apr-22,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,1440,4,April,2022,,,166,,Completed,10000+,N/A,51,Scheduled,161,Delayed,176,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,1909,Positive,Adult,462,Post-4th,17-May-22,covid,07-Apr-21,Pfizer,28-May-21,Pfizer,05-Nov-21,Pfizer,30-Apr-22,Pfizer,,,59,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,4836,5,May,2022,,,,17,Completed,10000+,N/A,51,Scheduled,161,Delayed,176,,,,17,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,2633,Positive,Adult,,Post-2nd (1-8 Weeks),25-May-21,baseline,14-Apr-21,Pfizer,06-May-21,Pfizer,09-Dec-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1005,1,May,2021,,19,,,Completed,,N/A,22,Scheduled,217,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,7,Negative,Adult,,Post-3rd (1-8 Weeks),21-Dec-21,baseline,14-Apr-21,Pfizer,06-May-21,Pfizer,09-Dec-21,Pfizer,,,,,47,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4280,2,December,2021,,,12,,Completed,10000+,N/A,22,Scheduled,217,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,2310,Positive,Adult,,Pre-1st,13-Apr-21,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,53,Scheduled,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,,,Adult,,Post-1st,09-Jun-21,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,2,June,2021,30,,,,Completed,50-249,N/A,53,Scheduled,229,Delayed,,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,69216,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1202,3,July,2021,,20,,,Completed,,N/A,53,Scheduled,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,11212,Positive,Adult,,Post-2nd (8+ Weeks),14-Feb-22,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,104,4,February,2022,,227,,,Completed,250-999,N/A,53,Scheduled,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,4169,Positive,Adult,,Post-3rd (1-8 Weeks),15-Mar-22,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2096,5,March,2022,,,27,,Completed,10000+,N/A,53,Scheduled,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,15266,Positive,Adult,,Post-3rd (8+ Weeks),23-Jun-22,baseline,10-May-21,Moderna,02-Jul-21,Moderna,16-Feb-22,Pfizer,,,,,53,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,530,6,June,2022,,,127,,Completed,1000-4999,N/A,53,Scheduled,229,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.05,Negative,1850,Positive,Adult,,Pre-1st,16-Apr-21,baseline,12-Apr-21,Moderna,22-May-21,Moderna,,,,,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,40,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,290,Positive,Adult,,Post-1st,30-Jul-21,baseline,11-Apr-21,Pfizer,26-Jul-21,Pfizer,29-Dec-21,Pfizer,,,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2293,2,July,2021,110,,,,Completed,10000+,N/A,106,Delayed,156,Delayed,,110,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,53,Positive,Adult,,Post-3rd (1-8 Weeks),11-Jan-22,baseline,11-Apr-21,Pfizer,26-Jul-21,Pfizer,29-Dec-21,Pfizer,,,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9747,3,January,2022,,,13,,Completed,10000+,N/A,106,Delayed,156,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,24237,Positive,Adult,-180,Post-3rd (1-8 Weeks),25-Oct-21,baseline,07-Apr-21,Pfizer,04-Jun-21,Pfizer,01-Oct-21,Pfizer,,,,,24,18-29,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,4298,1,October,2021,,,24,,Completed,10000+,N/A,58,Delayed,119,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,3,Negative,Adult,-435,Pre-1st,01-Mar-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,37,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,60,Delayed,117,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,10,Negative,Adult,-355,Post-1st,20-May-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,326,2,May,2021,40,,,,Completed,1000-4999,N/A,60,Delayed,117,Scheduled,153,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5520,Positive,Adult,-319,Post-2nd (1-8 Weeks),25-Jun-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3985,3,June,2021,,16,,,Completed,10000+,N/A,60,Delayed,117,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Combination Therapy,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.13,Negative,5,Negative,Adult,-194,Post-3rd (1-8 Weeks),28-Oct-21,baseline,10-Apr-21,Pfizer,09-Jun-21,Pfizer,04-Oct-21,Pfizer,06-Mar-22,Pfizer,,,38,30-39,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,8766,4,October,2021,,,24,,Completed,10000+,N/A,60,Delayed,117,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,5,Negative,Elderly,,Post-2nd (8+ Weeks),17-Sep-21,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,73,2,September,2021,,148,,,Completed,250-999,N/A,42,Scheduled,169,Delayed,166,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,87,Positive,Elderly,,Post-3rd (1-8 Weeks),26-Oct-21,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2792,3,October,2021,,,18,,Completed,10000+,N/A,42,Scheduled,169,Delayed,166,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,754,Positive,Elderly,,Post-4th,06-Jul-22,baseline,11-Mar-21,Pfizer,22-Apr-21,Pfizer,08-Oct-21,Pfizer,23-Mar-22,Pfizer,,,68,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,5680,5,July,2022,,,,105,Completed,10000+,N/A,42,Scheduled,169,Delayed,166,,,,105,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,24881,Positive,Elderly,-340,Post-2nd (1-8 Weeks),16-Apr-21,baseline,11-Mar-21,Pfizer,03-Apr-21,Pfizer,06-Oct-21,Pfizer,10-Jun-22,Pfizer,,,81,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,863,1,April,2021,,13,,,Completed,,N/A,23,Scheduled,186,Delayed,247,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,3461,Positive,Elderly,-315,Post-2nd (1-8 Weeks),11-May-21,baseline,11-Mar-21,Pfizer,03-Apr-21,Pfizer,06-Oct-21,Pfizer,10-Jun-22,Pfizer,,,81,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,125,2,May,2021,,38,,,Completed,250-999,N/A,23,Scheduled,186,Delayed,247,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,80000,Positive,Elderly,-203,Post-2nd (8+ Weeks),31-Aug-21,baseline,11-Mar-21,Pfizer,03-Apr-21,Pfizer,06-Oct-21,Pfizer,10-Jun-22,Pfizer,,,81,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,60,3,August,2021,,150,,,Completed,250-999,N/A,23,Scheduled,186,Delayed,247,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,5,Negative,Adult,,Post-2nd (8+ Weeks),25-Aug-21,baseline,12-Apr-21,Pfizer,11-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,51,1,August,2021,,75,,,Completed,250-999,N/A,60,Delayed,174,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,808,Positive,Adult,,Post-3rd (8+ Weeks),17-Feb-22,baseline,12-Apr-21,Pfizer,11-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,250,2,February,2022,,,77,,Completed,1000-4999,N/A,60,Delayed,174,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1102,Positive,Adult,,Post-3rd (8+ Weeks),05-Apr-22,baseline,12-Apr-21,Pfizer,11-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,115,3,April,2022,,,124,,Completed,250-999,N/A,60,Delayed,174,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,181,Positive,Adult,12,Pre-1st,18-Jan-21,covid,22-Apr-21,Pfizer,26-Jul-21,Pfizer,,,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,1,January,2021,,,,,Completed,50-249,N/A,95,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,38,Negative,Adult,68,Pre-1st,15-Mar-21,covid,22-Apr-21,Pfizer,26-Jul-21,Pfizer,,,,,,,29,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,2,March,2021,,,,,Completed,250-999,N/A,95,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,13,Negative,Adult,,Post-1st,31-May-21,baseline,13-Apr-21,Moderna,07-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,142,1,May,2021,48,,,,Completed,250-999,N/A,55,Scheduled,204,Delayed,,48,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,3,Negative,Adult,,Post-2nd (8+ Weeks),18-Aug-21,baseline,10-Apr-21,Pfizer,15-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1243,3,August,2021,,64,,,Completed,,N/A,66,Delayed,182,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.01,Negative,3698,Positive,Adult,103,Pre-1st,12-Mar-21,covid,21-Apr-21,Pfizer,25-Jun-21,Pfizer,,,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,1,March,2021,,,,,Completed,50-249,N/A,65,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.12,Negative,52548,Positive,Adult,87,Post-1st,10-Feb-21,covid,14-Jan-21,Pfizer,22-Feb-21,Pfizer,06-Dec-21,Pfizer,,,,,47,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2974,1,February,2021,27,,,,Completed,10000+,N/A,39,Scheduled,287,Delayed,,27,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.12,Negative,8636,Positive,Adult,341,Post-2nd (8+ Weeks),22-Oct-21,covid,14-Jan-21,Pfizer,22-Feb-21,Pfizer,06-Dec-21,Pfizer,,,,,48,40-49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,254,2,October,2021,,242,,,Completed,1000-4999,N/A,39,Scheduled,287,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,28017,Positive,Adult,,Pre-1st,06-Apr-21,baseline,02-Apr-21,Pfizer,28-May-21,Pfizer,17-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,56,Scheduled,203,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.23,Negative,17054,Positive,Adult,,Post-2nd (8+ Weeks),24-Aug-21,baseline,02-Apr-21,Pfizer,28-May-21,Pfizer,17-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,213,2,August,2021,,88,,,Completed,1000-4999,N/A,56,Scheduled,203,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.16,Negative,101,Positive,Adult,,Pre-1st,17-Mar-21,baseline,24-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,25,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,49,Scheduled,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,2449,Positive,Adult,,Post-1st,12-Jun-21,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,37,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,44,1,June,2021,45,,,,Completed,250-999,N/A,51,Scheduled,145,Delayed,,45,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,10717,Positive,Adult,,Post-2nd (1-8 Weeks),11-Jul-21,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,37,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,4548,2,July,2021,,23,,,Completed,10000+,N/A,51,Scheduled,145,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,1,Negative,Adult,,Post-3rd (1-8 Weeks),07-Dec-21,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,38,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,3620,3,December,2021,,,27,,Completed,10000+,N/A,51,Scheduled,145,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,3066,Positive,Adult,,Post-3rd (8+ Weeks),27-Mar-22,baseline,28-Apr-21,Pfizer,18-Jun-21,Pfizer,10-Nov-21,Pfizer,,,,,38,30-39,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,878,4,March,2022,,,137,,Completed,,N/A,51,Scheduled,145,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,2992,Positive,Adult,,Post-1st,17-May-21,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,57,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,2,May,2021,37,,,,Completed,50-249,N/A,62,Delayed,190,Delayed,,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,27789,Positive,Adult,,Post-2nd (8+ Weeks),16-Dec-21,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,72,3,December,2021,,188,,,Completed,250-999,N/A,62,Delayed,190,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,797,Positive,Adult,,Post-3rd (1-8 Weeks),25-Jan-22,baseline,10-Apr-21,AstraZeneca,11-Jun-21,Pfizer,18-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1171,4,January,2022,,,38,,Completed,,N/A,62,Delayed,190,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.03,Negative,6760,Positive,Adult,215,Pre-1st,22-Feb-21,covid,28-Jul-21,Pfizer,28-Aug-21,Pfizer,,,,,,,32,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,1,February,2021,,,,,Completed,250-999,N/A,31,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,12841,Positive,Adult,-306,Pre-1st,03-Apr-21,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,April,2021,,,,,Completed,0-49,N/A,57,Delayed,138,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,8956,Positive,Adult,-231,Post-1st,17-Jun-21,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,2,June,2021,36,,,,Completed,0-49,N/A,57,Delayed,138,Delayed,199,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.35,Negative,26,Negative,Adult,-196,Post-2nd (1-8 Weeks),22-Jul-21,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,6,3,July,2021,,14,,,Completed,0-49,N/A,57,Delayed,138,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,2518,Positive,Adult,91,Post-3rd (8+ Weeks),05-May-22,baseline,12-May-21,Pfizer,08-Jul-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,39,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,295,5,May,2022,,,163,,Completed,1000-4999,N/A,57,Delayed,138,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.07,Negative,842,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,09-Apr-21,Pfizer,30-May-21,Pfizer,03-Sep-21,Pfizer,15-Feb-22,Pfizer,,,26,18-29,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,62,1,July,2021,,40,,,Completed,250-999,N/A,51,Scheduled,96,Scheduled,165,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.07,Negative,473,Positive,Adult,,Post-3rd (8+ Weeks),07-Jan-22,baseline,09-Apr-21,Pfizer,30-May-21,Pfizer,03-Sep-21,Pfizer,15-Feb-22,Pfizer,,,27,18-29,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,63,2,January,2022,,,126,,Completed,250-999,N/A,51,Scheduled,96,Scheduled,165,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,2,Negative,Adult,,Post-4th,21-May-22,baseline,09-Apr-21,Pfizer,30-May-21,Pfizer,03-Sep-21,Pfizer,15-Feb-22,Pfizer,,,27,18-29,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,121,3,May,2022,,,,95,Completed,250-999,N/A,51,Scheduled,96,Scheduled,165,,,,95,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,8620,Positive,Adult,-28,Pre-1st,14-Mar-21,Baseline to COVID,19-May-21,Pfizer,01-Aug-21,Moderna,24-Jan-22,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,74,Delayed,176,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,26085,Positive,Adult,,Pre-1st,12-Mar-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,33,Scheduled,134,Delayed,229,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,42404,Positive,Adult,,Post-1st,07-May-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,39,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,73,2,May,2021,28,,,,Completed,250-999,N/A,33,Scheduled,134,Delayed,229,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,745,Positive,Adult,,Post-2nd (8+ Weeks),16-Aug-21,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,524,3,August,2021,,96,,,Completed,1000-4999,N/A,33,Scheduled,134,Delayed,229,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.16,Negative,69,Positive,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,09-Apr-21,Pfizer,12-May-21,Pfizer,23-Sep-21,Pfizer,10-May-22,Moderna,,,40,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1314,4,February,2022,,,133,,Completed,,N/A,33,Scheduled,134,Delayed,229,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,2,Negative,Adult,,Pre-1st,16-Mar-21,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,66,Delayed,179,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,2,Negative,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1444,3,July,2021,,24,,,Completed,10000+,N/A,66,Delayed,179,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,2039,Positive,Adult,,Post-3rd (8+ Weeks),22-Apr-22,baseline,20-Apr-21,AstraZeneca,25-Jun-21,Pfizer,21-Dec-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,186,6,April,2022,,,122,,Completed,1000-4999,N/A,66,Delayed,179,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,5408,Positive,Adult,,Post-1st,30-Mar-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,26,1,March,2021,38,,,,Completed,50-249,N/A,38,Scheduled,156,Delayed,144,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.92,Positive,2964,Positive,Adult,,Post-2nd (8+ Weeks),02-Jun-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,63,2,June,2021,,64,,,Completed,250-999,N/A,38,Scheduled,156,Delayed,144,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,961,Positive,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,22,3,September,2021,,156,,,Completed,50-249,N/A,38,Scheduled,156,Delayed,144,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,838,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,57,4,January,2022,,,140,,Completed,250-999,N/A,38,Scheduled,156,Delayed,144,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,2,Negative,Adult,,Post-4th,24-Mar-22,baseline,20-Feb-21,Pfizer,30-Mar-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Pfizer,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,312,5,March,2022,,,,59,Completed,1000-4999,N/A,38,Scheduled,156,Delayed,144,,,,59,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,2923,Positive,Adult,51,Pre-1st,10-Feb-21,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,48,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1279,1,February,2021,,,,,Completed,,N/A,67,Delayed,167,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,18419,Positive,Adult,147,Post-1st,17-May-21,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5488,2,May,2021,36,,,,Completed,10000+,N/A,67,Delayed,167,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,5293,Positive,Adult,234,Post-2nd (8+ Weeks),12-Aug-21,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1434,3,August,2021,,56,,,Completed,10000+,N/A,67,Delayed,167,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.19,Negative,4,Negative,Adult,399,Post-3rd (1-8 Weeks),24-Jan-22,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2767,4,January,2022,,,54,,Completed,10000+,N/A,67,Delayed,167,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,8,Negative,Adult,491,Post-3rd (8+ Weeks),26-Apr-22,covid,11-Apr-21,Pfizer,17-Jun-21,Pfizer,01-Dec-21,Pfizer,,,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1629,5,April,2022,,,146,,Completed,10000+,N/A,67,Delayed,167,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.02,Negative,0,Negative,Adult,76,Pre-1st,16-Feb-21,covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,116,1,February,2021,,,,,Completed,250-999,N/A,54,Scheduled,187,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.02,Negative,1,Negative,Adult,175,Post-1st,26-May-21,covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3505,2,May,2021,34,,,,Completed,10000+,N/A,54,Scheduled,187,Delayed,,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,,0.02,Negative,5891,Positive,Adult,271,Post-2nd (8+ Weeks),30-Aug-21,covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,39,30-39,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2069,3,August,2021,,76,,,Completed,10000+,N/A,54,Scheduled,187,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,2463,Positive,Adult,,Post-1st,20-Apr-21,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,1,April,2021,13,,,,Completed,0-49,N/A,69,Delayed,185,Delayed,,13,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,6,Negative,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,312,2,August,2021,,50,,,Completed,1000-4999,N/A,69,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,18,Negative,Adult,,Post-3rd (1-8 Weeks),25-Jan-22,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,740,3,January,2022,,,39,,Completed,,N/A,69,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Anti-TNF Only,Anti-TNF Only,,0.08,Negative,139,Positive,Adult,,Post-3rd (8+ Weeks),02-Jun-22,baseline,07-Apr-21,Pfizer,15-Jun-21,Pfizer,17-Dec-21,Pfizer,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1008,4,June,2022,,,167,,Completed,,N/A,69,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,108,Positive,Elderly,,Pre-1st,24-Mar-21,baseline,05-Apr-21,Pfizer,15-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,170,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,1379,Positive,Elderly,,Post-2nd (8+ Weeks),19-Aug-21,baseline,05-Apr-21,Pfizer,15-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2017,2,August,2021,,65,,,Completed,10000+,N/A,71,Delayed,170,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.8,Positive,31,Negative,Elderly,,Post-3rd (8+ Weeks),07-Feb-22,baseline,05-Apr-21,Pfizer,15-Jun-21,Pfizer,02-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4051,3,February,2022,,,67,,Completed,10000+,N/A,71,Delayed,170,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1233,Positive,Adult,-412,Post-1st,11-Feb-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,1,February,2021,30,,,,Completed,50-249,N/A,31,Scheduled,245,Delayed,,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,27250,Positive,Adult,-376,Post-2nd (1-8 Weeks),19-Mar-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,March,2021,,35,,,Processed,,N/A,31,Scheduled,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,2368,Positive,Adult,-216,Post-2nd (8+ Weeks),26-Aug-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,166,3,August,2021,,195,,,Completed,1000-4999,N/A,31,Scheduled,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,62,Positive,Adult,-78,Post-3rd (8+ Weeks),11-Jan-22,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,628,4,January,2022,,,88,,Completed,1000-4999,N/A,31,Scheduled,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,2545,Positive,Adult,,Pre-1st,19-Mar-21,baseline,04-Jun-21,Pfizer,04-Jul-21,Pfizer,,,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,30,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,515,Positive,Adult,-223,Post-1st,21-May-21,Post Vaccine covid,31-Mar-21,Pfizer,02-Jun-21,Pfizer,26-Oct-21,Pfizer,,,,,19,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,32,1,May,2021,51,,,,Completed,50-249,N/A,63,Delayed,146,Delayed,,51,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.46,Positive,1,Negative,Adult,-175,Post-2nd (1-8 Weeks),08-Jul-21,Post Vaccine covid,31-Mar-21,Pfizer,02-Jun-21,Pfizer,26-Oct-21,Pfizer,,,,,19,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,165,2,July,2021,,36,,,Completed,1000-4999,N/A,63,Delayed,146,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,1,Negative,Adult,,Post-2nd (1-8 Weeks),10-Aug-21,baseline,07-May-21,Pfizer,17-Jun-21,Pfizer,,,,,,,22,18-29,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,354,1,August,2021,,54,,,Completed,1000-4999,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,0,Negative,Adult,-205,Post-1st,02-Jun-21,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,1,June,2021,34,,,,Completed,50-249,N/A,48,Scheduled,227,Delayed,,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,957,Positive,Adult,-151,Post-2nd (1-8 Weeks),26-Jul-21,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,538,2,July,2021,,40,,,Completed,1000-4999,N/A,48,Scheduled,227,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,425,Positive,Adult,35,Post-2nd (8+ Weeks),28-Jan-22,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2330,3,January,2022,,226,,,Completed,10000+,N/A,48,Scheduled,227,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,12,Negative,Adult,152,Post-3rd (8+ Weeks),25-May-22,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,990,5,May,2022,,,116,,Completed,,N/A,48,Scheduled,227,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Ustekinumab Only,Ustekinumab Only,,,0.04,Negative,2094,Positive,Adult,19,Pre-1st,13-Feb-21,covid,07-Sep-21,Pfizer,05-Nov-21,Pfizer,,,,,,,45,40-49,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80,1,February,2021,,,,,Completed,250-999,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,3,Negative,Adult,121,Pre-1st,15-Mar-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,121 Days Before Collection Days After Collection,57,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,846,Positive,Adult,213,Post-1st,15-Jun-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69,2,June,2021,56,,,,Completed,250-999,213 Days Before Collection Days After Collection,57,Delayed,,Delayed,,56,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,31547,Positive,Adult,398,Post-2nd (8+ Weeks),17-Dec-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,3,December,2021,,184,,,Completed,50-249,398 Days Before Collection Days After Collection,57,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.5,Positive,42095,Positive,Adult,,Pre-1st,15-Apr-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.5,Positive,1,Negative,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,262,2,June,2021,,33,,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,549,Positive,Adult,,Post-2nd (1-8 Weeks),02-Jul-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,264,3,July,2021,,35,,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,376,Positive,Adult,,Post-3rd (1-8 Weeks),05-Oct-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1804,4,October,2021,,,13,,Completed,10000+,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.33,Negative,11975,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,162,5,February,2022,,,145,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,1408,Positive,Adult,-531,Post-1st,10-Feb-21,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,58,1,February,2021,41,,,,Completed,250-999,N/A,40,Scheduled,204,Delayed,187,41,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,2881,Positive,Adult,-470,Post-2nd (8+ Weeks),12-Apr-21,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,817,2,April,2021,,62,,,Completed,,N/A,40,Scheduled,204,Delayed,187,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.54,Negative,1258,Positive,Adult,-193,Post-3rd (8+ Weeks),14-Jan-22,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,598,4,January,2022,,,135,,Completed,1000-4999,N/A,40,Scheduled,204,Delayed,187,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.54,Negative,2816,Positive,Adult,-88,Post-4th,29-Apr-22,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1983,5,April,2022,,,,53,Completed,10000+,N/A,40,Scheduled,204,Delayed,187,,,,53,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.03,Negative,111,Positive,Adult,-132,Post-2nd (1-8 Weeks),25-Aug-21,Post Vaccine covid,05-May-21,Pfizer,03-Jul-21,Pfizer,,,,,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1870,1,August,2021,,53,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.14,Negative,1163,Positive,Adult,-329,Pre-1st,02-Mar-21,Post Vaccine covid,30-Apr-21,Pfizer,29-Sep-21,Pfizer,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,152,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.46,Negative,53414,Positive,Adult,-320,Post-2nd (1-8 Weeks),23-Feb-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,801,1,February,2021,,47,,,Completed,,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,6766,Positive,Adult,-238,Post-2nd (8+ Weeks),16-May-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,199,2,May,2021,,129,,,Completed,1000-4999,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,452,Positive,Adult,-87,Post-3rd (1-8 Weeks),14-Oct-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2205,3,October,2021,,,35,,Completed,10000+,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.7,Positive,459,Positive,Adult,11,Post-3rd (8+ Weeks),20-Jan-22,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2362,4,January,2022,,,133,,Completed,10000+,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.11,Negative,2133,Positive,Adult,100,Pre-1st,30-Apr-21,covid,26-May-21,Pfizer,29-Jun-21,Pfizer,,,,,,,51,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,180,1,April,2021,,,,,Completed,1000-4999,100 Days Before Collection Days After Collection,34,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.16,Negative,1122,Positive,Adult,,Pre-1st,01-Mar-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,1,March,2021,,,,,Completed,0-49,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.11,Negative,24982,Positive,Adult,,Post-1st,19-Apr-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,,2,April,2021,47,,,,Processed,,N/A,49,Scheduled,154,Delayed,156,47,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,8708,Positive,Adult,,Post-2nd (8+ Weeks),17-Jun-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,66,3,June,2021,,57,,,Completed,250-999,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.05,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,73,4,August,2021,,121,,,Completed,250-999,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,949,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1339,5,November,2021,,,42,,Completed,,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.05,Negative,653,Positive,Adult,,Post-3rd (8+ Weeks),25-Jan-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,174,6,January,2022,,,125,,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.26,Negative,802,Positive,Adult,,Post-4th,14-Mar-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,209,7,March,2022,,,,17,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,17,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.06,Negative,2518,Positive,Adult,,Post-4th,04-Jul-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,145,8,July,2022,,,,129,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,129,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,5,Negative,Adult,,Post-2nd (1-8 Weeks),24-Mar-21,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,40,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,378,2,March,2021,,28,,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,491,Positive,Adult,,Post-2nd (8+ Weeks),16-Sep-21,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,7,3,September,2021,,204,,,Completed,0-49,N/A,38,Scheduled,274,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.15,Negative,682,Positive,Adult,,Post-3rd (8+ Weeks),28-Jun-22,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,691,4,June,2022,,,215,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,1.27,Positive,121,Positive,Adult,209,Pre-1st,10-Feb-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46,1,February,2021,,,,,Completed,250-999,209 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.09,Negative,3147,Positive,Adult,282,Post-2nd (1-8 Weeks),24-Apr-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,851,2,April,2021,,25,,,Completed,,282 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.02,Negative,19905,Positive,Adult,393,Post-2nd (8+ Weeks),13-Aug-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,690,3,August,2021,,136,,,Completed,1000-4999,393 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.03,Negative,3881,Positive,Adult,525,Post-2nd (8+ Weeks),23-Dec-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1374,4,December,2021,,268,,,Completed,,525 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,4.47,Positive,3771,Positive,Adult,634,Post-3rd (8+ Weeks),11-Apr-22,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,615,5,April,2022,,,102,,Completed,1000-4999,634 Days Before Collection Days Before Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.19,Negative,4246,Positive,Adult,-309,Post-1st,24-Mar-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,144,1,March,2021,33,,,,Completed,1000-4999,N/A,38,Scheduled,158,Delayed,286,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.76,Positive,9962,Positive,Adult,-253,Post-2nd (1-8 Weeks),19-May-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1357,2,May,2021,,51,,,Completed,,N/A,38,Scheduled,158,Delayed,286,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.76,Positive,3,Negative,Adult,-155,Post-2nd (8+ Weeks),25-Aug-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,372,3,August,2021,,149,,,Completed,1000-4999,N/A,38,Scheduled,158,Delayed,286,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,742,Positive,Adult,-70,Post-3rd (8+ Weeks),18-Nov-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,951,4,November,2021,,,76,,Completed,,N/A,38,Scheduled,158,Delayed,286,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,2180,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,25-Apr-21,Moderna,21-Jun-21,Moderna,,,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1871,1,July,2021,,35,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,,,,,0.05,Negative,24192,Positive,Elderly,22,,18-Feb-21,covid,,,,,,,,,,,73,70+,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2105,1,February,2021,,,,,Completed,10000+,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,,,,,0.05,Negative,1922,Positive,Elderly,190,,05-Aug-21,covid,,,,,,,,,,,73,70+,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139,2,August,2021,,,,,Completed,250-999,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,7.62,Positive,88,Positive,Adult,,Post-2nd (1-8 Weeks),13-May-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,222,2,May,2021,,17,,,Completed,1000-4999,N/A,28,Scheduled,141,Delayed,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,2.09,Positive,3,Negative,Adult,,Post-2nd (8+ Weeks),26-Aug-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,8,3,August,2021,,122,,,Completed,50-249,N/A,28,Scheduled,141,Delayed,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.03,Negative,4,Negative,Adult,,Post-3rd (8+ Weeks),30-Nov-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,54,4,November,2021,,,77,,Completed,250-999,N/A,28,Scheduled,141,Delayed,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.11,Negative,1571,Positive,Adult,,Post-4th,28-Feb-22,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,519,5,February,2022,,,,13,Completed,1000-4999,N/A,28,Scheduled,141,Delayed,154,,,,13,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.11,Negative,14,Negative,Adult,93,Pre-1st,08-Mar-21,covid,29-Aug-21,Pfizer,01-Oct-21,Pfizer,,,,,,,47,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,189,1,March,2021,,,,,Completed,1000-4999,N/A,33,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.9,Positive,26979,Positive,Adult,333,Post-2nd (1-8 Weeks),03-Nov-21,covid,29-Aug-21,Pfizer,01-Oct-21,Pfizer,,,,,,,48,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4479,2,November,2021,,33,,,Completed,10000+,N/A,33,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.9,Positive,24142,Positive,Adult,,Post-2nd (1-8 Weeks),12-Mar-21,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,790,1,March,2021,,28,,,Completed,,N/A,38,Scheduled,238,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,12333,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4202,3,November,2021,,,26,,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,1,Negative,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1547,4,February,2022,,,118,,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,4.7,Positive,9237,Positive,Adult,,Post-4th,04-Apr-22,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3351,5,April,2022,,,,17,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,17,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,14149,Positive,Elderly,,Pre-1st,14-Mar-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.74,Positive,8081,Positive,Elderly,,Post-1st,27-Apr-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,31,2,April,2021,33,,,,Completed,50-249,N/A,71,Delayed,98,Scheduled,159,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,2,Negative,Elderly,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,664,3,June,2021,,26,,,Completed,1000-4999,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.04,Positive,1144,Positive,Elderly,,Post-3rd (1-8 Weeks),27-Sep-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2665,4,September,2021,,,17,,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,345,Positive,Elderly,,Post-3rd (8+ Weeks),12-Jan-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,610,5,January,2022,,,124,,Completed,1000-4999,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,386,Positive,Elderly,,Post-4th,17-Mar-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3091,6,March,2022,,,,29,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,29,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,0,Negative,Elderly,,Post-4th,17-Jun-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,7,June,2022,,,,121,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,121,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.04,Negative,30,Negative,Adult,100,Pre-1st,13-Mar-21,covid,10-Jun-21,Pfizer,04-Jul-21,Pfizer,11-Jan-22,Pfizer,,,,,25,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,1,March,2021,,,,,Completed,50-249,N/A,24,Scheduled,191,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,7,Negative,Adult,,Pre-1st,12-Apr-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,62,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,1,April,2021,,,,,Completed,0-49,N/A,29,Scheduled,144,Delayed,259,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.57,Negative,10109,Positive,Adult,,Post-2nd (1-8 Weeks),31-May-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,62,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,899,2,May,2021,,10,,,Completed,,N/A,29,Scheduled,144,Delayed,259,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,1284,Positive,Adult,,Post-3rd (1-8 Weeks),15-Nov-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,63,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1641,3,November,2021,,,34,,Completed,10000+,N/A,29,Scheduled,144,Delayed,259,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.16,Negative,185,Positive,Adult,,Pre-1st,25-Mar-21,baseline,06-Apr-21,Pfizer,10-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,34,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,65,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.16,Negative,59,Positive,Adult,,Post-1st,19-May-21,baseline,06-Apr-21,Pfizer,10-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,34,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,2,May,2021,43,,,,Completed,50-249,N/A,65,Delayed,201,Delayed,,43,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,7,Negative,Elderly,83,Post-1st,20-Apr-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2076,2,April,2021,28,,,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,25287,Positive,Elderly,174,Post-2nd (1-8 Weeks),20-Jul-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2894,3,July,2021,,42,,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,18823,Positive,Elderly,282,Post-3rd (1-8 Weeks),05-Nov-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4577,4,November,2021,,,21,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5191,Positive,Elderly,407,Post-3rd (8+ Weeks),10-Mar-22,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1483,5,March,2022,,,146,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,1949,Positive,Elderly,465,Post-4th,07-May-22,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5295,6,May,2022,,,,14,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,14,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,,0.04,Negative,4027,Positive,Adult,49,Pre-1st,01-Apr-21,covid,01-May-21,Pfizer,10-Jul-21,Pfizer,,,,,,,29,18-29,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101,1,April,2021,,,,,Completed,250-999,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.73,Positive,4,Negative,Adult,-285,Pre-1st,16-Mar-21,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,58,Delayed,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,4,Negative,Adult,-208,Post-1st,01-Jun-21,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,2,June,2021,51,,,,Completed,50-249,N/A,58,Delayed,231,Delayed,,51,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.28,Negative,618,Positive,Adult,24,Post-2nd (8+ Weeks),19-Jan-22,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5234,4,January,2022,,225,,,Completed,10000+,N/A,58,Delayed,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.75,Positive,37,Negative,Adult,99,Post-3rd (8+ Weeks),04-Apr-22,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4021,5,April,2022,,,69,,Completed,10000+,N/A,58,Delayed,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.58,Negative,622,Positive,Adult,,Pre-1st,10-Mar-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,253,Positive,Adult,,Post-1st,31-May-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,12,2,May,2021,35,,,,Completed,50-249,N/A,52,Scheduled,109,Scheduled,175,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.51,Negative,13,Negative,Adult,,Post-2nd (8+ Weeks),16-Sep-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,317,3,September,2021,,91,,,Completed,1000-4999,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.58,Positive,6,Negative,Adult,,Post-3rd (1-8 Weeks),18-Oct-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1512,4,October,2021,,,14,,Completed,10000+,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.58,Positive,4140,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,179,5,February,2022,,,133,,Completed,1000-4999,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.23,Negative,2094,Positive,Adult,,Post-4th,20-Apr-22,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1527,6,April,2022,,,,23,Completed,10000+,N/A,52,Scheduled,109,Scheduled,175,,,,23,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,3.9,Positive,80000,Positive,Adult,,Post-2nd (1-8 Weeks),05-Mar-21,baseline,13-Jan-21,Pfizer,20-Feb-21,Pfizer,22-Sep-21,Moderna,04-Apr-22,Pfizer,,,52,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,913,1,March,2021,,13,,,Completed,,N/A,38,Scheduled,214,Delayed,194,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,1.13,Positive,40000,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Jan-21,Pfizer,20-Feb-21,Pfizer,22-Sep-21,Moderna,04-Apr-22,Pfizer,,,53,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,95,2,September,2021,,201,,,Completed,250-999,N/A,38,Scheduled,214,Delayed,194,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.13,Positive,10805,Positive,Adult,-401,Post-1st,05-Apr-21,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,68,1,April,2021,34,,,,Completed,250-999,N/A,42,Scheduled,260,Delayed,,34,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,,18,Negative,Adult,-267,Post-2nd (8+ Weeks),17-Aug-21,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,59,3,August,2021,,126,,,Completed,250-999,N/A,42,Scheduled,260,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,893,Positive,Adult,-112,Post-3rd (1-8 Weeks),19-Jan-22,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2390,4,January,2022,,,21,,Completed,10000+,N/A,42,Scheduled,260,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,14853,Positive,Adult,9,Post-3rd (8+ Weeks),20-May-22,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,924,5,May,2022,,,142,,Completed,,N/A,42,Scheduled,260,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,3079,Positive,Adult,,Post-2nd (1-8 Weeks),18-Mar-21,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,184,1,March,2021,,39,,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,191,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.35,Negative,1,Negative,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,27,2,September,2021,,207,,,Completed,50-249,N/A,38,Scheduled,274,Delayed,191,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.76,Positive,433,Positive,Adult,,Post-3rd (8+ Weeks),09-Feb-22,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,354,3,February,2022,,,93,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,191,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,11011,Positive,Adult,-127,Post-1st,13-May-21,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,1,May,2021,35,,,,Completed,50-249,N/A,100,Delayed,96,Scheduled,,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,2196,Positive,Adult,112,Post-3rd (8+ Weeks),07-Jan-22,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2183,2,January,2022,,,78,,Completed,10000+,N/A,100,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,1,Negative,Adult,153,Post-3rd (8+ Weeks),17-Feb-22,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,586,3,February,2022,,,119,,Completed,1000-4999,N/A,100,Delayed,96,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,797,Positive,Adult,-177,Post-3rd (1-8 Weeks),06-Oct-21,baseline,07-Apr-21,Pfizer,11-May-21,Pfizer,05-Sep-21,Pfizer,26-Jul-22,Pfizer,,,36,30-39,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,963,1,October,2021,,,31,,Completed,,N/A,34,Scheduled,117,Scheduled,324,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,5941,Positive,Adult,,Pre-1st,26-Mar-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,385,Positive,Adult,,Post-1st,06-May-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,6,2,May,2021,22,,,,Completed,0-49,N/A,77,Delayed,139,Delayed,155,22,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,10522,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1359,3,July,2021,,30,,,Completed,,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,1205,Positive,Adult,,Post-3rd (1-8 Weeks),29-Dec-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1401,4,December,2021,,,43,,Completed,,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,7079,Positive,Adult,,Post-3rd (8+ Weeks),23-Mar-22,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,561,5,March,2022,,,127,,Completed,1000-4999,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,30138,Positive,Adult,,Post-4th,20-May-22,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1582,6,May,2022,,,,30,Completed,10000+,N/A,77,Delayed,139,Delayed,155,,,,30,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,0,Negative,Elderly,,Post-1st,18-May-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,859,1,May,2021,31,,,,Completed,,N/A,73,Delayed,112,Scheduled,,31,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,80,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3893,2,September,2021,,78,,,Completed,10000+,N/A,73,Delayed,112,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.8,Positive,8465,Positive,Elderly,,Post-3rd (1-8 Weeks),16-Nov-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9547,3,November,2021,,,28,,Completed,10000+,N/A,73,Delayed,112,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,735,Positive,Adult,,Pre-1st,16-Mar-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.42,Negative,14762,Positive,Adult,,Post-1st,06-May-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,26,2,May,2021,33,,,,Completed,50-249,N/A,79,Delayed,93,Scheduled,154,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,3730,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,144,3,July,2021,,36,,,Completed,1000-4999,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,2,Negative,Adult,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1924,4,October,2021,,,22,,Completed,10000+,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,604,Positive,Adult,,Post-3rd (8+ Weeks),19-Feb-22,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,104,5,February,2022,,,150,,Completed,250-999,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,16150,Positive,Adult,,Post-4th,18-Mar-22,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,570,6,March,2022,,,,23,Completed,1000-4999,N/A,79,Delayed,93,Scheduled,154,,,,23,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,68644,Positive,Adult,-482,Pre-1st,12-Mar-21,baseline,22-Apr-21,Pfizer,22-Jun-21,Moderna,05-Feb-22,Moderna,,,,,36,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,61,Delayed,228,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,,,Adult,-126,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1203,1,August,2021,,64,,,Completed,,N/A,61,Delayed,214,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,1077,Positive,Adult,99,Post-3rd (8+ Weeks),30-Mar-22,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11360,2,March,2022,,,75,,Completed,10000+,N/A,61,Delayed,214,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,517,Positive,Adult,155,Post-3rd (8+ Weeks),25-May-22,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11360,3,May,2022,,,131,,Completed,10000+,N/A,61,Delayed,214,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,19665,Positive,Elderly,,Pre-1st,16-Mar-21,baseline,23-Mar-21,Pfizer,06-May-21,Pfizer,12-Nov-21,Pfizer,06-May-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,44,Scheduled,190,Delayed,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,40000,Positive,Adult,,Pre-1st,13-Mar-21,baseline,08-Apr-21,Pfizer,20-Jun-21,Pfizer,17-Jan-22,Pfizer,20-Jul-22,Pfizer,,,40,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,73,Delayed,211,Delayed,184,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,361,Positive,Adult,,Post-2nd (1-8 Weeks),01-Aug-21,baseline,08-Apr-21,Pfizer,20-Jun-21,Pfizer,17-Jan-22,Pfizer,20-Jul-22,Pfizer,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,152,2,August,2021,,42,,,Completed,1000-4999,N/A,73,Delayed,211,Delayed,184,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,1760,Positive,Adult,-297,Pre-1st,08-Mar-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,812,Positive,Adult,-224,Post-1st,20-May-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,20,2,May,2021,28,,,,Completed,50-249,N/A,54,Scheduled,136,Delayed,164,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,997,Positive,Adult,-174,Post-2nd (1-8 Weeks),09-Jul-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,315,3,July,2021,,24,,,Completed,1000-4999,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,11,Negative,Adult,-20,Post-3rd (1-8 Weeks),10-Dec-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1255,4,December,2021,,,42,,Completed,,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.17,Negative,1168,Positive,Adult,76,Post-3rd (8+ Weeks),16-Mar-22,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3264,5,March,2022,,,138,,Completed,10000+,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,8755,Positive,Adult,132,Post-4th,11-May-22,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5680,6,May,2022,,,,30,Completed,10000+,N/A,54,Scheduled,136,Delayed,164,,,,30,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,1,Negative,Elderly,,Pre-1st,25-Mar-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,9959,Positive,Elderly,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2203,3,July,2021,,26,,,Completed,10000+,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,0,Negative,Elderly,,Post-2nd (8+ Weeks),03-Dec-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,153,4,December,2021,,176,,,Completed,1000-4999,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,313,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Jan-22,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7237,5,January,2022,,,22,,Completed,10000+,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,32029,Positive,Elderly,,Post-3rd (8+ Weeks),25-Apr-22,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1233,6,April,2022,,,134,,Completed,,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,25492,Positive,Adult,,Pre-1st,02-Mar-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,24,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,61,Delayed,104,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,6186,Positive,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,24,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,937,2,July,2021,,26,,,Completed,,N/A,61,Delayed,104,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,0,Negative,Adult,,Post-3rd (8+ Weeks),23-Dec-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,25,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,781,3,December,2021,,,92,,Completed,,N/A,61,Delayed,104,Scheduled,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,212,Positive,Adult,,Post-4th,17-Mar-22,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,25,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,617,4,March,2022,,,,23,Completed,1000-4999,N/A,61,Delayed,104,Scheduled,153,,,,23,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,505,Positive,Adult,-377,Post-2nd (8+ Weeks),19-Apr-21,baseline,29-Dec-20,Pfizer,21-Jan-21,Pfizer,19-Oct-21,Pfizer,,,,,40,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,657,1,April,2021,,88,,,Completed,1000-4999,N/A,23,Scheduled,271,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,8246,Positive,Adult,,Post-1st,14-May-21,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,53,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,133,1,May,2021,23,,,,Completed,250-999,N/A,48,Scheduled,212,Delayed,,23,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,1670,Positive,Adult,,Post-3rd (1-8 Weeks),01-Feb-22,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5436,2,February,2022,,,26,,Completed,10000+,N/A,48,Scheduled,212,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,437,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10024,3,June,2022,,,160,,Completed,10000+,N/A,48,Scheduled,212,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,446,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,04-May-21,Pfizer,15-Jun-21,Pfizer,,,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,212,1,August,2021,,66,,,Completed,1000-4999,N/A,42,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,849,Positive,Adult,,Pre-1st,25-Mar-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,30,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,68,Delayed,140,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,0,Negative,Adult,,Post-1st,18-May-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,16,2,May,2021,42,,,,Completed,50-249,N/A,68,Delayed,140,Delayed,,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,514,Positive,Adult,,Post-2nd (8+ Weeks),12-Aug-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,941,3,August,2021,,60,,,Completed,,N/A,68,Delayed,140,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.17,Negative,3692,Positive,Adult,,Post-3rd (8+ Weeks),26-Jan-22,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,1435,4,January,2022,,,87,,Completed,10000+,N/A,68,Delayed,140,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,9253,Positive,Elderly,243,Post-2nd (1-8 Weeks),18-Aug-21,covid,29-May-21,Moderna,07-Jul-21,Moderna,,,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2849,1,August,2021,,42,,,Completed,10000+,N/A,39,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,3,Negative,Adult,113,Pre-1st,26-Feb-21,covid,16-Jul-21,Pfizer,12-Aug-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,137,1,February,2021,,,,,Completed,250-999,N/A,27,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,44,Negative,Adult,-214,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,14-May-21,Pfizer,24-Jun-21,Pfizer,19-Jan-22,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,131,1,August,2021,,40,,,Completed,250-999,N/A,41,Scheduled,209,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,10169,Positive,Adult,,Pre-1st,23-Mar-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,530,Positive,Adult,,Post-2nd (8+ Weeks),09-Aug-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,403,2,August,2021,,67,,,Completed,1000-4999,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,10602,Positive,Adult,,Post-3rd (1-8 Weeks),20-Oct-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,1761,3,October,2021,,,23,,Completed,10000+,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,1309,Positive,Adult,,Post-3rd (8+ Weeks),17-Feb-22,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,282,4,February,2022,,,143,,Completed,1000-4999,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,447,Positive,Adult,,Pre-1st,19-Apr-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,152,Positive,Adult,,Post-2nd (1-8 Weeks),09-Aug-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,708,2,August,2021,,49,,,Completed,1000-4999,N/A,60,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,405,Positive,Adult,,Post-3rd (8+ Weeks),10-May-22,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1406,3,May,2022,,,139,,Completed,,N/A,60,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,2201,Positive,Elderly,,Post-1st,12-Apr-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,10,1,April,2021,38,,,,Completed,50-249,N/A,38,Scheduled,189,Delayed,152,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,26,Negative,Elderly,,Post-2nd (1-8 Weeks),04-May-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,,2,May,2021,,22,,,Processed,,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,2199,Positive,Elderly,,Post-2nd (8+ Weeks),13-Aug-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,60,3,August,2021,,123,,,Completed,250-999,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,5211,Positive,Elderly,,Post-3rd (1-8 Weeks),01-Nov-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2556,4,November,2021,,,14,,Completed,10000+,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,2.77,Positive,7098,Positive,Elderly,,Post-3rd (8+ Weeks),17-Feb-22,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,765,5,February,2022,,,122,,Completed,,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.1,Negative,0,Negative,Elderly,,Post-4th,07-Apr-22,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2914,6,April,2022,,,,19,Completed,10000+,N/A,38,Scheduled,189,Delayed,152,,,,19,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.03,Negative,14204,Positive,Elderly,,Post-1st,19-Apr-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71,1,April,2021,29,,,,Completed,250-999,N/A,39,Scheduled,286,Delayed,,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.16,Negative,28529,Positive,Elderly,,Post-2nd (1-8 Weeks),20-May-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,247,2,May,2021,,21,,,Completed,1000-4999,N/A,39,Scheduled,286,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.04,Negative,6552,Positive,Elderly,,Post-2nd (8+ Weeks),17-Dec-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,3,December,2021,,232,,,Completed,50-249,N/A,39,Scheduled,286,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.32,Negative,4,Negative,Elderly,,Post-1st,05-Apr-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,12,1,April,2021,37,,,,Completed,50-249,N/A,40,Scheduled,168,Delayed,153,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.03,Negative,2491,Positive,Elderly,,Post-2nd (1-8 Weeks),25-May-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,134,2,May,2021,,47,,,Completed,250-999,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.02,Negative,0,Negative,Elderly,,Post-2nd (8+ Weeks),30-Aug-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,24,3,August,2021,,144,,,Completed,50-249,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.01,Negative,1848,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1121,4,November,2021,,,41,,Completed,,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.02,Negative,1860,Positive,Elderly,,Post-3rd (8+ Weeks),24-Jan-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,995,5,January,2022,,,123,,Completed,,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.06,Negative,12703,Positive,Elderly,,Post-4th,21-Mar-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1643,6,March,2022,,,,26,Completed,10000+,N/A,40,Scheduled,168,Delayed,153,,,,26,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.04,Negative,1142,Positive,Elderly,,Post-4th,04-Jul-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,76,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,364,7,July,2022,,,,131,Completed,1000-4999,N/A,40,Scheduled,168,Delayed,153,,,,131,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.32,Negative,4,Negative,Adult,,Post-1st,18-Jun-21,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,1,June,2021,56,,,,Completed,50-249,N/A,70,Delayed,,Delayed,,56,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.03,Negative,,,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1126,2,August,2021,,34,,,Completed,,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.02,Negative,468,Positive,Adult,,Post-2nd (8+ Weeks),17-Feb-22,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5445,3,February,2022,,230,,,Completed,10000+,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.01,Negative,515,Positive,Adult,,Post-2nd (8+ Weeks),14-Jul-22,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,56,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4145,4,July,2022,,377,,,Completed,10000+,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,9428,Positive,Elderly,,Post-1st,13-Apr-21,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,1,April,2021,43,,,,Completed,50-249,N/A,40,Scheduled,198,Delayed,,43,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.06,Negative,1225,Positive,Elderly,,Post-2nd (8+ Weeks),08-Jun-21,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,428,2,June,2021,,59,,,Completed,1000-4999,N/A,40,Scheduled,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,1471,Positive,Elderly,,Post-3rd (8+ Weeks),11-May-22,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,79,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,707,3,May,2022,,,198,,Completed,1000-4999,N/A,40,Scheduled,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1018,Positive,Adult,-306,Post-2nd (1-8 Weeks),09-Apr-21,Post Vaccine covid,15-Jan-21,Pfizer,24-Feb-21,Pfizer,03-Oct-21,Pfizer,,,,,28,18-29,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,412,1,April,2021,,44,,,Completed,1000-4999,N/A,40,Scheduled,221,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,5.78,Positive,52,Positive,Adult,-106,Post-3rd (1-8 Weeks),26-Oct-21,Post Vaccine covid,15-Jan-21,Pfizer,24-Feb-21,Pfizer,03-Oct-21,Pfizer,,,,,29,18-29,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1226,2,October,2021,,,23,,Completed,,N/A,40,Scheduled,221,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,5.78,Positive,2664,Positive,Adult,,Post-2nd (8+ Weeks),23-Jul-21,baseline,23-Mar-21,Pfizer,29-Apr-21,Pfizer,19-Jan-22,Pfizer,,,,,56,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,283,1,July,2021,,85,,,Completed,1000-4999,N/A,37,Scheduled,265,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.48,Negative,46,Negative,Adult,-429,Post-1st,30-Mar-21,baseline,22-Feb-21,Pfizer,01-Apr-21,Pfizer,25-Nov-21,Pfizer,,,,,25,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,52,1,March,2021,36,,,,Completed,250-999,N/A,38,Scheduled,238,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.41,Negative,13174,Positive,Elderly,,Post-1st,09-Apr-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,87,1,April,2021,28,,,,Completed,250-999,N/A,35,Scheduled,140,Delayed,161,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.41,Negative,2,Negative,Elderly,,Post-2nd (1-8 Weeks),12-May-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,251,2,May,2021,,26,,,Completed,1000-4999,N/A,35,Scheduled,140,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,1566,Positive,Elderly,,Post-2nd (8+ Weeks),03-Sep-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,97,3,September,2021,,140,,,Completed,250-999,N/A,35,Scheduled,140,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,56,Positive,Elderly,,Post-3rd (8+ Weeks),29-Oct-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,510,4,October,2021,,,56,,Completed,1000-4999,N/A,35,Scheduled,140,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,380,Positive,Elderly,,Post-4th,19-Apr-22,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,76,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,826,5,April,2022,,,,67,Completed,,N/A,35,Scheduled,140,Delayed,161,,,,67,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,3656,Positive,Adult,-359,Pre-1st,09-Mar-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,35,Scheduled,56,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,5564,Positive,Adult,-209,Post-1st,06-Aug-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,8,2,August,2021,29,,,,Completed,50-249,N/A,35,Scheduled,56,Scheduled,,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.38,Negative,137,Positive,Adult,-113,Post-3rd (1-8 Weeks),10-Nov-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1639,3,November,2021,,,34,,Completed,10000+,N/A,35,Scheduled,56,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.38,Negative,29594,Positive,Adult,4,Post-3rd (8+ Weeks),07-Mar-22,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9808,4,March,2022,,,151,,Completed,10000+,N/A,35,Scheduled,56,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.35,Positive,10892,Positive,Adult,,Pre-1st,07-Apr-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,23601,Positive,Adult,,Post-1st,06-May-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,6,2,May,2021,23,,,,Completed,0-49,N/A,24,Scheduled,129,Delayed,,23,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,3,Negative,Adult,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,228,3,June,2021,,47,,,Completed,1000-4999,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,221,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,260,4,September,2021,,125,,,Completed,1000-4999,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.59,Negative,4674,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1761,5,October,2021,,,32,,Completed,10000+,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.2,Negative,4296,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,136,1,June,2021,,34,,,Completed,250-999,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,21765,Positive,Elderly,,Post-2nd (8+ Weeks),24-Aug-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,213,2,August,2021,,98,,,Completed,1000-4999,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,80000,Positive,Elderly,,Post-3rd (1-8 Weeks),22-Sep-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1143,3,September,2021,,,20,,Completed,,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,4,Negative,Elderly,,Post-3rd (8+ Weeks),09-Feb-22,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,132,4,February,2022,,,160,,Completed,250-999,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,6333,Positive,Elderly,,Post-4th,04-Apr-22,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1458,5,April,2022,,,,33,Completed,10000+,N/A,55,Scheduled,107,Scheduled,181,,,,33,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.23,Positive,11555,Positive,Elderly,,Post-1st,30-Apr-21,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,76,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1330,1,April,2021,29,,,,Completed,,N/A,23,Scheduled,213,Delayed,199,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.14,Negative,5,Negative,Elderly,,Post-2nd (8+ Weeks),23-Oct-21,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,102,2,October,2021,,182,,,Completed,250-999,N/A,23,Scheduled,213,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.14,Negative,133,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,759,3,February,2022,,,72,,Completed,,N/A,23,Scheduled,213,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.21,Negative,2,Negative,Elderly,,Post-3rd (8+ Weeks),09-May-22,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1012,4,May,2022,,,167,,Completed,,N/A,23,Scheduled,213,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.83,Positive,82,Positive,Adult,-268,Post-1st,08-Apr-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,1,April,2021,40,,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.01,Negative,2231,Positive,Adult,-164,Post-2nd (8+ Weeks),21-Jul-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59,2,July,2021,,103,,,Completed,250-999,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.01,Negative,10645,Positive,Adult,-72,Post-2nd (8+ Weeks),21-Oct-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,3,October,2021,,195,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,1264,Positive,Adult,31,Post-2nd (8+ Weeks),01-Feb-22,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1914,4,February,2022,,298,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,10751,Positive,Adult,53,Post-2nd (8+ Weeks),23-Feb-22,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,5,February,2022,,320,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.93,Positive,6428,Positive,Adult,,Pre-1st,29-Mar-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,94,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.93,Positive,666,Positive,Adult,,Post-1st,13-May-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,171,2,May,2021,23,,,,Completed,1000-4999,N/A,94,Delayed,,Delayed,,23,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.05,Negative,2918,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5208,3,August,2021,,14,,,Completed,10000+,N/A,94,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.05,Negative,1295,Positive,Adult,,Post-2nd (8+ Weeks),19-Jul-22,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5940,4,July,2022,,361,,,Completed,10000+,N/A,94,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,191,Positive,Adult,,Post-1st,10-Jun-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,78,1,June,2021,47,,,,Completed,250-999,N/A,65,Delayed,169,Delayed,,47,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,2494,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,437,2,August,2021,,39,,,Completed,1000-4999,N/A,65,Delayed,169,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.3,Negative,0,Negative,Adult,,Post-2nd (8+ Weeks),30-Nov-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,70,3,November,2021,,155,,,Completed,250-999,N/A,65,Delayed,169,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.3,Negative,43,Negative,Adult,,Post-3rd (8+ Weeks),10-May-22,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2874,4,May,2022,,,147,,Completed,10000+,N/A,65,Delayed,169,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.07,Negative,9573,Positive,Elderly,,Post-1st,12-Apr-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,April,2021,36,,,,Completed,50-249,N/A,38,Scheduled,192,Delayed,175,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.34,Negative,9865,Positive,Elderly,,Post-2nd (1-8 Weeks),06-May-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,817,2,May,2021,,22,,,Completed,,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.34,Negative,3947,Positive,Elderly,,Post-2nd (8+ Weeks),03-Sep-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,141,3,September,2021,,142,,,Completed,250-999,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,11142,Positive,Elderly,,Post-3rd (8+ Weeks),30-Dec-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,775,4,December,2021,,,68,,Completed,,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,6049,Positive,Elderly,,Post-3rd (8+ Weeks),28-Mar-22,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,332,5,March,2022,,,156,,Completed,1000-4999,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.15,Negative,27416,Positive,Elderly,,Post-4th,16-May-22,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3430,6,May,2022,,,,30,Completed,10000+,N/A,38,Scheduled,192,Delayed,175,,,,30,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,67229,Positive,Adult,,Pre-1st,07-Mar-21,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,23,Scheduled,142,Delayed,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.27,Negative,1,Negative,Adult,,Post-2nd (8+ Weeks),14-Aug-21,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,41,2,August,2021,,101,,,Completed,250-999,N/A,23,Scheduled,142,Delayed,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,1012,Positive,Adult,,Post-3rd (8+ Weeks),11-Jan-22,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,587,4,January,2022,,,109,,Completed,1000-4999,N/A,23,Scheduled,142,Delayed,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.71,Positive,13551,Positive,Adult,,Post-4th,09-May-22,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2152,5,May,2022,,,,42,Completed,10000+,N/A,23,Scheduled,142,Delayed,185,,,,42,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.71,Positive,731,Positive,Adult,-277,Pre-1st,31-Mar-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,60,Delayed,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.17,Positive,4012,Positive,Adult,-221,Post-1st,26-May-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,2,May,2021,42,,,,Completed,50-249,N/A,60,Delayed,183,Delayed,,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.09,Negative,538,Positive,Adult,-53,Post-2nd (8+ Weeks),10-Nov-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,4,November,2021,,150,,,Completed,50-249,N/A,60,Delayed,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,1074,Positive,Adult,128,Post-3rd (8+ Weeks),10-May-22,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1351,6,May,2022,,,148,,Completed,,N/A,60,Delayed,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.88,Positive,2,Negative,Adult,-341,Post-1st,04-Jun-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,84,1,June,2021,37,,,,Completed,250-999,N/A,52,Scheduled,178,Delayed,,37,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.88,Positive,178,Positive,Adult,-309,Post-2nd (1-8 Weeks),06-Jul-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1458,2,July,2021,,17,,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.08,Negative,15515,Positive,Adult,-152,Post-2nd (8+ Weeks),10-Dec-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,373,3,December,2021,,174,,,Completed,1000-4999,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,1077,Positive,Adult,-125,Post-3rd (1-8 Weeks),06-Jan-22,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,4376,4,January,2022,,,23,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,50963,Positive,Adult,16,Post-3rd (8+ Weeks),27-May-22,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,38,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,3534,5,May,2022,,,164,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,8682,Positive,Elderly,,Post-1st,24-Apr-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,70,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,3,1,April,2021,29,,,,Completed,0-49,N/A,71,Delayed,183,Delayed,155,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,6595,Positive,Elderly,,Post-2nd (8+ Weeks),01-Oct-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,70,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,112,3,October,2021,,118,,,Completed,250-999,N/A,71,Delayed,183,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.07,Negative,5500,Positive,Elderly,,Post-3rd (1-8 Weeks),22-Dec-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1837,4,December,2021,,,17,,Completed,10000+,N/A,71,Delayed,183,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.17,Negative,4347,Positive,Elderly,,Post-3rd (8+ Weeks),05-Apr-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1085,5,April,2022,,,121,,Completed,,N/A,71,Delayed,183,Delayed,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,934,Positive,Elderly,,Post-4th,30-May-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2235,6,May,2022,,,,21,Completed,10000+,N/A,71,Delayed,183,Delayed,155,,,,21,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,38283,Positive,Adult,,Pre-1st,30-Mar-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,70,Delayed,72,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,70589,Positive,Adult,,Post-1st,25-May-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,231,2,May,2021,42,,,,Completed,1000-4999,N/A,70,Delayed,72,Scheduled,154,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,1490,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,3714,3,July,2021,,30,,,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,111,Positive,Adult,,Post-3rd (8+ Weeks),27-Jan-22,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1481,5,January,2022,,,147,,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,6624,Positive,Adult,,Post-4th,06-Jun-22,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,2972,6,June,2022,,,,123,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,123,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,10109,Positive,Adult,,Post-2nd (1-8 Weeks),15-Mar-21,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1166,1,March,2021,,36,,,Completed,,N/A,35,Scheduled,296,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.32,Negative,2,Negative,Adult,,Post-2nd (8+ Weeks),09-Nov-21,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,283,2,November,2021,,275,,,Completed,1000-4999,N/A,35,Scheduled,296,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,7.01,Positive,2840,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,38,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,4392,3,February,2022,,,76,,Completed,10000+,N/A,35,Scheduled,296,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.05,Negative,12401,Positive,Adult,-383,Pre-1st,09-Apr-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.05,Negative,1988,Positive,Adult,-327,Post-1st,04-Jun-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,2,June,2021,26,,,,Completed,50-249,N/A,60,Delayed,106,Scheduled,281,26,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.11,Negative,17073,Positive,Adult,-271,Post-2nd (1-8 Weeks),30-Jul-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1805,3,July,2021,,22,,,Completed,10000+,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.02,Negative,1,Negative,Adult,-166,Post-3rd (1-8 Weeks),12-Nov-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2322,4,November,2021,,,21,,Completed,10000+,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.02,Negative,4988,Positive,Adult,-48,Post-3rd (8+ Weeks),10-Mar-22,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,281,5,March,2022,,,139,,Completed,1000-4999,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.39,Negative,9900,Positive,Adult,-299,Pre-1st,10-Mar-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,40,Scheduled,145,Delayed,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.39,Negative,69,Positive,Adult,-242,Post-1st,06-May-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,18,2,May,2021,30,,,,Completed,50-249,N/A,40,Scheduled,145,Delayed,185,30,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,,,Adult,-139,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,94,3,August,2021,,93,,,Completed,250-999,N/A,40,Scheduled,145,Delayed,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,421,Positive,Adult,-59,Post-3rd (1-8 Weeks),05-Nov-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,974,4,November,2021,,,28,,Completed,,N/A,40,Scheduled,145,Delayed,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,5391,Positive,Adult,130,Post-4th,13-May-22,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5296,6,May,2022,,,,32,Completed,10000+,N/A,40,Scheduled,145,Delayed,185,,,,32,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.84,Positive,20522,Positive,Adult,,Post-1st,04-May-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,6,1,May,2021,27,,,,Completed,0-49,N/A,65,Delayed,202,Delayed,,27,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,499,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9,2,July,2021,,49,,,Completed,50-249,N/A,65,Delayed,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.27,Negative,1736,Positive,Adult,,Post-3rd (1-8 Weeks),17-Jan-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,695,3,January,2022,,,18,,Completed,1000-4999,N/A,65,Delayed,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.66,Positive,86,Positive,Adult,,Post-3rd (8+ Weeks),03-May-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,3112,4,May,2022,,,124,,Completed,10000+,N/A,65,Delayed,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,1.66,Positive,82,Positive,Adult,,Post-1st,07-Jul-21,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,34,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,139,1,July,2021,47,,,,Completed,250-999,N/A,50,Scheduled,231,Delayed,,47,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.68,Negative,171,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1582,3,December,2021,,165,,,Completed,10000+,N/A,50,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.08,Negative,7896,Positive,Adult,,Post-3rd (8+ Weeks),08-Jun-22,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3948,4,June,2022,,,102,,Completed,10000+,N/A,50,Scheduled,231,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.08,Negative,7007,Positive,Adult,-356,Post-1st,13-May-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,41,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,10,1,May,2021,21,,,,Completed,50-249,N/A,28,Scheduled,112,Scheduled,215,21,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.37,Negative,11570,Positive,Adult,-328,Post-2nd (1-8 Weeks),10-Jun-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,41,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,22,2,June,2021,,21,,,Completed,50-249,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.05,Negative,2560,Positive,Adult,-211,Post-3rd (1-8 Weeks),05-Oct-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1167,3,October,2021,,,26,,Completed,,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.27,Negative,117,Positive,Adult,-83,Post-3rd (8+ Weeks),10-Feb-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,240,4,February,2022,,,154,,Completed,1000-4999,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.27,Negative,7931,Positive,Adult,-55,Post-3rd (8+ Weeks),10-Mar-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,132,5,March,2022,,,182,,Completed,250-999,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.02,Negative,38342,Positive,Adult,22,Post-4th,26-May-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,11241,6,May,2022,,,,44,Completed,10000+,N/A,28,Scheduled,112,Scheduled,215,,,,44,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.37,Negative,29192,Positive,Adult,-220,Post-1st,25-May-21,Post Vaccine covid,04-May-21,Pfizer,19-Jun-21,Pfizer,27-Feb-22,Moderna,,,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,1,May,2021,21,,,,Completed,50-249,-220 Days After Collection Days After Collection,46,Scheduled,253,Delayed,,21,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.11,Negative,57,Positive,Adult,-106,Post-2nd (8+ Weeks),16-Sep-21,Post Vaccine covid,04-May-21,Pfizer,19-Jun-21,Pfizer,27-Feb-22,Moderna,,,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,386,2,September,2021,,89,,,Completed,1000-4999,-106 Days After Collection Days After Collection,46,Scheduled,253,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.62,Positive,3011,Positive,Elderly,-232,Post-1st,17-May-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,1,May,2021,44,,,,Completed,50-249,N/A,83,Delayed,75,Scheduled,,44,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.19,Negative,4979,Positive,Elderly,-151,Post-2nd (1-8 Weeks),06-Aug-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,592,2,August,2021,,42,,,Completed,1000-4999,N/A,83,Delayed,75,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.29,Negative,1995,Positive,Elderly,-62,Post-3rd (8+ Weeks),03-Nov-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,516,3,November,2021,,,56,,Completed,1000-4999,N/A,83,Delayed,75,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,609,Positive,Elderly,16,Post-3rd (8+ Weeks),20-Jan-22,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2919,4,January,2022,,,134,,Completed,10000+,N/A,83,Delayed,75,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,1769,Positive,Adult,,Pre-1st,15-Mar-21,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,61,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,March,2021,,,,,Completed,0-49,N/A,52,Scheduled,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.16,Negative,684,Positive,Adult,,Post-2nd (1-8 Weeks),16-Aug-21,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,62,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,492,2,August,2021,,28,,,Completed,1000-4999,N/A,52,Scheduled,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.16,Negative,3592,Positive,Adult,,Post-3rd (8+ Weeks),13-Jun-22,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,63,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,2309,3,June,2022,,,137,,Completed,10000+,N/A,52,Scheduled,192,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.4,Negative,5820,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,28-Jan-22,Pfizer,,,62,60-69,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,397,1,July,2021,,34,,,Completed,1000-4999,N/A,80,Delayed,97,Scheduled,140,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,5,Negative,Elderly,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,06-Apr-21,Pfizer,29-Jun-21,Pfizer,03-Nov-21,Pfizer,02-May-22,Pfizer,,,70,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,134,1,August,2021,,36,,,Completed,250-999,N/A,84,Delayed,127,Delayed,180,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.89,Positive,41,Negative,Elderly,,Post-3rd (8+ Weeks),22-Feb-22,baseline,06-Apr-21,Pfizer,29-Jun-21,Pfizer,03-Nov-21,Pfizer,02-May-22,Pfizer,,,71,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,108,2,February,2022,,,111,,Completed,250-999,N/A,84,Delayed,127,Delayed,180,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.82,Positive,1607,Positive,Adult,-279,Post-2nd (8+ Weeks),16-Jul-21,baseline,07-Apr-21,Pfizer,01-May-21,Pfizer,10-Sep-21,Pfizer,18-Feb-22,Moderna,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,732,1,July,2021,,76,,,Completed,,N/A,24,Scheduled,132,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,4.19,Positive,1834,Positive,Elderly,-97,Post-3rd (8+ Weeks),14-Jan-22,baseline,07-Apr-21,Pfizer,01-May-21,Pfizer,10-Sep-21,Pfizer,18-Feb-22,Moderna,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,1369,2,January,2022,,,126,,Completed,,N/A,24,Scheduled,132,Delayed,161,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.16,Negative,2126,Positive,Elderly,,Post-1st,06-May-21,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,9,1,May,2021,42,,,,Completed,50-249,N/A,77,Delayed,159,Delayed,160,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.25,Positive,959,Positive,Elderly,,Post-3rd (8+ Weeks),17-Jan-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1417,2,January,2022,,,62,,Completed,,N/A,77,Delayed,159,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.25,Positive,1497,Positive,Elderly,,Post-3rd (8+ Weeks),11-Apr-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,296,3,April,2022,,,146,,Completed,1000-4999,N/A,77,Delayed,159,Delayed,160,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.55,Negative,8046,Positive,Elderly,,Post-4th,26-May-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3306,4,May,2022,,,,31,Completed,10000+,N/A,77,Delayed,159,Delayed,160,,,,31,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,1.46,Positive,929,Positive,Adult,,Post-1st,05-Apr-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,1,April,2021,24,,,,Completed,0-49,N/A,99,Delayed,188,Delayed,,24,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.05,Negative,10268,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,2,June,2021,,9,,,Completed,50-249,N/A,99,Delayed,188,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,1.03,Positive,9369,Positive,Elderly,,Post-2nd (8+ Weeks),09-Dec-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,51,3,December,2021,,173,,,Completed,250-999,N/A,99,Delayed,188,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,1.03,Positive,720,Positive,Elderly,,Post-3rd (1-8 Weeks),18-Jan-22,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9290,4,January,2022,,,25,,Completed,10000+,N/A,99,Delayed,188,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.1,Negative,7128,Positive,Adult,124,Pre-1st,25-Mar-21,covid,22-Sep-21,Pfizer,13-Oct-21,Pfizer,,,,,,,33,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,1,March,2021,,,,,Completed,250-999,N/A,21,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,8,Positive,1,Negative,Adult,,Post-1st,26-May-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,86,1,May,2021,42,,,,Completed,250-999,N/A,58,Delayed,155,Delayed,153,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,8,Positive,1207,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,455,2,July,2021,,42,,,Completed,1000-4999,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,3.92,Positive,36676,Positive,Adult,,Post-2nd (8+ Weeks),06-Nov-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,145,3,November,2021,,148,,,Completed,1000-4999,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.17,Negative,41828,Positive,Adult,,Post-3rd (1-8 Weeks),30-Nov-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3846,4,November,2021,,,17,,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2,Positive,550,Positive,Adult,,Post-3rd (8+ Weeks),28-Mar-22,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5438,5,March,2022,,,135,,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.11,Positive,3076,Positive,Adult,,Post-4th,03-May-22,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,6,May,2022,,,,18,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,18,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,1.76,Positive,490,Positive,Elderly,-400,Post-2nd (1-8 Weeks),15-Mar-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,64,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,1,1,March,2021,,16,,,Completed,0-49,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,1.11,Positive,20241,Positive,Elderly,-281,Post-2nd (8+ Weeks),12-Jul-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,1,2,July,2021,,135,,,Completed,0-49,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,1.76,Positive,128,Positive,Elderly,-155,Post-3rd (8+ Weeks),15-Nov-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,95,3,November,2021,,,74,,Completed,250-999,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,,5756,Positive,Elderly,-89,Post-3rd (8+ Weeks),20-Jan-22,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,56,4,January,2022,,,140,,Completed,250-999,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,,,995,Positive,Elderly,-8,Post-4th,11-Apr-22,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,178,5,April,2022,,,,77,Completed,1000-4999,N/A,40,Scheduled,187,Delayed,144,,,,77,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.14,Negative,5455,Positive,Elderly,,Post-2nd (1-8 Weeks),31-May-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,625,1,May,2021,,22,,,Completed,1000-4999,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,2339,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,2,September,2021,,123,,,Completed,250-999,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,24158,Positive,Elderly,,Post-3rd (1-8 Weeks),20-Dec-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2034,3,December,2021,,,20,,Completed,10000+,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3,Negative,Elderly,,Post-3rd (8+ Weeks),01-Apr-22,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,760,4,April,2022,,,122,,Completed,,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,285,Positive,Elderly,,Post-4th,10-Jun-22,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1984,5,June,2022,,,,11,Completed,10000+,N/A,23,Scheduled,205,Delayed,181,,,,11,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.07,Negative,8781,Positive,Elderly,,Post-1st,10-May-21,baseline,16-Mar-21,Moderna,14-Jun-21,Moderna,17-Nov-21,Pfizer,20-Apr-22,Moderna ,,,67,60-69,1,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,May,2021,55,,,,Completed,0-49,N/A,90,Delayed,156,Delayed,154,55,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,15154,Positive,Elderly,,Post-3rd (1-8 Weeks),24-Nov-21,baseline,16-Mar-21,Moderna,14-Jun-21,Moderna,17-Nov-21,Pfizer,20-Apr-22,Moderna ,,,67,60-69,1,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,115,3,November,2021,,,7,,Completed,250-999,N/A,90,Delayed,156,Delayed,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,3246,Positive,Elderly,,Post-2nd (1-8 Weeks),08-Jun-21,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,414,2,June,2021,,22,,,Completed,1000-4999,N/A,55,Scheduled,118,Scheduled,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,789,Positive,Elderly,,Post-3rd (1-8 Weeks),25-Oct-21,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,427,3,October,2021,,,43,,Completed,1000-4999,N/A,55,Scheduled,118,Scheduled,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,12938,Positive,Elderly,,Post-3rd (8+ Weeks),08-Feb-22,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,73,4,February,2022,,,149,,Completed,250-999,N/A,55,Scheduled,118,Scheduled,185,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,7641,Positive,Elderly,,Post-4th,21-Apr-22,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,861,5,April,2022,,,,36,Completed,,N/A,55,Scheduled,118,Scheduled,185,,,,36,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,15739,Positive,Adult,,Post-1st,10-May-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,97,1,May,2021,28,,,,Completed,250-999,N/A,52,Scheduled,196,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,3,Negative,Adult,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,588,2,June,2021,,18,,,Completed,1000-4999,N/A,52,Scheduled,196,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1626,Positive,Adult,,Post-2nd (8+ Weeks),01-Oct-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,60,3,October,2021,,120,,,Completed,250-999,N/A,52,Scheduled,196,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,26157,Positive,Adult,,Post-3rd (1-8 Weeks),07-Jan-22,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2476,4,January,2022,,,22,,Completed,10000+,N/A,52,Scheduled,196,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,5778,Positive,Adult,,Post-1st,28-May-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,50,1,May,2021,54,,,,Completed,250-999,N/A,68,Delayed,128,Delayed,186,54,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.58,Negative,10429,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1717,2,July,2021,,24,,,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,20932,Positive,Elderly,,Post-3rd (1-8 Weeks),24-Nov-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1998,3,November,2021,,,38,,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,8212,Positive,Elderly,,Post-3rd (8+ Weeks),15-Mar-22,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,453,4,March,2022,,,149,,Completed,1000-4999,N/A,68,Delayed,128,Delayed,186,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,1990,Positive,Elderly,,Post-4th,09-May-22,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,6523,5,May,2022,,,,18,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,18,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.01,Negative,30929,Positive,Elderly,,Post-1st,19-Apr-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,96,1,April,2021,32,,,,Completed,250-999,N/A,35,Scheduled,166,Delayed,,32,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.14,Negative,40,Negative,Elderly,,Post-2nd (8+ Weeks),22-Jul-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,215,2,July,2021,,91,,,Completed,1000-4999,N/A,35,Scheduled,166,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.07,Negative,61,Positive,Elderly,,Post-3rd (1-8 Weeks),02-Nov-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,2734,3,November,2021,,,28,,Completed,10000+,N/A,35,Scheduled,166,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.02,Negative,4895,Positive,Elderly,,Post-3rd (8+ Weeks),07-Apr-22,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,79,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,681,4,April,2022,,,184,,Completed,1000-4999,N/A,35,Scheduled,166,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,,,0.08,Negative,21918,Positive,Adult,-174,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,11-Apr-21,Pfizer,08-May-21,Pfizer,,,,,,,56,50-59,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,300,1,August,2021,,101,,,Completed,1000-4999,N/A,27,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.02,Negative,976,Positive,Elderly,,Post-1st,09-Jun-21,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,1,June,2021,72,,,,Completed,50-249,N/A,80,Delayed,185,Delayed,,72,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.02,Negative,11144,Positive,Elderly,,Post-2nd (8+ Weeks),12-Nov-21,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,236,3,November,2021,,148,,,Completed,1000-4999,N/A,80,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.01,Negative,27802,Positive,Elderly,,Post-3rd (8+ Weeks),12-May-22,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,509,4,May,2022,,,144,,Completed,1000-4999,N/A,80,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,3465,Positive,Elderly,,Post-2nd (8+ Weeks),13-Aug-21,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,72,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,66,2,August,2021,,64,,,Completed,250-999,N/A,79,Delayed,118,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.08,Negative,16258,Positive,Elderly,,Post-3rd (1-8 Weeks),04-Nov-21,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,73,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,684,3,November,2021,,,29,,Completed,1000-4999,N/A,79,Delayed,118,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,2795,Positive,Elderly,,Post-3rd (8+ Weeks),23-Feb-22,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,73,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,69,4,February,2022,,,140,,Completed,250-999,N/A,79,Delayed,118,Scheduled,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,947,Positive,Adult,,Post-1st,13-May-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,73,1,May,2021,36,,,,Completed,250-999,N/A,76,Delayed,153,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,760,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1597,2,July,2021,,30,,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,5.05,Positive,63,Positive,Elderly,,Post-2nd (8+ Weeks),09-Nov-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,283,3,November,2021,,140,,,Completed,1000-4999,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,5.05,Positive,9978,Positive,Elderly,,Post-3rd (8+ Weeks),11-Feb-22,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7136,4,February,2022,,,81,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,2082,Positive,Elderly,,Post-3rd (8+ Weeks),14-Apr-22,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,65,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,5,April,2022,,,143,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.1,Negative,23285,Positive,Adult,,Post-1st,30-Apr-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,341,1,April,2021,29,,,,Completed,1000-4999,N/A,57,Delayed,132,Delayed,151,29,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,20,Negative,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5008,2,June,2021,,28,,,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,142,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,3,October,2021,,,8,,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.03,Negative,356,Positive,Adult,,Post-4th,01-Apr-22,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,4,April,2022,,,,25,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,25,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,65420,Positive,Adult,,Post-1st,11-Jun-21,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,52,1,June,2021,47,,,,Completed,250-999,N/A,52,Scheduled,84,Scheduled,157,47,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,10100,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1010,2,July,2021,,23,,,Completed,,N/A,52,Scheduled,84,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,607,Positive,Adult,,Post-3rd (8+ Weeks),18-Feb-22,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,26,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,280,3,February,2022,,,163,,Completed,1000-4999,N/A,52,Scheduled,84,Scheduled,157,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,3205,Positive,Adult,,Post-4th,23-Mar-22,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,26,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,2009,4,March,2022,,,,39,Completed,10000+,N/A,52,Scheduled,84,Scheduled,157,,,,39,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,4.11,Positive,1023,Positive,Elderly,,Post-1st,21-Apr-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,1,April,2021,28,,,,Completed,50-249,N/A,79,Delayed,199,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.01,Negative,27081,Positive,Elderly,,Post-2nd (1-8 Weeks),07-Jul-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,499,2,July,2021,,26,,,Completed,1000-4999,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,38297,Positive,Elderly,,Post-2nd (8+ Weeks),17-Dec-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107,3,December,2021,,189,,,Completed,250-999,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.01,Negative,80000,Positive,Elderly,,Post-3rd (1-8 Weeks),21-Jan-22,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3200,4,January,2022,,,25,,Completed,10000+,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,4398,Positive,Elderly,,Post-3rd (8+ Weeks),09-May-22,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,67,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,856,5,May,2022,,,133,,Completed,,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.04,Negative,434,Positive,Adult,,Post-1st,21-May-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,59,50-59,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,98,1,May,2021,42,,,,Completed,250-999,N/A,63,Delayed,185,Delayed,,42,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.02,Negative,14324,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,59,50-59,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1649,2,August,2021,,54,,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.03,Negative,5352,Positive,Adult,,Post-3rd (1-8 Weeks),27-Jan-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,3521,3,January,2022,,,45,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.01,Negative,13972,Positive,Adult,,Post-3rd (8+ Weeks),08-Apr-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1452,4,April,2022,,,116,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.03,Negative,7,Negative,Adult,,Pre-1st,23-Mar-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,25,1,March,2021,,,,,Completed,50-249,N/A,27,Scheduled,125,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.01,Negative,273,Positive,Adult,,Post-1st,05-May-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,11,2,May,2021,26,,,,Completed,50-249,N/A,27,Scheduled,125,Delayed,153,26,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.06,Negative,813,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,53,3,June,2021,,48,,,Completed,250-999,N/A,27,Scheduled,125,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.03,Negative,43,Negative,Adult,,Post-3rd (1-8 Weeks),30-Sep-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,2559,4,September,2021,,,22,,Completed,10000+,N/A,27,Scheduled,125,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.07,Negative,2917,Positive,Adult,,Post-4th,01-Mar-22,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,1067,5,March,2022,,,,21,Completed,,N/A,27,Scheduled,125,Delayed,153,,,,21,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.06,Negative,3010,Positive,Adult,,Post-4th,03-Jun-22,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,526,6,June,2022,,,,115,Completed,1000-4999,N/A,27,Scheduled,125,Delayed,153,,,,115,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,513,Positive,Adult,-44,Pre-1st,06-May-21,covid,26-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,1,May,2021,,,,,Completed,50-249,N/A,43,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.07,Negative,6064,Positive,Adult,0,Post-1st,19-Jun-21,covid,26-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,667,2,June,2021,24,,,,Completed,1000-4999,N/A,43,Scheduled,,Delayed,,24,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.04,Negative,680,Positive,Adult,,Post-1st,26-May-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,27,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,61,1,May,2021,33,,,,Completed,250-999,N/A,67,Delayed,191,Delayed,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.02,Negative,4141,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,27,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,1047,2,July,2021,,22,,,Completed,,N/A,67,Delayed,191,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.76,Positive,426,Positive,Adult,,Post-2nd (8+ Weeks),21-Dec-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,247,3,December,2021,,175,,,Completed,1000-4999,N/A,67,Delayed,191,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.01,Negative,17436,Positive,Adult,,Post-3rd (1-8 Weeks),31-Jan-22,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,1439,4,January,2022,,,25,,Completed,10000+,N/A,67,Delayed,191,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,351,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,70,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,2584,1,May,2021,,12,,,Completed,10000+,N/A,59,Delayed,140,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,12090,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,71,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,287,2,September,2021,,124,,,Completed,1000-4999,N/A,59,Delayed,140,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,14068,Positive,Elderly,,Post-3rd (8+ Weeks),04-Mar-22,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,71,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,525,3,March,2022,,,154,,Completed,1000-4999,N/A,59,Delayed,140,Delayed,199,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.02,Negative,3190,Positive,Adult,-396,Post-1st,15-Jun-21,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,129,1,June,2021,44,,,,Completed,250-999,N/A,78,Delayed,92,Scheduled,169,44,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.02,Negative,45938,Positive,Adult,-229,Post-3rd (1-8 Weeks),29-Nov-21,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,2869,2,November,2021,,,41,,Completed,10000+,N/A,78,Delayed,92,Scheduled,169,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.02,Negative,675,Positive,Adult,-117,Post-3rd (8+ Weeks),21-Mar-22,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,92,3,March,2022,,,153,,Completed,250-999,N/A,78,Delayed,92,Scheduled,169,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,1511,Positive,Elderly,,Post-1st,26-Apr-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,April,2021,45,,,,Processed,,N/A,87,Delayed,183,Delayed,,45,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,19256,Positive,Elderly,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2178,2,June,2021,,21,,,Completed,10000+,N/A,87,Delayed,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,4794,Positive,Elderly,,Post-3rd (1-8 Weeks),29-Dec-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5821,3,December,2021,,,22,,Completed,10000+,N/A,87,Delayed,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.14,Negative,25814,Positive,Elderly,,Post-1st,21-Jul-21,baseline,08-May-21,Moderna,01-Oct-21,Pfizer,07-Jul-22,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,112,1,July,2021,74,,,,Completed,250-999,N/A,146,Delayed,279,Delayed,,74,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Combination Therapy,Vedolizumab Only,,,0.02,Negative,1660,Positive,Adult,,Post-1st,31-May-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,,,,,,,26,18-29,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64,1,May,2021,22,,,,Completed,250-999,N/A,59,Delayed,,Delayed,,22,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Immunomodulator Only,Combination Therapy,Vedolizumab Only,,,0.02,Negative,3585,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,,,,,,,26,18-29,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1985,2,July,2021,,12,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,465,Positive,Adult,,Post-1st,03-May-21,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,May,2021,33,,,,Completed,0-49,N/A,78,Delayed,183,Delayed,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,4818,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,11,2,July,2021,,39,,,Completed,50-249,N/A,78,Delayed,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,489,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,136,3,January,2022,,,20,,Completed,250-999,N/A,78,Delayed,183,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,511,Positive,Adult,-300,Post-2nd (1-8 Weeks),06-May-21,baseline,04-Apr-21,Pfizer,26-Apr-21,Pfizer,13-Nov-21,Pfizer,,,,,26,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3169,1,May,2021,,10,,,Completed,10000+,N/A,22,Scheduled,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,11244,Positive,Adult,-182,Post-2nd (8+ Weeks),01-Sep-21,baseline,04-Apr-21,Pfizer,26-Apr-21,Pfizer,13-Nov-21,Pfizer,,,,,27,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,615,2,September,2021,,128,,,Completed,1000-4999,N/A,22,Scheduled,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,1991,Positive,Adult,-119,Post-1st,27-May-21,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,6,1,May,2021,28,,,,Completed,0-49,N/A,46,Scheduled,215,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,50256,Positive,Adult,-79,Post-2nd (1-8 Weeks),06-Jul-21,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,327,2,July,2021,,22,,,Completed,1000-4999,N/A,46,Scheduled,215,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,80000,Positive,Adult,133,Post-3rd (1-8 Weeks),03-Feb-22,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,5142,3,February,2022,,,19,,Completed,10000+,N/A,46,Scheduled,215,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.03,Negative,2402,Positive,Adult,259,Post-3rd (8+ Weeks),09-Jun-22,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,786,4,June,2022,,,145,,Completed,,N/A,46,Scheduled,215,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.03,Negative,35266,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jun-21,baseline,15-Apr-21,Pfizer,08-May-21,Pfizer,30-Sep-21,Pfizer,02-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,97,1,June,2021,,49,,,Completed,250-999,N/A,23,Scheduled,145,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.03,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),18-Sep-21,baseline,15-Apr-21,Pfizer,08-May-21,Pfizer,30-Sep-21,Pfizer,02-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,62,2,September,2021,,133,,,Completed,250-999,N/A,23,Scheduled,145,Delayed,153,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,80000,Positive,Adult,,Post-1st,10-Jun-21,baseline,13-May-21,Moderna,12-Jul-21,Moderna,,,,,,,25,18-29,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,June,2021,28,,,,Completed,0-49,N/A,60,Delayed,,Delayed,,28,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,367,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,13-May-21,Moderna,12-Jul-21,Moderna,,,,,,,25,18-29,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54,2,August,2021,,24,,,Completed,250-999,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,7113,Positive,Elderly,-341,Post-2nd (8+ Weeks),26-Apr-21,baseline,15-Jan-21,Pfizer,12-Feb-21,Pfizer,27-Sep-21,Pfizer,10-May-22,Pfizer,,,83,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,13,1,April,2021,,73,,,Completed,50-249,N/A,28,Scheduled,227,Delayed,225,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,1970,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Apr-21,baseline,03-Mar-21,Pfizer,12-Apr-21,Pfizer,13-Oct-21,Pfizer,02-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,471,1,April,2021,,9,,,Completed,1000-4999,N/A,40,Scheduled,184,Delayed,201,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,14148,Positive,Elderly,,Post-2nd (8+ Weeks),07-Oct-21,baseline,03-Mar-21,Pfizer,12-Apr-21,Pfizer,13-Oct-21,Pfizer,02-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,14,2,October,2021,,178,,,Completed,50-249,N/A,40,Scheduled,184,Delayed,201,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,219,Positive,Adult,,Post-1st,11-May-21,baseline,08-Apr-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,52,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,1,May,2021,33,,,,Completed,50-249,N/A,61,Delayed,182,Delayed,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.03,Negative,3515,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,08-Apr-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,52,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,351,2,July,2021,,38,,,Completed,1000-4999,N/A,61,Delayed,182,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,756,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jun-21,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,474,1,June,2021,,15,,,Completed,1000-4999,N/A,60,Delayed,88,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.45,Negative,22535,Positive,Adult,,Post-3rd (1-8 Weeks),04-Oct-21,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1287,2,October,2021,,,24,,Completed,,N/A,60,Delayed,88,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,6030,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,174,3,January,2022,,,132,,Completed,1000-4999,N/A,60,Delayed,88,Scheduled,154,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,692,Positive,Adult,,Post-4th,26-Apr-22,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,983,4,April,2022,,,,74,Completed,,N/A,60,Delayed,88,Scheduled,154,,,,74,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,3.86,Positive,11614,Positive,Adult,,Post-1st,21-May-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,1,May,2021,66,,,,Completed,50-249,N/A,95,Delayed,201,Delayed,,66,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,24799,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,310,2,July,2021,,38,,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,10229,Positive,Adult,,Post-2nd (8+ Weeks),16-Nov-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,191,3,November,2021,,150,,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,180,Positive,Adult,,Post-3rd (8+ Weeks),18-Mar-22,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1114,4,March,2022,,,71,,Completed,,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,77,Positive,Adult,,Post-3rd (8+ Weeks),17-May-22,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,357,5,May,2022,,,131,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.06,Negative,376,Positive,Adult,,Post-2nd (8+ Weeks),20-Apr-22,baseline,05-May-21,Pfizer,06-Jul-21,Pfizer,,,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9503,1,April,2022,,288,,,Completed,10000+,N/A,62,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.03,Negative,18020,Positive,Adult,,Post-1st,10-May-21,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,33,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,May,2021,26,,,,Completed,0-49,N/A,28,Scheduled,113,Scheduled,158,26,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.05,Negative,3702,Positive,Adult,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,482,3,September,2021,,,27,,Completed,1000-4999,N/A,28,Scheduled,113,Scheduled,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.02,Negative,427,Positive,Adult,,Post-3rd (8+ Weeks),05-Jan-22,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,74,4,January,2022,,,125,,Completed,250-999,N/A,28,Scheduled,113,Scheduled,158,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.05,Negative,7375,Positive,Adult,,Post-4th,24-May-22,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,128,5,May,2022,,,,106,Completed,250-999,N/A,28,Scheduled,113,Scheduled,158,,,,106,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,1739,Positive,Adult,-292,Post-1st,19-May-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,64,1,May,2021,36,,,,Completed,250-999,N/A,43,Scheduled,175,Delayed,202,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,10135,Positive,Adult,-229,Post-2nd (8+ Weeks),21-Jul-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,2,July,2021,,56,,,Processed,,N/A,43,Scheduled,175,Delayed,202,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,18195,Positive,Adult,-138,Post-2nd (8+ Weeks),20-Oct-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,274,3,October,2021,,147,,,Completed,1000-4999,N/A,43,Scheduled,175,Delayed,202,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,2020,Positive,Adult,-26,Post-3rd (8+ Weeks),09-Feb-22,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2277,4,February,2022,,,84,,Completed,10000+,N/A,43,Scheduled,175,Delayed,202,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.45,Negative,,,Adult,-179,Post-2nd (1-8 Weeks),14-Jul-21,Post Vaccine covid,21-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,446,2,July,2021,,25,,,Completed,1000-4999,N/A,59,Delayed,130,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,15339,Positive,Adult,-337,Post-1st,17-May-21,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,1,May,2021,19,,,,Completed,50-249,N/A,45,Scheduled,198,Delayed,,19,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,40996,Positive,Adult,-252,Post-2nd (8+ Weeks),10-Aug-21,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,556,2,August,2021,,59,,,Completed,1000-4999,N/A,45,Scheduled,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.21,Negative,7587,Positive,Adult,-85,Post-3rd (1-8 Weeks),24-Jan-22,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,January,2022,,,28,,Completed,10000+,N/A,45,Scheduled,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,791,Positive,Adult,52,Post-3rd (8+ Weeks),10-Jun-22,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1824,4,June,2022,,,165,,Completed,10000+,N/A,45,Scheduled,198,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.21,Negative,449,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,19-Apr-21,Pfizer,14-Jun-21,Pfizer,02-Jan-22,Pfizer,,,,,22,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4381,1,June,2021,,7,,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,13978,Positive,Adult,,Post-3rd (1-8 Weeks),08-Feb-22,baseline,19-Apr-21,Pfizer,14-Jun-21,Pfizer,02-Jan-22,Pfizer,,,,,22,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,2,February,2022,,,37,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.08,Negative,3192,Positive,Adult,,Post-2nd (1-8 Weeks),18-May-21,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,60,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,593,1,May,2021,,8,,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.03,Negative,0,Negative,Adult,,Post-2nd (8+ Weeks),15-Sep-21,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,60,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,302,2,September,2021,,128,,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,74,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,61,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,455,3,June,2022,,,155,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.09,Negative,956,Positive,Adult,,Post-2nd (1-8 Weeks),20-May-21,baseline,06-Apr-21,Pfizer,08-May-21,Pfizer,07-Jan-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2726,1,May,2021,,12,,,Completed,10000+,N/A,32,Scheduled,244,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.09,Negative,439,Positive,Adult,0,Post-1st,12-May-21,baseline,02-Apr-21,Pfizer,03-Jun-21,Pfizer,,,,,,,30,30-39,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139,1,May,2021,40,,,,Completed,250-999,N/A,62,Delayed,,Delayed,,40,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,12,Negative,Adult,85,Post-2nd (8+ Weeks),05-Aug-21,baseline,02-Apr-21,Pfizer,03-Jun-21,Pfizer,,,,,,,30,30-39,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,866,2,August,2021,,63,,,Completed,,N/A,62,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,379,Positive,Adult,,Post-1st,11-Jun-21,baseline,22-Apr-21,Pfizer,18-Jun-21,Pfizer,22-Oct-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,95,1,June,2021,50,,,,Completed,250-999,N/A,57,Delayed,126,Delayed,,50,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,3316,Positive,Adult,,Post-2nd (8+ Weeks),14-Sep-21,baseline,22-Apr-21,Pfizer,18-Jun-21,Pfizer,22-Oct-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,424,2,September,2021,,88,,,Completed,1000-4999,N/A,57,Delayed,126,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,65,Positive,Adult,,Post-2nd (1-8 Weeks),18-May-21,baseline,23-Mar-21,Pfizer,04-May-21,Pfizer,,,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7634,1,May,2021,,14,,,Completed,10000+,N/A,42,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,2472,Positive,Adult,,Post-2nd (8+ Weeks),21-Sep-21,baseline,23-Mar-21,Pfizer,04-May-21,Pfizer,,,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,310,2,September,2021,,140,,,Completed,1000-4999,N/A,42,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3335,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,339,1,July,2021,,23,,,Completed,1000-4999,N/A,79,Delayed,217,Delayed,0,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,9061,Positive,Adult,,Post-2nd (8+ Weeks),29-Oct-21,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,11,2,October,2021,,121,,,Completed,50-249,N/A,79,Delayed,217,Delayed,0,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,1227,Positive,Adult,,Post-4th,24-Feb-22,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,758,3,February,2022,,,,22,Completed,,N/A,79,Delayed,217,Delayed,0,,,,22,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,183,Positive,Adult,,Post-2nd (1-8 Weeks),28-May-21,baseline,06-Apr-21,Moderna,10-May-21,Moderna,02-Sep-21,Moderna,04-Feb-22,Moderna,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2456,1,May,2021,,18,,,Completed,10000+,N/A,34,Scheduled,115,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,2181,Positive,Adult,,Post-3rd (1-8 Weeks),08-Oct-21,baseline,06-Apr-21,Moderna,10-May-21,Moderna,02-Sep-21,Moderna,04-Feb-22,Moderna,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3957,2,October,2021,,,36,,Completed,10000+,N/A,34,Scheduled,115,Scheduled,155,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,1345,Positive,Adult,-269,Post-1st,07-May-21,Post Vaccine covid,04-Apr-21,Pfizer,29-May-21,Pfizer,27-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,1,May,2021,33,,,,Completed,50-249,N/A,55,Scheduled,121,Delayed,,33,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,7845,Positive,Adult,-223,Post-2nd (1-8 Weeks),22-Jun-21,Post Vaccine covid,04-Apr-21,Pfizer,29-May-21,Pfizer,27-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,143,2,June,2021,,24,,,Completed,1000-4999,N/A,55,Scheduled,121,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,,,,,0.04,Negative,2514,Positive,Adult,,,19-May-21,baseline,,,,,,,,,,,36,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,May,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,3,Negative,Adult,,Post-1st,20-May-21,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,111,1,May,2021,38,,,,Completed,250-999,N/A,62,Delayed,184,Delayed,,38,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,3289,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,469,2,July,2021,,46,,,Completed,1000-4999,N/A,62,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,3392,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,3,January,2022,,,23,,Completed,10000+,N/A,62,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,520,Positive,Adult,,Post-3rd (8+ Weeks),13-Apr-22,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3579,4,April,2022,,,120,,Completed,10000+,N/A,62,Delayed,184,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,903,Positive,Adult,31,Pre-1st,19-Apr-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,20,1,April,2021,,,,,Completed,50-249,31 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,30850,Positive,Adult,60,Post-1st,18-May-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1017,2,May,2021,20,,,,Completed,,60 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,20,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.55,Negative,80000,Positive,Adult,157,Post-2nd (8+ Weeks),23-Aug-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,272,3,August,2021,,96,,,Completed,1000-4999,157 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,4176,Positive,Adult,236,Post-2nd (8+ Weeks),10-Nov-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,73,4,November,2021,,175,,,Completed,250-999,236 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,2128,Positive,Adult,328,Post-3rd (8+ Weeks),10-Feb-22,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,480,5,February,2022,,,65,,Completed,1000-4999,328 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,19199,Positive,Adult,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,664,2,July,2021,,37,,,Completed,1000-4999,N/A,58,Delayed,136,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,3650,Positive,Adult,,Post-3rd (1-8 Weeks),26-Nov-21,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2125,3,November,2021,,,30,,Completed,10000+,N/A,58,Delayed,136,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,666,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,234,4,February,2022,,,111,,Completed,1000-4999,N/A,58,Delayed,136,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,2985,Positive,Adult,55,Pre-1st,30-Mar-21,covid,09-Apr-21,Pfizer,04-May-21,Pfizer,22-Dec-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,13,1,March,2021,,,,,Completed,50-249,N/A,25,Scheduled,232,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,7684,Positive,Elderly,,Post-1st,21-Apr-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,28,1,April,2021,35,,,,Completed,50-249,N/A,71,Delayed,99,Scheduled,152,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,53759,Positive,Elderly,,Post-1st,26-May-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,23,2,May,2021,70,,,,Completed,50-249,N/A,71,Delayed,99,Scheduled,152,70,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.03,Negative,2184,Positive,Elderly,,Post-2nd (8+ Weeks),23-Jul-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,252,3,July,2021,,57,,,Completed,1000-4999,N/A,71,Delayed,99,Scheduled,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.78,Positive,2387,Positive,Elderly,,Post-3rd (1-8 Weeks),23-Sep-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1571,4,September,2021,,,20,,Completed,10000+,N/A,71,Delayed,99,Scheduled,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.78,Positive,74,Positive,Elderly,,Post-3rd (8+ Weeks),07-Jan-22,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,338,5,January,2022,,,126,,Completed,1000-4999,N/A,71,Delayed,99,Scheduled,152,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,5340,Positive,Elderly,,Post-4th,24-Feb-22,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,3367,6,February,2022,,,,22,Completed,10000+,N/A,71,Delayed,99,Scheduled,152,,,,22,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,0,Negative,Adult,75,Post-2nd (8+ Weeks),28-Mar-22,Post Vaccine covid,27-Apr-21,Pfizer,23-Jun-21,Pfizer,,,,,,,34,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6928,3,March,2022,,278,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,3,Negative,Elderly,-237,Post-2nd (1-8 Weeks),27-Aug-21,baseline,10-Jun-21,Pfizer,07-Jul-21,Pfizer,29-Jan-22,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,622,1,August,2021,,51,,,Completed,1000-4999,N/A,27,Scheduled,206,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,780,Positive,Elderly,40,Post-3rd (8+ Weeks),31-May-22,baseline,10-Jun-21,Pfizer,07-Jul-21,Pfizer,29-Jan-22,Pfizer,,,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8796,2,May,2022,,,122,,Completed,10000+,N/A,27,Scheduled,206,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.06,Negative,3302,Positive,Elderly,,Post-2nd (1-8 Weeks),21-May-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,770,1,May,2021,,23,,,Completed,,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.02,Negative,80000,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,30,2,September,2021,,134,,,Completed,50-249,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.7,Positive,25204,Positive,Elderly,,Post-3rd (8+ Weeks),04-Nov-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,172,3,November,2021,,,59,,Completed,1000-4999,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.05,Negative,33,Negative,Elderly,,Post-3rd (8+ Weeks),28-Jan-22,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,17,4,January,2022,,,144,,Completed,50-249,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.05,Negative,4678,Positive,Elderly,,Post-4th,28-Apr-22,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,71,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,981,5,April,2022,,,,41,Completed,,N/A,25,Scheduled,131,Delayed,193,,,,41,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,14962,Positive,Adult,101,Post-1st,25-Jun-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,309,1,June,2021,53,,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,53,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,6.71,Positive,1651,Positive,Adult,155,Post-2nd (1-8 Weeks),18-Aug-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,785,2,August,2021,,48,,,Completed,,N/A,59,Delayed,343,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,197,Positive,Adult,211,Post-2nd (8+ Weeks),13-Oct-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,407,3,October,2021,,104,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,165,Positive,Adult,272,Post-2nd (8+ Weeks),13-Dec-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,310,4,December,2021,,165,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.02,Negative,1775,Positive,Adult,110,Post-1st,17-May-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3190,1,May,2021,35,,,,Completed,10000+,0,62,Delayed,115,Scheduled,289,35,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.09,Negative,11062,Positive,Adult,161,Post-2nd (1-8 Weeks),07-Jul-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1501,2,July,2021,,24,,,Completed,10000+,161 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.18,Negative,2380,Positive,Adult,273,Post-3rd (1-8 Weeks),27-Oct-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1917,3,October,2021,,,21,,Completed,10000+,273 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.37,Negative,23708,Positive,Adult,385,Post-3rd (8+ Weeks),16-Feb-22,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1073,4,February,2022,,,133,,Completed,,385 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,2905,Positive,Adult,,Post-1st,18-May-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,117,1,May,2021,36,,,,Completed,250-999,N/A,44,Scheduled,,Delayed,,36,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,5423,Positive,Adult,,Post-2nd (8+ Weeks),27-Jul-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,404,2,July,2021,,62,,,Completed,1000-4999,N/A,44,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,214,Positive,Adult,,Post-2nd (8+ Weeks),06-Oct-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,183,3,October,2021,,133,,,Completed,1000-4999,N/A,44,Scheduled,,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.18,Negative,1210,Positive,Adult,-316,Post-2nd (8+ Weeks),05-Apr-21,Post Vaccine covid,30-Dec-20,Pfizer,20-Jan-21,Pfizer,10-Sep-21,Pfizer,,,,,52,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,651,1,April,2021,,75,,,Completed,1000-4999,N/A,21,Scheduled,233,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.04,Negative,120,Positive,Adult,29,Post-3rd (8+ Weeks),16-Mar-22,Post Vaccine covid,30-Dec-20,Pfizer,20-Jan-21,Pfizer,10-Sep-21,Pfizer,,,,,53,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,2,March,2022,,,187,,Completed,10000+,N/A,21,Scheduled,233,Delayed,,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.04,Negative,6908,Positive,Elderly,-257,Post-1st,09-May-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,6,1,May,2021,39,,,,Completed,0-49,N/A,74,Delayed,94,Scheduled,221,39,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.06,Negative,821,Positive,Elderly,-155,Post-2nd (8+ Weeks),19-Aug-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,199,2,August,2021,,67,,,Completed,1000-4999,N/A,74,Delayed,94,Scheduled,221,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.06,Negative,2844,Positive,Elderly,-76,Post-3rd (1-8 Weeks),06-Nov-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,543,3,November,2021,,,52,,Completed,1000-4999,N/A,74,Delayed,94,Scheduled,221,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.03,Negative,1286,Positive,Elderly,36,Post-3rd (8+ Weeks),26-Feb-22,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,1247,4,February,2022,,,164,,Completed,,N/A,74,Delayed,94,Scheduled,221,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,0.03,Negative,1165,Positive,Elderly,,Post-2nd (8+ Weeks),20-Aug-21,baseline,05-Mar-21,Pfizer,16-Apr-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,81,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,165,1,August,2021,,126,,,Completed,1000-4999,N/A,42,Scheduled,160,Delayed,201,,,,,
ICARUS: Mount Sinai Hospital University of Toronto,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,0.04,Negative,611,Positive,Elderly,,Post-3rd (8+ Weeks),04-Feb-22,baseline,05-Mar-21,Pfizer,16-Apr-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,82,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,87,2,February,2022,,,134,,Completed,250-999,N/A,42,Scheduled,160,Delayed,201,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,1233,Positive,Adult,-412,Post-1st,11-Feb-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,1,February,2021,30,,,,Completed,50-249,N/A,31,Scheduled,245,Delayed,,30,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,27250,Positive,Adult,-376,Post-2nd (1-8 Weeks),19-Mar-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,2,March,2021,,35,,,Processed,,N/A,31,Scheduled,245,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,2368,Positive,Adult,-216,Post-2nd (8+ Weeks),26-Aug-21,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,166,3,August,2021,,195,,,Completed,1000-4999,N/A,31,Scheduled,245,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,62,Positive,Adult,-78,Post-3rd (8+ Weeks),11-Jan-22,baseline,12-Jan-21,Pfizer,12-Feb-21,Pfizer,15-Oct-21,Pfizer,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,628,4,January,2022,,,88,,Completed,1000-4999,N/A,31,Scheduled,245,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.54,Negative,2545,Positive,Adult,,Pre-1st,19-Mar-21,baseline,04-Jun-21,Pfizer,04-Jul-21,Pfizer,,,,,,,30,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,30,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.54,Negative,515,Positive,Adult,-223,Post-1st,21-May-21,Post Vaccine covid,31-Mar-21,Pfizer,02-Jun-21,Pfizer,26-Oct-21,Pfizer,,,,,19,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,32,1,May,2021,51,,,,Completed,50-249,N/A,63,Delayed,146,Delayed,,51,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,1,Negative,Adult,-175,Post-2nd (1-8 Weeks),08-Jul-21,Post Vaccine covid,31-Mar-21,Pfizer,02-Jun-21,Pfizer,26-Oct-21,Pfizer,,,,,19,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,165,2,July,2021,,36,,,Completed,1000-4999,N/A,63,Delayed,146,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Ustekinumab Only,Ustekinumab Only,,,0.01,Negative,1,Negative,Adult,,Post-2nd (1-8 Weeks),10-Aug-21,baseline,07-May-21,Pfizer,17-Jun-21,Pfizer,,,,,,,22,18-29,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,354,1,August,2021,,54,,,Completed,1000-4999,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.18,Negative,0,Negative,Adult,-205,Post-1st,02-Jun-21,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,1,June,2021,34,,,,Completed,50-249,N/A,48,Scheduled,227,Delayed,,34,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,957,Positive,Adult,-151,Post-2nd (1-8 Weeks),26-Jul-21,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,538,2,July,2021,,40,,,Completed,1000-4999,N/A,48,Scheduled,227,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,425,Positive,Adult,35,Post-2nd (8+ Weeks),28-Jan-22,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2330,3,January,2022,,226,,,Completed,10000+,N/A,48,Scheduled,227,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.22,Negative,12,Negative,Adult,152,Post-3rd (8+ Weeks),25-May-22,Post Vaccine covid,29-Apr-21,Pfizer,16-Jun-21,Pfizer,29-Jan-22,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,990,5,May,2022,,,116,,Completed,,N/A,48,Scheduled,227,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Ustekinumab Only,Ustekinumab Only,,,0.07,Negative,2094,Positive,Adult,19,Pre-1st,13-Feb-21,covid,07-Sep-21,Pfizer,05-Nov-21,Pfizer,,,,,,,45,40-49,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,80,1,February,2021,,,,,Completed,250-999,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.07,Negative,3,Negative,Adult,121,Pre-1st,15-Mar-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,121 Days Before Collection Days After Collection,57,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,1.31,Positive,846,Positive,Adult,213,Post-1st,15-Jun-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69,2,June,2021,56,,,,Completed,250-999,213 Days Before Collection Days After Collection,57,Delayed,,Delayed,,56,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,31547,Positive,Adult,398,Post-2nd (8+ Weeks),17-Dec-21,Post Vaccine covid,20-Apr-21,Pfizer,16-Jun-21,Pfizer,,,,,,,39,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,3,December,2021,,184,,,Completed,50-249,398 Days Before Collection Days After Collection,57,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.13,Negative,42095,Positive,Adult,,Pre-1st,15-Apr-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,7.31,Positive,1,Negative,Adult,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,262,2,June,2021,,33,,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,549,Positive,Adult,,Post-2nd (1-8 Weeks),02-Jul-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,264,3,July,2021,,35,,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,376,Positive,Adult,,Post-3rd (1-8 Weeks),05-Oct-21,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1804,4,October,2021,,,13,,Completed,10000+,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,11975,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,18-Apr-21,Pfizer,28-May-21,Pfizer,22-Sep-21,Pfizer,16-May-22,Pfizer,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,162,5,February,2022,,,145,,Completed,1000-4999,N/A,40,Scheduled,117,Scheduled,236,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,1408,Positive,Adult,-531,Post-1st,10-Feb-21,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,58,1,February,2021,41,,,,Completed,250-999,N/A,40,Scheduled,204,Delayed,187,41,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,2881,Positive,Adult,-470,Post-2nd (8+ Weeks),12-Apr-21,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,817,2,April,2021,,62,,,Completed,,N/A,40,Scheduled,204,Delayed,187,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,1258,Positive,Adult,-193,Post-3rd (8+ Weeks),14-Jan-22,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,598,4,January,2022,,,135,,Completed,1000-4999,N/A,40,Scheduled,204,Delayed,187,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,2816,Positive,Adult,-88,Post-4th,29-Apr-22,baseline,31-Dec-20,Pfizer,09-Feb-21,Pfizer,01-Sep-21,Moderna,07-Mar-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1983,5,April,2022,,,,53,Completed,10000+,N/A,40,Scheduled,204,Delayed,187,,,,53,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,6.63,Positive,111,Positive,Adult,-132,Post-2nd (1-8 Weeks),25-Aug-21,Post Vaccine covid,05-May-21,Pfizer,03-Jul-21,Pfizer,,,,,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1870,1,August,2021,,53,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,1163,Positive,Adult,-329,Pre-1st,02-Mar-21,Post Vaccine covid,30-Apr-21,Pfizer,29-Sep-21,Pfizer,,,,,,,44,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,152,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,53414,Positive,Adult,-320,Post-2nd (1-8 Weeks),23-Feb-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,801,1,February,2021,,47,,,Completed,,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,6766,Positive,Adult,-238,Post-2nd (8+ Weeks),16-May-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,199,2,May,2021,,129,,,Completed,1000-4999,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.07,Negative,452,Positive,Adult,-87,Post-3rd (1-8 Weeks),14-Oct-21,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2205,3,October,2021,,,35,,Completed,10000+,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,459,Positive,Adult,11,Post-3rd (8+ Weeks),20-Jan-22,baseline,17-Dec-20,Pfizer,07-Jan-21,Pfizer,09-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2362,4,January,2022,,,133,,Completed,10000+,N/A,21,Scheduled,245,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,2133,Positive,Adult,100,Pre-1st,30-Apr-21,covid,26-May-21,Pfizer,29-Jun-21,Pfizer,,,,,,,51,50-59,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,180,1,April,2021,,,,,Completed,1000-4999,100 Days Before Collection Days After Collection,34,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,6.22,Positive,1122,Positive,Adult,,Pre-1st,01-Mar-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,1,March,2021,,,,,Completed,0-49,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,24982,Positive,Adult,,Post-1st,19-Apr-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,,2,April,2021,47,,,,Processed,,N/A,49,Scheduled,154,Delayed,156,47,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,8708,Positive,Adult,,Post-2nd (8+ Weeks),17-Jun-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,55,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,66,3,June,2021,,57,,,Completed,250-999,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.03,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,73,4,August,2021,,121,,,Completed,250-999,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.11,Negative,949,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1339,5,November,2021,,,42,,Completed,,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.42,Negative,653,Positive,Adult,,Post-3rd (8+ Weeks),25-Jan-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,174,6,January,2022,,,125,,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,2.18,Positive,802,Positive,Adult,,Post-4th,14-Mar-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,209,7,March,2022,,,,17,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,17,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.85,Positive,2518,Positive,Adult,,Post-4th,04-Jul-22,baseline,03-Mar-21,Pfizer,21-Apr-21,Pfizer,22-Sep-21,Pfizer,25-Feb-22,Moderna,,,56,50-59,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,145,8,July,2022,,,,129,Completed,1000-4999,N/A,49,Scheduled,154,Delayed,156,,,,129,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.85,Positive,5,Negative,Adult,,Post-2nd (1-8 Weeks),24-Mar-21,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,40,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,378,2,March,2021,,28,,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.23,Negative,491,Positive,Adult,,Post-2nd (8+ Weeks),16-Sep-21,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,7,3,September,2021,,204,,,Completed,0-49,N/A,38,Scheduled,274,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.23,Negative,682,Positive,Adult,,Post-3rd (8+ Weeks),28-Jun-22,baseline,17-Jan-21,Moderna,24-Feb-21,Moderna,25-Nov-21,Moderna,,,,,41,40-49,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,691,4,June,2022,,,215,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.04,Negative,121,Positive,Adult,209,Pre-1st,10-Feb-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46,1,February,2021,,,,,Completed,250-999,209 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.04,Negative,3147,Positive,Adult,282,Post-2nd (1-8 Weeks),24-Apr-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,29,18-29,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,851,2,April,2021,,25,,,Completed,,282 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.09,Negative,19905,Positive,Adult,393,Post-2nd (8+ Weeks),13-Aug-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,690,3,August,2021,,136,,,Completed,1000-4999,393 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,0.34,Negative,3881,Positive,Adult,525,Post-2nd (8+ Weeks),23-Dec-21,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1374,4,December,2021,,268,,,Completed,,525 Days Before Collection Days After Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,Corticosteroids,Immunomodulator Only,,7.63,Positive,3771,Positive,Adult,634,Post-3rd (8+ Weeks),11-Apr-22,covid,18-Feb-21,Pfizer,30-Mar-21,Pfizer,30-Dec-21,Pfizer,,,,,30,30-39,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,615,5,April,2022,,,102,,Completed,1000-4999,634 Days Before Collection Days Before Collection,40,Scheduled,275,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,4246,Positive,Adult,-309,Post-1st,24-Mar-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,144,1,March,2021,33,,,,Completed,1000-4999,N/A,38,Scheduled,158,Delayed,286,33,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,9962,Positive,Adult,-253,Post-2nd (1-8 Weeks),19-May-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,42,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1357,2,May,2021,,51,,,Completed,,N/A,38,Scheduled,158,Delayed,286,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,3,Negative,Adult,-155,Post-2nd (8+ Weeks),25-Aug-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,372,3,August,2021,,149,,,Completed,1000-4999,N/A,38,Scheduled,158,Delayed,286,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.08,Negative,742,Positive,Adult,-70,Post-3rd (8+ Weeks),18-Nov-21,baseline,19-Feb-21,Pfizer,29-Mar-21,Pfizer,03-Sep-21,Pfizer,16-Jun-22,Pfizer,,,43,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,951,4,November,2021,,,76,,Completed,,N/A,38,Scheduled,158,Delayed,286,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,2180,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,25-Apr-21,Moderna,21-Jun-21,Moderna,,,,,,,34,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1871,1,July,2021,,35,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,,,,,0.7,Positive,24192,Positive,Elderly,22,,18-Feb-21,covid,,,,,,,,,,,73,70+,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2105,1,February,2021,,,,,Completed,10000+,N/A,,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,,,,,0.7,Positive,1922,Positive,Elderly,190,,05-Aug-21,covid,,,,,,,,,,,73,70+,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139,2,August,2021,,,,,Completed,250-999,N/A,,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.99,Positive,88,Positive,Adult,,Post-2nd (1-8 Weeks),13-May-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,49,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,222,2,May,2021,,17,,,Completed,1000-4999,N/A,28,Scheduled,141,Delayed,154,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.99,Positive,3,Negative,Adult,,Post-2nd (8+ Weeks),26-Aug-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,8,3,August,2021,,122,,,Completed,50-249,N/A,28,Scheduled,141,Delayed,154,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.02,Negative,4,Negative,Adult,,Post-3rd (8+ Weeks),30-Nov-21,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,54,4,November,2021,,,77,,Completed,250-999,N/A,28,Scheduled,141,Delayed,154,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Combination Therapy,Combination Therapy,0.11,Negative,1571,Positive,Adult,,Post-4th,28-Feb-22,baseline,29-Mar-21,Pfizer,26-Apr-21,Pfizer,14-Sep-21,Pfizer,15-Feb-22,Pfizer,,,50,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,519,5,February,2022,,,,13,Completed,1000-4999,N/A,28,Scheduled,141,Delayed,154,,,,13,
ICARUS: University of Miami,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.04,Negative,14,Negative,Adult,93,Pre-1st,08-Mar-21,covid,29-Aug-21,Pfizer,01-Oct-21,Pfizer,,,,,,,47,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,189,1,March,2021,,,,,Completed,1000-4999,N/A,33,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,1.07,Positive,26979,Positive,Adult,333,Post-2nd (1-8 Weeks),03-Nov-21,covid,29-Aug-21,Pfizer,01-Oct-21,Pfizer,,,,,,,48,40-49,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4479,2,November,2021,,33,,,Completed,10000+,N/A,33,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,24142,Positive,Adult,,Post-2nd (1-8 Weeks),12-Mar-21,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,790,1,March,2021,,28,,,Completed,,N/A,38,Scheduled,238,Delayed,161,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.64,Negative,12333,Positive,Adult,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,4202,3,November,2021,,,26,,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.64,Negative,1,Negative,Adult,,Post-3rd (8+ Weeks),03-Feb-22,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1547,4,February,2022,,,118,,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,9237,Positive,Adult,,Post-4th,04-Apr-22,baseline,05-Jan-21,Pfizer,12-Feb-21,Pfizer,08-Oct-21,Pfizer,18-Mar-22,Pfizer,,,37,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3351,5,April,2022,,,,17,Completed,10000+,N/A,38,Scheduled,238,Delayed,161,,,,17,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,14149,Positive,Elderly,,Pre-1st,14-Mar-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.18,Negative,8081,Positive,Elderly,,Post-1st,27-Apr-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,31,2,April,2021,33,,,,Completed,50-249,N/A,71,Delayed,98,Scheduled,159,33,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,2,Negative,Elderly,,Post-2nd (1-8 Weeks),30-Jun-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,664,3,June,2021,,26,,,Completed,1000-4999,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,1144,Positive,Elderly,,Post-3rd (1-8 Weeks),27-Sep-21,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2665,4,September,2021,,,17,,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,345,Positive,Elderly,,Post-3rd (8+ Weeks),12-Jan-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,610,5,January,2022,,,124,,Completed,1000-4999,N/A,71,Delayed,98,Scheduled,159,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,386,Positive,Elderly,,Post-4th,17-Mar-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3091,6,March,2022,,,,29,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,29,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,6.39,Positive,0,Negative,Elderly,,Post-4th,17-Jun-22,baseline,25-Mar-21,Pfizer,04-Jun-21,Pfizer,10-Sep-21,Pfizer,16-Feb-22,Pfizer,,,68,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,7,June,2022,,,,121,Completed,10000+,N/A,71,Delayed,98,Scheduled,159,,,,121,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.02,Negative,30,Negative,Adult,100,Pre-1st,13-Mar-21,covid,10-Jun-21,Pfizer,04-Jul-21,Pfizer,11-Jan-22,Pfizer,,,,,25,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,1,March,2021,,,,,Completed,50-249,N/A,24,Scheduled,191,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,7,Negative,Adult,,Pre-1st,12-Apr-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,62,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,1,April,2021,,,,,Completed,0-49,N/A,29,Scheduled,144,Delayed,259,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.09,Negative,10109,Positive,Adult,,Post-2nd (1-8 Weeks),31-May-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,62,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,899,2,May,2021,,10,,,Completed,,N/A,29,Scheduled,144,Delayed,259,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,1284,Positive,Adult,,Post-3rd (1-8 Weeks),15-Nov-21,baseline,22-Apr-21,Pfizer,21-May-21,Pfizer,12-Oct-21,Pfizer,28-Jun-22,Pfizer,,,63,60-69,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1641,3,November,2021,,,34,,Completed,10000+,N/A,29,Scheduled,144,Delayed,259,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.52,Negative,185,Positive,Adult,,Pre-1st,25-Mar-21,baseline,06-Apr-21,Pfizer,10-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,34,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,65,Delayed,201,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,4.97,Positive,59,Positive,Adult,,Post-1st,19-May-21,baseline,06-Apr-21,Pfizer,10-Jun-21,Pfizer,28-Dec-21,Pfizer,,,,,34,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,2,May,2021,43,,,,Completed,50-249,N/A,65,Delayed,201,Delayed,,43,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.6,Positive,7,Negative,Elderly,83,Post-1st,20-Apr-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2076,2,April,2021,28,,,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,28,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,25287,Positive,Elderly,174,Post-2nd (1-8 Weeks),20-Jul-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2894,3,July,2021,,42,,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,18823,Positive,Elderly,282,Post-3rd (1-8 Weeks),05-Nov-21,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,74,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4577,4,November,2021,,,21,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.12,Negative,5191,Positive,Elderly,407,Post-3rd (8+ Weeks),10-Mar-22,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1483,5,March,2022,,,146,,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.12,Negative,1949,Positive,Elderly,465,Post-4th,07-May-22,covid,23-Mar-21,Pfizer,08-Jun-21,Pfizer,15-Oct-21,Pfizer,23-Apr-22,Pfizer,,,75,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5295,6,May,2022,,,,14,Completed,10000+,N/A,77,Delayed,129,Delayed,190,,,,14,
ICARUS: University of Miami,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,,0.03,Negative,4027,Positive,Adult,49,Pre-1st,01-Apr-21,covid,01-May-21,Pfizer,10-Jul-21,Pfizer,,,,,,,29,18-29,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,101,1,April,2021,,,,,Completed,250-999,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.7,Positive,4,Negative,Adult,-285,Pre-1st,16-Mar-21,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,58,Delayed,231,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,4,Negative,Adult,-208,Post-1st,01-Jun-21,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,2,June,2021,51,,,,Completed,50-249,N/A,58,Delayed,231,Delayed,,51,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,618,Positive,Adult,24,Post-2nd (8+ Weeks),19-Jan-22,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5234,4,January,2022,,225,,,Completed,10000+,N/A,58,Delayed,231,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,37,Negative,Adult,99,Post-3rd (8+ Weeks),04-Apr-22,Post Vaccine covid,11-Apr-21,Pfizer,08-Jun-21,Pfizer,25-Jan-22,Moderna,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4021,5,April,2022,,,69,,Completed,10000+,N/A,58,Delayed,231,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,622,Positive,Adult,,Pre-1st,10-Mar-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.14,Negative,253,Positive,Adult,,Post-1st,31-May-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,12,2,May,2021,35,,,,Completed,50-249,N/A,52,Scheduled,109,Scheduled,175,35,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,13,Negative,Adult,,Post-2nd (8+ Weeks),16-Sep-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,317,3,September,2021,,91,,,Completed,1000-4999,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,6,Negative,Adult,,Post-3rd (1-8 Weeks),18-Oct-21,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1512,4,October,2021,,,14,,Completed,10000+,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,4.98,Positive,4140,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,179,5,February,2022,,,133,,Completed,1000-4999,N/A,52,Scheduled,109,Scheduled,175,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,4.98,Positive,2094,Positive,Adult,,Post-4th,20-Apr-22,baseline,26-Apr-21,Pfizer,17-Jun-21,Pfizer,04-Oct-21,Pfizer,28-Mar-22,Pfizer,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1527,6,April,2022,,,,23,Completed,10000+,N/A,52,Scheduled,109,Scheduled,175,,,,23,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,2.92,Positive,80000,Positive,Adult,,Post-2nd (1-8 Weeks),05-Mar-21,baseline,13-Jan-21,Pfizer,20-Feb-21,Pfizer,22-Sep-21,Moderna,04-Apr-22,Pfizer,,,52,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,913,1,March,2021,,13,,,Completed,,N/A,38,Scheduled,214,Delayed,194,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,1.92,Positive,40000,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Jan-21,Pfizer,20-Feb-21,Pfizer,22-Sep-21,Moderna,04-Apr-22,Pfizer,,,53,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,95,2,September,2021,,201,,,Completed,250-999,N/A,38,Scheduled,214,Delayed,194,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,1.92,Positive,10805,Positive,Adult,-401,Post-1st,05-Apr-21,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,30,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,68,1,April,2021,34,,,,Completed,250-999,N/A,42,Scheduled,260,Delayed,,34,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,18,Negative,Adult,-267,Post-2nd (8+ Weeks),17-Aug-21,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,59,3,August,2021,,126,,,Completed,250-999,N/A,42,Scheduled,260,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,893,Positive,Adult,-112,Post-3rd (1-8 Weeks),19-Jan-22,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,31,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2390,4,January,2022,,,21,,Completed,10000+,N/A,42,Scheduled,260,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,3.32,Positive,14853,Positive,Adult,9,Post-3rd (8+ Weeks),20-May-22,baseline,02-Mar-21,Pfizer,13-Apr-21,Pfizer,29-Dec-21,Pfizer,,,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,924,5,May,2022,,,142,,Completed,,N/A,42,Scheduled,260,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,3.32,Positive,3079,Positive,Adult,,Post-2nd (1-8 Weeks),18-Mar-21,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,184,1,March,2021,,39,,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,191,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,1,Negative,Adult,,Post-2nd (8+ Weeks),02-Sep-21,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,35,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,27,2,September,2021,,207,,,Completed,50-249,N/A,38,Scheduled,274,Delayed,191,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,433,Positive,Adult,,Post-3rd (8+ Weeks),09-Feb-22,baseline,31-Dec-20,Pfizer,07-Feb-21,Pfizer,08-Nov-21,Pfizer,18-May-22,Pfizer,,,36,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,354,3,February,2022,,,93,,Completed,1000-4999,N/A,38,Scheduled,274,Delayed,191,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,11011,Positive,Adult,-127,Post-1st,13-May-21,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,1,May,2021,35,,,,Completed,50-249,N/A,100,Delayed,96,Scheduled,,35,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,2.67,Positive,2196,Positive,Adult,112,Post-3rd (8+ Weeks),07-Jan-22,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2183,2,January,2022,,,78,,Completed,10000+,N/A,100,Delayed,96,Scheduled,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.51,Negative,1,Negative,Adult,153,Post-3rd (8+ Weeks),17-Feb-22,Post Vaccine covid,08-Apr-21,Pfizer,17-Jul-21,Pfizer,21-Oct-21,Pfizer,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,586,3,February,2022,,,119,,Completed,1000-4999,N/A,100,Delayed,96,Scheduled,,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.51,Negative,797,Positive,Adult,-177,Post-3rd (1-8 Weeks),06-Oct-21,baseline,07-Apr-21,Pfizer,11-May-21,Pfizer,05-Sep-21,Pfizer,26-Jul-22,Pfizer,,,36,30-39,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,963,1,October,2021,,,31,,Completed,,N/A,34,Scheduled,117,Scheduled,324,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.04,Positive,5941,Positive,Adult,,Pre-1st,26-Mar-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,5.05,Positive,385,Positive,Adult,,Post-1st,06-May-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,6,2,May,2021,22,,,,Completed,0-49,N/A,77,Delayed,139,Delayed,155,22,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,5.05,Positive,10522,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1359,3,July,2021,,30,,,Completed,,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,1.5,Positive,1205,Positive,Adult,,Post-3rd (1-8 Weeks),29-Dec-21,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1401,4,December,2021,,,43,,Completed,,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,7079,Positive,Adult,,Post-3rd (8+ Weeks),23-Mar-22,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,561,5,March,2022,,,127,,Completed,1000-4999,N/A,77,Delayed,139,Delayed,155,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,30138,Positive,Adult,,Post-4th,20-May-22,baseline,14-Apr-21,Pfizer,30-Jun-21,Pfizer,16-Nov-21,Pfizer,20-Apr-22,Pfizer,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1582,6,May,2022,,,,30,Completed,10000+,N/A,77,Delayed,139,Delayed,155,,,,30,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.14,Negative,0,Negative,Elderly,,Post-1st,18-May-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,859,1,May,2021,31,,,,Completed,,N/A,73,Delayed,112,Scheduled,,31,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,80,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,65,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3893,2,September,2021,,78,,,Completed,10000+,N/A,73,Delayed,112,Scheduled,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.7,Positive,8465,Positive,Elderly,,Post-3rd (1-8 Weeks),16-Nov-21,baseline,17-Apr-21,Pfizer,29-Jun-21,Pfizer,19-Oct-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9547,3,November,2021,,,28,,Completed,10000+,N/A,73,Delayed,112,Scheduled,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,2.7,Positive,735,Positive,Adult,,Pre-1st,16-Mar-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,14762,Positive,Adult,,Post-1st,06-May-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,26,2,May,2021,33,,,,Completed,50-249,N/A,79,Delayed,93,Scheduled,154,33,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.1,Negative,3730,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,144,3,July,2021,,36,,,Completed,1000-4999,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.3,Positive,2,Negative,Adult,,Post-3rd (1-8 Weeks),14-Oct-21,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,60,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1924,4,October,2021,,,22,,Completed,10000+,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,4.27,Positive,604,Positive,Adult,,Post-3rd (8+ Weeks),19-Feb-22,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,104,5,February,2022,,,150,,Completed,250-999,N/A,79,Delayed,93,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,1.71,Positive,16150,Positive,Adult,,Post-4th,18-Mar-22,baseline,03-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Sep-21,Pfizer,23-Feb-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,570,6,March,2022,,,,23,Completed,1000-4999,N/A,79,Delayed,93,Scheduled,154,,,,23,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,2.91,Positive,68644,Positive,Adult,-482,Pre-1st,12-Mar-21,baseline,22-Apr-21,Pfizer,22-Jun-21,Moderna,05-Feb-22,Moderna,,,,,36,30-39,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,61,Delayed,228,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,3.03,Positive,,,Adult,-126,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1203,1,August,2021,,64,,,Completed,,N/A,61,Delayed,214,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.92,Positive,1077,Positive,Adult,99,Post-3rd (8+ Weeks),30-Mar-22,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11360,2,March,2022,,,75,,Completed,10000+,N/A,61,Delayed,214,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,1.44,Positive,517,Positive,Adult,155,Post-3rd (8+ Weeks),25-May-22,Post Vaccine covid,14-Apr-21,Moderna,14-Jun-21,Moderna,14-Jan-22,Moderna,,,,,47,40-49,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11360,3,May,2022,,,131,,Completed,10000+,N/A,61,Delayed,214,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.56,Negative,19665,Positive,Elderly,,Pre-1st,16-Mar-21,baseline,23-Mar-21,Pfizer,06-May-21,Pfizer,12-Nov-21,Pfizer,06-May-22,Pfizer,,,74,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,44,Scheduled,190,Delayed,175,,,,,
ICARUS: University of Miami,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.3,Negative,40000,Positive,Adult,,Pre-1st,13-Mar-21,baseline,08-Apr-21,Pfizer,20-Jun-21,Pfizer,17-Jan-22,Pfizer,20-Jul-22,Pfizer,,,40,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,73,Delayed,211,Delayed,184,,,,,
ICARUS: University of Miami,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.3,Negative,361,Positive,Adult,,Post-2nd (1-8 Weeks),01-Aug-21,baseline,08-Apr-21,Pfizer,20-Jun-21,Pfizer,17-Jan-22,Pfizer,20-Jul-22,Pfizer,,,41,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,152,2,August,2021,,42,,,Completed,1000-4999,N/A,73,Delayed,211,Delayed,184,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,4.67,Positive,1760,Positive,Adult,-297,Pre-1st,08-Mar-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.19,Negative,812,Positive,Adult,-224,Post-1st,20-May-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,20,2,May,2021,28,,,,Completed,50-249,N/A,54,Scheduled,136,Delayed,164,28,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.41,Positive,997,Positive,Adult,-174,Post-2nd (1-8 Weeks),09-Jul-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,315,3,July,2021,,24,,,Completed,1000-4999,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,1.41,Positive,11,Negative,Adult,-20,Post-3rd (1-8 Weeks),10-Dec-21,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1255,4,December,2021,,,42,,Completed,,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.31,Negative,1168,Positive,Adult,76,Post-3rd (8+ Weeks),16-Mar-22,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3264,5,March,2022,,,138,,Completed,10000+,N/A,54,Scheduled,136,Delayed,164,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,8755,Positive,Adult,132,Post-4th,11-May-22,Post Vaccine covid,22-Apr-21,Pfizer,15-Jun-21,Pfizer,29-Oct-21,Pfizer,11-Apr-22,Pfizer,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5680,6,May,2022,,,,30,Completed,10000+,N/A,54,Scheduled,136,Delayed,164,,,,30,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,1,Negative,Elderly,,Pre-1st,25-Mar-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.05,Negative,9959,Positive,Elderly,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2203,3,July,2021,,26,,,Completed,10000+,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,4.21,Positive,0,Negative,Elderly,,Post-2nd (8+ Weeks),03-Dec-21,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,153,4,December,2021,,176,,,Completed,1000-4999,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,4.21,Positive,313,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Jan-22,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7237,5,January,2022,,,22,,Completed,10000+,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,2.76,Positive,32029,Positive,Elderly,,Post-3rd (8+ Weeks),25-Apr-22,baseline,27-Mar-21,Pfizer,10-Jun-21,Pfizer,12-Dec-21,Pfizer,,,,,67,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1233,6,April,2022,,,134,,Completed,,N/A,75,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,2.76,Positive,25492,Positive,Adult,,Pre-1st,02-Mar-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,24,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,61,Delayed,104,Scheduled,153,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,5.44,Positive,6186,Positive,Adult,,Post-2nd (1-8 Weeks),06-Jul-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,24,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,937,2,July,2021,,26,,,Completed,,N/A,61,Delayed,104,Scheduled,153,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.5,Negative,0,Negative,Adult,,Post-3rd (8+ Weeks),23-Dec-21,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,25,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,781,3,December,2021,,,92,,Completed,,N/A,61,Delayed,104,Scheduled,153,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.86,Positive,212,Positive,Adult,,Post-4th,17-Mar-22,baseline,10-Apr-21,Pfizer,10-Jun-21,Pfizer,22-Sep-21,Pfizer,22-Feb-22,Pfizer,,,25,18-29,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,617,4,March,2022,,,,23,Completed,1000-4999,N/A,61,Delayed,104,Scheduled,153,,,,23,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.5,Negative,505,Positive,Adult,-377,Post-2nd (8+ Weeks),19-Apr-21,baseline,29-Dec-20,Pfizer,21-Jan-21,Pfizer,19-Oct-21,Pfizer,,,,,40,40-49,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,657,1,April,2021,,88,,,Completed,1000-4999,N/A,23,Scheduled,271,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.86,Positive,8246,Positive,Adult,,Post-1st,14-May-21,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,53,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,133,1,May,2021,23,,,,Completed,250-999,N/A,48,Scheduled,212,Delayed,,23,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,,1670,Positive,Adult,,Post-3rd (1-8 Weeks),01-Feb-22,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5436,2,February,2022,,,26,,Completed,10000+,N/A,48,Scheduled,212,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,,437,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,21-Apr-21,Moderna,08-Jun-21,Moderna,06-Jan-22,Moderna,,,,,54,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10024,3,June,2022,,,160,,Completed,10000+,N/A,48,Scheduled,212,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,2.51,Positive,446,Positive,Adult,,Post-2nd (8+ Weeks),20-Aug-21,baseline,04-May-21,Pfizer,15-Jun-21,Pfizer,,,,,,,58,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,212,1,August,2021,,66,,,Completed,1000-4999,N/A,42,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,,849,Positive,Adult,,Pre-1st,25-Mar-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,30,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,68,Delayed,140,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,,0,Negative,Adult,,Post-1st,18-May-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,16,2,May,2021,42,,,,Completed,50-249,N/A,68,Delayed,140,Delayed,,42,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,,,514,Positive,Adult,,Post-2nd (8+ Weeks),12-Aug-21,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,941,3,August,2021,,60,,,Completed,,N/A,68,Delayed,140,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,3692,Positive,Adult,,Post-3rd (8+ Weeks),26-Jan-22,baseline,06-Apr-21,Pfizer,13-Jun-21,Pfizer,31-Oct-21,Pfizer,,,,,31,30-39,1,0,0,1,0,0,0,1,0,0,1,0,0,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,1435,4,January,2022,,,87,,Completed,10000+,N/A,68,Delayed,140,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.06,Negative,9253,Positive,Elderly,243,Post-2nd (1-8 Weeks),18-Aug-21,covid,29-May-21,Moderna,07-Jul-21,Moderna,,,,,,,66,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2849,1,August,2021,,42,,,Completed,10000+,N/A,39,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.2,Negative,3,Negative,Adult,113,Pre-1st,26-Feb-21,covid,16-Jul-21,Pfizer,12-Aug-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,137,1,February,2021,,,,,Completed,250-999,N/A,27,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.2,Negative,44,Negative,Adult,-214,Post-2nd (1-8 Weeks),03-Aug-21,Post Vaccine covid,14-May-21,Pfizer,24-Jun-21,Pfizer,19-Jan-22,Pfizer,,,,,40,40-49,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,131,1,August,2021,,40,,,Completed,250-999,N/A,41,Scheduled,209,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,10169,Positive,Adult,,Pre-1st,23-Mar-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1,March,2021,,,,,Completed,0-49,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.01,Negative,530,Positive,Adult,,Post-2nd (8+ Weeks),09-Aug-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,403,2,August,2021,,67,,,Completed,1000-4999,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,10602,Positive,Adult,,Post-3rd (1-8 Weeks),20-Oct-21,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,1761,3,October,2021,,,23,,Completed,10000+,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.09,Negative,1309,Positive,Adult,,Post-3rd (8+ Weeks),17-Feb-22,Suspected COVID-19/Symptomatic,10-Apr-21,Pfizer,03-Jun-21,Pfizer,27-Sep-21,Pfizer,26-Apr-22,Pfizer,,,60,60-69,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,282,4,February,2022,,,143,,Completed,1000-4999,N/A,54,Scheduled,116,Scheduled,211,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,447,Positive,Adult,,Pre-1st,19-Apr-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,44,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,184,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,152,Positive,Adult,,Post-2nd (1-8 Weeks),09-Aug-21,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,708,2,August,2021,,49,,,Completed,1000-4999,N/A,60,Delayed,184,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,405,Positive,Adult,,Post-3rd (8+ Weeks),10-May-22,baseline,22-Apr-21,Pfizer,21-Jun-21,Pfizer,22-Dec-21,Pfizer,,,,,45,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1406,3,May,2022,,,139,,Completed,,N/A,60,Delayed,184,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,2201,Positive,Elderly,,Post-1st,12-Apr-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,10,1,April,2021,38,,,,Completed,50-249,N/A,38,Scheduled,189,Delayed,152,38,,,,
ICARUS: University of Miami,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,26,Negative,Elderly,,Post-2nd (1-8 Weeks),04-May-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,,2,May,2021,,22,,,Processed,,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: University of Miami,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.02,Negative,2199,Positive,Elderly,,Post-2nd (8+ Weeks),13-Aug-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,75,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,60,3,August,2021,,123,,,Completed,250-999,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: University of Miami,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.08,Negative,5211,Positive,Elderly,,Post-3rd (1-8 Weeks),01-Nov-21,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2556,4,November,2021,,,14,,Completed,10000+,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: University of Miami,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.08,Negative,7098,Positive,Elderly,,Post-3rd (8+ Weeks),17-Feb-22,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,765,5,February,2022,,,122,,Completed,,N/A,38,Scheduled,189,Delayed,152,,,,,
ICARUS: University of Miami,,Male,CD,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,0.05,Negative,0,Negative,Elderly,,Post-4th,07-Apr-22,baseline,05-Mar-21,Pfizer,12-Apr-21,Pfizer,18-Oct-21,Pfizer,19-Mar-22,Pfizer,,,76,70+,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2914,6,April,2022,,,,19,Completed,10000+,N/A,38,Scheduled,189,Delayed,152,,,,19,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.01,Negative,14204,Positive,Elderly,,Post-1st,19-Apr-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71,1,April,2021,29,,,,Completed,250-999,N/A,39,Scheduled,286,Delayed,,29,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.02,Negative,28529,Positive,Elderly,,Post-2nd (1-8 Weeks),20-May-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,247,2,May,2021,,21,,,Completed,1000-4999,N/A,39,Scheduled,286,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,,0.16,Negative,6552,Positive,Elderly,,Post-2nd (8+ Weeks),17-Dec-21,baseline,21-Mar-21,Pfizer,29-Apr-21,Pfizer,09-Feb-22,Pfizer,,,,,75,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,3,December,2021,,232,,,Completed,50-249,N/A,39,Scheduled,286,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.16,Negative,4,Negative,Elderly,,Post-1st,05-Apr-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,74,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,12,1,April,2021,37,,,,Completed,50-249,N/A,40,Scheduled,168,Delayed,153,37,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.1,Negative,2491,Positive,Elderly,,Post-2nd (1-8 Weeks),25-May-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,134,2,May,2021,,47,,,Completed,250-999,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.02,Negative,0,Negative,Elderly,,Post-2nd (8+ Weeks),30-Aug-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,24,3,August,2021,,144,,,Completed,50-249,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.02,Negative,1848,Positive,Elderly,,Post-3rd (1-8 Weeks),03-Nov-21,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1121,4,November,2021,,,41,,Completed,,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.4,Negative,1860,Positive,Elderly,,Post-3rd (8+ Weeks),24-Jan-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,995,5,January,2022,,,123,,Completed,,N/A,40,Scheduled,168,Delayed,153,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.01,Negative,12703,Positive,Elderly,,Post-4th,21-Mar-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,75,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,1643,6,March,2022,,,,26,Completed,10000+,N/A,40,Scheduled,168,Delayed,153,,,,26,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,Vedolizumab Only,Vedolizumab Only,0.01,Negative,1142,Positive,Elderly,,Post-4th,04-Jul-22,baseline,27-Feb-21,Pfizer,08-Apr-21,Pfizer,23-Sep-21,Pfizer,23-Feb-22,Pfizer,,,76,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,364,7,July,2022,,,,131,Completed,1000-4999,N/A,40,Scheduled,168,Delayed,153,,,,131,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.04,Negative,4,Negative,Adult,,Post-1st,18-Jun-21,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,1,June,2021,56,,,,Completed,50-249,N/A,70,Delayed,,Delayed,,56,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.01,Negative,,,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1126,2,August,2021,,34,,,Completed,,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.01,Negative,468,Positive,Adult,,Post-2nd (8+ Weeks),17-Feb-22,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,55,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5445,3,February,2022,,230,,,Completed,10000+,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.03,Negative,515,Positive,Adult,,Post-2nd (8+ Weeks),14-Jul-22,Suspected COVID-19/Symptomatic,23-Apr-21,Pfizer,02-Jul-21,Pfizer,,,,,,,56,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4145,4,July,2022,,377,,,Completed,10000+,N/A,70,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.02,Negative,9428,Positive,Elderly,,Post-1st,13-Apr-21,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,1,April,2021,43,,,,Completed,50-249,N/A,40,Scheduled,198,Delayed,,43,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.2,Negative,1225,Positive,Elderly,,Post-2nd (8+ Weeks),08-Jun-21,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,428,2,June,2021,,59,,,Completed,1000-4999,N/A,40,Scheduled,198,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.2,Negative,1471,Positive,Elderly,,Post-3rd (8+ Weeks),11-May-22,baseline,01-Mar-21,Pfizer,10-Apr-21,Pfizer,25-Oct-21,Pfizer,,,,,79,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,707,3,May,2022,,,198,,Completed,1000-4999,N/A,40,Scheduled,198,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1018,Positive,Adult,-306,Post-2nd (1-8 Weeks),09-Apr-21,Post Vaccine covid,15-Jan-21,Pfizer,24-Feb-21,Pfizer,03-Oct-21,Pfizer,,,,,28,18-29,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,412,1,April,2021,,44,,,Completed,1000-4999,N/A,40,Scheduled,221,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,52,Positive,Adult,-106,Post-3rd (1-8 Weeks),26-Oct-21,Post Vaccine covid,15-Jan-21,Pfizer,24-Feb-21,Pfizer,03-Oct-21,Pfizer,,,,,29,18-29,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1226,2,October,2021,,,23,,Completed,,N/A,40,Scheduled,221,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.23,Negative,2664,Positive,Adult,,Post-2nd (8+ Weeks),23-Jul-21,baseline,23-Mar-21,Pfizer,29-Apr-21,Pfizer,19-Jan-22,Pfizer,,,,,56,50-59,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,283,1,July,2021,,85,,,Completed,1000-4999,N/A,37,Scheduled,265,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,46,Negative,Adult,-429,Post-1st,30-Mar-21,baseline,22-Feb-21,Pfizer,01-Apr-21,Pfizer,25-Nov-21,Pfizer,,,,,25,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,52,1,March,2021,36,,,,Completed,250-999,N/A,38,Scheduled,238,Delayed,,36,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.23,Negative,13174,Positive,Elderly,,Post-1st,09-Apr-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,87,1,April,2021,28,,,,Completed,250-999,N/A,35,Scheduled,140,Delayed,161,28,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.08,Negative,2,Negative,Elderly,,Post-2nd (1-8 Weeks),12-May-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,251,2,May,2021,,26,,,Completed,1000-4999,N/A,35,Scheduled,140,Delayed,161,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,1566,Positive,Elderly,,Post-2nd (8+ Weeks),03-Sep-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,97,3,September,2021,,140,,,Completed,250-999,N/A,35,Scheduled,140,Delayed,161,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.15,Negative,56,Positive,Elderly,,Post-3rd (8+ Weeks),29-Oct-21,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,75,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,510,4,October,2021,,,56,,Completed,1000-4999,N/A,35,Scheduled,140,Delayed,161,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,380,Positive,Elderly,,Post-4th,19-Apr-22,baseline,12-Mar-21,Pfizer,16-Apr-21,Pfizer,03-Sep-21,Pfizer,11-Feb-22,Pfizer,,,76,70+,1,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,826,5,April,2022,,,,67,Completed,,N/A,35,Scheduled,140,Delayed,161,,,,67,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.15,Negative,3656,Positive,Adult,-359,Pre-1st,09-Mar-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,35,Scheduled,56,Scheduled,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,5564,Positive,Adult,-209,Post-1st,06-Aug-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,8,2,August,2021,29,,,,Completed,50-249,N/A,35,Scheduled,56,Scheduled,,29,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,137,Positive,Adult,-113,Post-3rd (1-8 Weeks),10-Nov-21,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1639,3,November,2021,,,34,,Completed,10000+,N/A,35,Scheduled,56,Scheduled,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,29594,Positive,Adult,4,Post-3rd (8+ Weeks),07-Mar-22,Post Vaccine covid,08-Jul-21,Pfizer,12-Aug-21,Pfizer,07-Oct-21,Pfizer,,,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9808,4,March,2022,,,151,,Completed,10000+,N/A,35,Scheduled,56,Scheduled,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.09,Negative,10892,Positive,Adult,,Pre-1st,07-Apr-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,April,2021,,,,,Completed,0-49,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.23,Negative,23601,Positive,Adult,,Post-1st,06-May-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,6,2,May,2021,23,,,,Completed,0-49,N/A,24,Scheduled,129,Delayed,,23,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.23,Negative,3,Negative,Adult,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,228,3,June,2021,,47,,,Completed,1000-4999,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.69,Negative,221,Positive,Adult,,Post-2nd (8+ Weeks),09-Sep-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,260,4,September,2021,,125,,,Completed,1000-4999,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,4674,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,13-Apr-21,Pfizer,07-May-21,Pfizer,13-Sep-21,Pfizer,,,,,51,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1761,5,October,2021,,,32,,Completed,10000+,N/A,24,Scheduled,129,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,4296,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,136,1,June,2021,,34,,,Completed,250-999,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.05,Negative,21765,Positive,Elderly,,Post-2nd (8+ Weeks),24-Aug-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,213,2,August,2021,,98,,,Completed,1000-4999,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,80000,Positive,Elderly,,Post-3rd (1-8 Weeks),22-Sep-21,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1143,3,September,2021,,,20,,Completed,,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,4,Negative,Elderly,,Post-3rd (8+ Weeks),09-Feb-22,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,132,4,February,2022,,,160,,Completed,250-999,N/A,55,Scheduled,107,Scheduled,181,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,6333,Positive,Elderly,,Post-4th,04-Apr-22,baseline,24-Mar-21,Pfizer,18-May-21,Pfizer,02-Sep-21,Pfizer,02-Mar-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1458,5,April,2022,,,,33,Completed,10000+,N/A,55,Scheduled,107,Scheduled,181,,,,33,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.07,Negative,11555,Positive,Elderly,,Post-1st,30-Apr-21,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,76,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1330,1,April,2021,29,,,,Completed,,N/A,23,Scheduled,213,Delayed,199,29,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.12,Negative,5,Negative,Elderly,,Post-2nd (8+ Weeks),23-Oct-21,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,102,2,October,2021,,182,,,Completed,250-999,N/A,23,Scheduled,213,Delayed,199,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.04,Negative,133,Positive,Elderly,,Post-3rd (8+ Weeks),03-Feb-22,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,759,3,February,2022,,,72,,Completed,,N/A,23,Scheduled,213,Delayed,199,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.7,Positive,2,Negative,Elderly,,Post-3rd (8+ Weeks),09-May-22,baseline,01-Apr-21,Pfizer,24-Apr-21,Pfizer,23-Nov-21,Pfizer,10-Jun-22,Pfizer,,,77,70+,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1012,4,May,2022,,,167,,Completed,,N/A,23,Scheduled,213,Delayed,199,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,82,Positive,Adult,-268,Post-1st,08-Apr-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,1,April,2021,40,,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,40,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.05,Negative,2231,Positive,Adult,-164,Post-2nd (8+ Weeks),21-Jul-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59,2,July,2021,,103,,,Completed,250-999,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.48,Negative,10645,Positive,Adult,-72,Post-2nd (8+ Weeks),21-Oct-21,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,43,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,3,October,2021,,195,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.06,Negative,1264,Positive,Adult,31,Post-2nd (8+ Weeks),01-Feb-22,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1914,4,February,2022,,298,,,Completed,10000+,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,10751,Positive,Adult,53,Post-2nd (8+ Weeks),23-Feb-22,Post Vaccine covid,27-Feb-21,Pfizer,09-Apr-21,Pfizer,,,,,,,44,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,5,February,2022,,320,,,Completed,50-249,N/A,41,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.02,Negative,6428,Positive,Adult,,Pre-1st,29-Mar-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,94,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.02,Negative,666,Positive,Adult,,Post-1st,13-May-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,171,2,May,2021,23,,,,Completed,1000-4999,N/A,94,Delayed,,Delayed,,23,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.03,Negative,2918,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5208,3,August,2021,,14,,,Completed,10000+,N/A,94,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,,0.03,Negative,1295,Positive,Adult,,Post-2nd (8+ Weeks),19-Jul-22,baseline,20-Apr-21,Moderna,23-Jul-21,Moderna,,,,,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5940,4,July,2022,,361,,,Completed,10000+,N/A,94,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,191,Positive,Adult,,Post-1st,10-Jun-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,78,1,June,2021,47,,,,Completed,250-999,N/A,65,Delayed,169,Delayed,,47,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.13,Negative,2494,Positive,Adult,,Post-2nd (1-8 Weeks),06-Aug-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,437,2,August,2021,,39,,,Completed,1000-4999,N/A,65,Delayed,169,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,0,Negative,Adult,,Post-2nd (8+ Weeks),30-Nov-21,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,70,3,November,2021,,155,,,Completed,250-999,N/A,65,Delayed,169,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,43,Negative,Adult,,Post-3rd (8+ Weeks),10-May-22,baseline,24-Apr-21,Pfizer,28-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2874,4,May,2022,,,147,,Completed,10000+,N/A,65,Delayed,169,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.11,Negative,9573,Positive,Elderly,,Post-1st,12-Apr-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,1,April,2021,36,,,,Completed,50-249,N/A,38,Scheduled,192,Delayed,175,36,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,9865,Positive,Elderly,,Post-2nd (1-8 Weeks),06-May-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,817,2,May,2021,,22,,,Completed,,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.02,Negative,3947,Positive,Elderly,,Post-2nd (8+ Weeks),03-Sep-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,76,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,141,3,September,2021,,142,,,Completed,250-999,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.16,Negative,11142,Positive,Elderly,,Post-3rd (8+ Weeks),30-Dec-21,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,775,4,December,2021,,,68,,Completed,,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.04,Negative,6049,Positive,Elderly,,Post-3rd (8+ Weeks),28-Mar-22,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,332,5,March,2022,,,156,,Completed,1000-4999,N/A,38,Scheduled,192,Delayed,175,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,2.31,Positive,27416,Positive,Elderly,,Post-4th,16-May-22,baseline,07-Mar-21,Pfizer,14-Apr-21,Pfizer,23-Oct-21,Pfizer,16-Apr-22,Pfizer ,,,77,70+,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3430,6,May,2022,,,,30,Completed,10000+,N/A,38,Scheduled,192,Delayed,175,,,,30,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,67229,Positive,Adult,,Pre-1st,07-Mar-21,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,61,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,23,Scheduled,142,Delayed,185,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.19,Negative,1,Negative,Adult,,Post-2nd (8+ Weeks),14-Aug-21,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,41,2,August,2021,,101,,,Completed,250-999,N/A,23,Scheduled,142,Delayed,185,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,1012,Positive,Adult,,Post-3rd (8+ Weeks),11-Jan-22,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,587,4,January,2022,,,109,,Completed,1000-4999,N/A,23,Scheduled,142,Delayed,185,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.1,Negative,13551,Positive,Adult,,Post-4th,09-May-22,baseline,12-Apr-21,Pfizer,05-May-21,Pfizer,24-Sep-21,Pfizer,28-Mar-22,Pfizer,,,62,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2152,5,May,2022,,,,42,Completed,10000+,N/A,23,Scheduled,142,Delayed,185,,,,42,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,731,Positive,Adult,-277,Pre-1st,31-Mar-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,60,Delayed,183,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.1,Negative,4012,Positive,Adult,-221,Post-1st,26-May-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,2,May,2021,42,,,,Completed,50-249,N/A,60,Delayed,183,Delayed,,42,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,538,Positive,Adult,-53,Post-2nd (8+ Weeks),10-Nov-21,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,4,November,2021,,150,,,Completed,50-249,N/A,60,Delayed,183,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.18,Negative,1074,Positive,Adult,128,Post-3rd (8+ Weeks),10-May-22,Post Vaccine covid,14-Apr-21,Pfizer,13-Jun-21,Pfizer,13-Dec-21,Pfizer,,,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1351,6,May,2022,,,148,,Completed,,N/A,60,Delayed,183,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.04,Negative,2,Negative,Adult,-341,Post-1st,04-Jun-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,84,1,June,2021,37,,,,Completed,250-999,N/A,52,Scheduled,178,Delayed,,37,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,178,Positive,Adult,-309,Post-2nd (1-8 Weeks),06-Jul-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1458,2,July,2021,,17,,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.57,Negative,15515,Positive,Adult,-152,Post-2nd (8+ Weeks),10-Dec-21,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,373,3,December,2021,,174,,,Completed,1000-4999,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.57,Negative,1077,Positive,Adult,-125,Post-3rd (1-8 Weeks),06-Jan-22,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,37,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,4376,4,January,2022,,,23,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.07,Negative,50963,Positive,Adult,16,Post-3rd (8+ Weeks),27-May-22,baseline,28-Apr-21,Pfizer,19-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,38,30-39,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,3534,5,May,2022,,,164,,Completed,10000+,N/A,52,Scheduled,178,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.07,Negative,8682,Positive,Elderly,,Post-1st,24-Apr-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,70,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,3,1,April,2021,29,,,,Completed,0-49,N/A,71,Delayed,183,Delayed,155,29,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.03,Negative,6595,Positive,Elderly,,Post-2nd (8+ Weeks),01-Oct-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,70,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,112,3,October,2021,,118,,,Completed,250-999,N/A,71,Delayed,183,Delayed,155,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.05,Negative,5500,Positive,Elderly,,Post-3rd (1-8 Weeks),22-Dec-21,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1837,4,December,2021,,,17,,Completed,10000+,N/A,71,Delayed,183,Delayed,155,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.24,Negative,4347,Positive,Elderly,,Post-3rd (8+ Weeks),05-Apr-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1085,5,April,2022,,,121,,Completed,,N/A,71,Delayed,183,Delayed,155,,,,,
ICARUS: University of Miami,,Male,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,0.24,Negative,934,Positive,Elderly,,Post-4th,30-May-22,baseline,26-Mar-21,Pfizer,05-Jun-21,Pfizer,05-Dec-21,Pfizer,09-May-22,Pfizer,,,71,70+,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,2235,6,May,2022,,,,21,Completed,10000+,N/A,71,Delayed,183,Delayed,155,,,,21,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.27,Negative,38283,Positive,Adult,,Pre-1st,30-Mar-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,March,2021,,,,,Completed,0-49,N/A,70,Delayed,72,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,70589,Positive,Adult,,Post-1st,25-May-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,231,2,May,2021,42,,,,Completed,1000-4999,N/A,70,Delayed,72,Scheduled,154,42,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.01,Negative,1490,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,51,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,3714,3,July,2021,,30,,,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,111,Positive,Adult,,Post-3rd (8+ Weeks),27-Jan-22,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1481,5,January,2022,,,147,,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,6624,Positive,Adult,,Post-4th,06-Jun-22,baseline,13-Apr-21,Pfizer,22-Jun-21,Pfizer,02-Sep-21,Pfizer,03-Feb-22,Pfizer,,,52,50-59,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,2972,6,June,2022,,,,123,Completed,10000+,N/A,70,Delayed,72,Scheduled,154,,,,123,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.43,Negative,10109,Positive,Adult,,Post-2nd (1-8 Weeks),15-Mar-21,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1166,1,March,2021,,36,,,Completed,,N/A,35,Scheduled,296,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,2,Negative,Adult,,Post-2nd (8+ Weeks),09-Nov-21,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,37,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,283,2,November,2021,,275,,,Completed,1000-4999,N/A,35,Scheduled,296,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.05,Negative,2840,Positive,Adult,,Post-3rd (8+ Weeks),14-Feb-22,baseline,03-Jan-21,Pfizer,07-Feb-21,Pfizer,30-Nov-21,Pfizer,,,,,38,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,4392,3,February,2022,,,76,,Completed,10000+,N/A,35,Scheduled,296,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.02,Negative,12401,Positive,Adult,-383,Pre-1st,09-Apr-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,April,2021,,,,,Completed,0-49,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.05,Negative,1988,Positive,Adult,-327,Post-1st,04-Jun-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,2,June,2021,26,,,,Completed,50-249,N/A,60,Delayed,106,Scheduled,281,26,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.05,Negative,17073,Positive,Adult,-271,Post-2nd (1-8 Weeks),30-Jul-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,49,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1805,3,July,2021,,22,,,Completed,10000+,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.07,Negative,1,Negative,Adult,-166,Post-3rd (1-8 Weeks),12-Nov-21,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2322,4,November,2021,,,21,,Completed,10000+,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,No Immunosuppressives,0.07,Negative,4988,Positive,Adult,-48,Post-3rd (8+ Weeks),10-Mar-22,baseline,09-May-21,Pfizer,08-Jul-21,Moderna,22-Oct-21,Moderna,30-Jul-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,281,5,March,2022,,,139,,Completed,1000-4999,N/A,60,Delayed,106,Scheduled,281,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.39,Negative,9900,Positive,Adult,-299,Pre-1st,10-Mar-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,1,March,2021,,,,,Completed,0-49,N/A,40,Scheduled,145,Delayed,185,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.39,Negative,69,Positive,Adult,-242,Post-1st,06-May-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,18,2,May,2021,30,,,,Completed,50-249,N/A,40,Scheduled,145,Delayed,185,30,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.64,Positive,,,Adult,-139,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,94,3,August,2021,,93,,,Completed,250-999,N/A,40,Scheduled,145,Delayed,185,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,2.64,Positive,421,Positive,Adult,-59,Post-3rd (1-8 Weeks),05-Nov-21,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,50,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,974,4,November,2021,,,28,,Completed,,N/A,40,Scheduled,145,Delayed,185,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,4.61,Positive,5391,Positive,Adult,130,Post-4th,13-May-22,Post Vaccine covid,06-Apr-21,Pfizer,16-May-21,Pfizer,08-Oct-21,Pfizer,11-Apr-22,Moderna,,,51,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5296,6,May,2022,,,,32,Completed,10000+,N/A,40,Scheduled,145,Delayed,185,,,,32,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,20522,Positive,Adult,,Post-1st,04-May-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,6,1,May,2021,27,,,,Completed,0-49,N/A,65,Delayed,202,Delayed,,27,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.46,Negative,499,Positive,Adult,,Post-2nd (1-8 Weeks),30-Jul-21,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9,2,July,2021,,49,,,Completed,50-249,N/A,65,Delayed,202,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,1.34,Positive,1736,Positive,Adult,,Post-3rd (1-8 Weeks),17-Jan-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,695,3,January,2022,,,18,,Completed,1000-4999,N/A,65,Delayed,202,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.54,Negative,86,Positive,Adult,,Post-3rd (8+ Weeks),03-May-22,baseline,07-Apr-21,Pfizer,11-Jun-21,Pfizer,30-Dec-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,3112,4,May,2022,,,124,,Completed,10000+,N/A,65,Delayed,202,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.54,Negative,82,Positive,Adult,,Post-1st,07-Jul-21,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,34,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,139,1,July,2021,47,,,,Completed,250-999,N/A,50,Scheduled,231,Delayed,,47,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,2.16,Positive,171,Positive,Adult,,Post-2nd (8+ Weeks),22-Dec-21,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1582,3,December,2021,,165,,,Completed,10000+,N/A,50,Scheduled,231,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.13,Negative,7896,Positive,Adult,,Post-3rd (8+ Weeks),08-Jun-22,baseline,21-May-21,Moderna,10-Jul-21,Moderna,26-Feb-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3948,4,June,2022,,,102,,Completed,10000+,N/A,50,Scheduled,231,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.13,Negative,7007,Positive,Adult,-356,Post-1st,13-May-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,41,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,10,1,May,2021,21,,,,Completed,50-249,N/A,28,Scheduled,112,Scheduled,215,21,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.13,Negative,11570,Positive,Adult,-328,Post-2nd (1-8 Weeks),10-Jun-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,41,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,22,2,June,2021,,21,,,Completed,50-249,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.13,Negative,2560,Positive,Adult,-211,Post-3rd (1-8 Weeks),05-Oct-21,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1167,3,October,2021,,,26,,Completed,,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.03,Negative,117,Positive,Adult,-83,Post-3rd (8+ Weeks),10-Feb-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,240,4,February,2022,,,154,,Completed,1000-4999,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.03,Negative,7931,Positive,Adult,-55,Post-3rd (8+ Weeks),10-Mar-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,132,5,March,2022,,,182,,Completed,250-999,N/A,28,Scheduled,112,Scheduled,215,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,0.66,Negative,38342,Positive,Adult,22,Post-4th,26-May-22,baseline,22-Apr-21,Pfizer,20-May-21,Pfizer,09-Sep-21,Pfizer,12-Apr-22,Pfizer,,,42,40-49,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,11241,6,May,2022,,,,44,Completed,10000+,N/A,28,Scheduled,112,Scheduled,215,,,,44,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,29192,Positive,Adult,-220,Post-1st,25-May-21,Post Vaccine covid,04-May-21,Pfizer,19-Jun-21,Pfizer,27-Feb-22,Moderna,,,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,1,May,2021,21,,,,Completed,50-249,-220 Days After Collection Days After Collection,46,Scheduled,253,Delayed,,21,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.08,Negative,57,Positive,Adult,-106,Post-2nd (8+ Weeks),16-Sep-21,Post Vaccine covid,04-May-21,Pfizer,19-Jun-21,Pfizer,27-Feb-22,Moderna,,,,,38,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,386,2,September,2021,,89,,,Completed,1000-4999,-106 Days After Collection Days After Collection,46,Scheduled,253,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.17,Negative,3011,Positive,Elderly,-232,Post-1st,17-May-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,1,May,2021,44,,,,Completed,50-249,N/A,83,Delayed,75,Scheduled,,44,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,4979,Positive,Elderly,-151,Post-2nd (1-8 Weeks),06-Aug-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,592,2,August,2021,,42,,,Completed,1000-4999,N/A,83,Delayed,75,Scheduled,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1995,Positive,Elderly,-62,Post-3rd (8+ Weeks),03-Nov-21,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,516,3,November,2021,,,56,,Completed,1000-4999,N/A,83,Delayed,75,Scheduled,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.37,Negative,609,Positive,Elderly,16,Post-3rd (8+ Weeks),20-Jan-22,Post Vaccine covid,03-Apr-21,Pfizer,25-Jun-21,Pfizer,08-Sep-21,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2919,4,January,2022,,,134,,Completed,10000+,N/A,83,Delayed,75,Scheduled,,,,,,
ICARUS: University of Miami,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.38,Negative,1769,Positive,Adult,,Pre-1st,15-Mar-21,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,61,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,March,2021,,,,,Completed,0-49,N/A,52,Scheduled,192,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.38,Negative,684,Positive,Adult,,Post-2nd (1-8 Weeks),16-Aug-21,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,62,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,492,2,August,2021,,28,,,Completed,1000-4999,N/A,52,Scheduled,192,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,3592,Positive,Adult,,Post-3rd (8+ Weeks),13-Jun-22,baseline,28-May-21,Pfizer,19-Jul-21,Pfizer,27-Jan-22,Pfizer,,,,,63,60-69,0,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,1,0,2309,3,June,2022,,,137,,Completed,10000+,N/A,52,Scheduled,192,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,5820,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,17-Mar-21,AstraZeneca,05-Jun-21,Pfizer,10-Sep-21,Pfizer,28-Jan-22,Pfizer,,,62,60-69,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,397,1,July,2021,,34,,,Completed,1000-4999,N/A,80,Delayed,97,Scheduled,140,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,5,Negative,Elderly,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,06-Apr-21,Pfizer,29-Jun-21,Pfizer,03-Nov-21,Pfizer,02-May-22,Pfizer,,,70,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,134,1,August,2021,,36,,,Completed,250-999,N/A,84,Delayed,127,Delayed,180,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,41,Negative,Elderly,,Post-3rd (8+ Weeks),22-Feb-22,baseline,06-Apr-21,Pfizer,29-Jun-21,Pfizer,03-Nov-21,Pfizer,02-May-22,Pfizer,,,71,70+,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,108,2,February,2022,,,111,,Completed,250-999,N/A,84,Delayed,127,Delayed,180,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.08,Negative,1607,Positive,Adult,-279,Post-2nd (8+ Weeks),16-Jul-21,baseline,07-Apr-21,Pfizer,01-May-21,Pfizer,10-Sep-21,Pfizer,18-Feb-22,Moderna,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,732,1,July,2021,,76,,,Completed,,N/A,24,Scheduled,132,Delayed,161,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.04,Negative,1834,Positive,Elderly,-97,Post-3rd (8+ Weeks),14-Jan-22,baseline,07-Apr-21,Pfizer,01-May-21,Pfizer,10-Sep-21,Pfizer,18-Feb-22,Moderna,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,1369,2,January,2022,,,126,,Completed,,N/A,24,Scheduled,132,Delayed,161,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.12,Negative,2126,Positive,Elderly,,Post-1st,06-May-21,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,9,1,May,2021,42,,,,Completed,50-249,N/A,77,Delayed,159,Delayed,160,42,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,959,Positive,Elderly,,Post-3rd (8+ Weeks),17-Jan-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1417,2,January,2022,,,62,,Completed,,N/A,77,Delayed,159,Delayed,160,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,1497,Positive,Elderly,,Post-3rd (8+ Weeks),11-Apr-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,296,3,April,2022,,,146,,Completed,1000-4999,N/A,77,Delayed,159,Delayed,160,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,8046,Positive,Elderly,,Post-4th,26-May-22,baseline,25-Mar-21,Pfizer,10-Jun-21,Pfizer,16-Nov-21,Pfizer,25-Apr-22,Pfizer,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3306,4,May,2022,,,,31,Completed,10000+,N/A,77,Delayed,159,Delayed,160,,,,31,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.04,Negative,929,Positive,Adult,,Post-1st,05-Apr-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,1,April,2021,24,,,,Completed,0-49,N/A,99,Delayed,188,Delayed,,24,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.37,Negative,10268,Positive,Adult,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,2,June,2021,,9,,,Completed,50-249,N/A,99,Delayed,188,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.21,Negative,9369,Positive,Elderly,,Post-2nd (8+ Weeks),09-Dec-21,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,51,3,December,2021,,173,,,Completed,250-999,N/A,99,Delayed,188,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Vedolizumab Only,,0.21,Negative,720,Positive,Elderly,,Post-3rd (1-8 Weeks),18-Jan-22,baseline,12-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,24-Dec-21,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9290,4,January,2022,,,25,,Completed,10000+,N/A,99,Delayed,188,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.02,Negative,7128,Positive,Adult,124,Pre-1st,25-Mar-21,covid,22-Sep-21,Pfizer,13-Oct-21,Pfizer,,,,,,,33,30-39,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,1,March,2021,,,,,Completed,250-999,N/A,21,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,1,Negative,Adult,,Post-1st,26-May-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,55,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,86,1,May,2021,42,,,,Completed,250-999,N/A,58,Delayed,155,Delayed,153,42,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.03,Negative,1207,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,455,2,July,2021,,42,,,Completed,1000-4999,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,36676,Positive,Adult,,Post-2nd (8+ Weeks),06-Nov-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,145,3,November,2021,,148,,,Completed,1000-4999,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.06,Negative,41828,Positive,Adult,,Post-3rd (1-8 Weeks),30-Nov-21,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,3846,4,November,2021,,,17,,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.11,Negative,550,Positive,Adult,,Post-3rd (8+ Weeks),28-Mar-22,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5438,5,March,2022,,,135,,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.11,Negative,3076,Positive,Adult,,Post-4th,03-May-22,baseline,14-Apr-21,Moderna,11-Jun-21,Moderna,13-Nov-21,Pfizer,15-Apr-22,Moderna ,,,56,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,11360,6,May,2022,,,,18,Completed,10000+,N/A,58,Delayed,155,Delayed,153,,,,18,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.02,Negative,490,Positive,Elderly,-400,Post-2nd (1-8 Weeks),15-Mar-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,64,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,1,1,March,2021,,16,,,Completed,0-49,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.02,Negative,20241,Positive,Elderly,-281,Post-2nd (8+ Weeks),12-Jul-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,1,2,July,2021,,135,,,Completed,0-49,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.01,Negative,128,Positive,Elderly,-155,Post-3rd (8+ Weeks),15-Nov-21,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,95,3,November,2021,,,74,,Completed,250-999,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.06,Negative,5756,Positive,Elderly,-89,Post-3rd (8+ Weeks),20-Jan-22,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,56,4,January,2022,,,140,,Completed,250-999,N/A,40,Scheduled,187,Delayed,144,,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.06,Negative,995,Positive,Elderly,-8,Post-4th,11-Apr-22,baseline,18-Jan-21,Pfizer,27-Feb-21,Pfizer,02-Sep-21,Pfizer,24-Jan-22,Moderna,,,65,60-69,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,178,5,April,2022,,,,77,Completed,1000-4999,N/A,40,Scheduled,187,Delayed,144,,,,77,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,5455,Positive,Elderly,,Post-2nd (1-8 Weeks),31-May-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,625,1,May,2021,,22,,,Completed,1000-4999,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2339,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,62,2,September,2021,,123,,,Completed,250-999,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.11,Negative,24158,Positive,Elderly,,Post-3rd (1-8 Weeks),20-Dec-21,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,66,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2034,3,December,2021,,,20,,Completed,10000+,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,3,Negative,Elderly,,Post-3rd (8+ Weeks),01-Apr-22,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,760,4,April,2022,,,122,,Completed,,N/A,23,Scheduled,205,Delayed,181,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,285,Positive,Elderly,,Post-4th,10-Jun-22,baseline,16-Apr-21,Pfizer,09-May-21,Pfizer,30-Nov-21,Pfizer,30-May-22,Pfizer,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1984,5,June,2022,,,,11,Completed,10000+,N/A,23,Scheduled,205,Delayed,181,,,,11,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.04,Negative,8781,Positive,Elderly,,Post-1st,10-May-21,baseline,16-Mar-21,Moderna,14-Jun-21,Moderna,17-Nov-21,Pfizer,20-Apr-22,Moderna ,,,67,60-69,1,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,1,1,May,2021,55,,,,Completed,0-49,N/A,90,Delayed,156,Delayed,154,55,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.06,Negative,15154,Positive,Elderly,,Post-3rd (1-8 Weeks),24-Nov-21,baseline,16-Mar-21,Moderna,14-Jun-21,Moderna,17-Nov-21,Pfizer,20-Apr-22,Moderna ,,,67,60-69,1,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,115,3,November,2021,,,7,,Completed,250-999,N/A,90,Delayed,156,Delayed,154,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.06,Negative,3246,Positive,Elderly,,Post-2nd (1-8 Weeks),08-Jun-21,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,71,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,414,2,June,2021,,22,,,Completed,1000-4999,N/A,55,Scheduled,118,Scheduled,185,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,2.38,Positive,789,Positive,Elderly,,Post-3rd (1-8 Weeks),25-Oct-21,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,427,3,October,2021,,,43,,Completed,1000-4999,N/A,55,Scheduled,118,Scheduled,185,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.11,Negative,12938,Positive,Elderly,,Post-3rd (8+ Weeks),08-Feb-22,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,73,4,February,2022,,,149,,Completed,250-999,N/A,55,Scheduled,118,Scheduled,185,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,7641,Positive,Elderly,,Post-4th,21-Apr-22,baseline,23-Mar-21,Pfizer,17-May-21,Pfizer,12-Sep-21,Pfizer,16-Mar-22,Pfizer,,,72,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,861,5,April,2022,,,,36,Completed,,N/A,55,Scheduled,118,Scheduled,185,,,,36,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,15739,Positive,Adult,,Post-1st,10-May-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,97,1,May,2021,28,,,,Completed,250-999,N/A,52,Scheduled,196,Delayed,,28,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,3,Negative,Adult,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,52,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,588,2,June,2021,,18,,,Completed,1000-4999,N/A,52,Scheduled,196,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,1626,Positive,Adult,,Post-2nd (8+ Weeks),01-Oct-21,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,60,3,October,2021,,120,,,Completed,250-999,N/A,52,Scheduled,196,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.13,Negative,26157,Positive,Adult,,Post-3rd (1-8 Weeks),07-Jan-22,baseline,12-Apr-21,Moderna,03-Jun-21,Moderna,16-Dec-21,Moderna,,,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2476,4,January,2022,,,22,,Completed,10000+,N/A,52,Scheduled,196,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.13,Negative,5778,Positive,Adult,,Post-1st,28-May-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,50,1,May,2021,54,,,,Completed,250-999,N/A,68,Delayed,128,Delayed,186,54,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.16,Negative,10429,Positive,Adult,,Post-2nd (1-8 Weeks),05-Jul-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1717,2,July,2021,,24,,,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.16,Negative,20932,Positive,Elderly,,Post-3rd (1-8 Weeks),24-Nov-21,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,64,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,1998,3,November,2021,,,38,,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.01,Negative,8212,Positive,Elderly,,Post-3rd (8+ Weeks),15-Mar-22,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,453,4,March,2022,,,149,,Completed,1000-4999,N/A,68,Delayed,128,Delayed,186,,,,,
ICARUS: University of Miami,,Female,UC,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.09,Negative,1990,Positive,Elderly,,Post-4th,09-May-22,baseline,04-Apr-21,Pfizer,11-Jun-21,Pfizer,17-Oct-21,Pfizer,21-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,6523,5,May,2022,,,,18,Completed,10000+,N/A,68,Delayed,128,Delayed,186,,,,18,
ICARUS: University of Miami,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.03,Negative,30929,Positive,Elderly,,Post-1st,19-Apr-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,96,1,April,2021,32,,,,Completed,250-999,N/A,35,Scheduled,166,Delayed,,32,,,,
ICARUS: University of Miami,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.03,Negative,40,Negative,Elderly,,Post-2nd (8+ Weeks),22-Jul-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,215,2,July,2021,,91,,,Completed,1000-4999,N/A,35,Scheduled,166,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.05,Negative,61,Positive,Elderly,,Post-3rd (1-8 Weeks),02-Nov-21,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,78,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,2734,3,November,2021,,,28,,Completed,10000+,N/A,35,Scheduled,166,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,,0.04,Negative,4895,Positive,Elderly,,Post-3rd (8+ Weeks),07-Apr-22,New biologic/Tofacitinib start,18-Mar-21,Pfizer,22-Apr-21,Pfizer,05-Oct-21,Pfizer,,,,,79,70+,1,0,1,0,0,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,681,4,April,2022,,,184,,Completed,1000-4999,N/A,35,Scheduled,166,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Ustekinumab Only,Ustekinumab Only,,,0.17,Negative,21918,Positive,Adult,-174,Post-2nd (8+ Weeks),17-Aug-21,Post Vaccine covid,11-Apr-21,Pfizer,08-May-21,Pfizer,,,,,,,56,50-59,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,300,1,August,2021,,101,,,Completed,1000-4999,N/A,27,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.06,Negative,976,Positive,Elderly,,Post-1st,09-Jun-21,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,1,June,2021,72,,,,Completed,50-249,N/A,80,Delayed,185,Delayed,,72,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.06,Negative,11144,Positive,Elderly,,Post-2nd (8+ Weeks),12-Nov-21,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,69,60-69,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,236,3,November,2021,,148,,,Completed,1000-4999,N/A,80,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.06,Negative,27802,Positive,Elderly,,Post-3rd (8+ Weeks),12-May-22,baseline,29-Mar-21,Pfizer,17-Jun-21,Pfizer,19-Dec-21,Pfizer,,,,,70,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,509,4,May,2022,,,144,,Completed,1000-4999,N/A,80,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.06,Negative,3465,Positive,Elderly,,Post-2nd (8+ Weeks),13-Aug-21,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,72,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,66,2,August,2021,,64,,,Completed,250-999,N/A,79,Delayed,118,Scheduled,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.11,Negative,16258,Positive,Elderly,,Post-3rd (1-8 Weeks),04-Nov-21,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,73,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,684,3,November,2021,,,29,,Completed,1000-4999,N/A,79,Delayed,118,Scheduled,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.11,Negative,2795,Positive,Elderly,,Post-3rd (8+ Weeks),23-Feb-22,baseline,23-Mar-21,Pfizer,10-Jun-21,Pfizer,06-Oct-21,Pfizer,,,,,73,70+,1,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,69,4,February,2022,,,140,,Completed,250-999,N/A,79,Delayed,118,Scheduled,,,,,,
ICARUS: University of Miami,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.09,Negative,947,Positive,Adult,,Post-1st,13-May-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,73,1,May,2021,36,,,,Completed,250-999,N/A,76,Delayed,153,Delayed,,36,,,,
ICARUS: University of Miami,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.45,Negative,760,Positive,Adult,,Post-2nd (1-8 Weeks),22-Jul-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1597,2,July,2021,,30,,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: University of Miami,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.45,Negative,63,Positive,Elderly,,Post-2nd (8+ Weeks),09-Nov-21,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,283,3,November,2021,,140,,,Completed,1000-4999,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: University of Miami,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.11,Negative,9978,Positive,Elderly,,Post-3rd (8+ Weeks),11-Feb-22,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,64,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7136,4,February,2022,,,81,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: University of Miami,,Male,IBD-U,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.11,Negative,2082,Positive,Elderly,,Post-3rd (8+ Weeks),14-Apr-22,baseline,07-Apr-21,Pfizer,22-Jun-21,Pfizer,22-Nov-21,Pfizer,,,,,65,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11360,5,April,2022,,,143,,Completed,10000+,N/A,76,Delayed,153,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,23285,Positive,Adult,,Post-1st,30-Apr-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,341,1,April,2021,29,,,,Completed,1000-4999,N/A,57,Delayed,132,Delayed,151,29,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,20,Negative,Adult,,Post-2nd (1-8 Weeks),25-Jun-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,5008,2,June,2021,,28,,,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.07,Negative,142,Positive,Adult,,Post-3rd (1-8 Weeks),15-Oct-21,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,3,October,2021,,,8,,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.02,Negative,356,Positive,Adult,,Post-4th,01-Apr-22,baseline,01-Apr-21,Pfizer,28-May-21,Pfizer,07-Oct-21,Pfizer,07-Mar-22,Pfizer,,,58,50-59,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,11360,4,April,2022,,,,25,Completed,10000+,N/A,57,Delayed,132,Delayed,151,,,,25,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,65420,Positive,Adult,,Post-1st,11-Jun-21,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,52,1,June,2021,47,,,,Completed,250-999,N/A,52,Scheduled,84,Scheduled,157,47,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,10100,Positive,Adult,,Post-2nd (1-8 Weeks),09-Jul-21,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,25,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1010,2,July,2021,,23,,,Completed,,N/A,52,Scheduled,84,Scheduled,157,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,607,Positive,Adult,,Post-3rd (8+ Weeks),18-Feb-22,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,26,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,280,3,February,2022,,,163,,Completed,1000-4999,N/A,52,Scheduled,84,Scheduled,157,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.07,Negative,3205,Positive,Adult,,Post-4th,23-Mar-22,baseline,25-Apr-21,Pfizer,16-Jun-21,Pfizer,08-Sep-21,Pfizer,12-Feb-22,Pfizer,,,26,18-29,1,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,2009,4,March,2022,,,,39,Completed,10000+,N/A,52,Scheduled,84,Scheduled,157,,,,39,
ICARUS: University of Miami,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.38,Negative,1023,Positive,Elderly,,Post-1st,21-Apr-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,1,April,2021,28,,,,Completed,50-249,N/A,79,Delayed,199,Delayed,,28,,,,
ICARUS: University of Miami,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.09,Negative,27081,Positive,Elderly,,Post-2nd (1-8 Weeks),07-Jul-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,499,2,July,2021,,26,,,Completed,1000-4999,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.28,Negative,38297,Positive,Elderly,,Post-2nd (8+ Weeks),17-Dec-21,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107,3,December,2021,,189,,,Completed,250-999,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.02,Negative,80000,Positive,Elderly,,Post-3rd (1-8 Weeks),21-Jan-22,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,66,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3200,4,January,2022,,,25,,Completed,10000+,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.15,Negative,4398,Positive,Elderly,,Post-3rd (8+ Weeks),09-May-22,baseline,24-Mar-21,Pfizer,11-Jun-21,Pfizer,27-Dec-21,Moderna,,,,,67,60-69,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,856,5,May,2022,,,133,,Completed,,N/A,79,Delayed,199,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.01,Negative,434,Positive,Adult,,Post-1st,21-May-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,59,50-59,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,98,1,May,2021,42,,,,Completed,250-999,N/A,63,Delayed,185,Delayed,,42,,,,
ICARUS: University of Miami,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.05,Negative,14324,Positive,Adult,,Post-2nd (1-8 Weeks),04-Aug-21,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,59,50-59,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1649,2,August,2021,,54,,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.05,Negative,5352,Positive,Adult,,Post-3rd (1-8 Weeks),27-Jan-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,3521,3,January,2022,,,45,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,Immunomodulator Only,,0.12,Negative,13972,Positive,Adult,,Post-3rd (8+ Weeks),08-Apr-22,baseline,09-Apr-21,Moderna,11-Jun-21,Moderna,13-Dec-21,Pfizer,,,,,60,60-69,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,1452,4,April,2022,,,116,,Completed,10000+,N/A,63,Delayed,185,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.02,Negative,7,Negative,Adult,,Pre-1st,23-Mar-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,25,1,March,2021,,,,,Completed,50-249,N/A,27,Scheduled,125,Delayed,153,,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.04,Negative,273,Positive,Adult,,Post-1st,05-May-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,11,2,May,2021,26,,,,Completed,50-249,N/A,27,Scheduled,125,Delayed,153,26,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.48,Negative,813,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jun-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,57,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,53,3,June,2021,,48,,,Completed,250-999,N/A,27,Scheduled,125,Delayed,153,,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.08,Negative,43,Negative,Adult,,Post-3rd (1-8 Weeks),30-Sep-21,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,2559,4,September,2021,,,22,,Completed,10000+,N/A,27,Scheduled,125,Delayed,153,,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.03,Negative,2917,Positive,Adult,,Post-4th,01-Mar-22,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,1067,5,March,2022,,,,21,Completed,,N/A,27,Scheduled,125,Delayed,153,,,,21,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Combination Therapy,Combination Therapy,0.01,Negative,3010,Positive,Adult,,Post-4th,03-Jun-22,baseline,09-Apr-21,Pfizer,06-May-21,Pfizer,08-Sep-21,Pfizer,08-Feb-22,Moderna,,,58,50-59,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,0,0,1,526,6,June,2022,,,,115,Completed,1000-4999,N/A,27,Scheduled,125,Delayed,153,,,,115,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.29,Negative,513,Positive,Adult,-44,Pre-1st,06-May-21,covid,26-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,1,May,2021,,,,,Completed,50-249,N/A,43,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.1,Negative,6064,Positive,Adult,0,Post-1st,19-Jun-21,covid,26-May-21,Pfizer,08-Jul-21,Pfizer,,,,,,,38,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,667,2,June,2021,24,,,,Completed,1000-4999,N/A,43,Scheduled,,Delayed,,24,,,,
ICARUS: University of Miami,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.1,Negative,680,Positive,Adult,,Post-1st,26-May-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,27,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,61,1,May,2021,33,,,,Completed,250-999,N/A,67,Delayed,191,Delayed,,33,,,,
ICARUS: University of Miami,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.03,Negative,4141,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jul-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,27,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,1047,2,July,2021,,22,,,Completed,,N/A,67,Delayed,191,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.14,Negative,426,Positive,Adult,,Post-2nd (8+ Weeks),21-Dec-21,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,247,3,December,2021,,175,,,Completed,1000-4999,N/A,67,Delayed,191,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Tofacitinib Only,Tofacitinib Only,Tofacitinib Only,Combination Therapy,,0.79,Positive,17436,Positive,Adult,,Post-3rd (1-8 Weeks),31-Jan-22,baseline,23-Apr-21,Pfizer,29-Jun-21,Pfizer,06-Jan-22,Pfizer,,,,,28,18-29,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,1439,4,January,2022,,,25,,Completed,10000+,N/A,67,Delayed,191,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,351,Positive,Elderly,,Post-2nd (1-8 Weeks),26-May-21,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,70,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,2584,1,May,2021,,12,,,Completed,10000+,N/A,59,Delayed,140,Delayed,199,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.08,Negative,12090,Positive,Elderly,,Post-2nd (8+ Weeks),15-Sep-21,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,71,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,287,2,September,2021,,124,,,Completed,1000-4999,N/A,59,Delayed,140,Delayed,199,,,,,
ICARUS: University of Miami,,Male,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,14068,Positive,Elderly,,Post-3rd (8+ Weeks),04-Mar-22,baseline,16-Mar-21,Pfizer,14-May-21,Pfizer,01-Oct-21,Pfizer,18-Apr-22,Pfizer,,,71,70+,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,525,3,March,2022,,,154,,Completed,1000-4999,N/A,59,Delayed,140,Delayed,199,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.05,Negative,3190,Positive,Adult,-396,Post-1st,15-Jun-21,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,40,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,129,1,June,2021,44,,,,Completed,250-999,N/A,78,Delayed,92,Scheduled,169,44,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.05,Negative,45938,Positive,Adult,-229,Post-3rd (1-8 Weeks),29-Nov-21,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,2869,2,November,2021,,,41,,Completed,10000+,N/A,78,Delayed,92,Scheduled,169,,,,,
ICARUS: University of Miami,,Female,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Combination Therapy,Combination Therapy,0.09,Negative,675,Positive,Adult,-117,Post-3rd (8+ Weeks),21-Mar-22,baseline,02-May-21,Pfizer,19-Jul-21,Pfizer,19-Oct-21,Pfizer,06-Apr-22,Pfizer,,,41,40-49,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,1,92,3,March,2022,,,153,,Completed,250-999,N/A,78,Delayed,92,Scheduled,169,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1511,Positive,Elderly,,Post-1st,26-Apr-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,1,April,2021,45,,,,Processed,,N/A,87,Delayed,183,Delayed,,45,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,19256,Positive,Elderly,,Post-2nd (1-8 Weeks),28-Jun-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,67,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2178,2,June,2021,,21,,,Completed,10000+,N/A,87,Delayed,183,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.03,Negative,4794,Positive,Elderly,,Post-3rd (1-8 Weeks),29-Dec-21,baseline,12-Mar-21,Pfizer,07-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,68,60-69,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5821,3,December,2021,,,22,,Completed,10000+,N/A,87,Delayed,183,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,25814,Positive,Elderly,,Post-1st,21-Jul-21,baseline,08-May-21,Moderna,01-Oct-21,Pfizer,07-Jul-22,Pfizer,,,,,64,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,112,1,July,2021,74,,,,Completed,250-999,N/A,146,Delayed,279,Delayed,,74,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Combination Therapy,Vedolizumab Only,,,0.04,Negative,1660,Positive,Adult,,Post-1st,31-May-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,,,,,,,26,18-29,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64,1,May,2021,22,,,,Completed,250-999,N/A,59,Delayed,,Delayed,,22,,,,
ICARUS: University of Miami,,Female,UC,Immunomodulator Only,Combination Therapy,Vedolizumab Only,,,0.07,Negative,3585,Positive,Adult,,Post-2nd (1-8 Weeks),19-Jul-21,baseline,09-May-21,Pfizer,07-Jul-21,Pfizer,,,,,,,26,18-29,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1985,2,July,2021,,12,,,Completed,10000+,N/A,59,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,465,Positive,Adult,,Post-1st,03-May-21,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,May,2021,33,,,,Completed,0-49,N/A,78,Delayed,183,Delayed,,33,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.01,Negative,4818,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jul-21,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,11,2,July,2021,,39,,,Completed,50-249,N/A,78,Delayed,183,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,489,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,31-Mar-21,Pfizer,17-Jun-21,Pfizer,17-Dec-21,Moderna,,,,,61,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,136,3,January,2022,,,20,,Completed,250-999,N/A,78,Delayed,183,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,511,Positive,Adult,-300,Post-2nd (1-8 Weeks),06-May-21,baseline,04-Apr-21,Pfizer,26-Apr-21,Pfizer,13-Nov-21,Pfizer,,,,,26,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3169,1,May,2021,,10,,,Completed,10000+,N/A,22,Scheduled,201,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,11244,Positive,Adult,-182,Post-2nd (8+ Weeks),01-Sep-21,baseline,04-Apr-21,Pfizer,26-Apr-21,Pfizer,13-Nov-21,Pfizer,,,,,27,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,615,2,September,2021,,128,,,Completed,1000-4999,N/A,22,Scheduled,201,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,1991,Positive,Adult,-119,Post-1st,27-May-21,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,6,1,May,2021,28,,,,Completed,0-49,N/A,46,Scheduled,215,Delayed,,28,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,50256,Positive,Adult,-79,Post-2nd (1-8 Weeks),06-Jul-21,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,327,2,July,2021,,22,,,Completed,1000-4999,N/A,46,Scheduled,215,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,80000,Positive,Adult,133,Post-3rd (1-8 Weeks),03-Feb-22,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,57,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,5142,3,February,2022,,,19,,Completed,10000+,N/A,46,Scheduled,215,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,2402,Positive,Adult,259,Post-3rd (8+ Weeks),09-Jun-22,Post Vaccine covid,29-Apr-21,Pfizer,14-Jun-21,Pfizer,15-Jan-22,Pfizer,,,,,58,50-59,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,786,4,June,2022,,,145,,Completed,,N/A,46,Scheduled,215,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.04,Negative,35266,Positive,Adult,,Post-2nd (1-8 Weeks),26-Jun-21,baseline,15-Apr-21,Pfizer,08-May-21,Pfizer,30-Sep-21,Pfizer,02-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,97,1,June,2021,,49,,,Completed,250-999,N/A,23,Scheduled,145,Delayed,153,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,No Immunosuppressives,0.08,Negative,80000,Positive,Adult,,Post-2nd (8+ Weeks),18-Sep-21,baseline,15-Apr-21,Pfizer,08-May-21,Pfizer,30-Sep-21,Pfizer,02-Mar-22,Pfizer,,,35,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,62,2,September,2021,,133,,,Completed,250-999,N/A,23,Scheduled,145,Delayed,153,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.03,Negative,80000,Positive,Adult,,Post-1st,10-Jun-21,baseline,13-May-21,Moderna,12-Jul-21,Moderna,,,,,,,25,18-29,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,June,2021,28,,,,Completed,0-49,N/A,60,Delayed,,Delayed,,28,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.05,Negative,367,Positive,Adult,,Post-2nd (1-8 Weeks),05-Aug-21,baseline,13-May-21,Moderna,12-Jul-21,Moderna,,,,,,,25,18-29,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54,2,August,2021,,24,,,Completed,250-999,N/A,60,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,7113,Positive,Elderly,-341,Post-2nd (8+ Weeks),26-Apr-21,baseline,15-Jan-21,Pfizer,12-Feb-21,Pfizer,27-Sep-21,Pfizer,10-May-22,Pfizer,,,83,70+,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,13,1,April,2021,,73,,,Completed,50-249,N/A,28,Scheduled,227,Delayed,225,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.05,Negative,1970,Positive,Elderly,,Post-2nd (1-8 Weeks),21-Apr-21,baseline,03-Mar-21,Pfizer,12-Apr-21,Pfizer,13-Oct-21,Pfizer,02-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,471,1,April,2021,,9,,,Completed,1000-4999,N/A,40,Scheduled,184,Delayed,201,,,,,
ICARUS: University of Miami,,Male,CD,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,0.14,Negative,14148,Positive,Elderly,,Post-2nd (8+ Weeks),07-Oct-21,baseline,03-Mar-21,Pfizer,12-Apr-21,Pfizer,13-Oct-21,Pfizer,02-May-22,Pfizer,,,80,70+,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,14,2,October,2021,,178,,,Completed,50-249,N/A,40,Scheduled,184,Delayed,201,,,,,
ICARUS: University of Miami,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.05,Negative,219,Positive,Adult,,Post-1st,11-May-21,baseline,08-Apr-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,52,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,1,May,2021,33,,,,Completed,50-249,N/A,61,Delayed,182,Delayed,,33,,,,
ICARUS: University of Miami,,Female,UC,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,0.14,Negative,3515,Positive,Adult,,Post-2nd (1-8 Weeks),16-Jul-21,baseline,08-Apr-21,Pfizer,08-Jun-21,Pfizer,07-Dec-21,Pfizer,,,,,52,50-59,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,351,2,July,2021,,38,,,Completed,1000-4999,N/A,61,Delayed,182,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,756,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jun-21,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,474,1,June,2021,,15,,,Completed,1000-4999,N/A,60,Delayed,88,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,22535,Positive,Adult,,Post-3rd (1-8 Weeks),04-Oct-21,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1287,2,October,2021,,,24,,Completed,,N/A,60,Delayed,88,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.06,Negative,6030,Positive,Adult,,Post-3rd (8+ Weeks),20-Jan-22,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,174,3,January,2022,,,132,,Completed,1000-4999,N/A,60,Delayed,88,Scheduled,154,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,692,Positive,Adult,,Post-4th,26-Apr-22,baseline,15-Apr-21,Pfizer,14-Jun-21,Pfizer,10-Sep-21,Pfizer,11-Feb-22,Pfizer,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,983,4,April,2022,,,,74,Completed,,N/A,60,Delayed,88,Scheduled,154,,,,74,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,11614,Positive,Adult,,Post-1st,21-May-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,1,May,2021,66,,,,Completed,50-249,N/A,95,Delayed,201,Delayed,,66,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.04,Negative,24799,Positive,Adult,,Post-2nd (1-8 Weeks),27-Jul-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,62,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,310,2,July,2021,,38,,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,10229,Positive,Adult,,Post-2nd (8+ Weeks),16-Nov-21,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,191,3,November,2021,,150,,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,180,Positive,Adult,,Post-3rd (8+ Weeks),18-Mar-22,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1114,4,March,2022,,,71,,Completed,,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,77,Positive,Adult,,Post-3rd (8+ Weeks),17-May-22,baseline,16-Mar-21,AstraZeneca,19-Jun-21,AstraZeneca,06-Jan-22,Moderna,,,,,63,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,357,5,May,2022,,,131,,Completed,1000-4999,N/A,95,Delayed,201,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,No Immunosuppressives,No Immunosuppressives,No Immunosuppressives,,,0.03,Negative,376,Positive,Adult,,Post-2nd (8+ Weeks),20-Apr-22,baseline,05-May-21,Pfizer,06-Jul-21,Pfizer,,,,,,,40,40-49,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9503,1,April,2022,,288,,,Completed,10000+,N/A,62,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.08,Negative,18020,Positive,Adult,,Post-1st,10-May-21,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,33,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,May,2021,26,,,,Completed,0-49,N/A,28,Scheduled,113,Scheduled,158,26,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.04,Negative,3702,Positive,Adult,,Post-3rd (1-8 Weeks),29-Sep-21,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,482,3,September,2021,,,27,,Completed,1000-4999,N/A,28,Scheduled,113,Scheduled,158,,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.08,Negative,427,Positive,Adult,,Post-3rd (8+ Weeks),05-Jan-22,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,74,4,January,2022,,,125,,Completed,250-999,N/A,28,Scheduled,113,Scheduled,158,,,,,
ICARUS: University of Miami,,Male,CD,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,Corticosteroids,0.02,Negative,7375,Positive,Adult,,Post-4th,24-May-22,baseline,14-Apr-21,Moderna,12-May-21,Moderna,02-Sep-21,Moderna,07-Feb-22,Moderna,,,34,30-39,1,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,128,5,May,2022,,,,106,Completed,250-999,N/A,28,Scheduled,113,Scheduled,158,,,,106,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.1,Negative,1739,Positive,Adult,-292,Post-1st,19-May-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,64,1,May,2021,36,,,,Completed,250-999,N/A,43,Scheduled,175,Delayed,202,36,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.02,Negative,10135,Positive,Adult,-229,Post-2nd (8+ Weeks),21-Jul-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,2,July,2021,,56,,,Processed,,N/A,43,Scheduled,175,Delayed,202,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,18195,Positive,Adult,-138,Post-2nd (8+ Weeks),20-Oct-21,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,58,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,274,3,October,2021,,147,,,Completed,1000-4999,N/A,43,Scheduled,175,Delayed,202,,,,,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,0.05,Negative,2020,Positive,Adult,-26,Post-3rd (8+ Weeks),09-Feb-22,Post Vaccine covid,13-Apr-21,Pfizer,26-May-21,Pfizer,17-Nov-21,Pfizer,07-Jun-22,Pfizer,,,59,50-59,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,2277,4,February,2022,,,84,,Completed,10000+,N/A,43,Scheduled,175,Delayed,202,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.04,Negative,,,Adult,-179,Post-2nd (1-8 Weeks),14-Jul-21,Post Vaccine covid,21-Apr-21,Pfizer,19-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,36,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,446,2,July,2021,,25,,,Completed,1000-4999,N/A,59,Delayed,130,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,15339,Positive,Adult,-337,Post-1st,17-May-21,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,41,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,1,May,2021,19,,,,Completed,50-249,N/A,45,Scheduled,198,Delayed,,19,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.17,Negative,40996,Positive,Adult,-252,Post-2nd (8+ Weeks),10-Aug-21,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,556,2,August,2021,,59,,,Completed,1000-4999,N/A,45,Scheduled,198,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,7587,Positive,Adult,-85,Post-3rd (1-8 Weeks),24-Jan-22,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,3,January,2022,,,28,,Completed,10000+,N/A,45,Scheduled,198,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.06,Negative,791,Positive,Adult,52,Post-3rd (8+ Weeks),10-Jun-22,baseline,28-Apr-21,Pfizer,12-Jun-21,Pfizer,27-Dec-21,Pfizer,,,,,42,40-49,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1824,4,June,2022,,,165,,Completed,10000+,N/A,45,Scheduled,198,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.06,Negative,449,Positive,Adult,,Post-2nd (1-8 Weeks),21-Jun-21,baseline,19-Apr-21,Pfizer,14-Jun-21,Pfizer,02-Jan-22,Pfizer,,,,,22,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4381,1,June,2021,,7,,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.1,Negative,13978,Positive,Adult,,Post-3rd (1-8 Weeks),08-Feb-22,baseline,19-Apr-21,Pfizer,14-Jun-21,Pfizer,02-Jan-22,Pfizer,,,,,22,18-29,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,2,February,2022,,,37,,Completed,10000+,N/A,56,Scheduled,202,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.07,Negative,3192,Positive,Adult,,Post-2nd (1-8 Weeks),18-May-21,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,60,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,593,1,May,2021,,8,,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.01,Negative,0,Negative,Adult,,Post-2nd (8+ Weeks),15-Sep-21,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,60,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,302,2,September,2021,,128,,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,74,Positive,Adult,,Post-3rd (8+ Weeks),15-Jun-22,baseline,18-Apr-21,Pfizer,10-May-21,Pfizer,11-Jan-22,Pfizer,,,,,61,60-69,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,455,3,June,2022,,,155,,Completed,1000-4999,N/A,22,Scheduled,246,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,,0.04,Negative,956,Positive,Adult,,Post-2nd (1-8 Weeks),20-May-21,baseline,06-Apr-21,Pfizer,08-May-21,Pfizer,07-Jan-22,Pfizer,,,,,35,30-39,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2726,1,May,2021,,12,,,Completed,10000+,N/A,32,Scheduled,244,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.04,Negative,439,Positive,Adult,0,Post-1st,12-May-21,baseline,02-Apr-21,Pfizer,03-Jun-21,Pfizer,,,,,,,30,30-39,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,139,1,May,2021,40,,,,Completed,250-999,N/A,62,Delayed,,Delayed,,40,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,,,0.02,Negative,12,Negative,Adult,85,Post-2nd (8+ Weeks),05-Aug-21,baseline,02-Apr-21,Pfizer,03-Jun-21,Pfizer,,,,,,,30,30-39,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,866,2,August,2021,,63,,,Completed,,N/A,62,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.02,Negative,379,Positive,Adult,,Post-1st,11-Jun-21,baseline,22-Apr-21,Pfizer,18-Jun-21,Pfizer,22-Oct-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,95,1,June,2021,50,,,,Completed,250-999,N/A,57,Delayed,126,Delayed,,50,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.07,Negative,3316,Positive,Adult,,Post-2nd (8+ Weeks),14-Sep-21,baseline,22-Apr-21,Pfizer,18-Jun-21,Pfizer,22-Oct-21,Pfizer,,,,,46,40-49,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,424,2,September,2021,,88,,,Completed,1000-4999,N/A,57,Delayed,126,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,65,Positive,Adult,,Post-2nd (1-8 Weeks),18-May-21,baseline,23-Mar-21,Pfizer,04-May-21,Pfizer,,,,,,,34,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7634,1,May,2021,,14,,,Completed,10000+,N/A,42,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.04,Negative,2472,Positive,Adult,,Post-2nd (8+ Weeks),21-Sep-21,baseline,23-Mar-21,Pfizer,04-May-21,Pfizer,,,,,,,35,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,310,2,September,2021,,140,,,Completed,1000-4999,N/A,42,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,3335,Positive,Adult,,Post-2nd (1-8 Weeks),23-Jul-21,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,339,1,July,2021,,23,,,Completed,1000-4999,N/A,79,Delayed,217,Delayed,0,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,9061,Positive,Adult,,Post-2nd (8+ Weeks),29-Oct-21,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,53,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,11,2,October,2021,,121,,,Completed,50-249,N/A,79,Delayed,217,Delayed,0,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.03,Negative,1227,Positive,Adult,,Post-4th,24-Feb-22,baseline,12-Apr-21,Pfizer,30-Jun-21,Pfizer,02-Feb-22,Pfizer,02-Feb-22,Pfizer,,,54,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,758,3,February,2022,,,,22,Completed,,N/A,79,Delayed,217,Delayed,0,,,,22,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.25,Negative,183,Positive,Adult,,Post-2nd (1-8 Weeks),28-May-21,baseline,06-Apr-21,Moderna,10-May-21,Moderna,02-Sep-21,Moderna,04-Feb-22,Moderna,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2456,1,May,2021,,18,,,Completed,10000+,N/A,34,Scheduled,115,Scheduled,155,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,2181,Positive,Adult,,Post-3rd (1-8 Weeks),08-Oct-21,baseline,06-Apr-21,Moderna,10-May-21,Moderna,02-Sep-21,Moderna,04-Feb-22,Moderna,,,57,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3957,2,October,2021,,,36,,Completed,10000+,N/A,34,Scheduled,115,Scheduled,155,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,1345,Positive,Adult,-269,Post-1st,07-May-21,Post Vaccine covid,04-Apr-21,Pfizer,29-May-21,Pfizer,27-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,1,May,2021,33,,,,Completed,50-249,N/A,55,Scheduled,121,Delayed,,33,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.02,Negative,7845,Positive,Adult,-223,Post-2nd (1-8 Weeks),22-Jun-21,Post Vaccine covid,04-Apr-21,Pfizer,29-May-21,Pfizer,27-Sep-21,Pfizer,,,,,24,18-29,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,143,2,June,2021,,24,,,Completed,1000-4999,N/A,55,Scheduled,121,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,,,,,0.07,Negative,2514,Positive,Adult,,,19-May-21,baseline,,,,,,,,,,,36,30-39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,May,2021,,,,,Completed,0-49,N/A,,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,3,Negative,Adult,,Post-1st,20-May-21,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,111,1,May,2021,38,,,,Completed,250-999,N/A,62,Delayed,184,Delayed,,38,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,3289,Positive,Adult,,Post-2nd (1-8 Weeks),29-Jul-21,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,60,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,469,2,July,2021,,46,,,Completed,1000-4999,N/A,62,Delayed,184,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.01,Negative,3392,Positive,Adult,,Post-3rd (1-8 Weeks),06-Jan-22,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11360,3,January,2022,,,23,,Completed,10000+,N/A,62,Delayed,184,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,0.03,Negative,520,Positive,Adult,,Post-3rd (8+ Weeks),13-Apr-22,baseline,12-Apr-21,Pfizer,13-Jun-21,Pfizer,14-Dec-21,Pfizer,,,,,61,60-69,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3579,4,April,2022,,,120,,Completed,10000+,N/A,62,Delayed,184,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,903,Positive,Adult,31,Pre-1st,19-Apr-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,20,1,April,2021,,,,,Completed,50-249,31 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.01,Negative,30850,Positive,Adult,60,Post-1st,18-May-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1017,2,May,2021,20,,,,Completed,,60 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,20,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,80000,Positive,Adult,157,Post-2nd (8+ Weeks),23-Aug-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,272,3,August,2021,,96,,,Completed,1000-4999,157 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.02,Negative,4176,Positive,Adult,236,Post-2nd (8+ Weeks),10-Nov-21,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,32,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,73,4,November,2021,,175,,,Completed,250-999,236 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,0.04,Negative,2128,Positive,Adult,328,Post-3rd (8+ Weeks),10-Feb-22,covid,28-Apr-21,Pfizer,19-May-21,Pfizer,07-Dec-21,Pfizer,30-May-22,Moderna,,,33,30-39,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,480,5,February,2022,,,65,,Completed,1000-4999,328 Days Before Collection Days After Collection,21,Scheduled,202,Delayed,174,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,19199,Positive,Adult,,Post-2nd (1-8 Weeks),20-Jul-21,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,664,2,July,2021,,37,,,Completed,1000-4999,N/A,58,Delayed,136,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.05,Negative,3650,Positive,Adult,,Post-3rd (1-8 Weeks),26-Nov-21,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2125,3,November,2021,,,30,,Completed,10000+,N/A,58,Delayed,136,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.15,Negative,666,Positive,Adult,,Post-3rd (8+ Weeks),15-Feb-22,baseline,16-Apr-21,Pfizer,13-Jun-21,Pfizer,27-Oct-21,Pfizer,,,,,59,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,234,4,February,2022,,,111,,Completed,1000-4999,N/A,58,Delayed,136,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.05,Negative,2985,Positive,Adult,55,Pre-1st,30-Mar-21,covid,09-Apr-21,Pfizer,04-May-21,Pfizer,22-Dec-21,Pfizer,,,,,29,18-29,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,13,1,March,2021,,,,,Completed,50-249,N/A,25,Scheduled,232,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.66,Negative,7684,Positive,Elderly,,Post-1st,21-Apr-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,28,1,April,2021,35,,,,Completed,50-249,N/A,71,Delayed,99,Scheduled,152,35,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.33,Negative,53759,Positive,Elderly,,Post-1st,26-May-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,23,2,May,2021,70,,,,Completed,50-249,N/A,71,Delayed,99,Scheduled,152,70,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.09,Negative,2184,Positive,Elderly,,Post-2nd (8+ Weeks),23-Jul-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,252,3,July,2021,,57,,,Completed,1000-4999,N/A,71,Delayed,99,Scheduled,152,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.02,Negative,2387,Positive,Elderly,,Post-3rd (1-8 Weeks),23-Sep-21,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,66,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1571,4,September,2021,,,20,,Completed,10000+,N/A,71,Delayed,99,Scheduled,152,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.05,Negative,74,Positive,Elderly,,Post-3rd (8+ Weeks),07-Jan-22,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,338,5,January,2022,,,126,,Completed,1000-4999,N/A,71,Delayed,99,Scheduled,152,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,0.43,Negative,5340,Positive,Elderly,,Post-4th,24-Feb-22,baseline,17-Mar-21,Moderna,27-May-21,Moderna,03-Sep-21,Moderna,02-Feb-22,Moderna,,,67,60-69,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,3367,6,February,2022,,,,22,Completed,10000+,N/A,71,Delayed,99,Scheduled,152,,,,22,
ICARUS: University of Miami,,Female,CD,Ustekinumab Only,Ustekinumab Only,Ustekinumab Only,,,0.02,Negative,0,Negative,Adult,75,Post-2nd (8+ Weeks),28-Mar-22,Post Vaccine covid,27-Apr-21,Pfizer,23-Jun-21,Pfizer,,,,,,,34,30-39,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6928,3,March,2022,,278,,,Completed,10000+,N/A,57,Delayed,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.01,Negative,3,Negative,Elderly,-237,Post-2nd (1-8 Weeks),27-Aug-21,baseline,10-Jun-21,Pfizer,07-Jul-21,Pfizer,29-Jan-22,Pfizer,,,,,67,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,622,1,August,2021,,51,,,Completed,1000-4999,N/A,27,Scheduled,206,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,0.21,Negative,780,Positive,Elderly,40,Post-3rd (8+ Weeks),31-May-22,baseline,10-Jun-21,Pfizer,07-Jul-21,Pfizer,29-Jan-22,Pfizer,,,,,68,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8796,2,May,2022,,,122,,Completed,10000+,N/A,27,Scheduled,206,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.04,Negative,3302,Positive,Elderly,,Post-2nd (1-8 Weeks),21-May-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,770,1,May,2021,,23,,,Completed,,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.04,Negative,80000,Positive,Elderly,,Post-2nd (8+ Weeks),09-Sep-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,30,2,September,2021,,134,,,Completed,50-249,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.05,Negative,25204,Positive,Elderly,,Post-3rd (8+ Weeks),04-Nov-21,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,172,3,November,2021,,,59,,Completed,1000-4999,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.05,Negative,33,Negative,Elderly,,Post-3rd (8+ Weeks),28-Jan-22,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,70,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,17,4,January,2022,,,144,,Completed,50-249,N/A,25,Scheduled,131,Delayed,193,,,,,
ICARUS: University of Miami,,Male,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Corticosteroids,No Immunosuppressives,0.03,Negative,4678,Positive,Elderly,,Post-4th,28-Apr-22,baseline,03-Apr-21,Pfizer,28-Apr-21,Pfizer,06-Sep-21,Pfizer,18-Mar-22,Pfizer,,,71,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,981,5,April,2022,,,,41,Completed,,N/A,25,Scheduled,131,Delayed,193,,,,41,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.04,Negative,14962,Positive,Adult,101,Post-1st,25-Jun-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,309,1,June,2021,53,,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,53,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.27,Negative,1651,Positive,Adult,155,Post-2nd (1-8 Weeks),18-Aug-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,785,2,August,2021,,48,,,Completed,,N/A,59,Delayed,343,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.43,Negative,197,Positive,Adult,211,Post-2nd (8+ Weeks),13-Oct-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,407,3,October,2021,,104,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,,,,,
ICARUS: University of Miami,,Male,CD,Combination Therapy,Combination Therapy,Combination Therapy,Combination Therapy,,0.02,Negative,165,Positive,Adult,272,Post-2nd (8+ Weeks),13-Dec-21,covid,03-May-21,Pfizer,01-Jul-21,Pfizer,09-Jun-22,Pfizer,,,,,37,30-39,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,310,4,December,2021,,165,,,Completed,1000-4999,N/A,59,Delayed,343,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.02,Negative,1775,Positive,Adult,110,Post-1st,17-May-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3190,1,May,2021,35,,,,Completed,10000+,0,62,Delayed,115,Scheduled,289,35,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.14,Negative,11062,Positive,Adult,161,Post-2nd (1-8 Weeks),07-Jul-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1501,2,July,2021,,24,,,Completed,10000+,161 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.14,Negative,2380,Positive,Adult,273,Post-3rd (1-8 Weeks),27-Oct-21,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,55,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1917,3,October,2021,,,21,,Completed,10000+,273 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,No Immunosuppressives,0.08,Negative,23708,Positive,Adult,385,Post-3rd (8+ Weeks),16-Feb-22,covid,12-Apr-21,Pfizer,13-Jun-21,Pfizer,06-Oct-21,Pfizer,22-Jul-22,Moderna,,,56,50-59,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1073,4,February,2022,,,133,,Completed,,385 Days Before Collection Days Before Collection,62,Delayed,115,Scheduled,289,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.03,Negative,2905,Positive,Adult,,Post-1st,18-May-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,63,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,117,1,May,2021,36,,,,Completed,250-999,N/A,44,Scheduled,,Delayed,,36,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,0.06,Negative,5423,Positive,Adult,,Post-2nd (8+ Weeks),27-Jul-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,404,2,July,2021,,62,,,Completed,1000-4999,N/A,44,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,CD,Anti-TNF Only,Anti-TNF Only,Anti-TNF Only,,,1.76,Positive,214,Positive,Adult,,Post-2nd (8+ Weeks),06-Oct-21,baseline,12-Apr-21,Pfizer,26-May-21,Pfizer,,,,,,,64,60-69,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,183,3,October,2021,,133,,,Completed,1000-4999,N/A,44,Scheduled,,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.32,Negative,1210,Positive,Adult,-316,Post-2nd (8+ Weeks),05-Apr-21,Post Vaccine covid,30-Dec-20,Pfizer,20-Jan-21,Pfizer,10-Sep-21,Pfizer,,,,,52,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,651,1,April,2021,,75,,,Completed,1000-4999,N/A,21,Scheduled,233,Delayed,,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Anti-TNF Only,,0.32,Negative,120,Positive,Adult,29,Post-3rd (8+ Weeks),16-Mar-22,Post Vaccine covid,30-Dec-20,Pfizer,20-Jan-21,Pfizer,10-Sep-21,Pfizer,,,,,53,50-59,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11360,2,March,2022,,,187,,Completed,10000+,N/A,21,Scheduled,233,Delayed,,,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.58,Negative,6908,Positive,Elderly,-257,Post-1st,09-May-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,6,1,May,2021,39,,,,Completed,0-49,N/A,74,Delayed,94,Scheduled,221,39,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.02,Negative,821,Positive,Elderly,-155,Post-2nd (8+ Weeks),19-Aug-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,199,2,August,2021,,67,,,Completed,1000-4999,N/A,74,Delayed,94,Scheduled,221,,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,0.04,Negative,2844,Positive,Elderly,-76,Post-3rd (1-8 Weeks),06-Nov-21,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,65,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,543,3,November,2021,,,52,,Completed,1000-4999,N/A,74,Delayed,94,Scheduled,221,,,,,
ICARUS: University of Miami,,Male,UC,Corticosteroids,Corticosteroids,Ustekinumab Only,Ustekinumab Only,Corticosteroids,1.54,Positive,1286,Positive,Elderly,36,Post-3rd (8+ Weeks),26-Feb-22,Post Vaccine covid,31-Mar-21,Pfizer,13-Jun-21,Pfizer,15-Sep-21,Pfizer,24-Apr-22,Pfizer,,,66,60-69,0,0,0,1,0,1,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,1247,4,February,2022,,,164,,Completed,,N/A,74,Delayed,94,Scheduled,221,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,0.02,Negative,1165,Positive,Elderly,,Post-2nd (8+ Weeks),20-Aug-21,baseline,05-Mar-21,Pfizer,16-Apr-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,81,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,165,1,August,2021,,126,,,Completed,1000-4999,N/A,42,Scheduled,160,Delayed,201,,,,,
ICARUS: University of Miami,,Female,UC,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,Vedolizumab Only,No Immunosuppressives,0.02,Negative,611,Positive,Elderly,,Post-3rd (8+ Weeks),04-Feb-22,baseline,05-Mar-21,Pfizer,16-Apr-21,Pfizer,23-Sep-21,Pfizer,12-Apr-22,Pfizer,,,82,70+,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,87,2,February,2022,,,134,,Completed,250-999,N/A,42,Scheduled,160,Delayed,201,,,,,